isoniazid has been researched along with rifampin in 5095 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1307 (25.65) | 18.7374 |
| 1990's | 712 (13.97) | 18.2507 |
| 2000's | 965 (18.94) | 29.6817 |
| 2010's | 1645 (32.29) | 24.3611 |
| 2020's | 466 (9.15) | 2.80 |
| Authors | Studies |
|---|---|
| Kitaura, K; Mineura, K; Murayama, Y; Nakamizo, A; Nakamizo, Y; Niino, H; Okachi, R; Ono, T | 1 |
| Johansson, CB; Topcu, G; Ulubelen, A | 1 |
| Biava, M; Deidda, D; Fioravanti, R; Maullu, C; Pompei, R; Porretta, GC | 1 |
| Bottari, B; Maccari, R; Monforte, F; Ottanà, R; Rotondo, E; Vigorita, MG | 2 |
| Banfi, E; Bosi, S; Castellano, S; Da Ros, T; Prato, M | 1 |
| Bansal, NP; Dick, JD; Houston, TA; Jones, PB; Parrish, NM; Stapon, A; Townsend, CA | 1 |
| Gerena, L; Milhous, WK; Opsenica, D; Pocsfalvi, G; Solaja, BA; Terzić, N; Tinant, B | 1 |
| Abe, T; Daigo, M; Fukuoka, T; Furukawa, M; Harasaki, T; Hotoda, H; Inukai, M; Ishii, MM; Kakuta, M; Kaneko, M; Miyakoshi, S; Muramatsu, Y; Murayama, K; Ohya, S; Takatsu, T; Utsui, Y | 1 |
| Abe, T; Daigo, M; Fukuoka, T; Furukawa, M; Hasegawa, CA; Hotoda, H; Inukai, M; Ishii, MM; Kakuta, M; Kaneko, M; Miyakoshi, S; Muramatsu, Y; Murayama, K; Ohya, S; Takatsu, T; Utsui, Y | 1 |
| Andreevskaya, SN; Brennan, PJ; Gusev, DV; Lisichkina, IN; Marshakov, VY; Medvedev, AE; Peregudov, AS; Smirnova, TG; Tchernousova, LN; Velezheva, VS | 1 |
| Sriram, D; Thirumurugan, R; Yogeeswari, P | 1 |
| Bottari, B; Maccari, R; Ottanà, R; Rotondo, E; Vigorita, MG | 1 |
| Andries, K; Cambau, E; de Chaffoy, D; Göhlmann, HW; Guillemont, J; Hoffner, S; Huitric, E; Jarlier, V; Lee, E; Lounis, N; Neefs, JM; Timmerman, P; Truffot-Pernot, C; Van Gestel, J; Verhasselt, P; Williams, P; Winkler, H; Zhu, M | 1 |
| Arora, SK; Jain, S; Jana, GH; Kishore, N; Sinha, N; Tilekar, A; Upadhayaya, RS | 1 |
| Christiansen, HC; Copp, BR; G Franzblau, S; Lindsay, BS | 1 |
| Panda, G; Sinha, S; Srivastava, AK | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Aponte, JC; Caviedes, L; Gilman, RH; Hammond, GB; Lamas, G; Lewis, WH; Rojas, R; Sarasara, C; Vaisberg, AJ | 1 |
| Pavana, RK; Sriram, D; Thirumurugan, R; Yogeeswari, P | 1 |
| Agarwal, KC; Chaturvedi, V; Gaikwad, A; Manju, YK; Pandey, J; Sinha, S; Srivastva, AK; Tripathi, RP; Verma, SS | 1 |
| Biava, M; Botta, M; Deidda, D; Manetti, F; Molicotti, P; Poce, G; Pompei, R; Porretta, GC; Supino, S | 1 |
| Beifuss, U; Conrad, J; Klaiber, I; Leutbecher, H; Mika, S; Möller, W; Mongkolvisut, W; Rösner, H; Sutthivaiyakit, S | 1 |
| Hashizume, H; Kawasaki, M; Komatsu, M; Matsumoto, M; Sasaki, H; Shimokawa, Y; Tomishige, T; Tsubouchi, H | 1 |
| Andries, K; Chauffour, A; Ibrahim, M; Jarlier, V; Lounis, N; Truffot-Pernot, C; Veziris, N | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Ballell, L; Chung, GA; Field, RA; Young, RJ | 1 |
| Banerjee, D; Dhakla, P; Senthilkumar, P; Sriram, D; Yogeeswari, P | 1 |
| Abe, C; Chiba, T; Morikawa, H; Nishimura, K; Onozaki, K; Takii, T; Yamamoto, Y | 1 |
| Baldeviano, C; Glover, W; Siddiqi, S; Takhar, P; Zhang, Y | 1 |
| Duarte-Fajardo, ZV; Estrada-Soto, S; González-Salazar, F; Hernández-Núñez, E; Molina-Salinas, GM; Navarrete-Vázquez, G; Said-Fernández, S; Vargas-Villarreal, J | 1 |
| Agrawal, B; Desroches, N; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Tse, C | 1 |
| Biswas, K; Crick, DC; Dhiman, R; Kurosu, M; Narayanasamy, P | 1 |
| Ahmed, SK; Kamal, A; Khan, IA; Khan, MN; Kumar, M; Murthy, US; Ram, AB; Reddy, KS; Sharma, S; Shetty, RV; Siddhardha, B | 1 |
| Chaturvedi, V; Das, SK; Gaikwad, AK; Manju, YS; Panda, G; Sinha, S | 1 |
| Alves, LL; Araújo, DP; de Almeida, MV; de Souza, MA; Ferreira, AP; Hyaric, ML; Lourenço, MC; Reis, EF; Taveira, AF; Vicente, FR | 1 |
| Byrne, ST; Chong, C; Denkin, SM; Gu, P; Liu, JO; Sullivan, D; Zhang, Y; Zhou, J | 1 |
| de Souza, MV; Ferreira, Mde L; Henriques, Md; Lourenço, MC; Peralta, MA; Vasconcelos, TR | 1 |
| Borges Gonçalves, RS; de Lima Ferreira, M; de Oliveira Henriques, Md; Nogueira, TC; Nora de Souza, MV; Peixoto Candéa, AL; Rodrigues Vicente, F; Silva Lourenço, MC | 1 |
| Chaturvedi, V; Manju, YK; Panda, G; Parai, MK; Sinha, S | 1 |
| Akhalaia, M; Gegia, M; Han, J; Khechinashvili, G; Li, H; Mdivani, N; Mendes, RE; Tang, YW | 1 |
| Bitting, C; Gruppo, V; Johnson, CM; Lenaerts, AJ; Marietta, KS; Orme, IM; Woolhiser, L | 1 |
| Alland, D; Hazbón, MH; Safi, H; Sayers, B | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Biava, M; Botta, M; De Logu, A; De Rossi, E; Manetti, F; Meleddu, R; Poce, G; Porretta, GC; Saddi, M | 1 |
| Allen, J; De Beule, K; De Marez, T; Diacon, AH; Donald, PR; Kerstens, R; Koul, A; McNeeley, DF; Mthiyane, TC; Patientia, RF; Reddy, C; Rustomjee, R; van Heeswijk, R; Venter, A | 1 |
| Bhat, AR; Bryant, B; Dayan, FE; Kini, SG; Williamson, JS | 1 |
| Basaraba, RJ; Brooks, EJ; Caraway, ML; Driver, ER; Hoff, DR; Lenaerts, AJ; Orme, IM; Peloquin, CA; Ryan, GJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Amirthaganesan, S; Aridoss, G; Jeong, YT; Kabilan, S; Kim, JT; Kumar, NA; Lim, KT | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Fabian, WM; Faist, J; Kungl, AJ; Rajkovic, E; Schunack, W; Schweiger, K; Seebacher, W; Weis, R | 1 |
| Banerjee, D; Dhakla, P; Manjashetty, TH; Senthilkumar, P; Sriram, D; Yogeeswari, P | 1 |
| Alborzi, A; Edraki, N; Javidnia, K; Khoshneviszadeh, M; Mardaneh, J; Miri, R; Pourabbas, B | 1 |
| Franzblau, SG; Kozikowski, AP; Lilienkampf, A; Mao, J; Wan, B; Wang, Y | 1 |
| Dettrakul, S; Kittakoop, P; Rajviroongit, S; Surerum, S | 1 |
| Alborzi, A; Azadpour, Z; Delbari, N; Fassihi, A; Mardaneh, J; Memarian, HR; Miri, R; Moeinifard, B; Mousavi, P; Pourabbas, B; Sabet, R; Sadeghi-Aliabadi, H; Saghaie, L | 1 |
| Karthikeyan, SV; Perumal, S; Shetty, KA; Sriram, D; Yogeeswari, P | 1 |
| Banfi, E; Fermeglia, M; Laurini, E; Mamolo, MG; Posocco, P; Pricl, S; Scialino, G; Vio, L; Zampieri, D | 1 |
| Amirthaganesan, S; Aridoss, G; Jeong, YT; Kim, JT; Kim, MS | 1 |
| Coy, ED; Cuca, LE; Sefkow, M | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Altarelli, M; Butini, S; Camodeca, C; Campiani, G; Chiasserini, L; Clarizio, S; Coccone, SS; Delogu, G; Gemma, S; Kumar, V; Novellino, E; Savini, L; Tripaldi, P | 1 |
| Govender, K; Govender, P; Govender, T; Kruger, HG; Maguire, GE; Muthusamy, K; Onajole, OK; Pillay, M; van Helden, PD; Wiid, I | 1 |
| Rieder, RJ; Zavizion, B; Zhao, Z | 1 |
| Franzblau, SG; Kozikowski, AP; Lilienkampf, A; Pieroni, M; Wan, B; Wang, Y | 2 |
| Banerjee, D; Indumathi, S; Perumal, S; Sriram, D; Yogeeswari, P | 1 |
| Franzblau, SG; Guo, S; Kozikowski, AP; Mesecar, AD; Mo, S; Orjala, J; Pegan, SD; Tipparaju, SK; Wan, B | 1 |
| Brun, R; Franzblau, SG; Huang, Q; Kozikowski, AP; Mao, J; Wan, B; Wang, Y | 1 |
| Alland, D; Fleischmann, RD; Jarrahi, B; Jones, MB; Peterson, SN; Safi, H | 1 |
| Abe, C; Chiba, T; Horita, Y; Inagaki, E; Kuroishi, R; Kurono, Y; Maeda, Y; Mori, M; Nishimura, K; Onozaki, K; Takii, T; Yamamoto, Y | 1 |
| Kumar, RS; Perumal, S; Shetty, KA; Sriram, D; Yogeeswari, P | 1 |
| Bala, BD; Karthikeyan, SV; Perumal, S; Raja, VP; Sriram, D; Yogeeswari, P | 1 |
| Banerjee, D; Bhat, P; Dinakaran, M; Gadhwal, S; Sriram, D; Yogeeswari, P | 1 |
| DeRiemer, K; Gao, Q; Gui, X; Li, X; Luo, T; Mei, J; Pickerill, S; Xu, P; Zhao, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Franzblau, SG; He, R; Mao, J; Pak, D; Wan, B; Wang, Y; Yuan, H | 1 |
| Adhikari, AV; Ajay Kumar, R; Eswaran, S | 1 |
| Chibale, K; Franzblau, SG; Guantai, EM; Gut, J; Hans, RH; Lategan, C; Rosenthal, PJ; Smith, PJ; Wan, B | 1 |
| Adhikari, AV; Chowdhury, IH; Eswaran, S; Pal, NK | 1 |
| Angulo-Barturen, I; Beltrán, M; Cáceres, N; Cardona, PJ; García, JI; García-Bustos, JF; Rullas, J | 1 |
| Fowler, JS; Hooker, JM; Liu, L; Shea, C; Tonge, PJ; Xu, Y | 1 |
| Dahse, HM; Kaustová, J; Klimesová, V; Kunes, J; Möllmann, U; Palát, K; Perina, M; Petrlíková, E; Waisser, K | 1 |
| Ding, Y; Ferreira, D; Franzblau, S; Hamann, MT; Kelly, M; Li, XC; Na, M; Schinazi, RF; Stone, R; Tekwani, BL; Wang, B | 1 |
| Agrawal, B; Desroches, N; Kumar, R; Kunimoto, DY; Shakya, N; Srivastav, NC | 1 |
| Bishai, WR; Grosset, JH; Nuermberger, EL; Zhang, T | 1 |
| Ackerman, M; Cynamon, MH; Pucci, MJ; Shoen, CM; Thanassi, JA | 1 |
| Adhikari, AV; Chowdhury, IH; Eswaran, S; Pal, NK; Thomas, KD | 1 |
| Cook, JM; Kabir, MS; Krueger, SM; Monte, A; Namjoshi, OA; Polanowski, R; Rott, MA; Schwan, WR; Sherman, D; Verma, R | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Agrawal, YK; Manna, K | 1 |
| Bhat, P; Senthilkumar, P; Sriram, D; Srividya, M; Vyas, DR; Yogeeswari, P | 1 |
| Changtam, C; Hongmanee, P; Suksamrarn, A | 1 |
| Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ | 1 |
| Agrawal, B; Kumar, R; Kunimoto, DY; Rai, D; Srivastav, NC; Tse, C | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Charnock, C; Franzblau, S; Gundersen, LL; Khoje, AD; Kulendrn, A; Wan, B | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Balamurugan, K; Perumal, S; Prasanna, P; Sriram, D; Yogeeswari, P | 1 |
| Balamurugan, K; Maheswari, SU; Perumal, S; Sriram, D; Yogeeswari, P | 1 |
| Banerjee, D; Bhat, P; Sriram, D; Srividya, M; Thomas, A; Yogeeswari, P | 1 |
| Chai, Y; Feng, LS; Guan, Y; Guo, HY; Liu, ML; Lv, K; Wang, B; Xiao, CL; Zhang, S; Zhang, YB | 1 |
| Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
| Barazarte, A; Camacho, J; Charris, J; Gamboa, N; Gilman, R; Rodrigues, J; Rojas, R; Vaisberg, A | 1 |
| Chibale, K; Franzblau, SG; Gut, J; Hans, RH; Rosenthal, PJ; van Helden, PD; Wan, B; Wiid, IJ | 1 |
| Bazzocchi, IL; Gilman, RH; Jiménez, IA; López, M; Rojas, R; Torres-Romero, D | 1 |
| Adhikari, AV; Chowdhury, IH; Pal, NK; Sumesh, E; Thomas, KD | 1 |
| Kumar, RS; Libertsen, LA; Perumal, S; Rajesh, SM; Sriram, D; Yogeeswari, P | 1 |
| Aguinaldo, MA; Chen, X; Cordell, GA; Decker, M; Franzblau, SG; Galvez, EV; Heilmann, J; Macabeo, AP; Vidar, WS; Wan, B | 1 |
| Charnock, C; Franzblau, S; Gundersen, LL; Khoje, AD; Wan, B | 1 |
| Menéndez, JC; Perumal, S; Ranjith Kumar, R; Sriram, D; Yogeeswari, P | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Mugunthan, G; Ramakrishna, K; Ravindranathan Kartha, KP; Sriram, D; Yogeeswari, P | 1 |
| Boshoff, H; Cho, S; Franzblau, SG; Hipskind, PA; Markley, LD; Miller, MJ; Moraski, GC | 1 |
| Kantevari, S; Sridhar, B; Sriram, D; Surineni, G; Yempala, T; Yogeeswari, P | 1 |
| Agrawal, UK; Ahsan, MJ; Dutt, KR; Kaur, R; Samy, JG; Vyas, S; Yadav, BS; Yadav, G | 1 |
| Aguiar, AC; Bastos, MM; Bezerra, FA; Boechat, N; Camilo, AL; Costa, CC; da Silva, GP; da Silva, NV; de C da Silva, F; de Lourdes G Ferreira, M; Dos S Costa, M; Ferreira, SB; Ferreira, VF; Krettli, AU; Lourenço, MC; Martins, PR; Pinto, AC; Teixeira, BM | 1 |
| Chaturvedi, V; Roy, KK; Saxena, AK; Sharma, SK; Singh, S; Srivastava, R | 1 |
| Ahsan, MJ; Devenda, NS; Jain, CB; Jain, N; Kalyansing, RG; Kumar, L; Prasad, R; Saini, L; Samy, JG; Sharma, LK; Soni, S; Yadav, H | 1 |
| Carneiro, PF; Cavalcanti, BC; Coelho, TS; da Silva Júnior, EN; da Silva, PA; de Almeida, RG; de Moura, KC; de Oliveira, NM; de Simone, CA; Nunes, IK; Pessoa, C; Pinto, AV; Pinto, Mdo C | 1 |
| Gunasekaran, P; Perumal, S; Sriram, D; Yogeeswari, P | 1 |
| Chitra, S; Manisankar, P; Muthusubramanian, S; Paul, N; Sriram, D; Yogeeswari, P | 2 |
| Joseph-Nathan, P; Lankin, DC; Molina-Salinas, GM; Muñoz, MA; Pauli, GF; Rivas-Galindo, VM; Said-Fernández, S; Waksman, N | 1 |
| Adhikari, AV; Bhattacharya, B; Chowdhury, IH; Mahmood, R; Sandeep, T; Sumesh, E; Thomas, KD | 1 |
| Franzblau, SG; Garcia, GA; Gill, SK; Jin, Y; Kirchhoff, PD; Showalter, HD; Wan, B | 1 |
| Adhikari, AV; Chowdhury, IH; Mahmood, R; Pal, NK; Row, G; Sumesh, E; Telkar, S; Thomas, KD | 1 |
| Aiello, C; Anzaldi, M; Balbi, A; Castagnola, P; Gangemi, R; Macciò, C; Mazzei, M; Miele, M; Rosano, C; Viale, M | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Berrue, F; Haltli, B; Kerr, RG; McCulloch, MW | 1 |
| Akhaja, TN; Raval, JP | 1 |
| Chen, RX; Du, NN; Li, YB; Liu, YX; Lu, Y; Song, DQ; Wang, B; Xie, YY; Xu, HZ; Yu, Y | 1 |
| Augustynowicz-Kopeć, E; Bojanowski, K; Foks, H; Gobis, K; Napiórkowska, A | 1 |
| Murugavel, M; Muthusubramanian, S; Paul, N; Sriram, D | 1 |
| Haridas, KR; Karuvalam, RP; Kumari, NS; Nayak, SK; Rajeesh, P; Rishikesan, R; Row, TN | 1 |
| Alagawadi, KR; Alegaon, SG; Chaudhary, SM; Dadwe, DH; Shah, AS; Sonkusare, PV | 1 |
| Constant, P; Daffé, M; Massimba Dibama, H; Mourer, M; Regnouf-de-Vains, JB | 1 |
| Boshoff, H; Chang, M; Cho, S; Franzblau, SG; Hwang, CH; Markley, LD; Miller, MJ; Moraski, GC | 1 |
| Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Senadeera, SP; Sureram, S | 1 |
| Baulard, AR; Crauste, C; Déprez, B; Flipo, M; Villemagne, B; Willand, N | 1 |
| Crick, DC; Debnath, J; Franzblau, SG; Kurosu, M; Lenaerts, AJ; Siricilla, S; Wan, B | 1 |
| Cierpicki, T; Franzblau, SG; Garcia, GA; Gill, SK; Kirchhoff, PD; Peng, KW; Showalter, HD; Turbiak, AJ; Wan, B; Xu, H; Zhang, N | 1 |
| Bucar, F; Gröblacher, B; Kunert, O | 1 |
| Bi, CW; Gao, LM; Jiang, JD; Li, YB; Li, YH; Liu, YX; Song, DQ; Wang, YX; Xiao, CL; Yang, YH | 1 |
| Chikhalia, KH; Kumari, P; Patel, PK; Patel, RV; Rajani, DP | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Almansour, AI; Arumugam, N; Sriram, D; Suresh Kumar, R | 1 |
| Chestnova, RV; Fattakhov, SG; Mingaleev, DN; Reznik, VS; Saifina, LF; Shulaeva, MM; Valijev, RSh; Voloshina, AD | 1 |
| Patel, MP; Patel, RG; Shah, NM | 1 |
| Agrawal, B; Bhavanam, S; Desroches, N; Kumar, R; Kunimoto, DY; Shakya, N; Srivastav, NC; Tse, C | 1 |
| Chopra, S; Doppalapudi, RS; Franzblau, SG; Green, CE; Iyer, LV; Koolpe, GA; Madrid, PB; Matsuyama, KN; Riccio, ES; Ryan, KJ; Tambo-Ong, AA; Tran, TB; Wan, B | 1 |
| Dulla, B; Franzblau, SG; Iqbal, J; Kapavarapu, R; Pal, M; Reiser, O; Wan, B | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Gan, M; Guan, Y; Liu, Y; Xiao, C; Zheng, X | 1 |
| Cantos, J; Carneiro, PF; Coelho, TS; da Silva, EN; da Silva, JA; da Silva, PE; de Simone, CA; Dias, GG; Jardim, GA; Malta, VR; Moura, KC; Pinto, Mdo C | 1 |
| Alexandrova, L; Andreevskaya, S; Chernousova, L; Chizhov, A; Karpenko, I; Khandazhinskaya, A; Kochetkov, S; Matyugina, E; Smirnova, T | 1 |
| Chibale, K; Franzblau, SG; Gut, J; Little, S; Rosenthal, PJ; Tukulula, M; Wan, B | 1 |
| Brahmkshatriya, PS; Dinda, SC; Kumar, V; Mohan, SB; Naik, D; Prabu Seenivasan, S; Rana, DN; Ravi Kumar, BV | 1 |
| Alvala, M; Chandran, M; Jeankumar, VU; Koushik, PV; Salina, EG; Samala, G; Sriram, D; Yogeeswari, P | 1 |
| Ali, MA; Choon, TS; Ismail, R; Kumar, RS; Wei, AC; Yoon, YK | 1 |
| Chaturvedi, V; Chauhan, K; Chauhan, PM; Puri, SK; Saxena, J; Saxena, JK; Sharma, M; Singh, SV; Srivastava, K; Trivedi, P | 1 |
| Kathrotiya, HG; Patel, MP | 1 |
| Jardosh, HH; Patel, MP | 1 |
| Fruziński, A; Gamian, A; Karczmarzyk, Z; Malinka, W; Sliwińska, M; Swiątek, P; Szponar, B | 1 |
| Cappoen, D; Claes, P; De Kimpe, N; Huygen, K; Jacobs, J; Mathys, V; Mbala, BM; Mertens, B; Verschaeve, L | 1 |
| Alexandrova, LA; Andreevskaya, SN; Chernousova, LN; Chizhov, AO; Efremenkova, OV; Karpenko, IL; Kochetkov, SN; Shmalenyuk, ER; Smirnova, TG | 1 |
| Barry, CE; Dartois, V | 1 |
| Alling, T; Bailey, M; Boshoff, H; Cramer, J; Hipskind, PA; Markley, LD; Miller, MJ; Moraski, GC; Ollinger, J; Parish, T | 1 |
| Haridas, KR; Kumari, NS; Rajeesh, P; Ranjith, PK; Rishikesan, R; Row, TN; Susanta, NK | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alam, S; Gupta, A; Maurya, HK; Negi, AS; Pandey, S; Pathak, V; Sharma, S; Srivastava, KK; Verma, R | 1 |
| Franzblau, SG; Gunatilaka, AA; He, H; Hoffman, AM; Wijeratne, EM | 1 |
| Choi, TA; Franzblau, SG; Knölker, HJ; Schmidt, AW; Theumer, G | 1 |
| Cho, SH; Franzblau, SG; Fryling, NA; Hwang, CH; Jaki, BU; Klein, LL; Lankin, DC; McAlpine, JB; Napolitano, JG; Pauli, GF; Stamets, PE; Wang, Y | 1 |
| Ahuja, V; Barde, S; Basavarajappa, H; Boriack-Sjodin, PA; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghorpade, SR; Ghosh, A; Giridhar, J; Guptha, S; Humnabadkar, V; Jena, Lk; Kale, MG; Koushik, K; Kranthi, U; Kumar, CN; Kumar, KN; Madhavapeddi, P; Manjunatha, MR; McKinney, D; Ogg, D; P, SH; Panduga, V; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatna, S; Sambandamurthy, VK; Sharma, S; Shinde, V; Tucker, JA; Vachaspati, P; Waterson, D | 1 |
| Cantos, JB; Coelho, TS; D'Oca, CR; D'Oca, MG; da Silva, PA; Piovesan, LA; Rodrigues, MO; Russowsky, D; Soares, KL | 1 |
| Ambady, A; Bandodkar, B; Bhat, J; Davies, G; Hameed, S; Hegde, N; Holdgate, G; Kumar, A; Madhavapeddi, P; McMiken, H; Murugan, K; Naik, M; Nandishaiah, R; Panda, M; Read, JA; Sambandamurthy, VK; Shinde, V; Shirude, PS; Venkatraman, J | 1 |
| Joshi, SP; Kulkarni, RR; Puranik, VG; Sarkar, D; Shurpali, K | 1 |
| Chandra Sekhar, KV; Nagesh, HN; Naidu, KM; Rao, DH; Sridevi, JP; Sriram, D; Yogeeswari, P | 1 |
| Alla, M; Kotipalli, SS; Rachakonda, V; Ummani, R | 1 |
| Close, W; Cook, JM; Deschamps, JR; Kabir, MS; Lane, M; Medina-Bielski, S; Monte, A; Polanowski, RL; Rott, M; Schwan, WR; Sherman, D; Tiruveedhula, VV; Verma, R; Witzigmann, CM | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Danac, R; Mangalagiu, II | 1 |
| Kantevari, S; Sridevi, JP; Sriram, D; Yempala, T; Yogeeswari, P | 1 |
| Franzblau, SG; Klein, LL; Lankin, DC; Pauli, GF; Petukhova, V; Santasiero, BD; Wan, B; Wang, Y | 1 |
| Banerjee, B; Cushman, M; Franzblau, SG; Ghafoor, A; Hamed, MI; Lv, W; Mesecar, AD; Molland, KL; Seleem, MN; Wan, B | 1 |
| Cho, S; Costantino, G; Franzblau, SG; Pieroni, M; Wan, B | 1 |
| Haridas, KR; Kumari, SN; Pakkath, R; Ranjith, PK | 1 |
| Asís, SE; Buldain, GY; Muscia, GC | 1 |
| Abonia, R; Bueno, J; Cobo, J; Diaz, Y; Insuasty, B; Nogueras, M; Ortiz, A; Quiroga, J | 1 |
| Arun, B; Chandra Sekhar, KV; Mahalakshmi Naidu, K; Nagesh, HN; Padma Sridevi, J; Sriram, D; Suresh, N; Yogeeswari, P | 1 |
| Abbas, N; Ibrar, A; Khan, I; Saeed, A | 1 |
| Alam, MS; Kalia, NP; Khan, IA; Mir, F; Mulakayala, C; Mulakayala, N; Rajput, VS; Shafi, S; Zaman, MS | 1 |
| China Raju, B; Divya, D; Ramesh, U; Saidachary, G; Singh, A; Sridhar, B; Veera Prasad, K | 1 |
| Anthonissen, R; Cappoen, D; Claes, P; De Kimpe, N; Huygen, K; Jacobs, J; Mathys, V; Verschaeve, L | 1 |
| Balkan, A; Dharmarajan, S; Ozadali, K; Tan, OU; Yogeeswari, P | 1 |
| Kalaria, PN; Raval, DK; Satasia, SP | 1 |
| Chikhalia, KH; Kumari, P; Patel, AB | 1 |
| Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J | 1 |
| Ambady, A; Guptha, S; Hegde, N; Hosagrahara, VP; Humnabadkar, V; Kaur, P; Mahadevaswamy, J; Nagalapur, K; Narayan, A; Panda, M; Raichurkar, A; Ramachandran, S; Ramachandran, V; Rudrapatna, SS; Sambandamurthy, VK; Sharma, S; Shirude, PS | 1 |
| Khare, G; Kidwai, S; Kumar, D; Rawat, DS; Singh, R; Tyagi, AK | 1 |
| Ahn, S; Choi, I; Jang, J; Kang, H; Kang, S; Kim, HJ; Kim, J; Kim, RY; Kim, YM; Ko, Y; Lee, S; Nam, J; Nam, K; No, Z; Park, S; Pethe, K; Seo, JJ; Seo, M; Seo, MJ | 1 |
| Achar, V; Ambady, A; Awasthy, D; Bathula, C; Binda, C; Chatterji, M; Chiarelli, LR; Dhar, N; Dinesh, N; Ghorpade, SR; Gorai, G; Guptha, S; Hegde, N; Hosagrahara, V; Humnabadkar, V; Iyer, PS; Jatheendranath, S; Jena, LK; Kaur, P; Kavanagh, S; Koushik, K; Madhavapeddi, P; Mahadevaswamy, J; Manjrekar, P; Manjunatha, MR; McKinney, JD; McLaughlin, B; Naik, M; Narayan, A; Narayan, C; Narayanan, S; Neres, J; Panda, M; Panduga, V; Pasca, MR; Prabhakar, K; Ramachandran, V; Ravishankar, S; Reddy, J; Riccardi, G; Rudrapatna, S; Sambandamurthy, VK; Saralaya, R; Shanbhag, G; Shandil, R; Sharma, S; Signorino-Gelo, F; Tantry, SJ; Tommasi, R; Whiteaker, J | 1 |
| Cho, S; Franzblau, SG; Markley, LD; Miller, MJ; Moraski, GC; Oliver, AG | 1 |
| Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
| Cai, Q; Chen, R; Hong, B; Ren, H; Wang, L; Wu, L; Xie, Y; Xu, H | 1 |
| Achar, V; Ambady, A; Awasthy, D; Bandodkar, B; Bellale, E; Chatterji, M; Guptha, S; Kaur, P; McLaughlin, R; Morayya, S; Naik, M; Narayan, A; Panda, M; Raichurkar, A; Ramachandran, V; Ravishankar, S; Sharma, S; V B, V; Vachaspati, P; Whiteaker, J | 1 |
| Avalani, JR; Kalaria, PN; Raval, DK; Satasia, SP | 1 |
| Karad, SC; Purohit, VB; Raval, DK | 1 |
| Basireddy, VS; Dharmarajan, S; Guttala, RS; Jagarlamudi, PS; Mukkara, LD; Pagadala, LR; Perumal, Y; Ravirala, N; Singh, A; Singireddi, S; Thummaluru, VR; Ummanni, R; Upadhyayula, SM | 1 |
| Hameed P, S; Kaur, P; Madhavapeddi, P; Menasinakai, S; Nandishaiah, R; Panduga, V; Raichurkar, A; Reddy, J; Sambandamurthy, VK; Sharma, S; Sriram, D | 1 |
| Chandra Sekhar, KV; Nagesh, HN; Sairam, SD; Sriram, D; Suresh, A; Yogeeswari, P | 1 |
| Gangwal, R; Jain, R; Patel, SR; Sangamwar, AT | 2 |
| Biava, M; Cocozza, M; Consalvi, S; Poce, G | 1 |
| Devi, PB; Jeankumar, VU; Pedgaonkar, GS; Renuka, J; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 2 |
| Guo, H; Huang, J; Liu, H; Liu, M; Lu, Y; Wang, B; Wang, J; Wang, M | 1 |
| Balakrishnan, G; Bhat, J; Chatterji, M; Dinesh, N; Ghorpade, S; Gorai, G; Guptha, S; Humnabadkar, V; Iyer, PS; Jena, LK; Kaur, P; Khadtare, P; Naik, M; Nandishaiah, R; Narayan, A; Naviri, LK; Panda, M; Ramachandran, V; Sharma, S | 1 |
| Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
| Chandra Sekhar, KV; Naidu, KM; Raghavaiah, P; Sriram, D; Subbalakshmi, J; Suresh, A; Yogeeswari, P | 1 |
| Alejandro, GJ; Dahse, HM; Franzblau, SG; Heilmann, J; Knorn, M; Kurtán, T; Macabeo, AP; Mándi, A; Martinez, FP; Schmidt, S; Tóth, L | 1 |
| Dwivedi, AK; Malasoni, R; Naqvi, A; Pandey, RR; Srivastava, A | 1 |
| Babu, KS; Chuppala, A; Jeankumar, VU; Reddy, KI; Renuka, J; Sree, KS; Sridevi, JP; Srihari, K; Sriram, D; Yogeeswari, P | 1 |
| Aree, T; Ganihigama, DU; Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Sangher, S; Sureram, S | 1 |
| Augustynowicz-Kopeć, E; Foks, H; Gobis, K; Napiórkowska, A; Serocki, M | 1 |
| Chandrika, N; Guru Row, TN; Hosamani, AA; Jose, G; Nagendrappa, G; Narendra, LV; Sowmya, HB; Sridevi, JP; Sriram, D; Sujan Ganapathy, PS; Suresha Kumara, TH; Yogeeswari, P | 1 |
| Boido, V; Cannas, S; Loddo, R; Molicotti, P; Novelli, F; Parapini, S; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M; Zanetti, S | 1 |
| Devi, PB; Samala, G; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 1 |
| Gowri Chandra Sekhar, KV; Nagesh, HN; Naidu, KM; Singh, M; Sriram, D; Yogeeswari, P | 1 |
| Chaturvedi, V; Dasgupta, A; Gupta, AD; Jaiswal, S; Kashyap, VK; Khan, SR; Krishnan, MY; Lal, J; Roy, KK; Saxena, AK; Sharma, A; Sharma, SK; Singh, S; Sinha, S; Srivastava, R | 1 |
| Cho, S; Franzblau, SG; Miller, MJ; Miller, PA; Tiwari, R | 1 |
| Bowornwiriyapan, K; Daengrot, C; Phongpaichit, S; Rukachaisirikul, V; Sakayaroj, J; Tansakul, C; Thongpanchang, T | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Anantaraju, HS; Anireddy, JS; Balasubramanian, S; Dharmarajan, S; Kotapalli, SS; Perumal, Y; Polkam, N; Rayam, P; Ummanni, R; Yennam, S | 1 |
| Renuka, J; Samala, G; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 1 |
| Baig, IA; Cui, CJ; Dong, M; Guo, R; Jung, IP; Lu, W; Sun, HJ; Wang, D; Wang, JG; Yoon, MY | 1 |
| Augustynowicz-Kopeć, E; Bojanowski, K; Foks, H; Gobis, K; Napiórkowska, A; Suchan, K | 1 |
| Kulkarni, P; Medapi, B; Medishetti, R; Renuka, J; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 1 |
| Bobal, P; Coffey, A; Gonec, T; Jampilek, J; Kollar, P; Kos, J; Kralova, K; Kushkevych, I; Liptaj, T; Nevin, E; O'Mahony, J; Soral, M | 1 |
| Bera, S; Chaturvedi, V; Jana, AK; Kumar M, SL; Manna, SK; Mishra, P; Mondal, S; Panda, G; Parai, MK; Saha, T; Singh, P; Singh, S; Sinha, S; Trivedi, P | 1 |
| Bhakta, S; Brucoli, F; Fox, KR; Guzman, JD; James, CH; Maitra, A | 1 |
| Bharate, SB; Khan, IA; Khan, SI; Singh, S; Vishwakarma, RA; Yadav, RR | 1 |
| Atmakur, K; Bingi, C; Emmadi, NR; Kotapalli, SS; Nanubolu, JB; Ummanni, R | 1 |
| Costantino, G; Franzblau, SG; Pieroni, M; Rivara, M; Wan, B; Zuliani, V | 1 |
| Chinnapattu, M; Hameed P, S; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Nandishaiah, R; Patil, V; Puttur, J; Raichurkar, A; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Shinde, V; Solapure, S; Sriram, D | 1 |
| Ding, K; Franzblauc, SG; Lu, X; Njire, M; Tang, J; Tu, Z; Wan, B; Wan, J; Wang, B; Wu, T; Zhang, T | 1 |
| Daletos, G; de Voogd, NJ; Hartmann, R; Kalscheuer, R; Koliwer-Brandl, H; Lin, W; Proksch, P; Wray, V | 1 |
| Czerwonka, D; Gajecka, M; Kubicka, MM; Przybylski, P; Pyta, K | 1 |
| Askri, M; Boudriga, S; Golz, C; Knorr, M; Mhiri, C; Nana, F; Sriram, D; Strohmann, C; Yogeeswari, P | 1 |
| Peraman, R; Reddy, YP; Varma, RV | 1 |
| Charolkar, CR; Divse, JM; Khedkar, VM; Nawale, LU; Pore, VS; Sarkar, D | 1 |
| Medapi, B; Renuka, J; Sridevi, JP; Sriram, D; Suryadevara, P; Yogeeswari, P | 1 |
| Guo, H; Li, L; Liu, M; Lu, Y; Shen, W; Wang, B; Wang, M; Zhang, R; Zhang, T | 1 |
| Chen, M; Gao, N; Jiang, JD; Jiang, W; Li, D; Li, Y; Lin, Y; Lu, Y; Si, S; Wan, K; You, X; Zhu, N | 1 |
| Huang, J; Li, L; Liu, H; Liu, M; Lu, Y; Wang, B; Wang, C; Wang, M; Zhang, R | 1 |
| Dixit, PP; Thore, SN | 1 |
| Bhatt, JD; Chudasama, CJ; Patel, KD | 1 |
| Arkile, M; Jadhav, N; Khedkar, VM; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD | 1 |
| Dusthackeer, AVN; Jaswanth S, B; Malathi, J; Narender, M; Raghuram R, A; Raghuram Reddy, A; Umadevi, KR; Umasankar, K; Venkat Rao, K | 1 |
| Kulkarni, P; Meda, N; Medapi, B; Sriram, D; Yogeeswari, P | 1 |
| Devi, PB; Meda, N; Samala, G; Saxena, S; Sriram, D; Yogeeswari, P | 1 |
| Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
| Bhatt, K; Desai, NC; Jha, PC; Khedkar, VM; Nawale, L; Sarkar, D; Somani, H; Trivedi, A | 1 |
| Arkile, MA; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD; Yeware, A | 1 |
| Centárová, I; Cole, ST; Čonka, P; Hrabálek, A; Karabanovich, G; Klimešová, V; Mikušová, K; Němeček, J; Pávek, P; Pávková, I; Roh, J; Šarkan, M; Smutný, T; Stolaříková, J; Székely, R; Vávrová, K; Vejsová, M; Vocat, A; Zemanová, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arunkumar, GR; Athmaram, TN; Gandhi, PT | 1 |
| Abbadi, BL; Back, DF; Basso, LA; Bonan, CD; Campos, MM; Giacobbo, BC; Grams, ES; Machado, P; Pissinate, K; Rodrigues-Junior, V; Roesler Nery, L; Santos, DS; Trindade, RV; Villela, AD | 1 |
| Agrawal, A; Garg, G; Kumar, R; Li, J; Pande, M | 1 |
| Arkile, MA; Asgaonkar, KD; Chitre, TS; Dharme, AB; Jha, PC; Khedkar, VM; Miniyar, PB; Sarkar, D; Yeware, A | 1 |
| Feng, L; Huang, J; Li, X; Liu, M; Lu, Y; Wang, B; Wang, M; Wu, Z; Yang, Y; Zhang, J | 1 |
| Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E | 1 |
| Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Pancholia, S; Shah, P; Sridevi, JP; Sriram, D; Yogeshwari, P | 1 |
| Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Kumar, D; Sridevi, JP; Sriram, D; Vaja, MD; Yogeeswari, P | 1 |
| Aminabhavi, TM; Dixit, SR; Joshi, SD; Kumar, D; Lherbet, C; More, UA; Tigadi, N; Yang, KS | 1 |
| Bowornwiriyapan, K; Duangjai, A; Muanprasat, C; Phainuphong, P; Phongpaichit, S; Rukachaisirikul, V; Saithong, S; Sakayaroj, J; Srimaroeng, C | 1 |
| Bishai, WR; Guo, H; Kozikowski, AP; Lun, S; Merenbloom, B; Onajole, OK; Stec, J; Vistoli, G | 1 |
| Janupally, R; Jeankumar, VU; Reshma, RS; Saxena, S; Sriram, D; Vats, R; Yogeeswari, P | 1 |
| Almqvist, H; Brunner, K; Gustavsson, AL; Lundbäck, T; Maric, S; Poyraz, Ö; Reshma, RS; Schneider, G; Schnell, R; Seashore-Ludlow, B; Sriram, D; Vallin, M; Yogeeswari, P | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bruhn, DF; Lee, RE; Lin, H; Maddox, MM; Singh, AP; Sun, D | 1 |
| Chandrasekaran, B; Hampannavar, GA; Karpoormath, R; Palkar, MB; Shaikh, MS | 1 |
| Bantu, R; Jilla, L; Nagarapu, L; Sajja, Y; Sriram, D; Vanguru, S; Vulupala, HR; Yogeswari, P | 1 |
| Bobesh, KA; Gunda, S; Jeankumar, VU; Reshma, RS; Saxena, S; Sriram, D; Yogeeswari, P | 1 |
| Chegaev, K; Chung, MC; de Souza, PC; Dos Santos, JL; Fernandes, GFDS; Fruttero, R; Guglielmo, S; Lazzarato, L; Marino, LB; Pavan, FR | 1 |
| Beuerman, RW; Cao, D; Corkran, HM; Dick, T; Koh, JJ; Lakshminarayanan, R; Lim, F; Lin, S; Liu, S; Mukherjee, D; Stocker, BL; Tan, DTH; Tan, DZ; Tan, JK; Timmer, MSM; Zou, H | 1 |
| Gill, CH; Khedkar, VM; Mahajan, PS; Nawale, LU; Nikam, MD; Sarkar, D | 1 |
| Chaudhari, K; Jain, P; Patel, HM; Surana, S | 1 |
| Cui, S; Ding, K; Franzblauc, SG; Lu, X; Tang, J; Wan, B; Zhang, T; Zhang, X | 1 |
| Agrawal, B; Garg, S; Kumar, R; Kunimoto, DY; Shakya, N; Srivastav, NC | 1 |
| Brindha Devi, P; Gunda, S; Samala, G; Saxena, S; Sriram, D; Yogeeswari, P | 1 |
| Bai, X; Deng, Q; Li, Z; Liu, Y; Wang, J; Wang, Y; Zhang, G; Zhou, L | 1 |
| Chakraborti, AK; Kumar, A; Sriram, D; Tanwar, B; Yogeeswari, P | 1 |
| Ding, K; Li, M; Liu, Z; Lu, X; Tang, J; Zhang, T; Zhang, X | 1 |
| Balaji, NV; Hari Babu, B; Murali Krishna Kumar, M; Purna Nagasree, K; Subbaraju, GV | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Abbadi, BL; Back, DF; Basso, LA; Campos, MM; Giacobbo, BC; Grams, ES; Machado, P; Pissinate, K; Rodrigues-Junior, V; Santos, DS; Sperotto, N; Subtil, FT; Trindade, RV; Villela, AD | 1 |
| Bhakta, S; Brown, AK; Castagnolo, D; Maitra, A; Manetti, F; Pavan, FR; Petricci, E; Ribeiro, CM; Scalacci, N; Smith, DL | 1 |
| Sankar, C; Umamatheswari, S | 1 |
| Alcock, P; Ambady, A; Ashton, H; Balakrishnan, G; Balasubramanian, V; Bharath, S; Bhat, J; Collier, M; Cooper, CB; Dinesh, N; Gupta, AK; Guptha, S; Hameed P, S; Hosagrahara, VP; Iyer, P; Kandaswamy, K; Kaur, P; Kavanagh, S; Kedari, C; Mallya, M; Markad, SD; McLaughlin, RE; Mdluli, K; Mudugal, NV; Mukherjee, K; Murray, D; Nanduri, R; Narayan, A; Narayanan, S; Naveen Kumar, CN; Naylor, K; Panda, M; Panduga, V; Plant, D; Plant, H; Prabhakar, KR; Preston, M; Raichurkar, A; Ramachandran, V; Ravishankar, S; Reddy, J; Rich, K; Rubin, H; Rudrapatna, S; Sambandamurthy, VK; Saralaya, R; Shandil, R; Sharma, S; Shinde, V; Solapure, S; Tantry, SJ; Walsh, J; Whiteaker, J; Yano, T | 1 |
| Börger, C; Brütting, C; Franzblau, SG; Hesse, R; Julich-Gruner, KK; Knölker, HJ; Kumar, VP; Kutz, SK; Rönnefahrt, M; Thomas, C; Wan, B | 1 |
| Erdélyi, M; Fitzpatrick, P; Gruhonjic, A; Kombo, M; Lu, Y; Mgina, CA; Munissi, JJ; Nyandoro, SS; Pan, F; Rissanen, K; Wang, B | 1 |
| Avalos-Alanís, FG; Carranza-Rosales, P; Guzmán-Delgado, NE; Hernández-Fernández, E; Hernández-Fernández, J; López-Cortina, S; Morales-Vargas, A; Ordóñez, M; Santiago-Mauricio, MG; Velázquez-Moreno, VM | 1 |
| Adhikari, C; Krishna, VS; Reshma, RS; Sharada, DS; Sriram, D; Vidyacharan, S | 1 |
| Benková, M; Hrabálek, A; Karabanovich, G; Kavková, V; Klimešová, V; Konečná, K; Macháček, M; Němeček, J; Roh, J; Soukup, O; Stolaříková, J; Sychra, P; Vávrová, K | 1 |
| Bobesh, KA; Jeankumar, VU; Kapoor, N; Kolattukudy, PE; Reshma, RS; Saxena, S; Sriram, D; Vachaspathy, AR | 1 |
| Feng, LS; Gao, C; Hu, YQ; Lv, ZS; Wu, X; Xu, Z; Zhang, S; Zhao, F | 1 |
| Bishai, W; Chaira, T; Dupont, C; Kozikowski, AP; Kremer, L; Lun, S; Onajole, OK; Ordway, D; Raj, VS; Richard, M; Stec, J; Viljoen, A | 1 |
| Guo, H; Li, L; Liu, M; Lu, Y; Lv, K; Shen, W; Wang, B | 1 |
| Andrade, CH; Braga, RC; Cho, S; Franzblau, SG; Gomes, MN; Grzelak, EM; Klein, LL; Ma, R; Muratov, E; Neves, BJ; Oliveira, GR | 1 |
| Chai, Y; Huang, G; Liu, M; Lu, Y; Lv, K; Wang, A; Wang, B; Wei, Z; You, X | 1 |
| Cappoen, D; Cools, F; Cos, P; de Macedo, MB; Gazvoda, M; Kafka, S; Kimmel, R; Klásek, A; Košmrlj, J; Lima, ES; Lyčka, A; Milićević, D; Peixoto, A; Torfs, E; Urankar, D; Verschaeve, L | 1 |
| Chang, L; Feng, LS; Gao, C; Lv, ZS; Ren, QC; Xu, Z; Zhang, S | 1 |
| Bloomer, WD; Kaiser, M; Papadopoulou, MV; Rosenzweig, HS | 1 |
| Feng, LS; Gao, C; Lv, ZS; Ren, QC; Song, XF; Xu, Z | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Sychra, P; Valášková, L; Vávrová, K; Vlčková, H | 1 |
| Bosquesi, PL; Chegaev, K; Cho, SH; Chorilli, M; da Silva, PB; de Carvalho, LPS; de Souza Costa, CA; de Souza, PC; Dos Santos Fernandes, GF; Dos Santos, JL; Franzblau, SG; Fruttero, R; Guglielmo, S; Hunt, DM; Lazzarato, L; Man Chin, C; Marino, LB; Moreno-Viguri, E; Paucar, R; Pavan, FR; Pérez-Silanes, S; Ribeiro, CM; Santivañez-Veliz, M; Silva, CSP; Solcia, MC; Wang, Y | 1 |
| Bernardino, AMR; Boechat, N; Dos Santos, MS; Faria, JV; Miguita, AGC; Vegi, PF | 1 |
| Bloomer, WD; Papadopoulou, MV; Rosenzweig, HS | 1 |
| Bantu, R; Nagarapu, L; Sajja, Y; Sriram, D; Vanguru, S; Vulupala, HR; Yogeswari, P | 1 |
| Abay, E; Axtman, M; Ballell, L; Barry, CE; Boesche, M; Boshoff, HIM; Brunschwig, C; Chibale, K; Drewes, G; Gessner, RK; Ghidelli-Disse, S; Ghorpade, SR; Gordon, R; Harris, CJ; Lafuente-Monasterio, MJ; Lawrence, N; Lelièvre, J; Mizrahi, V; Moosa, A; Mueller, R; Nchinda, A; Njoroge, M; Pflaumer, H; Rebollo-Lopez, MJ; Santos, G; Sanz, O; Seldon, R; Selenski, C; Simelane, SB; Sirgel, FA; Soares de Melo, C; Street, LJ; Taylor, D; Urones, B; van Helden, P; Warner, DF; Wilson, CR | 1 |
| Aziz, DB; Dick, T; Go, ML; Gopal, P; Li, M; Nyantakyi, SA | 1 |
| Baikova, IP; Giniyatullina, GV; Kataev, VE; Kazakova, OB; Lopatina, TV; Medvedeva, NI; Smirnova, IE | 1 |
| Coffey, A; Endersen, L; Fontinha, D; Jampilek, J; Machado, M; Pavić, K; Perković, I; Pospíšilová, Š; Prudêncio, M; Rimac, H; Zorc, B | 1 |
| Malapati, P; Meda, N; Nallangi, R; Reshma Srilakshmi, R; Siva Krishna, V; Sriram, D | 1 |
| Bonnet, M; Cooper, CB; Denny, WA; Franzblau, SG; Lee, HH; Thompson, AM; Wan, B; Wong, GS | 1 |
| Krishna, VS; Malapati, P; Nallangi, R; Srilakshmi, RR; Sriram, D | 1 |
| Aiub, CAF; Araujo-Lima, CF; Boechat, N; Castelo-Branco, FS; Costa, TEMM; Costa-Lima, MM; de Lima, EC; Domingos, JLO; Felzenszwalb, I; Gomes, KM; Henriques, MG; Lourenço, MCS; Penido, C; Pinto, AC | 1 |
| Cheng, XW; Fan, YL; Feng, LS; Wu, JB; Zhang, FZ | 1 |
| Alluri, KK; Gottapu, S; Reshma, RS; Sriram, D; Suraparaju, R | 1 |
| Bimal, D; Bohra, K; Jain, R; Maity, J; Ponnan, P; Prasad, AK; Singh, B; Srivastava, S; Thirumal, M; Varma-Basil, M | 1 |
| Fan, YL; Feng, LS; Gao, T; Huang, ZP; Jin, XH; Yu, HF; Zeng, ZG | 1 |
| Guo, H; Jun, Y; Liu, M; Lu, Y; Lv, K; Wang, A; Wang, B; Yang, Y | 1 |
| Huang, M; Liu, M; Liu, Q; Lu, Y; Lv, K; Tao, Z; Wang, A; Wang, B; Wu, S; Yang, L | 1 |
| Dartois, V; Dick, T; Gengenbacher, M; Go, ML; Gopal, P; Li, M; Nyantakyi, SA; Zimmerman, M | 1 |
| Banerjee, A; Chakraborti, AK; Dhameliya, TM; Pancholia, S; Panda, D; Sriram, D; Tiwari, R | 1 |
| Guo, H; Huang, G; Liu, M; Lu, Y; Lv, K; Tao, Z; Wang, A; Wang, B; Wang, H | 1 |
| Jachak, SM; Krishna, VS; Kumar, G; Sriram, D | 1 |
| Jachak, SM; Krishna, VS; Kumar, G; Sathe, A; Sriram, D | 1 |
| Bhushan Tripathi, S; Chanda, D; Chaturvedi, AK; Khwaja, S; Kumar, BS; Negi, AS; Roy, S; Sachan, NK; Saikia, D; Shanker, K; Sharma, A; Thakur, JP; Verma, AK | 1 |
| Ahmad, Z; Amin, S; Bhat, BA; Bhat, ZS; Dar, MJ; Lone, AM; Maqbool, M; Rather, MA; Shairgojray, BA; Singh, P; Teli, B; Yousuf, SK | 1 |
| Ashok, D; Goud, GL; Manga, V; Ramesh, S; Reddy, VP; Saikrishna, B; Sriram, D; Yogeeswari, P | 1 |
| Franzblau, SG; Hu, X; Liu, Z; Lu, X; Wan, B; Wang, R; You, Q; Zhang, T | 1 |
| Ahmad, Z; Ara, T; Bhat, ZS; Maqbool, M; Rather, MA; Ul Lah, H; Yousuf, SK | 1 |
| Doležal, M; Jand'ourek, O; Kuneš, J; Navrátilová, L; Paterová, P; Vinšová, J; Zitko, J | 1 |
| Fan, YL; Huang, ZP; Ke, X; Wu, JB | 1 |
| Charrier, C; Cooper, IR; Kerr, WJ; Lindsay, DM; Maclean, J; McGarry, DH; Moyo, E; Pichowicz, M; Ratcliffe, AJ; Salisbury, AM; Savage, VJ; Smith, A; Stokes, NR; Walker, R; Warrilow, CE | 1 |
| Eslamimehr, S; Franzblau, SG; Kong, Y; Kurosu, M; Lemieux, MR; Mitachi, K; Park, F; Pressly, JD; Siricilla, S; Wang, Y; Yang, D | 1 |
| Gao, YM; Liang, J; Liu, ZY; Qian, L; Tang, YX; Yan, M; Zhang, NN; Zhang, TY | 1 |
| Cavet, JS; Chakraborty, A; Fernandez, P; Gutierrez, MG; Kreiswith, BN; Kurepina, N; Naranjo, Y; Park, S; Perlin, DS; Pons, M; Saville, C; Schnettger, LS; Silva, APG; Tabernero, L; Thomas, EJ; Vickers, CF | 1 |
| Borra, RS; Chopra, S; Das, S; Dasgupta, A; Gatadi, S; Gour, J; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
| Batt, SM; Besra, GS; Huang, H; Li, G; Li, P; Lin, Z; Lu, Y; Ma, C; Wang, B; Zhang, D; Zhang, T; Zhang, X | 1 |
| Eswaran, S; Narayanan, S; Shivarudraiah, P; Shruthi, TG; Subramanian, S | 1 |
| Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ | 1 |
| AnkiReddy, S; Bharathi Reddy, K; Rao Sagurthi, S; Sabitha, G; Shiva Raju, K; Siva Krishna, V; Sriram, D | 1 |
| Chang, L; Ding, C; Feng, LS; Gao, C; Wu, X; Xu, Z; Yan, XF; Zhao, F | 1 |
| Kantevari, S; Krishna, VS; Marvadi, SK; Sriram, D | 2 |
| Fu, L; Gu, J; Guo, H; Liu, M; Lu, Y; Lv, K; Ma, C; Tao, Z; Wang, A; Wang, B; Wang, H | 1 |
| Chopra, S; Dusthackeer, VNA; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D | 1 |
| Gerwick, WH; Hou, XM; Shao, CL; Wang, CY | 1 |
| Fu, L; Geng, Y; Gu, J; Liu, M; Lu, Y; Lv, K; Ma, C; Tao, Z; Wang, A; Wang, B; Wang, H | 1 |
| Ansari, I; Jadhav, H; Patel, H; Pawara, R; Surana, S | 1 |
| da Silva Emery, F; de Melo, SMG; Fumagalli, F; Pavan, FR; Ribeiro, CM; Solcia, MC | 1 |
| Akhter, M; Alam, MM; Ali, S; Deora, GS; Krishna, VS; Sharma, K; Sriram, D; Tanwar, O; Zaman, MS | 1 |
| Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Beteck, RM; Hoppe, HC; Jordaan, A; Khanye, SD; Laming, D; Legoabe, LJ; Seldon, R; Warner, DF | 1 |
| Bera, S; Mondal, D | 1 |
| Han, B; Li, L; Liu, H; Liu, M; Lu, Y; Lv, K; Ma, C; Ma, X; Tao, Z; Wang, A; Wang, B | 1 |
| Fu, L; Han, B; Liu, H; Liu, M; Lu, Y; Lv, K; Ma, C; Ma, X; Tao, Z; Wang, A; Wang, B; Wang, H; Zhang, K | 1 |
| Chen, L; Chen, Z; Fan, Y; Gao, F; Lu, G; Ma, L | 1 |
| Esaulkova, YL; Kantevari, S; Krishna, VS; Marvadi, SK; Muryleva, AA; Sinegubova, EO; Sriram, D; Tentler, DG; Volobueva, AS; Zarubaev, VV | 1 |
| Dušek, J; Hrabálek, A; Huszár, S; Jand'ourek, O; Karabanovich, G; Klimešová, V; Kočová Vlčková, H; Konečná, K; Konyariková, Z; Korábečný, J; Korduláková, J; Kučera, T; Mikušová, K; Pávek, P; Pávková, I; Pavliš, O; Roh, J; Savková, K; Stolaříková, J; Vávrová, K | 1 |
| Baranyai, Z; Bősze, S; Janďourek, O; Krátký, M; Novotná, E; Stolaříková, J; Vinšová, J | 1 |
| Franzblau, SG; Fu, L; Gu, J; Han, B; Liu, M; Lu, Y; Lv, K; Ma, C; Ma, X; Tao, Z; Wan, B; Wang, A; Xu, S | 1 |
| Balasubramanian, S; Bhukya, S; Kumar Sthalam, V; Linga Murthy Thampunuri, R; Pabbaraja, S; Ramprasad, J; Ummanni, R | 1 |
| Mabhula, A; Singh, V | 1 |
| Ambady, A; Butler, S; Chatterji, M; Cooper, C; Guptha, S; Iyer, PS; Kumar, N; Mahadevaswamy, J; Mallya, M; Mdluli, K; Narayan, A; Narayanan, S; Panda, M; Panduga, V; R, MM; Ramachandran, V; Sadler, C; Sambandamurthy, VK; Shandil, R; Sharma, S; Shirude, PS; Sreenivasaiah, M; Tommasi, R | 1 |
| Augustynowicz-Kopeć, E; Bielenica, A; Chrzanowska, A; Dobrowolski, M; Głogowska, A; Roszkowski, P; Stępień, K; Struga, M; Szulczyk, D | 1 |
| Bangalore, PK; Bollikanda, RK; Choudante, PC; Kantevari, S; Misra, S; Sridhar, B; Sriram, D; Vagolu, SK; Veeragoni, DK | 1 |
| Krishna, VS; Sirim, MM; Sriram, D; Unsal Tan, O | 1 |
| Doğan, H; Doğan, ŞD; Gündüz, MG; Krishna, VS; Lherbet, C; Şahin, O; Sarıpınar, E; Sriram, D | 1 |
| Ginalska, G; Golus, J; Kazimierczak, P; Paneth, A; Przekora, A; Trotsko, N; Wujec, M | 1 |
| Fu, L; Liu, Y; Lu, Y; Sheng, L; Wang, B; Zhang, D; Zhao, H; Zhao, W | 1 |
| Abad-Zapatero, C; Bisson, J; Chen, SN; Cheng, J; Cho, SH; Franzblau, SG; Jin, Y; Klein, LL; Lee, H; McAlpine, JB; Pauli, GF; Santarsiero, BD; Shetye, G; Suh, JW; Wolf, NM; Yu, Y; Zhou, B | 1 |
| Abbadi, BL; Basso, LA; Bizarro, CV; Borsoi, AF; Macchi, FS; Machado, D; Machado, P; Paz, JD; Pissinate, K; Rambo, RS; Ramos, AS; Sperotto, N; Viveiros, M | 1 |
| George, SE; Guddat, LW; Krishna, VS; Nallangi, R; Rekha, EM; Sai Prasad, DV; Sriram, D; Zheng, S | 1 |
| Jayathirtha Rao, V; Kishore, G; Kumar, SB; Ravinder, M; Sriram, D; Yogeeswari, P | 1 |
| Joji, A; Kannan, T; Mani, M; Ramesh, D; Sethumadhavan, A; Vijayakumar, BG | 1 |
| Doğan, H; Doğan, ŞD; Gündüz, MG; Krishna, VS; Lherbet, C; Sriram, D | 1 |
| Begum, N; Bhakta, S; Castagnolo, D; Gupta, A; Kyriazi, M; Manetti, F; McHugh, TD; Pavan, FR; Ribeiro, CM; Scalacci, N; Semenya, D; Senderowitz, H; Touitou, M; Zrebna, K | 1 |
| Chai, Y; Fu, L; Jia, X; Liu, M; Liu, X; Lu, Y; Lv, K; Ma, C; Wang, A; Wang, B | 1 |
| Baulard, AR; Biela, A; Blaise, M; Bourbiaux, K; Cantrelle, FX; Déprez, B; Djaout, K; Faïon, L; Flipo, M; Frita, R; Hanoulle, X; Herledan, A; Kremer, L; Leroux, F; Moune, M; Pintiala, C; Piveteau, C; Tanina, A; Vandeputte, A; Willand, N; Wintjens, R | 1 |
| Barreca, ML; Bojarski, AJ; Cecchetti, V; Cook, GM; Desantis, J; Felicetti, T; Franzblau, SG; Handzlik, J; Hards, K; Kolář, MH; Latacz, G; Manfroni, G; Massari, S; Mazzarella, MA; Nakatani, Y; Nizi, MG; Rushton-Green, R; Sabatini, S; Satała, G; Shetye, G; Tabarrini, O | 1 |
| Platonova, YB; Tomilova, LG; Volov, AN | 1 |
| Fu, L; Huang, H; Li, G; Li, Y; Liu, Y; Lu, H; Lu, Y; Ma, C; Sheng, L; Wang, B; Zhang, B; Zhang, D; Zhao, H | 1 |
| Dixit, PP; Haval, KP; Haval, NB; Kasare, SL; Khedkar, VM; Patil, PS; Rekha, EM; Sriram, D | 1 |
| Asthana, S; Kumar, A; Kumar, V; Mahajan, D; Meena, CL; Shaliwal, RP; Singh, P; Singh, R; Tiwari, AK | 1 |
| Fu, L; Huang, H; Li, G; Li, P; Lin, Z; Lu, Y; Wang, B; Zhang, D | 1 |
| Bortolotti, A; Defelipe, LA; Ghiano, DG; Labadie, GR; Morbidoni, HR; Recio-Balsells, A; Turjanski, A | 1 |
| Rakesh, KP; Tiwari, SP; Vaishnav, Y; Verma, R; Verma, S; Verma, SK | 1 |
| Chen, M; Jiang, W; Jiang, X; Li, D; Li, Y; Lin, Y; Liu, C; Si, S; Xu, Y; You, X; Zhang, J | 1 |
| Camoin, L; Canaan, S; Cavalier, JF; Durand, T; Spilling, CD | 1 |
| Cordeiro, R; Kachroo, M | 1 |
| Dhawan, S; Girase, PS; Karpoormath, R; Kumar, V; Palkar, MB; Shinde, SR | 1 |
| Ahmad, MN; Akunuri, R; Chopra, S; Dasgupta, A; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
| Boshoff, HIM; Caljon, G; Forbes, HE; Hulpia, F; Jian, Y; Munier-Lehmann, H; Risseeuw, MDP; Van Calenbergh, S | 1 |
| Bishai, WR; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Wang, SS; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Beteck, RM; Dube, PS; Jesumoroti, OJ; Jordaan, A; Legoabe, LJ; Tshiwawa, T; Warner, DF | 1 |
| Alexandrova, LA; Avdanina, DA; Boykova, YV; Efimenko, TA; Efremenkova, OV; Glukhova, AA; Jasko, MV; Karpenko, IL; Kochetkov, SN; Kolonitskaya, DP; Kost, NV; Negrya, SD; Nuraeva, GK; Shevchenko, OV; Solodinin, AP; Solyev, PN; Volkov, IA; Zhgun, AA | 1 |
| Trotsko, N | 1 |
| Chai, Y; Liu, M; Lu, Y; Lv, K; Ma, C; Qin, X; Wang, A; Wang, B; Wang, D; Xia, G; Xu, S | 1 |
| Ahmad, MN; Chopra, S; Dasgupta, A; Gaikwad, NB; Kaul, G; Nanduri, S; Rani, B; Sahoo, SK; Shukla, M; Yaddanapudi, VM | 1 |
| Ahmad, I; Patel, H; Shinde, Y; Surana, S | 1 |
| Fu, L; Guo, K; Huang, H; Li, G; Li, P; Lin, Z; Lu, Y; Ma, C; Wang, B | 1 |
| Brunschwig, C; Chibale, K; Lawrence, N; Mabhula, A; Manjunatha, UH; Moosa, A; Müller, R; Ngumbu Muhunga, D; Njaria, PM; Njoroge, M; Rao, SPS; Singh, V; Smith, PW; Street, LJ; Taylor, D; van der Westhuyzen, R; Warner, DF | 1 |
| Platonova, YB; Volov, AN; Volov, NA | 1 |
| Abay, E; Barry, CE; Basarab, GS; Boshoff, HIM; Boyle, GA; Chibale, K; Eyermann, CJ; Fienberg, S; Ghorpade, SR; Khonde, LP; Lawrence, N; Lenaerts, AJ; Massoudi, LM; Müller, R; Myers, TG; Myrick, A; Nchinda, AT; Njoroge, M; Reddy, V; Robertson, GT; Singh, V; Sirgel, FA; Su, Q; van Helden, PD | 1 |
| Brucoli, F; Gupta, M; Parish, T; Zloh, M | 1 |
| Dai, H; Liu, H; Liu, J; Tian, Z; Wang, B; Zhang, Y | 1 |
| Boonlarppradab, C; Choowong, W; Kornsakulkarn, J; Saepua, S; Suriyachadkun, C; Thongpanchang, C | 1 |
| Chai, Y; Jiang, B; Liu, M; Lu, Y; Lv, K; Qin, X; Wang, A; Wang, B; Wang, D; Wu, W; Xia, G; Xu, S | 1 |
| Bagnéris, C; Basavanakatti, VN; Bhakta, S; Bhattacharje, G; Brucoli, F; Das, AK; Das, S; Dasgupta, A; Dev, A; Dickman, R; Jalani, P; Jayaprakash, V; Kamilya, S; Mondal, A; Mukherjee, P; Naresh Babu, P; Sankaran, V; Shyam, M; Singh, A; Singh, S; Sinha, BN; Verma, H | 1 |
| Bano, G; Castagnolo, D; Chibale, K; Gianibbi, B; Manetti, F; Pavan, FR; Pisano, L; Ribeiro, CM; Semenya, D; Singh, V; Toscani, A; Touitou, M | 1 |
| Batt, SM; Besra, GS; Fu, L; Huang, H; Li, G; Lu, Y; Qin, R; Wang, B; Wang, P; Wang, Y; Wu, C | 1 |
| Britton, WJ; Cheung, CY; Clausen, T; Cook, GM; Hawkins, PME; Hoi, DM; Jackson, CJ; Linington, RG; Liu, DY; Oehlers, SH; Payne, RJ; Quan, D; Sasi, VM; Wang, T | 1 |
| Canaan, S; Cavalier, JF; Magrioti, V; Mallick, I; Mavrikaki, V; Pagonis, A; Poncin, I | 1 |
| Castagnolo, D; Dos Santos Fernandes, GF; Gianibbi, B; Manetti, F; Masci, D; Pavan, FR; Ribeiro, CM; Semenya, D; Touitou, M | 1 |
| Chopra, S; Dasgupta, A; Kaul, G; Kumar Sahoo, S; Maddipatla, S; Madhavi Yaddanapudi, V; Nageswara Rao Gajula, S; Naiyaz Ahmad, M; Nanduri, S; Sonti, R | 1 |
| Agrahari, AK; Rajkhowa, S; Sharma, A; Tiwari, VK | 1 |
| Chen, S; Ding, CZ; Franzblau, SG; Guo, F; Huang, Z; Li, L; Li, Y; Luo, W; Shen, L; Tang, D; Wang, B; Xu, D; Yang, M; Zhu, Y | 1 |
| Ahmad, MN; Chopra, S; Dasgupta, A; Kaul, G; Nanduri, S; Sahoo, SK; Yaddanapudi, VM | 1 |
| Bin, W; Chen, S; Ding, CZ; Franzblau, SG; Hu, Y; Huang, Z; Jiang, N; Luo, W; Shen, L; Tao, X; Wei, X; Wei, Y; Xu, D; Yang, M; Zhu, Y | 1 |
| Abbadi, BL; Alice, LM; Basso, LA; Bizarro, CV; Borsoi, AF; Costa, TD; de Araújo Lock, G; de Araújo, BV; de Matos Czeczot, A; de Oliveira, SD; Galina, L; González, LC; Leyser, M; Macchi Hopf, FS; Machado, P; Madeira Silva, RB; Muniz, MN; Neves, CE; Paz, JD; Perelló, MA; Pissinate, K; Rambo, RS; Ramos, AS; Silva Dadda, AD; Sperotto, N | 1 |
| Ang, CW; Avery, VM; Bernhardt, PV; Blaskovich, MAT; Bolisetti, R; Cooper, MA; Francisco, AF; Franzblau, SG; Hinton, AO; Jackson, CJ; Kelly, JM; Lee, BM; Sykes, ML; Tan, L; Wang, Y; West, NP | 1 |
| Chen, D; Chen, J; Chen, X; Cheng, S; Huang, H; Lu, Y; Shen, D; Tian, J; Wang, B; Wang, Q; Ye, F; Zhang, D | 1 |
| Alshabani, LA; Bhakta, S; Estrada, DF; Kumar, A; Simons, C; Srithiran, G; Willcocks, SJ | 1 |
| Angebault, M; Bonniot, JP; Homasson, JP; Parent, G; Salignac, P | 1 |
| Erooga, MA; Jenkins, MV; Perry, W; Stamp, TC | 1 |
| Martin, PD | 1 |
| Bates, JH | 1 |
| Tuli, SM | 1 |
| Fox, W; Mitchison, DA | 2 |
| Anah, CO | 3 |
| Newton, RW | 1 |
| Schröder, KH | 1 |
| Farid, Z; Hassan, A; Miner, WF; Trabolsi, B | 1 |
| Jindani, A | 2 |
| Springett, VH | 1 |
| Fawcett, IW; Watkins, BJ | 1 |
| Iwai, K; Yamada, S | 1 |
| Clarke, PD | 1 |
| Allan, GW; Lees, AW; Smith, J; Tyrrell, WF | 1 |
| Angel, JH | 2 |
| Pearson, JO | 2 |
| Mitchison, DA | 7 |
| Fox, W | 5 |
| Warkany, J | 1 |
| Santhanam, K; Venkitasubramanian, TA | 1 |
| Hadgu, AG; Keterew, W; Pattyn, SR; Van Den Breen, L | 1 |
| Brodsky, ML; Michael, NL; Ow, CL; Pien, FD; Vennesland, K | 1 |
| Iwainsky, H; Reutgen, H; Sesser, I | 1 |
| Onadeko, BO; Sofowora, EO | 1 |
| Farer, LS; Long, MW; Snider, DE | 2 |
| Harris, AA; Karakusis, P | 1 |
| Loudon, RG | 2 |
| Grosset, J | 4 |
| Fox, W; Nunn, AJ | 1 |
| Dickinson, JM; Mitchison, DA | 6 |
| Kozlova, NV; Kozulitsyna, TI | 1 |
| Gow, JG | 6 |
| Garcia, FS; Reinlein, JM | 1 |
| Bek, E; Janowiec, M; Zwolska-Kwiek, Z | 1 |
| Benhamou, JP; Pessayre, D | 1 |
| Alberghina, M; Palermo, F | 2 |
| Duroux, P | 1 |
| Broquié, G | 2 |
| Grenville-Mathers, R | 1 |
| Sutherland, AM | 6 |
| Zierski, M | 3 |
| Hanke, CW; Higaki, M; Izumi, AK | 1 |
| Chan, SL | 1 |
| Freerksen, E; Rosenfeld, M | 3 |
| van Geuns, HA | 1 |
| Kuntz, HD; Rausch, V | 2 |
| Spiess, H | 1 |
| Girling, DJ | 1 |
| Alexander, MR; Guernsey, BG | 1 |
| Georgi, M; Kissler, W; Rubin, R; Rumpelt, HJ; Schulz, V | 1 |
| Fujuda, T; Hagiwara, S; Ishihara, S | 1 |
| Burckart, GJ; Ch'ien, LT; McKenzie, MS | 1 |
| Black, M | 1 |
| Radenbach, KL | 3 |
| Aquinas, M | 1 |
| Grosset, J; Perdrizet, S; Pretet, S | 1 |
| Coutts, II; Jegarajah, S; Stark, JE | 1 |
| Clavel, S; Clement, F | 1 |
| Abensohn, MK; Kobayashi, GS; Marr, JJ; McDaniel, RE; Medoff, G; Spoon, DR | 1 |
| Simmons, NA | 1 |
| Janowiec, M; Wiśniewska, A; Wróblewska, H; Zwolska-Kwiek, Z | 1 |
| Gulevskaia, SA; Milovanova, EV | 1 |
| Fox, TG | 1 |
| Freerksen, E | 5 |
| Awe, RJ; Bunyan, SB; Edsall, JR; Hackney, RL; Iseman, MD; Reagan, WP | 1 |
| Aber, VR; Dickinson, JM; Mitchison, DA | 1 |
| Kunze, M; Sanabria de Isele, T; Vogt, A | 1 |
| Stur, D; Thiel, W | 1 |
| Afanas'eva, IuP; Kuznetsova, VI | 1 |
| Camargo, EE; Charache, P; Chen, MF; Hwangbo, CC; Kertcher, JA; McIntyre, PA; Wagner, HN | 1 |
| Bach, VT; Thadepalli, H; Webb, DW | 1 |
| Kittel, H | 1 |
| Campbell, PB | 1 |
| Lester, W | 3 |
| Dutt, AK; Jones, L; Stead, WW | 1 |
| Karli, P; Kovanen, J | 1 |
| Peatfield, RC; Shawdon, HH | 1 |
| Eule, H | 3 |
| Campbell, IA; Dyson, AJ | 2 |
| Dutt, AK; Stead, WW | 11 |
| Malègue, D; Tillement, JP | 1 |
| Lebeau, B; Rochemaure, J | 1 |
| Aluoch, JA | 1 |
| de Wael, J; Kreukniet, J; Mattie, H; Mouton, RP; Swart, K | 1 |
| Darnis, F; Gustot, P; Meyniel, D; Petit, J; Poupon, RY | 1 |
| Johnston, RF; Promisloff, RA | 1 |
| Burke, M; Logan, J | 1 |
| Kuze, F; Lee, Y; Maekawa, N; Suzuki, Y | 1 |
| Aizawa, H; Inoue, I; Kameda, K; Sasaoka, M; Shimada, M; Suzuki, T; Yamaguchi, W; Yamamoto, K | 1 |
| Wipf, R | 1 |
| Addington, WW | 1 |
| Dawson, DJ; Woolcock, WJ | 1 |
| Göbel, D; Jungbluth, H; Kropp, R; Matthiessen, W; Radenbach, KL; Wundschock, M | 1 |
| Canavate, A; Sainte-Laudy, J; Sauvaget, J | 1 |
| Boediman, I; Lazuardi, S; Rahajoe, N; Rahajoe, NN; Said, M | 1 |
| Lange, W | 1 |
| Ioffe, RA | 1 |
| Balogh, F; Borthwick, WM; Mallo, N; Mazurek, L; Trnka, L; Victorov, J | 1 |
| Kimbel, KH | 1 |
| Austerhoff, A; Kindler, U; Knop, P | 1 |
| Kohan, S | 1 |
| Llorens, J; Sanchez, R; Serrano, RJ | 1 |
| Fallon, RJ | 1 |
| Seaton, A | 1 |
| Medici, TC; Steiner, A | 1 |
| Dalet, F; Mallo, N; Villavicencio, H | 2 |
| Sunakorn, P; Wongsaroj, P | 1 |
| Donta, ST; Doty, DB; Goeken, JA; Lohr, DC | 1 |
| Chang, CE; Luan, HW; Luh, KT; Yang, SP | 1 |
| Bobrowitz, ID | 3 |
| Lauver, GL | 1 |
| Robinson, D | 1 |
| Berthelot, P | 1 |
| Heising, J; Seiferth, J | 1 |
| Bammel, E; Kuntz, HD; Rausch, V | 1 |
| Thompson, JE | 2 |
| Groopman, JE; Soloff, L; Tessler, S | 1 |
| Audet, PR; Johnston, RF | 1 |
| Bonnici, E; Depasquale, G; Freerksen, E; Kriiger-Thiemer, M; Rosenfeld, M | 1 |
| Kanai, K; Kondo, E | 3 |
| Bergogne-Berezin, E; Berthelot, G; Coulaud, JP; Modai, J; Vivien, JM | 1 |
| Ehring, F | 1 |
| Gutman, L | 1 |
| Azuma, Y; Baba, H; Shinkai, A | 1 |
| Rouy, JM; Vallat, G; Vivés, JF; Wagner, A | 1 |
| Junnanond, C; Kotchabhakdi, N | 1 |
| Fröseth, B; Grönhagen-Riska, C; Hellstrom, PE | 1 |
| Elliott, J | 1 |
| Utkin, VV | 1 |
| Badalik, L; Kruty, R; Matula, F; Virsik, K | 1 |
| Craig, RM; Neumann, TG; Poticha, S | 1 |
| Kabuubi, JB | 1 |
| Halpern, AA; Nagel, DA | 1 |
| Gieraths, A; Musch, E; Rudolf, G; Schunter, C; von Oldershausen, HF | 1 |
| Aujard, Y; Beaufils, F; Caron, M; Choulot, JJ; Labrune, B | 1 |
| Ait Khaled, N; Benachenhou, A; Chaulet, P; Fekar, A; Virot, JP | 1 |
| Kleber, FX | 1 |
| Koerner, SK; Pinsker, KL | 1 |
| Haubensak, K; Osterhage, HR | 1 |
| Fairshter, RD; Garlin, J; Randazzo, GP; Wilson, AF | 1 |
| Cho, CT; D'Souza, BJ; Lansky, LL | 1 |
| Beggs, WH | 1 |
| Havel, A; Rosenfeld, M | 1 |
| Stottmeier, KD | 1 |
| MacGregor, RR; Mayock, RL | 1 |
| Blaha, H; Göb, A | 1 |
| Neubert, R | 1 |
| Kumar, S; Mehta, JA; Trivedi, HL | 1 |
| Pawłowska, I; Szydłowska, T | 1 |
| Benhamou, JP; Bentata, M; Degott, C; Miguet, JP; Nouel, O; Pessayre, D; Rueff, B | 1 |
| Buckingham, WB | 2 |
| Kasik, JE; Schuldt, S | 1 |
| Dhumeaux, D; Mavier, P; Miguet, JP; Soussy, CJ | 1 |
| Hinshaw, HC | 1 |
| Pilheu, JA | 1 |
| Aizawa, H; Sasaoka, M; Suzuki, T; Yamaguchi, W; Yamamoto, K | 1 |
| Bossaert, H; Geboes, K | 1 |
| Bessot, JC; Burghard, G; Petitjean, R; Vandevenne, A | 1 |
| Rosenzweig, DY | 1 |
| Abeledo Mezquita, G; Otero Reigada, MC | 1 |
| Gol'dshteĭn, VD; Ioffe, RA; Kriukov, VL | 1 |
| Mahlberg, FA; Müller, RW; Rodermund, OE | 1 |
| Solomonraj, G; Thomas, BH | 1 |
| Inaba, N; Kuze, F; Maekawa, N; Ohi, Y; Yamada, E; Yasubuchi, Y | 1 |
| Angelillo, VA; Scheinhorn, DJ | 1 |
| Grundmann, E; Schmidt-Wilcke, HA; Wolfert, W | 1 |
| Frey, N; Legrand, M; Peltier, G; Teyssier, L | 1 |
| Albengres, E; Breau, JL; Chrétien, J; Hirsch, A; Houin, G; Saltiel, JC; Tillement, JP | 1 |
| Buchanan, N; van der Walt, LA | 1 |
| Van Scoy, RE | 1 |
| McDonald, RJ; Reichman, LB | 1 |
| McGuire, WW | 1 |
| Bloomfield, SE; Gray, GF; Mondino, B | 1 |
| McConville, JH; Rapoport, MI | 1 |
| Kvapilová, M; Mison, P; Trnka, L | 1 |
| Pereira, V | 1 |
| Chasseaud, LF; Garnham, JC; Taylor, T; Turner, P | 1 |
| Cordero, O; Pacheco, CR; Pacheco, J; Sierra, D; Vázquez, E | 1 |
| Collier, J; Joekes, AM; Philalithis, PE; Thompson, FD | 1 |
| Kindler, U; Stiehl, G | 1 |
| Deck, KA; Gehrhardt, A; Klein, HO; Ludes, H | 1 |
| Burgher, LW; Novak, RA | 1 |
| Repnitskaia, ZD | 1 |
| Allué, X; Bilbao, F; Fidalgo, I; Sanjurjo, P | 1 |
| Chandra, B | 1 |
| Leinweber, B; Mahrt, R | 1 |
| Corradini, A; Deck, C; Farga, V; Fernandez, M; Isekson, I; Zamorano, T | 1 |
| Lee, SK | 1 |
| Eule, H; Iwainsky, H; Kaernbach, E; Kaluza, P; Saerens, E; Werner, E | 1 |
| Leowski, J; Mroz-Czajka, D; Nachman-Bijas, J; Pecak, W; Trzcinski, K; Wlazlo, Z | 1 |
| Harris, GD; Johnason, WG; Nicholson, D | 1 |
| Angel, JH; Campbell, IA; Citron, K; Somner, AR | 1 |
| Dubra, FA | 1 |
| Calvete, C; Cetrangolo, A; Dambrosi, A; Gonzalez Montaner, LJ; Leston, JM; Mosca, C; Szemzo, J | 1 |
| De Las Aguas, JT | 1 |
| Ammen, VK | 1 |
| Casteels-Van Daele, M; Corbeel, L; Eeckels, R; Igodt-Ameye, L | 1 |
| Tala, E | 1 |
| Terencio de las Aguas, J | 1 |
| Alvarenga, AE; Innami, S; Leguizamón, OR | 1 |
| Depasquale, G | 2 |
| Hamzah, M; Kosasih, A | 1 |
| Krenzien, HN | 1 |
| Rohde, R | 1 |
| Somner, AR | 2 |
| Colmers, RA; Wilkes, LL | 1 |
| Johnson, J | 1 |
| Haegi, V | 1 |
| Francis, PB; Jay, SJ; Johanson, WG | 1 |
| Irwin, RS; Parker, MD | 1 |
| Beuscart, F; Carre, A; Ginestet, A; Jaillard, J; Perrard, C; Warembourg, H | 1 |
| Harris, GD; Johanson, WG; Nicholson, DP | 1 |
| Israel, HL | 2 |
| Lattimer, JK; Wechsler, M | 1 |
| Dall, G; Jenkin, DJ | 1 |
| McClement, JH | 1 |
| Aschhoff, M | 1 |
| Bentley, SE; Flynn, JP | 1 |
| Grassi, C; Grassi, GG | 1 |
| Heffernan, JF | 1 |
| Allen, BW; Ellard, GA; Gammon, PT; King, RC; McDougall, AC; Rees, RJ; Weddell, AG | 1 |
| Sifontes, JE | 1 |
| Chiemchanya, S; Visudhiphan, P | 2 |
| David, S; Fuchs, FF; Schaefer, G; Zervoudakis, IA | 1 |
| Rosen, DI | 1 |
| Morrison-Smith, J | 1 |
| Hoose, C | 1 |
| Vale, JR | 1 |
| Gow, JG; O'Boyle, P | 1 |
| Elliott, RC; Gunther, SF | 1 |
| Derichs, R; Kindler, U; Merholz, S | 1 |
| Kindler, U; Knop, P; Merholz, T | 1 |
| Garfield, JW; Giusti, LM; Gutjahr, CL; Kreek, MJ | 1 |
| Szymański, A | 1 |
| Dovlatian, AA; Dzhenzhera, NA | 1 |
| Chen, YM; Lee, PY; Perng, RP; Su, WJ | 1 |
| Demura, H; Horiba, N; Kono, A; Nomura, K; Suda, T; Sun, ZH; Toraya, S; Tsushima, T; Ujihara, M | 1 |
| Kumar, L | 1 |
| Kwan, SY; Lee, J; Wong, PC; Yew, WW | 1 |
| Benichou, P; Boyer, G; Darbas, H; Jean-Pierre, H; Rivière, M | 1 |
| Cheng, WB; Li, D; Wang, ZY; Zhang, RL | 1 |
| Dinh-Xuan, AT; Grosset, J; Lebeaut, A; Parrot, R; Pretet, S; Truffot, C | 1 |
| Aber, VR; Allen, BW; Chan, SL; Felmingham, D; Girling, DJ; Ma, WK; Mitchison, DA; Yew, WW | 1 |
| Abdi, A; Lema, E; Roscigno, G; Wolde, K | 1 |
| Kimura, H; Kusaba, T; Nagasawa, K; Otsuka, T; Sakata, T; Tada, Y; Tsuda, Y | 1 |
| Culliton, BJ | 1 |
| Malhi, R; Sharma, PL; Uppal, R | 1 |
| Arora, R; Arora, VK; Oumachigui, A; Rajaram, P | 1 |
| Rüsch-Gerdes, S; Schaper, KJ; Seydel, JK | 1 |
| Kumaresan, JA; Maganu, ET | 1 |
| Yu, BZ | 1 |
| Ichiyama, S; Shimokata, K; Tsukamura, M; Yamori, S | 1 |
| el-Yazigi, A; Raines, DA | 1 |
| Dickinson, J; Guy, A; Mitchison, DA | 1 |
| Aroni, S; Farmakis, M; Fertakis, A; Travlou, O | 1 |
| Hara, K; Kaku, M; Koga, H; Kohno, S; Maesaki, S | 1 |
| Schmidt, M | 1 |
| Hitoglou-Makedou, A; Pratsidou, P; Sofroniadis, I; Tsakalidis, D; Tzouvelekis, G | 1 |
| Nolan, CM | 1 |
| Kikuchi, Y; Kimura, S; Mitamura, K; Oka, S; Shimada, K | 1 |
| Aleksandrova, AE; Bispen, AV; Vakhmistrova, TI; Vinogradova, TI | 1 |
| Cole, ST; Heym, B | 1 |
| Kobayashi, H; Narita, M; Shibata, M; Togashi, T | 1 |
| Clayton, AS; Harrison, RH; Pang, SC | 1 |
| Fujimoto, K; Honda, T; Kobayashi, T; Kubo, K; Matsuzawa, Y; Nakagawa, S; Nakamura, Y; Sekiguchi, M | 1 |
| Cox, NL; Maddison, MC; Maddison, PJ; Prowse, MV | 1 |
| Blanc, JM; de Francisco, JE; Fumanal, L; Garcia Guzman, A; Valles, H | 1 |
| Gokal, R; Johnson, RW; O'Donoghue, DJ; Short, CD | 1 |
| Chotpitayasunonah, T; Jacobs, RF; Kelleher, K; Pope, S; Sunakorn, P | 1 |
| Khoo, SH; Warner, TT; Wilkins, EG | 1 |
| Stingl, P | 1 |
| Berlin, OG; Giladi, M; Lee, BE; Panosian, CB | 1 |
| Dutt, AK; Moers, D; Stead, WW | 7 |
| Annam, O; Duque, JP; Idigbe, EO; John, EK | 1 |
| Hasegawa, T; Ishii, M; Tada, K | 1 |
| Kovaleva, SI | 1 |
| Pust, RE | 1 |
| Alberte, A; Estébanez, MJ; Martínez-Sagarra, JM; Pascual, PP | 1 |
| Grosset, J; Ji, B; Lacroix, C; Truffot-Pernot, C | 1 |
| Nakazono, T | 1 |
| Kleeberg, HH; Weyer, K | 1 |
| al Hajjaj, MS; al Shareef, AH; al-Shammari, SA; Bukhari, MS; Elias, AK; Jarallah, JS | 1 |
| Bhatt, KM; Okelo, GB; Sang, D | 1 |
| Chirgwin, KD; Dahdouh, MA; Glatt, AE; Landesman, SH; Shafer, RW; Suster, B | 1 |
| Misra, RS; Mukherjee, A; Ramesh, V; Saxena, U | 1 |
| Lalwani, AK; Lee, KC; Schecter, G; Tami, TA | 1 |
| Lumb, R; Shaw, D | 1 |
| Donald, PR; Parkin, DP; Seifart, HI | 1 |
| Adrados, M; Díaz, F; García Aguado, C; González Lahoz, JM; Laguna, F; Martínez, R; Puente, S | 1 |
| Baenskiĭ, AV; Chukanov, VI; Litvinov, VI; Tikhtaev, MT | 1 |
| Bobarykin, VS | 1 |
| Skakun, NP; Tabachuk, OE | 1 |
| Barnes, L; Clancy, L; Collins, P | 1 |
| Alvarenga, AE; de Morra, MV; Freerksen, E; Leguizamon, O; Reyes, LA; von Ballestrem, W | 2 |
| Iwainsky, H; Wiesner, B; Winsel, K | 1 |
| Cramer, G; Hamel, U; Roth, G; Wiesner, B | 1 |
| Cheng, KP; Cheung, WC; Ip, M | 1 |
| Mahashur, AA; Prabhudesai, PP | 1 |
| Burk, RF; DesPrez, RM; Steele, MA | 1 |
| Berlie, HC; Chevret, S; Dautzenberg, B; Grosset, J; Legris, S; Mercat, A; Meyohas, MC; Truffot, C | 1 |
| Alexander, M; Held, T; Mielke, M; Reichelt, A; Rössler, W | 1 |
| Loboda, MV | 1 |
| Skakun, NP; Slivka, IuI | 1 |
| Hoffner, SE; Svenson, SB | 1 |
| Tsukamura, M | 3 |
| Barton, SE; Gazzard, B; Kell, PD; Marwood, RP; Nelson, M; Smith, DE | 1 |
| Mel'nik, VP | 1 |
| Barry, C; Coughlan, RJ; Deegan, RI; Foley-Nolan, AA; Foley-Nolan, D; Hone, R | 1 |
| Lode, H; Schaberg, T | 2 |
| Chaisson, RE; Goodman, PC; Hopewell, PC; Sande, MA; Schecter, GF; Small, PM | 1 |
| Kunichan, AD; Shapatava, MN; Sokolova, GB | 2 |
| Collins, FM; Flory, CM; Hubbard, RD | 1 |
| Govil, YC; Kumar, A; Mehotra, R; Misra, PK; Rana, GS | 1 |
| Zhang, YS | 1 |
| Gamzaeva, NF; Kalankhodzhaev, AA | 1 |
| Horsfield, N; McCarthy, OR; Ormerod, LP; Rudd, RM | 2 |
| Abernathy, RS; Jacobs, RF; Stead, WW | 1 |
| Chan, HS; Chan, K; Walubo, A; Wong, CL; Woo, J | 2 |
| Eng, J; Hoel, T | 1 |
| Dhall, GI; Jindal, SK; Jindal, UN | 1 |
| Actis, G; Alberico, G; Genovesio, L; Goitre, M; Mele, M; Molinaro, GC; Puiatti, P; Salvai, M | 1 |
| Kaojarern, S; Krittiyanunt, S; Mokkhavesa, C; Phuapradit, P; Supmonchai, K | 1 |
| Gupta, EV; Rac, VV; Thomas, IM | 1 |
| Finsterbush, A; Husseini, N; Mann, G; Shaul, J | 1 |
| Ichikawa, Y; Kawahara, M; Nakamura, M; Oizumi, K; Rikimaru, T | 1 |
| Adachi, M; Kimura, M; Kobashi, Y; Matsushima, T | 1 |
| Kempf, HG | 1 |
| O'Brien, RJ | 1 |
| Bhide, M; Madhukar, K; Prasad, CE | 1 |
| Hara, M; Hirata, H; Iwasaki, T; Kinjo, T; Kino, C; Kinoshita, T; Odo, A; Sato, M; Takase, A; Yamaguchi, T | 1 |
| Dietz, M; Haas, M; Lindner, B; Seydel, U; Tebebe, YB | 1 |
| Kuze, F | 1 |
| Catlin, BJ; Cohn, DL; Judson, FN; Peterson, KL; Sbarbaro, JA | 1 |
| Agounitestane, D; Ait Khaled, N; Boulahbal, F; Chaulet, P; Chiheb, M; Khaled, S | 1 |
| Byrne, C; Clancy, LJ; Costello, E; Kelly, P; O'Reilly, L | 1 |
| Eberhardt, K; Hartmann, W; Hoose, C; Wosniok, W | 1 |
| Magnussen, H; Nowak, D; Radenbach, D | 2 |
| Kaur, S; Kumar, B; Radotra, BD; Sharma, VK | 1 |
| Cowie, RL | 3 |
| Carré, G; Hershfield, E; Jean-Baptiste, M; Long, R; Nelz, K; Parker, S; Scalcini, M; Wolfe, J | 1 |
| Chau, PY; Khin, MA; Kwan, SY; Ma, WK; Yew, WW | 1 |
| Croughan, M; Harris, G; Rayner, A; Watt, B | 1 |
| Balasubramanian, R; Jawahar, MS; Paramasivan, CN; Ramachandran, R; Selvakumar, N; Sivasubramanian, S; Somasundaram, PR; Vijayan, VK | 1 |
| Stazi, C; Stazi, F | 1 |
| Combs, DL; Geiter, LJ; O'Brien, RJ | 1 |
| Agnew, RA; Bucknall, RC; Nisar, M; Watkin, SW | 1 |
| Tsukamura, M; Yamori, S | 1 |
| Brink, BA; Cowie, RL | 1 |
| Rasmussen, KL | 1 |
| Sehgal, VN; Wagh, SA | 1 |
| Campbell, IA | 3 |
| Balakrishnan, A; Christian, M; Nagarajan, M; Prabhakar, R; Somasundaram, PR; Thomas, A; Tripathy, SP | 1 |
| Cappell, MS; Javeed, M | 1 |
| Golyshevskaia, VI; Kalmykova, GN; Khomenko, AG; Maslova, LI; Uvarova, OA | 1 |
| Kusema, T; Mhonda, M; Neill, P; Nhachi, CF; Pringle, D | 1 |
| Sbarbaro, J | 1 |
| Iurchenko, LN; Koriakin, VA; Onishchenko, VV; Shapatava, MN; Sokolova, GB | 1 |
| Assis, I; Bedran, MB; Moura, JA; Reis, FJ; Rodrigues, ME | 1 |
| Farrell, VJ | 1 |
| Bielory, L; Holland, CL; Malasky, C; Ogunkoya, A | 1 |
| Wu, QQ | 1 |
| Alarcón, F; Banda, H; Chacón, G; Dueñas, G; Escalante, L; Pérez, Y | 1 |
| Dupuis, M; Rousseau, P | 1 |
| Morland, L | 1 |
| Dhand, R; Katariya, S; Kumar, L; Rao, KL; Singhi, PD | 1 |
| Eriksen, NH; Jensen, TH; Magnussen, P; Skinhøj, P | 1 |
| Absadykova, FT; Kazakov, KS; Zakharova, RI | 1 |
| Bibergal', EA; Fadeeva, NI; Golyshevskaia, VI; Safonova, SG | 1 |
| Aoyagi, T; Toyoda, T | 1 |
| Cheung, WL; Ng, A; Siu, KF | 1 |
| Chan, CY; Huang, YS; Lee, PY; Lee, SD; Lo, KJ; Ting, LP; Tsai, YT; Wang, YJ; Wu, JC; Yeh, PF | 1 |
| Anthoine, D; Derelle, J | 1 |
| Goromaru, T | 1 |
| Pitchenik, AE | 1 |
| Loos, U; Musch, E; Schwabe, HK | 2 |
| Bosch Castañé, J; Carrascosa Lezcano, A; Castillo Salinas, F; Gussiñé Canadell, M; Montané Pasamontes, C; Pérez LaCasta, P; Sóle Mir, E | 1 |
| Gurumurthy, P; Narayana, AS; Rahman, F; Sarma, GR | 1 |
| Dylewski, J; Thibert, L | 1 |
| Gerasimova, TG; Marveeva, SL; Pashkov, IuN; Roslik, SM | 1 |
| Benatar, SR; Maartens, G; Willcox, PA | 1 |
| Li, YD | 1 |
| Haymond, R; Mansour, AM | 1 |
| Holdiness, MR | 4 |
| Mengistu, G; Warndorff van Diepen, T | 1 |
| Mitchison, DA; Nunn, AJ | 1 |
| Barnum, HN | 1 |
| Katoch, K; Ramanathan, U; Ramu, G | 1 |
| Daramas, M; Jittinandana, A; Kecharanandana, P; Payanandana, W | 1 |
| Heifets, L | 1 |
| Chung, YM; Liu, JH; Sheu, SJ; Yeh, TS | 1 |
| Aziz, A; Aziz, K; Ishaq, M; Siddiqi, SH | 1 |
| Jittinandana, A | 1 |
| Domingo, Z; Peter, JC | 1 |
| Rao, VR; Subhashini, M; Subramanian, MS | 1 |
| Dhillon, J; Mitchison, DA | 2 |
| Chugh, KS; Kumar, L; Pereira, BJ; Sakhuja, V; Singh, U; Singhi, PD | 1 |
| Gheorghiu, M; Grosset, J; Lagrange, PH; Lecoeur, HF; Truffot-Pernot, C | 1 |
| Cohen, AH; Finkelstein, Y; Talmi, YP; Versano, I; Zohar, Y | 1 |
| Yokouchi, H | 1 |
| Beliakova, OI; Sibirnaia, RI; Snitinskaia, Os | 1 |
| al-Orainey, IO; al-Shareef, N; el-Kassimi, FA; Saeed, ES | 1 |
| Elghoul, MT; Joshi, RM; Rizghalla, T | 1 |
| Ichiyama, S; Miyachi, T; Tsukamura, M | 1 |
| Celle, G; Gesu, GP; Picciotto, A; Schito, GC; Testa, R; Varagona, G | 1 |
| Castelo, A; da Silva, EA; Dalboni, MA; Goihman, S; Haynes, RB; Jardim, JR; Kalckman, AS | 1 |
| Volosevich, GV | 1 |
| Chadwick, M; Gaya, H; Nicholson, G | 1 |
| Svinchuk, VS | 1 |
| Boguikouma, JB; Gahouma, D; Gendrel, D; Mouba, JF; Moussavou, A; Nardou, M | 1 |
| Sinha, PK; Thakur, CP | 1 |
| McCarthy, OR; Rudd, RM | 1 |
| Ellard, GA; Jenner, PJ | 1 |
| Heap, BJ | 1 |
| Basu, D; Mahalanabis, KK; Roy, B | 1 |
| Gharpuray, MB; Kulkarni, DS; Kulkarni, V | 1 |
| Tournier, G | 1 |
| Choudhury, AR | 1 |
| Beotra, A; Seth, V | 1 |
| Andrzejczyk, Z; Janowiec, M; Marczewska, J | 1 |
| Ladron de Guevara, R | 1 |
| Abtroun, N; Amrane, R; Boulahbal, F; Mazouni, L; Zidane, C | 1 |
| Bellabas, M; Boulahbal, F; Chaulet, P; Khaled, NA; Khaled, S | 1 |
| Baumann, HR; Bohn, W; Brändli, O; Haegi, V; Villiger, B; Zäch, R | 1 |
| Alvarenga, AE; Haubitz, I; Leguizamon, O; Pritze, S | 1 |
| Bellon, G; Gallet, S | 1 |
| Borque Andrés, C; Castán Vidal, ML; de José Gómez, MI; García Hortelano, J; Garciá López, JR; Vidal López, ML | 1 |
| Acevedo, C; De Salvo, MC; Galati, MR; García Fernández, JC; Masana, M; Mingolla, L; Negroni, R; Pilheu, JA; Rubio, MC; Yunis, AS | 1 |
| Jones, LK; Koestner, JA; Polk, WH; Sawyers, JL | 1 |
| Kasantikul, V | 1 |
| Bakir, M; Doğanay, M; Dökmetaş, I | 1 |
| Felten, MK | 1 |
| Ben-Ami, M; Flatau, E; Kaufman, N; Raz, R | 1 |
| Klimniuk, EV; Slivka, IuI; Tabachuk, OE | 1 |
| Acocella, G | 3 |
| Gerritsen, J; Knol, K | 1 |
| Boccon-Gibod, L; Debré, B; Leleu, C; Sicard, D; Steg, A | 1 |
| Chan, JC; Humphries, MJ; Ng, HK; O'Mahony, G; Teoh, R | 1 |
| Akhtyrskiĭ, AI; German, AK; Shevchenko, RN; Smirnova, VV | 1 |
| Rajasekaran, S; Soundarapandian, S | 1 |
| Weinecke, A | 1 |
| Fischer, P; Merkel, S; Weinecke, W | 1 |
| Felten, MK; van der Merwe, CA | 1 |
| Iseman, MD | 3 |
| Grosset, JH; Lecoeur, HF; Truffot-Pernot, C | 1 |
| Ogiwara, S | 1 |
| Zeis, BM | 1 |
| Leppert, D; Waespe, W | 1 |
| Bolinger, AM; Levin, RH | 1 |
| Harman, EM | 1 |
| Donald, PR; O'Kennedy, A; Schoeman, JF | 1 |
| Cantraine, F; Fuss, M; Toppet, M; Vainsel, M; Vertongen, F | 1 |
| Peng, DH; Wang, ZX | 1 |
| Herrero, JA; Lamas, S; Mampaso, F; Matesanz, R; Ortuno, J; Teruel, JL | 1 |
| Aeberhardt, G; Bernheim, J; Dautzenberg, B; Gallinari, C; Grosset, J; Lévy, A; Sors, C | 1 |
| Ellis, ME; Tayoub, F | 1 |
| Gangadharam, PR | 1 |
| Aluoch, JA; Babu Swai, O; Darbyshire, JH; Edwards, EA; Githui, WA; Nunn, AJ; Thiong'o, R | 1 |
| Cox, JH; Ivanyi, J | 1 |
| Nariman, S | 1 |
| Woodley, CL | 1 |
| Hawkins, JE | 1 |
| Nardi, M; Notterman, DA; Saslow, JG | 1 |
| Etzkorn, ET; Lillis, PK; McAllister, CK | 1 |
| Coates, AR; Khor, M; Lowrie, DB; Mitchison, DA | 1 |
| Ismatullaev, F; Sodikov, ES | 1 |
| Mitchell, M; Rao, M; Steiner, M; Steiner, P | 1 |
| Gibson, J | 1 |
| Ayres, JG; Thomas, HE | 1 |
| Nash, DR; Steele, LC; Steingrube, V; Wallace, RJ | 1 |
| Khor, M; Lowrie, DB; Mitchison, DA | 1 |
| Ashtekar, DR; Fernandes, F; Khadse, BG; Shirodkar, MV | 1 |
| Helsens, C; Krespine, C | 1 |
| Demidchik, NIa; Firsova, VA; Ovsiankina, ES; Sarkisian, MA | 1 |
| Casal, M; Gonzalez, J; Gutierrez, J; Ruiz, P | 2 |
| Constantopoulos, A; Krikos, X; Loupa, H | 1 |
| Baohong, J; Grosset, JH; Ito, T | 1 |
| Xu, RX | 1 |
| Azuma, Y; Baba, H; Izuchi, R; Shinkai, A | 1 |
| Davis, JR; Libonati, JP; Siddiqi, SH; Stager, CE | 1 |
| Desai, SG; Trivedi, SS | 1 |
| Anséhn, S; Hoffner, SE; Nilsson, LE | 1 |
| Chang, CE; Heifets, LB; Lin, TP; Suo, J | 1 |
| Hopewell, PC; Schecter, GF; Slutkin, G | 1 |
| Hawkins, DB; Kahlstrom, EJ; Schwartz, MS | 1 |
| Acker, EJ; Bither, HD; Gezon, HM; Gibbs, HC; Hanson, LA; Jorgenson, RD; Thompson, JK | 1 |
| Collins, CH; Uttley, AH | 1 |
| Grosset, JH; Lecoeur, H; Truffot-Pernot, C | 1 |
| Almog, S; Bank, HZ; Farfel, Z; Halkin, H; Martinowitz, U | 1 |
| Dal Negro, R; De Conti, F; Trevisan, F; Turco, P | 1 |
| Abadie-Kemmerly, S; Dalovisio, JR; Dalvisio, JR; Pankey, GA | 1 |
| Cheung, R; Deshmukh, AA; Dickins, J; Dobbs, RJ; Dobbs, SM; Larson, HE; Nicholson, PW; Smith, HH; Thomas, AS | 1 |
| Acocella, G; Gialdroni-Grassi, G; Grassi, C; Nonis, A | 1 |
| Acocella, G; Gialdroni-Grassi, G; Grassi, C; Nonis, A; Patane, E; Perna, G | 1 |
| Anisimova, NB; Karkishchenko, NN; Khoron'ko, VV; Lavrushko, AN; Vorob'ev, VS | 1 |
| Dhand, R; Garg, SK; Gupta, PH; Jha, VK; Kalra, S; Lal, R; Malik, SK; Shukla, VK | 1 |
| Hara, Y; Okamoto, Y; Umeki, S | 1 |
| Andrzejczyk, Z; Janowiec, M; Szwedowicz, I | 1 |
| Mehta, S | 1 |
| Tan, KK; Tan, TH | 1 |
| Ormerod, LP | 5 |
| MacIntyre, D; Perros, P; Sim, DW | 1 |
| Kamigawara, N; Ueshiba, Y | 1 |
| Boulahbal, F; Chaulet, P; Hamadi, A; Khaled, S | 1 |
| Goldberger, MJ | 1 |
| Baskin, GB; Gibson, SV; Watson, EA; Wolf, RH | 1 |
| Kleeberg, HH | 1 |
| Lee, CN; Lee, JJ; Lin, TP; Suo, J; Yang, SP | 1 |
| Czaplińska-Jóźwiak, E; Szymański, A | 1 |
| Combs, DL; Geiter, LJ; O'Brien, RJ; Snider, DE | 1 |
| Ichiyama, S; Tsukamura, M | 1 |
| McConkey, B; Situnayake, RD | 1 |
| Elias-Jones, AC; Heard, SR; Leitch, RN; Sequeira, J | 1 |
| Rieder, HL | 2 |
| Anisimova, NB; Chubarian, VT; Karkishchenko, NN; Khoron'ko, VV; Vorob'ev, VS | 1 |
| Banks, J; Jenkins, PA | 1 |
| Fox, H; Legmann, P; Levesque, M; Ollivier, C | 1 |
| Krishnaswamy, K; Polasa, K | 1 |
| Hoffner, SE; Källenius, G; Svenson, SB | 1 |
| Kim, I; Moon, MS; Park, YO; Woo, YK | 1 |
| Aftimos, S; Nicol, R | 1 |
| Saito, H; Tsukamura, M; Yasuda, Y; Yoshii, S | 1 |
| Camí, J; de la Torre, R; Llorens-Terol, J; Martinez-Roíg, A; Perich, F | 1 |
| Du, BY; Zhang, JY | 1 |
| Kim, ACh; Krasnova, TK; Romanova, VIa | 1 |
| Bek, E; Farer, LS; Graczyk, J; Snider, DE; Zierski, M | 1 |
| Des Prez, RM; Sheller, JR | 1 |
| Konishiike, J; Unno, M; Yamamoto, S | 1 |
| Ramírez, O; Ramírez, R | 1 |
| Ahn, CH; Ahn, SS; Anderson, RA; Mammo, A; Murphy, DT | 1 |
| Beck, H; Eule, H; Evers, H; Fischer, P; Kwiatkowski, H; Merkel, S; Reech, R; Sieler, R; Thomas, E; Weinecke, W | 1 |
| Davidson, PT; Hanh, LQ | 1 |
| Aderinto, EB; Awotedu, AA; Ogunbanjo, BO; Onadeko, BO | 1 |
| Adendorff, JJ; Boeke, EJ; Lazarus, C | 1 |
| Albertini, M; Boutte, P; Mariani, R; Picon, M | 1 |
| Corsello, BF | 1 |
| Liu, C; Yoshida, F | 1 |
| Hashimoto, M; Higai, S; Taniguchi, H; Yokoyama, S | 1 |
| Leiker, DL | 1 |
| Alvarenga, AE | 1 |
| Dietrich, M; Wabitsch, R | 1 |
| Chum, HJ | 1 |
| Thomas, BH; Whitehouse, LW; Zeitz, W | 1 |
| Casal, M; Rodriguez, F; Villalba, R | 1 |
| Geiter, LJ; O'Brien, RJ | 1 |
| Heifets, LB; Lee, CN | 1 |
| Kobayashi, Y; Mochizuki, K; Nagasawa, S; Shigeto, E | 1 |
| Homma, S; Morinari, H; Okubo, S; Tanaka, M; Terashi, R | 1 |
| Baĭborodova, TI; Gavrilova, TA; Kislitsyna, NA; Kukchenko, GA; Shatskaia, GI | 1 |
| Phuapradit, P; Vejjajiva, A | 1 |
| Aubert, JD; Beer, V; Leuenberger, P | 1 |
| Horsfield, N; Ormerod, LP | 1 |
| Behera, D; Gilhotra, R; Malik, SK | 1 |
| Ivleva, AIa; Koriakin, VA; Sokolova, GB; Zeliger, LR; Ziia, AV | 1 |
| Caglayan, S; Gun, M; Kasirga, E; Kayran, K; Timocin, N; Yegin, O | 1 |
| el-Attar, H; Israili, ZH; Rogers, CM | 1 |
| Van Scoy, RE; Wilkowske, CJ | 2 |
| Bassan, HM; Oliven, A | 1 |
| Arnkvaern, R; Boye, NP; Fjeld, NB; Mellem, H | 1 |
| Konishiike, J; Mochizuki, K; Sasaki, Y; Shigeto, E | 1 |
| Chang, CE; lin, TP; Luh, KT; Yang, SP | 1 |
| Kamińska, M; Kopeć, H; Maternowska, W; Nikodemowicz, E; Prus, F; Sembratowicz, L | 1 |
| Duraipandian, M; Nagarajan, M; Prabhakar, R; Ramachandran, P; Ramakrishnan, CV; Tripathy, SP | 1 |
| Immanuel, C; Kailasam, S; Narayana, AS; Sarma, GR; Venkatesan, P | 1 |
| Allen, BW; Chan, SL; Ellard, DR; Ellard, GA; Girling, DJ; Ng, HK; Nunn, AJ; Tan, TH; Teo, SK | 1 |
| Berkani, M; Chaulet, P; Darbyshire, JH; Fox, W; Nunn, A | 1 |
| Burghard, G; Chenuet, J; Liard, R; Perdrizet, S; Petitjean, R; Pierau, F; Rempp, M | 1 |
| Crewe-Brown, HH; Glatthaar, E; McCutcheon, JP; Summers, RS | 1 |
| Matsubayashi, T; Nishimura, T; Nishinuma, K; Takeda, M; Tanino, S; Yamashita, S | 1 |
| Buss, WC; Spalding, CT | 1 |
| Jenkins, MV; Perry, W | 2 |
| Firsova, VA; Melikova, VM; Nadyrshina, RSh | 1 |
| Carpenter, JL; Davis, CE; McAllister, CK; Ognibene, AJ | 1 |
| Huang, M | 1 |
| Zhang, YD | 1 |
| Onwubalili, JK; Scott, GM; Smith, H | 1 |
| Behari, M; Maheshwari, MC; Pauranik, A | 1 |
| Azuma, Y; Baba, H; Izuchi, R; Schinkai, A | 1 |
| Beltrán, RM; Mendoza, PM; Orozco, LC; Quintana, FO; Rodriguez, G; Wasserman, M | 1 |
| Beltrán, RM; de Moreno, I; Orozco, LC; Quintana, FO; Rodriguez, G; Wasserman, M | 1 |
| Janardhanam, B; Parthasarathy, R; Ramachandran, P; Santha, T; Sarma, GR; Sivasubramanian, S; Somasundaram, PR; Tripathy, SP | 1 |
| Burns, DK; Cargile, JS; Fisher, DF; Fry, WJ | 1 |
| Hiro, Y; Kondou, H; Kutsukake, F; Mochizuki, K; Nagano, H; Shinoda, A; Taga, Y; Takamoto, M; Takano, T; Yasutake, T | 1 |
| Acocella, G; Angel, JH | 1 |
| Glozman, VN; Miltin'sh, AP | 1 |
| Ringelmann, R; Schmidt, M; Schönian, U | 1 |
| Egan, N; Murray-Leisure, KA; Weitekamp, MR | 1 |
| Cooke, NJ; Peacock, M; Taylor, GA; Wardman, AG; Williams, SE | 1 |
| Farer, LS; Snider, DE | 1 |
| McKenzie, DK; Mukerjee, CM | 1 |
| Tofte, RW | 1 |
| Huchon, G; Marin, I; Sandron, D | 1 |
| Kodama, N; Konishiike, J; Mori, T | 1 |
| Kunii, O | 1 |
| Baron, RB; Ganter, B; Hopewell, PC; Sanchez-Hernandez, M | 1 |
| Aoyagi, T; Fukuhara, Y; Gomi, J; Matsumiya, T; Yamaguchi, T | 1 |
| Bezel, R; Brändli, O; Häcki, M; Karrer, W; Röthlisberger, K; Rubin, S | 1 |
| Ganapati, R; Maniar, JK; Parikh, AC; Parikh, DA | 1 |
| Claiborne, RA; Dutt, AK | 1 |
| Gröschel, DH; Tarrand, JJ | 1 |
| Behera, D; Malik, SK | 2 |
| Hawkins, JE; Laszlo, A; Siddiqi, SH | 1 |
| Boulahbal, F; Chaulet, P; Mazouni, L; Tazir, M | 1 |
| Beckers, B; Lammers, A; Lang, HR; Schimke, D | 1 |
| Bialik, IB; Klimenko, MT | 1 |
| Leff, AR; Leff, DR | 1 |
| Craven, PC | 1 |
| Grzybowski, S | 1 |
| Bobst, JG; Foster, LR; Livengood, JR; Sigler, TG; Snider, DE | 1 |
| Lofgren, JP; Stead, WW; Thomas, C; Warren, E | 1 |
| Pillans, PI | 1 |
| Anderson, S; Lehrer, RI; Liebhaber, M; Peerless, AG; Stiehm, ER | 1 |
| Kislitsyna, NA | 1 |
| Yernault, JC | 1 |
| Cantraine, F; Franckson, M; Toppet, M; Vainsel, M | 1 |
| Harland, SJ; Park, BK; Timbrell, JA | 1 |
| Goto, S; Hsu, KY; Noda, A; Noda, H; Ohno, K; Sendo, T | 1 |
| Shman'ko, VV; Skakun, NP | 2 |
| Lees, AW | 1 |
| Acocella, G; Conti, R; Grassi, C; Luisetti, M; Pozzi, E | 1 |
| Obsitník, M; Skutil, V; Varsa, J | 1 |
| Manastyrskaia, OS; Podusovskiĭ, VF; Sibirnaia, RI | 1 |
| Banks, J; Jenkins, PA; Smith, AP | 1 |
| Hof, DG; Neihart, RE | 1 |
| Jittinandana, A; Kecharananta, P; Rattarasarn, S; Sriyabhaya, N | 1 |
| Petrenko, VI | 1 |
| Cowie, RL; Escreet, BC; Langton, ME | 1 |
| Cowie, RL; Langton, ME | 1 |
| Haenselt, V; Iwainsky, H; Köhler, H; Winsel, K | 1 |
| Hansen, JE; Kampmann, JP; Kay, L; Kristensen, M; Skovsted, L; Svendsen, TL; Vergman, B | 1 |
| Kerri, O; Martini, M | 1 |
| deSa, D; Leahy, F; Mina, M | 1 |
| Khalil, M; Lindley, S; Matouk, E | 1 |
| Christensen, PB; Haase, J; Ingstrup, HM; Kock, K | 1 |
| Eichelbaum, M; Jensen, JC; Loos, U; Mikus, G; Musch, E; Schwabe, HK | 1 |
| Acharya, VN; Kudva, BT; Mehta, PJ; Retnam, VJ | 1 |
| Citron, KM | 2 |
| Canetti, G; Gay, P; Le Lirzin, M | 1 |
| Almeyda, J; Levantine, A | 1 |
| Mühlberger, F | 1 |
| Ritter, W | 1 |
| Engbaek, HC; Larsen, SO; Rasmussen, KN; Vergmann, B | 2 |
| Ellard, GA; Forgan-Smith, R; Mitchison, DA; Newton, D | 1 |
| Hermann, P | 1 |
| Riska, H | 1 |
| Pätiälä, J; Tani, P | 1 |
| Wessel-Aas, T | 1 |
| Lal, S; Scheuer, PJ; Sherlock, S; Summerfield, JA | 1 |
| Eule, H; Iwainsky, H; Krebs, A | 1 |
| Brühl, P; Tümmers, H | 1 |
| Wolinsky, E | 2 |
| Iisalo, EJ; Pihlajamäki, KK; Syvälahti, EK | 1 |
| Jentgens, H | 1 |
| Tousek, J; Trnka, L | 1 |
| Nwokolo, U | 1 |
| Brown, RC; Day, JL; Maisey, DN | 1 |
| Baker, JT; Pioli, E; Williams, WJ | 1 |
| Boman, G; Ringberger, VA | 1 |
| Byrd, RB; Gracey, DR; Kaplan, PD | 1 |
| Courtenay-Evans, RJ; Edwards, OM; Galley, JM; Hunter, J; Tait, AD | 1 |
| Gerloff, W; Kalich, R; Mydlak, G; Nitschke, M; Reinhold, L; Ulber, H; Werner, E | 1 |
| Karuga, WK | 1 |
| Andrews, RH; Jenkins, PA; Marks, J; Pines, A; Selkon, JB; Somner, AR | 1 |
| Kameda, K | 2 |
| Wstepna, C | 1 |
| Batten, J | 3 |
| Dickinson, JM | 1 |
| Beggs, WH; Jenne, JW | 1 |
| Braman, SS; Goldman, AL; Schwarz, MI | 1 |
| Radner, DB | 2 |
| Abbott, MR | 1 |
| Lakshminarayan, S; Petty, TL; Pierson, DJ | 1 |
| Raleigh, JW; Wichelhausen, R | 1 |
| Felton, CP; Jones, JM | 1 |
| Reutgen, H | 1 |
| Selkon, JB; Somner, AR; Walton, M; White, AB | 2 |
| Lakshiminarayan, S; Sahn, SA | 1 |
| Doster, BE; Murray, FJ; Newman, R; Woolpert, SF | 1 |
| El'shanskaia, MP; Golyshevskaia, VI | 1 |
| Swinburn, PD | 1 |
| Lefford, MJ; McGregor, DD | 2 |
| Chioléro, R | 1 |
| Eidus, L; Gale, GL; Jessamine, AG | 1 |
| Freshwater, DB; Jacques, S; Randle, RE; Shelden, CH | 1 |
| Johnston, RF; Wildrick, KH | 1 |
| Armstrong, EL; David, HL; Takayama, K | 1 |
| Boytar-Papirnyik, V; Hobby, GL; Johnson, PM | 3 |
| Goldberg, R; Rao, M; Steiner, M; Steiner, P | 1 |
| Bartal, M; Laraki, A; Nejjar, A | 1 |
| Mison, P; Staflova, S; Trnka, L | 1 |
| Vejjajiva, A | 1 |
| Slany, E | 1 |
| Regli, J; Ziegler, WJ | 1 |
| McDonald, HM; McDonald, PJ; Murray, CJ | 1 |
| Rao, M; Steiner, M; Steiner, P; Victoria, M | 1 |
| Berg, G; Kazemi, H; Stottmeier, K; Zack, MB | 1 |
| Bates, JH; Hampton, JR | 1 |
| Bartashevich, TA; Dushkevich, AK | 1 |
| Brouet, G | 1 |
| Deshayes, P; Desseauve, P; Houdent, G; Lemercier, JP; Morere, P; Simonin, JL | 1 |
| Allan, GW; Fallon, RJ; Lees, AW; Smith, J; Tyrrell, WF | 2 |
| Allan, GW; Fallon, RJ; Lees, AW; Smith, J; Tyrell, WF | 1 |
| Heise, PP; Knappmann, J | 1 |
| Poley, JR; Rudoy, R; Stuemky, J | 1 |
| Charachon, R; Faivre, A; Junien-Lavillauroy, C; Roux, O | 1 |
| Clark, J; Wallace, A | 1 |
| Lucchesi, M; Mancini, P; Matzeu, M | 1 |
| Charles, A; Demonet, B; Germouty, J; Serizay, B | 1 |
| Baess, I; Engbaek, HC; Vergmann, B | 1 |
| Jarniou, AP | 1 |
| Jagueux, M; Marien, C; Piéron, R | 1 |
| Makarevich, NM; Rudoĭ, NM | 1 |
| Bethge, H | 1 |
| Eagle, MC; Goldstein, E; LaCasse, ML | 1 |
| Eulenberger, J; Mordasini, ER | 1 |
| Duhurt, J; Gautier, H; Kauffmann, JP; Piéron, R | 1 |
| Neumann, G | 2 |
| Burgher, LW; Kass, I | 1 |
| Decroix, G; Pujet, JC | 1 |
| Barranger, C; Boury, G; Favre, M; Houdard, C; Lancastre, F; Le Fichoux, Y; Mafart, Y; Piéron, R | 1 |
| Caulin, CH; Delavierre, PH; Freyer, M; Lebas, F; Segrestaa, JM | 1 |
| Blanchon, B; Blanchon, F; Blanchon, P; Groseille, Y; Holler, A; Paillas, J | 1 |
| Abiven, M; Bonfante, N; Plonteux, G; Toulet, J; Viteau, JM | 1 |
| Clark, MA | 1 |
| Bernard, S; Le Cam, M; Madec, Y | 1 |
| Freerksen, E; Kazda, J | 1 |
| Fraley, EE; Gonzalez, R; Pergament, M | 1 |
| Härö, AS; Hjaltested, OP; Nielsen, E | 1 |
| Toyoara, M | 2 |
| Brooks, SM; Loudon, RG; Nelson, DG; Schwarz, J | 1 |
| Grosse-Brockhoff, F; Hausamen, TU; Peters, U | 1 |
| Daynes, G | 1 |
| Barbier, JP; Carnot, F; Cornet, A; Cornu, P; Dubrisay, J; Hirsch, JF | 1 |
| Eule, H; Iwainsky, H; Werner, E; Winsel, K | 3 |
| Charitonov, RA; Osadchaja, L; Pushkov, WW | 1 |
| Stevenson, DK | 1 |
| Boman, G | 2 |
| Cordero, O; Pacheco, CR; Pacheco, Mde J; Sierra, D; Vázquez, E | 1 |
| Sehm, G; Urbanczik, R | 1 |
| Kradolfer, F | 3 |
| Buyssens, N; Haber, I; Hubens, H | 1 |
| Kameda, K; Kino, C | 1 |
| Hentschel, U | 1 |
| Bernadou, M; Chomy, P; Fréour, P | 1 |
| Bayliss, CG | 1 |
| Catto, GR; MacLeod, M; Smith, FW | 1 |
| Isaacs, AJ; Sturrock, RD | 1 |
| Chazan, BI; Khogali, AM; Metcalf, VJ; Ramsay, JH | 1 |
| Cosemans, J; Gyselen, A; Lacquet, L; Verbist, L | 1 |
| Eule, H; Fanter, D; Herrmann, H; Kahlau, U; Kuhnert, R; Lau, W; Schönert, E; Werner, E | 1 |
| Kalich, R; Reutgen, H | 1 |
| Brocheriou, C; Guilbert, F; Oger, JP; Rigolet, D | 1 |
| Mattson, K | 2 |
| Stradling, P | 1 |
| Mattson, K; Riska, N | 1 |
| Dieu, MJ | 1 |
| Bates, JH; Gunnels, JJ | 1 |
| Kraan, JK; Mulder, RJ; Mulder-De Jong, MT; van Dijk, B | 1 |
| Delli Veneri, F; Meola, G; Ninni, A; Nitti, V | 1 |
| Dubra, F | 1 |
| Corpe, R | 1 |
| Feldmann, H; Kelleter, R | 1 |
| Boivin, P; Boucherot, J; Feldmann, G; Guibout, P; Hakim, J; Kreis, B; Penaud, J; Troube, H | 1 |
| Breuer, H; Nocke-Finck, L; Reimers, D | 1 |
| Algeorge, G; Petre, A; Rudescu, D | 1 |
| Bignall, JR | 1 |
| Allan, WG | 1 |
| Kradolfer, F; Schnell, R | 4 |
| Leiber, DL; Verhagen, AR | 1 |
| Eidus, L; Helbaque, DM; Jessamine, AG; Narasimhan, V | 1 |
| Eule, H; Herrmann, H; Kaluza, P; Kärnbach, E | 1 |
| Nitti, V | 6 |
| Eule, H; Herrmann, H | 1 |
| Fraga, H; Gerhardt, G; Gomes, O; Paz de Almeida, A; Santiago, AC | 1 |
| Tousek, J; Votruba, R | 1 |
| Ehrlich, RM; Lattimer, JK | 1 |
| Baculard, A; Bonnet, M; Dresh, C; Gerbeaux, J; Sultan, C | 1 |
| Brito, AA; Laborne Valle, JH; Poppe de Figueiredo, F; Tavares, PM; Trannin, PL | 1 |
| Baron, DN; Bell, JL | 1 |
| Hobby, GL; Lenert, TF | 3 |
| Dorken, E; Grzybowski, S; Schonell, M | 1 |
| Berberich, R; Kläser, E; König, K; May, P; Oberhausen, E | 1 |
| Baron, A; Constans, P; Coury, C; Parrot, R | 1 |
| Darras, T; Gyselen, A; Mbete, S; Van Landuyt, H; Verbist, L | 1 |
| Davidson, PT; Goble, M; Lester, W | 1 |
| Chioléro, R; Favez, G; Willa, C | 1 |
| Grumbach, F; Le Lirzin, M | 1 |
| Eickeler, R; Zeilhofer, R | 1 |
| Hyde, L | 1 |
| Delepoulle, E; François, C; Grignet, JP; Pecqueur, G; Venel, JG; Wallaert, C | 1 |
| Dürr, DK; Wissler, H | 1 |
| Douma, J | 1 |
| Evans, C; Proust, A | 1 |
| Konno, K; Ogata, K; Oizumi, K; Sato, M; Yamada, S | 1 |
| Kobayashi, T; Matsuda, T; Oka, S; Sasaki, M | 1 |
| Mlczoch, F | 1 |
| Sighart, H | 1 |
| Schmidt, W | 1 |
| François, H; Halligon, J; Schnitzler, L; Schubert, B; Verret, JL | 1 |
| Brouet, G; Canetti, G; Roussel, G | 1 |
| Hendrikse, JC; Hulsebosch, HJ; Ruiter, D | 1 |
| Dölle, W | 1 |
| Dilts, PV; Thelin, TJ; Wilson, EA | 1 |
| Rudnicka, M; Szymaczek-Meyer, L; Westfal, I; Wiza, J | 1 |
| Lockshin, M; Waxman, J | 1 |
| Cellesi, C; Debolini, A; Rossolini, A | 1 |
| Flieder, J; Gehanno, P; Lallemant, Y | 1 |
| Favez, G | 3 |
| Rocklin, RE; Whitcomb, ME | 1 |
| Pescetti, G; Porrino, F; Rodicchi, A | 1 |
| Banaszkiewicz, H; Chetkowski, A; Czaplińska-Jóźwiak, E; Dabrowska-Solecka, Z; Ignaczak, J; Kondratowicz, W; Królikowska, H; Pawlik, J; Pawlowska, I; Ropek, M; Sliwińska, M; Szuster, I; Szymánska, W; Szymański, A | 1 |
| Kato, M; Nakano, N; Shishito, S; Sugawara, H | 1 |
| Gastpar, H | 1 |
| Lever, M; Small, CW; Wilson, DM | 1 |
| Capier, P; Devulder, B; Lelievre, G; Tacquet, A | 1 |
| Campbell, AH; Cowen, K; O'Connell, J; Verins, A | 1 |
| Ambrosiani, S; Brignone, S | 1 |
| Krohn, J | 1 |
| Cramers, MK | 1 |
| Hirsch, A | 1 |
| Ward, JM | 1 |
| Blenska, W; Kolakowska, E | 1 |
| Verhagen, AR | 1 |
| Agius-Ferrante, A; Bonnici, E; Depasquale, G; Grima, W; Paris, C | 1 |
| Rasmussen, KN | 1 |
| Shukiurov, ShZ | 1 |
| Boman, G; Dahlström, G; Hanngren, A; Stavenow, S; Wiman, LG | 1 |
| Poppe de Figueiredo, F | 1 |
| Favez, G; Wiser, H | 1 |
| Davis, P | 1 |
| Grzybowshi, S | 1 |
| Bouteiller, JJ; Dossogne, M; Wilmus, X | 1 |
| Rohwedder, JJ | 1 |
| Decroix, G; Homberg, JC; Pujet, JC | 1 |
| Austerhoff, A; Kindler, U; Knieriem, HJ; Knop, P | 1 |
| Ferdinande, R; Heusghem, C; Lecoq, A; Parmentier, JC; Plomteux, G; Winandy, A | 1 |
| Berthelot, P; Dhumeaux, D; Nebout, T | 1 |
| Barwick, DD; Thrush, DC | 1 |
| Anastasatu, C; Barcan, F; Bercea, O; Cărpinişan, L; Cristea, M; Dinulică, E; Gheorghiu, M; Ghinescu, S; Iancovici, O; Marcovici, M; Stinghe, R | 1 |
| Davidson, PT; Sahn, SA | 1 |
| Kerby, G; Rauscher, CR; Ruth, WE | 1 |
| Gerbeaux, J | 1 |
| Menghini, P; Pozzi, E | 1 |
| Jash, DK; Page, JR | 1 |
| May, P; Schindler, E | 1 |
| Brooks, SM; Claes, F; Litwin, A | 1 |
| Dormer, BA | 1 |
| Krebs, A | 2 |
| Meissner, G | 1 |
| Kraan, JK; Mulder, RJ; van Dijk, B | 1 |
| Cosemans, J; Debrabandere, R; Devriendt, J; Gyselen, A; Lacquet, LM; Prignot, J; Simon-Pouthier, F; Verbist, L | 1 |
| Favez, G; Willa, C | 1 |
| Wilson, TM | 1 |
| Bariéty, M; Bonnaud, G; Constans, P; Coury, C; Morin, Y; Saint-Paul, M | 1 |
| Friess, JM; Guignon, JP; Lecoq, H; Lévy, A; Maman, P; Weill, G | 1 |
| Donomae, I; Fujita, S; Gomi, J; Hibino, S; Horai, Z | 1 |
| Devine, CM; Mitchison, DA; Nunn, AJ; Tall, R | 1 |
| El'nik, VI | 1 |
| Oka, S | 1 |
| Bundi, R; Pines, A; Raafat, H | 1 |
| Catena, E; Di Filippo, A; Ninni, A; Nitti, V | 1 |
| Daniel, TM | 1 |
| Natali, P; Ninni, A; Nitti, V | 1 |
| Canetti, G; Grumbach, F; Le Lirzin, M; Porven, G; Rist, N | 1 |
| Finland, M; Lorian, V | 1 |
| Boytar-Papirnyik, V; Hobby, GL; Johnson, PM; Wilber, J | 1 |
| Kubica, GP; Stottmeier, KD; Woodley, CL | 2 |
| Centrella, G; Delli Veneri, F; Stefanelli, R | 1 |
| Erhard, G | 1 |
| Iodice, F; Ninni, A; Razza, I; Scoles, E | 1 |
| Canetti, G; Grumbach, F; Le Lirzin, M | 2 |
| Ninni, A; Nitti, V | 2 |
| Trnka, L | 1 |
| Verbist, L | 2 |
| Steinbrück, PW | 1 |
| Augier, J; Gillet, P; Parrot, R | 1 |
| Daddi, G; Lucchesi, M | 2 |
| Fabbrocini, V | 1 |
| Davidson, PT; Lester, W; McClatchy, JK; Moulding, T; Vall-Spinosa, A | 1 |
| David, HL | 1 |
| Doster, B; Ferebee, S; Murray, FJ; Newman, R | 1 |
| Constans, P; Coury, C; Parrot, R | 1 |
| Schaich, W | 1 |
| Canetti, G; Djurovic, V; Le Lirzin, M; Lepeuple, A; Thibier, R | 1 |
| Acar, JF | 1 |
| Lester, TW; Vall-Spinosa, A | 1 |
| Pines, A | 1 |
| Proust, AJ | 1 |
| Mkrtchian, SV; Ushkin, VV | 1 |
| Grumbach, F | 3 |
| Adámek, L; Havel, A; Simonová, S | 1 |
| Hayashi, I; Konno, K; Oizumi, K; Oka, S | 1 |
| Rist, N | 1 |
| Freerksen, E; Hokama, S; Rosenfeld, M | 1 |
| Orlowski, EH | 3 |
| Formosa, GM | 1 |
| Catena, E; De Michele, G; Delli Veneri, F; Marra, A; Nitti, V | 1 |
| Ariji, F; Kumano, N; Madokoro, K; Oka, S; Yamaguchi, J | 1 |
| Golden, B; Polascik, M | 1 |
| Burley, DM; Crossley, G; Lal, S; Singhal, SN | 1 |
| Raleigh, JW | 2 |
| Theile, U | 1 |
| Jarumilin, A; Sriyabhaya, N | 2 |
| Badger, TL | 1 |
| Houk, AN | 1 |
| Nakagawa, H; Sunahara, S | 1 |
| Corpe, RF; Sanchez, ES | 1 |
| Allan, GW; Gow, A; Lees, AW; Smith, J; Tyrell, WF | 1 |
| Hölzl, M | 1 |
| Drabkina, RO; Ginzburg, TS | 1 |
| Gyselen, A; Verbist, L | 1 |
| Ludes, H | 1 |
| Acocella, G; Bonollo, L; Garimoldi, M; Mainardi, M; Nicolis, FB; Tenconi, LT | 1 |
| Rothstein, E | 1 |
| Dormer, BA; Salinger, PL | 2 |
| Bonnet, H; Dumas, R; Greze, J; Jean, R; Pages, P | 1 |
| Almansa de Cara, S | 1 |
| Castellano, A; Cornudella, R; Garcia-Besada, JA | 1 |
| Clarke, GB; Cuthbert, J; Cuthbert, RJ; Lees, AW | 1 |
| Marr, JJ | 1 |
| Mangion, PD; Schiller, KF | 1 |
| Rynearson, TK; Shronts, JS; Wolinsky, E | 1 |
| Blaha, H; Petersen, KF; Urbanczik, G | 1 |
| Chevrel, B | 1 |
| Attock, B; Evans, DI | 1 |
| Graisely, B; Hugues, FC; Marche, C; Marche, J | 2 |
| Abiven, M; Bonfante, N; Plomteux, G; Toulet, J; Viteau, JM | 1 |
| Caquet, R; Desche-Labarthe, S; Fraisse, B; Laroche, C; Lemaigre, G | 1 |
| Rollier, F; Verbist, L | 1 |
| Flemming, J; Oschkinat, F | 1 |
| Chauvet, G; Oury, M; Tuchais, E; Viallet, S | 1 |
| Koskinen, R; Venho, VM | 1 |
| Poole, G; Stradling, P; Worlledge, S | 2 |
| De Michele, G; Iodice, F; Lappa, B | 1 |
| Alves, JP; Bethlem, N; de Andrade, EM; Dias, L; Franca, JL; Tavares, W; Tavares, WC | 1 |
| Boman, G; Borgå, O; Hanngren, A; Malmborg, AS; Sjöqvist, F | 2 |
| Hokama, S | 1 |
| Beacham, EG | 1 |
| Bariety, M; Constans, P; Coury, C; Morin, Y | 1 |
| Israël, L; Kreis, B; Pretet, S | 1 |
| Daddi, G; Lucchesi, M; Mancini, P | 2 |
| Strauss, I | 1 |
| Thibault, P | 1 |
| Asgher, B; Hashem, MA; Lees, AW; Sinha, BN | 1 |
| Koch-Weser, D | 1 |
| König, K | 1 |
| Unholtz, K | 1 |
| Gerbeaux, J; Hanoteau, J | 1 |
| Algeorge, G; Rudesco, D; Sibilla, S | 1 |
| Repo, K; Riska, N | 1 |
| Borthwick, WM | 1 |
| Hollins, PJ; Simmons, AV | 1 |
| Chenebault, J | 2 |
| Bosio, AM; Estampes, B; Hinaut, G | 1 |
| Bréfort, G; Drutel, P; Lesobre, R; Ruffino, J; Teyssier, L | 1 |
| Boutonnet, G; Kreis, B | 1 |
| Bourreille, J; Morère, P; Nouvet, G; Stain, JP | 1 |
| Kesztele, V; Niederkofler, J | 1 |
| Gyselen, A | 1 |
| Stäubli, C | 1 |
| Yoshida, F | 1 |
| Fukuhara, T; Mitsui, M; Sasaoka, A; Yoshida, F | 1 |
| Tveit, J | 1 |
| Frey, N; Lesobre, R | 1 |
| Mitchell, RS | 1 |
| Korotaev, GA; Kozulitsyna, TI | 1 |
| Daddi, G | 1 |
| Arioli, V; Bolzoni, G; Furesz, S; Pallanza, R | 1 |
| Cavanagh, P | 1 |
| Begg, KJ | 1 |
| Kotchen, TA; Long, D; McClure, R; McMurry, JF | 1 |
| Engelhard, D; Marks, MI; Stutman, HR | 1 |
| Balodimos, H; Calafati-Tjimaka, H; Papadimitriou, J; Stavropoulos, C; Tjimakas, C; Vamvalis, C | 1 |
| Lainson, R; Leão, AF; Peters, W; Robinson, BL; Shaw, JJ | 1 |
| Fekete, E; Mock, B; Sarojini, PA; van der Meulen, J | 1 |
| Bruart, J; Ducobu, J; Dupont, P; Laurent, M | 1 |
| Emerson, PA; Jenkins, P; Michelson, R | 1 |
| Porter, KM | 1 |
| Perry, W; Stamp, TC | 1 |
| Fischer, V; Haubensak, K; Osterhage, HR | 1 |
| Chaudhury, S; Ghosh, S; Hazra, S; Kundu, SK | 1 |
| Kalra, L; Mahanta, A; Maheshwari, MC; Mishra, NK | 1 |
| Avant, ME; Carpenter, JL; Covelli, HD; Higbee, JW; McAllister, CK; Ognibene, AJ | 1 |
| Ramu, G | 1 |
| Buraglio, M; Eandi, M | 1 |
| Fischer, P; Schilling, W | 1 |
| George, RH | 1 |
| Shennan, DH | 1 |
| Quevauvilliers, J; Richard, C | 1 |
| Alcáide Megías, J; Altet Gómez, MN; Boque Genovard, MA | 1 |
| Bollinelli, R | 1 |
| Berman, JD; Lee, LS | 1 |
| Blumer, JL; Reed, MD | 1 |
| Bailey, WC | 1 |
| Grosset, J; Guelpa-Lauras, CC; Lecoeur, H; Truffot-Pernot, C | 1 |
| Abbate, E; Dambrosi, A; González Montaner, LJ; Mosca, C; Palma Beltrán, O | 1 |
| Bernadou, M; Cheminat, JC; Choffel, C; Decroix, G; Fréour, P; Guillet, P; Lemanissier, AF; Milleron, B; Molina, C; Roussel, G | 1 |
| Pretet, S | 1 |
| Cross, FS; Farer, LS; Long, MW; Snider, DE | 1 |
| Snider, D | 1 |
| Bennhoff, DF | 1 |
| Nagami, P; Yoshikawa, TT | 2 |
| Maliuk, VI | 1 |
| Carpenter, JL; Gorby, EW; Koch, JR; Neimes, RE; Obnibene, AJ; Perkins, WL | 1 |
| Burghard, G; Cooreman, J; Grosset, J | 1 |
| Janků, I; Papezová, E; Stastná, J; Tousek, J; Zítková, L | 1 |
| Majewska-Zalewska, H; Rudnik, J | 1 |
| Lepe, R; Ponce, J; Scheel, G; Valenzuela, MT; Valenzuela, P; Velasco, M | 1 |
| Carroll, SR; Jenner, JR; Newson, SW | 1 |
| Good, RC; Jones, WD; Snider, DE | 1 |
| Chiyotani, K; Honma, K; Miura, H; Nagato, H; Onozato, T; Saito, K | 1 |
| Al Motez, M; Engbaek, HC; Kassim, I; Schiøtt, CR; Vergmann, B | 1 |
| Eng, R; Smith, LG; Smith, SM; Suwanogool, S | 1 |
| Bach, VT; Thadepalli, H | 1 |
| Collins, FM; Watson, SR | 1 |
| Perdrizet, S; Pretet, S | 1 |
| Borowy, ZJ; Deitel, M; Krajden, S; Ronald, AC; Saldanha, CF | 1 |
| Gallofré, M; Laporte, JR; Latorre, P; Massons, J | 1 |
| Mehta, S; Rugmini, PS | 1 |
| Valenzuela, MT; Valenzuela, P | 1 |
| Farga, V; Fernández, M; Grinspun, M; Icekson, I; Mendoza, F; Scheel, G; Torres, E; Valenzuela, MT; Valenzuela, P; Yañez, A | 2 |
| Berg, JD; Pandov, HI; Sammons, HG | 1 |
| Bondarev, IM; Ivanov, VL; Kovaleva, LA; Novoselova, VP; Shtegel'man, LA | 1 |
| Arnau, J; Guardia, J; Lopez-Vivancos, J; Vilaseca, J | 1 |
| Ikeda, K; Maeda, T; Miyata, Y; Ohkubo, K; Shinohara, S | 1 |
| Aoki, M; Hashimoto, T; Misawa, H; Shimao, T; Shiozawa, S; Takasawa, N | 1 |
| Bakir, F; Sabri, G | 1 |
| Maat, RB; Miles, SH | 1 |
| Kang, HJ; Lee, CW; Lim, JH | 1 |
| Greenberg, M; Hashimoto, K; Heller, GL; Pavlidakey, GP; Rosenberg, M | 1 |
| Bek, E; Graczyk, J; Rogowski, J; Snider, DE | 1 |
| Borah, NC; Goulatia, RK; Maheshwari, MC; Mishra, NK | 1 |
| Boman, G; Löfdahl, CG; Sjögren, I; Skoogh, BE | 1 |
| Gairí Tahull, JM; Poo Argüelles, P; Samarra Riera, JM; Vernet Bori, A | 1 |
| Caban, M; Kamińska, M; Nikodemowicz, E; Struzik, T | 1 |
| Chan, SL; Fan, ST; Ho, KK; Lau, WY; Wong, SH; Yiu, TF | 1 |
| Barbosa, S; Gow, JG | 1 |
| Boumphrey, FR; Calabrese, LH; Cook, SA; Rehm-Graves, S; Weinstein, AJ | 1 |
| Steiner, M | 1 |
| Cross, FS; Long, MW; Lyle, MA; O'Brien, RJ; Snider, DE | 1 |
| Abernathy, RS; Dutt, AK; Moers, DJ; Stead, WW | 1 |
| Bouveret, JP; Gerbeaux, J; Hanoteau, J; Houin, G; Tillement, JP | 1 |
| Gvasaliia, T | 1 |
| Bartelink, AK; Lenders, JW; van Haelst, UJ; van Herwaarden, CL; van Tongeren, JH | 2 |
| Carey, SM; Kleeberg, HH; Swart, DJ | 1 |
| Dolgikh, VT; Iakovleva, TA; Poluéktov, LV | 1 |
| Davis, HL; Henderson, RP; Self, TH | 1 |
| Dolgikh, VT; Iakovleva, TA; Red'kin, IuV; Sokolova, TF | 1 |
| Ortenberg, EA; Zhikhareva, AI | 2 |
| Perova, TL; Titarenko, OT; Vakhmistrova, TI | 1 |
| Ahn, CH; Ahn, SI; Ahn, SS; Hurst, GA; Lowell, JR | 1 |
| Ait Khaled, N; Boulahbal, F; Chaulet, P; El Awadi, Z; Tazir, M | 1 |
| Brändli, O; Fiala, W; Häcki, MA | 1 |
| Bismuth, R; Grosset, J; Lecoeur, H; Truffot-Pernot, C | 1 |
| Hetrick, G; Humarau, H | 1 |
| Tamura, N | 1 |
| Hsu, KY; Kurozumi, T; Noda, A; Noda, H; Yamamoto, Y | 1 |
| Jones, FL | 1 |
| Stafford, N; von Haacke, N | 1 |
| Chan, SL; Fan, ST; Ho, KK; Lau, WY; Poon, GP; Wong, SH; Yiu, TF | 1 |
| Glik, MS; Sokolova, GB | 1 |
| Grassi, C | 1 |
| Bisagni, L; Combetto, MG; Lanza, A | 1 |
| Arena, G; Sesia, G | 1 |
| Mazaev, MB | 1 |
| Chaube, CK; Gautam, KD; Mehrotra, ML | 2 |
| Izumikawa, K; Koga, H; Nagasawa, M; Nakazato, H; Shigeno, H; Shigeno, Y; Suzuyama, Y; Tomita, H; Tomonaga, A; Yamaguchi, K | 1 |
| Källenius, G; Möller, E; Ringdén, O; Strandvik, B; Sundelin, P | 1 |
| Brumbach, J; Davis, BR; Sanders, WJ; Wolinsky, E | 1 |
| Gallofre López, M; Latorre Murillo, P; Massons Cirera, J; Sumalla Suñe, J | 1 |
| Borderon, E; Borderon, JC; Calamy, G; Hamel, B; Jamet, M | 1 |
| Boulahbal, F; Chaulet, P; el Awadi, Z; Khaled, S; Tazir, M | 1 |
| Daschner, F | 1 |
| Balta, IuE; Chukanov, VI; Dorozhkova, IR; Karachunskiĭ, MA; Khomenko, AG | 1 |
| Gerstenhaber, BJ | 1 |
| Aber, VR; Edwards, EA; Jindani, A; Mitchison, DA | 1 |
| Farer, LS; Koplan, JP | 1 |
| Fujii, K; Moriguchi, T; Sakurai, H; Uenoyama, T; Watanabe, Y; Yamanaka, M | 1 |
| Good, RC; Kilburn, JO; Laskowski, LF; Lusk, RH; Marr, JJ; Middlebrook, G; Reggiardo, Z; Snider, DE | 1 |
| Amelio, M; Bardessono, F; Giorgis, GE; Moschini, MT | 1 |
| Aziz, A; Middlebrook, G; Reggiardo, Z; Siddiqi, SH | 1 |
| Cooke, NJ; Curzon, PG; Page, RL; Wardman, AG; Williams, SE | 1 |
| Campbell, IA; Hunter, AM; Kilpatrick, GS; Monie, RD; Rocchiccioli, K; White, J | 1 |
| Fujita, NK; Yoshikawa, TT | 1 |
| Anderson, RH; Brown, FS; Burnett, JW | 1 |
| Chaĭkovskaia, SM; Kivman, GIa; Makarova, RA; Zeliger, LR | 1 |
| Fermanian, J; Grosset, J; Lecoeur, H; Truffot, C | 1 |
| Cockett, AT; Cos, LR | 1 |
| Favez, G; Leuenberger, P | 1 |
| Augé, C; Bussi, S; Lecocguic, Y; Pariente, R; Touaty, E | 1 |
| Fairley, JA; King, AJ; Rasmussen, JE | 1 |
| Brändli, O; Häcki, MA; Scheel, A; Stiefel, M | 1 |
| Lefrock, JL; Smith, BR | 1 |
| Drăghicescu, T; Roman, IC; Socosan, I; Vainer, E | 1 |
| Funakoshi, M; Kameda, K; Kawabata, S | 1 |
| Perry, W | 2 |
| Buechner, HA | 2 |
| Styblo, K | 1 |
| Lowe, J; Pfau, A; Stein, H | 1 |
| Cohen, CD; Kirsch, RE; Sayed, AR | 1 |
| Hyland, RN | 1 |
| Kelderman, CS; van der Grient, AJ | 1 |
| Esanbaev, DE; Ganiev, KG; Kirina, SB | 1 |
| Armstrong, EM | 1 |
| Eichelbaum, M; Gläser, R; Hengstmann, J; Loos, U; Mackes, KG; Musch, E; Reetz, KP; Schwabe, HK | 1 |
| Dall, L | 1 |
| Hopkins, SJ | 1 |
| Dambrosi, A; Dambrosi, VM; Gonzalez Montaner, LJ; Manassero, M | 1 |
| Barzilay, Z; Bistritzer, T; Jonas, A | 1 |
| Linna, O; Uhari, M | 1 |
| Burton-Kee, EJ; Johnson, NM; McNicol, MW; Mowbray, JF | 1 |
| Kern, F; Mallory, A | 1 |
| Bek, E; Zierski, M | 2 |
| Sbarbaro, JA | 3 |
| Johnson, MW; Layde, PM; Lyle, MA; Snider, DE | 1 |
| Gavrilenko, VS; Shesterina, MV; Sokolova, GV; Tarasova, EF; Tregubov, IuG | 1 |
| Batmanov, NIa; Bondarev, IM; Gavrilenko, VS; Shesterina, MV; Tarasova, EF | 1 |
| Banner, AS; Cross, FS; Long, MW; Snider, DE | 1 |
| Bek, E; Long, MW; Snider, DE; Zierski, M | 2 |
| Pilipchuk, NS | 1 |
| Raver, JM; Spagnolo, SV | 1 |
| Cowie, RL; Escreet, BC | 1 |
| Lesar, TS; Zaske, DE | 1 |
| Engbaek, HC; Heckscher, T; Højgaard, C; Larsen, SO; Rasmussen, KN; Vergmann, B | 1 |
| Bergogne-Berezin, E; Lafaix, C; Nouhouayi, A | 1 |
| Thaler, H | 1 |
| Thulasimany, M | 1 |
| Baĭramaliev, G; Chukanov, VI; Kolosovskaia, VP; Krasheninnikova, MA | 1 |
| Anderson, HR | 1 |
| Casimir, MT; Fainstein, V; Papadopolous, N | 1 |
| Andrzheiuk, NI; Chelnokova, NV; Medunitsyna, ND; Sagalovich, AV; Sagalovich, VIa | 1 |
| Bek, E; Long, MW; Rogowski, J; Snider, DE; Zierski, M | 1 |
| Hirasing, RA; van Bel, F | 1 |
| Dautzenberg, B; Grosset, J; Sors, C | 1 |
| Bonifazi, F; Gasparini, S; Sanguinetti, CM | 1 |
| Pearson, JO; Zabow, M | 1 |
| Pessayre, D | 1 |
| Efimova, LN; Khomenko, AG; Kuz'mina, NV; Vysochina, IV | 1 |
| Nagami, PH; Yoshikawa, TT | 1 |
| Brown, J; Erooga, MA; Perry, W; Stamp, TC | 1 |
| Castro-Parra, M; Dengler, HJ; Eichelbaum, M; Musch, E; von Sassen, W; Wang, JK | 1 |
| Findlay, JM | 1 |
| Castro-Parra, M; Dengler, HJ; Eichelbaum, M; Musch, E; Ochs, HR; von Sassen, W; Wang, JK | 1 |
| Abeyasekera, G; Boobis, AR; Brodie, MJ; Hillyard, CJ; MacIntyre, I; Park, BK; Stevenson, JC | 1 |
| Bogaerts, Y; Elinck, W; Pauwels, R; van der Straeten, M; van Renterghem, D | 1 |
| Gayotto, LC; Waitzberg, VR | 1 |
| DeYoung, DR; Roberts, GD; Zimmer, BL | 1 |
| Campbell, IA; Griffiths, TM; Thomas, P | 1 |
| Kozma, D; Lapis, K; Mihalik, P; Schaff, Z | 1 |
| Lebedeva, MN; Sokolova, GB; Ziia, AV | 1 |
| Brodie, MJ; Hillyard, CJ | 1 |
| Kozma, D; Lapis, K; Schaff, Z; Tompa, A | 1 |
| Frobert, Y; Guillaumont, M; Guise, B; Harf, R; Leclercq, M | 1 |
| Kunichan, AD; Nemsadze, MN | 1 |
| Mikayel, M; Pink, P | 1 |
| Wagatsuma, H | 1 |
| Nash, DR; Steingrube, VA | 1 |
| Linares Rodríguez, A; Recarte Alvarez, J; Rodrigo Sáez, L; Valerdiz Casasola, S | 1 |
| Opl, G; Sighart, H; Weirich, H | 1 |
| Chailleux, E; Kergueris, MF; Larousse, C; Le Normand, Y; Ordronneau, J | 1 |
| Back, DJ; Breckenridge, AM; Crawford, FE; Hall, JM; MacIver, M; Orme, ML; Rowe, PH; Smith, E; Watts, MJ | 1 |
| Oda, T | 1 |
| Dengler, HJ; Greenblatt, DJ; Ochs, HR; Roberts, GM | 1 |
| Bondarev, IM; Kunichan, AD; Zhigalina, LI | 1 |
| Dayton, PG; Olson, WA; Pruitt, AW | 1 |
| Bondarev, IM; Dolzhanskiĭ, VM; Novoselova, VP; Tsuprova, AE; Zhigalina, LI | 1 |
| Jain, VK; Mathur, KC | 1 |
| Keiner, F | 1 |
| Górnicka-Wilczyńska, M; Krawczyk, Z; Pawlik, J; Pilarska-Machowicz, A; Pruszyńska, S; Sosnowski, W; Tomaszkiewicz, L; Wardowa, A; Woźniak, B | 1 |
| Bilczak, Z; Czaplińska-Jóźwiak, E; Gaik, A; Kuczborska, Z; Swiatnicka, I; Swica, T; Szymański, A; Walecki, J; Zdawski, T | 1 |
| Beresneva, RE; Ivanova, VB; Sagalovich, VIa | 1 |
| Ershov, AI; Grigaliunas, AP; Guzeeva, SA; Sushkin, AG; Tikhonov, VA | 1 |
| King, JW; White, MC | 1 |
| Korzhov, VI; Maliuk, VI; Molotkov, VN | 1 |
| Abeyasekera, G; Boobis, AR; Brodie, MJ; Hillyard, CJ; MacIntyre, I; Park, BK | 1 |
| McDonagh, DJ | 1 |
| Mochizuki, K | 1 |
| Araszkiewicz, Z; Chrostowski, K; Radomyski, A; Styszewska, H | 1 |
| Bahri, AK; Chiang, CS; Timbrell, JA | 1 |
| Solomonraj, G; Thomas, BH; Wong, LT; Zeitz, W | 1 |
| Bek, E; Long, M; Rogowski, J; Snider, D; Zierski, M | 1 |
| Bonora, G; De La Pierre, L; Perletti, L | 1 |
| Campbell, IA; Hunter, AM; Jenkins, PA; Smith, AP | 1 |
| Arioli, V; Berti, M; Carniti, G; Randisi, E; Rossi, E; Scotti, R | 1 |
| Iwai, K; Tanaka, I | 1 |
| Kitamura, S; Kosaka, K; Kudo, S; Sugiyama, Y | 1 |
| Carrasco, E | 1 |
| Bofill Bernaldo, AM; Masvidal Aliberch, RM; Sabriá Pau, J; Uriz Urzainqui, S | 1 |
| Calvo Rigual, F; Frontera Izquierdo, P; Pérez Tamarit, D; Tomás Vila, M; Unceta Aguirre, L | 1 |
| Barcat, JA; de Salvo, MC; Koch, O; Pilheu, JA | 1 |
| Sun, DQ | 1 |
| Armas Merino, R; Estay, S; Soto, JR; Vega, C | 1 |
| Andrew, OT; Hopewell, PC; Humphreys, MH; Schoenfeld, PY | 1 |
| Powell, DA; Walker, DH | 1 |
| Moulding, TS | 2 |
| Stead, WW | 1 |
| Brasfield, DM; Stallworth, JR; Tiller, RE | 1 |
| Novoselova, VP | 1 |
| Chulay, JD; Hendricks, LD; White, SW | 1 |
| Chailleux, E; Kergueris, MF; Larousse, C; Le Normand, Y; Moigneteau, C; Ordronneau, J; Veyrac, MJ | 1 |
| Bergan, S; Bjartveit, K; Laake, K | 1 |
| Campbell, IA; Jenkins, PF; Williams, TD | 1 |
| Palsson, G; Samuelson, G | 1 |
| Kolesnikov, VV; Matviiakina, TS; Mikhaĭlov, VI | 1 |
| Girgis, NI; Guindi, S; Mansour, MM; Miner, WF | 1 |
| Demedts, M; Derveaux, L; Fevery, J; Gyselen, A | 1 |
| Schalm, SW; Taal, BG | 1 |
| Kislitsyna, NA; Kotova, NI | 1 |
| Burkhardt, KR; Nel, EE | 1 |
| Khomenko, AG | 2 |
| Pongparit, S; Sunakorn, P; Wongrung, S | 1 |
| Kameda, K; Kawabata, S; Shirai, S | 1 |
| El'shanskaia, MP; Golyshevskaia, VI; Kozulitsyna, TI; Uvarova, OA | 1 |
| Albert, R; Farer, LS; Iseman, MD; Locks, M; Raleigh, J; Sutton, F | 1 |
| Aber, VR; Aluoch, JA; Girling, DJ; Humber, DP; Mitchison, DA; Nsanzumuhire, H; Nunn, AJ; Webster, AD | 1 |
| Drápela, J; Papezová, E; Staflová, S; Tousek, J; Trnka, L; Zítková, L | 1 |
| Melo, JC; Raff, MJ; Templeton, WC; Waterfill, DB | 1 |
| Opl, G | 1 |
| Tong, YY | 1 |
| Wechsler, H | 1 |
| Kailasam, S; Nair, NG; Narayana, AS; Sarma, GR; Tripathy, SP | 1 |
| Larousse, C | 1 |
| Bharadwaj, VP; Desikan, KV; Ramu, G; Venkatesan, K | 1 |
| Jay, SJ; Kiblawi, SS; Norton, J; Stonehill, RB | 1 |
| Ben-Zvi, J; Comer, GM; Donelson, SS; Felton, CP; Jacob, L; Lee, TP; Ozick, LA | 1 |
| Düren, M; Durgun, V; Göksoy, E; Uygun, N | 1 |
| Babst, A; Cawthon, VL; Gee, B; Hadley, WK; Lancaster, MV; Madej, JJ; Sanders, CA; Yajko, DM | 1 |
| Boulahbal, F; Chaulet, P | 1 |
| Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE | 1 |
| Byekwaso, F; Ellner, J; Huebner, R; Johnson, J; Mugerwa, R; Okwera, A; Vjecha, M; Whalen, C | 1 |
| Folb, PI; Smith, PJ; Walubo, A | 1 |
| Chakorn, T; Pumprueg, U; Punnotok, J | 1 |
| Balambal, R; Ganapathy, S; Parthasarathy, R; Rajeswari, R; Ranjani, R; Santha, T; Sayeed, ZA; Sivasubramanian, S; Somasundaram, PR; Sudarsana, K | 1 |
| Aichane, A; Amrani, S; Bahlaoui, A; Bouayad, Z; Trombati, N | 1 |
| Sedlaczek, AM; Serwatowski, P; Spiewak, W | 1 |
| Aboutaieb, R; Benjelloun, S; Bennani, S; el Mrini, M | 1 |
| Demedts, M; van den Brande, P; van Steenbergen, W; Vervoort, G | 1 |
| de Villiers, CL; Macnab, MF | 1 |
| Del Corso, L; Pentimone, F | 1 |
| Saunderson, PR | 1 |
| Bownds, SE; Callister, SM; Kurzynski, TA; Norden, MA; Schell, RF | 1 |
| Aspiroz, C; Gimeno, E; Gotor, MA; Guerrero, L; Mur, M; Romero, D | 1 |
| Hatfull, GF; Jacobs, WR; Sarkis, GJ | 1 |
| Nitta, AT; Peterson, C; Stone, MM; Storch, SK; Vannier, AM; Zhang, Y | 1 |
| Heathcote, J; Wanless, IR | 1 |
| Arora, A; Garg, PK; Pande, JN; Singh, J; Tandon, RK; Thakur, VS | 1 |
| Groenewald, P; Lombard, CJ; Weyer, K; Zwarenstein, M | 1 |
| Gómez Marín, JE; Portaels, F; Rigouts, L; Villegas Londoño, LE | 1 |
| Choi, HY; Wong, CF; Wong, PC; Yew, WW | 1 |
| de Kantor, IN | 2 |
| Cave, MD; Eisenach, KD; el-Hajj, H; Goldberg, SV; Hooton, TM; Nolan, CM; Thompson, RL; Williams, DL | 1 |
| Askgaard, DS; Døssing, M; Wilcke, T | 1 |
| Belaiche, J; Belghiti, J; Bernuau, J; Bismuth, H; Degott, C; Durand, F; Erlinger, S; Pessayre, D; Rueff, B; Samuel, D | 1 |
| Garg, PK; Singh, J; Tandon, RK; Thakur, VS | 1 |
| Bai, GH; Fairchok, M; Morris, S; Portillo-Gomez, L; Rouse, D; Suffys, P | 1 |
| Elufimova, VF; Iavorskiĭ, KM; Iukhimenko, NV; Mitinskaia, LA; Pogodaeva, NP | 1 |
| Witebsky, FG; Woods, GL | 2 |
| Celdrán Gil, J; Durán Pérez Navarro, A; Marcos Sánchez, F; Palomo Arellano, A; Zapata Ingelmo, A | 1 |
| McKeon, J; Patel, AM | 1 |
| Ong, EL | 1 |
| Bureau, E; Chetail, N; Cotton, JB; Durra, A; Grenier, JL; Ligeon-Ligeonnet, P; Sartre, J | 1 |
| Bohmer, PD; Macnab, MF; Seager, JR | 1 |
| DeHaven, JI; Koukol, SC; Lamm, DL; Riggs, DR | 1 |
| Barki, Y; Fliss, DM; Hertzanu, Y; Kraus, M; Leiberman, A | 1 |
| Dutt, AK; Moulding, T; Reichman, LB | 1 |
| Zylber-Katz, E | 1 |
| Angarano, G; Carbonara, D; Costa, D | 1 |
| Kroegel, C; Schrappe, M; Wassermann, K | 1 |
| Ausina, V; Castro, E; Coll, P; Hernández, L; Hernández-Flix, S; Sauret, J | 1 |
| Smith, P; Zent, C | 1 |
| Gangadharam, PR; Jagannath, C; Reddy, VM | 1 |
| al-Majed, SA | 1 |
| Bourke, SJ; Hendrick, DJ; Stenton, SC; White, J | 1 |
| Fitt, S; Mitchell, I; Wendon, J; Williams, R | 1 |
| Tschida, SJ; Vance-Bryan, K; Zaske, DE | 1 |
| Alaoui, R; Alyoune, M; Cherkaoui, A; Ismail, R; Jamil, D; Larabi, K; Nadir, S | 1 |
| Hill, AR; Hudak, A; Mateo, F | 1 |
| Arizzi-Rusche, AF; Geiter, LJ; Magdorf, K; O'Brien, RJ; Wahn, U | 1 |
| Folb, PI; Smith, P; Walubo, A | 1 |
| Macnab, MF; Seager, JR | 1 |
| Young, D; Zhang, Y | 1 |
| Cañete, C; Estopà, R; Farrero, E; Galarza, I; Granados, A; Manresa, F | 1 |
| Gohara, AF; Hamilton, RW; Kohler, LJ; Reeves, RS | 1 |
| Rao, S | 1 |
| Chan, JC; Cockram, CS; Lai, FM; Lo, RS | 1 |
| Nakasono, T; Ogata, H; Sugie, T; Sugita, H; Wada, M; Yosikawa, M; Yosiyama, T | 1 |
| Cynamon, MH; Grossi, MA; Klemens, SP | 1 |
| Karagöz, T; Kizkin, O; Partal, M; Sadoğlu, T; Tahaoğlu, K; Tor, M | 1 |
| Anglaret, X; Lacassin, F; Leport, C; Longuet, P; Perronne, C; Saba, J; Vildé, JL | 1 |
| Devred, P; Dubus, JC; Faure, F; Garnier, JM; Panuel, M; Piarroux, R; Unal, D | 1 |
| Gutman, LT; Moye, J; Tian, C; Zimmer, B | 1 |
| Davies, PD; Grange, JM; Winstanley, PA | 1 |
| García-Herola, A; García-Lázaro, M; Jurado, R; Kindelán, JM; Serrano, I; Torre Cisneros, J; Villanueva, JL | 1 |
| Cole, ST | 1 |
| Iukhimenko, NV; Kamaeva, VF; Mitinskaia, LA | 1 |
| Ekmekçi, A; Sayli, A | 1 |
| Beotra, A; D'monty, V; Mukhopadhya, S; Semwal, OP; Seth, SD; Seth, V | 1 |
| De Cock, KM; Grant, A; Porter, JD | 1 |
| Behrens, J; Janes, SL | 1 |
| Banerjee, A; Cole, ST; Grosset, JH; Heym, B; Honoré, N; Jacobs, WR; Schurra, C; Truffot-Pernot, C; van Embden, JD | 1 |
| Chaudhary, RS; Gangwal, SS; Jindal, KC; Khanna, S; Singla, AK | 1 |
| Ageta, M; Kubo, H; Kubota, H; Nagamachi, S; Wada, S; Yamanaka, T | 1 |
| Esquivel, CO; Farrell, FJ; Imperial, JC; Keeffe, EB; Man, KM | 1 |
| Gateley, K | 1 |
| Pavlova, MV | 1 |
| Chan, SL; Tam, CM; Wong, PC | 1 |
| Chapuis, L; Grosset, JH; Ji, B; O'Brien, RJ; Raviglione, MC; Truffot-Pernot, C | 1 |
| Antoniskis, D; Barnes, PF; Davidson, PT; Jones, BE; Mercado, A; Otaya, M; Sian, S; Wang, F | 1 |
| Arai, T; Baba, H; Ito, M; Kabe, J; Suzuki, T; Tagawa, K; Takahara, M; Toyota, E | 1 |
| Bataille, B; Castets, M; Dore, P; Lamotte, F; Levard, G; Meurice, JC; Patte, F | 1 |
| Desai, SS | 1 |
| Aliev, ShT; Eshankhanov, ME; Khodzhaeva, ME; Kozarez, MI | 1 |
| Adamek, RJ; Müller, KM; Wedmann, B; Wegener, M | 1 |
| Hasegawa, N; Kanazawa, M; Kawashiro, T; Sakamaki, F; Terashima, T | 1 |
| Grassi, C; Peona, V | 1 |
| Hayashi, A; Kino, T; Ogata, H; Sugita, N; Wada, M; Yamamoto, S | 1 |
| Ong, LT; Starke, JR; Vallejo, JG | 1 |
| Antela, A; Fortún, J; Gómez-Mampaso, E; Guerrero, A; Hermida, JM; Navas, E | 1 |
| Alfalla, C; Butler, WR; Haas, WH; Hewlett, D; Horn, DL; Levine, A; Nayak, A; Opal, SM; Tan, E | 1 |
| Rösslein, R; Weber, P | 1 |
| Nightingale, SL | 1 |
| Bhat, G; Chintu, C; Diwan, V; DuPont, HL; Luo, C; Raviglione, M; Zumla, A | 1 |
| Harwood, C; Kelly, R; Roblin, D; Wansbrough-Jones, M | 1 |
| Halpern, M; Mendelson, MH; Meyers, BR; Miller, C; Neibart, E; Sheiner, P | 1 |
| Davaris, P; Papagiannopoulos, N; Patsouris, E; Ragos, B; Vairaktaris, E | 1 |
| Suvanapha, R; Suwangool, P; Tantawichien, T | 1 |
| Ahn, CH; Brown, BA; Dunbar, D; Dunlap, R; Murphy, DT; Onyi, G; Wallace, RJ | 1 |
| Bloch, AB; Cauthen, GM; Dansbury, KG; Driver, CR; Kelly, GD; Onorato, IM; Snider, DE | 1 |
| Strang, JI | 1 |
| Asquasciati, G; Casu, F; Mantero, E; Marazzi, MG; Pinelli, G; Ratto, S; Risso, S; Sènès, FM; Tomà, P | 1 |
| Chanteau, S; Gicquel, B; Glaziou, P; Levée, G | 1 |
| al Jarad, N; Empey, DW; Gaya, H; Parastatides, S; Paul, EA; Rudd, RM; Sheldon, CD | 1 |
| Beck-Sague, CM; Coronado, VG; Crawford, JT; Davis, BJ; Frieden, TR; Hutton, MD; Kilburn, JO; Nicholas, P; Villareal, C; Woodley, CL | 1 |
| Allen, FJ; de Kock, ML | 1 |
| Beotra, A; Jain, Y; Kabra, S; Mukhopadhya, S; Semwal, OP; Seth, SD; Seth, V | 1 |
| Aleksandrova, AE; Tschegoleva, RA; Vinogradova, TI | 1 |
| Mahadevan, S; Nalini, P; Padmini, R; Srinivasan, S | 1 |
| Botha, FJ; Clark, PK; Donald, PR; Mitchison, DA; Parkin, DP; Sirgel, FA; Van De Wal, BW | 1 |
| Lawrie, BW; Newcombe, RG; Pullan, RD; Rhodes, J; Rhodes, P; Roberts, G; Srivastava, ED; Stone, R; Swift, GL; Wilkinson, S | 1 |
| Delhomme, A; Flamand, JR; Greth, A | 1 |
| Crofton, J; de Kantor, I; Felten, M; Grosset, J; Kochi, A; Laszlo, A; Raviglione, MC; Vareldzis, BP | 1 |
| Orüç, O; Tülek, N; Türktaş, H; Unsal, M | 1 |
| Binkin, NJ; Boeri, V; Ghersi, G; Lo Monaco, R; Salamina, G | 1 |
| Chakaya, JM; Githui, WA; Karimi, FG; Kwamanga, D; Waiyaki, PG | 1 |
| Gusset, T; Rieder, HL; Salfinger, M | 1 |
| Pillans, P; Robson, SC; Willcox, PA | 1 |
| Calero del Castillo, JB; Esteban Sánchez, T; Galindo León, A; Pérez Martínez, F; Redondo Luciáñez, ER; Rodríguez Herrero, D | 1 |
| Mukendi Kavulu, R; Tshilolo Mwepu, L | 1 |
| Altman, C; Biour, M; Grangé, JD | 1 |
| Classen, V; Degitz, K; Messer, G; Meurer, M; Schirren, H | 1 |
| He, GJ | 1 |
| Fox, R; Gillespie, SH; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Saruni, AO; Uiso, LO | 1 |
| Dickinson, JM; Guy, A; Mitchison, DA | 1 |
| Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Saiki, S; Usami, M | 1 |
| Alvarez, D; Chomón, B; Del Rio, MJ; San José, ME; Sarandeses, A; Valdés, L | 1 |
| Hovig, B; Jensen, P | 1 |
| Riley, LW | 1 |
| Bonk, S; Bromberg, A; Bromberg, R; Hanna, BA; Neville, K; Rom, WN | 1 |
| Méndez Ramos, MJ; Negreira Cepeda, S; Palacios, PT | 1 |
| Cheshek, VG; Golyshevskaia, VI; Shevchenko, NI | 1 |
| Campbell, IA; Friend, JA; Jenkins, PA; Ormerod, LP; Prescott, RJ | 1 |
| Chandra, RS; Dalvi, SS; Karnad, PD; Kshirsagar, NA; Powar, HS | 1 |
| Krasnov, VA; Naryshkina, SL; Potashova, VA; Zyrianova, TV | 1 |
| Elistratova, NA; Khalbaeva, IV; Koriakin, VA; Sokolova, GB; Ziia, AV | 1 |
| Ellard, GA | 2 |
| Dias, F; Hoffner, SE; Källenius, G; Martins, L; Michael, SG; Norberg, R | 1 |
| Wilson, BA | 1 |
| Akksilp, S; Chunhaswasdikul, B; Jittinandana, A; Kamolratanakul, P; Tangcharoensathien, V; Udomrati, N | 1 |
| Dopfer, R; Hassberg, D; Niethammer, D; Wolff, M | 1 |
| Langer, B; Quader, Z; Simon, D; Wurtz, R | 1 |
| Ernst, W; Gossmann, J; Kachel, HG; Peschke, B; Scheuermann, EH; Schoeppe, W | 1 |
| Kochi, A; Styblo, K; Vareldzis, B | 1 |
| David, HL; Rastogi, N | 1 |
| Brändli, O; Dreher, D; Morger, D | 1 |
| Habot, B; Leibovitz, A; Rabinovitz, H; Rozenfeld, V; Schwartz, J; Stelian, J | 1 |
| Jezierska-Anczuków, A; Zalewska-Schöntaler, N | 1 |
| Aziah, AM; Faridza, MY; Jalleh, RD; Kuppusamy, I; Soshila, R | 1 |
| Anagonou, SY; Foundohou, J; Gninafon, M; Josse, R; Kinde-Gazard, D; Tawo, L | 1 |
| Mori, T; Ogata, H; Seita, A; Sugie, T; Sugita, H; Wada, M | 1 |
| Hamaguchi, Y; Ibe, T; Kashiwagi, H; Taguchi, O; Takahashi, Y; Teramura, S | 1 |
| Allen, BW; Ellard, GA; Humphries, MJ | 1 |
| Datta, M; Gopalan, BN; Paramasivan, CN; Prabhakar, R; Radhamani, MP; Selvaraj, R; Sudeendra, CR | 1 |
| Acocella, G; Grassi, C; Grassi, GG; Luisetti, M; Peona, V; Pozzi, E | 1 |
| Cauthen, GM; Dooley, SW; Frieden, TR; Kilburn, JO; Pablos-Mendez, A; Sterling, T | 1 |
| Gupta, PR; Gupta, RB; Sharma, TN; Singhal, B | 1 |
| Herbert, D; Paramasivan, CN; Prabhakar, R | 1 |
| Ackerson, L; Goble, M; Horsburgh, CR; Iseman, MD; Madsen, LA; Waite, D | 1 |
| Carroll, CP; Kim, JY; Opremcak, EM | 1 |
| Cremin, BJ; Crosier, JH; Hoffman, EB | 1 |
| Passannante, MR; Reichman, LB; Restifo, RA | 1 |
| Develioğlu, O; Gürgan, T; Urman, B; Yarali, H; Zeyneloğlu, H | 1 |
| Bergmann, F; Fehrenbach, J; Jautzke, G; Mauch, H; Ruf, B; Schürmann, D | 1 |
| Dhand, R; Ganguly, NK; Jaswal, S; Kohli, KK; Sethi, AK | 1 |
| Radermecker, M | 2 |
| Tekavec, J; Trkanjec, Z | 1 |
| Chandrasekaran, V; Paramasivan, CN; Prabhakar, R; Santha, T; Sudarsanam, NM | 1 |
| Ahuja, A; Li, AK; Poon, WS | 1 |
| Atkin, SL; Bodmer, CW; Masson, EA; Walker, BA; White, MC | 1 |
| Delaney, V; Hong, JH; Sommer, B; Sumrani, N | 1 |
| Abouya, LY; Ackah, A; Coulibaly, D; Coulibaly, IM; Digbeu, H; Doorly, R; Kassim, S; Sassan-Morokro, M; Whitaker, PJ; Yesso, G | 1 |
| Katayama, T; Kurashima, A; Mori, M; Nagai, H; Sato, K | 1 |
| Coville, PF; Kang, W; Thitiarchakul, S; Viriyayudhakorn, S; Wanwimolruk, S | 1 |
| O'Connell, MT; Patsalos, PN; Quinn, NP; Wenning, GK | 1 |
| Cañete, C; Estopà, R; Galarza, I; Granados, A; Manresa, F | 1 |
| Asai, T; Hara, K; Kawano, S; Masumoto, H; Matsuse, A; Monden, J; Nakamura, H; Nakamura, Y; Shimoda, T | 1 |
| Gatson, AM; Reisner, BS; Woods, GL | 1 |
| Daneluzzi, D; Gangadharam, PR; Luna-Herrera, J; Reddy, VM | 1 |
| Chan, HS; Chan, K; Chan, R; Cheng, A; Cheung, W; Woo, J | 1 |
| Pugliese, G | 1 |
| Fahn, HJ; Hsu, HS; Huang, MH; Wang, LS; Wu, YC | 1 |
| Botha, FJ; Donald, PR; Mitchison, DA; Parkin, DP; Sirgel, FA; van de Wal, BW | 1 |
| McColloster, P; Neff, NE | 1 |
| Belfort, R; Muccioli, C | 1 |
| Albertos Castro, JM; Alonso Vaquero, D; Junquera Gutiérrez, LM; Palacios Gutierrez, JJ; Vicente Rodriguez, JC | 1 |
| Gunn-Moore, DA; Jenkins, PA; Lucke, VM | 1 |
| Canty, TG; Collins, DL; Danker, WM; Lynch, FP; Veeragandham, RS | 1 |
| Andrés Soler, J; González, F; Moreno, R; Pardo, F; Prada Alfaro, PL | 1 |
| Aguilar, X; Fernández-Muixí, J; Gallego, M; Morera, J; Ribas, J; Richart, C; Ruiz, J; Teixidó, A | 1 |
| Sane, NS; Sane, SV; Thakker, SV | 1 |
| Haag, SD; Malone, JL; O'Neill, J; Pace, E; Roberts, J; Rusnak, J; Sartin, JS | 1 |
| Ali, J | 1 |
| Trehan, AK | 1 |
| Abdullaev, RIu; Kaminskaia, GO | 1 |
| Batyrov, FA; Dorozhkova, IR; Kornilova, ZKh | 1 |
| Gonzalez, J; Martinez, ME; Peña, JM; Sanchez-Cabezudo, MJ; Vazquez, JJ | 1 |
| Davey, JR; Kreder, HJ | 1 |
| Arranz Nieto, MJ; Barbudo Ousset, MA; Celdrán Gil, J; Durán Pérez-Navarro, A; Marcos Sánchez, F | 1 |
| McConville, JH | 1 |
| Demkow, U; Lewandowski, Z; Małkowska-Zwierz, W; Rogala, E; Skopińska-Rózewska, E | 1 |
| Chan, C; Chan, K; Chan, R; Cheung, W; Or, K; Woo, J | 1 |
| Berger, L; Curram, J; Fox, R; Gillespie, SH; Gutmann, J; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Sam, N; Saruni, AO; Tillotson, G; Uiso, LO; Yates, M | 1 |
| Birnbaum, J; Chan, SP; Rao, M; Steiner, P | 1 |
| Arain, TM; Resconi, AE; Singh, DC; Stover, CK | 1 |
| Fujimoto, T; Morishima, T; Ueda, M | 1 |
| Hara, K; Koga, H; Kohno, S; Miyamoto, J; Tashiro, T | 1 |
| Karrer, W; Rothe, TB | 1 |
| Alito, A; Cataldi, A; de Kantor, IN; Dolmann, A; Morcillo, N; Reniero, A; Romano, MI | 1 |
| Aita, J; Barrera, L; Biglione, J; Largacha, C; Lopez, B; Rajmil, JC; Reniero, A; Ritacco, V; Weisburd, G | 1 |
| Barrera, L; de Kantor, IN; Ritacco, V | 1 |
| Hanna, BA; Walters, SB | 1 |
| Gubkina, MF | 1 |
| Liang, G; Lu, H; Wu, H | 1 |
| Barry, P; Isselin, J; Regnard, PJ | 1 |
| Chopra, K; Roy, V; Tekur, U | 1 |
| Mills, K; Wanger, A | 1 |
| Cole, ST; Heym, B; Philipp, W | 1 |
| Askgaard, DS; Døssing, M; Nybo, B; Wilcke, JT | 1 |
| Das, PC; Radhakrishna, K; Rao, PL | 1 |
| Morris, CD | 1 |
| Broor, SL; Chaudhary, A; Kumar, N; Malhotra, V; Malik, VK; Puri, AS; Sachdev, A; Vij, JC | 1 |
| Ackerstein, A; Engelhard, D; Gazit, D; Kupolovicz, U; Nagler, A; Or, R; Raveh, D; Toren, A | 1 |
| Cynamon, MH; Klemens, SP | 1 |
| Amitani, R; Kuze, F; Murayama, T; Suzuki, K; Tanaka, E; Yamamoto, T | 1 |
| Alland, D; Brudney, K; Crawford, JT; Frieden, TR; Fujiwara, PI; Hewlett, D; Kreisworth, BN; Maw, KL; Nivin, B; Sharp, V; Sherman, LF | 1 |
| Dhillon, J; Dickinson, JM; Mitchison, DA; Sole, K | 1 |
| Daneluzzi, D; Gangadharam, PR; Nadadhur, G; O'Sullivan, JF; Reddy, VM | 1 |
| Atweh, S; Hachem, R; Leeds, N; Raad, I; Salem, Z; Sawaya, R | 1 |
| Camilo, E; Cruz, E; Espinal, MA; Gonzalez, G; Matos, N; Pérez, G; Reingold, AL; Soto, S | 1 |
| Bustreo, F; Chaulet, P; Raviglione, M | 1 |
| Begić-Janeva, A; Boricić, I; Brmbolić, BJ; Jevtović, DL; Ranin, JT; Salemović, DR | 1 |
| Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
| Argekar, AP; Kunjir, SS; Purandare, KS | 1 |
| Herbert, D; Kubendiran, G; Mitchison, DA; Paramasivan, CN; Prabhakar, R; Venkatesan, P | 1 |
| Lode, H; Rebhan, K; Schaberg, T | 1 |
| Aleksandrova, AE; Pigareva, NV; Prokop'eva, ED; Zabolotnykh, NV | 1 |
| Berry, D; Scriven, JM | 1 |
| Escobar, MA; Saravia, NG; Weigle, KA | 1 |
| Kuijper, EJ; Prins, JM; Schultsz, C; van Soolingen, D | 1 |
| Beyers, N; Botha, P; Coetzee, GJ; Donald, PR; Gie, RP; Groenewald, P; Schaaf, HS; Vermeulen, HA | 1 |
| Bernardo, J; Farber, HW; Gottlieb, DJ; Levinson, S; McInnis, B; Nieves, RL; O'Connell, JJ; Park, H; Polesky, A | 1 |
| Brennan, PJ; MacGregor, RR | 1 |
| Duursema, L; Groenewoud, G; Hundt, HK; Middle, MV; Mogilnicka, EM; Müller, FO; Schall, R; Swart, KJ | 1 |
| Paul, CR; Rabah, R; Rao, RB | 1 |
| Belt, EL; Durrheim, DN | 1 |
| Egawa, H; Inomata, Y; Kiuchi, T; Okajima, H; Sano, K; Satomura, K; Tanaka, K; Uemoto, S; Uyama, S; Yamaoka, Y | 1 |
| Alvarez, L; Diliz, HS; Hernandez, A; Treviño, M; Zaragoza, RM | 1 |
| Sarela, AI; Supe, AN | 1 |
| Barakat, MT; Calam, J; Friedland, JS; Hughes, JM; Ind, PW; McKenna, C; Scott, J; Walport, M | 1 |
| Hadiarto, M; Hudoyo, A; Tjandra, YA | 1 |
| Durak, AC; Gülmez, I; Keleştimur, F; Ozesmi, M | 1 |
| Furukawa, T; Komachi, H; Nagai, R; Saito, Y; Takewaki, S; Uchihara, T | 1 |
| Chan, TY | 2 |
| Bruguera, M; Mas, A; Moitinho, E; Rodés, J; Salmerón, JM | 1 |
| Berghaus, A; Schütte, A; Schütte, W | 1 |
| Greenwell, H; Kerns, DG; Kerns, LL; Zuehlke, RK | 1 |
| Hsu, RW; Lin, TY; Shih, HN | 1 |
| Jacqueson, A; Nicod, L; Regnier, A; Richert, L; Viollon, C | 1 |
| Ohgimi, T; Ohtake, M; Okuno, M; Saito, H; Yamamoto, S | 1 |
| Bernasconi, C; Cole, ST; Heym, B; Honoré, N; March, J; Ortega, A; Takiff, HE; Telenti, A | 1 |
| Chan, SL; Lau, SK; Tam, CM; Wei, WI; Wong, SH; Yuen, AP | 1 |
| Pozniak, A | 1 |
| Bia, FJ; de la Hoz, RE; Garcia, D; Melendez, R; Waycott, S | 1 |
| Cook, SV; Crawford, JT; Ebrahimzadeh, A; Frieden, TR; Fujiwara, PI; Glickman, SE; Kreiswirth, BN; Osahan, SS; Rutherford, CM; Sachdev, PS | 1 |
| Campos Aguilera, A; Cañabate Reche, F; Daza Torres, A; López Muñoz, J; López Prieto, F; Vázquez López, M | 1 |
| al-Suwaidi, Z; Drobniewski, F; McNerney, R; Porter, J; Wilson, SM | 1 |
| Bishai, WR; Chaisson, RE | 1 |
| Deol, P; Khuller, GK | 1 |
| Garavelli, PL | 1 |
| Kang, C; Nachamkin, I; Weinstein, MP | 1 |
| Hayase, Y; Tobita, K | 1 |
| Andrade, MK; Haffner, A; Kritski, AL; Riley, LW; Rodrigues de Jesus, LS; Vieira, MA; Werneck-Barroso, E | 1 |
| Carson, ML; Elcock, M; Geiter, LJ; Maxwell, RM; Meador, J; Ridzon, R; Smith, PJ; Villarino, ME; Weismuller, PC | 1 |
| Drobniewski, FA; Yates, MD | 1 |
| Davies, PD | 1 |
| Deol, P; Joshi, K; Khuller, GK | 1 |
| Chang, SY; Changchien, CC; Hsu, TY; Lin, JW; Ma, YY | 1 |
| Cohen, LB; Knowles, SR; Liu, BA; Shear, NH; Werb, MR | 1 |
| Benator, DA; Gordin, FM; Kan, V | 1 |
| Chebbi, ML; Dakhlaoui, R; Drira, I; Jeguirim, MS; Souissi, R | 1 |
| Kumar, D; Srivastava, BS; Srivastava, R; Subramaniam, P | 1 |
| Braunschweig, S; Fattinger, K; Krähenbühl, S; Meier-Abt, PJ; Reichen, J | 1 |
| Capelastegui, A; Collazos, J; Fernández Cantón, G; García-Moncó, JC; Gómez Beldarrain, M | 1 |
| Bloom, B; Cole, S; Duncan, K; Enarson, D; Fine, P; Ginsberg, A; La Montagne, J; Smith, P; Young, D | 1 |
| Bentabol, G; Colmenero, JD; García-Ordoñez, MA; Juárez, C; Pérez-Ruiz, E; Sánchez-González, J; Sánchez-Lora, J; Sebastián, MD | 1 |
| Aoki, FY; Choudhri, SH; Gathua, S; Hawken, M; Long, R; Minyiri, GO; Sahai, J; Sitar, DS; Watkins, W | 1 |
| Fuursted, K | 1 |
| Husain, S; Malaviya, GN; Mishra, B | 1 |
| Cameron, DW; Gallicano, K; Garber, G; Oliveras, L; Rachlis, A; Sahai, J; Seguin, I; Swick, L; Tailor, S; Walker, S | 1 |
| Kayantao, D; Keïta, B; Sangaré, S | 1 |
| Attari, S; Mehta, S; Mehta, SK; Rana, SV; Sodhi, CP; Vaiphei, K | 1 |
| Bergmann, JS; Woods, GL | 2 |
| Ellner, JJ; Hom, DL; Huebner, R; Johnson, JL; Mugerwa, RD; Mugyenyi, P; Okwera, A; Whalen, CC | 1 |
| Di Fede, GF; Musumeci, S; Pavone, V; Polizzi, A; Ruggieri, M; Smilari, P; Sorge, G | 1 |
| Padeĭskaia, EN | 1 |
| Banerjee, A; Harries, A; Salaniponi, F | 1 |
| Siribaddana, SH; Wijesundera, A | 1 |
| Arcalis, L; González, T; Martin-Casabona, N; Rossello, J; Xairó Mimó, D | 1 |
| Chirgwin, K; El Sadr, WM; Hafner, R; Heifets, LB; Klein, O; Kreiswirth, BN; Matts, JP; Musser, JM; Nelson, ET; Perlman, DC; Salomon, N; Telzak, EE | 1 |
| Sybrecht, GW | 1 |
| Lin, S; Yan, S; Ye, H | 1 |
| Jiang, M; Wang, S; Yang, T | 1 |
| Asakura, H; Matsuda, T; Mizuhashi, K; Mizushima, N; Nakao, S; Takami, A; Yamazaki, H | 1 |
| Fukunaga, H; Higashimoto, I; Hirotsu, Y; Jounsono, M; Kawabata, M; Koreeda, Y; Mizuno, K; Niina, K; Osame, M; Tomiyama, Y | 1 |
| Coll, P; Garriga, X; Garrigó, M; March, F; Moreno, C; Prats, G; Rodríguez, P | 1 |
| Bouchta, F; Erreimi, N; Hida, M; Mouane, N | 1 |
| Barry, CE | 1 |
| Bulpitt, AE; Jaresko, GS; Jelliffe, RW; Keung, AC; Peloquin, CA; Yong, CL | 1 |
| Elcock, M; Kent, JH; Maxwell, R; Meador, J; Onorato, I; Ridzon, R; Royce, S; Shefer, A; Smith, P; Valway, S; Weismuller, P; Woodley, C | 1 |
| Bustreo, F; Laszlo, A; Rahman, M; Raviglione, M | 1 |
| Cambiaso, CL; Drowart, A; Huygen, K; Jann, E; Portaels, F; Serruys, E; Van Vooren, JP | 1 |
| Balambal, R; Balasubramanian, R; Nagarajan, M; Paramasivam, CN; Prabhakar, R; Rajasambandam, P; Rangabashyam, N; Sundararaman, R; Tripathy, SP; Venkatesan, P | 1 |
| Berhane, Y; Demissie, M; Gebeyehu, M | 1 |
| Hoeppner, VH | 1 |
| Bilgiç, H; Ciftçi, F; Köylü, R; Pabuşçu, Y; Seber, O; Tozkoparan, E | 1 |
| Cook, MB; Degnan, MT; Ferguson, RM; Franzblau, SG; Gilman, RH; Hernandez, A; Madico, G; McLaughlin, JC; Quenzer, VK; Torres, P; Witzig, RS | 1 |
| Bocharova, IV; Iakhin, RT; Khaĭdukov, SV; Litvinov, IS; Mezhlumova, MB; Nikonenko, BV | 1 |
| Churchyard, GA; Kleinschmidt, I; Mqoqi, NP; Williams, B | 1 |
| Yano, I | 1 |
| Aubry, P; Jounieaux, V; Leleu, O; Verhoest, P | 1 |
| Kuś, J; Michałowska-Mitczuk, D | 2 |
| Boudville, IC; Snodgrass, I; Wong, SY | 1 |
| Benghanem, MG; Fatihi, E; Hachim, K; Ramdani, B; Zahiri, K; Zaid, D | 1 |
| Aït Khaled, N; Billo, N; Enarson, D | 1 |
| Dautzenberg, B; Jouveshomme, S | 1 |
| Devoto, FM; González, C; González, CD; Iannantuono, R; Sáenz, C; Serra, HA | 1 |
| Beji, M; Ben Rhomdane, N; Daghfous, J; Louzir, B; Mtimet, B; Zouari, M | 1 |
| Benzarti, M; Garrouche, A; Hayouni, A; Jerray, M; Klabi, N; Maalel, K | 1 |
| Alvarez Baleriola, I; Moreira Vicente, V; Pérez Fernández, T; Sanz Villalobos, E | 1 |
| el Fassi, J; el Khader, K; Hachimi, M; Ibnattya, A; Karmouni, T; Lakrissa, A; Tazi, K | 1 |
| Drobniewski, FA; Wilson, SM | 1 |
| Atkinson, J; Boulos, R; Chaisson, RE; Coberly, JS; Contave, M; Davis, H; Desormeaux, J; Geiter, L; Halsey, NA; Huebner, R; Johnson, E; Johnson, M; Losikoff, P; Moulton, LH | 1 |
| Hurle, R; Lembo, A; Losa, A; Ranieri, A | 1 |
| Choi, BW; Hue, SH; Park, IW | 1 |
| Rieder, HL; Trébucq, A | 1 |
| Ali, SA; Amanullah, S; Arif, K; Khan, JA; Nayani, P; Siddiqui, I | 1 |
| Amitani, R; Hitomi, S; Kuze, F; Matsumoto, H; Mizuno, H; Suzuki, K; Tanaka, E; Tsuyuguchi, K; Yanagihara, K | 1 |
| Nakao, M; Toyoda, K | 1 |
| Fujishima, M; Hirakata, H; Kubo, M; Ogata, H; Okuda, S; Tamaki, K | 1 |
| Iwamatsu, H; Kikuchi, M; Teramura, T; Yoshida, K | 1 |
| Handa, J; Kizuki, H; Takebe, Y; Tokuriki, Y; Tsuji, A | 1 |
| Bechan, S; Connolly, C; Short, GM; Standing, E; Wilkinson, D | 1 |
| Finelli, L; Liu, Z; Shilkret, KL | 1 |
| Barry, CE; Fischer, E; Lee, RE; Mdluli, K; Swanson, J | 1 |
| Coninx, R; de Haller, R; Debacker, M; Ismailov, A; Jabrailov, I; Jafarov, F; Mathieu, C; Mirzoev, F; Pfyffer, GE; Portaels, F; Savina, D | 1 |
| Bhatia, E; Gupta, RK; Jain, SK; Pandey, R | 1 |
| Bai, KJ; Chiang, CY; Chiang, IH; Lin, TP; Luh, KT; Suo, J; Yu, MC | 1 |
| Cho, BK; Cho, SH; Hong, JK; Park, YM | 1 |
| Dunlap, NE; Hall, M; Kimerling, ME; Patterson, P; Phillips, P; Robinson, CA | 1 |
| Su, Y; Wen, S; Zhang, F | 1 |
| Chirgwin, KD; Cohn, DL; el-Sadr, WM; Hafner, R; Heifets, L; Jones, BE; Klein, O; Matts, JP; Medard, F; Mildvan, D; Nelson, ET; Olibrice, M; Perlman, DC; Salomon, N; Telzak, EE | 1 |
| Hashimoto, Y; Honda, I; Teramoto, H; Uchino, M; Yonemura, K | 1 |
| Freedman, VH; Kaplan, G; Sokol, K; Tsenova, L | 1 |
| Borque, C; del Castillo Martín, F; García-Hortelano, J; García-Miguel, MJ; Sánchez-Albisua, I; Vidal López, ML | 1 |
| Antoun, F; Crespy, M; Momas, I; Poinsard, R; Vieu, V | 1 |
| Binkin, N; Bustreo, F; Chaulet, P; Cohn, DL; Kim, SJ; Lambregts-van Weezenbeek, CS; Laszlo, A; Nunn, P; Pablos-Méndez, A; Raviglione, MC; Rieder, HL | 1 |
| Callister, SM; Kirk, SM; Mazurek, GH; Moore, AV; Schell, RF | 1 |
| Chan, SL; Kam, KM; Lam, CW; Leung, CC; Mitchison, DA; Morris, JS; Tam, CM | 1 |
| de Silva, AP; de Silva, HJ; Fonseka, MM; Gunatilake, SB; Premaratne, R | 1 |
| Patel, A; Paterson, DL | 1 |
| Colebunders, R; Florence, E | 1 |
| Chang, AB; Grimwood, K; Harvey, AS; Olinsky, A; Rosenfeld, JV | 1 |
| Ben-Dov, I; Gochstein, B; Grinshpoon, A; Miron, M; Rosenman, J; Zeenreich, A | 1 |
| Laippala, PJ; Marjamäki, M; Otten, TF; Soini, H; Vasilyef, AV; Viljanen, MK; Vyshnevskaya, E; Vyshnevskiy, BI | 1 |
| Dilber, E; Göçmen, A; Kiper, N; Ozçelik, U | 1 |
| Autret, E; Carré, P; Jonville-Bera, AP; Lemarié, E; Radal, M; Van-Egroo, C | 1 |
| Attri, S; Mehta, S; Mehta, SK; Rana, SF; Sodhi, CP; Yaiphei, K | 1 |
| Cohn, DL; Sudre, P | 1 |
| Chaisuksuwan, R; Pransujarit, V; Punnotok, J; Riantawan, P | 1 |
| Smith, PJ; Taylor, B | 1 |
| Collazos, J; España, P; Izquierdo, F; Martínez, E; Mayo, J | 1 |
| Brear, SG; Clarke, KW; Morgan, JR | 1 |
| Ivanyi, J; Moreno, C; Pasvol, G; Sjölund, A; Vordermeier, HM; Wilkinson, KA; Wilkinson, RJ | 1 |
| Chaisson, R; Coberly, J; Halsey, NA | 1 |
| Atabey, N; Fetil, E; Günes, AT; Gürler, N; Ozkan, S | 1 |
| Mansour, AM | 1 |
| Eerola, E; Marttila, HJ; Otten, TF; Soini, H; Vasilyef, AV; Viljanen, MK; Vyshnevskaya, E; Vyshnevskiy, BI | 1 |
| Aoyagi, T | 1 |
| Fujino, T; Hasegawa, N; Kawada, K; Komatsu, H; Satou, R | 1 |
| Dylewska, K; Kurylak, D; Smukalska, E; Staszak-Kowalska, R | 1 |
| De Villiers, JN; Donald, PR; Pretorius, M; Schoeman, JF; Springer, P; Van Zyl, LE | 1 |
| Fodor, T; Lõrinczi, I; Vadász, I | 1 |
| Okazawa, Y; Sato, N; Tanno, K; Yamazaki, T | 1 |
| Chow, SK; Tong, FM | 1 |
| Gordin, F | 1 |
| Filippou, N; Ilias, I; Papachristou, K; Vassilikos, G | 1 |
| Kharoubi, S | 1 |
| B1tashova, VA; Borovinskaia, TA; Gromyko, NI; Krasnov, VA; Kudelia, OA; Ursov, IG; Volkova, ZhA | 1 |
| Bercion, R; Kuaban, C | 1 |
| Augustynowicz-Kopec, E; Grubek-Jaworska, H; Niemirowska-Mikulska, H; Safianowska, A; Stambrowska, H; Walkiewicz, R; Zwolska, Z | 1 |
| Drobniewski, FA | 1 |
| Herbert, D; Kubendiran, G; Paramasivan, CN | 1 |
| Antia, NH; Dholakia, Y; Harboe, M; Mistry, NF; Sethna, KB | 1 |
| Eladari, D; Klotz, F; Mbaye, PS; Sane, M; Talarmin, F | 1 |
| Paterson, DL; Singh, N | 1 |
| Collazos, J; Martínez, E; Mayo, J | 1 |
| Castillejos, ML; Cuenca, D; Espinosa, A; Martínez Alfaro, E; Sáez, L; Serna, E; Solera, J | 1 |
| Rose, DN | 1 |
| Achi, V; Beugre, LK; Coulibaly, G; Coulibaly, IM; Coulibaly, V; Daix, T; Domoua, K; Koffi, J; Konan, JB; N'Dhatz, M; Ouattara, Y; Ouedraogo, M; Traore, F; Yapi, A | 1 |
| Farnell, DR; Giles, HD; Heath, JE; Lindamood, C; Rao, GN | 1 |
| Kim, CT; Park, SK; Song, SD | 1 |
| Dass, A; Goyal, A; Mohan, H; Nagarkar, NM; Uppal, KS | 1 |
| Bancel, B; Biron, F; Boibieux, A; Bouhour, D; Chidiac, C; Peyramond, D; Rode, A; Sève, P | 1 |
| Domehl, C; Gismondo, MR; Nardi, G; Pfyffer, GE; Rüsch-Gerdes, S; Welscher, HM | 1 |
| Augustynowicz-Kopeć, E; Niemirowska-Mikulska, H; Stambrowska, A; Zofia, Z | 1 |
| Bao, O; Diouf, B; Diouf, ML; Ka, MM; Mbengue, M; Moreira-Diop, T; Niang, A; Pouye, A | 1 |
| Elliott, AM; Godfrey-Faussett, P; Hosp, M; Luo, N; McAdam, KP; Mugala, BN; Mwaba, P; Mwinga, A; Nyirenda, O; Pobee, J; Porter, JD; Quigley, M | 1 |
| Arora, S; Bambery, P; Gupta, A; Gupta, V; Ram, J; Sehgal, S | 1 |
| Kohno, S; Ohno, H | 1 |
| Araki, J; Asai, S; Futsuki, Y; Tomari, S | 1 |
| O'Flanagan, J; Syed, AA | 1 |
| Cave, MD; DesJardin, LE; Eisenach, KD; Hehman, GL; Hellyer, TJ | 1 |
| Del Brutto, OH; Mosquera, A | 1 |
| Benbouazza, K; Bensabbah, R; Bezza, A; el Maghraoui, A; Hajjaj-Hassouni, N; Hassouni, F; Kettani, M; Lazrak, N; Missaoui, A; Mohattane, A; Niamane, R; Rhazali, L | 1 |
| Bamber, S; Coovadia, HM; Corr, PD; Topley, JM | 1 |
| Kaul, CL; Kaur, K; Panchagnula, R; Sharda, N; Sood, A | 1 |
| Heald, SH; Leitch, AG; Simpson, AJ; Sudlow, MF; Watt, B | 1 |
| Corrigan, D; Paton, J | 1 |
| Bennett, D; Chadwick, M; Drobniewski, F; Gilham, C; Herbert, J; Irish, C; Magee, JG; Smith, EG; Watson, JM; Watt, B; Williams, R | 1 |
| Aguilera, JA; Anderberg, SJ; Av-Gay, Y; delCardayre, SB; Fahey, RC; Newton, GL; Oh, NN; Unson, MD | 1 |
| Coward, RA; Kistler, A; Lappin, DW | 1 |
| Greinert, U; Müller-Quernheim, J; Schlaak, M; Schreiber, J; Zissel, G | 1 |
| Chen, J; Xing, T; Zhang, G | 1 |
| Doig, C; Fang, Z; Forbes, KJ; Kenna, DT; Rayner, A; Watt, B | 1 |
| Bardarov, S; Carrière, C; Chan, J; Freundlich, L; Hatfull, G; Jacobs, WR; Kumar, V; Riska, PF; Sarkis, G; Su, Y | 1 |
| Chandrasekaran, V; Gurumurthy, P; Kumar, AK; Kumaraswami, V; Prabhakar, R; Ramachandran, G; Venkatesan, P; Vijayalakshmi, S; Vjayasekaran, V | 1 |
| Teo, SK | 1 |
| Binkin, N; Huebner, R; Kenyon, TA; Maganu, E; Mwasekaga, MJ; Rumisha, D | 1 |
| Miyao, H; Okazawa, Y; Sato, N; Tanno, K; Yamashita, K; Yamazaki, T | 1 |
| Le Lostec, Z; Louletzian, O; Mornet, P; Welker, Y | 1 |
| Amdekar, YK | 1 |
| Gibson, GG; Goldfarb, PS; Gray, TJ; Ogg, MS; Tarbit, M; Williams, JM | 1 |
| Childs, JM; Fish, DN; Malone, RS; Peloquin, CA; Spiegel, DM | 1 |
| Aljada, IS; Amsterdam, D; Corriere, N; Crane, JK; Wagle, DG | 1 |
| Autret, E; Jonville-Béra, AP; Martel, C; Mazaud, S; Olivier, C; Radal, M | 1 |
| Kalita, J; Mistra, UK | 1 |
| Grange, JM; Mwaba, P; Squire, SB; Zumla, A | 1 |
| Ito, K; Mizutani, S; Ogata, H; Sugita, H; Wada, M; Yoshiyama, T | 1 |
| Connolly, C; Davies, GR; McAdam, KP; Sturm, AW; Wilkinson, D | 1 |
| Benator, D; Bozeman, L; Burman, W; Khan, A; Vernon, A | 1 |
| Ming, A | 1 |
| Wu, X; Zhang, J; Zhuang, Y | 1 |
| Fu, Y; Li, Z; Xiao, C | 1 |
| Bianco, B; Botti, G; Iannello, A | 1 |
| Bhatt, AD; D'Sa, S; Desai, ND; Gandewar, K; Padgaonkar, KA; Revankar, SN; Shah, V; Vaz, JA | 1 |
| Baello, BQ; Balagtas, ED; Cardano, RC; Co, VM; Mantala, MJ; Pascual, LG; Quelapio, ID; Rivera, AB; Tupasi, TE; Villa, LA | 1 |
| Duchin, JS; Goldberg, SV; Nolan, CM; Shields, T | 1 |
| Chinchilla, D; Martorano, A; Rodriguez, E; Villanueva, C | 1 |
| Maia, S; Moniz-Pereira, J; Portugal, I | 1 |
| Coninx, R; de Haller, R; Debacker, M; Ismaelov, A; Mathieu, C; Meddings, DR; Mirzoev, F | 1 |
| Gleissberg, V | 1 |
| Bishai, WR; Chaisson, RE; Miyazaki, E | 1 |
| Lall, N; Meyer, JJ | 1 |
| Chang, CH; Chang, JP; Kao, CL | 1 |
| Shemiakin, IG; Stepanshin, IuG; Stepanshina, VN | 1 |
| Long, R; Scalcini, M | 1 |
| Cheung, MC; Li, JH; Peh, WC; Yip, SK | 1 |
| Chase, SE; Chmielewski, AJ; Cynamon, MH; Lenaerts, AM | 1 |
| Alwood, K; Bishai, WR; Blazes, D; Chaisson, RE; Coggin, W; Gachuhi, R; Sterling, TR | 1 |
| Asai, S; Endou, T; Iwamoto, A; Nakamura, T; Takahashi, T; Yoshikawa, K | 1 |
| Butcher, PD; Drobniewski, FA; Eltringham, IJ; Mangan, JA; Wilson, SM | 1 |
| Kotecha, JS; Rathod, IS; Savale, SS; Shah, PB; Shah, SA; Shishoo, CJ | 1 |
| D'Cruz, D; Dodd, SM; Helbert, M; Raftery, MJ; Skinner, CJ; Smith, PR | 1 |
| Bottasso, O; Dlugovitzky, D; Dominino, JC; Hartopp, R; Singh, M; Stanford, C; Stanford, J; Valentini, E | 1 |
| Barrière, V; Blétry, O; Bricaire, F; Caumes, E; Gepner, P | 1 |
| Mezzetti, F; Moro, ML; Salamina, G; Sodano, L | 1 |
| Barnaba, V; Bruno, G; De Siati, L; Ferri, C; Muda, AO; Paroli, M | 1 |
| Alberti, F; Gonzàlez Montaner, LJ; Palmero, D | 1 |
| Ayarza, R; Berdonces, P; Echeverría, MJ; Ibarretxebea, AB; Jiménez, MS; López de Goicoechea, MJ | 1 |
| Kobashi, Y; Okimoto, N; Soejima, R | 1 |
| Duman, S; Ece, T; Kiliçaslan, Z; Ozkahya, M; Sayiner, A; Tokat, Y; Yildiz, A | 1 |
| Komatsu, H; Tabata, N; Tagami, H; Terunuma, A | 1 |
| Fredericks, A; Smith, PJ; van Dyk, J | 1 |
| Kuroda, F; Mizutani, F; Sasaki, Y; Wada, A; Yagi, T; Yamagishi, F | 1 |
| Ferreiro Seoane, JL; Gómez Rodríguez, N; Ibáñez Ruán, J; Sevillano Castaño, J | 1 |
| Bahadur, T; Raj, GA; Sah, SP | 1 |
| Akçay, S; Arslan, H; Demirag, A; Gürdogan, K; Haberal, M; Kalpaklioglu, F; Oner-Eyüboglu, F | 1 |
| Haberal, M; Kalpaklioglu, AF; Moray, G; Oner-Eyüboglu, AF | 1 |
| Bergmann, JS; Fish, G; Woods, GL | 1 |
| Mathew, S; Narayanan, A; Paramasivan, CN; Segaran, R | 1 |
| Musser, JM; Ramaswamy, S | 1 |
| Horiguchi, Y; Imamura, S; Matsui, M; Matsuyoshi, N; Ohta, K; Ohtoshi, E; Toda, K; Yamaoka, J | 1 |
| Aznar, J; González, N; Palomares, JC; Torres, MJ | 1 |
| Suarez, L; Taylor, JP | 1 |
| Kaul, CL; Kaur, KJ; Panchagnula, R; Singh, I | 1 |
| Barker, J; Makatini, Z; Millard, J | 1 |
| Laheij, RJ; Richter, C; van Loenhout-Rooyackers, JH; Verbeek, AL | 1 |
| Chitemerere, C; Gumbo, J; Ndudzo, P; Nyazema, NZ; Rabvukwa, P | 1 |
| Berg, DE; Caviedes, L; Gilman, RH; Lee, EH; Lee, TS; Montenegro-James, S; Sheen, P; Spellman, E | 1 |
| Goicoechea, HC; Olivieri, AC | 1 |
| Bogomazova, AV; Gurevich, GL; Okulovskaia, SS | 1 |
| Martynova, LP; Mishin, VIu; Vasil'eva, IA | 1 |
| Aktuglu, Y; Bilir, M; Mert, A; Ozaras, R; Ozturk, R; Senturk, H; Tabak, F; Tahan, V | 1 |
| Barry, MA; Chaisson, RE; Coberly, J; de Lourdes Garcia, M; Gordin, F; Hafner, R; Klukowicz, AJ; Matts, JP; Miller, C; O'Brien, RJ; Schechter, M; Valdespino, JL | 1 |
| Van Vooren, JP | 1 |
| Korobova, OV; Medvedeva, IM; Mitrofanova, GN; Panfertsev, EA; Shemiakin, IG; Stepanshin, IuG; Stepanshina, VN | 1 |
| Borgdorff, MW; Bretzel, G; Bwire, R; Kawuma, HJ; Rieder, HL; Rüsch-Gerdes, S; Sticht-Groh, V | 1 |
| Aleixo-Dias, J; Antunes, AF; Antunes, ML; Pereira, MF; Raymundo, E; Rodrigues, MF | 1 |
| Azuma, J; Fukuda, T; Igarashi, T; Ito, M; Komuta, K; Maeda, K; Maekura, R; Ogura, T; Ohno, M; Yamaguchi, I; Yamamoto, I; Yamamoto, Y; Yokota, S | 1 |
| Al-Ghusein, H; Chan, SL; Kam, KM; Mitchison, DA; Sim, E; Sole, KM; Staples, D; Tam, CM | 1 |
| Havelková, M; Hyncicová, I; Kaustová, J; Kremer, K; Kubín, M; Svecová, Z; van Soolingen, D | 1 |
| Cooksey, RC; Holloway, BP; Listenbee, S; Miller, CW; Oldenburg, MC | 1 |
| Joshi, SR | 1 |
| Bouza, E; Díaz-Infantes, MS; Martínez-Sánchez, L; Ortega, A; Ruiz-Serrano, MJ | 1 |
| Baruchin, AM; Nelly, P; Oren, S; Weiler, Z | 1 |
| Daniel, N; Geiter, LJ; Grosset, J; Hejblum, G; Ji, B; Lounis, N; O'Brien, RJ; Szpytma, M; Truffot-Pernot, C; Vernon, A | 1 |
| Baéz, J; Dye, C; Espinal, MA; Kam, KM; Khomenko, AG; Kim, SJ; Kochi, A; Migliori, GB; Raviglione, MC; Suarez, PG | 1 |
| Donald, PR; Hussey, GD; Kibel, MA; Louw, A; Perkins, DR; Schaaf, HS; Te Water Naude, JM | 1 |
| Morehead, RS | 1 |
| Donald, PR; Githui, W; Kam, KM; Lam, CW; Mitchison, DA; Odhiambo, J; Paramasivan, CN; Sirgel, FA; Sole, KM; Tam, CM; Umapathy, KC | 1 |
| Dye, C; Williams, BG | 1 |
| Achi, V; Coulibaly, G; Diagbouga, S; Domoua, K; N'Dathz, M; Ouedraogo, M; Ouedraogo, SM; Yapi, A | 1 |
| Lombard, CJ; Schoeman, JH; Tatley, M; Vundule, C; Zwarenstein, M | 1 |
| Parthasarathy, R; Prabhakar, R; Santha, T; Sivasubramanian, S; Somasundaram, PR; Sriram, K | 1 |
| Rao, GP | 1 |
| Gerber, F; Herrmann, JL; Lagrange, PH; Lavergne, F; Poinsignon, Y; Simonney, N; Sousa, AO; Wargnier, A | 1 |
| Kaminskaĭte, A; Mishkinis, K; Purvanetskene, B | 1 |
| Iukhimenko, NV | 2 |
| Carbonnelle, B; Grosset, J; Robert, J; Truffot-Pernot, C; Trystram, D | 1 |
| Horvath, JA; Talwani, R | 1 |
| Cohn, DL | 1 |
| Alves, SM; Belo Neto, E; Brandão, RZ; Novis, SA; Pimentel, ML | 1 |
| Mason, JO | 1 |
| Kihara, Y; Otsuki, M | 1 |
| Jasmer, RM; Small, PM | 1 |
| Chagaluka, S; Drobniewski, F; Fine, PE; Glynn, JR; Jenkins, PA; Ngwira, B; Pönnighaus, JM; Warndorff, DK; Yates, M | 1 |
| Geerligs, WA; Van Altena, R; Van Der Werf, TS; Van Soolingen, D | 1 |
| Aral, Y; Cakir, B; Demirbaş, B; Güler, S; Gürsoy, G; Odabaşi, E; Yönem, A | 1 |
| Angeli, A; Fiorini, S; Gonzatto, I; Orlandi, F; Pasquali, R; Pivano, G; Saggiorato, E | 1 |
| Aznar, J; Criado, A; Palomares, JC; Torres, MJ | 1 |
| Naumov, VN; Shaĭkhaev, AIa | 1 |
| Chedore, P; Haddad, A; Jamieson, F; Remis, RS; Vernich, L | 1 |
| Alvi, RA; Hoeppner, VH; Marciniuk, DD; McNab, BD; Tan, L | 1 |
| Aguilar-Benavides, S; Aguirre-Avalos, G; Amaya-Tapia, G; Covarrubias-Pinedo, A; Martín-Del Campo, L; Portillo-Gómez, L | 1 |
| Madan, I; Patel, D | 1 |
| Blanch, JJ; Cuadra, F; Espinosa, A; Geijo, P; Largo, J; Maciá, MA; Martínez Alfaro, EM; Mateos, F; Rodríguez Zapata, M; Rosa, C; Sánchez Martínez, PA; Sánchez, L; Sepúlveda, MA; Solera, J | 1 |
| Bajaksouzian, S; Jacobs, MR; Joloba, ML | 1 |
| Taniguchi, H | 1 |
| Nakae, K; Nishiyama, M; Roosihermiatie, B | 1 |
| D'Souza, D | 1 |
| Bartolini, L; Beer, J; Mattei, R; Savarino, A; Tortoli, E | 1 |
| Chase, SE; Cynamon, MH; Lenaerts, AM | 1 |
| Cotton, MF; Gie, RP; Schaaf, HS; Seifart, HI; van Helden, PD; van Rie, A | 1 |
| Ewa, AK; Magdalena, K; Zofia, Z | 1 |
| Abe, T; Kawahara, S; Kobashi, Y; Kuraoka, T; Matsushima, T; Nishimura, K; Okimoto, N; Shigeto, E; Shishido, S; Takeyama, H | 2 |
| Antonio Paz, E; Chin, DP; Cuthbert, SS; Daley, CL; Hopewell, PC; Jasmer, RM; Snyder, DC | 1 |
| Dokouhaki, P; Heidary, A; Masjedi, MR; Mohammadi, F; Velayati, AA | 1 |
| Erokhin, VV | 1 |
| Casal, MJ; Ruiz, P; Zerolo, FJ | 1 |
| Choi, IS; Huh, WS; Joh, JW; Kim, MK; Kim, SJ; Kim, SM; Ko, YH; Lee, BB; Lee, SK; Oh, HY; Park, JB; Peck, KR; Song, JH | 1 |
| Gupta, HP; Gupta, R; Rathi, GL; Sharma, AK; Tolani, SL | 1 |
| Asakuma, J; Asano, T; Hayakawa, M; Kawamoto, H; Kobayashi, H; Tanimoto, T | 1 |
| Dutt, M; Khuller, GK | 3 |
| Wada, M | 2 |
| Bellakhdar, F; El Abbadi, N; Lmejjati, M; Maaqili, M | 1 |
| Allali, F; Benomar, A; Chkili, T; El Yahyaoui, M; Hajjaj-Hassouni, N | 1 |
| Assengone-Zeh, Y; Kengue-Lechiombeka, PR; Loembe, PM; Mwanyombet-Ompounga, L | 1 |
| Aguar Benito, MC; Arnedo Pena, A; González Morán, F; Marín Royo, M; Moreno Muñoz, R; Pardo Serrano, F; Prada Alfaro, P | 1 |
| Cetin, M; Coban, AY; Gunaydin, M; Sanic, A | 1 |
| Hurwitz, M; Lee, TT; Malecky, G; Simpson, E | 1 |
| Barberis, MC; Cannone, M; De Rosa, G; Delfino, M; Ferrara, G; Scalvenzi, M; Staibano, S | 1 |
| Akçali, O; Alici, E; Günal, I; Tatari, H | 1 |
| Horikawa, Y; Kato, Y; Nishimura, Y; Shigeto, E; Shimoda, H; Ueda, K | 1 |
| Arora, VK; Puri, MM | 1 |
| Attri, S; Goel, RC; Katyal, R; Nain, CK; Rana, SV; Singh, K; Sodhi, CP; Vaiphei, K | 1 |
| Fuchs, D; Godfrey-Faussett, P; Hosp, M; Lisse, I; Mwinga, A; Quigley, MA | 1 |
| De Logu, A; Pellerano, ML; Pusceddu, MC; Saddi, B; Schivo, ML; Uda, P | 1 |
| Dietze, R; Eisenach, K; Ellner, JJ; Johnson, JL; Maciel, E; Palaci, M; Phillips, M; Rocha, LM; Rose, L; Teixeira, L; Wallis, RS; Wells, C | 1 |
| Fujita, A; Nitta, S; Onuki, T; Otsuka, T; Sasano, S; Yamamoto, H | 1 |
| Cheon, SH; Dietze, R; Ellner, JJ; Hise, AG; Landen, K; Palaci, M; Phillips, M; Ribeiro, FC; Song, HY; Vinhas, S; Wallis, RS | 1 |
| Lin, Y; Wu, Q; Zhang, W | 1 |
| Arnadottir, T; Enarson, DA; Rieder, HL; Trébucq, A | 1 |
| Bastian, I; Goloubeva, V; Lassowsky, P; Lecocq, M; Matthys, F; Portaels, F | 1 |
| Gusmão Filho, FA; Marques, HH; Marques-Dias, MJ; Ramos, SR | 1 |
| Block, JA; Co, H; Sequeira, W | 1 |
| Cui, D; Guo, Y | 1 |
| Baraia-Etxaburu, J; Ibarrola, M; Miguel Santamaría, J; Sánchez, R; Teira, R; Unzaga, J | 1 |
| Binkin, NJ; Kenyon, AS; Kenyon, TA; Laserson, KF; Layloff, T | 1 |
| Khan, MY; Kinsara, AJ; Memish, Z; Osoba, AO; Samman, Y; Wali, S | 1 |
| Huang, J; Huang, W; Jiaan, B; Lee, Y; Wang, J; Yu, C | 1 |
| Marinis, E; Matsiota-Bernard, P; Vogiatzakis, E; Vrioni, G | 1 |
| Barrow, EL; Barrow, WW; Quenelle, DC; Staas, JK; Winchester, GA | 1 |
| Boccia, S; Delogu, G; Fadda, G; La Sorda, M; Leori, G; Molicotti, P; Romano, L; Sanguinetti, M; Sechi, LA; Zanetti, S | 1 |
| Turgut, M | 1 |
| Bowersox, J | 1 |
| James, JS | 1 |
| Chaisson, RE | 1 |
| Bakare, NA; Ige, OM; Onadeko, BO | 1 |
| Chau, CH; Leung, SK; Lui, KS; Tong, SC; Wang, EP; Yew, WW | 1 |
| Cole, ST; Heym, B; Honoré, N; Maniscalco, M; Molino, A; Mormile, M; Sofia, M | 1 |
| Binkin, NJ; Cĵ, NV; Lademarco, MF; Quy, HT; Tung, LB | 1 |
| del Bosque-Moncayo, MA; Garza-González, E; Guerrero-Olazarán, M; Tijerina-Menchaca, R; Valdez-Leal, R; Viader-Salvadó, JM | 1 |
| Anandan, R; Devaki, T; Prabakan, M | 1 |
| Abe, T; Ebihara, M; Fujino, T; Harada, S; Hotta, N; Ishibashi, T; Iwanaga, T; Kawahara, S; Kuba, M; Mohri, M; Morimoto, T; Nakagawa, S; Nishimura, K; Oe, T; Sakatani, M; Sasaki, Y; Sato, K; Sato, R; Shigeto, E; Shimazu, K; Takamoto, M; Tanabe, K; Tanizawa, M; Tano, M; Yamagishi, F | 1 |
| Ataç, G; Kapakli, N; Karasulu, L; Kir, A; Ozmen, I; Sevim, T; Tahaoğlu, K; Törün, T | 1 |
| Duan, L; Lin, Y; Wu, Q | 1 |
| Ma, W; Yan, B; Zhu, L | 1 |
| Chen, H; Gao, J; Huaibei, M; Jiang, W | 1 |
| Peng, Y; Wang, G; Xu, J | 1 |
| Bhalla, RK; Jones, TM; Rothburn, MM; Swift, AC | 1 |
| Dorozhkova, IR; Medvedeva, IM; Popov, SA | 1 |
| Gavril'ev, SS; Gavril'eva, LP; Malogulova, ISh; Nikolaev, VP; Petukhova, NIu; Vinokurova, MK | 1 |
| Abe, C; Aoyagi, T; Hirano, K; Wada, M | 1 |
| Ellard, GA; Fourie, PB; Pillai, G; Smith, PJ | 1 |
| Golyshevskaia, VI; Sevast'ianova, EV; Voronina, GA | 1 |
| Gamazkov, RV; Iagafarova, RK; Ivanova, LA | 1 |
| Kirtane, MV; Muranjan, SN | 1 |
| Saraswathy, SD; Shyamala Devi, CS | 1 |
| Gawkrodger, DJ; Green, ST; Strauss, RM | 1 |
| Kam, KM; Yip, CW | 1 |
| Long, R; Ollé-Goig, J; Scalcini, M | 1 |
| Rathod, IS; Savale, SS; Shah, SA; Shishoo, CJ; Vora, MJ | 1 |
| Carlin, E; Childs, K; Kingston, M | 1 |
| Mauch, H; Nikolenko, EN; Roth, A; Skriagina, EM; Zalutskaia, OM | 1 |
| Khomiakov, IuN; Kiselev, VI; Pal'tsev, MA; Perel'man, MI; Severin, ES | 1 |
| Long, CF; Lou, YC; Zhang, Y | 1 |
| Macdonald, L; Vu, D | 1 |
| He, X; Li, G; Wu, X; Zhang, J; Zhang, X; Zhuang, Y | 1 |
| Hira, SK; Kura, MM | 1 |
| Ellner, JJ; Hom, DL; Johnson, JL; Loughlin, AM; Mayanja, H; Mugerwa, RD; Mugyenyi, PN; Mutuluuza Kityo, C; Nakibali, JG; Nsubuga, P; Okwera, A; Vernon, A; Whalen, CC; Yun, H | 1 |
| Parsons, LM; Salfinger, M; Somoskovi, A | 1 |
| Dwivedi, AK; Misra, A; Saxena, D; Sharma, R | 1 |
| Ena, P; Lorrai, MP; Molicotti, P; Saccabusi, S; Sechi, LA; Siddi, M; Zanetti, S | 1 |
| Almeida da Silva, PE; de Souza Fonseca, L; Dellagostin, OA; Osório, M; Reinhardt, MC | 1 |
| Bentoucha, A; Grosset, J; Ji, B; Lounis, N; O'Brien, RJ; Roscigno, G; Truffot-Pernot, C; Vernon, A | 1 |
| Keyser, A; Laheij, RJ; van der Meer, JW; van Loenhout-Rooyackers, JH; Verbeek, AL | 1 |
| de Castro, B; Gameiro, P; Lima, JL; Reis, S; Rodrigues, C | 1 |
| Espinal, MA; Gupta, R; Raviglione, MC | 1 |
| Hargreaves, NJ; Harries, AD; Salaniponi, FM | 1 |
| Al-Marri, MR | 1 |
| McEwan, JA; McKendrick, MW; Mohsen, AH; Schmid, ML | 1 |
| Coulter, JB; Meissner, PE | 1 |
| Chen, Z; Wang, H | 1 |
| Bhardwaj, M; Gautam, RK; Kar, HK; Sharma, PK | 1 |
| Cocco, MT; Congiu, C; De Logu, A; Onnis, V; Saddi, B; Schivo, ML | 1 |
| Khuhawar, MY; Rind, FM | 1 |
| Spedini, P | 1 |
| Al-Dossary, FS; Correa, AG; Ong, LT; Starke, JR | 1 |
| Arjratanakul, W; Chaiprasert, A; Chierakul, N; Pattanakitsakul, SN; Tingtoy, N | 1 |
| Boukriche, Y; Fantin, B; Masson, C; Zarrouk, V | 1 |
| Belianin, II; Martynova, LP; Shmelev, EI | 1 |
| Grange, JM; Zumla, A | 1 |
| Hayashi, R; Kawasaki, A; Kobayashi, M; Maruyama, M; Shinoda, C | 1 |
| Alcalá, L; Bouza, E; Chaves, F; del Sol Díaz Infantes, M; García de Viedma, D; Lasala, F | 1 |
| Ding, D; Duanmu, HJ; Li, D; Peng, YL; Song, H; Wang, G; Wang, L; Xing, J; Zhang, G; Zhang, L; Zhang, Z | 1 |
| Agrawal, S; Bhade, SR; Kaul, CL; Kaur, KJ; Panchagnula, R; Singh, I | 3 |
| Arnold, SM; Els, T; Kassubek, J; Lücking, CH; Oehm, E; Serr, A; Zucker, B | 1 |
| Harsch, IA | 1 |
| Burman, W; Horsburgh, CR; Vernon, A | 1 |
| Chan, SL; Goodall, RL; Kam, KM; Mitchison, DA; Tam, CM | 1 |
| Aznar, J; Criado, A; Gónzalez, N; Palomares, JC; Torres, MJ | 1 |
| Dosumu, EA | 1 |
| Palittapongarnpim, P; Phongdara, A; Silapapojakul, K; Sretrirutchai, S; Vuddhakul, V | 1 |
| Driver, CR; Fujiwara, PI; Munsiff, SS; Osahan, SS; Sundaram, V | 1 |
| Jutte, PC; van Loenhout-Rooyackers, JH; Verbeek, AL | 1 |
| Bendayan, D; Kramer, MR; Raz, M | 1 |
| Farthing, MJ; Hosp, M; Kelly, P; Mulambo, S; Mwinga, A; Zulu, I | 1 |
| de Almeida Netto, JC; Kritski, AL; Queiroz de Mello, F; Rabahi, MF; Rodrigues, AB | 1 |
| Hida, T; Hirakata, A; Kawahara, S; Kawai, S; Miyamoto, Y; Morimura, Y; Okada, AA | 1 |
| Bettendorf, M; Meyburg, J; Nützenadel, W; Schmidt, KG | 1 |
| Flaherty, JP; Gupta, SN; Shaw, JC | 1 |
| LeLacheur, S; Petryszyn, K | 1 |
| Huang, TS; Huang, WK; Lee, SS; Liu, YC; Tu, HZ | 1 |
| Seth, R; Sharma, U | 1 |
| Bjune, G; Caugant, DA; Mariandyshev, AO; Sandven, P; Toungoussova, S | 1 |
| Bagg, LR; Brown, TJ; Dickens, A; French, GL; Lacey, S; McHugh, TD; Melzer, M; Storring, RA | 1 |
| Badsha, H; Chong, AP; Kong, KO; Teh, CL | 1 |
| Bock, NN; Conwell, DS; Hamilton, CD; Mosher, A; Pachucki, C; Samuels, M; Sterling, TR; Vernon, A; Wang, YC | 1 |
| Agarwal, U; Nanda, S; Sangwan, K | 1 |
| Ain, Q; Garg, SK; Khuller, GK; Sharma, S | 1 |
| Carnelio, S; Rodrigues, G | 1 |
| Isla, AM; Riaz, AA; Robshaw, P; Singh, A | 1 |
| Albert, H; Blumberg, L; Hatch, SJ; Mole, RJ; Trollip, AP | 1 |
| Jayasankar, K; Ramanathan, VD; Shakila, H; Umapathy, KC | 1 |
| Ghebremichael, S; Hoffner, SE; Koivula, T; Krüüner, A; Mikelsaar, M; Pehme, L | 1 |
| Al-Sayegh, MO; Al-Sharif, N; Osman, MM; Shaikh, MA; Singla, R | 1 |
| Caccialanza, G; Calleri, E; De Lorenzi, E; Furlanetto, S; Massolini, G | 1 |
| Camacho, M; Guerra, H; Martin, A; Palomino, JC; Portaels, F; Swings, J | 1 |
| Dye, C; Espinal, MA | 1 |
| Chong, LY; Ho, MH; Lee, KC | 1 |
| Bambery, P; Bhatnagar, A; Khullar, M; Singh, S; Sud, A; Wanchu, A | 1 |
| Cabria, F; Dominguez-Garrido, MN; Esteban, J; García-Cía, JI; Jimenez, MS; Torres, MV | 1 |
| Fujimoto, H; Higashimoto, Y; Ishiguchi, T; Itoh, H; Itoh, Y; Kawabe, K; Nishiyama, A; Ohata, M; Okamura, K; Ono, H; Suruda, T; Ueda, A | 1 |
| Echizen, H; Hashiguchi, M; Kiuchi, C; Kondo, S; Ogata, H; Ohkawa, K; Ohno, K; Takahashi, S | 1 |
| Coelho JC, JC; Marinho, MM; Pereira-Silva, JL; Veloso, TV | 1 |
| Burger, M; Donald, P; Fertig, G; Schoeman, J; Springer, P; van Rensburg, AJ; van Zyl, F; Wait, J | 1 |
| Castiñeiras, AA; Della-Latta, P; Herreras, A; Pérez-Pascual, P; Zarranz, JE | 1 |
| Chernousova, LN; Mikhaĭlovich, VM; Sobolev, AIu; Vasil'eva, IA; Zasedatelev, AS | 1 |
| Espinal, M; Laszlo, A; Rahman, M; Raviglione, M | 1 |
| Kawakami, K | 1 |
| Benator, D; Bhattacharya, M; Bozeman, L; Burman, W; Cantazaro, A; Chaisson, R; Gordin, F; Horsburgh, CR; Horton, J; Khan, A; Lahart, C; Metchock, B; Pachucki, C; Stanton, L; Vernon, A; Villarino, ME; Wang, YC; Weiner, M; Weis, S | 1 |
| Bajaj, M; Bhutani, H; Kaur, H; Mariappan, TT; Pakhale, S; Singh, S | 1 |
| Augustynowicz-Kopeć, E; Drozd, I; Jaworski, A; Klatt, M; Kostrzewa, E; Swiderska, A; Zwolska, Z | 1 |
| Fujishima, M; Ibayashi, S; Iida, M; Ogasawara, T; Saku, Y; Sugimori, H | 1 |
| Rodrigues, VS; Rossetti, ML; Silva, MS; Valim, AR | 1 |
| Danilova, ID; Espinal, M; Grzemska, M; Migliori, GB; Punga, VV; Raviglione, MC | 1 |
| Bunn, JE; Coulter, JB; Meissner, PE; Musoke, P; Okwera, A | 1 |
| Acedo-Valenzuela, MI; Cañada-Cañada, F; Espinosa-Mansilla, A; Muñoz De La Peña, A | 1 |
| Bernardo, J; Blumberg, HM; Daley, CL; Hopewell, PC; Jasmer, RM; Kawamura, LM; King, MD; Saukkonen, JJ; Vittinghoff, E | 1 |
| Chakaya, JM; Gakiria, G; Githui, WA; Kibuga, D; Kwamanga, D; Maende, J; Mansoer, JR; Ng'ang'a, L | 1 |
| Gerum, AB; Jacobus, DP; Jensen, NP; Sherman, DR; Sibley, CH; Ulmer, JE | 1 |
| Khuller, GK; Labana, S; Pandey, R; Sharma, S | 1 |
| Barbaud, A; Fays, S; Martin, S; Schmutz, JL | 1 |
| Bahceci, F; Bayindir, Y; Ozen, S; Sari, R; Sevinc, A | 1 |
| Bogadel'nikova, IV; Kunichan, AD; Semenova, OV; Sokolova, GB | 1 |
| Bogadel'nikova, IV; Elistratova, NA; Kunichan, AD; Semenova, OV; Sokolova, GB; Zeliger, LR | 1 |
| Amorim, AB; Bori, A; Cruz, AF; Pini, MI; Sato, DN; Telles, MA | 1 |
| Bonnet, D; Briant, JF; Koeck, JL; Miltgen, J; Morillon, M; Nguyen, G; Varnerot, A; Verrot, D; Vincent, V | 1 |
| Bishai, WR; Chaisson, RE; Dorman, SE; Park, WG | 1 |
| Haruta, T; Kobayashi, K; Kubota, M; Maeda, H; Nishio, T | 1 |
| Aguilar, R; Auclair, B; Maslow, JN; Mikota, SK; Peloquin, CA | 1 |
| Hopewell, PC; Jasmer, RM; Nahid, P | 1 |
| Goldberg, SV; Nolan, CM | 1 |
| Perng, RP; Su, WJ | 1 |
| Giller, BM; Giller, DB; Giller, GV; Kostenko, AD | 1 |
| Bielecki, I; Gierek, T; Kieda-Szurkowska, J; Markowski, J; Paluch, J | 1 |
| Doré, CJ; Jindani, A; Mitchison, DA | 1 |
| Allen, M; Cook, P; Estrada, C; McNeill, L | 1 |
| Benator, D; Burman, W; Hodge, T; Khan, A; King, B; Peloquin, CA; Shah, N; Vernon, A; Weiner, M; Weis, S | 1 |
| Biava, M; Cesare Porretta, G; Deidda, D; Manetti, F; Pompei, R; Tafi, A | 1 |
| Chang, SC; Hung, CC; Luh, KT; Sheng, WH; Wang, JT; Wang, JY | 1 |
| Lee, JJ; Lee, TY; Park, HJ; Park, HY; Shin, KY; Woo, YN | 1 |
| Agarwal, SK; Shah, AR; Shah, KV | 1 |
| Martínez-Rossier, LA; Pérez-Guzmán, C; Torres-Cruz, A; Vargas, MH; Villarreal-Velarde, H | 1 |
| Arjrattanakool, W; Chaiprasert, A; Chuchottaworn, C; Foongladda, S; Franzblau, SG; Roengsanthia, D | 1 |
| Curley, C | 1 |
| Baptista, IM; Oelemann, MC; Opromolla, DV; Suffys, PN | 1 |
| Bonnaud, F; Zigani, A | 1 |
| Menzies, D; Parisien, I; Pelletier, M; Rocher, I; Valiquette, C; Yee, D | 1 |
| Bhat, DI; Devi, BI; Dubey, S; Jawalkar, VK | 1 |
| Delgadillo-Polanco, R; Enciso-Moreno, JA; Franzblau, SG; Luna-Herrera, J; Martínez-Cabrera, G; Parra-Maldonado, R; Quesada-Pascual, F; Torres-López, J | 1 |
| de Castro, B; Gameiro, P; Prieto, M; Rodrigues, C | 1 |
| Bjorvatn, B; Grewal, HM; Hmun, T; Htun, A; Jureen, R; Myint, H; Phyu, S; Ti, T | 1 |
| Mohan, B; Sharda, N; Singh, S | 1 |
| Buchmeier, NA; Fahey, RC; Koledin, T; Newton, GL | 1 |
| Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ | 1 |
| Antonian, L; Burton, LA; Carroll, KM; Czerwinski, M; Downey, AD; Forster, J; Gan, LS; Graham, RA; Koch, P; Krueger, LA; LeCluyse, EL; Madan, A; Mudra, DR; Parkinson, A; Ribadeneira, MD; Robertson, P; Wagner, G; Yu, L; Zech, K | 1 |
| Cauchoix, B; Rakotoarisaonina, A; Rakotoherisoa, A; Rakotondramarina, D; Rakotonirina, V; Ralamboson, M; Ramarokoto, H; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsirahonana, O | 1 |
| Beena, S; Pai, MR; Rao, KN | 1 |
| Erdem, E; Gültekin, D; Kayaalp, N; Palanduz, A | 1 |
| Kumar, A; Malik, P; Mathur, MB; Prakash, G; Sharma, PM; Singh, RP | 1 |
| Furuta, I; Yamazumi, T | 1 |
| Garg, SK; Khuller, GK; Sharma, S | 1 |
| Branchi, A; Dessì-Fulgheri, P; Giangiacomi, M; Mantovani, P; Minardi, D; Muçaj, A; Muzzonigro, G; Onesta, M; Sarzani, R | 1 |
| Lepage, P | 1 |
| Dekker, TG; Lötter, AP | 1 |
| Danckwerts, MP; Ebrahim, S; Pillay, V | 1 |
| Mohan, B; Singh, S | 1 |
| Aznar, J; Criado, A; Llanos, AC; Palomares, JC; Ruiz, M; Torres, MJ | 1 |
| Abdelaziz, M; Al-Mowaallad, A; Haidar, M; Krayem, A; Mimesh, S; Osoba, A; Samman, Y; Wali, S | 1 |
| Gurumurthy, P; Ramachandran, G | 1 |
| González Guijarro, J; Pérez Alvarez, MJ; Santos Gil, I | 1 |
| Bellanova, S; Bracciale, P; Legari, G; Manisco, V; Quitadamo, M; Valerio, G | 1 |
| Benito González, F; Benito González, JJ; Cordero Sánchez, M; Coscarón Blanco, E; del Cañizo Alvarez, A; Gómez González, JL; Santa Cruz Ruiz, S | 1 |
| Homma, S; Kawabata, M; Kishi, K; Kono, T; Kurosaki, A; Motoi, N; Nakata, K; Nakatani, T; Narui, K; Tanimoto, H; Tsuboi, E | 1 |
| Campbell, IA; Jenkins, PA | 1 |
| Kudzyte, I; Steponaviciene, D | 1 |
| Binkin, NJ; Kenyon, TA; Mallon, V; Moeti, TL; Mwasekaga, MJ; Talbot, EA | 1 |
| del Bosque-Moncayo, Mde L; Guerrero-Olazarán, M; Luna-Aguirre, CM; Reyes-Ruiz, JM; Tijerina-Menchaca, R; Valdez-Leal, R; Viader-Salvadó, JM | 1 |
| Nagai, H | 1 |
| Arya, SC | 1 |
| Fernández, MA; García Figueras, R; Golpe Gómez, R; Mateos Colino, A; Pérez Valcarcel, J; Sousa Escandón, MA | 1 |
| Arcangeletti, C; Benecchi, M; Calderaro, A; Cavirani, S; Chezzi, C; Dettori, G; Fanti, F; Medici, MC; Taddei, S | 1 |
| Akagawa, S; Baba, M; Kawabe, Y; Kurashima, A; Machida, K; Masuda, K; Mohri, M; Nagai, H; Nagayama, N; Tamura, A; Yotsumoto, H | 1 |
| Hong, SJ; Kim, BS; Kim, HB; Kim, JH | 1 |
| Gultekin, D; Kayaalp, N; Palanduz, A | 1 |
| Cheng, J; Deng, YF; Han, JP; Li, RZ; Sun, SL; Wang, SC; Wang, Y; Yu, CB; Zhang, FS | 1 |
| Fan, BD; Gao, Z; Xu, WG | 1 |
| Maes, B; Peetermans, WE; Van Audenhove, A; Vandermarliere, A; Vanrenterghem, Y | 1 |
| Fujikane, T; Fujita, Y; Fujiuchi, S; Matsumoto, H; Nakao, S; Okamoto, K; Sato, K; Shimizu, T; Takahashi, M; Takeda, A; Yahara, O; Yamazaki, Y | 1 |
| Ahn, HC; Lee, YC | 1 |
| Kuraoka, T; Murai, H; Nakao, R; Onari, Y; Taniwaki, M; Terada, M; Yamaoka, N | 1 |
| Allen, C; Bergeron, KG; Bonebrake, RG; Gray, CJ | 1 |
| Brown, RS; Farquharson, AA; Nasseri, S | 1 |
| Charalambous, BM; Gillespie, SH | 1 |
| Archakova, LI; Ivanova, LA; Pavlova, MV | 1 |
| Agrawal, S; Kaul, CL; Panchagnula, R; Rungta, S; Sancheti, P | 1 |
| Sankar, R; Sharda, N; Singh, S | 1 |
| Bongard, E; Gillespie, SH; Gosling, RD; Kanduma, EG; Morris, RW; Nyindo, M; Sam, NE; Uiso, LO | 1 |
| Mariappan, TT; Singh, S | 1 |
| Manicheva, OA; Miakotina, EN; Vishnevskiĭ, BI | 1 |
| Khuller, GK; Sharma, S; Ul-Ain, Q | 1 |
| Botha, T; Ryffel, B | 1 |
| Ferro, BE; Guarín, N; Hazbón, MH; Jacobs, WR; Labrada, LA; Riska, PF; Rodríguez, AL; Tovar, R | 1 |
| Badaró, R; Bandeira, AC; Barberin, MG; Brites, C; Guerra, C; Netto, EM; Pedral-Sampaio, DB | 1 |
| Ahmad, RN; Anwar, M; Butt, T; Karamat, KA; Kazmi, SY; Mahmood, A | 1 |
| Maida, A; Masia, MD; Muresu, E; Orrù, M; Piana, A; Sotgiu, G | 1 |
| Agdamag, DM; Espantaleon, AS; Kageyama, S; Sangco, JC; Solante, R; Suzuki, Y | 1 |
| Bjorvatn, B; Grewal, HM; Phyu, S; Sandven, P; Syre, H | 1 |
| Drlica, K; Lu, T | 1 |
| Khuller, GK; Pandey, R; Prasad, B; Sharma, A; Sharma, S; Zahoor, A | 1 |
| Akagawa, S; Baba, M; Hara, H; Kawabe, Y; Kurashima, A; Machida, K; Masuda, K; Miyamoto, M; Nagai, H; Nagayama, N; Saito, W; Suzuki, J; Tamura, A; Yotsumoto, H | 1 |
| Khuller, GK; Pandey, R; Sharma, S; Zahoor, A | 1 |
| Bergstermann, KH; Denk, GU; Gallmeier, E; Göke, B; Lamerz, R; Schirra, J; Wagner, H | 1 |
| Barrie, J; Bochar, K; Chomyc, S; Kunimoto, D; Long, R; Talbot, J; Tilley, P | 1 |
| Ishikawa, O; Negishi, I; Shimizu, A; Takahashi, A; Tamura, A | 1 |
| Barskiĭ, VE; Chudinov, AV; Griadunov, DA; Lapa, SA; Mikhaĭlovich, VM; Mirzabekov, AD; Rudinskiĭ, NI; Zasedatelev, AS | 1 |
| Chan, CK; Chang, KC; Law, WS; Leung, CC; Tam, CM; Wong, MY; Yew, WW | 1 |
| Biryukova, MN; Ginda, SS; Golishcheva, OV; Gryadunov, DA; Irtuganova, OA; Kalyanina, OV; Krudu, VN; Lapa, SA; Litvinov, VI; Markova, OV; Mikhailovich, VM; Moroz, AM; Nosova, EY; Skotnikova, OI; Strel'tsova, EN | 1 |
| Castro, A; Frisch, IB; Krastel, H; Kunze, AK; Meinck, HM | 1 |
| Donald, PR; Schaaf, HS; Shean, K | 1 |
| Akagawa, S; Baba, M; Kawabe, Y; Komatsu, H; Kurashima, A; Machida, K; Masuda, K; Nagai, H; Nagayama, N; Shishido, Y; Tamura, A; Yotsumoto, H | 2 |
| Burgos, M; Daley, CL; DeRiemer, K; Hopewell, PC; Small, PM | 1 |
| Greinert, U; Zabel, P | 1 |
| Semenova, OV | 1 |
| Au-Yeang, C; Chan, CY; Cheng, AF; Leung, CC; Yew, WW | 1 |
| Gurumurthy, P; Hemanth Kumar, AK; Krishnarajasekhar, OR; Kumar, S; Padmapriyadarsini, C; Paramesh, P; Rajasekaran, S; Ramachandran, G; Sekar, L; Swaminathan, S; Venkatesan, P | 1 |
| Chandrasekaran, V; Gurumurthy, P; Immanuel, C; Prabhakar, R; Ramachandran, G; Venkatesan, P | 1 |
| Arevalo, J; Campos, PE; Holmes, KK; Hooton, TM; Nolan, CM; Sanchez, J; Suarez, PG; Ticona, E; Zavala, D | 1 |
| Jankowska, R; Krecicki, T; Skrzydlewska-Kaczmarek, B; Zalesska-Krecicka, M; Zatonski, T | 1 |
| Bernardo, J; Daley, CL; Hopewell, PC; Jasmer, RM; Kawamura, LM; King, MD; Saukkonen, JJ; Snyder, DC | 1 |
| Fernández, X; García de la Torre, M; Noguerado, A; Sánchez-Arcilla, I; Vílchez, JM | 1 |
| Anagnostou, S; Costopoulos, C; Gitti, Z; Kontos, F; Maniati, M; Maniatis, AN; Nicolaou, S; Petinaki, E; Tselentis, I | 1 |
| Schuh, A; Zeiler, G | 1 |
| Dash, S; Jain, D | 1 |
| Jacunskiene, L; Naudziūnas, A; Tarūta, A | 1 |
| Bock, N; Burman, WJ; Goldberg, S; Hayden, K; Khan, A; Peloquin, CA; Sterling, TR; Vernon, A; Weiner, M; Weis, S; Zhao, Z | 1 |
| Cynamon, MH; DeStefano, MS; Monica, BJ; Shoen, CM; Sklaney, MR; Slee, AM | 1 |
| Mori, T; Nampaisan, O; Palittapongarnpim, P; Rhiengtong, D; Supawitkul, S; Uthaivorawit, W; Yanai, H; Yoshiyama, T | 1 |
| Jaganathan, KS; Prabakaran, D; Singh, P; Vyas, SP | 1 |
| Choudhary, J; Mubarik, M; Naikoo, MA; Parvez, A | 1 |
| Allen, J; Bhagwan, B; Bhigjee, AI; Moodley, AA; Mthiyane, T; Padayatchi, N; Patel, VB | 1 |
| Hamada, H; Hamada, M; Hara, Y; Higaki, J; Katayama, H; Ogimoto, A; Saeki, H; Shigematsu, Y | 1 |
| Filipenko, ML; Kinsht, VN; Krasnov, VA; Kurunov, IuN; Nikonova, AA; Norkina, OV; Tat'kov, SI | 1 |
| Chaudhary, H; Raghavendran, M; Srivastava, A | 1 |
| Furrer, J; Günthard, HF; Hättenschwiler, A; Schulthess, G | 1 |
| Brito, RC; Caldas, PC; Fonseca, Lde S; Freixo, MI; Martins, F; Saad, MH; Said, A | 1 |
| Birinci, A; Coban, AY; Durupinar, B; Ekinci, B | 2 |
| Arroyo, A; Aznar, J; Llanos, AC; Palomares, JC; Ruiz, M; Torres, MJ | 1 |
| Khuller, GK; Pandey, R; Sharma, S | 2 |
| Cormican, LJ; Milburn, HJ; Schey, S | 1 |
| Mitchison, DA; Prabhaker, R; Reetha, AM; Rehman, F; Santha, T; Sarma, GR | 1 |
| Ahmed, I; Obaideen, AM; Rahman, NU; Shahat, AH; Zahman Au, Au | 1 |
| Khuller, GK; Pandey, R | 2 |
| Gürsoy, A; Kut, E; Ozkirimli, S | 1 |
| Fonseca, LS; Lourenço, MC; Lourenço, SL; Neves, I; Reis, RS | 1 |
| Beyers, N; Cotton, MF; Gie, RP; Hesseling, AC; Marais, BJ; Schaaf, HS; van Helden, P; Victor, T; Warren, RM; Wiid, I | 1 |
| Kong, R; Liu, J; Peng, RX; Yang, J; Yue, J | 1 |
| Kheleani, BA; Moolani, MK; Sarwari, RA; Smego, AR; Smego, RA; Wasay, M; Zaheer, J | 1 |
| Tariq, S; Tariq, SM | 1 |
| Bhanu, NV; Cho, SN; Gomes, HM; Jordaan, AM; Kadival, GV; Khan, BK; Kulkarni, SP; Lee, H; Lim, KC; Mokrousov, I; Narvskaya, O; Schouls, LM; Singh, UB; Suffys, PN; van Soolingen, D; Victor, TC; Yap, SF | 1 |
| Kondakova, MN; Pavlova, MV; Sapozhnikova, NV; Skvortsova, LA | 1 |
| Boudville, IC; Chee, CB; Do, SE; Teleman, MD; Wang, YT | 1 |
| Maartens, G; Texeira-Swiegelaar, C; Visser, ME | 1 |
| Brannan, GL; Clancey, T; Conklin, TJ; Lincoln, T; Lynch, V; Rose, DN; Tuthill, RJ | 1 |
| Chimzizi, R; Gausi, F; Harries, AD; Salaniponi, FM | 1 |
| Asencios-Solis, L; Bayona, J; Becerra, MC; Leo-Hurtado, E; Quispe-Torres, N; Salazar-Lindo, E; Vásquez-Campos, L | 1 |
| Stout, JE | 1 |
| Sharma, SK | 1 |
| Arora, S; Dhillon, S; Nagpal, A; Rani, G | 1 |
| Gordin, FM | 1 |
| Brassard, P; Dion, MJ; Mannix, S; Menzies, D; Rabinovitch, B; Schwartzman, K | 1 |
| Gausi, F; Harries, AD; Salaniponi, FM | 1 |
| Davidson, P; Le, HQ; Moulding, TS; Rikleen, D | 1 |
| Augustynowicz-Kopec, E; Brzostek, A; Dziadek, J; Hillemann, D; Niemann, S; Poplawska, M; Sajduda, A; Zwolska, Z | 1 |
| Cisa Lluís, E; Dicenta Sousa, M; Doménech Juan, I; González Compta, X; Nogués Orpí, JJ; Tornero Saltó, J | 1 |
| Ditto, AM; Story, RE | 1 |
| Gurumurthy, P; Kumar, AK | 1 |
| Ahaghotu, CA; Oben, FT; Wright, RD | 1 |
| Wade, MM; Zhang, Y | 1 |
| Hayden, CH; Lardizabal, A; Reichman, LB | 1 |
| Jiang, QW; Jiang, WL; Xu, B; Yang, BF; Zhou, PY | 1 |
| Cui, ZL; Hu, ZY; Jing, FX; Wu, ZR; Zhao, JL | 1 |
| Ahmedani, MY; Islam, N | 1 |
| Karachunskiĭ, MA; Uvarova, TE | 1 |
| Krasnov, VA; Ursov, IG | 1 |
| Iuditskiĭ, MV; Khodashova, ML; Semenova, OV | 1 |
| Andreevskaia, SN; Chernousova, LN; Nikolaeva, GM; Smirnova, TG | 1 |
| Bishai, WR; Grosset, J; Karakousis, PC; Lamichhane, G; Nuermberger, EL; Woolwine, SC; Yoshimatsu, T | 1 |
| Pinto, A; Sullivan, J; Yepes, JF | 1 |
| Baars, H; Borgdorff, M; Cobelens, F; Kalisvaart, N; Keizer, S; Kik, S; Mensen, M; Trompenaars, MC; van Gerven, P; van Hest, R | 1 |
| Chaisson, RE; Cohn, DL; Gordin, FM; Matts, JP; O'Brien, RJ | 1 |
| Fujimura, M; Nakao, S; Nishizawa, Y; Tagami, A; Yamamori, C; Yasui, M | 1 |
| De Pauw, FF; Francque, SM; Gentens, PA; Michielsen, PP; Pelckmans, PA; Van den Bogaert, E; Van Marck, EA; Van Outryve, SM | 1 |
| Aydin, G; Keleş, I; Kendi, TK; Orkun, S | 1 |
| Kalita, A; Khuller, GK; Verma, I | 1 |
| Belianin, II; Shmelev, EI | 2 |
| Cirillo, DM; Frisicale, L; Marchiaro, G; Penati, V; Piana, F; Quaranta, M; Riccabone, A; Vaccarino, P | 1 |
| Balabanova, Y; Brown, T; Drobniewski, F; Fedorin, I; Nikolayevsky, V; Ruddy, M | 1 |
| Johansen, IS; Lundgren, B; Marjamäki, M; Sosnovskaja, A; Thomsen, VØ | 1 |
| Alves, CR; Badaro, R; Brites, C; Netto, EM; Oliveira, AS; Pedral-Sampaio, DB | 1 |
| Bozeman, L; Burman, WJ; Cave, MD; Jasmer, RM; Khan, A; Metchock, B; Saukkonen, JJ; Schwartzman, K | 1 |
| Avkan Oğuz, V; Cakmak, R; Erkut, M; Güneri, S; Ozgü, A; Oztop, A; Unsal, I | 1 |
| Gelmanova, IE; Golubchikova, VT; Pavlova, VE; Peremitin, GG; Seung, KJ; Sirotkina, OB; Strelis, AK; Yanova, GV | 1 |
| Bouza, E; García de Viedma, D; Marín, M; Ruíz-Serrano, MJ | 1 |
| Bhagavathy, S; Gurumurthy, P; Hemanth Kumar, AK; Mahilmaran, A; Padmapriyadarsini, C; Paramesh, P; Rajasekaran, S; Ramachandran, G; Ravichandran, N; Sekar, L; Swaminathan, S; Venkatesan, P | 1 |
| Bastian, I; Chew, W; Gilpin, C; Haverkort, F; James, G; Lumb, R; Sievers, A | 1 |
| Dworniczak, S; Kozielski, J; Maksymowicz-Mazur, W; Mazurek, U; Oklek, K; Pendzich, J; Wilczok, T | 1 |
| Geetha, T; Jindal, KC; Mariappan, TT; Pandey, R; Singh, S | 1 |
| Jindal, KC; Mariappan, TT; Singh, S | 1 |
| Chacko, AG; Chandy, MJ; Moorthy, RK | 1 |
| Agrawal, S; Panchagnula, R | 1 |
| Einck, L; Nacy, CA; Nikonenko, BV; Samala, R | 1 |
| Gupta, S; Lal, S; Negi, SS | 1 |
| Bhalla, P; Dhingra, VK; Hanif, M; Jain, SK; Rajpal, S; Yadav, A | 1 |
| Leung, KT; Siu, YP; Tong, MK; Yung, CY | 1 |
| Delgado, R; Lambert, ML; Michaux, G; Van der Stuyft, P; Volz, A | 1 |
| Jutte, PC; Rutgers, SR; Uges, DR; Van Altena, R; Van Horn, JR | 1 |
| Costa-de-Oliveira, S; Pina-Vaz, C; Rodrigues, AG | 1 |
| Antonucci, G; Bassetti, D; Carbonara, S; Girardi, E; Ippolito, G; Koehler, B; Vanacore, P; Zacchini, F | 1 |
| Calonge, M; Torres, RM | 1 |
| Moritaka, T; Nakanishi, N; Ueda, N | 1 |
| Inoue, T; Maeda, Y; Maniwa, K; Sakuramoto, M; Taguchi, Y; Tanaka, E | 1 |
| Chiang, CY; Huang, WL; Jou, R | 1 |
| Chongsuvivatwong, V; Janchawee, B; Owatranporn, T; Wongpoowarak, W | 1 |
| Amat, I; Arcos, V; Ausina, V; Cardona, PJ; Díaz, J; Gordillo, S; Guirado, E; Tapia, G; Vilaplana, C | 1 |
| Kubendiran, G; Mitchison, DA; Paramasivan, CN; Sulochana, S; Venkatesan, P | 1 |
| Aily, DC; de Albuquerque, DM; Ferrazoli, L; Giampaglia, CM; Höfling, CC; Pavan, EM; Ramos, MC | 1 |
| Dubiley, S; Ignatova, A; Kirillov, E; Kolesnikov, A; Mayorova, A; Shemyakin, I; Stepanshina, V | 1 |
| Loots, DT; Mienie, LJ; Page, BJ; van Helden, PD; Wiid, IJ | 1 |
| Boibieux, A; Chidiac, C; Issartel, B; Petiot, P; Peyramond, D; Rabar, D | 1 |
| Bjune, G; Brantsaeter, AB; Farah, MG; Heldal, E; Steen, TW; Tverdal, A | 1 |
| Bose, M; Dam, T; Isa, M | 1 |
| Ena, J; Valls, V | 2 |
| Chernykh, NA; Kaminskaia, GO; Karachunskiĭ, MA; Kossiĭ, IuE | 1 |
| Belotserkovets, VG; Ubaĭdullaev, AM | 1 |
| Hillemann, D; Kubica, T; Niemann, S; Rüsch-Gerdes, S | 1 |
| Echemendia, M; Lemus, D; Martin, A; Montoro, E; Palomino, JC; Portaels, F | 1 |
| Hoeppner, VH; Jones, W; Marciniuk, DD; Ward, HA | 1 |
| Cicenaite, J; Davidaviciene, E; Dewan, P; Johansen, I; Laserson, K; Sosnovskaja, A; Thomsen, V; Wells, C | 1 |
| Becerra, MC; Han, LL; Nardell, EA; Salazar, JJ; Sloutsky, A; Smith-Fawzi, MC; Timperi, R | 1 |
| Ijaz, K; Lambert, LA; Navin, TR | 1 |
| Aman, K; Aono, A; Hoshino, H; Ito, K; Mitarai, S; Ogata, H; Okumura, M; Wada, M; Yoshiyama, T | 1 |
| Ridzon, R | 1 |
| Bai, YJ; Luo, M; Wang, Y; Yan, XJ; Zhang, QH; Zhao, JR | 1 |
| Shah, BA; Splain, S | 1 |
| Akgunes, A; Bilgin, K; Birinci, A; Cihan, CC; Coban, AY; Durupinar, B; Tasdelen Fisgin, N; Uzun, M | 1 |
| Ige, OM; Odaibo, GN; Olaleye, OD; Sogaolu, OM | 1 |
| Callister, SM; DeCoster, DJ; Schell, RF; Vena, RM | 1 |
| Choi, MS; Chung, MP; Kim, H; Koh, WJ; Kwon, OJ; Lee, BH; Suh, GY | 1 |
| Fukuoka, A; Kasahara, K; Kimura, H; Mikasa, K; Murakawa, K; Narita, N; Okamura, H | 1 |
| Aono, A; Ito, K; Ogata, H; Wada, M; Yoshiyama, T | 2 |
| Filliol, I; Kadival, G; Kulkarni, S; Rastogi, N; Sola, C | 1 |
| Cebrián, L; López, M; Rodríguez, JC; Royo, G; Ruiz, M | 1 |
| LoBue, PA; Moser, KS | 1 |
| Abarca, H; Aguilar, R; Caminero, JA; Garay, J; Ramirez, M; Villatoro, F; Villatoro, M | 1 |
| Alcaide, F; Aragón, LM; Coll, P; Espasa, M; González-Martín, J; Lonca, J; Manterola, JM; Orús, P; Salvadó, M; Tudó, G | 1 |
| Rao, M; Rattan, A; Singhal, S; Sood, R | 1 |
| Baykam, N; Celikbaş, AK; Dokuzoguz, B; Eren, S; Ergönül, O; Ulu, A | 1 |
| Aktas, E; Durmaz, R; Yang, D; Yang, Z | 1 |
| Alcaide, F; Aragón, LM; Coll, P; Espasa, M; Garrigó, M; González, J; Manterola, JM; Orús, P; Salvadó, M | 1 |
| Gupta, DK; Johri, RK; Jyotsna, S; Kaisar, P; Kapahi, BK; Maheshwari, HS; Tasduq, SA | 1 |
| Flood, J; Granich, RM; Lewis, B; Oh, P; Porco, TC | 1 |
| De Potter, P; Levecq, LJ | 1 |
| Jenkins, C | 1 |
| Chernousova, L; Donnikov, M; Gryadunov, D; Kuz'min, A; Lapa, S; Markova, O; Mikhailovich, V; Mirzabekov, A; Moroz, A; Pan'kov, S; Roudinskii, N; Skotnikova, O; Zasedatelev, A | 1 |
| Valencia Ortega, ME | 1 |
| Duraipandian, M; Kripasankar, AS; Raghavan, A; Ramachandran, P; Swaminathan, S | 1 |
| Bhutani, H; Chakraborti, AK; Jindal, KC; Singh, S | 1 |
| Akselband, Y; Cabral, C; McGrath, P; Shapiro, DS | 1 |
| Han, LL; Llanos, F; Shin, SS; Sloutsky, A; Solis, LA; Stowell, M | 1 |
| Ashokraj, Y; Bhade, SR; Kaul, CL; Kaur, KJ; Kohli, G; Panchagnula, R; Singh, I; Varma, MV | 1 |
| Endoh, M; Morozumi, S; Mukaigawa, J; Yanagawa, Y | 1 |
| Agerton, TB; Bradford, WZ; Hopewell, P; Kenyon, TA; Lockman, S; Moeti, TL; Moffat, HJ; Oyewo, A; Peloquin, CA; Reingold, AL; Talbot, EA; Tappero, JW | 1 |
| Karthikeyan, S | 1 |
| Göpel, B; Götte, K | 1 |
| Hillemann, D; Kubica, T; Niemann, S; Richter, E; Weizenegger, M | 1 |
| Shiraishi, Y | 1 |
| Cambau, E; Jarlier, V; Robert, J; Sougakoff, W; Veziris, N | 1 |
| Bai, GH; Koh, WJ; Kwon, OJ; Lew, WJ; Park, YK | 1 |
| Oberdorfer, P; Punjaisee, S; Puthanakit, T; Sirisanthana, T; Sirisanthana, V; Wannarit, P | 1 |
| Ahmad, Z; Khuller, GK; Sharma, S | 1 |
| Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
| Anthony, RM; Brown, TJ; Drobniewski, FA; Herrera-Leon, L | 1 |
| Ahmad, Z; Khuller, GK; Sharma, S; Zahoor, A | 1 |
| Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
| Holm, JP; Schram, AJ; van Altena, R | 1 |
| Gu, XR; He, HJ; Lu, W; Xu, WG | 1 |
| Alosi, MM; Ruggeri, C; Scibilia, G; Valenzise, M; Wasniewska, M | 1 |
| He, Y; Li, B; Lv, J; Zhang, Z | 1 |
| Galkina, KIu; Krasnova, MA; Moroz, AM; Nosova, EIu; Skotnikova, OI | 1 |
| Dwivedi, A; Kohli, N; Kumar, P; Kumar, R | 1 |
| Agzamova, R; Hillemann, D; Kubica, T; Niemann, S; Rüsch-Gerdes, S; Venera, B | 1 |
| Durmaz, R; Foxman, B; Gunal, S; Marrs, CF; Sanic, A; Yang, D; Yang, Z; Zhang, L | 1 |
| Ceyhan, I; Kaya, D; Ozturk, CE; Sanic, A | 1 |
| Ananthalakshmi, V; Chandrasekar, K; Jawahar, MS; Kamaludeen, MN; Paramasivan, CN; Prabhakar, R; Rajaram, K; Sivasubramanian, S; Thirithuvathas, AJ | 1 |
| Gkiatas, K; Kararizos, G; Kararizou, E; Likomanos, D; Markou, I; Triantafyllou, N; Vassilopoulos, D; Zalonis, I; Zambelis, T | 1 |
| Curry, K; Yoon, Y | 1 |
| Izumi, S; Taniguchi, H | 2 |
| Donald, PR; Langdon, G; Maritz, JS; Sirgel, FA; Smith, PJ; Venter, A | 1 |
| Ader, F; Bernard, L; Carlier, R; Perronne, C; Salomon, J; Toubiana, J | 1 |
| Esteban, J; Jiménez, MS; Ortiz, A | 1 |
| Currie, GP; Devereux, G; Emmanuel, FX; Ford, D | 1 |
| Cai, YY; Hu, ZH; Liu, ZW | 1 |
| Anandan, R; Mathew, PT; Santhosh, S; Sini, TK | 2 |
| Listernick, R | 1 |
| Apers, L; Colebunders, R; Lynen, L; Worodria, W | 1 |
| Günther, I; Hahn, H; Ignatius, R; Menner, N; Orawa, H; Persaud, S; Rambajan, I; Roth, A; Wagner, J | 1 |
| Makanjuola, OO | 1 |
| Bhutani, H; Jindal, KC; Singh, S | 1 |
| Davidson, RN; Kon, OM; Meintjes, G; Newton, SM; Pasvol, G; Wilkinson, KA; Wilkinson, RJ | 1 |
| Jutte, PC; Van Loenhout-Rooyackers, JH | 2 |
| Amano, T; Kobori, Y; Shigehara, K; Takemae, K | 1 |
| Boffo, MM; da Silva, PA; de Mattos, IG; Martin, A; Palomino, JC; Silva, AB; Takiff, HE | 1 |
| Mäkinen, J; Marjamäki, M; Marttila, HJ; Soini, H; Viljanen, MK | 1 |
| Jang, H; Kang, SJ; Kim, C; Kim, SY; Park, YJ; Song, E; Yoo, J | 1 |
| Beyers, N; Gie, RP; Hesseling, AC; Marais, BJ; Schaaf, HS; van Zyl, S | 1 |
| Chandrasekaran, V; Gopi, PG; Narayanan, PR; Paramasivan, CN; Perumal, M; Rajeswari, R; Rani, B; Santha, T; Selvakumar, N; Subramani, R; Thomas, A; Wares, F | 1 |
| Dion, MJ; Francis, D; Mannix, S; Menzies, D; Parisien, I; Rocher, I; Schwartzman, K | 1 |
| Agatonovic-Kustrin, S; Glass, BD; Wisch, MH | 1 |
| Barnes, GL; Chaisson, RE; Coberly, JS; Falco, G; Faulhaber, JC; Moore, RD; Schechter, M; Zajdenverg, R | 1 |
| Pal, R; Rana, SV; Sikander, A; Singh, K; Vaiphei, K | 1 |
| Adamovich, NV; Khudushina, TA; Maslakova, MG; Terekhova, ND; Voloshina, EP | 1 |
| Aggarwal, N; Aggarwaln, JK; Dhingra, VK; Jain, SK; Rajpal, S; Shadab, K | 1 |
| Drobniewski, FA; Krüüner, A; Yates, MD | 1 |
| Abe, C; Kobayashi, I; Mitarai, S | 1 |
| Alrajhi, AA | 1 |
| Bhattacharjee, K; Chowdhury, A; Dhali, GK; Ghatak, S; Saha, DR; Santra, A | 1 |
| Aragón, LM; Coll, P; Español, M; Garrigó, M; Heiser, V; Navarro, F | 1 |
| Mouzou, T; Padonou, C; Pitche, P; Tchangai-Walla, K | 1 |
| Atun, R; Balabanova, Y; Coker, R; Drobniewski, F; Fedorin, I; Nikolayevskyy, V; Zakharova, S | 1 |
| Burger, A; Folb, PI; McIlleron, H; Norman, J; Smith, P; Wash, P | 1 |
| Bishai, WR; Grosset, JH; Nuermberger, EL; Peloquin, CA; Rosenthal, IM; Tyagi, S; Vernon, AA; Williams, K | 1 |
| Pal, R; Rana, SV; Singh, K; Vaiphie, K | 1 |
| Akgunes, A; Bilgin, K; Cetinkaya, E; Cihan, CC; Coban, AY; Durupinar, B; Uzun, M | 1 |
| Bhutani, H; Prasad, B; Singh, S | 1 |
| Ahmad, Z; Khuller, GK; Pandey, R; Sharma, S | 1 |
| Gupta, DK; Johri, RK; Satti, NK; Singh, K; Suri, KA; Tasduq, SA | 1 |
| Bai, GH; Chang, CL; Jeong, J; Jeong, SH; Kim, CM; Kim, S; Lee, EY; Park, H; Park, YK; Shin, JH; Song, EJ; Song, ES | 1 |
| Dhamija, P; Malhotra, S; Pandhi, P | 1 |
| Amat, I; Arcos, V; Ausina, V; Caceres, N; Cardona, PJ; Díaz, J; Gil, O; Guirado, E | 1 |
| Anagnostou, S; Falagas, ME; Kanavaki, S; Karambela, S; Mantadakis, E; Nikolaou, S; Papavassiliou, A; Samonis, G | 1 |
| Bohnker, BK; Brenner, E; Freier, G; Mase, S; Matthews, KL; Nelson, G; Tasker, S; Wright, A | 1 |
| Horsburgh, CR; Khan, A; Reves, R; Sterling, TR; Vernon, A | 1 |
| Akgunes, A; Bilgin, K; Cekic Cihan, C; Cetinkaya, E; Coban, AY; Durupinar, B; Uzun, M | 1 |
| Fatma, T; Malhotra, S; Rao, M; Rattan, A; Sood, R; Upadhyay, DJ | 1 |
| Boutemy, M; Bruniau, A; Devauchelle, B; Gbaguidi, C; Jounieaux, V; Mbuyamba, S; Moure, C; Testelin, S | 1 |
| Chen, P; Einck, L; Gearhart, J; Nacy, CA; Protopopova, M | 1 |
| Azaev, MSh; Baranova, OI; Blinova, LN; Bodnev, SA; Boldyrev, AN; Ivlev-Dantau, AP; Medvedeva, EV; Pasechnikov, AD; Sivkov, AIu; Tat'kov, SI | 1 |
| Ivanov, IIu; Lipin, MIu; Shemiakin, IG; Stepashina, VN | 1 |
| Hoffner, SE; Klintz, L; Werngren, J | 1 |
| Baraka, S; Khaled, S; Martin, A; Nateche, F; Palomino, JC; Portaels, F | 1 |
| De Broucker, T; Martinez-Almoyna, L; Steichen, O | 1 |
| Okada, M; Sugimoto, K; Tabata, N; Takemura, T; Yagi, K; Yanagida, H | 1 |
| Caws, M; Duy, PM; Farrar, J; Hoa, DV; Lan, NT; Tho, DQ | 1 |
| Akinci, P; Cavusoglu, C; Soyler, I; Turhan, A | 1 |
| Canducci, F; Cirillo, DM; Migliori, GB; Miotto, P; Penati, V; Piana, F | 1 |
| Bang, D; Bengård Andersen, A; Thomsen, VØ | 1 |
| Bauer, TW; Fraser, TG; Hall, GS; Joyce, MJ; Kobayashi, N; Procop, GW; Tuohy, MJ | 1 |
| Kokosali, K; Lloyd, RE | 1 |
| Jugheli, L; Portaels, F; Rigouts, L; Sadradze, N; Shamputa, IC; Supply, P; Willery, E | 1 |
| Chau, TN; Chiu, MC; Lai, ST; Ng, TK; Tam, CM; Yu, WC | 1 |
| Chanwong, S; Makonkawkeyoon, L; Makonkawkeyoon, S; Maneekarn, N | 1 |
| Almeida, D; Bishai, WR; Grosset, JH; Nuermberger, E; Peloquin, CA; Rosenthal, I; Tyagi, S; Williams, KN | 1 |
| Alland, D; Billman-Jacobe, H; Bobadilla del Valle, M; Bose, M; Brimacombe, M; Cavatore, M; Cave, MD; Chaves, F; Eisenach, KD; Fyfe, J; García-García, L; Guerrero, MI; Hazbón, MH; Lavender, C; León, CI; Murray, M; Ponce de León, A; Sifuentes-Osornio, J; Varma-Basil, M | 1 |
| Anand, R; Basir, SF; Gupta, S; Khare, S; Lal, S; Negi, SS; Pasha, ST | 1 |
| Perera, GA; Pinidiyapathirage, MJ; Senaratne, WV; Wickremasinghe, AR | 1 |
| Caminero, JA; Chiang, CY; Van Deun, A | 1 |
| Caminero, JA | 1 |
| Asencios, L; Cegielski, P; Ferrousier, O; Perales, MT; Saavedra, M; Salazar, C; Shin, S; Suarez, C; Vergara, L; Yagui, M; Yale, G | 1 |
| Elwood, RK; FitzGerald, JM; Moniruzzaman, A; Schulzer, M | 1 |
| Barr, G; Grimard, F; Jacquet, V; Menzies, D; Morose, W; Oxlade, O; Schwartzman, K | 1 |
| Babu, RB; Biswas, J; Kumarasamy, N; Sudharshan, S; Therese, L | 1 |
| Aarons, LJ; Brindle, R; Davies, GR; Khoo, SH | 1 |
| Campos-Varela, I; Ferrer-Sancho, J; Perich-Jackson, D | 1 |
| Chang, HC; Chen, J; Chen, SC; Hsieh, JT; Wu, WC | 1 |
| Dede, F; Demir, M; Doğan, E; Eskioğlu, E; Kös, M; Sener, D; Tad, M | 1 |
| Hillemann, D; Richter, E; Rüsch-Gerdes, S | 2 |
| Adelakun, A; Baruch, N; Bur, S; Cronin, WA; Doherty, MC; Dorman, SE; Federline, L; Karney, W; Milman, J; Montes de Oca, R; Page, KR; Sifakis, F; Walsh, T | 1 |
| Chernousova, LN; Kuz'min, AV; Vasil'eva, IA | 1 |
| Begum, R; Paramasivan, CN; Rahman, F; Ramanathan, VD; Ravichandran, G; Umapathy, KC | 1 |
| Dubiley, S; Ignatova, A; Shemyakin, I; Stepanshina, V | 1 |
| Amirmozafari, N; Farnia, P; Ghadertotonchi, Z; Ghazi, F; Kamran, J; Masjedi, M; Mirsaedi, M; Mohammadi, F; Ramazanzadeh, R | 1 |
| Brossier, F; Jarlier, V; Sougakoff, W; Truffot-Pernot, C; Veziris, N | 1 |
| El-Sayed Zaki, M; Goda, T | 1 |
| Dormandy, J; Mitsani, D; Rivenburg, J; Salfinger, M; Somoskovi, A | 1 |
| Goldstein, HB; Siefring, RP | 1 |
| Gao, XF; Li, YP; Liu, GJ; Sun, X; Wang, L; Wen, J; Xie, Y | 1 |
| Aziz, MA; Htun, A; Kluge, HH; Lwin, T; Mar, TT; Maung, W; Noe, P; Paramasivan, CN; Ti, T; Wright, A | 1 |
| Chloros, D; Patakas, D; Settas, L; Sichletidis, L; Spyratos, D | 1 |
| Leung, CC; Yew, WW | 1 |
| Alavez-Ramírez, J; Castellanos, JR; Esteva, L; Flores, JA; Fuentes-Allen, JL; García-Ramos, G; Gómez, G; López-Estrada, J | 1 |
| Agrawal, S; Ashokraj, Y; Kumar Bajpai, A; Panchagnula, R | 1 |
| Chiani, Y; Imaz, MS; Mengatto, L | 1 |
| Sougakoff, W; Truffot-Pernot, C; Véziris, N | 1 |
| Aubry, A; Truffot-Pernot, C; Veziris, N | 1 |
| Aires, NB; Nico, MM; Santi, CG | 1 |
| Coutinho, E; Jain, R; Malde, A; Monga, V; Nayyar, A | 1 |
| Behdani, M; Farnia, P; Ghanaat, J; Ghazvini, K; Mohammadzadeh, A; Rashed, T | 1 |
| Aufschild, J; Boehm, BO; Zenz, T | 1 |
| Asimakis, P; Bilous, M; Jennings, A; Maloof, AJ | 1 |
| Hoskyns, W; Panickar, JR | 1 |
| Berady, S; Chaari, J; Ennibi, K; Rabhi, M; Toloune, F | 1 |
| Ashkin, D; Hollender, E; Julien, J; Lauzardo, M | 1 |
| Hayden, C; Kojakali, F; Lardizabal, A; Passannante, M; Reichman, LB | 1 |
| Ecder, T; Erelel, M; Kocabay, G; Tutkun, IT | 1 |
| Aziz, MA; Blanc, L; De Muynck, A; Laszlo, A; Nunn, P; Portaels, F; Raviglione, M; Van Deun, A; Wells, C; Wright, A | 1 |
| Chazan, R; Grubek-Jaworska, H; Walkiewicz, R | 1 |
| Difonzo, EM; Fabroni, C; Lotti, L; Salvini, C; Sestini, S | 1 |
| Baveja, S; Kanade, S; Mehta, P; Nataraj, G; Poojary, A | 1 |
| Beyers, N; Hesseling, AC; Marais, BJ; Maree, F; Schaaf, HS; Schoeman, JF; van Helden, P; Warren, RM | 1 |
| Cappelletty, DM | 1 |
| Ahuja, SD; Frieden, TR; Munsiff, SS | 1 |
| Chau, CH; Wong, HY; Yew, WW | 1 |
| Augusto, CJ; Augusto, MV; Barouni, AS; Lopes, MT; Ribeiro, MA; Salas, CE | 1 |
| Bajpai, VK; Mani, U; Misra, A; Muttil, P; Rath, SK; Sharma, R; Yadav, AB | 1 |
| Demessie, D; Gebeyehu, M; Girmachew, F; Lemma, E; Shiferaw, G; Woldeamanuel, Y | 1 |
| Agatonovic-Kustrin, S; Chen, YJ; Glass, BD; Wisch, MH | 1 |
| Back, DJ; Bertel Squire, S; Chandler, B; Hartkoorn, RC; Khoo, SH; Owen, A; Ward, SA | 1 |
| Favila, A; Gallo, M; Glossman-Mitnik, D | 1 |
| Folb, PI; Fourie, PB; Gabriels, GA; McIlleron, H; Smith, PJ | 1 |
| Basinga, P; Fissette, K; Gasana, M; Gatabazi, J; Nyiramasarabwe, L; Nzabintwali, F; Pauwels, P; Portaels, F; Rigouts, L; Struelens, MJ; Umubyeyi, AN; Vandebriel, G; Zawadi, JP | 1 |
| Kubendiran, G; Mitchison, DA; Paramasivan, CN; Sulochana, S | 1 |
| Brittle, W; Donald, PR; Engelke, E; Hesseling, AC; Marais, BJ; Schaaf, HS; van Helden, PD; Victor, TC | 1 |
| Cho, DI; Chun, BC; Ha, KY; Jeon, CH; Kim, EH; Kim, KT; Kim, MJ; Lee, JB; Lee, JH; Lee, JS; Park, DW; Shim, DM; Sohn, JW | 1 |
| Chauca, JA; Guerra, H; Palomino, JC | 1 |
| Asmolov, AA; Balabanova, YM; Bazhora, YI; Brown, TJ; Drobniewski, FA; Nikolayevskyy, VV | 1 |
| Boloorsaz, MR; Farnia, P; Khalilzadeh, S; Safavi, A; Velayati, AA | 1 |
| Bachiller-Luque, P; Briongos-Figuero, LS; Eiros-Bouza, JM; Pons-Renedo, F | 1 |
| Jun, SH; Kim, JQ; Lee, JH; Park, KU; Song, J; Song, SH; Yoon, Y | 1 |
| Amara, B; Belahsen, MF; Benjelloun, FZ; Benjelloun, MC; Messouak, O; Tizniti, S | 1 |
| Fonollosa, A; Garcia-Arumi, J; Giralt, J; Segura, A | 1 |
| Barroso, EC; Bushen, OY; Façanha, MC; Guerrant, RL; Lima, AA; Monteiro, HS; Peloquin, CA; Pinheiro, VG; Ramos, LM | 1 |
| Aydin, O; Bakir Ozbey, S; Helvaci, S; Kasapoğlu, F | 1 |
| Bai, GH; Bai, JI; Chang, CL; Choi, YW; Kim, HJ; Kim, SJ; Lee, JK; Park, YK | 1 |
| Afanas'ev, MV; Cherednichenko, AG; Chernousova, LN; Govorun, VM; Ikryannikova, LN; Il'ina, EN; Kamaev, EY; Kinsht, VN; Kuz'min, AV; Larionova, EE; Sidorenko, SV; Skorniakov, SN; Smirnova, TG | 1 |
| Alcaide, F; Aragón, LM; Borrell, S; Cardeñosa, E; Coll, P; Galán, JJ; Garrigó, M; Gonzalez-Martín, J; Martin-Casabona, N; Moreno, C; Salvado, M | 1 |
| Ikeda, T; Ishikawa, S; Kobayashi, K; Takeyama, H; Tokuda, Y; Touge, H; Yano, S | 1 |
| Aarnoutse, RE; Alisjahbana, B; Nijland, HM; Parwati, I; Ruslami, R; van Crevel, R | 1 |
| Singh, MM | 1 |
| Hinrichs, R; Maetzke, J; Scharffetter-Kochanek, K; Sigge, A | 1 |
| Ajayi, IO; Awodu, OA; Famodu, AA | 1 |
| Burman, WJ | 1 |
| Dimas, JF; García, AJ; García, M; Geijo, MP; Herranz, CR; Vaño, D | 1 |
| Canueto, J; Castillo, R; Díez, F; Escribano, JC; García, MA; Hernández, JJ; Kindelán, JM; López-Cortés, L; Lozano, F; Márquez, M; Martínez-Marcos, FJ; Pasquau, J; Rivero, A; Verdejo, J | 1 |
| Aly, S; Andries, K; Basaraba, RJ; Cantarero, L; Ehlers, S; Hoff, D; Lenaerts, AJ; Orme, IM | 1 |
| Martin, A; Portaels, F; Ramarokoto, H; Rasolofo Razanamparany, V; Rasolonavalona, T; Ravololonandriana, P; Rivoire, N | 1 |
| Ebrahim, GJ | 1 |
| Jiao, WW; Li, M; Liu, JW; Mokrousov, I; Narvskaya, O; Shen, AD; Sun, GZ | 1 |
| Cho, YJ; Han, SK; Kim, YW; Lee, SM; Shim, YS; Yim, JJ; Yoo, CG | 1 |
| Augustynowicz-Kopeć, E; Zwolska, Z | 1 |
| Cheng, X; Hao, X; Liu, J; Su, M; Xu, X; Yang, L; Yu, W; Zhang, J | 1 |
| Cynamon, M; Shoen, C; Sklaney, MR | 1 |
| Baldan, HM; Brunetti, IL; De Rosa, HJ; Machado, RG; Ximenes, VF | 2 |
| Bui, L; Jahng, AW; Joyner, JL; Tran, T | 1 |
| Adhvaryu, MR; Parabia, MH; Reddy, N | 1 |
| Bed, ST; Chottanapund, S; Eampokalap, B; Manosuthi, W; Sungkanuparph, S | 1 |
| Gursoy, B; Ozturk, A; Sirmatel, F; Sirmatel, O; Yazgan, P; Zeyrek, FY | 1 |
| Afanas'ev, MV; Akopian, TA; Chernousova, LN; Govorun, VM; Ikryannikova, LN; Il'ina, EN; Kuz'min, AV; Larionova, EE; Smirnova, TG | 1 |
| Bates, IP; Bothamley, GH; Engova, D; Rennie, TW | 1 |
| Akhtar, S; Haidri, FR; Memon, AM | 1 |
| Byrne, ST; Denkin, SM; Gu, P; Nuermberger, E; Zhang, Y | 1 |
| Goldschmidt-Clermont, P; Murdoch, D; Stout, J; Tabatabaei, N | 1 |
| Aldashev, AA; Alisherov, ASh; Chubakov, TCh; Goncharova, ZK; Isakova, ZhT; Iusupova, EU; Kozhomkulov, DK; Kozhomkulov, MD; Tumashova, AF | 1 |
| Tu, DH | 1 |
| Xia, YY; Zhan, SY | 1 |
| Edwards, CM; Fitzpatrick, RW | 1 |
| Besozzi, G; Cirillo, DM; Codecasa, LR; Ferrara, G; Girardi, E; Gori, A; Kliiman, K; Lange, C; Matteelli, A; Migliori, GB; Raviglione, MC; Spanevello, A; Toungoussova, OS | 1 |
| Alvarado-Gálvez, C; Andrade, MK; Arias, MS; Chaisson, RE; Dorman, SE; Fonseca, LS; Kimerling, ME; Kritski, AL; Marsico, AG; Mello, FC; Pavón, A; Pérez, M; Pessôa, CL; Rosales, S | 1 |
| Anitha, S; Hemanth Kumar, AK; Kumaraswami, V; Padmapriyadarsini, C; Ramachandran, G; Sarala, K; Swaminathan, S; Tharani, CB | 1 |
| Bruchet, N; Elwood, RK; Fitzgerald, JM; Marra, CA; Marra, F; Moadebi, S; Richardson, K | 1 |
| Kwon, SY; Lee, CT; Lee, JH; Lee, SW; Park, KU; Song, J; Um, SW; Yoon, HI | 1 |
| Fonseca, Lde S; Giampaglia, CM; Hadad, DJ; Kritski, A; Marsico, AG; Martins, MC; Mello, FC; Palaci, M; Telles, MA; Vieira, GB; Vinhas, SA | 1 |
| Gelesme, A; Gourgiotis, D; Metsou, F; Spyridis, NP; Spyridis, PG; Sypsa, V; Tsolia, MN; Valianatou, M | 1 |
| D'Amelio, R; Di Rosa, R; Diamanti, AP; Germano, V; Laganà, B; Luzi, G; Salemi, S; Stoppacciaro, A | 1 |
| Afanas'ev, MV; Cherednichenko, AG; Chernousova, LN; Govorun, VM; Ikriannikova, LN; Il'ina, EN; Kamaev, EIu; Kinsht, VN; Kuz'min, AV; Larionova, EE; Skorniakov, SN; Smirnova, TG | 1 |
| Otomo, K; Shi, R; Sugawara, I; Zhang, G; Zhang, J | 1 |
| Aibar Arregui, M; Blanca Torrubia Pérez, C; de Escalante Yangüela, B; Sáenz Abad, D | 1 |
| Aarnoutse, RE; Alisjahbana, B; Burger, DM; Nijland, HM; Ruslami, R; Suroto, AJ; van Crevel, R | 1 |
| Danckwerts, MP; du Toit, LC; Penny, C; Pillay, V | 1 |
| Jaggarajamma, K; Krishnan, N; Mohan, NS; Narayanan, PR; Ramachandran, R; Rehaman, F; Santha, T; Selvakumar, N; Sundaram, V; Thomas, A; Wares, F | 1 |
| Li, DX; Li, L; Shen, JG; Sun, Q; Sun, ZQ; Xu, PH; Yang, ZR; Zhang, SL | 1 |
| Zhang, Y | 1 |
| Chandramuki, A; Nagarathna, S; Rafi, W; Ravi, V; Venkataswamy, MM | 1 |
| Gohel, MC; Sarvaiya, KG | 1 |
| Aibar Arregui, M; de Escalante Yangüela, B; Sáenz Abad, D; Torrubia Pérez, CB | 1 |
| Beker, G; Cesur, S; Ceyhan, I; Coşkun, E; Gümüişlü, F; Güner, U; Ocak, F; Sayğan, MB; Tarhan, G | 1 |
| Fourie, PB; Horton, J; Kanyok, TP; McIlleron, H; Norman, J; Smith, PJ | 1 |
| Harada, Y; Kawakami, K; Kimura, Y; Koyama, K; Yamaryo, T | 1 |
| Banaiee, N; Barthus, C; Behr, MA; Jacobs, WR; January, V; Lambrick, M; Roditi, D; Steyn, LM | 1 |
| Fissette, K; Kabedi, MJ; Kashongwe, M; Kayembe, JM; Mampasi, P; Mbaya, P; Mumba Ngoyi, D; Muyembe-Tamfum, JJ; Portaels, F; Verhaegen, J | 1 |
| Aarnoutse, RE; Boeree, MJ; de Lange, WC; Dekhuijzen, R; Tostmann, A; van der Ven, AJ | 1 |
| Matsuki, A; Saito, K; Suzuki, K; Tanaka, Y | 1 |
| Ahmad, FU; Ahmad, H; Das, CJ; Tahir, M | 1 |
| Al-Absi, AN; Al-Akhali, A; Fujiki, A; Masui, T; Mitarai, S; Mori, T; Ohkado, A; Otomo, K; Seita, A; Yamada, H; Yamada, N | 1 |
| Hattori, T; Koyama, A; Mitarai, S; Otomo, K; Sato, A; Seki, M; Shishido, Y; Yano, I | 1 |
| Andrade, MK; Dalcolmo, MP; Picon, PD | 1 |
| Cotton, MF; Schaaf, HS; Sneag, DB; Zar, HJ | 1 |
| Hu, W; Meng, Q; Shen, C; Zhang, G | 1 |
| Kibadi, K | 1 |
| Banerjee, R; Chimote, G | 1 |
| Agrawal, D; DiMase, JD | 1 |
| Bishai, WR; Chaisson, RE; Grosset, JH; Nuermberger, EL; Peloquin, CA; Rosenthal, IM; Tyagi, S; Vernon, AA; Williams, KN; Zhang, M | 1 |
| Pal, R; Rana, SV; Singh, K; Vaiphei, K | 1 |
| Chandramuki, A; Mani, R; Nagarathna, S; Rafi, W; Satishchandra, P; Veenakumari, HB | 1 |
| Chaturvedi, V; Dwivedi, N; Sinha, S; Tripathi, RP | 1 |
| Hoshino, H; Ishikawa, N; Itagaki, N; Kazumi, Y; Mitarai, S; Mori, T; Ohmori, M; Sugawara, I; Wada, M | 1 |
| Gonda, H; Ida, N; Kinoshita, K; Oishi, T; Suganuma, N; Suzuki, R; Yamaguchi, I; Yamamoto, K | 1 |
| Gelman, SS; Meyer, JJ | 1 |
| Albert, H; Barnard, M; Bosman, ME; Coetzee, G; O'Brien, R | 1 |
| Chung, MP; Kim, H; Kim, YH; Koh, WJ; Kwon, OJ; Lim, SY; Suh, GY | 1 |
| Krinke, GJ; Wells, MY | 1 |
| Allen, J; Coleman, DJ; Davies, GR; Fourie, B; Kanyok, T; Levin, J; Lienhardt, C; Mitchison, DA; Mthiyane, T; Reddy, C; Rustomjee, R; Sirgel, FA; Sturm, AW | 1 |
| Agarwal, S; Gupta, U; Kalra, BS; Khurana, N; Tayal, V | 1 |
| Kaneko, T; Kashiwabara, Y; Kudoh, S; Matsushita, N; Nomura, K; Tamura, T; Yoshida, I | 1 |
| Gomathy, P; Iliayas, S; Kumar, SR; Mathew, M; Narayanan, PR; Padmapriyadarsini, C; Sukumar, B; Swaminathan, S; Thomas, B; Triveni, C | 1 |
| Akagawa, S; Ariga, H; Kaneko, Y; Kawabe, Y; Kawashima, M; Kunogi, M; Kurashima, A; Machida, K; Masuda, K; Matsui, H; Matsui, Y; Nagai, H; Nagayama, N; Oshima, N; Shimada, M; Suzuki, J; Tamura, A; Toyoda, E; Yotsumoto, H | 1 |
| Ejigu, GS; Gebyehu, M; Lemma, E; Selassie, A; Shah, NS; Woldeamanuel, Y | 1 |
| Mäkinen, J; Marjamäki, M; Marttila, HJ; Ruutu, P; Soini, H | 1 |
| Kuz'mina, NV; Musatova, NV | 1 |
| Arbeláez, A; Arbeláez, MP; Arias, SL; Betancourt, G; Gómez, RD; Nagles, J; Peláez, LM; Rojas, C; Velásquez, G; Vélez, L | 1 |
| Gao, F; Jiang, X; Lu, C; Wang, H; Zhang, W; Zhang, X; Zhang, Y | 1 |
| Diémé, C; Fall, I; Ndoye, M; Ngom, G | 1 |
| Aarnoutse, RE; Boeree, MJ; Dekhuijzen, PN; Peters, WH; Roelofs, HM; Tostmann, A; van der Ven, AJ | 1 |
| Chang, KC; Lau, TY; Leung, CC; Tam, CM; Yew, WW | 1 |
| Ambarkhane, SV; Joshi, AS; Panchabhai, TS; Rege, NN; Samant, BD | 1 |
| Chaudhry, A; Jamshaid, M; Zaka-Ur-Rehman, Z | 1 |
| Constenla, L; Fernández-Villar, A; González-Quintela, A; Leiro, V; Piñeiro, L; Valverde, D; Vázquez, R | 1 |
| Kornfeld, H | 1 |
| Angeby, K; Hoffner, S; Martin, A; Palomino, JC; Panaiotov, S; Portaels, F | 1 |
| Cakir, E; Dagli, E; Dagli, T; Ersu, R; Gocmen, B; Karadag, B; Karakoc, F; Kiyan, G; Oktem, S; Uyan, ZS | 1 |
| Cirillo, DM; Migliori, GB; Miotto, P; Piana, F | 1 |
| Cilleruelo Ortega, MJ; García Hortelano, M; Martín Fontelos, P; Mellado Peña, MJ; Méndez Echevarría, A; Piñeiro Pérez, R; Villota Arrieta, J | 1 |
| Awan, S; Dar, NR; Raza, N; Zafar, O | 1 |
| Kella, N; Qureshi, MA; Rathi, PK | 1 |
| Jhamb, SS; Singh, PP; Singh, RP | 1 |
| Dhanlaklshmi, M; Ethirajan, N; Padmavathy, L; Rao, LL | 1 |
| Hoshino, H; Mitarai, S; Ogata, H; Ohmori, M; Okumura, M; Uchimura, K; Wada, M; Yoshiyama, T | 1 |
| Apisarnthanarak, A; Apisarnthanarak, P; Khawcharoenporn, T; Kiratisin, P; Mundy, LM; Rakskul, P; Warnnissorn, N | 1 |
| Cáceres, N; Cardona, PJ; Gil, O; Guirado, E; Singh, M; Vilaplana, C | 1 |
| Andersen, AB; Bang, D; Sosnovskaja, A; Stegger, M; Thomsen, VØ; Vijdea, R | 1 |
| Bunmaprasert, T; Chiengthong, K; Luewan, S; Tongsong, T | 1 |
| Opondo, EA | 1 |
| El Nazir, B; Mahesh, B; McShane, D; Molloy, J; Shandilya, M | 1 |
| Isakova, ZhT | 3 |
| Mehta, A; Rodrigues, C; Shenai, S | 1 |
| Dodiya, D; Jarsania, S; Mathukiya, H; Ravat, N; Shah, V; Surani, J; Trivedi, A | 1 |
| Chida, K; Fujita, K; Hayakawa, H; Miwa, S; Murakami, M; Nakamura, H; Ohba, H; Shirai, M; Suda, T; Suzuki, Y | 1 |
| Bradaric, A; Goic-Barisic, I; Karanovic, J; Mise, K; Tonkic, M; Vrsalovic, N | 1 |
| Hiremath, PS; Saha, RN | 1 |
| Alur, SB; Amarkhed, SS; Kamat, GV; Koura, A; Nerli, RB; Vikram, P | 1 |
| Andries, K; Gevers, T; Lounis, N; Van Den Berg, J | 1 |
| Aslan, G; Emekdas, G; Serin, MS; Tezcan, S | 1 |
| Guo, JH; Huang, M; Luo, T; Sun, Q; Xiang, WL; Yang, ZR; Zhang, J; Zhao, J; Zhao, QR | 1 |
| Asiimwe, BB; Ghebremichael, S; Joloba, ML; Kallenius, G; Koivula, T | 1 |
| Grosset, J; Nuermberger, E; Tasneen, R; Tyagi, S; Williams, K | 1 |
| Dixit, R; Nawal, CL; Sharma, S | 1 |
| Akpaka, PE; Baboolal, S; Clarke, D; Francis, L; Rastogi, N | 1 |
| Boldy, DA; Butt, MT; Oko, MO; Wray, D | 1 |
| Detjen, A; Magdorf, K; Thee, S; Wahn, U | 1 |
| Mäkinen, J; Marjamäki, M; Marttila, HJ; Soini, H | 1 |
| Adhvaryu, MR; Reddy, N; Vakharia, BC | 1 |
| Almeida, D; Grosset, JH; Nuermberger, EL; Rosenthal, IM; Zhang, M | 1 |
| Inge, LD; Wilson, JW | 1 |
| Cho, JS; Kang, H; Kim, JH; Park, SK; Smego, RA | 1 |
| Domínguez, J; Garcia-Sierra, N; Haba, L; Lacoma, A; Maldonado, J; Prat, C; Rosés, S; Ruiz-Manzano, J | 1 |
| Ani, AE; Dalyop, YB; Idoko, J; Pitmang, SL | 1 |
| Ge, Z; Wang, Z; Wei, M | 1 |
| Guo, WL; Lu, JH; Meng, QF; Teng, LR; Zhang, YB; Zhang, ZY | 1 |
| Gupta, A; Kumar, V; Sabat, D | 1 |
| Acharya, PR; Baliga, P; Sahoo, R | 1 |
| Sterling, TR | 1 |
| Akgüneş, A; Bilgin, K; Coban, AY; Durupinar, B | 1 |
| Gönlügür, T; Gönlügür, U; Hasbek, M; Katrancioğlu, O; Sapmaz, F | 1 |
| Feldmann, K; Hoffmann, H; Hofmann-Thiel, S; Murmusaeva, G; Turaev, L; Uzakova, GT; van Ingen, J; van Soolingen, D | 1 |
| Benito-Arévalo, JL; Letona-Carbajo, S; Ruiz-Ruiz, FJ; Sáenz-Abad, D; Sanioaquín-Conde, I | 1 |
| Choi, CW; Kim, DH | 1 |
| Faulkner, C; McHugh, A; Siller, G; Williamson, R | 1 |
| Evans, J; Nicol, MP; Segal, H; Stead, MC | 1 |
| Ho, YJ; Lee, CH; Lee, CL; Wei, YS | 1 |
| de Barros e Silva, MJ; de Paiva, TF; Fanelli, MF; Gimenes, DL; Rinck, JA | 1 |
| Guo, WL; Song, J; Teng, LR; Teng, LS; Wang, D; Zhang, YB | 1 |
| Antolín, J; Azahara, M; Blanco, M; Cigüenza, R; Hernández, C; Mao, L | 1 |
| Kim, B; Punaro, M | 1 |
| Caylà, JA; Maldonado, J; Tost, JR; Vidal, R | 1 |
| Coelho, E; De Capitani, EM; Joaquim, OA; Nunes, EA; Panunto, AC; Ramos, Mde C | 1 |
| Ali, A; Hasan, R; Hasan, Z; Moatter, T; Tanveer, M | 1 |
| Chen, J; Dong, G; Liu, Y; Peng, R; Yue, J | 1 |
| Guzmán, A; Martin, A; Mejia, GI; Paniagua, L; Robledo, J | 1 |
| Al Jahdali, H; Benedetti, A; Dion, MJ; Gardam, M; Hoeppner, V; Khan, K; Long, R; Memish, Z; Menzies, D; Schwartzman, K; Trajman, A; Yang, J | 1 |
| Blumberg, HM | 1 |
| Oo, YH; Syn, WK | 1 |
| Kanagaraj, A; Marthandam, LR; Meenakumari, P; Rajesh, A; Sriramakrishnan, V | 1 |
| Brady, MF; Coronel, J; Gilman, RH; Moore, DA | 1 |
| Borgdorff, MW; He, GX; Jiang, GL; Liu, YH; van den Hof, S; van der Werf, MJ; Wang, LX; Wang, SF; Xia, H; Zhao, YL | 1 |
| Barboza, CE; Santos, Ude P; Seiscento, M; Terra Filho, M; Winter, DH | 1 |
| Braz, AG; Maia, JA; Morrone Junior, N; Morrone, N | 1 |
| Horcajada, JP; Pelfort, X; Puig, L; Salvadó, M | 1 |
| Alcaide, F; Casas, S; Dorca, J; Gonzalez, L; Guerra, MR; Lopez, M; Santin, M | 1 |
| Cailleaux-Cezar, M; Chaisson, RE; Conde, MB; de A Melo, D; de Mello, FC; de Salles, CL; Efron, A; Golub, JE; Ruffino-Netto, A; Xavier, GM | 1 |
| Brossier, F; Jarlier, V; Sougakoff, W; Veziris, N | 1 |
| Belknap, R; Kestler, M; Reves, R | 1 |
| Arefin, KE; Helal, MA; Mutanabbi, M; Rahman, MA; Rahman, MH | 1 |
| Abdelaal, A; Badran, E; El Mashad, N; El-Ghaffar, HA; Fathy, A; Zaghloul, MH | 1 |
| Chitre, PS; Ghildiyal, RG; Sawant, HV; Tullu, MS | 1 |
| Al-Rikabi, A; AlAni, A; Khan, FY; Mizrakhshi, A; Osman, Mel-M | 1 |
| Kononets, AS | 1 |
| Archakova, LI; Kondakova, MN; Kovaleva, RG; Pavlova, MV; Skvortsova, LA; Vinogradova, TI | 1 |
| de Reina, L; Duca, A; Ramos, A; Saucedo, G | 1 |
| Cuadrado, JM; Jover, F; Peris, J; Wikman, PE | 1 |
| Christenson, JC; Downs, SM; Finnell, SM | 1 |
| Castro, KG; Jereb, JA; Lobato, MN | 1 |
| Dovgaliuk, IF; Ovchinnikova, IuE; Starshinova, AA | 1 |
| Arora, B; Lal, H; Sharma, S; Srivastava, RK; Verma, S | 1 |
| Gatt, P; Jacobson, RR | 1 |
| Crick, DC; Kurosu, M | 1 |
| Amiri, MV; Chitsaz, E; Esmaeili, M; Farnia, P; Kazempour, M; Mansouri, D; Marjani, M; Masjedi, MR; Mirsaeidi, M; Shamaei, M; Tabarsi, P; Velayati, AA | 1 |
| Hamilton, CD; Holland, DP; Sanders, GD; Stout, JE | 3 |
| Mavrogenis, AF; Papagelopoulos, PJ; Sakellariou, VI; Tsiodras, S | 1 |
| Chan, S; Keo, C; Leng, C; Min, DC; Monchy, D; Saman, M; Sar, B; Sarthou, JL | 1 |
| Biscopink, RJ; Davis, TL; Naidu, VG; Tammineni, AK; Veerabagu, MP | 1 |
| Benmansour, N; El Alami, MN; Oudidi, A | 1 |
| Bishai, WR; Cezar, MC; Chaisson, RE; Chaudhary, MA; Conde, MB; De Souza, GR; Efron, A; Graça, NP; Kritski, AL; Loredo, C; Ram, M | 1 |
| Bukulmez, A; Dogru, O; Koken, R; Konakci, R; Melek, H; Ozturk, F | 1 |
| Engemann, JJ; Fortenberry, ER; Hamilton, CD; Holland, DP; Peloquin, CA; Stout, JE; Weintrob, AC | 1 |
| Garg, R; Mehra, S; Prasad, R | 1 |
| Alvarez-Espejo, T; Daza, R; Guzmán, MF; Ramos, A | 1 |
| Boonsarngsuk, V; Kiatboonsri, S; Tansirichaiya, K | 1 |
| Kubendiren, G; Mitchison, DA; Paramasivan, CN; Sulochana, S; Venkatesan, P | 1 |
| Bradford, WZ; Chideya, S; Hopewell, PC; Kenyon, TA; Moeti, TL; Peloquin, CA; Reingold, AL; Tappero, JW; Wells, CD; Winston, CA | 1 |
| Benjelloun, MC; Benmansour, N; El alami, MN; El hord, S; Oudidi, A | 1 |
| Garner, P; Ziganshina, LE | 1 |
| Bwanga, F; Haile, M; Hoffner, S; Joloba, ML | 2 |
| Bartacek, A; Borek, M; Panosch, B; Schütt, D | 1 |
| Deftereos, S; Kantartzi, K; Kriki, P; Mourvati, E; Panagoutsos, S; Passadakis, P; Prassopoulos, P; Theodoridis, M; Thodis, E; Vargemezis, V | 1 |
| Kanwar, AJ; Khuller, GK; Sharma, A; Sharma, S | 2 |
| Alexander, DC; Bolotin, S; Chedore, P; Drews, SJ; Jamieson, F | 1 |
| Agarwal, S; Datta, S; Kaur, P | 1 |
| Alcaneses, MR; Boom, WH; Debanne, SM; Dietze, R; Eisenach, KD; Gitta, P; Hadad, DJ; Horter, L; Johnson, JL; Maciel, EL; Mugerwa, RD; Okwera, A; Quelapio, MI; Sewali, B; Tupasi, TE | 1 |
| Daly, JS; Ellis, J; Kaminski, M; Wessolossky, M; Young, H | 1 |
| Arslan, Z; Babacan, F; Cimen, NO; Kurutepe, M; Ocak, K; Saygi, A | 1 |
| Ang, M; Chee, SP; Htoon, HM | 1 |
| Anthony, RM; Bergval, IL; Klatser, PR; Schuitema, AR | 1 |
| Andries, K; Ibrahim, M; Jarlier, V; Truffot-Pernot, C; Veziris, N | 1 |
| Abughali, N; Auletta, J; Esper, F; LaBeaud, AD; Lancioni, C | 1 |
| Almeida, D; Grosset, J; Nuermberger, E; Peloquin, C; Rosenthal, I; Tasneen, R; Tyagi, S; Williams, K | 1 |
| Aslan, G; Emekdaş, G; Tezcan, S | 1 |
| Bilgin, K; Coban, AY; Durupinar, B; Uzun, M | 1 |
| Chen, JD; Li, B; Liu, YH; Wang, YC; Xu, YY; Zhao, MQ; Zhu, RY | 1 |
| Angeby, KA; Chryssanthou, E; Giske, CG; Hoffner, SE; Juréen, P; Kahlmeter, G; Schön, T; Sturegård, E; Werngren, J | 1 |
| Kay, AW; McCarthy, CA | 1 |
| Barroso, EC; Campelo, CL; Carvalho, MR; Façanha, MC; Guerrant, RL; Lima, AA; Moura, ME; Peloquin, CA; Pinheiro, VG | 1 |
| Fisher, M; Hemingway, C; Innes, J; Scott, G; Solomon, T; Thwaites, G | 1 |
| Aldashev, A; Isakova, J; Mokrousov, I; Rastogi, N; Sovhozova, N; Valcheva, V | 1 |
| Curtis, N; Ritz, N; Streeton, J; Tebruegge, M | 1 |
| Dorsinville, M; Li, J; Munsiff, SS; Tarantino, T | 1 |
| Chien, YJ; Lee, LN; Wang, JY; Yang, PC; Yu, CJ | 1 |
| Byeon, JS; Choe, JW; Kim, JH; Kim, KJ; Myung, SJ; Park, SH; Yang, DH; Yang, SK; Ye, BD; Yoon, SM | 1 |
| Chen, YH; Eng, HL; Huang, CK; Lai, CH; Lin, HF; Lin, HH; Lin, JN | 1 |
| Bocanegra-García, V; Cruz-Pulido, W; Garza-González, E; González, GM; Rentería, A; Rivera, G | 1 |
| Hanna, LE; Narayanan, PR; Nayak, K; Subramanyam, S; Swaminathan, S; Venkatesan, P | 1 |
| Carow, B; Heuts, F; Rottenberg, ME; Wigzell, H | 1 |
| Prasad, B; Singh, S | 1 |
| Budkina, TE; Churina, EG; Khasanova, RR; Kolosova, AE; Naslednikova, IO; Novitskiĭ, VV; Serebriakova, VA; Strelis, AK; Urazova, OI; Vasil'eva, OA; Voronkova, OV | 1 |
| Carroll, WD; Nair, S | 1 |
| Grewal, HM; Kross, M; Phyu, S; Stavrum, R; Syre, H; Ti, T; Valvatne, H | 1 |
| Badoum, G; Cirillo, DM; Dembelé, M; Matteelli, A; Migliori, GB; Miotto, P; Ouedraogo, M; Pinsi, G; Saleri, N | 1 |
| Chiang, CY; Jou, R; Wu, MH; Yu, CY | 1 |
| Chadha, S; Chandrasekar, V; Chauhan, LS; Dave, PV; Dewan, P; Nalini, S; Narayanan, PR; Paramasivan, CN; Parmar, M; Ramachandran, R; Sahu, S; Sanghvi, AS; Wares, F | 1 |
| Gupta, BD; Johri, RK; Monica, P; Sachin, BS; Satti, NK; Sharma, SC; Suri, KA; Tikoo, AK; Tikoo, MK | 1 |
| Albini, TA; Fraig, MM; Karakousis, PC; Kumaradas, M; Pinn, ML; Rao, NA | 1 |
| Benedetti, A; Burman, W; Lienhardt, C; Martin, I; Menzies, D; Pai, M; Paydar, A; Royce, S; Vernon, A | 1 |
| Bueno-Sánchez, JG; Martínez-Morales, JR; Ribón, W; Stashenko, EE | 1 |
| Alexander, HL; Balabanova, Y; Drobniewski, F; Fedorin, I; Ilyina, N; Kruuner, A; Lebedeva, N; Malomanova, N; Nikolayevskyy, V; O'Brien, R; Shakhmistova, A; Simak, T; Sohn, H; Zakharova, S | 1 |
| Haile, M; Hoffner, SE; Malakhov, VN; Shulgina, MV; Wright, A | 1 |
| Gedikoğlu, S; Ozakin, C; Sinirtaş, M | 1 |
| Behera, D; Meharwal, SK; Myneedu, VP; Visalakshi, P | 1 |
| Freidlin, PJ; Goldblatt, D; Kaidar-Shwartz, H; Rorman, E | 1 |
| Ang, C; Bravo, LT; Destura, RV; Gordon, SM; Hall, GS; Mendoza, M; Procop, GW; Shrestha, NK; Tuohy, MJ | 1 |
| Choonara, Y; du Toit, L; Pillay, V | 1 |
| Bae, HK; Cho, EH; Kang, SK; Lee, EH | 1 |
| Bhasin, KK; Kaur, G; Mehta, SK | 2 |
| Guo, X; Liu, Y; Sun, J; Wu, W; Zheng, Q | 1 |
| Mylonakis, E; Ziakas, PD | 1 |
| Douhal, A; Elharradi, A; Elouarsani, A; Houmadi, A; Khayati, A; Kriet, M; Laktaoui, A; Mounahc, J; Naoumi, A; Reda, K; Rouimi, A | 1 |
| Jhamb, SS; Singh, PP | 1 |
| Chinnaiyan, P; Iliayas, S; Menon, PA; Narayanan, PR; Narendran, G; Padmapriyadarsini, C; Ramachandran, R; Sakthivel, R; Santhanakrishnan, R; Suhadev, M; Swaminathan, S; Venkatesan, P | 1 |
| Chauhan, DS; Gupta, AK; Katoch, VM; Sharma, R; Sharma, VD; Singh, M; Venkatesan, K | 1 |
| Baraka, A; Cobelens, F; Egwaga, S; Grewal, P; Haag-Arbenz, V; Lwilla, F; Mkopi, A; Mshinda, H; Range, N; van Leth, F | 1 |
| de Bree, R; Tijink, BM | 1 |
| Hoffner, S; Hu, Y; Jiang, W; Wang, W; Xu, B | 1 |
| Deng, X; Fan, J; Ge, F; Guo, N; Jin, Q; Liu, S; Song, Y; Wang, X; Wu, X; Ye, H; Yu, L; Zeng, F | 1 |
| Andersen, AB; Bang, D; Lillebaek, T; Thomsen, VØ | 1 |
| Bame, R; Djella, S; Kuaban, C; Mouangue, L; Yomgni, C | 1 |
| Gumbo, T | 1 |
| Bray, MG; Dougados, M; Gossec, L; Poulain, C | 1 |
| Benedetti, A; Burman, W; Lienhardt, C; Madhukar, P; Menzies, D; Paydar, A; Royce, S; Vernon, A | 1 |
| Avachat, AM; Bhise, SB | 1 |
| Chin, BS; Choi, HK; Choi, JY; Choi, SH; Han, SH; Jeong, SJ; Kim, CO; Kim, JM; Kim, KM; Kim, MS; Lee, HS; Song, YG | 1 |
| Ahmad, Z; Grosset, JH; Karakousis, PC; Nuermberger, EL; Peloquin, CA; Pinn, ML; Tasneen, R; Williams, KN | 1 |
| Becker, M; Mackensen, F; Zimmermann, S | 1 |
| Oliver, GF; Wong, KK | 1 |
| Jayaswal, A; Makharia, G; Mohan, A; Sarda, P; Sharma, SK; Singh, S; Singla, R; Sreenivas, V | 1 |
| Ackart, D; Basaraba, RJ; Bucy, DS; Caraway, ML; Harton, MR; Hascall-Dove, L; Henao-Tamayo, M; Kraft, SL; Lenaerts, AJ; Ordway, DJ; Orme, EA; Orme, IM; Shang, S; Shanley, CA | 1 |
| Lee, AS; Ong, DC; Siu, GK; Yam, WC | 1 |
| Aditya, NP; Madhusudhan, B; Patankar, S | 1 |
| Baseke, J; Boom, WH; Charlebois, E; Chervenak, KA; Havlir, DV; Johnson, DF; Lancioni, C; Mahan, CS; Mayanja-Kizza, H; Mugerwa, RD; Walusimbi, M; Whalen, CC | 1 |
| Ademun, JP; Albert, H; Bwanga, F; Haile, M; Hoffner, S; Joloba, M; Lukyamuzi, G; Mukkada, S; Nyesiga, B; O'Brien, R | 1 |
| Barroso, EC; Façanha, MC; Gondim, AM; Guerrant, RL; Lima, AA; Peloquin, CA; Pinheiro, VG | 1 |
| Acharya, SK; Bhatia, V; Gupta, SD; Khanal, S; Kumar, R; Panda, SK; Sreenivas, V | 1 |
| Blomberg, B; Dyrhol-Riise, AM; Gran, G; Haanshuus, CG; Mørkve, O; Wentzel-Larsen, T | 1 |
| Bessong, PO; de Villiers, BE; Green, E; Hoosen, AA; Letsoalo, T; Nchabeleng, M; Ndip, RN; Obi, CL; Sein, PP | 1 |
| Abrams, EJ; Coovadia, A; Ko, S; Kuhn, L; Meyers, T; Reitz, C; Sherman, G; Strehlau, R | 1 |
| Abe, M; Kobashi, Y; Miyashita, N; Mouri, K; Obase, Y; Oka, M | 1 |
| Cansü, E; Erdogan, F; Ulusam, AO | 1 |
| Andersen, AB; Andersen, PH; Bang, D; Thomsen, VØ | 1 |
| Baquero, F; Buitrago, LA; Burgos Revilla, J; Gómez García, I; Gómez Mampaso, E; Gómez Rodríguez, A; Molina, MR; Sampietro Crespo, A | 1 |
| Benedetti, A; Heymann, J; Menzies, D; Oxlade, O; Pai, M; Royce, S; Schwartzman, K | 1 |
| Gao, Q; Gui, XH; Li, J; Mei, J; Wang, LL; Wu, J; Xu, P; Zhao, M | 1 |
| Guleria, K; Gupta, B; Vaid, N | 1 |
| Al-Otaibi, B; Dion, MJ; Long, R; Menzies, D; Trajman, A; Zylberberg, D | 1 |
| Jablenska, L; Lo, S; Toma, A; Uddin, J | 1 |
| Nakamichi, N; Ogawa, K | 1 |
| Laniado-Laborín, R | 1 |
| Bistawroos, AE; El-Gowilly, SM; Saad, EI; Sherhaa, MO | 1 |
| Ambekar, S; Banerjee, AD; Chandramouli, BA; Pandey, P | 1 |
| Basu, S; Padhi, TR | 1 |
| Andrei, I; Biver, E; Duquesnoy, B; Flipo, RM; Paccou, J; Philippe, P; Wibaux, C | 1 |
| Başustaoğlu, AC; Ceyhan, I; Güllü, U; Kiliç, A; Kiliç, S; Simşek, H; Tarhan, G; Uçar, E; Yilmaz, S | 1 |
| Baniasadi, S; Eftekhari, P; Fahimi, F; Masjedi, MR; Raoufy, MR; Tabarsi, P; Velayati, AA | 1 |
| Chen, SL; Guo, WJ; Shieh, GR | 1 |
| Agarwal, A; Arora, A; Kumar, S | 1 |
| Allton, DR; Ballard, EA; Folio, L; Jesinger, RA; Lane, JW | 1 |
| Anek-Vorapong, R; McCarthy, K; Ngamlert, K; Podewils, LJ; Promsarin, B; Sinthuwattanawibool, C; Varma, JK | 1 |
| Fu, W; Huang, J; Li, Y; Yao, C; Zhang, B; Zhang, L; Zhu, T | 1 |
| Chiu, YC; Feng, JY; Huang, SF; Lee, YC; Su, WJ | 1 |
| Buu, TN; Caws, M; Cobelens, FG; Dung, NH; Hang, PT; Huyen, MN; Kremer, K; Lan, NT; O'Brien, R; Sy, DN; Tiemersma, EW; van Soolingen, D | 1 |
| Bright-Thomas, R; Morris, JA; Nandwani, S; Ormerod, LP; Smith, J | 1 |
| Ermertcan, AT; Gençoğlan, G; İnanir, I; Özkütük, N; Öztürk, F; Temiz, P | 1 |
| Adjei, O; Browne, EN; Chinbuah, A; Gyapong, J; Hillemann, D; Homolka, S; Horstmann, RD; Kubica, T; Meyer, CG; Niemann, S; Osei, I; Owusu-Dabo, E; Ruesch-Gerdes, S | 1 |
| Arquinio, L; García-Gasalla, M; Losada, I; Sarasibar, H | 1 |
| Bates, M; Centis, R; Dheda, K; Hoelscher, M; Migliori, GB; Mwaba, P; O'Grady, J; Zumla, A | 1 |
| Bai, KJ; Chiang, CY; Enarson, DA; Lee, CN; Luh, KT; Suo, J | 1 |
| Altet Gómez, N; Ruiz-Manzano, J | 1 |
| Alvarez, GG; Cohen, T; Murray, M; Samuel, EY; Wallengren, K; Wilson, D | 1 |
| Daza, R; Martín-Jiménez, ML; Tutor-Ureta, P; Vargas, JA | 1 |
| Elwood, RK; Fitzgerald, JM; Guo, N; Marra, CA; Marra, F | 1 |
| Chang, KC; Leung, CC | 1 |
| Helbling, CA; Iizuka, T; Kuttenberger, J; Lieger, O; Smolka, W | 1 |
| Donald, PR | 3 |
| Aspler, A; Dion, MJ; Khan, K; Long, R; Menzies, D; Schwartzman, K; Trajman, A | 1 |
| Ioannidis, P; Kanavaki, S; Karabela, S; Konstantinidou, E; Marinou, I; Nikolaou, S; Papaventsis, D; Sainti, A | 1 |
| Devlin, J; Haroon, M; Martin, U | 1 |
| Cai, HL; Chen, YC; Fang, PF; Gao, W; Li, HD; Liu, YP; Tan, QY; Xu, P; Zhang, F; Zhang, WY; Zhu, RH | 1 |
| Augustynowicz-Kopeć, E; Napiórkowska, A; Zwolska, Z | 1 |
| Cole, ST; Dhar, N; Ha, YH; Hartkoorn, RC; Sala, C; Schneider, P; Zhang, M | 1 |
| Lange, C; Leung, CC; Rieder, HL; Yew, WW | 1 |
| Aloui, N; Bousnina, S; Boussetta, K; Brini, I; Ghaffari, H; Jaubert, F; Tinsa, F | 1 |
| Cattamanchi, A; Flood, J; Hopewell, PC; Kato-Maeda, M; Kim, EY; Lin, SY; Metcalfe, JZ; Oh, P | 1 |
| Aguirre, U; Altube, L; Capelastegui, A; Diez, R; Egurrola, M; Pascual Erquicia, S; Salinas, C | 1 |
| Azevedo, F; Bettencourt, H; Ferreira, O; Morais, P; Nogueira, A | 1 |
| Boeree, MJ; Kibiki, GS; Tostmann, A; van der Ven, AJ; Verhoef, H; Wielders, JP | 1 |
| Andries, K; Diacon, AH; Donald, PR; Maritz, JS; McNeeley, DF; van Helden, PD; Venter, A | 1 |
| Chang, CL; Cho, EH; Choi, GE; Hwang, SH; Kim, HH; Kim, HJ; Kim, JH; Lee, EY; Lee, SM; Yi, J | 1 |
| Kafle, P; Kolade, V | 1 |
| Aida, S; Nakano, Y; Nishio, K; Okabayashi, K; Shimada, H | 1 |
| Delarbre, JM; Gravet, A; Habermacher, J; Lohmann, C; Moser, A; Schmitt, F; Souillard, N | 1 |
| Boutignon, H; Dubrulle, S; Romeo, B; Vervel, C | 1 |
| Duo, L; Lu, X; Song, X; Wang, L; Wang, T; Ye, Y; Ying, B; Zhang, L | 1 |
| Ascenzi, P; Bolli, A; Coletta, M; di Masi, A; Fanali, G; Fasano, M; Tundo, GR | 1 |
| Heysell, SK; Houpt, ER; Keller, SJ; Moore, JL | 1 |
| Martín, JM; Pérez, J; Renau, A; Ricart, JM | 1 |
| Antonini, TM; Antoun, F; Azoulay, D; Castaing, D; Delvart, V; Escaut, L; Ichai, P; Saliba, F; Samuel, D; Sebagh, M | 1 |
| Del Portillo, P; Hernández-Neuta, I; Hoffner, S; Imperiale, B; Jureen, P; López, B; Martin, A; Morcillo, N; Palomino, JC; Ritacco, V; Sķenders, G; Varela, A; von Groll, A | 1 |
| Altintas, AK; Beyazyildiz, E; Ozdal, PC; Ozdamar, Y; Ozkan, SS; Teberik, K | 1 |
| Hashida, N; Ohguro, N; Terubayashi, A | 1 |
| Ola, RP; Pal, R; Rana, SV; Singh, K; Vaiphei, K | 1 |
| Drechsler, A; Kirch, W | 1 |
| Camara, P; Chevalier, B; Debonne, JM; Fabre, M; Gueye, M; Herve, V; Lefebvre, N; Margery, J; Mbaye, PS; Perrier-Gros-Claude, JD; Sane, M; Simon, F; Soler, C; Thiam, M | 1 |
| Chung, DR; Jeon, K; Kang, ES; Koh, WJ; Kwon, OJ; Park, HY; Suh, GY; Yoonchang, SW | 1 |
| Khan, KS; Kunst, H | 1 |
| Maharjan, B; Shrestha, B; Yoshiyama, T | 1 |
| Li, C; Li, Y; Liu, Y; Song, H; Sun, Z; Tian, M; Zhang, J; Zhang, X; Zhao, Y | 1 |
| Domínguez-Ramírez, AM; Jung-Cook, H; Magaña-Aquino, M; Medellín-Garibay, SE; Milán-Segovia, RC; Romano-Moreno, S; Romero-Méndez, MC; Vigna-Pérez, M | 1 |
| Castillo, E; Coronel, J; Drobniewski, F; Gamarra, N; Luna, G; Mendoza, A; Mitchell, S; Moore, DA; Roper, M | 1 |
| Patra, S; Singh, V | 1 |
| Fabre, M; Hauck, Y; Pourcel, C; Soler, C; Vergnaud, G; Vong, R | 1 |
| Chen, L; Liu, P; Shen, M; Zhou, Z; Zou, F | 1 |
| Azevedo, V; Barnard, M; Coetzee, D; Coetzee, G; Cox, HS; Goemaere, E; McDermid, C; Muller, O; Simpson, J; van Cutsem, G | 1 |
| Brooks, EJ; De Groote, MA; Gilliland, JC; Gruppo, V; Lenaerts, AJ; Orme, IM; Peloquin, CA; Wells, CL; Woolhiser, LK | 1 |
| Kanade, S; Limaye, K; Mehta, P; Nataraj, G | 1 |
| Alvarado, M; Morales, S; Pérez, J; Ramos, W; Vílchez, R | 1 |
| He, H; He, Q; Hua, X; Liu, J; Shi, J; Wang, H; Ye, X; Zhang, L; Zhu, M | 1 |
| Chang, KC; Grosset, J; Leung, CC; Yew, WW | 1 |
| Archer, JA; Köser, CU; Summers, DK | 1 |
| Fujita, M; Ikegame, S; Kajiki, A; Nakanishi, Y; Wakamatsu, K | 1 |
| Blyn, LB; Ecker, DJ; Hofstadler, SA; Ivy, CA; Khechinashvili, G; Kreiswirth, BN; Kurepina, N; Li, H; Lovari, R; Massire, C; Sampath, R; Stratton, CW; Tang, YW | 1 |
| Alffenaar, JW; de Neeling, H; Simons, S; van de Kasteele, PJ; van der Laan, T; van der Werf, TS; van Soolingen, D | 1 |
| Ishimaru, D; Ito, Y; Ogawa, H; Shimizu, K | 1 |
| Acurio, M; Asencios, L; Bonilla, C; Castillo, E; Coronel, J; Gamarra, N; Huamán, T; Mendoza, A; Monroi, Y; Moore, DA; Obregón, G; Perea, M; Roper, M; Salazar, R | 1 |
| Bartlett, G; Menzies, D; Schwartzman, K; Smith, BM | 1 |
| Bhanot, N | 1 |
| Ahmad, S; Al-Mutairi, NM; Mokaddas, E | 1 |
| Kaur, G; Mehta, SK | 2 |
| Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
| Jiang, J; Liu, P; Zhu, Q | 1 |
| Angrup, A; Banavaliker, JN; Bose, M; Kumar, S; Pathak, RK; Sharma, H; Varma-Basil, M | 1 |
| Ahmad, Z; Almeida, DV; Converse, PJ; Grosset, JH; Li, SY; Nuermberger, EL; Peloquin, CA; Rosenthal, IM; Zhang, M | 1 |
| Chen, X; Feng, Y; Guo, N; Huang, F; Lai, R; Liu, J; Sun, Q | 1 |
| Beloncle, C; Bosdure, E; Chadelat, K; Dagorne, M; Dubus, JC; Gaudelus, J; Losi, S; Renoux, MC; Salles, M; Tochon, M; Veziris, N | 1 |
| Aydın, F; Bayramoğlu, G; Buruk, K; Dede, R; Dinç, U; Kaklıkkaya, N; Köse, T; Ozkul, G | 1 |
| Abdi, Z; Rasoolinejad, M; Soleimani, A | 1 |
| Bello, T; Chirinos, G; De Donato, M; de Waard, JH; Mendoza, R; Takiff, H | 1 |
| Asencios, L; Atwood, S; Bayona, J; Bonilla, C; Cegielski, JP; Contreras, CC; Jave, HO; Shin, SS; Suárez, C; Velásquez, GE; Yagui, M; Yale, G | 1 |
| Cataldi, AA; Imperiale, BR; Morcillo, NS | 1 |
| Khajotia, R; Manthari, K | 1 |
| Keino, H; Nakashima, C; Okada, AA; Taki, W; Watanabe, T | 1 |
| Chen, X; Duan, ZH; Wang, H; Xu, DX; Xu, J; Xu, JM; Yu, T; Zhang, C; Zhang, Y; Zhao, M | 1 |
| Fortes-Alen, J; Gómez-Escolar, PF; Gómez-Seco, J; Presa-Abos, T; Rodríguez-Guzmán, MJ; Rodríguez-Nieto, MJ | 1 |
| Cherednichenko, AG; Dymova, MA; Filipenko, ML; Khrapov, EA; Kinsht, VN; Svistelnik, AV | 1 |
| Dymova, MA; Filipenko, ML; Khrapov, EA; Krutko, VS; Liashenko, OO; Poteiko, PI | 1 |
| DeGroote, MA; Gilliland, JC; Kendall, LV; Lenaerts, AJ; Magden, ER; Weiner, CM | 1 |
| Abourashed, EA; Galal, AM; Shibl, AM | 1 |
| Asiimwe, BB; Bazira, J; Bwanga, F; Joloba, ML; Matee, MI | 1 |
| Kalimuthu, G; Karunakaran, G; Muthumanikkam, A; Parameswari S, A; Sundarapandian, R; Thattakudian Sheik Uduman, MS; Vasanthi Srinivas, TR | 1 |
| Hari, DT; Mohapatra, PR | 1 |
| Agarwal, N; Kriplani, A; Kulshrestha, V; Rana, T; Singh, UB | 1 |
| Mbassi Fouda, FL; Mulliez, P; Roy Saint-Georges, F | 1 |
| Anyo, G; Burgos, M; Cook, SV; Enarson, DA; Jindani, A; Kim, SJ; Lienhardt, C; Nunn, AJ; Rigouts, L; Yorke-Edwards, V | 2 |
| Horsburgh, CR; Rubin, EJ | 1 |
| Ambrose, PG; Bhavnani, SM; Caws, M; Chau, TT; Dung, NT; Farrar, J; Hammel, JP; Hien, TT; Kulawy, R; Mai, PP; Reynolds, DK; Thwaites, GE; Török, ME; Van Wart, SA | 1 |
| Thakur, BK; Verma, S | 1 |
| Alegre de Miquel, V; Martínez Casimiro, L; Vilata Corell, JJ | 1 |
| Laurenzo, D; Mousa, SA | 1 |
| Ha, KY; Oh, IS | 1 |
| Anupurba, S; Gupta, A; Mohapatra, TM; Sen, MR | 1 |
| Abes, FL; Abes, GT; Jamir, JC | 1 |
| Chen, YL; Chiang, CJ; Chiang, YL; Huang, ST; Sun, FM; Tsai, CM; Weng, CJ | 1 |
| Bayhan, GI; Ekşioğlu, AS; Kitiş Çelik, B; Tanır, G | 1 |
| Hossain, A; Hossain, M; Islam, S; Khalil, I; Mottalib, A | 1 |
| Abdurrahman, ST; Cuevas, LE; Dacombe, R; David, JS; Davies, PD; Ebisike, JN; Emenyonu, N; Lawson, L; Lawson, LO; Ouoha, JO; Parry, CM; Sogaolu, OM; Uzoewulu, GN; Yassin, MA | 1 |
| Batchoun, R; Nimri, L; Samara, H | 1 |
| Kononova, TE; Naslednikova, IO; Novitsky, VV; Serebryakova, VA; Urazova, OI; Vasilyeva, OA | 1 |
| Enarson, DA; Jindani, A; Nunn, AJ | 1 |
| da Silva, PE; Martin, A; Palomino, JC; Ramos, DF; Ribeiro, AW; Ribeiro, MO; Rossetti, ML; Spies, FS; Zaha, A | 1 |
| Wilson, ML | 2 |
| Duo, LN; Fan, H; Lu, XJ; Song, XB; Wang, LL; Wang, TT; Xie, Y; Ying, BW; Zhang, L | 1 |
| Menzies, D; Smith, BM | 1 |
| Akhmetova, A; Alenova, A; Belova, E; Bismilda, V; Chingissova, L; Ismailov, S; Kozhamkulov, U; Momynaliev, K; Rakhimova, S; Ramanculov, E | 1 |
| Anand, A; Datye, AS; Inamdar, V; Iyer, R; Kale, V; Kanoj, DM; Khillare, KM; Manoj, MM; Pereira, M; Risbud, AR; Thakar, M; Tripathy, S | 1 |
| Bifani, P; Camacho, L; Dartois, V; Foo, DG; Hervé, M; Siew, JY; Singhal, A; Tay, HC | 1 |
| da Silva Junior, GB; Daher, Ede F; de Oliveira, JL | 1 |
| Amarti, A; Baybay, H; Bounouar, M; Chraibi, M; Gallouj, S; Harmouch, T; Mernissi, F; Meziane, M; Mikou, O | 1 |
| Connolly, C; Friedland, G; Gandhi, N; Moodley, P; Shah, NS; Sturm, AW; Tayob, N; Zetola, N | 1 |
| Akgunes, A; Cayci, YT; Coban, AY; Deveci, A; Durupinar, B; Uzun, M | 1 |
| Jia, F; Li, X; Liu, X; Wang, Y; Zhang, Y; Zhao, L; Zhou, X | 1 |
| Achawal, S; Anderson, G; Lee, WY; Ling, M; Thaker, HK | 1 |
| Choonara, YE; du Toit, LC; Jarvis, DL; Khan, RA; Kumar, P; Murphy, CS; Ndesendo, VM; Pillay, V | 1 |
| Achi, VH; Ahui, BJ; Aka-Danguy, E; Anon, JC; Bemba, EL; Brou-Gode, VC; Demine, B; Horo, K; Kendja, K; Koffi, NB; Kouassi, AB; Motsebo, SF; N'gom, AS | 1 |
| Fletcher, S; Lambie, M; Maundrell, J; Roberts, P; Stein, A | 1 |
| Basra, D; Chonde, TM; De Rijk, P; Egwaga, SM; Hoza, AS; Rigouts, L; Torrea, G; Van Deun, A; van Leth, F; Zignol, M | 1 |
| Choi, WC; Hong, JH; Jeon, TJ; Kim, SY; Oh, TH; Seo, DD; Seo, JY; Shin, WC | 1 |
| Gallo, A; Hurwitz, M; Hwang, C; Mojtahed, A; Whitney, J | 1 |
| Baveja, CP; Bhalla, P; Gautam, H; Jha, H; Saini, S; Vidyanidhi, G | 1 |
| Cavalcanti, P; Giraldi, C; Ledonne, R; Mauro, MV; Sperlì, D | 1 |
| Leung, CC; Leung, EC; Leung, WM; Tam, CM; Yew, WW | 1 |
| Barnes, GL; Chaisson, RE; Gray, GE; Hausler, H; Martinson, NA; McIntyre, JA; Moulton, LH; Msandiwa, R; Ram, M | 1 |
| Churchyard, G; Nardell, E | 1 |
| Cen, S; Jia, PP; Li, XY; Liu, ZL; Wang, X; Yu, LY; Zhang, Q; Zhao, LL; Zhao, LX | 1 |
| Ferro, BE; Forero, L; Nieto, LM; Rozo, JC; van Soolingen, D | 1 |
| Coulter, C; Jia, Q; Jin, Q; Li, H; Li, L; Shi, D; Zhao, Y; Zhu, G | 1 |
| Kirmani, M; Lerra, S; Mir Qadri, S; Nazir, T | 1 |
| Chen, L; Li, N; Liu, M; Zhang, H; Zhang, J | 1 |
| Abbasi, S; Ikram, A; Khalid, MM; Manzar, MA; Sattar, A; Satti, L | 1 |
| Hsueh, PR; Huang, YT; Lai, CC; Liao, CH; Tan, CK | 1 |
| Cho, EH; Jeon, CY; Kang, H; Kim, H; Kim, M; Murray, MB; Park, YK | 1 |
| Marcoval, J | 1 |
| Ausina, V; Domínguez, J; García-Sierra, N; Gavin, P; Haba, L; Lacoma, A; Maldonado, J; Prat, C; Ruiz-Manzano, J; Samper, S | 1 |
| Bouhasan, L; Consunji-Araneta, R; Higgins, R; Qing, G | 1 |
| Colucci, G; Silzle, T; Solenthaler, M | 1 |
| Falzon, D; Menzies, D; Oxlade, O | 1 |
| Dubois Cauwelaert, N; Ramarokoto, H; Rasolofo, V; Ravololonandriana, P; Richard, V | 1 |
| Chen, X; Gilbert, GL; Kong, F; Li, C; Wang, Q; Zhang, J | 1 |
| Kuwabara, K | 1 |
| Aïssi, E; Ettahar, N; Huleux, T; Massongo, M; Melliez, H; Pasquet, A; Yazdanpanah, Y | 1 |
| Bridevaux, PO; Fresard, I; Janssens, JP; Rochat, T | 1 |
| Liu, Y; Zhang, J; Zhang, M | 1 |
| Cardoso, RF; de Melo, FA; Hirata, MH; Leite, CQ; Marino, LB; Miyata, M; Pavan, FR; Sato, DN; Zanelli, CF | 1 |
| Barbedo, J; Centis, R; D'Ambrosio, L; Diogo, N; Fernandes, L; Lange, C; Migliori, GB; Raymundo, E; Sotgiu, G; Villar, M | 1 |
| Gumbo, T; Leff, R; Meek, C; Sherman, C; Srivastava, S | 1 |
| da Costa, FS; de Lima, KM; de Morais, SC; de Oliveira Neves, AC; Porto, DL; Soares, GM | 1 |
| Eide, GE; Kielland, LG; Naess, A; Sørnes, S; Vage, RA | 1 |
| Aggarwal, N; Arya, A; Baghel, AS; Bose, M; Gupta, G; Nath, M; Parmar, VS; Pathak, R; Ponnan, P; Prasad, AK; Raj, HG; Tandon, R | 1 |
| Aono, A; Chikamatsu, K; Mitarai, S; Mizuno, K; Nishiyama, H; Sugamoto, T; Yamada, H | 2 |
| Almendarez, N; Hoffner, SE; Membreño, H; Pineda-Garcia, L; Rosales, S | 1 |
| Huang, YH; Ko, JH; Lu, CF; Shih, YC; Yang, CH | 1 |
| Donald, PR; Hesseling, AC; Magdorf, K; Roll, S; Rosenkranz, B; Schaaf, HS; Seddon, JA; Seifart, HI; Thee, S; Werely, CJ | 1 |
| Aarnoutse, RE; Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Mpagama, S; Mtabho, C; Mwaigwisya, S; Ndusilo, N; Pholwat, S | 1 |
| George, JM; Rodvold, KA; Yoo, L | 1 |
| Barry, CE; Dartois, V; Goh, A; Kern, S; Kjellsson, MC; Low, KM; Pillai, G; Via, LE; Weiner, D | 1 |
| Byun, J; Daskalaki, I; Dogbey, MC; Tolbert-Warren, C; Watson, BM | 1 |
| Badri, T; Belghith, I; Benmously, R; Mokhtar, I; Zaiem, A | 1 |
| Malhotra, A; Manchanda, Y; Mittal, R; Ramam, M; Ramesh, V; Sharma, S; Tejasvi, T | 1 |
| Alves, SL; Araújo-Filho, JA; Junqueira-Kipnis, AP; Kipnis, A; Metzker, FS | 1 |
| Gumbo, T; Leff, R; Meek, C; Pasipanodya, JG; Srivastava, S | 1 |
| Bonkoungou, V; Carvalho, AC; Comelli, M; Cusato, M; Dembélé, SM; Kouanda, S; Matteelli, A; Nacanabo, R; Regazzi, M; Saleri, N; Villani, P | 1 |
| Imanishi, H; Ishii, M; Mizuno, N; Nakagawa, K; Oshimo, T; Sowa, J; Tsuruta, D | 1 |
| Dahal, K; Khattri, S; Kushawaha, A; Lee, M; Mobarakai, N | 1 |
| Majeed, A; Marnewick, J; Peck, MT; Stephen, LX | 1 |
| Jaka-Moreno, A; López-Núñez, M; López-Pestaña, A; Tuneu-Valls, A | 1 |
| Deriemer, K; Flood, JM; Pascopella, L; Watt, JP | 1 |
| Cifuentes, C; García, M; Losada, I; Martín, C | 1 |
| Biçmen, C; Demirci, M; Gül Yurtsever, S; Gündüz, AT; Ozkütük, N; Salman, S | 1 |
| Bedotto, M; Ben Kahla, I; Ben Selma, W; Boukadida, J; Cohen-Bacrie, S; Drancourt, M; Henry, M; Marzouk, M | 1 |
| Cavanaugh, JS; Cegielski, JP; Kurbatova, EV; Smith, SE | 1 |
| De Groote, MA; Gilliland, JC; Gruppo, V; Lenaerts, AJ; Orme, IM; Woolhiser, LK | 1 |
| Bliven-Sizemore, E; Borisov, AS; Bozeman, L; Chaisson, RE; Conde, MB; Gordin, F; Hackman, J; Hamilton, CD; Horsburgh, CR; Kerrigan, A; Menzies, D; Shang, N; Sterling, TR; Villarino, ME; Weiner, M; Weis, SE; Wing, D | 1 |
| Dye, C | 1 |
| Alvarez, C; Imaz, MS; López, M | 1 |
| Cassano, R; Fadda, AM; Ferrarelli, T; Giraldi, C; Manconi, M; Mauro, MV; Picci, N; Trombino, S | 1 |
| Cuong, NH; Ha, CH; Le, TH; Lien, VT; Mai, CT; Minh, NN; Son, NT; Van Bac, N | 1 |
| Aldridge, BB; Ambravaneswaran, V; Fernandez-Suarez, M; Fortune, SM; Heller, D; Irimia, D; Toner, M | 1 |
| Aarnoutse, R; Boeree, M; Ijdema, D; Magis-Escurra, C; van den Boogaard, J | 1 |
| Adali, G; Çolak, Y; Enç, F; Kiziltaş, Ş; Öztürk, O; Tuncer, İ; Ulaşoğlu, C; Yorulmaz, E | 1 |
| Anthony, R; Bergval, I; Klatser, P; Kremer, K; Kwok, B; Schuitema, A; van Soolingen, D | 1 |
| Abbassi, H; Aboulfalah, A; Benkaddour, YA; Fakhir, B; Fichtali, K | 1 |
| de Rijk, P; Fissette, K; Martin, A; Palomino, JC; Ramos, E | 1 |
| Beylis, N; Chihota, VN; Churchyard, GJ; Dorman, SE; Fielding, KL; Grant, AD; Lewis, JJ; Mathema, B; van der Meulen, M | 1 |
| Kariuki, S; Ndung'u, PW; Ng'ang'a, Z; Revathi, G | 1 |
| Ackart, D; Basaraba, RJ; Caraway, ML; Hascall-Dove, L; Henao-Tamayo, M; Ordway, DJ; Orme, EA; Orme, IM; Shang, S; Shanley, CA | 1 |
| D'souza, DT; Mistry, NF; Tolani, MP | 1 |
| Eisenberg, N; Govender, K; Hartman, TE; Hatfull, GF; Jacobs, WR; Jain, P; Kriakov, J; Larsen, MH; Makume, M; Moodley, P; O'Donnell, MR; Sturm, AW; Thaler, DS | 1 |
| Aspler, A; Esfahani, K; Menzies, D; Schwartzman, K | 1 |
| Agúndez, JA; Botana-Rial, M; Constenla, L; Fernández-Villar, A; Leiro-Fernandez, V; Valverde, D; Vázquez-Gallardo, R | 1 |
| Allerheiligen, V; Crudu, V; Hillemann, A; Moraru, N; Romancenco, E; Stratan, E | 1 |
| Diao, N; Fan, X; Hu, P; Jin, J; Shao, L; Wang, F; Wang, S; Weng, X; Zhang, W; Zhang, Y | 1 |
| Beer, J; Emmrich, F; Rodloff, AC; Sack, U; Tessema, B | 1 |
| Al-Hajoj, S; Al-Omari, R; Al-rabiah, F; Hillemann, A; Shoukri, M; Varghese, B; Wijayanti, DR | 1 |
| Cui, YY; Gui, J; Hu, SY; Li, QG; Liu, XL; Wang, F; Yang, H | 1 |
| Peloquin, CA | 1 |
| Chen, XY; Wu, RH; Zeng, YM | 1 |
| Fukushima, K; Higuchi, N; Inamine, T; Kohno, S; Kondo, S; Mawatari, T; Nakaura, A; Nanashima, K; Suyama, N; Tahara, N; Tsukamoto, K; Yanagihara, K | 1 |
| González-Martín, J; Martínez, JA; Rey-Jurado, E; Tudó, G | 1 |
| Clemens, DL; Ferris, D; Horwitz, MA; Lee, BY; Meng, H; Nel, AE; Thomas, CR; Xue, M; Zink, JI | 1 |
| Berrada, S; El Kandry, S; Ennafae, I; Kechna, H; Mountassir, M | 1 |
| Cuellar, A; Cuevas-Cordoba, B; Enciso, A; Enciso, L; Zenteno-Cuevas, R | 1 |
| Coban, AY; Ikram, A; Martin, A; Satti, L | 1 |
| Angheben, A; Boriani, L; Gasbarrini, A; Luzi, CA; Marocco, S; Rigotti, S; Zorzi, C | 1 |
| Chitnis, DS; Hemvani, N; Patidar, V | 2 |
| Caws, M; Dai, VH; Dang, TM; Farrar, J; Hoang, TT; Nguyen, HD; Nguyen, TB; Nguyen, TN; Nguyen, TP; Phan, TH; To, MH; Tran, VQ; Vo, SK; Vo, TH; Vuong, MB; Wolbers, M | 1 |
| Angoulvant, F; Aujard, Y; Chadelat, K; De Lauzanne, A; Faye, A; Gaudelus, J; Grimprel, E; Houdouin, V; Kheniche, A; Lorrot, M; Mesples, B; Nouyrigat, V; Perry, A | 1 |
| Arévalo Gómez, A; Llinares Modejar, P; Sánchez Vidal, E; Servia Dopazo, M | 1 |
| Chan, PC; Chang, LY; Fang, CT; Hsueh, PR; Huang, LM; Lu, BY; Lu, CY; Shao, PL; Wang, KF; Yang, CH | 1 |
| Connolly, C; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, PC; Pym, A; Rida, W; Rustomjee, R; Smith, PJ; Vahedi, M | 1 |
| Ahuja, SD; Anger, HA; Harris, TG; Kreiswirth, BN; Li, J; Proops, D; Shashkina, E | 1 |
| Chen, L; Goldenson, J; Kawamura, LM; Lee, JR; Spetz, J; Tulsky, JP; White, MC | 1 |
| Choonara, YE; du Toit, LC; Kumar, P; Pillay, V; Shaikh, RP | 1 |
| Becker, P; Dawson, R; Diacon, AH; Donald, PR; du Bois, J; Erondu, N; Ginsberg, AM; Narunsky, K; Spigelman, MK; van Niekerk, C; Venter, A | 1 |
| Chen, PC; Lee, CH; Wang, JD | 1 |
| Rao, ChV; Rawat, AK; Singh, A; Singh, AP; Verma, N | 1 |
| Hou, YN; Tang, JH; Wu, HH; Zhan, ZL; Zhang, XL; Zhang, ZH | 1 |
| Aarnoutse, RE; Bakker-Woudenberg, IA; Boeree, MJ; de Knegt, GJ; de Steenwinkel, JE; Kremer, K; ten Kate, MT; van Soolingen, D; Verbrugh, HA | 1 |
| Amoabeng, O; Andries, K; Mdluli, KE; Minkowski, A; Nuermberger, EL; Peloquin, CA; Taylor, D; Wallis, RS; Williams, K | 1 |
| Bang, ND; Caws, M; Day, J; Dung, NH; Farrar, J; Kiet, VS; Lan, NT; Tho, DQ; Török, ME; van Vinh Chau, N; Wolbers, M; Yen, NT | 1 |
| Altpeter, E; Bodmer, T; Borrell, S; Böttger, EC; Bruderer, T; Calmy, A; Dubuis, O; Egger, M; Fehr, J; Fenner, L; Furrer, H; Gagneux, S; Jaton, K; Ninet, B; Pfyffer, GE; Siegrist, HH; Stalder, JM; Zwahlen, M | 1 |
| Friedrich, C; Grundmann, K | 1 |
| Block, C; Caviedes, L; Elinav, H; Kalter, HD; Lemma, E; Maayan, S; Moulton, LH; Rajs, A | 1 |
| Amaral, L; Baptista, P; Couto, I; Machado, D; Perdigão, J; Portugal, I; Rodrigues, L; Veigas, B; Viveiros, M | 1 |
| Johnson, JR | 1 |
| Mirsaeidi, M | 1 |
| Cohen, T; Furin, J; Gegia, M; Kalandadze, I; Vashakidze, L | 1 |
| Acurio, M; Asencios, L; Cáceres, O; Galarza, M; Leo, E; Mendoza-Ticona, A; Quispe, N; Ramírez, J; Salazar, R; Valencia, E; Vásquez, L | 1 |
| Angeby, K; Chryssanthou, E | 1 |
| Cajigas-Pezo, D; Lorenzo-Hernandez, A; Rentero-Martínez, Z; Vives-Rivero, GR | 1 |
| Fraisse, P | 1 |
| Dutta, NK; Grosset, JH; Illei, PB; Karakousis, PC; Mdluli, KE; Nuermberger, EL; Peloquin, CA; Pinn, ML | 1 |
| Garg, PK; Kumar, A | 1 |
| Bhat, S; Kotian, M; Radhakrishna, M; Rao, S | 1 |
| D'Meza, R; Escuyer, VE; Fitzgerald, DW; Gauthier, M; Joseph, P; Morose, W; Ocheretina, O; Pape, JW; Rastogi, N; Vernet, G | 1 |
| Sarkar, D; Sarkar, S | 1 |
| Abdissa, A; Abdissa, K; Abebe, G; Agonafir, M; Apers, L; Colebunders, R; de-Jong, BC | 1 |
| Person, AK; Sterling, TR | 1 |
| Hesseling, AC; Jordaan, A; Marais, BJ; Schaaf, HS; Seddon, JA; Victor, T | 1 |
| Chihota, VN; Churchyard, GJ; Fielding, KL; Grant, AD; Lewis, JJ; van Halsema, CL | 1 |
| Ahmed, OI; El-Moghazy, EH; Faramawy, MA; Hafez, SF; Hashem, M; Khalifa, MA; Khater, WS; Mohamed, MI; Rasslan, O; Saleh, DA; Shoukry, FA | 1 |
| Lee, SH; Lee, SW; Yim, JJ | 1 |
| Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
| Behera, D; Gupta, R; Jaiswal, A; Kumar, L; Murar, A; Puri, MM | 1 |
| Carvalho, A; Correia, A; Duarte, R | 1 |
| Gönlügür, U; Koşar, S; Mirici, A | 1 |
| Arias, F; Barrera, L; Boulahbal, F; Cavanaugh, JS; Cegielski, JP; Coulter, C; Drobniewski, F; Kim, H; Kurbatova, EV; Lumb, R; Martín-Casabona, N; Metchock, B; Richter, E; Santos Silva, A; Shah, NS; Van Deun, A; Wright, A; Zemanova, I | 1 |
| Boehme, C; Nabeta, P; Rodrigues, C; Shetty, A; Vadwai, V | 1 |
| Almeida, D; Grosset, JH; Karakousis, PC; Mdluli, KE; Nuermberger, EL; Peloquin, CA; Rosenthal, IM; Tasneen, R; Zhang, M | 1 |
| Almeida, AC; Costa, JM; Galveia, JN; Guedes, ME | 1 |
| Barry, CE; Cai, Y; Carny, JE; Dartois, V; Dayao, E; Dreher, MR; Flynn, JL; Herscovitch, P; Kastenmayer, RJ; Laymon, CM; Schimel, D; Via, LE; Weiner, DM; Yoon, YS | 1 |
| Fu, L; Jin, H; Li, P; Lu, Y; Mdluli, K; Upton, AM; Wang, B; Xu, J; Zhao, W; Zheng, M; Zhu, H | 1 |
| Ghoury, I; Habous, M; Hebbo, B; Madania, A; Zarzour, H | 1 |
| Mitruka, K; Winston, CA | 1 |
| Castelnuovo, B; Hermans, SM; Kuznik, A; Lamorde, M; Manabe, YC; Mullins, CD | 1 |
| Dhatwalia, SK; Gupta, D; Mewara, A; Sethi, S; Sharma, M; Yadav, R | 1 |
| Fitzgibbon, M; Foley, SC; Gibbons, N; Hayes, JP; Keane, J; McLaughlin, AM; Power, JT; Rogers, T | 1 |
| Balabanova, Y; Drobniewski, F; Evans, CA; Kummik, T; Mitchell, S; Nikolayevskyy, V; Toit, K | 1 |
| Della Pasqua, O; Sahota, T | 1 |
| Kim, CK; Ko, Y; Koh, WJ; Lee, NY; Park, KS | 1 |
| Ağca, S; Arda, H; Babalık, A; Bakırcı, N; Calışır, HC; Cetintaş, G; Kızıltaş, S; Oruç, K | 1 |
| Bravo, J; Chia, BS; Einarsson, V; Herrera, A; Ioerger, TR; Karakousis, PC; Kim, EY; Lanzas, F; Narayanaswamy, P; Pascale, JM; Rifat, D; Sacchettini, JC; Sailer, C; Torres-Chavolla, E | 1 |
| Nau, JY | 1 |
| Camacho Martínez, FM; Ferrándiz, L; Muniaín Ezcurra, MA; Pichardo, AR; Toledo-Pastrana, T | 1 |
| Aarnoutse, RE; Bakker-Woudenberg, IA; Boeree, MJ; de Knegt, GJ; de Steenwinkel, JE; den Bakker, MA; ten Kate, MT; van Soolingen, D; Verbrugh, HA | 1 |
| Bhatta, DR; Ghimire, P; Khadka, JB; Maharjan, B; Rai, SK; Shrestha, S | 1 |
| Peña-Santos, G; Ruiz-Moreno, JL | 1 |
| Jacobs, WR; Vilchèze, C | 2 |
| Green, E; Ndip, RN; Silaigwana, B | 1 |
| Afifi, S; Eissa, S; El-Dahshan, R; El-Sharif, A; Rafeh, N | 1 |
| Akgunes, A; Coban, AY; Durupinar, B; Uzun, M | 1 |
| Barría M, C; Nieme S, C; Varas M, C | 1 |
| Benoit, JP; Bertrand, JB; Coignard, S; Cosson, MA; Goulvestre, C; Martin, C; Morand, PC; Moro, MR; Picard, C; Poyart, C; Silvera, S; Veziris, N | 1 |
| Endtz, HP; Nakajima, C; Rahim, Z; Raqib, R; Suzuki, Y; van der Zanden, AG; Zaman, K | 1 |
| Chang, KC; Leung, CC; Leung, EC; Leung, WM; Tam, CM; Yew, WW; Zhang, Y | 1 |
| Cho, JE; Clark, TG; Cliff, JM; Constantinou, N; Dockrell, HM; Duncan, K; King, EC; Lee, JS; Lukey, PT; Ronacher, K; Van Helden, PD; Walzl, G | 1 |
| Baker, B; Cotton, MF; Diacon, AH; Harper, C; Hesseling, A; Macingwana, L; Ngwane, AH; van Helden, P; Wiid, I | 1 |
| Hestekin, CN; Krothapalli, S; May, MK | 1 |
| Anderson, AM; Kalokhe, AS; Lee, JC; Metchock, B; Nguyen, ML; Ray, SM; Shafiq, M; Wang, YF | 1 |
| Bhardwaj, A; Kumar, L; Murthy, RS; Narang, RK | 1 |
| Baldwin, SL; Bertholet, S; Coler, RN; Davis, C; Kahn, M; Orr, MT; Pine, SO; Reed, SG; Reese, V; Windish, HP | 1 |
| Allen, J; Bassett, IV; Chetty, S; Freedberg, KA; Giddy, J; Hom, JK; Losina, E; Mazibuko, M; Walensky, RP; Wang, B | 1 |
| Chandran, PA; Ismail, R; Jalalonmuhali, M; Lee, CK; Lee, YY | 1 |
| Cole, ST; Hartkoorn, RC; Lechartier, B | 1 |
| Gołąb, R; Hryncewicz-Gwóźdź, A; Jankowska-Konsur, A; Maj, J; Plomer-Niezgoda, E; Pluciński, P; Woźniak, Z | 1 |
| Crampin, AC; French, N; Glynn, JR; Houben, RM; Mboma, S; Mpunga, J; Mwaungulu, L; Mwaungulu, NJ; Mwenibabu, M; Mzemba, T | 1 |
| Bai, KJ; Chiang, CY; Hsu, YL; Lin, TP; Shih, HC; Yang, SL; Yen, MY; Yu, MC | 1 |
| Liu, XQ; Shi, XC; Xie, XL; Xu, YC; Zhao, ZX | 1 |
| Kano, T; Matsushima, M; Sasaki, H; Sato, K; Takahashi, I; Yabe, I; Yamada, M | 1 |
| Dejaegher, B; Kaale, E; Risha, PG; Shewiyo, DH; Smeyers-Verbeke, J; Vander Heyden, Y | 1 |
| Mimori, A; Takahashi, Y; Ueda, Y; Yamashita, H | 2 |
| Baldan, HM; Brunetti, IL; Campos, ML; Davanço, MG; de Pontes Machado, DV; Filho, MA; Padilha, EC; Peccinini, RG; Pires, RV | 1 |
| Jindal, N; Mehta, SK | 1 |
| Liu, J; Shao, L; Wang, X; Wang, Y; Xian, Q; Yang, Z; Zhang, Y | 1 |
| Balne, PK; Basu, S; Mittal, R; Sharma, S | 1 |
| Adán, A; González-Martin, J; Keller, J; Llorenç, V; Mesquida, M; Pelegrín, L; Rey, A | 1 |
| Aarnoutse, RE; Boeree, MJ; Burger, DM; Fillekes, Q; Kibiki, GS; Kisanga, ER; Kisonga, RM; Mleoh, L; Mtabho, CM; Ndaro, A; Semvua, HH; van den Boogaard, J; van der Ven, A | 1 |
| Chauhan, LS; Jain, NK; Mohan, A; Sharma, SK; Solanki, R | 1 |
| Aggarwal, T; Sharma, C; Sharma, M; Sharma, V; Shekhar, S | 1 |
| González, C; Herrmann, E; Jajati, M; Kaplan, P; Monzón, D; Sáenz, C | 1 |
| Byers, P | 1 |
| Aarnoutse, RE; de Groot, R; de Waard, JH; García, JF; Hermans, PW; López, D; Verhagen, LM; Warris, A | 1 |
| Cegielski, JP; Kurbatova, EV; Taylor, AB | 1 |
| Fukasawa, LO; Gonçalves, MG; Harrison, LH; Oliveira, RS; Sacchi, CT; Salgado, MM; Shutt, KA | 1 |
| Cheng, P; Hou, T; Li, L; Luo, F; Wu, F; Wu, Z; Xu, J; Zhang, Z; Zhong, M | 1 |
| Chalmers, JD; Gilhooley, S; Hill, AT; Jones, ME; Laurenson, IF; McSparron, C; Tiernan, JF | 1 |
| Elson, I; Friedland, G; Gandhi, NR; Kreiswirth, BN; Mathema, B; Moll, AP; Moodley, P; Ramathal, M; Rothenberg, R; Shah, NS; Shashkina, E; Sturm, AW; Weissman, D | 1 |
| Rätsep, T | 1 |
| Chigutsa, E; Denti, P; Karlsson, MO; Kirkpatrick, CM; Maartens, G; McIlleron, H; Patel, K; Visser, M | 1 |
| Bonovas, S; Lytras, T; Panagiotopoulos, T; Spala, G | 1 |
| Akçalı, A; Akman, T; Değirmenci, Y; Karatağ, O; Koşar, S; Sener, A | 1 |
| Caminero, JA; Ferro, BE; Forero, L; Martínez, E; Moreira, CA; Perez-Velez, CM; Rastogi, N; Villegas, SL | 1 |
| Lu, J; Pang, Y; Song, Y; Wang, S; Wang, Y; Zhao, Y | 1 |
| Benard, G; Miyamoto, D; Naafs, B; Sakai-Valente, NY; Trindade, MÂ; Vasconcelos, Dde M | 1 |
| Dara, M; Falzon, D; Floyd, K; Glaziou, P; Sismanidis, C; Zignol, M | 1 |
| Coetzee, G; Dorman, SE; Erasmus, L; Golub, JE; Hanrahan, CF; Koornhof, H | 1 |
| Fasih, N; Hasan, R; Jabeen, K; Rafiq, Y | 1 |
| Shaweno, D; Worku, A | 1 |
| Clotet, L; Domínguez, A; Ferrer, A; Garrido, P; Pina, JM; Sala, MR; Salleras, L | 2 |
| Lueangniyomkul, A; Mankatitham, W; Manosuthi, S; Manosuthi, W; Nilkamhang, S; Sukasem, C; Sungkanuparph, S; Thongyen, S | 1 |
| Chen, C; Ding, X; Li, G; Lu, W; Peng, H; Shao, Y; Shi, J; Song, H; Yang, D; Zhong, C; Zhou, Y; Zhu, L | 1 |
| Dalcolmo, MP; de Andrade Silva, BJ; de Oliveira, EB; Dos Santos, G; Milagres, A; Pinheiro, RO; Sampaio, EP; Sarno, EN; Sperandio da Silva, GM; Teles, RM | 1 |
| Gao, HY; Lai, YX; Li, WP; Lian, ZQ; Wang, Q; Xu, J; Yang, JM; Yu, HJ; Zhang, AQ; Zhu, CX | 1 |
| Albanna, AS; Cowan, D; Menzies, D; Smith, BM | 1 |
| Aggarwal, AN; Ahmed, Z; Gupta, D; Gupta, KB; Janmeja, AK; Jindal, SK; Kashyap, S; Mohan, A; Singh, M; Whig, J | 1 |
| Bate, R; Hess, K; Jensen, P; Milligan, J; Mooney, L | 1 |
| Bergmann, JF; Cambau, E; Evans, J; Hoang-Nguyen, DT; Lloret-Linares, C; Lopes, A; Mouly, S; Raskine, L; Sellier, P | 1 |
| Anupurba, S; Gupta, A; Prakash, P; Singh, SK | 1 |
| Barber, N; Doerholt, K; Le Doare, K; Sharland, M | 1 |
| Booysen, LL; Brooks, E; du Plessis, LH; Gilliland, J; Gruppo, V; Hansen, R; Kalombo, L; Kotze, AF; Lenaerts, A; Lungenhofer, P; Semete-Makokotlela, B; Swai, HS | 1 |
| Gochi, M; Kaneko, Y; Kinoshita, A; Kuwano, K; Saitou, Z; Samejima, T; Seki, A; Seki, Y; Takeda, H | 1 |
| Banavaliker, JN; Behera, D; Bhatnagar, AK; Hanif, M; Kaushik, A; Makkar, N; Pande, JN; Porwal, C; Singh, UB; Singla, R | 1 |
| Geetharani, A; Hemanth Kumar, AK; Nandhakumar, B; Nandini, R; Ramachandran, G; Srinivasan, R; Sugirda, P; Tharani, CB | 1 |
| Arora, J; Behera, D; Bhalla, M; Lal, P; Myneeedu, VP; Singhal, R | 1 |
| Garg, K; Mohapatra, PR | 1 |
| Coban, AY | 3 |
| Seear, M | 1 |
| Chee, CB | 1 |
| Altet-Gómez, MN; de Souza-Galvao, ML; Jiménez-Fuentes, MA; Mila Augé, C; Solsona Peiró, J | 1 |
| Agrela Rojas, E; Cuesta Hernández, M; Díaz Pérez, JÁ; Gómez Hoyos, E; Téllez Molina, MJ | 1 |
| Bhandari, R; Kaur, IP; Singh, H | 1 |
| Chen, M; Fu, L; Jin, H; Liu, C; Lu, Y; Wang, B; Xu, J; Zhao, W; Zheng, M; Zhou, L; Zhu, H | 1 |
| Cuello-García, CA; Jiménez Gutiérrez, C; Pérez-Gaxiola, G | 1 |
| Abuljadayel, N; Al-Hajoj, S; Al-Herbwai, M; Al-Omari, R; Al-Thawadi, S; Alrabiah, F; Alrajhi, AA; Memish, Z; Raviglione, MC; Shoukri, MM; Varghese, B; Zignol, M; Zumla, A | 1 |
| Vernon, A | 1 |
| Hara, M; Hatta, T; Ohtani, M; Sawada, K; Segawa, H; Ueno, R | 1 |
| Machado, TR; Maschmann, Rde A; Nunes, Lde S; Ribeiro, AW; Rossetti, ML; Sá Spies, F; Zaha, A | 1 |
| Anthony, RM; de Vos, AF; den Hertog, AL; Klatser, PR | 1 |
| Hishiki, H; Ichimoto, K; Ishiwada, N; Kinoshita, K; Kohno, Y; Nagasawa, K; Tokunaga, O | 1 |
| Cheng, J; Csanaky, IL; Gonzalez, FJ; Klaassen, CD; Li, F; Lu, J; Ma, X; Matsubara, T; Wang, L | 1 |
| Alpuche, C; Bäcker, CE; Balandrano, S; Bojorquez-Chapela, I; Castellanos, M; Díaz-Quiñonez, A; Hernández-Ávila, M; Hernández-Serrato, MI; López, A; López-Gatell, H; Orejel, I; Romero, M; Téllez-Rojo Solís, MM | 1 |
| Ali Aitbenasser, M; Benjelloun, A; Bouaity, B; Bouchentouf, R; Touati, M | 1 |
| Achour, A; El Barni, R; Lahkim, M | 1 |
| Cho, SN; Han, CD; Oh, T; Park, KK; Yang, JH | 1 |
| Ikram, A; Khan, FA; Martin, A; Palomino, JC; Satti, L | 1 |
| Graham, SM; Maeurer, M; Marais, BJ; Zumla, A | 1 |
| Flores-Treviño, S; Garza-González, E | 1 |
| Aguayo-Verdugo, Mdel R; Alegría-Morquecho, FM; Alvarez-Hernández, G; Bolado-Martínez, E; Candia-Plata, Mdel C; Pérez-Mendoza, A | 1 |
| Ayles, H; Beyers, N; Borgdorff, M; Claassens, M; den Haan, L; Dunbar, R; Enarson, D; Floyd, S; Godfrey-Faussett, P; van Helden, P; van Schalkwyk, C | 1 |
| Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S | 1 |
| Aljalil, A; Ammar, H; Bouaity, B; Bouchentouf, R; Chihani, M; Touati, M | 1 |
| Arif, MD; Faiyazuddin, MD; Gupta, RK; Hussain, A; Hussain, MD; Hussain, T; K, S; Khan, MS; Rao, CV | 1 |
| Braga, JU; da Conceição, DA; Trajman, A | 1 |
| Gelli, V; Manyam, R; Mutalik, SS; Mutalik, VS | 1 |
| Hsieh, CB; Hu, OY; Lee, HS; Shih, TY; Young, TH | 1 |
| Choi, Y; Jeon, BY; Kim, S; Lee, D; Lee, H; Munkhdelger, J; Park, KH; Park, S; Wairagu, PM; Wang, HY | 1 |
| Donald, PR; Schoeman, JF | 1 |
| Aarnoutse, RE; Boeree, MJ; Kibiki, GS; Mtabho, CM; Semvua, HH; Tostmann, A; van den Boogaard, J | 1 |
| Coghlan, B; Curtis, N; Gwee, A | 1 |
| Chikamatsu, K; Fujita, A; Matsumoto, T; Mitarai, S; Mizuno, K; Ogata, H; Saito, T; Suetake, T; Suzuki, K; Toyota, E | 1 |
| Banu Rekha, VV; Bhavani, PK; Hemanth Kumar, AK; Mathevan, G; Poorana Gangadevi, N; Ramachandran, G; Ramesh Kumar, S; Ravichandran, N; Sekar, L; Swaminathan, S; Vijayasekaran, D | 1 |
| Farnia, P; Hoffner, S; Masjedi, MR; Velayati, AA | 1 |
| Aarnoutse, R; Ascobat, P; Burhan, E; Donders, R; Ginanjar, A; Mangunnegoro, H; Ruesen, C; Ruslami, R; van Crevel, R | 1 |
| Buu, TN; Cobelens, FG; Dung, NH; Huyen, MN; Kremer, K; Lan, NT; Tiemersma, EW; van Soolingen, D | 1 |
| Ho, SC; Hsiong, CH; Hu, OY; Huang, TY; Shih, TY | 1 |
| Eeftinck Schattenkerk, JK; Rauws, EA; van Altena, R; van Steenwijk, RP; Veldhuis, S | 1 |
| Liu, P; Liu, Y; Ma, A; Wei, Q; Wu, X; Zhou, Z; Zou, F | 1 |
| Bandyopadhyay, D; Banerjees, S; Gupta, S; Sadhukhan, S | 1 |
| Antas, PR; Bastos, ML; Belo, MT; de Abreu, ST; Menzies, D; Teixeira, EG; Trajman, A | 1 |
| Almonte-Becerril, M; Bello-Monroy, O; Bucio, L; Clavijo-Cornejo, D; Enriquez-Cortina, C; Gómez-Quiroz, LE; Gutiérrez-Ruiz, MC; Hernández-Pando, R; López, A; Muñoz, L; Nuño, N; Palestino-Domínguez, M; Souza, V | 1 |
| Benson, SM; Narasimhamurthy, R | 1 |
| Bah-Sow, O; Gninafon, M; Horton, J; Lienhardt, C; Lo, MB; McIlleron, H; Merle, CS; Olliaro, PL; Rustomjee, R; Simonsson, US; Smith, P; Smythe, W | 1 |
| Ahmad, I; Barnes, SW; Batt, SM; Besra, GS; Chatterjee, AK; Franzblau, S; Fütterer, K; Halder, R; Hassani, M; Huszar, S; Jacobs, WR; Johnson, K; Johnsson, K; Kaneko, T; Kim, J; Ma, Z; Mdluli, KE; Mikusova, K; Robbins, SH; Sambandan, D; Schultz, PG; Trefzer, C; Walker, JR; Wang, F; Wang, J; Weinrick, B; Yang, P; Zhang, Y | 1 |
| Boerrigter, BG; van den Berk, GE; van Sandwijk, MS | 1 |
| Chawla, R; Jaiswal, S; Mishra, B | 1 |
| Camara, C; Furtado, A; Gerstoft, J; Katzenstein, TL; Lüneborg-Nielsen, M; Sodemann, M; Wejse, C | 1 |
| Allard, R; Rivest, P; Street, MC | 1 |
| Couvin, D; Dominguez, M; Gilman, RH; Grandjean, L; Luna, G; Moore, DA; Rastogi, N; Sheen, P; Zimic, M | 1 |
| Adatu-Engwau, F; Ahoua, L; Akeche, G; Ardizzoni, E; Bonnet, M; Martin, A; Salaniponi, F; Sanchez-Padilla, E; Sauvageot, D; Varaine, F | 1 |
| Cataldi, AA; Di Giulio, AB; Imperiale, BR; Morcillo, NS; Zumárraga, MJ | 1 |
| Kadhiravan, T; Sharma, A; Sharma, SK; Tharyan, P | 1 |
| Barry, PM; Flood, J; Hopewell, PC; Metcalfe, JZ; Pascopella, L; Porco, TC; Prach, LM | 1 |
| Alam, SM; Ali, A; Farooqi, JQ; Hasan, R; Hasan, Z; Khan, E | 1 |
| Denno, K; Horiki, M; Minoda, Y; Tada, K; Yano, K; Yoneda, M; Yoshida, T | 1 |
| Burger, A; Gumbo, T; McIlleron, H; Pasipanodya, JG; Smith, P; Wash, PA | 1 |
| Albanna, AS; Bachmann, K; Menzies, D; Valiquette, C; White, D | 1 |
| Gouya, L; Karim, Z; Lefebvre, T; Lyoumi, S; Puy, H | 1 |
| Han, SK; Kim, SY; Kim, YW; Lee, SM; Yang, SC; Yim, JJ; Yoo, CG | 1 |
| Cassano, R; Fadda, AM; Ferrarelli, T; Manca, ML; Manconi, M; Picci, N; Trombino, S; Valenti, D | 1 |
| Chandrasekaran, V; Dewan, P; Hemanth Kumar, AK; Ramachandran, G; Swaminathan, S; Thomas, A | 1 |
| Alarcón, V; Mendoza-Ticona, A; Moore, DA; Samalvides, F; Seas, C | 1 |
| Bhadauria, M; Jaswal, A; Shrivastava, S; Shukla, S; Sinha, N | 1 |
| Bachiyska, E; del Portillo, P; Gomgnimbou, MK; Hernández-Neuta, I; Martin, A; Palomino, JC; Panaiotov, S; Refregier, G; Sola, C | 1 |
| Fu, Z; Jia, L; Jing, L; Lian, Y; Liu, G; Peng, S; Wang, Y; Xu, P; Zhao, J | 1 |
| Arpag, H; Babalik, A; Bakirci, N; Capaner, E; Dagyildizi, L; Kuyucu, T; Ulus, IH | 1 |
| Calleja, S; Cordero-Coma, M; Franco, M; Garzo, I; Ruiz de Morales, JM; Salazar, R | 1 |
| Bertrand, J; Blanc, FX; Borand, L; Chea, P; Chou, M; Mentré, F; Nay, KH; Taburet, AM; Verstuyft, C | 1 |
| Alcántara, F; Atwood, SS; Becerra, MC; Bonilla, CA; Mitnick, CD; Seung, KJ | 1 |
| Cardone, M; Colasanti, P; Cordedda, M; Grande, A; Mozzillo, R; Zanchini, R | 1 |
| Abdissa, A; Abebe, M; Aseffa, A; Berg, S; Girma, T; Tsegaye, W; Workalemahu, B | 1 |
| Bozzola, E; Bozzola, M; Calcaterra, V; Lancella, L; Larizza, D; Magistrelli, A; Villani, A | 1 |
| Fueyo-Casado, A; Gonzalez-Lara, L; Vazquez-Lopez, F | 1 |
| Bodenmann, P; Daher, O; Langenskiold, E; Lutchmaya-Flick, C; Sarivalasis, A; Zellweger, JP | 1 |
| Chien, JY; Tsou, CC | 1 |
| Arora, SK; Hanif, M; Kumar, A; Myneedu, VP; Paramasivan, CN; Raizada, N; Sachdeva, KS; Sharma, R; Sharma, SK; Singh, BK; Sinha, S; Soneja, M; Sreenivas, V; Thakur, R; Vollepore, B; Yadav, RN | 1 |
| Gumbo, T; Leff, R; Meek, C; Musuka, S; Pasipanodya, J; Siyambalapitiyage Dona, CW; Srivastava, S | 1 |
| Biadglegne, F; Rodloff, AC; Sack, U; Tessema, B | 2 |
| Parekh, MJ; Schluger, NW | 1 |
| Caire Estévez, JP; González-Ocampo Dorta, S; Sanz Solana, P | 1 |
| Benzekri, A; Benzekri, L; El Amrani, F; Hassam, B; Khalil, F; Raffas, W; Tbatou, F | 1 |
| Alland, D; Armakovitch, S; Armstrong, DT; Barry, CE; Chien, G; Cho, SN; Dorman, SE; Ellner, JJ; Joloba, ML; Lee, J; Mboowa, G; Mumbowa, F; Nakayita, G; Namaganda, C; Park, JA; Ssengooba, W; Via, LE; Yu, Y | 1 |
| Bonilla, C; Caviedes, L; Coronel, J; Gianella, C; Herrera, C; Huancaré, V; Jave, O; Leo, E; Mendoza-Ticona, A; Moore, DA; Roper, MH; Sabogal, I; Tyas, A | 1 |
| Arpag, H; Babalık, A; Bakirci, N; Çarpaner, E; Dagyildiz, L; Kuyucu, T; Ulus, IH | 1 |
| Bark, CM; Boom, WH; Eisenach, KD; Gitta, P; Johnson, JL; Joloba, ML; Nsereko, M; Ogwang, S; Thiel, BA | 1 |
| Barry, CE; Cho, E; Cho, S; Hwang, S; Jeon, D; Kim, CT; Kwak, HK; Lee, J; Lee, JS; Lee, M; Shamputa, IC; Via, LE | 1 |
| Abd-El Aziz, AM; El-Shokry, MH; Nour, MS; Shehata, IH | 1 |
| de Castilla, DL; Jain, R; Limaye, AP; Narita, M; Rakita, RM; Spitters, CE | 1 |
| Andres, S; Hillemann, D; Richter, E; Rüsch-Gerdes, S | 1 |
| Metushi, IG; Uetrecht, J | 1 |
| Özkaya, E | 1 |
| Anuwatnonthakate, A; Chiengson, N; Inyaphong, J; Kaewkungwal, J; Kasetjaroen, Y; Kavinum, S; Limsomboon, P; Moolphate, S; Silachamroon, U; Suriyon, N; Tunteerapat, P; Varma, JK; Whitehead, SJ | 1 |
| Głowacki, J; Głowacki, M; Jagodziński, PP; Lehmann, TP; Misterska, E; Walczak, M | 1 |
| Ahui, BJ; Aka-Danguy, E; Anon, JC; Bakayoko, AS; Brou-Gode, VC; Horo, K; Itchy, MV; Koffi, MO; Kouassi, AB; N'Gom, AS; N'Goran, NB | 1 |
| Ando, H; Hang, NT; Hung, NV; Keicho, N; Kuwahara, T; Lien, LT; Sakurada, S; Thuong, PH; Thuy, TT | 1 |
| Diel, R; Loddenkemper, R; Migliori, GB; Sotgiu, G | 1 |
| Borisov, AS; Chesson, H; Heilig, CM; Holland, DP; Kerrigan, A; Mac Kenzie, WR; Marks, SM; Scott, N; Shang, N; Shepardson, D; Sterling, TR; Tian, X; Villarino, ME | 1 |
| Crownover, P; Jafri, I; Naqvi, A; O'Gorman, M; Wang, HF; Wang, R | 1 |
| Bozorg, BD; Dastan, F; Emami, S; Fahimi, F; Goodarzi, A; Habibi, M; Kobarfard, F; Salamzadeh, J; Shahsavari, N; Tabarsi, P | 1 |
| Chen, C; Liu, X; Rui, D; Wang, Y; Xu, X; Zhang, H; Zhao, H; Zheng, L; Zhu, M; Zhu, Z | 1 |
| Chen, TC; Chou, LT; Huang, CC; Lai, AB; Wang, JH | 1 |
| Chanez, P; Gouitaa, M; Neino Mourtala Mohamed, A; Tummino, C | 1 |
| Hosaka, K; Kurosawa, T; Nomi, F | 1 |
| Chen, GZ; Ding, BB; Guo, XK; Li, R; Li, Y; Wang, HH; Wen, ZL; Wu, H; Yao, YF; Yu, XL; Zhang, SL | 1 |
| Chen, S; Huai, P; Jiang, S; Li, J; Ma, W; Peng, Y; Wang, K; Wang, L; Wang, X; Wu, L; Yao, H; Zhong, J | 1 |
| Caminero, JA; Monedero, I | 1 |
| Cheng, W; Fan, J; Guo, N; Jin, K; Li, W; Shi, Q; Tang, X; Wu, J; Yu, L; Yuan, P; Zhang, Y; Zhao, X | 1 |
| Akkerman, OW; Alffenaar, JW; Bolhuis, MS; van Altena, R; van der Werf, TS | 1 |
| Aarnoutse, R; Burhan, E; Ruesen, C; Ruslami, R; van Crevel, R | 1 |
| Magaña-Aquino, M; Medellín-Garibay, SE; Milán-Segovia, RC; Romano-Moreno, S; Romero-Méndez, MC; Vargas-Morales, JM; Vigna-Pérez, M | 1 |
| Chang, TC; Hsu, ZJ; Huang, WL; Jou, R | 1 |
| Casal, M; Gutiérrez-Aroca, JB; Ruiz, P | 1 |
| Coban, AY; Uzun, M | 1 |
| Denkinger, CM; Dowdy, DW; Pai, M | 1 |
| Hocht, C; Moretton, MA; Sosnik, A; Taira, C | 1 |
| Chen, Z; Dong, Y; Huang, J; Huang, R; Jiao, Y; Liang, T; Lin, X; Zhang, S | 1 |
| Castells, M; Dioun, A; Logsdon, S; Ramirez-Avila, L | 1 |
| Chen, Y; Li, GL; Liu, HC; Liu, ZG; Sun, Q; Wan, KL; Wu, XC; Xia, Q; Zhao, LL; Zhao, XQ | 1 |
| Biswas, A; Makharia, GK; Satyaraddi, A; Sharma, A; Sharma, SK; Singh, S; Sinha, S; Sirohiwal, A; Velpandian, T; Vishnubhatla, S | 1 |
| Baptista, PV; Couto, I; Machado, D; Pedrosa, P; Veigas, B; Viveiros, M | 1 |
| Cao, M; Gu, J; Li, Y; Liu, W; Ma, J; Ma, L; Mao, Y; Merle, C; Milligan, P; Wang, Q; Wu, W; Wubuli, A; Xiang, Y; Xin, X; Yang, L; Yao, X; Zhu, X | 1 |
| Celiński, R; Kłopotowski, T; Miskiewicz, Ł; Motyka, S; Nowakowski, R; Pajak, J; Pawlas, N | 1 |
| Bandawane, DD; Bibave, KH; Jaydeokar, AV; Patil, TV | 1 |
| Ackart, DF; Basaraba, RJ; Caceres, SM; Hascall-Dove, L; Kirk, NM; Leid, JG; Melander, C; Nick, JA; Orme, IM; Podell, BK | 1 |
| Denti, P; Donald, PR; McIlleron, HM; Schaaf, HS; Seddon, JA; Seifart, HI; Simonsson, US; Smith, PJ; Thee, S; Zvada, SP | 1 |
| Cinel, G; Çobanoğlu, N; Doğru, D; Göçmen, A; Kiper, N; Köse, M; Koyun, M; Özçelik, U; Pekcan, S; Tana Aslan, A; Yalçın, E | 1 |
| Ishiguro, A; Katsuta, T; Kawai, T; Komuro, H; Miyairi, I; Morita, K; Nakazawa, Y; Ohya, Y; Onodera, M; Shoji, K; Takeda, K; Yamamoto, M | 1 |
| George, C; Kurup, R | 1 |
| Chen, X; Gilbert, GL; Jelfs, P; Kong, F; Li, C; Sun, Z; Wang, B; Yang, W | 1 |
| Chauhan, DS; Das, R; Dave, PV; Dewan, PK; Malhotra, B; Mundade, Y; O'Brien, R; Paramasivan, CN; Patel, P; Raizada, N; Ramachandran, R; Reddy, K; Sachdeva, KS; Sahu, S; Solanki, R; Wares, DF | 1 |
| Chen, W; Deng, CL; He, HY; Huang, YM; Li, Q; Sheng, YJ; Wu, G; Zhong, L; Zou, YS | 1 |
| Dadu, A; Dara, M; Dean, AS; Falzon, D; Floyd, K; Hoffmann, H; Hoffner, S; Kremer, K; Zignol, M | 1 |
| Aritomo, Y; Fujihara, S; Kamada, H; Kanaji, N; Katou, K; Kobara, H; Masaki, T; Mori, H; Nishiyama, N; Ono, M; Oryu, M; Rafiq, K | 1 |
| Driscoll, J; Hartline, D; Lentz, AJ; Metchock, B; Sikes, D; Starks, AM; Yakrus, MA | 1 |
| Amin, A; Barau, C; Barrail-Tran, A; Baudin, E; Bhatt, NB; Bonnet, M; Furlan, V; Grinsztejn, B; Meggi, B; Silva, C; Taburet, AM | 1 |
| Egelund, EF; Hunter, RP; Isaza, R; P Brock, A; Peloquin, CA | 1 |
| Daubercies, G; Mahé, E; Marchal, A; Sigal, ML; Sin, C; Tella, E | 1 |
| Czupryna, P; Grygorczuk, S; Guziejko, K; Kondrusik, M; Moniuszko, A; Pancewicz, S; Zajkowska, J | 1 |
| Bhoi, SK; Kalita, J; Misra, UK; Prasad, S | 1 |
| Kircher, J; Krauspe, R; Patzer, T; Richter, J; Ziskoven, C | 1 |
| Migliori, GB; Sotgiu, G | 1 |
| Dutta, NK; Karakousis, PC; Pinn, ML | 3 |
| Pal, P; Patra, SK; Ray, S | 1 |
| Almutairi, FE; Bourgea, J; Court, MH; Greenblatt, DJ; Hazarika, S; Klein, K; Kwara, A; Patten, CJ; Sheng, H; Zanger, UM | 1 |
| Dalla Costa, ER; Esteves, LS; Ferreira Junior, SL; Gomes, HM; Kritski, AL; Maschmann, Rde A; Oliveira, MM; Rossetti, ML; Santos, PG; Silva, MS; Suffys, PN | 1 |
| Bhattacharya, S; Choudhury, S; Das, A; Das, SK; Pandit, S | 1 |
| Bruiners, N; Gennaro, ML; Karakousis, PC; Pine, R; Pinn, ML; Skerry, C | 1 |
| Cheng, S; Du, X; Gao, T; Goel, S; Harries, AD; Lin, Y; Wang, L; Xia, Y; Zhang, Z | 1 |
| Garg, T; Goyal, AK; Gupta, P; Gupta, UD; Kaur, R; Malik, B; Rath, G | 1 |
| Elkington, PT; Friedland, JS; Gardiner, H; Kubler, A; Prasad, R; Singh, A; Singh, S; Singh, UK | 1 |
| Adrián Cataldi, A; Di Giulio, ÁB; Imperiale, BR; Morcillo, NS | 1 |
| Bock, N; Bozeman, L; Goldberg, SV; Hamilton, CD; Heilig, CM; Hershfield, E; Kyle, RP; Narita, M; Reves, R; Tapy, JM; Wing, D | 1 |
| MacKenzie, WR; Shepardson, D | 1 |
| Kedarisetty, CK; Khillan, V; Kumar, N; Kumar, S; Sarin, SK | 1 |
| de Melo Guedes de Oliveira, HM; de Oliveira, MM; Delogo, KN; Dos Anjos, MJ; Kritski, AL; Mesquita, ED; Miranda, PF; Moraes, ML; Netto, AR; Ramalho, DM | 1 |
| Fu, EQ; Jin, FG | 1 |
| Díaz, R; Echemendía, M; Lemus, D; Llanes, MJ; Llop, A | 1 |
| Chen, FC; Chen, YY; Dou, HY; Hsiung, CA; Huang, JM; Liao, YC; Lin, CH | 1 |
| Akçay, A; Arslan, K; Dündar, M; İşcan, KM; Kanbur, M; Karabacak, M; Sarıca, ZS; Taşçıoğlu, N | 1 |
| Das Gupta, U; Garg, T; Goyal, AK; Gupta, P; Kaur, R; Rath, G | 1 |
| Fahy, R; Keane, J; Lyons, J; McDonnell, C; McLaughlin, AM; Vandenberghe, E | 1 |
| Farrar, J; Nguyen Pouplin, J; Phuong, PN; Pouplin, T; Toi, PV | 1 |
| Abuljadayel, N; Al-Hajoj, S; Alhakeem, R; Alrabiah, F; Memish, Z; Shoukri, M; Varghese, B | 1 |
| Baykal, ES; Berktaş, M; Güdücüoğlu, H; Yaman, G | 1 |
| Bodmer, T; Chantana, Y; Laurent, D; Richner, B; Rieder, HL; Schopfer, K; Steinlin-Schopfer, JF; Studer, P; van Soolingen, D; Zwahlen, M | 1 |
| Fluegge, KR | 1 |
| Aonuma, H; Hatazi, O; Kobayashi, T; Ogura, S; Saitou, Y; Yamamoto, N | 1 |
| Burger, A; Gumbo, T; McIlleron, H; Pasipanodya, JG; Wash, P | 2 |
| Pasca, MR; Riccardi, G | 1 |
| Alfano, R; Caccavale, S; Caccavale, T; Capasso, R; Cozzi, R; La Montagna, M; Lo Schiavo, A; Mea, EE; Romano, F | 1 |
| Anupurba, S; Gupta, A; Kulkarni, S; Rastogi, N | 1 |
| Abubakar, I; Harris, RJ; Lipman, MC; Muñoz, L; Stagg, HR; Zenner, D | 1 |
| Farhan, N; Kawde, AN; Temerk, Y | 1 |
| Baskaran, UL; Martin, SJ; Sabina, EP; Vedi, M | 1 |
| Natham, R; Rajaram, S; Vemuri, VD | 1 |
| Al-Dwibe, H; Amro, A; El-Zubi, S; Gashout, A; Morogum, AM | 1 |
| Alkhovik, OI; Cherednichenko, AG; Dymova, MA; Filipenko, ML; Khrapov, EA; Petrenko, TI | 1 |
| Bhembe, NL; Govender, S; Green, E; Hayes, C; Ndip, RN; Nwodo, UU; Okoh, AI | 1 |
| Chen, C; Ding, X; Kong, W; Li, G; Liu, Q; Lu, W; Peng, H; Shao, Y; Shi, J; Song, H; Yang, H; Yu, H; Zhong, C; Zhou, Y; Zhu, L | 1 |
| Byeon, JS; Jo, KW; Jung, YJ; Kim, HC; Kim, KJ; Kim, YG; Lee, CK; Shim, TS; Yang, SK; Ye, BD; Yoo, B | 1 |
| Crook, AM; Gillespie, SH; McHugh, TD; Mendel, CM; Meredith, SK; Murray, SR; Nunn, AJ; Pappas, F; Phillips, PP | 1 |
| Abate, D; Ameni, G; Meressa, D; Tedla, Y | 1 |
| Monforte Cirac, ML; Samper Blasco, S; Vidal García, M | 1 |
| Abimbola, T; Bennett, R; Date, A; Granich, R; Gupta, S; Sangrujee, N; Suthar, AB | 1 |
| Arora, J; Bhalla, M; Couvin, D; Myneedu, VP; Rastogi, N; Sarin, R; Sharma, S; Sidiq, Z; Singhal, R | 1 |
| de Droogh, E; Groenen, G; Mathys, V; Soetaert, K; van de Vyvere, M | 1 |
| Ardrey, A; Davies, G; Jave, O; López-Romero, SL; Moore, DA; Requena-Méndez, A; Ward, SA; Waterhouse, D | 1 |
| Castillo, E; Caviedes, L; Coronel, J; Crudder, C; Faulx, D; Friedland, JS; Gilman, RH; Grandjean, L; Martin, L; Metzler, M; Moore, DA; Rodriguez, M; Valdez, M | 1 |
| Fang, F; Guo, J; Liu, Y; Qu, J; Yu, Q; Zhang, JH; Zhao, P | 1 |
| Mokry, J; Porvaznik, I; Solovic, I | 1 |
| Azad, UP; Ganesan, V; Prajapati, N | 1 |
| Hung, DZ; Kao, CH; Lim, YP; Lin, CL; Lin, YN | 1 |
| Baena, IG; Falzon, D; Floyd, K; Jaramillo, E; Linh, N; Mirzayev, F; Raviglione, M; Wares, F; Weyer, K; Zignol, M | 1 |
| Dutta, NK; Karakousis, PC | 2 |
| Cao, X; Wei, K; Wei, X; Xu, W; Zhong, S | 1 |
| Ceyhan, B; Eryuksel, E; Giral, A; Ozdogan, OC; Yegin, EG | 1 |
| Boum, Y; Katawera, V; Siedner, M | 1 |
| Bhattacharya, B; Chakraborty, U; Das, A; Das, S; Dey, SK; Goswami, A; Mahapatra, S; Mahapatra, T; Mukherjee, T; Pal, NK; Ray, S | 1 |
| Elnour, T; Frick, M; Lee, C; McKenna, L; Seaworth, B | 1 |
| Basso, LA; Batista, EL; Campos, MM; Dias, AC; Leite, CE; Nicoletti, NF; Rodrigues-Junior, V; Santos, AA; Santos, DS; Souto, AA | 1 |
| Sharma, S; Singh, A | 1 |
| Chigutsa, E; Gumbo, T; McIlleron, H; Pasipanodya, JG; Sirgel, FA; Smith, PJ; van Helden, PD; Visser, ME | 1 |
| Bhatnagar, S; Faurholt-Jepsen, D; Friis, H; Grewal, HM; Kabra, SK; Lodha, R; Mukherjee, A; Saini, S; Singh, S; Singh, V | 1 |
| Amukoye, E; Bah, B; de Jong, BC; Fielding, K; Gninafon, M; Horton, J; Kassa, F; Lapujade, O; Lienhardt, C; Lo, MB; Merle, CS; Mthiyane, T; N'Diaye, A; Odhiambo, J; Olliaro, PL; Perronne, C; Rustomjee, R; Sismanidis, C; Sow, OB | 1 |
| Bateson, AL; Butcher, PD; Charalambous, S; Churchyard, GJ; Clouting, HE; Coleman, D; Geldenhuys, H; Harrison, TS; Hatherill, M; Jindani, A; Magweta, L; McHugh, TD; McIlleron, HM; Mitchison, DA; Mungofa, S; Nunn, AJ; Nyirenda, S; Phillips, PP; Shah, NA; Shepherd, J; van Dijk, JH; Zizhou, S; Zvada, SP | 1 |
| Alobu, I; Oshi, DC; Oshi, SN; Ukwaja, KN | 2 |
| Jang, WS; Lee, BE; Nam, KW; Podder, B; Song, HY | 1 |
| Aleo, A; Bonura, C; Fasciana, T; Giammanco, A; Gomgnimbou, MK; Mammina, C; Refrégier, G; Sola, C | 1 |
| Juneja, R; Kalakoti, P; Sahu, S; Sharma, K; Singh, V; Subramanian, PS | 1 |
| Garcia-Rodriguez, F; Martinez-Longoria, CA; Rios-Solis, JE; Rubio-Perez, NE | 1 |
| Beamer, G; Campos-Neto, A; Das, B; Major, S | 1 |
| Hee, KH; Lee, LS; Seo, JJ | 1 |
| Li, H; Liu, C; Liu, M; Lu, J; Pang, Y; Qu, G; Wang, J; Wang, Y; Zhang, Z; Zhao, Y | 1 |
| Banurekha, VV; Bhavani, PK; Dayal, R; Gangadevi, NP; Kannan, T; Kumar, AK; Kumar, SR; Mathevan, G; Ramachandran, G; Ravichandran, N; Sanjeeva, GN; Sekar, L; Swaminathan, S | 1 |
| Arora, J; Myneedu, VP; Sah, GC; Sarin, R; Singh, N; Singhal, R | 1 |
| Butler, JR; Cilfone, NA; Dartois, V; Flynn, JL; Kirschner, DE; Lin, PL; Linderman, JJ; Mattila, JT; Pienaar, E | 1 |
| Chen, MT; Chi, JY; Fu, L; Guo, SC; Hao, LH; Liu, CC; Lu, Y; Nie, WJ; Wang, B; Yang, W; Zhou, L; Zhu, H | 1 |
| Cardoso, RF; Cortez, DA; da Silva, RZ; de Lima Scodro, RB; Ferracioli, KR; Lopes, MA; Siqueira, VL | 1 |
| Fushimi, K; Matsui, H; Yamana, H; Yasunaga, H | 1 |
| Ahmed, R; Cooper, R; Der, E; Gao, Z; Hansen, E; Kharrat, H; Kunimoto, D; Long, R; Mah, A | 1 |
| Conde, MB; Goldberg, SV; Jones, B; Moro, RN; Nachman, S; Oliveira, R; Scott, NA; Shang, N; Sterling, TR; Villarino, ME; Weiner, M; Weis, SE | 1 |
| Marais, BJ | 1 |
| Cacho Calvo, J; Martín Díaz, A | 1 |
| Cai, X; Ding, X; Li, Y; Tan, S; Tan, Y | 1 |
| Bakayoko, AS; Daix, AT; Domoua, K; Gbery, I; Kaloga, M; Kamagate, M; Kone, Z; Ohui, E | 1 |
| Aarnoutse, R; Bakker-Woudenberg, IA; Boeree, MJ; de Knegt, GJ; de Steenwinkel, JE; ten Kate, MT; van Soolingen, D | 1 |
| Akkerman, OW; Alffenaar, JW; Boeree, MJ; Bolhuis, MS; de Lange, WC; van der Werf, TS | 1 |
| Choi, SB; Jo, KW; Jung, H; Kang, MR; Lee, YS; Shim, TS | 1 |
| Manicheva, O; Mokrousov, I; Mushkin, A; Narvskaya, O; Solovieva, N; Vishnevsky, B; Vyazovaya, A; Zhuravlev, V | 1 |
| Li, K; Ye, X; Zhang, J; Zhu, M; Zhu, Y | 1 |
| Cho, YJ; Jeong, I; Lee, CT; Lee, JH; Park, JS; Song, J; Yoon, HI | 1 |
| Aarnoutse, RE; Boeree, MJ; Burger, D; Dawson, R; Diacon, AH; du Bois, J; Gillespie, SH; Heinrich, N; Hoelscher, M; Magis-Escurra, C; McHugh, TD; Narunsky, K; Phillips, PP; Plemper van Balen, G; Rehal, S; van Ingen, J; van Soolingen, D; Venter, A | 1 |
| Gilde, AK; Kane, KR; Rispler, DT; Stirton, JW | 1 |
| Archuleta, S; Huggan, PJ; Molton, JS | 1 |
| Mohanty, S; Mohapatra, D; Sahoo, RK; Sarangi, GS | 1 |
| Garg, T; Goyal, AK; Rath, G | 1 |
| Hershow, RC; Huo, D; Jimenez, A; Johnson, W; Paul, W; Prachand, N; Rahimian, A; Ricks, PM; Wiebel, W | 1 |
| Crownover, P; Damle, B; O'Gorman, M; Wang, HF; Wang, R | 1 |
| Byeon, JS; Jo, KW; Kim, KJ; Kim, YG; Lee, CK; Park, SH; Park, SJ; Shim, TS; Yang, SK; Ye, BD; Yoo, B | 1 |
| Arnoldi, FG; Brandão, IT; Cagnard, N; Chiocchia, G; Jacques, S; Letourneur, F; Masson, AP; Ramos, SG; Rios, WM; Rodrigues, RF; Silva, CL; Soares, LS; Souza, PR; Zárate-Bladés, CR | 1 |
| Jhobta, A; Kanga, A; Mokta, J; Negi, RS; Singh, DV; Verma, G; Verma, S | 1 |
| Báez Saldaña, R; Flores-Suárez, LF; Rivera Rosales, RM; Ruiz, N; Saldarriaga Rivera, LM | 1 |
| Török, ME | 1 |
| Aranda-Álvarez, M; Castellanos-Joya, M; Díaz-Ornelas, DE; Gómez-Gómez, A; Hernández-Segura, MG; López-Meza, S; Magaña-Aquino, M; Noyola, DE; Salazar-Lezama, MÁ | 1 |
| Belen, FB; Polat, M | 1 |
| Grzegorzewska, AE; Niepolski, L | 1 |
| Millard, J; Moore, DA; Ugarte-Gil, C | 1 |
| Brigden, G; Furin, J; Marais, B; Van Gulik, C | 1 |
| Eckold, C; Evangelopoulos, D; Gillespie, SH; Honeyborne, I; Lipman, MC; McHugh, TD; Pym, A | 1 |
| Arai, M | 1 |
| Ajbani, K; Catanzaro, A; Georghiou, SB; Kambli, P; Nikam, C; Rodrigues, C; Rodwell, TC; Sadani, M; Shetty, A; Udwadia, Z | 1 |
| Ardrey, A; Davies, GR; Dzinjalamala, F; Mlotha, R; Molyneux, E; Ward, S; Waterhouse, D | 1 |
| Akkerman, OW; Alffenaar, JW; Bolhuis, MS; de Lange, WC; Sturkenboom, MG; van der Werf, TS | 1 |
| Davies, G; Moore, DA; Requena-Méndez, A | 1 |
| Hamana, S; Matsuoka, S; Miyazawa, S; Moriyama, M; Nagai, S; Nakamura, H; Nirei, K | 1 |
| Burger, DA; Conradie, A; Dawson, R; Diacon, AH; Donald, PR; Eisenach, K; Everitt, D; Ive, P; Mendel, CM; Ntinginya, NE; Page-Shipp, L; Pym, A; Reither, K; Schall, R; Spigelman, M; van Niekerk, C; Variava, E; Venter, A; von Groote-Bidlingmaier, F | 1 |
| D'Addio, SM; Einck, L; Liu, Y; Prud'homme, RK; Reddy, VM; Sinko, PJ | 1 |
| Abimiku, AG; Agbede, OO; Blattner, WA; Dakum, P; Gidado, M; Iwakun, M; Mensah, C; Ndembi, N; Nwabuisi, C; Nwofor, AC; Nyamngee, A | 1 |
| Balooni, V; Kumar, P; Singh, S | 1 |
| Lipman, MC; Phillips, PP | 1 |
| Reves, RR | 1 |
| Chakraborty, S; Rhee, KY | 1 |
| Braga, JU; Trajman, A | 1 |
| Cobelens, FG; Gomez, GB; Joloba, M; Kasule, GW; Lukoye, D; Musisi, K; Ssengooba, W | 1 |
| Aarnoutse, RE; Alffenaar, JW; Greijdanus, B; Harteveld, AR; Robijns, K; Sturkenboom, MG; Touw, DJ; Uges, DR | 1 |
| Deng, Y; Guo, YX; He, LY; Jiang, P; Li, C; Peng, WX; Xu, XF; Zhang, QZ | 1 |
| Kabra, SK; Kanhiya, K; Lodha, R; Mukherjee, A; Singla, M; Velpandian, T | 2 |
| Adkinson, NF; Borisov, AS; Ho, C; Moro, RN; Phillips, E; Shepherd, G; Sterling, TR; Villarino, ME; Weis, S | 1 |
| Gao, Q; Jiang, Y; Li, J; Shen, X; Tian, J; Wang, L; Wu, J | 1 |
| Keshavjee, S; Rich, ML; Seung, KJ | 1 |
| Chang, TC; Chien, JY; Chiu, WY; Hsueh, PR; Yu, CJ | 1 |
| Acuña-Villaorduña, C; Ayakaka, I; Dryden-Peterson, S; Fennelly, KP; Hosford, J; Jones-López, EC; Nakubulwa, S; Okwera, A; Reilly, N; Worodria, W | 1 |
| Alawad, AAM; Khalifa, AFM | 1 |
| Bhanjana, G; Dilbaghi, N; Kaur, G; Kumar, S; Mehta, SK | 1 |
| Abubakar, I; Broda, A; Casali, N; Cooke, M; Drobniewski, F; Green, N; Jit, M; Jordan, J; Lipman, M; Lord, J; Mugwagwa, T; Sivaramakrishnan, A; Townsend, C; White, PJ | 1 |
| Bancroft, LW; Engel, AJ; Macke, JJ; Sawin, PD | 1 |
| Ahmad, A; Ahmad, S; Akhtar, M; Al-Abbasi, FA; Amir, M; Khan, MA; Khan, SA; Mujeeb, M | 1 |
| Dong, W; Gu, Y; Huang, H; Li, Y; Ma, Y; Qin, S; Shang, Y; Wang, G | 1 |
| Devi, J; Rajkumar, J; Sankar, M | 1 |
| Chaisson, RE; Getahun, H; Matteelli, A; Raviglione, M | 1 |
| Aprile, V; Centis, R; Costa, D; D'Ambrosio, L; Donateo, L; Fedele, A; Gillini, L; Migliori, GB; Pasanisi, G; Tundo, P | 1 |
| Manaenkova, EV; Savin, AA | 1 |
| Apostolides, Z; Buys, A; Nardell, EA; Stoltz, AC; van Breda, SV | 1 |
| Collins, SE; Escuyer, VE; Fitzgerald, DW; Mabou, MM; Ocheretina, O; Pape, JW; Royal-Mardi, G; Shen, L | 1 |
| Igari, H; Imasawa, T; Ishikawa, S; Kadomura, M; Mizuno, S; Nagayoshi, M; Nishimura, M; Noguchi, N; Yamagishi, F | 1 |
| Aarnoutse, RE; Alffenaar, JW; de Jager, A; de Lange, WC; Kosterink, JG; Mulder, LW; Proost, JH; Sturkenboom, MG; van Altena, R; van der Werf, TS | 1 |
| Barnes, GL; Carman, D; Chaisson, RE; Dawson, R; Dorman, SE; Efron, A; Gupte, N; Hoffman, J; McIlleron, H; Narunsky, K; Whitelaw, A | 1 |
| Boonin, C; Chaiyasirinrote, B; Kondo, Y; Mahasirimongkol, S; Namwat, C; Rienthong, D; Rienthong, S; Satproedprai, N; Yoshida, H | 1 |
| Mokos, ZB; Paštar, Z; Rezaković, S | 1 |
| John, TJ; Mathew, JL; Parakh, A | 1 |
| Ayati Fard, SF; Bahrami Taghanaki, HR; Ghazvini, K; Salehi, M; Shakiba, A; Tavanaee Sani, A | 1 |
| Chi, X; Gao, C; Hu, YW; Huang, Z; Wang, Q; Zeng, T; Zheng, L | 1 |
| Minemura, H; Munakata, M; Oshima, K; Saito, J; Tanino, Y; Yokouchi, H | 1 |
| Andersen, JW; Bao, Y; Benson, CA; Chaisson, RE; Fletcher, CV; Gupta, A; Kim, P; Mohapi, L; Mwelase, T; Podany, AT; Supparatpinyo, K; Swindells, S | 1 |
| Abebe, M; Adane, K; Ameni, G; Aseffa, A; Bekele, S | 1 |
| Augustynowicz-Kopeć, E; Bakuła, Z; Bielecki, J; Jagielski, T; Kamiński, M; Napiórkowska, A; Zwolska, Z | 1 |
| Abera, B; Admassu, A; Amor, A; Benito, A; Biadglegne, F; Gelaye, W; Mekonnen, D; Mulu, W | 1 |
| Abera, B; Admassu, A; Mekonnen, D; Mulu, W; Yimer, M | 1 |
| Anselmo, LM; Bellissimo-Rodrigues, F; Bollela, VR; Feliciano, CS; Nascimento, MM; Pocente, RH | 1 |
| Ismail, F; Ismail, N; Matabane, MM; Omar, SV; Onwuegbuna, O; Strydom, K | 1 |
| Anandkumar, A; Balasubramanian, V; Datta, S; Karmarkar, M; Khandelwal, S; Kumar, N; Nanduri, R; Narayanan, S; Panduga, V; Prabhakar, KR; Rajagopalan, S; Ramachandran, V; Rao, N; Reddy, J; Saralaya, R; Shandil, R; Sharma, S; Singh, R; Solapure, S | 1 |
| Hasan, R; Kadavigere, R; Kumar, S; Mathew, M | 1 |
| Cheung, I; Collins, RA | 1 |
| Chan, KS; Ho, PL; Leung, CC; Mok, TY; Tam, CM; Yam, WC; Yew, WW | 1 |
| Asante-Poku, A; Bonsu, F; Danso, E; Gagneux, S; Mensah, DD; Otchere, ID; Yeboah-Manu, D | 1 |
| Ansarin, K; Farajnia, S; Monfaredan, A; Sabour, S; Sahebi, L | 1 |
| Chin, DP; Dong, HY; Huan, ST; Kam, KM; Li, JC; Li, Q; Ou, XC; Pang, Y; Xia, H; Zhang, JK; Zhang, ZY; Zhao, YL | 1 |
| Al-Tawfiq, JA; Hinedi, K; Memish, ZA | 1 |
| Chan, CK; Chang, KC; Law, WS; Lee, SN; Leung, CC; Leung, EC; Tai, LB; Tam, CM | 1 |
| Augusto, CJ; Carvalho, Wda S; Dantas, NG; de Almeida, IN; de Assis, LJ; de Miranda, SS; Gomes, HM; Gomgnimbou, MK; Refregier, G; Sola, C; Suffys, PN | 1 |
| Becker, AL; Cangelosi, GA; Chung, JH; Inoue, S; Kim, JH; Lee, HB; Lee, KH; Weigel, KM | 1 |
| Shi, G; Zhang, L | 1 |
| Alcaide, F; Cabibbe, AM; Cirillo, DM; Drobniewski, F; Feuerriegel, S; Miotto, P; Moure, R; Niemann, S; Nikolayevskyy, V; Pozzi, G; Reither, K | 1 |
| Davies, G; Dimba, A; Dzinjalamala, FK; Molyneux, EM; Molyneux, ME; van Oosterhout, JJ; Ward, S; Waterhouse, D; Zijlstra, EE | 1 |
| Gao, T; Huang, X; Tan, QC; Tian, CL; Yang, M; Yao, Y; Yu, SY; Zhang, JT | 1 |
| Dedicoat, M; Lange, C | 1 |
| Benator, D; Bliven-Sizemore, EE; Bock, N; Drobeniuc, J; Reves, R; Schwartzman, K; Shang, N; Sterling, TR; Villarino, ME | 1 |
| Aggarwal, S; Alpana, M; Daga, MK; Nidhi, A | 1 |
| Balagaddé, FK; Luthuli, BB; Purdy, GE | 1 |
| Izzatun, N; K, S; Lisdawati, V; M, M; Parwati, I; Puspandari, N; Ratnasari, L; Rif'ati, L; Soekarno, T | 1 |
| Bahrmand, A; Ghanei, M; Hadizadeh Tasbiti, A; Shokrgozar, MA; Yari, S | 1 |
| Garg, T; Goyal, AK; Murthy, RS; Rath, G | 1 |
| Burzynski, JN; Herbert, C; Macaraig, M; Nilsen, D; Stennis, NL | 1 |
| Chew, N; Hee, KH; Khoo, SH; Lee, LS; Seng, KY; Soon, GH | 1 |
| Azami, R; Bawa, T; Haroon, N; Khan, S | 1 |
| Baskaran, UL; Sabina, EP | 1 |
| Javid, B; Kong, C; Liu, C; Qian, F; Wu, G; Zhu, J | 1 |
| Abubakar, I; Aziz, MA; Baddeley, A; Barreira, D; Borroto Gutierrez, SM; Bruchfeld, J; Burhan, E; Cavalcante, S; Cedillos, R; Chaisson, R; Chee, CB; Chesire, L; Corbett, E; D Grant, A; Dara, M; de Vries, G; Den Boon, S; Denholm, J; Falzon, D; Ford, N; Gale-Rowe, M; Getahun, H; Gilpin, C; Girardi, E; Go, UY; Govindasamy, D; Grzemska, M; Harris, R; Horsburgh, CR; Ismayilov, A; Jaramillo, E; Kik, S; Kranzer, K; Lienhardt, C; LoBue, P; Lönnroth, K; Marks, G; Matteelli, A; Menzies, D; Migliori, GB; Mosca, D; Mukadi, YD; Mwinga, A; Nelson, L; Nishikiori, N; Oordt-Speets, A; Rangaka, MX; Raviglione, M; Reis, A; Rotz, L; Sandgren, A; Sañé Schepisi, M; Schünemann, HJ; Sharma, SK; Sotgiu, G; Stagg, HR; Sterling, TR; Tayeb, T; Uplekar, M; van der Werf, MJ; van Kessel, F; van't Hoog, A; Vandevelde, W; Varma, JK; Vezhnina, N; Voniatis, C; Vonk Noordegraaf-Schouten, M; Weil, D; Weyer, K; Wilkinson, RJ; Yoshiyama, T; Zellweger, JP | 1 |
| Bai, ZT; Chen, P; Cui, P; Du, JJ; Li, HY; Li, Y; Sun, Y; Wang, X; Wu, ZR; Yang, R; Yang, ZG; Zhang, Y; Zhi, DJ | 1 |
| Abuaku, BK; Chen, M; Deng, J; Li, W; Li, X; Su, C; Tan, H; Wang, M; Wen, SW; Xia, Y | 1 |
| Chen, J; Ding, B; Jiang, D; Li, Y; Peng, J; Xue, W; Yu, X; Zhang, S; Zhou, B; Zhu, B | 1 |
| Baldin, VP; Caleffi-Ferracioli, KR; Cardoso, RF; Leite, CQ; Lopes, MA; Pagliotto, AD; Pavan, FR; Scodro, RB; Siqueira, VL | 1 |
| Demiroz, AS; Dulgar, O; Ersen, E; Eskazan, AE; Oz, B; Turna, A; Tuzuner, N | 1 |
| Cho, YJ; Kim, SJ; Lee, CT; Lee, JH; Lee, JY; Lee, YJ; Park, JS; Song, J; Yoon, HI | 1 |
| Bai, D; Fan, L; Yang, X; Yao, J; Yi, L; Zhang, Y | 1 |
| Hatsuda, K; Hayashi, S; Ibaraki, M; Kagawa, T; Kurata, M; Nakatsuji, H; Ogata, K; Sakaguchi, M; Sasaki, Y; Takeuchi, M | 1 |
| Boutou, A; Chatzika, K; Kioumis, I; Kontou, P; Manika, K; Papaioannou, M; Zarogoulidis, K | 1 |
| Dang, R; He, X; Jiang, P; Li, H; Sheng, L; Tang, M; Wu, Y; Xue, Y; Zhu, Y | 1 |
| Chen, L; Chen, T; Chen, X; Guo, H; Guo, L; Li, H; Li, Q; Li, Z; Wu, T; Yu, L; Zhao, M; Zhong, Q; Zhou, L | 1 |
| Egan, D; Hennig, S; Kellerman, T; McIlleron, H; Naiker, S; Owen, A; Pym, A; Reddy, T; Wiesner, L | 1 |
| Chen, Y; Liu, HC; Liu, ZG; Sun, Q; Wan, KL; Zhao, B; Zhao, LL; Zhao, XQ | 1 |
| Albert, Y; Charlemagne, G; Cyrille, B; Désire, I; Florencia, D; Jacques, S; Martial, O; Rebecca, C; Rémy, M; Simplice, KD; Souba, D; Tamboura, D; Valerie, BJ; Virginio, P | 1 |
| Eshetie, S; Gelaw, A; Kumera, G; Mekonnen, F; Moges, F; Tessema, B | 1 |
| Homorodean, D; Jodal, AM; Man, MA; Pop, CM | 1 |
| Hatakeyama, N; Kagawa, K; Machida, H; Naito, N; Ogushi, F; Ohno, A; Okano, Y; Shinohara, T; Takahashi, N; Wada, T; Yoshida, S | 1 |
| Albuquerque, J; David, S; Duarte, EL; Gonçalves, G; Lavinha, J; Mateus, AR; Portugal, C; Sancho, L | 1 |
| Akbar, S; Ali, Z; Avula, B; Khan, IA; Masoodi, MH; Mushtaq, A; Rehman, MU; Wali, AF | 1 |
| Bleything, S; Hunter, P; Lines, G | 1 |
| Chirehwa, MT; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, P; Rustomjee, R; Smith, P | 2 |
| Gie, RP; Graham, SM; Grzemska, M | 1 |
| Cruz, AT; Martinez, BJ | 1 |
| Dartois, V; Kirschner, DE; Linderman, JJ; Pienaar, E | 1 |
| Aneiros-Fernández, J; Garrido-Colmenero, C; Martínez-López, A; Ruiz-Villaverde, R | 1 |
| Amani, A; Fazly Bazzaz, BS; Khameneh, B; Rostami, J; Vahdati-Mashhadian, N | 1 |
| Chang, KC; Sotgiu, G; Yew, WW | 1 |
| Casal, M; Causse, M; Gutierrez, JB; Ruiz, P; Vaquero, M | 1 |
| Ardizzoni, E; Aspindzelashvili, R; Bastard, M; de Jong, BC; Goginashvili, L; Kotrikadze, T; Mulders, W; Pangtey, H; Rigouts, L; Varaine, F | 1 |
| Barnett, B; Bokosi, M; Chikaonda, T; Gokhale, RH; Hoffman, IF; Hosseinipour, MC; Kanyemba, C; Krysiak, R; Mukuzunga, C; Phiri, S; Saidi, F | 1 |
| Akkus, E; Avcu, G; Duyu, M; Karapinar, B; Sahbudak Bal, Z; Vardar, F | 1 |
| Abate, G; Campbell, M; Chibale, K; Eickhoff, CS; Hamzabegovic, F; Hoft, DF; Kumar, M; Ruminiski, PG; Selimovic, A; Singh, K | 1 |
| Betoudji, F; Lanoix, JP; Nuermberger, E | 1 |
| Chan, HH; Mpe, J | 1 |
| Ageshio, F; Fujikawa, T; Kagawa, H; Kitada, S; Maekura, R; Mori, M; Oshitani, Y; Saito, H; Sako, H; Yano, Y | 1 |
| Chen, S; Fu, Y; Han, Y; Huang, H; Liu, Z; Qin, M; Shang, Y; Zhao, L | 1 |
| Feder, HM; Rigos, L; Teti, K | 1 |
| Corti, N; Fehr, J; Gutteck, U; Henning, L; Meloni, M; Müller, D; von Braun, A; Weber, R | 1 |
| Carroll, J | 1 |
| Lim, JI; Thomas, M | 1 |
| Ma, C; Shen, S; Wang, J; Xu, J; Zhao, L; Zhou, EM | 1 |
| Bekker, A; Donald, PR; Draper, HR; Hesseling, AC; McIlleron, HM; Murray, S; Schaaf, HS; van der Laan, L; Wiesner, L | 1 |
| Chidiac, R; Dobler, CC; Jelfs, PJ; Williamson, JP | 1 |
| Gotoh, H; Kurasima, A; Matsuda, S; Morimoto, K; Ogata, H; Okumura, M; Osawa, T; Sasaki, Y; Yanai, H; Yoshiyama, T | 1 |
| Agarwal, D; Banurekha, VV; Bhavani, PK; Gangadevi, NP; Kalpana, S; Kannan, T; Kumar, AK; Kumar, SR; Mathevan, G; Ramachandran, G; Ravichandran, N; Sanjeeva, GN; Sudha, V; Swaminathan, S; Venkatesh, S | 1 |
| Ai, JW; Liu, QH; Ruan, QL; Zhang, WH | 1 |
| Castro, GP; Guerrero, MI; Martínez, LM | 1 |
| Du, J; Fu, Y; Gao, J; Hu, D; Li, L; Li, Q; Li, X; Liu, F; Ma, L; Ma, Y; Tan, S; Zhang, L; Zhang, Y; Zhu, G | 1 |
| Domínguez, J; García-García, E; Gómez, A; Haba, L; Kazdaglis, G; Lacoma, A; Maldonado, J; Molina-Moya, B; Prat, C; Ruiz-Manzano, J; Samper, S; Villar-Hernández, R | 1 |
| Sibbald, B | 1 |
| Allnutt, JC; Bacon, J; Bottley, G; Doris, KS; Hatch, KA; Hendon-Dunn, CL; Marriott, AA; Marsh, PD; Taylor, SC; Thomas, SR; Watson, RJ | 1 |
| Cobelens, F; de Vries, G; Erkens, CG; Schimmel, H; Slump, E; van den Hof, S; Verhagen, M | 1 |
| Adamson, J; Almeida, DV; Ammerman, NC; Bester, LA; Dorasamy, A; Grosset, JH; Mgaga, Z; Moodley, C; Moodley, S; Ngcobo, B; Singh, SD; Swanson, RV | 1 |
| Bai, Y; Hao, Y; Jin, Y; Shao, C; Wang, Y | 1 |
| Barbosa, AR; Caleffi-Ferracioli, KR; Cardoso, RF; García-Ramos, JC; Leite, CQ; Pavan, FR; Ruiz-Azuara, L; Siqueira, VL; Toledano-Magaña, Y | 1 |
| Guo, Q; Liu, R; Pan, Y; Peng, Z; Xing, L; Yang, Z; Zhu, C | 1 |
| Li, H; Luo, J; Wei, HP; Yang, H; Yu, JP; Zhou, LP | 1 |
| Deng, YT; Huang, ZK; Li, JM; Luo, Q; Qing, C; Xiong, GL | 1 |
| Ahsan, CR; Alam, MM; Irin, F; Kamal, SM; Mistri, SK; Nessa, J; Sultana, M; Yasmin, M | 1 |
| Qin, H; Song, Y; Wu, X; Zhang, G; Zhao, J; Zhou, L; Zhou, Y | 1 |
| Arumugam, G; Evan Prince, S; Sunitha, PS; Udhaya, LB | 1 |
| Alonso, E; Batlle, M; Marcos, P; Martínez de Lagrán, I; Plana, A; Tomasa, T | 1 |
| Han, M; Ma, Y; Qin, H; Rao, Z; Wei, Y; Wu, X; Xi, L; Zhang, G; Zhou, Y; Zhu, J | 1 |
| Bang, ND; Caws, M; Day, JN; Dung, NH; Duong, TN; Phuong, PN; Pouplin, T; Tarning, J; Thwaites, GE; Toi, PV | 1 |
| Chang, PJ; Cheng, CW; Chou, YL; Lin, HS; Lin, JC; Lin, MS; Ye, JJ | 1 |
| Gotuzzo, E; Huaman, MA; Otero, L; Seas, C; Sterling, TR; Van der Stuyft, P; Villegas, L | 1 |
| Bao, J; Liu, SJ; Lu, LZ; Lv, CF; Wang, J; Zhang, T; Zheng, WB | 1 |
| Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X | 1 |
| Adaramoye, OA; Adefisan, A; Adeyemi, O; Akanni, OO; Kehinde, AO; Oyinlola, I | 1 |
| Cho, YJ; Jeong, YY; Kim, HC; Kim, HJ; Lee, JD; Lee, SJ; Menzies, D; Park, SH | 1 |
| Albay, A; Albayrak, N; Alp, A; Aslantürk, A; Biçmen, C; Ceyhan, İ; Çoban, AY; Esen, N; Kalaycı, F; Özkütük, A; Özkütük, N; Sarıbaş, Z; Sığ, AK; Sürücüoğlu, S; Taştekin, B; Uzun, M | 1 |
| Jang, WS; Jyoti, MA; Kim, S; Lee, BE; Nam, KW; Song, HY | 1 |
| Boehme, C; Denkinger, CM; Havumaki, J; Hillemann, D; Ismail, N; Nathavitharana, RR; Omar, SV; Schlueter, B; Schumacher, SG; Sikhondze, W; Valli, E | 1 |
| Cruz, AT; Graviss, EA; Hatzenbuehler, LA; Smith, EO; Starke, JR | 1 |
| He, XC; Li, HC; Liu, Y; Yang, GR; Yu, CB; Zhang, XX; Zhao, JN | 1 |
| Cruz, AT; Starke, JR | 2 |
| Catanzaro, A; Catanzaro, D; Crudu, V; Garfein, RS; Georghiou, SB; Rodrigues, C; Rodwell, TC; Seifert, M; Valafar, F; Victor, TC | 1 |
| Joloba, ML; Kasule, GW; Kateete, DP | 1 |
| Khushtar, M; Mujahid, M; Rahman, MA; Siddiqui, HH; Usmani, A | 1 |
| Abramovitch, RB; Chen, C; Dartois, V; Huang, L; Liu, Y; Rohde, KH; Russell, DG; Tan, S; VanderVen, BC; Zimmerman, MD | 1 |
| Cavalcanti, IM; Ferraz-Carvalho, RS; Linhares, LA; Lira-Nogueira, MC; Montenegro, LM; Pereira, MA; Santos-Magalhães, NS | 1 |
| Behera, D; Dhatwalia, SK; Kaur, H; Rudramurthy, SM; Sethi, S; Yadav, R | 1 |
| Al-Efraij, K; Campbell, JR; Cook, VJ; Johnston, J; Marra, F; Mota, L | 1 |
| Hamilton, CD; Holland, DP; Stout, JE | 1 |
| Atwine, D; Bonnet, M; Borgulya, G; Burgos, M; Checkley, AM; de Fernandes, RA; de Patiño, IW; Dubash, F; Gonzales, T; Harrison, TS; Jindani, A; Mitchison, D; Patel, N; Shrestha, B | 1 |
| Betai, S; Bhoi, SK; Kalita, J; Misra, UK | 1 |
| Datta, G; Davidson, RM; Dobos, KM; Mehaffy, C; Nieto, LM; Pederson, C; Strong, M | 1 |
| Armstrong, DT; Barnes, GL; Cavalcante, SC; Chaisson, RE; Cohn, S; Conde, MB; Dalcolmo, M; Dooley, KE; Dorman, SE; Duarte, RS; Durovni, B; Efron, A; Loredo, C; Marzinke, MA; Mello, FC; Moulton, LH; Rolla, V; Savic, RM | 1 |
| Carter, EJ; Cohen, T; Gardner, A; Hedt-Gauthier, BL; Injera, W; Jezmir, J; Kamle, L; Nyakan, E; Zignol, M | 1 |
| Basher, MA; Bhakta, S; Brucoli, F; Evangelopoulos, D; Fox, KR; Guzman, JD; McHugh, TD; McMahon, E; Munshi, T | 1 |
| Martin, SJ; Sabina, EP | 1 |
| Alameda-Martin, L; Coates, A; Davies, G; Hu, Y; Liu, Y; Ortega-Muro, F; Pertinez, H; Schipani, A | 1 |
| Chang, MC; Chou, PH; Lin, CP; Liu, CL; Ma, HL; Wang, ST; Yu, WK | 1 |
| Dixit, P; Jain, A; Jaiswal, I; Singh, M; Singh, P; Singhal, P | 1 |
| Abdella, K; Abdissa, K; Abebe, G; Aragaw, D; Dimah, B; Efa, F; Kebede, W; Tadesse, M | 1 |
| Benator, DA; Benson, CA; Calvet, G; Chaisson, RE; Chen, MP; Gordin, F; Infante, R; La Rosa, A; Miro, JM; Scott, NA; Sterling, TR; Villarino, ME | 1 |
| Sharma, R; Sharma, VL | 1 |
| Abe, T; Akahori, D; Enomoto, Y; Hasegawa, H; Koda, K; Matsui, T; Omae, M; Suda, T; Yokomura, K | 1 |
| Barreda, N; Castillo, E; Fasabi, M; Galarza, M; Guio, H; Levano, KS; Rodriguez, M | 1 |
| Garg, T; Goyal, AK; Gupta, P; Gupta, UD; Rath, G | 1 |
| Chiu, W; Hu, R; Lewis, C; Maze, MJ; Nisbet, M; Paynter, J | 1 |
| Lu, JM; Sha, W; Xiao, HP; Yang, H; Zhang, LL; Zhang, Q | 1 |
| Chahar, M; Chauhan, DS; Das, R; Katoch, K; Katoch, VM; Parashar, D; Sharma, P; Sharma, R; Singh, AV; Singh, PK | 1 |
| Gonzalez-Juarrero, M; Jackson, M; Lee, RE; Li, W; North, EJ; Obregón-Henao, A; Schnappinger, D; Wallach, JB | 1 |
| Akbal, AU; Birinci, A; Cayci, YT; Coban, AY; Durupinar, B; Uzun, M | 1 |
| Günther, G; Hunter, C; Kibuule, D; Rennie, TW; Verbeeck, RK | 1 |
| Aderaye, G; Aguwa, EN; Aseffa, A; Bedru, A; Chukwu, JN; Connolly, C; Ezechi, OC; Mebrahtu, T; Medhin, G; Onyebujoh, PC; Rida, W; Vahedi, M; Yamuah, LK; Yimer, G; Zumla, AI | 1 |
| Baker, B; Chibale, K; Chouteau, F; de Kock, C; Macingwana, L; Madikane, E; Mmutlane, EM; Ngwane, AH; Panayides, JL; Parkinson, CJ; van Helden, P; Viljoen, A; Wiesner, L; Wiid, I | 1 |
| Ban, GY; Hur, GY; Jee, YK; Kim, SH; Naisbitt, DJ; Park, HS; Ye, YM | 1 |
| Demissie, M; Hamusse, SD; Hussen, MS; Lindtjørn, B; Teshome, D | 1 |
| Baghaei, P; Farnia, P; Javanmard, P; Marjani, M; Masjedi, MR; Moniri, A; Tabarsi, P; Velayati, AA | 1 |
| Cooper, R; Hansen, E; Houston, S; Krinke, V; Rennert-May, E; Zadeh, T | 1 |
| Chen, SS; Guan, CX; Liu, HC; Liu, M; Liu, ZG; Song, Y; Wan, KL; Wan, L; Wu, YM; Xu, YJ; Zhao, XQ | 1 |
| Mathivha, KT; Velaphi, S | 1 |
| Geiter, L; Mallikaarjun, S; Paccaly, A; Patil, S; Petersen, C; Shoaf, SE; Wells, C | 1 |
| Darley, DR; Glanville, AR; Goeman, EE; Jensen, TO; Marriott, DJ; Shaw, K | 1 |
| Attalla, SM; Carter, WG; Christie, D; Elmorsy, E; Fikry, E; Kocon, A; Nwidu, LL; Turner, R; Warren, A | 1 |
| Alameda, L; Chen, C; Ferrer, S; Ortega, F; Simonsson, US | 1 |
| Chirehwa, M; Denti, P; McIlleron, H; Meintjes, G; Rockwood, N; Wiesner, L; Wilkinson, RJ | 1 |
| Akkerman, OW; Alffenaar, JC; de Lange, WC; Kosterink, JG; Sturkenboom, MG; van Altena, R; van der Werf, TS | 1 |
| Chandrasekaran, V; Hemanth Kumar, AK; Kannan, T; Lavanya, J; Ramachandran, G; Ramesh, K; Sudha, V; Swaminathan, S; Vijayakumar, A | 1 |
| du Preez, K; Garcia-Prats, AJ; Hesseling, AC; Rautenbach, C; Schaaf, HS | 1 |
| Diangs, K; Fueza, SB; Kalla, GC; Kebela, I; Magazani, N; Mbopi-Kéou, FX; Misombo-Kalabela, A; Nguefack-Tsague, G; Panda, T; Ze, EA | 1 |
| Chishiki, M; Horinosono, H; Kawakubo, Y; Maeshima, H; Sakiyama, M | 1 |
| Bollela, VR; Ferro, JJ; Harrison, LH; Lisboa, M; Namburete, EI; Passeri, M; Pocente, R; Tivane, I | 1 |
| Andersen, ÅB; Bahl, JM; Cohen, AS; Frimodt-Møller, N; Johansen, IS; Lundqvist, M; Prahl, JB | 1 |
| Abbo, LM; Camargo, JF; Morris, MI; Rosa, R; Simkins, J | 1 |
| Huang, YW; Tsao, SM; Tsao, TC; Yang, SF; Yeh, YP | 1 |
| Akbas, G; Akkoc, G; Atici, S; Bakir, M; Karaaslan, A; Kepenekli Kadayifci, E; Ocal Demir, S; Soysal, A; Yakut, N; Zeliha Cinel, L | 1 |
| Catanzaro, A; Catanzaro, D; Crudu, V; Garfein, RS; Georghiou, SB; Jackson, RL; Lin, SY; Rodrigues, C; Rodwell, TC; Seifert, M; Victor, TC | 1 |
| Alonso, P; Barbeito-Castiñeiras, G; Fernández, A; González-Mediero, G; Mejuto, B; Pérez Del Molino, ML | 1 |
| Akkerman, OW; Alffenaar, JC; Bruchfeld, J; Davies Forsman, L; Hu, Y; Migliori, GB; Tiberi, S; Zheng, R; Zuur, MA | 1 |
| Fu, L; Guo, Z; Li, P; Liu, S; Mu, X; Wang, B; Zhao, W; Zheng, M | 1 |
| Kammoun, S; Marouane, C; Messadi-Akrout, F; Slim, L; Smaoui, S | 1 |
| Dabboussi, F; Hamze, M; Ismail, MB; Rahmo, AK | 1 |
| Chandrasekaran, V; Kannan, T; Kumar, AK; Lavanya, J; Murali, AL; Ramachandran, G; Sudha, V; Swaminathan, S | 1 |
| Alsultan, A; Egelund, EF; Isaza, R; Peloquin, CA | 1 |
| Blackmore, T; McNaughton, A; McNaughton, H | 1 |
| Ahidjo, BA; Andrade, BB; Beck, S; Bishai, WR; Cheung, LS; Ihms, EA; Jain, S; Maiga, M; Maiga, MC; Ordonez, AA | 1 |
| He, JQ; Ji, GY; Liu, QQ; Sandford, AJ; Wang, Y; Wu, JC; Wu, SQ; Zhang, MM | 1 |
| Bogg, L; de Costa, A; Haile, M; Katamba, A; Kwesiga, B; Rodrigues, R; Walusimbi, S | 1 |
| Antonenka, U; Hoffmann, H; Hofmann-Thiel, S; Molodtsov, N | 1 |
| Burger, A; Draper, HR; du Plessis, L; Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS; Seddon, JA; Zimri, K | 1 |
| Aldaba, JG; Ama, CG; Geraldino, XD; Lopez, AL; Salonga, AM; Sarol, JN; Sylim, PG | 1 |
| Dookie, N; Moodley, P; Sturm, AW | 1 |
| Ahuja, V; Jain, S; Jullien, S; Ryan, H | 1 |
| Juthong, S; Laohapojanart, N; Padmavathi, AR; Pungrassami, P; Ratanajamit, C; Srichana, T; Suwandecha, T | 1 |
| Patel, K; Patel, S; Vora, A | 1 |
| Asres, A; Deressa, W; Jerene, D | 1 |
| Aung, HL; Cook, GM; Crump, JA; Latt, KZ; Nyunt, WW; Samaranayaka, A; Thinn, KK; Tun, T | 1 |
| Abdul-Aziz, AA; Elhassan, MM; Elmekki, MA; Hemeg, HA; Turkistani, KA | 1 |
| Ahmed, V; Chopra, KK; Dubey, M; Hanif, M; Khanna, A; Saini, S; Sharma, S; Shrivastava, D; Sidiq, Z; Vashistha, H | 1 |
| Chawla, K; Mukhopadhyay, C; Rao, P; Shenoy, VP | 1 |
| Abravaya, K; Kostera, J; Lampinen, J; Leckie, G; Szostak, M; Tang, N; Wang, H | 1 |
| D'Ambrosio, L; Migliori, GB; Sotgiu, G | 1 |
| Benedetti, A; Gegia, M; Menzies, D; van Soolingen, D; Winters, N | 1 |
| Kotecha, D; Latimer, MD; Sardar, M | 1 |
| Andrés Franch, MI; Grau Delgado, J; Prats Sánchez, I; Ruiz-García, MM | 1 |
| Ginalska, G; Sawicki, R; Sieniawska, E; Skalicka-Woźniak, K; Swatko-Ossor, M | 1 |
| Ayorinde, JO; Kadota, K; Senda, A; Tagishi, H; Tozuka, Y | 1 |
| Bacher, U; Jung, W; Schulze, MH; Seif Amir Hosseini, A; Trümper, L; Venkataramani, V; Wulf, G | 1 |
| Ahuja, S; Crossa, A; Iwata, K; King, L; Munsiff, S; Pasipanodya, J; Proops, D; Vinnard, C | 1 |
| Collantes, J; Rigouts, L; Solari, FB | 1 |
| Bright-Thomas, RJ; Gondker, AR; Morris, J; Ormerod, LP | 1 |
| Ameni, G; Bedewi Omer, Z; Medhin, G; Mekonnen, Y; Mohammed, T; Pieper, R; Worku, A; Zewde, A | 1 |
| Akbal, AU; Albay, A; Albayrak, N; Alp, A; Aslan, G; Bektore, B; Bicmen, C; Ceyhan, I; Coban, AY; Delialioğlu, N; Esen, N; Ozkutuk, A; Ozkutuk, N; Ozyurt, M; Selale, DS; Sig, AK; Surucuoglu, S; Ucarman, N; Uzun, M | 1 |
| Jo, KW; Kim, MN; Shim, TS; Sung, H; Yeo, Y | 1 |
| AbdelRahim, KA; Ahmed, AO; Almaary, KS; Mohamed, AM; Yousef, SA | 1 |
| Allen, SJ; Carlson, SL; Furukawa, NW; Haider, MZ; Lindquist, SW | 1 |
| Khanna, SR; Kralovic, SM; Prakash, R | 1 |
| Guirao-Arrabal, E; Redel, J; Santos, F; Torre-Cisneros, J; Vaquero, JM | 1 |
| Balin, SO; Denk, A; Dogdu, O; Kara, SS; Kobat, MA | 1 |
| Abdel-Hamid, MK; Abdelrahman, MH; Abdu-Allah, HH; Aboul-Fadl, T; Reshma, RS; Sriram, D; Yogeeswari, P; Youssif, BG | 1 |
| Gessesse, A; Hundie, GB; Woldemeskel, D | 1 |
| Abbo, LM; Camargo, JF; Morris, MI; Simkins, J | 1 |
| Barbouche, MR; Ben Ameur, S; Ben Mustapha, I; Hachicha, M; Kamoun, F; Sfaihi, L | 1 |
| Bartoletti, M; Bertuzzo, V; Cristini, F; Giannella, M; Lewis, RE; Martelli, G; Morelli, M; Pianta, P; Pinna, AD; Tadolini, M; Tedeschi, S; Viale, P | 1 |
| Deng, JY; Gu, J; Li, K; Wang, XD; Yang, SS; Zhang, XE | 1 |
| Chiappini, E; de Martino, M; Galli, L; Tersigni, C; Venturini, E | 1 |
| Abeel, T; Alland, D; Armstrong, DT; Barry, CE; Birren, BW; Bishai, WR; Brand, J; Cassell, GH; Chapman, SB; Cho, SN; Cohen, KA; Cohen, T; Crudu, V; Desjardins, CA; Dorman, SE; Earl, AM; Ellner, J; Farnia, P; Gabrielian, A; Galagan, JE; Gomez, J; Hoffner, S; Homorodean, D; Hsueh, PR; Jodals, AM; Joloba, M; Jureen, P; Lee, JS; Maiga, M; Malinga, L; Manson, AL; Narayanan, S; Nordenberg, D; Noroc, E; Pym, AS; Romancenco, E; Rosenthal, A; Salazar, A; Skrahina, A; Ssengooba, W; Swaminathan, S; Van der Walt, M; Velayati, AA; Via, LE; Winglee, K; Zalutskaya, A | 1 |
| Kreiswirth, BN; Kurepina, N; Meinke, PT; Olsen, DB; Singh, SB; Xu, L; Young, K | 1 |
| Aarnoutse, R; Boeree, MJ; Charalambous, S; Churchyard, G; Colbers, A; Dawson, R; Diacon, AH; Gillespie, SH; Hanekom, M; Heinrich, N; Henne, S; Hoelscher, M; Hunt, RD; Kibiki, GS; Manyama, C; Mekota, A; Minja, LT; Mpagama, SG; Mtafya, B; Narunsky, K; Ntinginya, NE; Phillips, PPJ; Rehal, S; Reither, K; Sanne, I; Semvua, HH; van Balen, GP; Venter, A; Wallis, RS | 1 |
| Cudahy, PG; Denkinger, CM; Nathavitharana, RR; Pai, M; Schumacher, SG; Steingart, KR | 1 |
| Buzibye, A; Byakika-Kibwika, P; Castelnuovo, B; Corti, N; Fehr, J; Gutteck, U; Kambugu, A; Kamya, MR; Lamorde, M; Ledergerber, B; Manabe, YC; Muller, D; Scherrer, AU; Sekaggya-Wiltshire, C; von Braun, A | 1 |
| Baya, B; Belson, M; Coulibaly, N; Coulibaly, YI; Dao, S; Dembele, BPP; Diabate, S; Diallo, MH; Diallo, S; Diarra, B; Goita, D; Kone, A; Kone, B; M'Baye, O; Maiga, M; Murphy, RL; Orsega, S; Polis, MA; Saleeb, P; Sanogo, M; Sarro, YS; Siddiqui, S; Somboro, AM; Togo, ACG; Traore, B | 1 |
| Deng, Y; Guo, Y; He, L; Li, C; Peng, W; Zuo, C | 1 |
| Al-Shaer, MH; Elewa, H; Iqbal, F; Mansour, H; Salameh, P | 1 |
| Mebrahtu, T; Weldegebreal, S | 1 |
| Rieder, HL; Van Deun, A | 1 |
| Chen, S; Dong, L; Han, Y; Huang, H; Huo, F; Li, Y; Liu, Z; Wang, F; Yu, D | 1 |
| Dhanireddy, S; Eastment, M; McClintock, AH; McKinney, CM; Molnar, A; Narita, M; Park, DR; Pitney, CL | 1 |
| Barnard, M; Dolby, T; Jacobson, KR; Kleinman, MB; Ragan, EJ; Scott, L; Shapira, O; Simpson, J; Stevens, W; Streicher, EM; van Helden, PD; Van Rie, A; Warren, RM; White, LF | 1 |
| Denti, P; Gumbo, T; Lesosky, M; McIlleron, H; Meintjes, G; Pasipanodya, JG; Rockwood, N; Sirgel, F; Wilkinson, RJ | 1 |
| Bañuls, AL; Contamin, L; Dang, AD; Nguyen, HQ; Nguyen, HV; Nguyen, NLT; Nguyen, NV; Nguyen, ST; Nguyen, VAT; Tran, THT; Vu, TT | 1 |
| Reichman, LB | 1 |
| Mendel, C; Murray, S; Spigelman, M | 1 |
| Agibothu Kupparam, HK; Dusthackeer, A; Jayapal, L; Karunaianantham, R; Rajagandhi, V; Ramachandran, G; Swaminathan, S; Thiruvengadam, K; Vedhachalam, C | 1 |
| Andre, E; Martin, A | 1 |
| Chien, JY; Wang, JY | 1 |
| Menzies, D | 1 |
| Dhand, A; Knoll, BM; Nog, R; Wu, Y | 1 |
| Amale, RA; Ashavaid, TF; Chawla, PK; Dherai, AJ; Lokhande, RV; Mahashur, AA; Naik, PR; Soman, R; Udwadia, ZF | 1 |
| Bengtson, HN; da Silva, PE; Gerasimova, YV; Homolka, S; Kolpashchikov, DM; Niemann, S; Reis, AJ; Rohde, KH | 1 |
| Badrane, N; Bengueddour, R; Bouazzi, OE; Bourkadi, JE; Hammi, S; Soulaymani-Bencheikh, R; Tanani, DS; Tebaa, A | 1 |
| Caminero Luna, JA | 1 |
| Ambaw, F; Dagnew, M; Eshetie, S; Gizachew, M; Kumera, G; Moges, F; Tessema, B; Woldie, H | 1 |
| Gokarn, K; Pal, RB | 1 |
| Filipe, P; Machado, AP; Marcos-Pinto, A; Marques, T; Soares-de-Almeida, L | 1 |
| Anthwal, D; Bhalla, M; Bhatnagar, S; Gupta, RK; Haldar, S; Tyagi, JS | 1 |
| Boehme, C; Denkinger, CM; Georghiou, SB; Havumaki, J; Hillemann, D; Ismail, N; Omar, SV; Schumacher, SG | 1 |
| Huamán, M; Otero, L; Seas, C; Sterling, T; Villegas, L | 1 |
| Chen, G; He, JQ; Sandford, AJ; Wang, FJ; Wang, MG; Wang, Y; Wu, SQ; Xiang, X; Zhang, MM | 1 |
| Alvarez, GG; Hamel, C; Hutton, B; Moher, D; Pease, C; Quach, P; Skidmore, B; Wolfe, D; Yazdi, F | 1 |
| Bahi, GA; Bidié, AD; Boyvin, L; Djaman, AJ; M'Boh, GM; Méité, S; N'Guessan, KR; Yeo, K | 1 |
| Cobelens, FG; de Jong, BC; Joloba, ML; Kateete, DP; Lukoye, D; Meehan, CJ; Ssengooba, W; van Leth, F | 1 |
| Boyd, R; Farmer, B; Johnston, V; Krause, VL | 1 |
| Agarwal, A; Airun, M; Bansal, R; Meena, M; Sharma, S | 1 |
| Hara, Y; Horita, N; Ikeda, M; Kaneko, T; Kobayashi, N; Kudo, M; Nagai, K; Nagakura, H; Nagashima, A; Nakashima, K; Narita, A; Sato, T; Shibata, Y; Shinkai, M; Tashiro, K; Ushio, R; Watanabe, H; Yamamoto, M | 1 |
| Conyers, A; Dunlay, J; Griffin, P; Holzschuh, EL; Johnson, K; Martin, G; Province, S; Shemwell, C; Showalter, A; Tausz, N; Walls, C | 1 |
| Haley, CA | 1 |
| Adisse, D; Dagne, Z; Desta, K; Diriba, G; Getahun, M; Kebede, A; Meaza, A; Moga, S; Molalign, H; Tadesse, M; Yaregal, Z; Yenew, B | 1 |
| Babrak, L; Bermudez, LE; Burrows, G; Chinison, JJJ; Danelishvili, L; Hu, J; Morgun, A; Shulzhenko, N | 1 |
| Chaisson, RE; Cohn, S; Denti, P; Dooley, KE; Hoffmann, JD; Lala, SG; Martinson, N; Mashabela, F; McIlleron, H; Msandiwa, R; Shembe, S; Velaphi, S; Wiesner, L | 1 |
| Baek, SO; Han, HH; Ko, HS | 1 |
| Chen, J; Chen, L; Du, Y; Peng, P; Rao, Y; Ren, Y; Wang, W | 1 |
| Cardoso, RF; de Almeida, AL; de Souza Filho, AF; Franco, MMJ; Heinemann, MB; Miyata, M; Paes, AC; Pavan, FR; Ribeiro, MG; Sakate, RI | 1 |
| Mujahid, M; Rahman, MA; Urfi, MK | 1 |
| Caws, M; Dang, HTM; Day, J; Do, TDA; Heemskerk, AD; Le, TTP; Nguyen, BD; Nguyen, LH; Nguyen, MTH; Nguyen, TTT; Thwaites, GE; Vinh Nguyen, CV; Wolbers, M | 1 |
| Ahn, Y; Eun, BW; Kim, HJ; Ryoo, S; Yoon, HH | 1 |
| Chen, T; Guo, CX; Guo, HX; Huang, XC; Li, HC; Li, ZY; Sun, Q; Wei, WJ; Wu, ZH; Zhang, CC; Zhong, Q; Zhou, L | 1 |
| Desmond, E; Feng, JY; Flood, J; Graviss, EA; Hopewell, PC; Janes, M; Jarlsberg, LG; Jost, KC; Kato-Maeda, M; Lin, SG; Moonan, PK; Nahid, P; Osmond, DH; Rose, J; Salcedo, K; Soehnlen, MK | 1 |
| Llerena, C; Medina, R | 1 |
| Castro, C; Llerena, C; Puerto, G; Ricardo, A; Zabaleta, A | 1 |
| Llerena, C; Murcia, M; Valbuena, A; Zabaleta, A | 1 |
| Abanda, NN; Djieugoué, JY; Eyangoh, SI; Leke, RGF; Lim, E; Mbacham, WF; Pefura-Yone, EW; Penlap, VM; Taylor, DW; Vernet, G | 1 |
| Ansari, K; Chaturvedi, A; Chourey, M; Desikan, P; Kumar, P; Mirza, SB; Pandey, M; Panwalkar, N; Varathe, R | 1 |
| Chauhan, DS; Dashora, D; Goyal, S; Gupta, KN; Katoch, K; Katoch, VM; Kumar, M; Kumar, V; Malhotra, B; Sharma, B; Sharma, VD | 1 |
| Bamrah-Morris, S; Chorba, T; Griffin, P; Ho, CS; Holcombe, JM; Hunt, G; Jereb, J; Lobato, MN; Marco, A; Marks, S; Mase, S; Moro, RN; Mukasa, L; Nwana, N; Patil, N; Sandul, AL; Shah, N; Stewart, B; Wang, SH; Webb, R | 1 |
| Anthony, RM; Barcellos, RB; Bergval, I; Costa, ERD; Esteves, LS; Kritski, A; Nunes, LS; Oliveira, MM; Ramalho, DM; Rodenbusch, R; Rossetti, ML; Santos, PFGD; Sengstake, S; Viveiros, M | 1 |
| Kubo, M; Omonge, E; Otieno, F; Shiruli, B | 1 |
| Bakker-Woudenberg, IAJM; Davies, GR; de Knegt, GJ; de Steenwinkel, JEM; Dickinson, L; Evangelopoulos, D; McHugh, TD; Pertinez, H | 1 |
| Du, J; Gao, J; Gao, M; Li, L; Liu, Y; Ma, L; Mi, F; Tang, S; Zhang, Y | 1 |
| Cheng, SM; Guan, HY; Jia, ZW; Jin, YY; Liu, XL; Lu, ZH; Tan, WG; Wu, QF; Yang, YZ; Zhao, MG; Zhu, L | 1 |
| Chen, C; Li, GL; Liu, Q; Lu, W; Martinez, L; Wang, JM; Zhu, LM | 1 |
| Attar, A; Bakir, C; Birbir, M; Cakmakci, E; Danis, O; Demir, S; Ogan, A; Yuce-Dursun, B | 1 |
| Costa, DL; Dzutsev, A; Glickman, MS; Maiga, M; Mittereder, LR; Namasivayam, S; Sher, A; Thovarai, V; Trinchieri, G; Wipperman, MF; Yuan, W | 1 |
| Khan, MI; Mahmood, N; Munir, S; Shahid, S | 1 |
| Kwak, M; Lee, SH; Lee, WK; Lim, YJ; Ryoo, S | 1 |
| Arora, S; Ghosh, B; Goel, N; Kumar, V | 1 |
| Li, L; Sun, XW; Wang, Z; Xiao, H; Zhang, CL; Zhang, H | 1 |
| Indumati, V; Krishnaswamy, D; Rajeshwari, V; Ramesh, A; Shantala, D; Shilpa, A; Vijay, V | 1 |
| Chopra, KK; Hanif, M; Khanna, A; Shrivastava, D; Vashistha, H | 1 |
| Feng, M; He, JQ; Zhang, M | 1 |
| Booth, H; Breuer, J; Brown, M; Burgess, C; Doyle, R; Gorton, R; McHugh, TD; Morris-Jones, S; Nimmo, C; Williams, R | 1 |
| Chellini, PR; Franco, PHC; Oliveira, MAL; Pianetti, GA | 1 |
| Gleeson, F; Larson, A; Rajan, E | 1 |
| Baghaei, P; Farnia, P; Jabbehdari, S; Marjani, M; Moniri, A; Tabarsi, P; Velayati, AA | 1 |
| Bax, HI; de Knegt, GJ; de Steenwinkel, JEM; Mourik, BC; Mouton, JW; Verbon, A | 1 |
| Alvarez-Maya, I; Gonzalez-Barrios, JA; Gonzalez-Palomar, G; Lopez-Avalos, G; Lopez-Rodriguez, M; Miranda-Hernández, U; Mora-Aguilera, G; Sandoval-Diaz, M; Vazquez-Chacon, CA; Villanueva-Arias, JC | 1 |
| Beer, N; Harris, RJ; Lipman, MC; Stagg, HR; van der Werf, MJ; Zenner, D | 1 |
| Ho, PL; Lau, TC; Leung, KS; Shek, VC; Siu, GK; Tam, KK; To, SW; Tse, CW; Wong, SS; Yam, WC | 1 |
| Dilrukshi, MDSA; Gnanathasan, CA; Ratnayake, CAP | 1 |
| Agarwal, P; Aggarwal, A; Behera, D; Khaneja, R; Sethi, S; Singh, S; Yadav, R | 1 |
| Amruthavalli, C; Nachappa, SA; Neelambike, SM; Ramachandra, NB | 1 |
| Andreou, A; Gerhardy, B; Nagel, RA; Sellars, R | 1 |
| Alene, KA; Bai, L; Clements, ACA; Gray, DJ; McBryde, ES; Viney, K; Xu, Z; Yang, K; Yi, H | 1 |
| Anupurba, S; Balgam, S; Fakir, NA; Gupta, A; Nema, V; Pal, SK; Pandey, D; Periera, M; Rathod, S; Sekar, G; Sinha, D; Sinha, P; SivaKumar, S; UmaDevi, KR | 1 |
| Barry Iii, CE; Cole, ST; Dartois, V; Duque-Correa, MA; Gengenbacher, M; Kaiser, P; Kaufmann, SHE; Lazar, D; Makarov, V; Nayyar, A; Reece, ST; Schuerer, S; Zedler, U | 1 |
| Amin, M; Aslani, HR; Feizabadi, MM; Halabian, R; Imani Fooladi, AA; Nasiri, MJ; Pormohammad, A; Zamani, S | 1 |
| Aarnoutse, RE; Boeree, MJ; Colbers, A; Gillespie, SH; Haraka, F; Hoelscher, M; Kibiki, GS; Logger, JGM; Magis-Escurra, C; Mpagama, SG; Mtabho, CM; Phillips, PPJ; Plemper van Balen, G; Reither, K; Semvua, HH; Sumari-de Boer, IM; Te Brake, LHM; van den Boogaard, J; Wattenberg, M | 1 |
| Andres, S; Feuerriegel, S; Havlicek, J; Labugger, I; Merker, M; Niemann, S; Rivera-Milla, E; Slickers, P | 1 |
| Bay, ML; Besedovsky, H; Bongiovanni, B; Bottasso, O; Brandan, N; D'Attilio, L; Del Rey, A; Díaz, A; Dídoli, G; Fernández, RDV; Gardeñez, W; Kovalevski, L; Lioi, S; Nannini, LJ; Santucci, N | 1 |
| Saikia, UN; Sharma, R; Sharma, S; Verma, I | 1 |
| Chandrasekaran, V; Kawaskar, M; Kumar, AK; Kumar, AKH; Lavanya, J; Ramachandran, G; Swaminathan, S | 1 |
| Jinbo, J; Kloetzel, M; Lustik, M; West, GF | 1 |
| Allender, C; Colman, RE; Engelthaler, DM; Lemmer, D; Metcalfe, JZ; Penaloza, R; Streicher, E; Theron, G; Warren, RM | 1 |
| DeJesus, MA; Ehrt, S; Engelhart, CA; Healy, C; Ioerger, TR; Lin, K; Park, SW; Rücker, N; Schnappinger, D; Wang, R; Wright, MG; Xu, W | 1 |
| Dhlamini, Z; Mandishora, RSD; Munemo, E; Stray-Pedersen, B; Takawira, FT | 1 |
| Gao, TJ; Han, L; Ma, SB; Wang, L; Wang, LQ; Wu, JF; Zhang, ZG | 1 |
| Buzibye, A; Castelnuovo, B; Corti, N; Fehr, J; Gutteck, U; Henning, L; Kambugu, A; Lamorde, M; Ledergerber, B; Muller, D; Musaazi, J; Sekaggya-Wiltshire, C; von Braun, A | 1 |
| Meintjes, G; Rockwood, N; Sirgel, F; Streicher, E; Warren, R; Wilkinson, RJ | 1 |
| Chen, G; Feng, M; He, JQ; Ji, GY; Liu, QQ; Wang, Y; Wu, JC; Wu, SQ; Zhang, MM | 1 |
| Chang, HY; Chen, CJ; Chen, JJ; Cheng, WK; Lee, YR; Lim, YP; Lin, YN | 1 |
| Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS | 1 |
| He, XC; Li, HC; Liu, Y; Tao, NN; Yu, CB; Zhang, XX | 1 |
| Giribhattanavar, P; Kumar, K; Patil, S; Sagar, C | 1 |
| Chapman, ALN; Shepherd, JG | 1 |
| Aono, A; Chikamatsu, K; Igarashi, Y; Mitarai, S; Takaki, A; Yamada, H; Yi, L | 1 |
| Duckett, SB; Green, GGR; Norcott, P; Rayner, PJ | 1 |
| Boonsarngsuk, V; Chavalertsakul, K; Saengsri, S; Santanirand, P | 1 |
| Boetker, JP; Bohr, A; Colombo, S; Genina, N; Harmankaya, N; Rantanen, J | 1 |
| Charof, R; Cherki, W; Ennassiri, W; Filali-Maltouf, A; Jaouhari, S; Lahlou, O; Sabouni, R | 1 |
| Boldrin, F; Espinosa, DM; Hernandez-Pando, R; Manganelli, R; Palù, G; Payan, JB; Pisu, D; Provvedi, R | 1 |
| Baillie, T; Cho, D; Lee, CK; Moses, J; Sivasubramaniam, R; Tjokrowidjaja, A | 1 |
| Arguello Perez, E; Brown, AE; Eisenstein, C; Schneider, WJ; Seo, SK | 1 |
| Chesov, D; Ciobanu, N; Crudu, V; Heyckendorf, J; Lange, C | 1 |
| Horsburgh, CR; Linas, BP; Marks, SM; Salomon, JA; Tasillo, A; Trikalinos, TA | 1 |
| Dezfuli, SK; Goodarzi, H; Hashemzadeh, M; Khosravi, AD; Mohajeri, P; Shahraki, AH | 1 |
| Bi, LJ; Deng, JY; Li, CY; Wang, DB; Zhang, JB; Zhang, XE; Zhang, ZT | 1 |
| Ader, F; Dumitrescu, O; Genestet, C; Goutelle, S; Lina, G; Pichat, C | 1 |
| Fairbairn, I; Gray, A; MacKenzie, J; Nimmo, A; Patel, A | 1 |
| Elias, J; Kohlmorgen, B; Schoen, C | 1 |
| Chen, J; Chiang, CY; Innes, AL; Li, L; Xu, L | 1 |
| Bonamonte, D; Costa, D; Fortarezza, F; Saracino, A | 1 |
| Barbero, S; Davis, JL; Haynesworth, K; Jacobs, J; Jarlsberg, L; Lewinsohn, DM; Mathew, A; Nahid, P; Schorey, J; Segal, MR; Sigal, GB; Small, N; Wang, M; Weiner, M; Whitworth, WC | 1 |
| Arevalo, B; Belknap, R; Borisov, AS; Caylà, JA; Chen, MP; Feng, PJ; Holland, D; Martinson, NA; Millet, JP; Miró, JM; Moro, RN; Scott, NA; Villarino, ME; Weiner, M; Wright, A | 1 |
| Anukool, U; Butr-Indr, B; Gamngoen, R; Intorasoot, S; Jaresitthikunchai, J; Kasinrerk, W; Phaonakrop, N; Phunpae, P; Putim, C; Roytrakul, S; Tayapiwatana, C; Tharincharoen, CS; Tragoolpua, K | 1 |
| de Kock, M; Denti, P; Garcia-Prats, AJ; Hesseling, AC; McIlleron, H; Norman, J; Schaaf, HS; Tikiso, T; van der Laan, LE; Wiesner, L; Winckler, J | 1 |
| Chatterjee, A; Mistry, N; Nilgiriwala, K; Saranath, D; Sriraman, K | 1 |
| Chang, HY; Chen, CJ; Chen, JJ; Cheng, WK; Lee, YR; Lim, YP; Lin, YN; Ma, WC | 1 |
| Bawa, Z; Bradley, P; Crook, DW; Del Ojo Elias, C; Foster, D; Iqbal, Z; Mowbray, J; Peto, TEA; Quan, TP; Rathod, P; Smith, EG; Walker, AS; Walker, T; Wyllie, DH | 1 |
| Huh, HJ; Jeon, K; Jeong, BH; Kim, S; Lee, H; Lee, NY; Park, HY | 1 |
| Charfi, S; Ghorbel, A; Mnejja, M; Sellami, M | 1 |
| Ameni, G; Assefa, M; Demisse, D; Getachew, Z; Kebede, A; Tedla, Y; Yenew, B | 1 |
| Addo, KK; Addo, SO; Bonsu, FA; Mensah, GI; Mosi, L | 1 |
| Ameni, G; Medihn, G; Mersha, W; Tamirat, M; Teklu, T; Wondale, B | 1 |
| Abanda, NN; Deng, Y; Djieugoué, JY; Eyangoh, SI; Khadka, VS; Leke, RGF; Mbacham, WF; Pefura-Yone, EW; Penlap, VM; Taylor, DW; Vernet, G | 1 |
| Biggs, B; Chen, C; Denholm, JT; Eisen, D; Leder, K; Matchett, E; McBryde, ES; Shultz, TR; Street, A | 1 |
| Bonora, S; Calcagno, A; Motta, I | 1 |
| Clifton, DA; Crook, DW; Iqbal, Z; Niehaus, KE; Peto, TEA; Smith, EG; Walker, AS; Walker, TM; Wilson, DJ; Yang, Y; Zhu, T | 1 |
| Hsia, YC; Naseri, A; Schallhorn, JM | 1 |
| Alameda-Martin, L; Coates, A; Davies, G; Harrison, T; Hu, Y; Liu, Y; Ortega-Muro, F; Pertinez, H | 1 |
| Bhavani, PK; Dooley, KE; Gangadevi, NP; Guiastrennec, B; Gupta, A; Karlsson, MO; Kumar, AKH; Ramachandran, G; Savic, RM; Swaminathan, S | 1 |
| Bastard, M; Bonnet, M; Boum, Y; de Beaudrap, P; Kumbakumba, E; Mwanga, JA; Nansumba, M; Orikiriza, P | 1 |
| Antiabong, JF; Lekalakala, RM; Malinga, LA; Maningi, NE; Mbelle, NM | 1 |
| Asumta, Z; Mawarti, H; Rajin, M | 1 |
| Ahmed, P; Gardezi, AH; Ikram, AI; Lalani, FK; Satti, ML; Zaman, G | 1 |
| Jacobs, WR; Kim, J; Vilchèze, C | 1 |
| Jagannath, K; Patel, A; Patel, M; Patel, N; Vora, A | 1 |
| Aggarwal, A; Gupta, M; Gupta, P; Gupta, R; Jalan, N; Kushwaha, S; Manchanda, V; Rawat, P; Thakur, R | 1 |
| Wu, G; Wu, WG; Zheng, QX; Zhou, JB | 1 |
| Chen, Z; Ge, Z; Hei, L; Ma, R; Ma, W; Wang, Q; Xu, G; Zhang, D | 1 |
| Ahmed, AE; Al Ammari, M; Al Essa, M; Al Turaiki, A; Eltigani, SA; Kashkary, AM | 1 |
| Belknap, RW; Chaisson, RE; Goldberg, SV; Leung, CC; Lopez, M; Machado, ES; Moro, RN; Narita, M; Sanchez, J; Schluger, NW; Schwartzman, K; Scott, NA; Sterling, TR; Tepper, NK; Vernon, A; Villarino, ME | 1 |
| Manosuthi, W; Ruxrungtham, K; Siripassorn, K | 1 |
| Alfaro, RM; Brooks, KM; De, P; Dobos, KM; George, JM; Hadigan, C; Kellogg, A; Kovacs, JA; Kumar, P; McLaughlin, M; McManus, M; Mehaffy, C; Pau, AK; Rupert, A | 1 |
| Deml, SM; Dionne, K; Martin, IW; Parrish, NM; Wengenack, NL | 1 |
| Caminero Luna, JA; Cerezo Lajas, A; de Miguel Díez, J; Rodríguez Guzmán, MDC | 1 |
| Chen, Y; Shen, X; Wu, J; Wu, Z; Xu, B; Yuan, Z | 1 |
| Budd, MA; Cook, V; Hajek, J; Johnston, JC; Lester, RT; Marra, F; Ogilvie, G; Romanowski, K; Sadatsafavi, M; Smillie, K; van der Kop, ML | 1 |
| Abebe, M; Ameni, G; Aseffa, A; Desta, K; Tilahun, M; Yamuah, L; Zewude, A | 1 |
| Ahmad Tajudin, LS; Neoh, PF; Tai, ELM | 1 |
| Bian, Y; Cao, J; Huang, C; Liu, L; Mi, Y; Miao, L; Shi, C; Ye, Z | 1 |
| Battini, S; Mannava, MKC; Nangia, A | 1 |
| Adane, K; Dinant, GJ; Spigt, M | 1 |
| Abello, A; Das, AK | 1 |
| Bianchi, L; Chiappini, E; Cordola, C; de Martino, M; Galli, L; Montagnani, C; Piccini, P; Sollai, S; Tersigni, C; Venturini, E | 1 |
| Alvarez-Uria, G; Midde, M | 1 |
| Huang, TH; Lan, CE; Wei, YC | 1 |
| An, J; Bai, X; Cai, H; Chu, N; Gao, M; Huang, C; Huang, H; Li, B; Li, L; Pang, Y; Xu, H; Zhang, F; Zhang, X | 1 |
| Maeurer, M; Rao, M; Valentini, D; Zumla, A | 1 |
| Agiboth, HKK; Angamuthu, P; Arasan, G; Ayyamperumal, M; Chandrasekaran, P; Chockalingam, C; Gopalan, N; Jayabal, L; Jayanthi, N; Kannabiran, BP; Kesavamurthy, B; Krishnamoorthy, V; Krishnaraja, R; Lakshman, S; Manoharan, T; Menon, PA; Murali, L; Narayanan, R; Palaniappan, AN; Ramachandran, R; Rathinam, P; Rathinam, S; Reddy, D; Santhanakrishnan, RK; Satagopan, K; Sathiyavelu, S; Selvachitiram, M; Sivaramakrishnan, GN; Suresh, C; Susaimuthu, S; Swaminathan, S; Tripathy, SP | 1 |
| Ahmad, Z; Amin, S; Bhat, BA; Bhat, ZS; Lone, AM; Maqbool, M; Rather, MA | 1 |
| Caws, M; Day, J; Dung, NH; Dunstan, S; Farrar, J; Ha, DTM; Hanh, NT; Hội, NV; Hồng, NT; Kiet, VS; Lan, NH; Lan, NN; Lan, NTN; Liễu, PTT; Minh, HQ; Nghĩa, NV; Nhu, NTQ; Thai, PVK; Thanh, NTK; Thơm, NV; Thuong, NT; Đại, TN; Điệp, ĐC | 1 |
| Buzibye, A; Byakika-Kibwika, P; Castelnuovo, B; Corti, N; de Kock, M; Denti, P; Eberhard, N; Fehr, JS; Gutteck, U; Henning, L; Jetter, A; Joloba, M; Kambugu, A; Kamya, MR; Lamorde, M; Ledergerber, B; Manabe, YC; Matovu, J; Muller, D; Musaazi, J; Sekaggya-Wiltshire, C; von Braun, A | 1 |
| Gumbo, T; Pasipanodya, JG | 1 |
| Butr-Indr, B; Gamngoen, R; Phunpae, P; Putim, C; Salee, P | 1 |
| Chen, W; Gao, S; Wang, Z; Xi, Y; Xie, X; Yang, Y; You, C | 1 |
| Aldashev, A; Aldasheva, N; Goncharova, Z; Isakova, J; Sovkhozova, N; Talaibekova, E; Vinnikov, D | 1 |
| Falzon, D; Halleux, CM; Jaramillo, E; Merle, C; Mirzayev, F; Olliaro, P; Weyer, K | 1 |
| Alvarez, GG; Barbeau, P; Hamel, C; Hutton, B; Pease, C; Skidmore, B; Wolfe, D; Yazdi, F | 1 |
| Andres, S; Behn, T; Haasis, C; Hillemann, D; Kranzer, K | 1 |
| Migliori, GB; Sotgiu, G; Tiberi, S | 1 |
| Leong, BCS; Lightman, S; McCluskey, PJ; Tomkins-Netzer, O; Zhang, X | 1 |
| Beyene, T; Desissa, F; Workineh, T | 1 |
| Churchyard, GJ; Dowdy, DW; Johnson, KT; Sohn, H | 1 |
| Atwine, D; Bonnet, M; Taburet, AM | 1 |
| Acar, EM; Bayramoğlu, Z; Çalışkan, E; Erköse, G; Hançerli Törün, S; Kılıçaslan, Z; Şatana, D; Somer, A | 1 |
| Carrera-Pineda, R; Garcia-Luna, RC; Soto-Cabrera, E; Villamil-Osorio, LV | 1 |
| Jung, BH; Lee, SG; Park, JI | 1 |
| Chen, DY; Chen, HH; Chen, YM; Liao, TL | 1 |
| Blackwell, G; Bowker, R; Broda, A; Casali, N; Drobniewski, F; Hume, J; Hussain, W; Khan, H; Nikolayevskyy, V; Patel, B | 1 |
| Alffenaar, JC; Gumbo, T; Pasipanodya, JG; van der Werf, TS; van Soolingen, D; Zuur, MA | 1 |
| Bu, P; Chen, KY; Dartois, V; Fu, DJ; Huang, L; Kaya, F; Nazarova, EV; Rakhilin, N; Russell, DG; Shen, X; Wang, L; Xu, Y; Zimmerman, MD | 1 |
| Stock, D | 1 |
| Arslan, K; Ayca, B; Efe, SC; Karabag, T; Taner, U | 1 |
| Al-Shaer, MH; Alghamdi, WA; Peloquin, CA | 1 |
| Li, Q; Liu, W; Lu, M; Qian, HZ; Wang, K; Wang, L; Wu, L; Wu, Y; Xie, L; Zhao, G | 1 |
| Kirschner, DE; Linderman, JJ; Pienaar, E | 1 |
| Assefa, Y; Getahun, H; Hamada, Y; Woldeyohannes, S | 1 |
| Das, A; Das, SK | 1 |
| Bokhari, H; Ibrahim, M; Khurshid, M; Yan, C; Yar, AM; Zaman, G | 1 |
| Agrawal, S; Anjum, R; Gupta, A; Mallik, D | 1 |
| Nwidu, LL; Teme, RE | 1 |
| Bollela, VR; Dippenaar, A; Feliciano, CS; Namburete, EI; Peronni, K; Rodrigues Plaça, J; Silva, WA; Warren, RM | 1 |
| Guan, W; LaZhou, C; Lin, S; Shi, Y | 1 |
| Brucoli, F; Fattorini, L; Giannoni, F; Iacobino, A | 1 |
| Copeland, J; Jacobs, WR; Jain, P; Keiser, TL; Malek, A; Vilchèze, C; Washington, J; Weinrick, B; Weisbrod, T | 1 |
| Joloba, ML; Kasule, GW; Katabazi, FA; Kateete, DP; Kigozi, E; Kyobe, S; Lukoye, D; Musisi, K; Wampande, EM | 1 |
| Choi, EY; Kim, JS; Kim, KJ | 1 |
| Chen, H; Song, X; Wang, W; Wu, S; Xiong, W; Yu, X | 1 |
| Cui, X; Li, BN; Li, G; Li, L; Ma, YG; Shi, F; Wang, F; Wang, H; Wang, L; Weng, J; Zhang, C; Zhou, CX; Zhou, Z | 1 |
| Al-Dhabi, NA; Balakrishna, K; Darvin, SS; Esakkimuthu, S; Ignacimuthu, S; Pandikumar, P; Paulraj, MG; Toppo, E | 1 |
| Addise, D; Admasu, A; Amare, M; Beyene, D; Dagne, B; Mesfin, EA; Tesfaye, A; Tesfaye, E; Tessema, B; Yaregal, Z | 1 |
| Chipungu, G; Chiumya, K; Kaimila, Y; Kumwenda, GP; Pangani, H; Sloan, DJ | 1 |
| Benmerzoug, S; Garcia, I; Gosset, D; Jacobs, M; Mackowiak, C; Marinho, FV; Poisson, E; Quesniaux, VFJ; Rose, S; Ryffel, B; Sedda, D; Uyttenhove, C; Van Snick, J | 1 |
| Chen, TC; Chen, YH; Chiu, YW; Hsieh, MH; Hwang, SJ; Lin, SY; Lu, PL | 1 |
| Borisov, AS; Moro, RN; Morris, SB; Njie, GJ; Vernon, AA; Woodruff, RY | 1 |
| Dong, W; Fan, J; Huang, H; Jiang, G; Lan, T; Li, Y; Ma, Y; Qin, S; Shang, Y; Tang, K; Wang, G; Yan, G | 1 |
| Chandrasekaran, V; Kannan, T; Kumar, AKH; Lavanya, J; Ramachandran, G; Swaminathan, S | 1 |
| Allen, L; Bamrah Morris, S; Borisov, AS; Burton, D; Goldberg, S; LoBue, P; Njie, GJ; Vernon, A; Winston, CA; Yelk Woodruff, R | 1 |
| McGuffin, SA; O'Hare, AM; Olson, AP; Trowbridge, RL | 1 |
| Abreha, G; Ameya, G; Debela, T; Gobena, D; Haile, K; Worku, Y | 1 |
| Hadda, V; Khilnani, GC; Madan, K; Mittal, S; Mohan, A; Tiwari, P | 1 |
| Flexner, C; Moss, DM; Owen, A; Podany, AT; Rajoli, RKR; Siccardi, M; Swindells, S | 1 |
| Cai, X; Chen, T; Guo, L; Liao, W; Ma, D; Tan, W; Wang, W; Wu, T; Xiang, W; Yu, W; Zhang, J; Zhou, J | 1 |
| Chiang, TY; Fan, SY; Jou, R | 1 |
| Ahmad, M; Ahmad, W; Akbar, HS; Akbar, MT; Jan, F; Khalid, A; Sadia, S; Wali, S | 1 |
| Cho, E; Kim, S; Lee, H; Lee, JS; Uh, Y; Wang, HY | 1 |
| Chan, PC; Chang, LY; Chuang, YC; Huang, WC; Huang, YW; Ruan, SY; Sun, HY; Wang, JT; Wang, JY | 1 |
| Carvalho, TDSC; Corrêa Barros, LP; da Silva, PEA; de Moura, KCG; Del Rio, KP; Halicki, PCB; Pinto, MDCFR; Ramos, DF | 1 |
| Baldin, VP; Caleffi-Ferracioli, KR; Campanerut-Sá, PAZ; Cardoso, RF; de Almeida, AL; Nakamura de Vasconcelos, SS; Santos, NCS; Scodro, RBL; Siqueira, VLD | 1 |
| Ader, F; Bernard-Barret, F; Dumitrescu, O; Genestet, C; Ginevra, C; Goutelle, S; Hodille, E; Lina, G | 1 |
| Gardezi, AH; Ikram, A; Khadim, MT; Satti, L; Tayyab, N; Zaman, G | 1 |
| Adjobimey, M; Apriani, L; Benedetti, A; Diallo, T; Elwood, K; Fregonese, F; Gninafon, M; Hill, PC; Hornby, K; Li, PZ; Long, R; Marks, GB; Menzies, D; Obeng Baah, J; Ruslami, R; Schwartzman, K; Sow, O; Trajman, A; Valiquette, C; Wulandari, DA; Zielinski, D | 1 |
| Adjobimey, M; Al-Jahdali, H; Apriani, L; Bah, B; Benedetti, A; Boakye, I; Camara, A; Cook, VJ; Dion, MJ; Elwood, K; Gninafon, M; Goldberg, H; Hill, PC; Hoeppner, V; Hornby, K; Kim, H; Koesoemadinata, RC; Kritski, A; Li, PZ; Long, R; Marks, GB; Menzies, D; Obeng Baah, J; Rolla, V; Ruslami, R; Schwartzman, K; Sow, O; Trajman, A; Valiquette, C | 1 |
| Belknap, RW; Haas, MK | 1 |
| Adamson, JH; Govender, K; Owira, P | 1 |
| Boffito, M; Cerrone, M; Day-Weber, I; Fedele, S; Hill, A; McClure, M; Neary, M; Owen, A; Wang, X; Weaver, C | 1 |
| Avni, T; Bercovici, E; Hodak, E; Pavlovsky, L; Shitenberg, D; Snast, I | 1 |
| Bairy, I; Gaonkar, SL; Guru, BR; Hakkimane, SS; Shenoy, VP | 1 |
| Aleksa, A; Alffenaar, JWC; Postma, MJ; van 't Boveneind-Vrubleuskaya, N; van Asselt, ADI; Zuur, MA | 1 |
| Kotwal, A; Maheshwari, R; Raghuvanshi, S; Sindhwani, G | 1 |
| Alfarisi, O; Atre, S; Barthwal, M; Chon, S; Deshmukh, S; Dooley, KE; Gaikwad, S; Golub, JE; Gupta, A; Gupte, N; Kakrani, A; Kulkarni, V; Kumar, H; Lokhande, R; Mave, V; Ramachandran, G; Raskar, S; Sahasrabudhe, T | 1 |
| Abrahem, R; Cao, R; Gyurjian, K; Islamoglu, H; Munjal, S; Teskey, G; Venketaraman, V; Zhong, L | 1 |
| Barnard, M; Dolby, T; Jacobson, KR; Jenkins, HE; Kleinman, MB; McIntosh, AI; Murray, MB; Ragan, EJ; Simpson, J; Streicher, EM; Thomson, DR; van Helden, PD; Warren, RM; White, LF | 1 |
| Alland, D; Boom, WH; Chakravorty, S; Chippada Venkata, UD; Colangeli, R; Connell, R; Diem, L; Dietze, R; Gupta, A; Jedrey, H; Johnson, JL; Kim, S; Ma, S; Mac Kenzie, WR; Okwera, A; Sherman, DR; Sizemore, EE | 1 |
| Kadota, K | 1 |
| Bagga, P; Meena, SZ; Mujahid, M; Rahman, MA | 1 |
| Bhaskar, N; Chauhan, DS; Gothwal, A; Gupta, U; Gupta, UD; Khan, I; Pachouri, PK; Rani, S | 1 |
| Dong, R; Ge, D; Han, Y; Ke, X; Li, B; Liao, Y; Luo, W; Lv, J; Wang, C; Wang, J; Yu, H; Zhang, C | 1 |
| Han, Y; Xia, S; Zhou, J | 1 |
| Lawlor, M; Nothling, S; Yates, WB | 1 |
| Alffenaar, JC; Heysell, SK; Mpagama, SG | 1 |
| Bonnet, S; Leflot, M | 1 |
| Affolabi, D; Bah-Sow, O; Chirehwa, MT; Denti, P; McIlleron, H; Merle, C; Wiesner, L | 1 |
| Allix-Béguec, C; Arandjelovic, I; Beckert, P; Bi, L; Bonnet, M; Bradley, P; Cabibbe, AM; Cancino-Muñoz, I; Caulfield, MJ; Chaiprasert, A; Cirillo, DM; Clifton, DA; Comas, I; Crook, DW; De Filippo, MR; de Neeling, H; Diel, R; Drobniewski, FA; Faksri, K; Farhat, MR; Fleming, J; Fowler, P; Fowler, TA; Gao, Q; Gardy, J; Gascoyne-Binzi, D; Gibertoni-Cruz, AL; Gil-Brusola, A; Golubchik, T; Gonzalo, X; Grandjean, L; Guthrie, JL; He, G; Hoosdally, S; Hunt, M; Iqbal, Z; Ismail, N; Johnston, J; Khanzada, FM; Khor, CC; Kohl, TA; Kong, C; Lipworth, S; Liu, Q; Maphalala, G; Martinez, E; Mathys, V; Merker, M; Miotto, P; Mistry, N; Moore, DAJ; Murray, M; Niemann, S; Omar, SV; Ong, RT; Peto, TEA; Posey, JE; Prammananan, T; Pym, A; Rodrigues, C; Rodrigues, M; Rodwell, T; Rossolini, GM; Sánchez Padilla, E; Schito, M; Shen, X; Shendure, J; Sintchenko, V; Sloutsky, A; Smith, EG; Snyder, M; Soetaert, K; Starks, AM; Supply, P; Suriyapol, P; Tahseen, S; Tang, P; Teo, YY; Thuong, TNT; Thwaites, G; Tortoli, E; van Soolingen, D; Walker, AS; Walker, TM; Wilcox, M; Wilson, DJ; Wyllie, D; Yang, Y; Zhang, H; Zhao, Y; Zhu, B | 1 |
| Doan, TN; Fox, GJ; McBryde, ES; Meehan, MT; Ragonnet, R; Scott, N; Trauer, JM; Viney, K | 1 |
| Choi, JY; Ha, EJ; Kang, YA; Kim, SJ; Kim, SY; Kim, YS; Lee, EH; Leem, AY; Park, ES; Park, MS | 1 |
| Alarcón, V; Alarcón-Arrascue, E; Chávez Inagaki, O; Heldal, E; Mendoza-Ticona, A; Moore, DAJ; Obregón, G; Puyén, ZM; Zevallos, K | 1 |
| Chan, DP; Chang, KC; Leung, CC; Yew, WW; Zhang, Y | 1 |
| Adriano, LHC; Amorim, TL; Chellini, PR; de Oliveira, MAL; Duarte, LM | 1 |
| Cao, X; Chen, X; Chen, Y; Cui, W; Feng, B; Gao, L; Guan, L; Guan, X; Jin, Q; Li, H; Li, X; Liu, J; Liu, Z; Ma, Y; Pan, S; Shen, F; Wang, D; Xin, H; Yan, J; Zhang, H; Zhang, Z; Zhou, X | 1 |
| Arreh, WI; Baptiste, E; Bouzid, F; Delerce, J; Drancourt, M; Garnotel, E; Hassan, MO; Levasseur, A; Osman, DA | 1 |
| Chen, DC; Feng, YG; Jia, JJ | 1 |
| Augustino, D; Gratz, J; Heysell, SK; Houpt, ER; Justine, M; Kibiki, GS; Kivuyo, S; Mduma, E; Mfinanga, S; Mmbaga, B; Nicodemu, I; Peloquin, CA; Thomas, TA; Yeconia, A; Zagurski, T | 1 |
| Bruchfeld, J; Fröberg, G; Jansson, L | 1 |
| Ardrey, A; Davies, G; Jave, O; López-Romero, SL; Moore, DAJ; Requena-Méndez, A; Ward, SA; Waterhouse, D | 1 |
| Andersen, HE; Arnesen, TM; Dyrhol-Riise, AM; Madebo, T; Schein, YL; Tveiten, H; White, RA; Winje, BA | 1 |
| Burzynski, J; Chuck, C; Haque, A; Lam, CK; Macaraig, M; McGinnis Pilote, K | 1 |
| Fitzgerald, DW; Lee, MH; Mathurin, LD; McAulay, K; Nathan, CF; Ocheretina, O; Pape, JW; Royal-Mardi, G; Saito, K; Walsh, KF; Warrier, T | 1 |
| Sun, YX; Xu, L; Zhan, SY | 1 |
| Ahn, H; Cho, YJ; Choi, HS; Choi, SM; Hahn, S; Han, J; Heo, EY; Hwang, YR; Jeong, I; Jo, YS; Joh, JS; Ki, J; Kim, DK; Kim, H; Kim, HS; Kim, J; Kim, SJ; Kwak, N; Lee, CH; Lee, J; Lee, JH; Lee, JK; Lee, JY; Lee, M; Lee, SH; Lee, SM; Lee, YJ; Lim, JN; Park, JH; Park, JS; Park, SS; Park, YS; Song, T; Yim, JJ; Yoon, HI | 1 |
| Dong, RJ; Ge, DY; Han, Y; Ke, XH; Li, B; Liao, Y; Liu, HS; Luo, WZ; Lv, JP; Tu-Erxun, RY; Wang, CG; Wang, J; Wang, YC; Yang, YJ | 1 |
| Alarcón Guizado, VA; Alarcon, E; Cornejo Garcia, JG; Heldal, E; Mendoza Ticona, A; Moore, DAJ | 1 |
| Indumathi, CK; Jain, S; Krishnamurthy, S; Sethuraman, A | 1 |
| Brewer, CT; Chen, T; Edwards, A; Lee, RE; Low, J; Lu, Y; Wu, J; Yang, L | 1 |
| Aung, HL; Basu, I; Bower, JE; Cook, G; Henderson, G; Lowe, O; Newton, S; Roberts, SA | 1 |
| Tadele, H | 1 |
| Nwidu, LL; Oboma, YI | 1 |
| Menzies, D; Trajman, A | 1 |
| Ahmad, SR; Chaudhry, MN; Hameed, S; Mahmood, N; Rahman, MA | 1 |
| Aruldhas, BW; Bose, A; Hoglund, RM; Mathew, BS; Mathew, SK; Ranjalkar, J; Tarning, J; Verghese, VP | 1 |
| Araj, GF; Khazen, G; Panossian, B; Salloum, T; Tokajian, S | 1 |
| Ahmad, S; Al-Mutairi, NM; Eldeen, HS; Joseph, S; Mokaddas, E | 1 |
| Ford, N; Getahun, H; Hamada, Y; Schenkel, K | 1 |
| Allahyar Torkaman, MR; Amini, S; Hamzehloo, G; Hoffner, S; Mir, R; Mohsenpoor, M; Nasiri, MJ; Salehi, M; Sami Kashkooli, G; Shahraki, MS; Soleimanpour, S | 1 |
| Balanag, V; Bielskiene, V; Cadena, E; Caoili, J; Cirule, A; Danilovits, M; Davidaviciene, E; Domente, L; Geiter, LJ; Gupta, R; Hafkin, J; Hittel, N; Lizarbe, V; Patientia, R; Petersen, C; Sanchez, E; Segura, P; Staples, S; Ticona, E; Variava, E; von Groote-Bidlingmaier, F; Wells, C; Yu, C | 1 |
| Aragón Fernández, C; Gomez-Pastrana, D; Morales Pérez, C; Pérez Escolano, E | 1 |
| Ito, K | 1 |
| Amini, S; Feizabadi, MM; Haeili, M; Harati, AA; Kardan-Yamchi, J; Kazemian, H | 1 |
| Huh, HJ; Jhun, BW; Kang, OK; Koh, WJ; Lee, NY; Yoo, IY | 1 |
| Campbell, JR; Fregonese, F; Johnston, JC; Menzies, D; Oxlade, O; Romanowski, K | 1 |
| Ban, GY; Jeong, YJ; Kim, SH; Lee, SH; Park, HS; Shin, SS; Shin, YS; Ye, YM | 1 |
| Capocefalo, A; Castellano, C; Costantino, L; Domenici, F; Iannuccelli, V; Leo, E; Maretti, E; Meneghetti, F; Mori, M; Rogers, S; Truzzi, E | 1 |
| Ronald, BSM; Senthil Kumar, TMA; Sweetline Anne, N; Thangavelu, A | 1 |
| Iwata, K; Nagata, M; Ohji, G | 1 |
| Adams, KN; Adikesavalu, H; Gopalaswamy, R; Hernandez, RE; Ramakrishnan, L; Ranganathan, UD; Sherman, DR; Singhal, DK; Tripathy, S; Urdahl, KB; Verma, AK | 1 |
| Adamson, J; Chirehwa, M; Denti, P; Govender, K; McIlleron, H; Naidoo, A; Naidoo, K; Ncgapu, S; Padayatchi, N; Ramsuran, V; Singh, R; Yende-Zuma, N | 1 |
| Calcagno, A; Castelnuovo, B; Cusato, J; Di Perri, G; Fehr, J; Lamorde, M; Motta, I; Sekaggya-Wiltshire, C; Turyasingura, G; von Braun, A | 1 |
| Dhariwal, A; Divangahi, M; Fontes, G; Khan, N; King, IL; Mendonca, L; Menzies, D; Xia, J | 1 |
| Anh, LTN; Anh, NT; Bestrashniy, J; Britton, WJ; Fox, GJ; Hoa, NB; Hoa, NLP; Jan, S; Lung, T; Marks, GB; Nhung, NV | 1 |
| Abd-Ellatief, RB; Hasanain, AFA; Nafee, AMA; Zayed, AAH | 1 |
| Nair, SG; Patel, DB; Patel, HD; Rathwa, SK; Vasava, MS | 1 |
| Ali, M; Mertaniasih, NM; Novita, BD; Pranoto, A; Soediono, EI | 1 |
| Alcocer, I; Barba, P; Espinel, N; Ortega-Paredes, D; Rojas, Y; Zurita, J; Zurita-Salinas, C | 1 |
| Chen, Y; Li, J; Luo, J; Luo, M; Wei, H; Yang, H; Yi, X; Yu, J | 1 |
| Balganesh, T; Bhavani, PK; Gomathy, SN; Guleria, R; Jawahar, SM; Kumar, H; Natrajan, M; Padmapriyadarsini, C; Ponnuraja, C; Singh, M; Swaminathan, S | 1 |
| Choe, J; Daley, CL; Huh, HJ; Jeon, K; Jhun, BW; Koh, WJ; Kwon, OJ; Lee, NY; Moon, SM | 1 |
| AlMatar, M; Eker, E; Kafkas, E; Kayar, B; Köksal, F; Var, I; Zarifikhosroshahi, M | 1 |
| Chang, AH; Holcombe, M; Lan, E; Marks, SM; Morris, SB; Nwana, N | 1 |
| Andersen, J; Banda, P; Benson, CA; Chaisson, RE; da Silva Escada, RO; Fletcher, CV; Gupta, A; Hakim, J; Jean Juste, MA; Kanyama, C; Lama, JR; Langat, D; Leon-Cruz, J; Masheto, G; Mawlana, S; Mohapi, L; Moran, L; Mwelase, N; Nuermberger, E; Omoz-Oarhe, A; Ramchandani, R; Severe, P; Supparatpinyo, K; Swindells, S; Valencia, J | 1 |
| Evans, CA; Saunders, MJ | 1 |
| Aarnoutse, R; Bergsma-de Guchteneire, I; Boeree, M; Hoefsloot, W; Kuipers, S; Magis-Escurra, C; Seijger, C; Te Brake, L; van Crevel, R; van Ingen, J | 1 |
| Cancino-Muñoz, I; Chiner-Oms, Á; Comas, I; Furió, V; Goig, GA; Guna-Serrano, MR; Moreno-Molina, M; Sanz, F; Torres-Puente, M; Villamayor, LM | 1 |
| Chan, PC; Chen, WW; Chiang, CY; Feng, TY; Huang, YC; Huang, YF; Lee, CC; Lee, PH; Lu, MJ | 1 |
| Ambhore, AN; Dawane, BS; Gacche, RN; Gaikwad, MV; Hebade, MJ; Hese, SV; Kadam, SN; Kamble, RD; Kamble, SS; Meshram, RJ | 1 |
| He, JQ; Liu, Q; Sandford, AJ; Wang, MG; Wang, Y; Wu, SQ; Xue, M; Zhang, MM | 1 |
| Amukoye, E; Nonoh, J; Nyamache, AK; Ogari, CO | 1 |
| Abakur, EHA; Abuduhier, F; Albalawi, FMA; Alfifi, KAS; Alnour, TMS | 1 |
| Kabra, SK; Lodha, R; Mukherjee, A | 1 |
| Chen, X; Hu, X; Liu, T; Peng, W; Song, J; Wu, Q; Ying, B; Zhao, Z | 1 |
| Alene, KA; Clements, ACA; Gray, DJ; McBryde, ES; Melku, M; Viney, K | 1 |
| Li, QF; Li, YJ; Liao, Y; Luo, J; Wang, DM; Wu, GH; Xu, YH; Zhong, J; Zhu, M | 1 |
| Bang, H; Barry, CE; Dartois, V; Eum, S; Fox, WS; Gupta, SV; Lee, M; Savic, RM; Shim, T; Strydom, N; Via, LE; Zimmerman, M | 1 |
| Huerta-García, AP; Magaña-Aquino, M; Medellín-Garibay, SE; Milán-Segovia, RDC; Ortiz-Álvarez, A; Portales-Pérez, DP; Rodríguez-Pinal, CJ; Romano-Moreno, S; Salazar-González, RA | 1 |
| Calderon, R; Contreras, C; Dixit, A; Drobniewski, F; Farhat, MR; Freschi, L; Galea, JT; Kolokotronis, SO; Lecca, L; Mathema, B; Sacchettini, J; Vargas, R; Yataco, R; Zhang, Z | 1 |
| Dharmendra, S; Sharma, E; Sharma, JB; Sharma, S | 1 |
| Barry, PM; Cattamanchi, A; Flood, J; Goodell, AJ; Hill, A; Kahn, JG; Marks, SM; McCabe, D; Porco, TC; Shete, PB; Vreman, R | 1 |
| Blagodatny, V; Brovarets, V; Hodyna, D; Kovalishyn, V; Metelytsia, L; Poda, G; Semenyuta, I; Sinenko, VO; Slivchuk, SR | 1 |
| Ahid, S; Benamor, J; Bourkadi, JE; Cherrah, Y; El Hamdouni, M; Hassar, M | 1 |
| Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G | 1 |
| Brandao, AP; Caiaffa-Filho, HH; Ferrazoli, L; Galesi, VMN; Oliveira, RS; Pinhata, JMW | 1 |
| Aerts, O; Baeck, M; Coster, A; Hainaut, P; Herman, A; Horst, N; Kenyon, C; Marot, L; Vlieghe, E | 1 |
| Gaikwad, S; Ghanekar, C; Pujari, S; Runwal, K; Saldanha, N; Sane, S | 1 |
| Agibothu Kupparam, HK; Balasubramanian, U; Chandrasekaran, P; Dhanasekaran, K; Dooley, KE; Gaikwad, S; Golub, J; Gupta, A; Gupte, A; Gupte, N; Hanna, LE; Kadam, D; Kagal, A; Kulkarni, V; Mave, V; Murali, L; Paradkar, M; Pradhan, N; Ramachandran, G; Shivakumar, SVBY; Sivaramakrishnan, GN; Swaminathan, S; Thiruvengadam, K; Thomas, B | 1 |
| Prasad, K; Vibha, D | 1 |
| Chen, K; Chen, Q; Chen, X; Liu, T; Luo, D; Peng, Y; Xiong, G; Zeng, L | 1 |
| Ajitkumar, P; Nair, RR; Sebastian, J; Sharan, D; Swaminath, S | 1 |
| Amarnath Praphakar, R; Rajan, M; Sam Ebenezer, R; Shakila, H; Sumathra, M; Vignesh, S | 1 |
| Feiterna-Sperling, C; Kirchberger, V; Kölsch, U; Krüger, R; Meisel, C; Thee, S; von Bernuth, H | 1 |
| Li, L; Li, Q | 1 |
| Aucamp, M; Geldenhuys, M; Liebenberg, W; Okaecwe, T; Stieger, N | 1 |
| Andriescu, EC; Khetan, NG; Mazur, L; Smith, KC | 1 |
| Bunte, A; Fätkenheuer, G; Jaspers, N; Jung, N; Lehmann, C; Maria Fünger, S; Mehrkens, D; Plum, G; Reimer, RP; Rybniker, J; Schmidt, M; Suárez, I | 1 |
| Altmann, D; Brodhun, B; Glasauer, S; Haas, W; Hauer, B; Perumal, N | 1 |
| Abebaw, Y; Alemu, A; Amare, M; Dagne, B; Diriba, G; Kebede, A; Meaza, A; Mehamed, Z; Moga, S; Molalign, H; Sied, G; Sinshaw, W; Tadesse, M; Tesfaye, E; Tola, HH; Yenew, B | 1 |
| Canaan, S; Cavalier, JF; Johansen, MD; Kremer, L; Point, V; Poncin, I; Santucci, P; Viljoen, A | 1 |
| Asaoka, M; Baba, T; Hagiwara, E; Katano, T; Kitamura, H; Komatsu, S; Ogura, T; Okuda, R; Sekine, A; Suido, Y | 1 |
| Chorba, T; Goodman, M; Marks, SM; Mase, S; Sharling, L | 1 |
| Barrios-Payán, J; Bello-Monroy, O; Bucio, L; Enríquez-Cortina, C; Gomez-Quiroz, LE; Gutiérrez-Ruiz, MC; Hernández-Pando, R; Marquina-Castillo, B; Mata-Espinosa, D; Miranda, RU; Rodríguez-Ochoa, I; Rosales, P; Souza, V | 1 |
| Ahmad, K; Ali, SA; Fatima, P; Hassan, RM; Jehan, F; Lalani, N; Qamar, FN; Qureshi, S; Sherali, F | 1 |
| Basham, CA; Derksen, S; Kinew, KA; Larcombe, L; Lix, LM; McCulloch, S; Plourde, PJ; Schultz, J | 1 |
| Muntean, PE | 1 |
| Blundell, TL; Kumar, N; Malhotra, S; Munir, A; Nair, D; Natarajan, M; Palaniappan, AN; Parkhill, J; Peacock, SJ; Priyadarshini, P; Ramalingam, SB; Ranganathan, UD; Shanmugam, SK; Tamilzhalagan, S; Tripathy, S | 1 |
| Dodd, PJ; Dooley, KE; Garcia-Prats, AJ; Hesseling, AC; McKenna, L; Radtke, KK; Savic, RM | 1 |
| Akkerman, OW; Alffenaar, JC; Hak, E; Pradipta, IS; Van't Boveneind-Vrubleuskaya, N | 1 |
| Dokoumetzidis, A; Nalda-Molina, R; Sfouni, M; Tsiligiannis, A | 1 |
| Charambira, K; Chirenda, J; Kalisvaart, N; Manyame-Murwira, B; Matambo, R; Metcalfe, JZ; Mutunzi, H; Ngwenya, M; Sandy, C; Scholten, JN; Timire, C | 1 |
| Bhatt, N; Davies, G; Gillespie, SH; Kibiki, GS; Ntinginya, NE; Sabiiti, W; Simonsson, USH; Svensson, RJ | 1 |
| Abbara, A; Abubakar, I; Alexander, E; Booth, H; Bothamley, GH; Creer, DD; Davidson, JA; Harris, RJ; Kon, OM; Kunst, H; Lalor, MK; Lipman, MC; Loebinger, MR; Loutet, MG; Lozewicz, S; McHugh, TD; Milburn, HJ; Mohiyuddin, T; Palchaudhuri, P; Phillips, PPJ; Schmok, E; Stagg, HR; Taylor, L | 1 |
| Álvarez-Díaz, H; García-Rodríguez, JF; Mariño-Callejo, A; Valcarce-Pardeiro, N | 1 |
| Geetha, A; Peter S, J; S, P; Sabina, EP | 1 |
| Dong, H; Liu, Z; Pang, Y; Wang, X; Wu, B; Zhang, M; Zhu, Y | 1 |
| Anthwal, D; Gupta, A; Gupta, NK; Gupta, RK; Haldar, S; Lavania, S; Malhotra, V; Myneedu, VP; Sarin, R; Sharma, PP; Tyagi, JS; Verma, A; Verma, H | 1 |
| Crook, AM; Dawson, R; Diacon, AH; Gillespie, SH; McHugh, TD; Mendel, CM; Meredith, SK; Mohapi, L; Murphy, ME; Nunn, AJ; Phillips, PPJ; Singh, KP; Spigelman, M; Tweed, CD | 1 |
| Altın, S; Hırçın Cenger, D; Kılıç, L; Yazısız, H; Yazısız, V | 1 |
| Escobedo-Sánchez, R; Esparza-Ahumada, S; Flores-Treviño, S; Garza-González, E; González-Díaz, E; León-Garnica, G; Morfín-Otero, R; Pérez-Gómez, HR; Rodríguez-Noriega, E | 1 |
| Acosta, F; Bérmudez Ruiz, P; Correa Ruiz, A; Guzman, A; Montiel Quezel-Guerraz, N; Ortega Torres, M; Pérez Santos, MJ; Sánchez-Porto, A | 1 |
| Bano, S; Becerra, MC; Brooks, MB; Fuad, J; Hussain, H; Malik, AA; Nazish, A; Siddiqui, S | 1 |
| Esmail, H; Lipman, MC; Nunn, A; Walker, TM | 1 |
| Chien, LY; Dlamini, NC; Ji, DD | 1 |
| Chang, TC; Chen, CJ; Huang, HH; Lu, PL; Yang, YC | 1 |
| Hussain, W; Khadim, MT; Khurshid, U; Salim, S; Younis, S; Zaman, G | 1 |
| Bamfo, TD; Bouton, TC; Carter, J; Forson, A; Jacobson, K; Jenkins, H; Kudzawu, S; Kwara, A; Zigah, F | 1 |
| Copas, A; Della Pasqua, O; Gillespie, SH; Hammond, R; Kloprogge, F | 1 |
| Chaput, U; Grimprel, E; Guedj, R; Mornand, P; Romain, AS | 1 |
| McCaw, ZR; Meng, Z; Wei, LJ | 1 |
| Gupta, A; Tornheim, JA; Udwadia, ZF | 1 |
| Nunn, AJ; Phillips, PPJ | 1 |
| Horsburgh, CR; Sterling, TR; Stout, JE | 1 |
| Chaisson, RE; Ramchandani, R; Swindells, S | 1 |
| Baek, MS; Choi, H; Choi, JH; Hyun, IG; Kim, CH; Kim, HI; Kim, Y; Noh, CS | 1 |
| Han, SS; Kang, YA; Lee, EH; Lee, SJ; Song, JH; Yim, JJ | 1 |
| Armstrong, D; Betz, J; Beylis, N; Bharadwaj, R; Caceres, T; Cooper, CK; Dorman, SE; Gotuzzo, E; Joloba, M; King, B; Knecht, D; Manabe, YC; Maus, CE; Mave, V; Nakiyingi, L; Nicol, MP; Paradis, S; Pradhan, N; Shah, M | 1 |
| Anupurba, S; Banerjee, T; Sinha, P; Srivastava, GN | 1 |
| Benson, CA; Blaschke, T; Browne, SH; Gonzalez Garcia, J; Low, J; Moser, K; Peloquin, CA; Tucker, AJ; Umlauf, A; Vaida, F | 1 |
| Dang, L; Lei, Q; Lv, X; Wang, H; Zhao, Y; Zhou, J; Zhu, C | 1 |
| AlMatar, M; Kayar, B; Köksal, F; Var, I | 1 |
| Ahmad, SR; Aqeel Ur Rahman, M; Chaudhry, MN; Hameed, S; Mahmood, N | 1 |
| Farokhi-Fard, A; Golichenari, B; Mohammadi Ghanbarlou, M; Vaziri, F; Zanganeh, S | 1 |
| Akkhavong, V; Bañuls, AL; Berland, JL; Chanthavilay, P; Gauthier, M; Iem, V; Inthavong, D; Keovichit, I; Nguyen, QH; Nguyen, TVA; Paboriboune, P; Paranhos-Baccalà, G; Somphavong, S; Soundala, S; Vongvichit, P; Vu, TT | 1 |
| Heyckendorf, J; Kalsdorf, B; Lange, C; Maurer, FP | 1 |
| Altman, J; Blumberg, HM; Bucşan, AN; Day, CL; Doyle, LA; Ernst, JD; Foreman, TW; Gandhi, NR; Kaushal, D; Mehra, S; Peloquin, C; Rengarajan, J; Russell-Lodrigue, K | 1 |
| Bai, H; Jiao, L; Liu, T; Lu, X; Lv, Y; Song, J; Wu, Q; Wu, T; Ying, B; Zhao, Z | 1 |
| Atwood, S; Bayona, J; Becerra, MC; Calderon, R; Cohen, T; Contreras, C; Farmer, P; Galea, J; Huang, CC; Lecca, L; Mitnick, CD; Murray, M; Yataco, R; Zhang, Z | 1 |
| Aarnoutse, RE; Boeree, MJ; Burger, DM; Colbers, A; Irongo, CF; Kibiki, GS; Mtabho, CM; Semvua, HH; Tostmann, A; van Crevel, R; van den Boogaard, J; van der Ven, AJAM | 1 |
| Aman, R; Assefa, T; Hailemariam, Z; Tekalegn, Y; Woldeyohannes, D | 1 |
| Ambreen, A; Jamil, M; Mustafa, T; Rahman, MAU | 1 |
| Balada-Llasat, JM; Evans, CA; Gelaw, B; Kelley, HV; Shibabaw, A; Tesfaye, E; Tessema, B; Torrelles, JB; Wang, SH | 1 |
| Arevalo, B; Bessler, P; Borisov, AS; Bozeman, L; Dukes Hamilton, C; Goldberg, SV; Hecker, EJ; Hedges, KNC; Kerrigan, A; Moreno-Martinez, A; Saukkonen, JJ; Scott, NA | 1 |
| Balakrishna, Y; Lutchminarain, K; Mlisana, K; Mvelase, NR | 1 |
| Andrade, BB; Arriaga, MB; Calvacante, S; Cordeiro-Santos, M; Durovni, B; Figueiredo, MC; Kritski, A; Peetluk, LS; Rebeiro, PF; Rolla, VC; Sterling, TR; Turner, MM | 1 |
| Mir, SA; Sharma, S | 1 |
| He, X; Song, Y; Wang, L; Xu, J | 1 |
| Dlodlo, RA; Harries, AD; Kumar, AMV; Satyanarayana, S; Takarinda, KC; Timire, C | 1 |
| Bishai, W; Vernon, A | 1 |
| Adiga, SK; Kalthur, G; Kalthur, SG; Kumari, S; Mutalik, S; Mutalik, SP; Nayak, G; Rao, A | 1 |
| Cook, V; Long, R; Menzies, D; Ruslami, R | 1 |
| Cai, L; Huang, X; Jiang, T; Lin, M; Liu, X; Pan, K; Ruan, Q; Shao, L; Shen, Y; Wu, J; Yang, Q; Zhang, W | 1 |
| Costales-Álvarez, C; Fernández-García, M; Macías-Franco, S; Mayordomo-Colunga, J; Rozas-Reyes, P | 1 |
| Aiona, K; Belknap, R; Flynn, AG; Haas, MK; Reves, R | 1 |
| Cornish, EF; Hudson, J; Loveday, M; Sayers, R | 1 |
| Bagtharia, R; Haque, AKM; Rawal, J | 1 |
| Alves, S; Barcellos, RB; da Silva Carvalho, W; da Silva, EC; Dalla Costa, ER; de Almeida, IN; de Assis Figueredo, LJ; de Miranda, SS; Dos Santos, ÍR; Gomes, HM; Halon, ML; Kritski, A; Rossetti, ML; Sola, C; Suffys, P; Vater, MC | 1 |
| Nagpal, A; Storandt, M | 1 |
| Behra, PRK; Dasgupta, S; Kirsebom, LA; Pettersson, BMF; Ramesh, M | 1 |
| Adjobimey, M; Benedetti, A; Campbell, JR; Cook, VJ; Eisenbeis, L; Fregonese, F; Johnston, JC; Menzies, D; Ruslami, R; Trajman, A; Valiquette, C | 1 |
| Migliori, GB; Tiberi, S | 1 |
| Chen, WW; Chiou, HL; Huang, WC; Huang, YW; Lin, CH; Tsao, SM; Yang, SF; Yang, WT; Yu, YY | 1 |
| Chu, N; Guo, H; Lin, J; Liu, H; Liu, X; Wu, L; Ye, Z; Zheng, L | 1 |
| Kazakova, OB; Lopatina, TV; Medvedeva, NI; Smirnova, IE; Veselovsky, AV | 1 |
| Mishra, DK; Murthy, SI; Pappuru, RR; Rathi, VM; Tyagi, M | 1 |
| Bartlett-Esquilant, G; Benedetti, A; Boivin, JF; FitzGerald, JM; Menzies, D; Ronald, LA; Schwartzman, K | 1 |
| Barbarini, D; Lombardi, A; Marone, P; Monzillo, V; Muzzi, A; Schimmenti, A; Scudeller, L; Seminari, E | 1 |
| Combrink, M; du Preez, I; Loots, DT | 1 |
| Altin, S; Hircin Cenger, D; Uçarman, N; Yazisiz, H | 1 |
| Burger, DA; Dawson, R; De Jager, VR; Diacon, AH; Everitt, D; Mendel, CM; Narunsky, K; Nedelman, J; Pappas, F; Vanker, N | 1 |
| Ader, F; Berland, JL; Bryant, JE; Dumitrescu, O; Genestet, C; Ginevra, C; Hodille, E; Lina, G | 1 |
| Krause, RWM; Nkanga, CI; Noundou, XS; Roth, M; Walker, RB | 1 |
| Alexander, H; Cegielski, JP; Chen, MP; Click, ES; Dalton, TL; Ershova, J; Kurbatova, EV; Posey, JE | 1 |
| Amini, S; Feizabadi, MM; Haeili, M; Hamzelou, G; Haratiasl, AA; Heidari, F; Kardan-Yamchi, J | 1 |
| Bachyrycz, A; Borrego, ME; Burgos, M; Ferreira, J; Fortune, D; Jakeman, B; Logothetis, SJ; Roberts, MH | 1 |
| Cao, X; Feng, B; Gao, L; Guan, L; Guan, X; Jin, Q; Li, H; Li, X; Liu, J; Liu, Z; Pan, S; Shen, F; Wang, D; Xin, H; Yan, J; Yang, Q; Zhang, H; Zhang, M | 1 |
| Caleffi-Ferracioli, KR; Cardoso, RF; Costacurta, GF; da Silva, LA; de Almeida, AL; de Pádua, RA; do Prado, SM; Ghiraldi Lopes, LD; Ieque, AL; Leal, DC; Micheletti, DF; Sampiron, EG; Santos, NCS; Scodro, RBL; Siqueira, VL | 1 |
| Beraldi-Magalhães, F; Boger, B; Cordeiro-Santos, M; de Fátima Cobre, A; de Liz, MV; Domingos, EL; Dos Santos, JMMF; Fachi, MM; Junkert, AM; Momade, DRO; Pontarolo, R; Vilhena, RO | 1 |
| Arend, SM; Bakker, JA; Duinkerk, DL; Kroft, LJM; Ottenhoff, THM; Ramai, RSRS; Uzorka, JW | 1 |
| Bambal, R; Bhatnagar, PK; Chaira, T; Kaur, IP; Khanna, A; Singh, H; Singh, M; Sood, R; Upadhaya, DJ | 1 |
| Buchanan, R; Ciesielczuk, H; Kouvas, N; North, N; Tiberi, S | 1 |
| Coates, ARM; Hu, Y; Simonsson, USH; Susanto, BO; Wicha, SG | 1 |
| Basil, MV; Bhatnagar, A; Deepak, R; Guleria, R; Gupta, P; Gupta, UD; Kamboj, D; Kumar, P; Mehta, G; Misra, P; Mitra, DK; Mohan, A; Saurabh, A; Tandon, R; Thakral, D | 1 |
| Cao, B; Cui, X; Gao, L | 1 |
| Chumpa, N; Kawkitinarong, K; Petsong, S; Rotcheewaphan, S; Sawatpanich, A; Suwanpimolkul, G; Tumwasorn, S | 1 |
| de Jong, BC; Decroo, T; Lynen, L; Piubello, A; Souleymane, MB; Van Deun, A | 1 |
| Diacon, AH; Donahue, K; Dooley, KE; Hafner, R; Ignatius, EH; Miyahara, S; Moran, L; Nuermberger, EL; Rosenkranz, SL; Sun, X; Swindells, S; Vanker, N; von Groote-Bidlingmaier, F | 1 |
| Wang, Q; Wang, Y; Xie, W; Zhang, T; Zhao, H | 1 |
| Dolgushin, MV | 1 |
| Li, Q; Ou, X; Su, D; Wang, S; Xia, H; Zhao, B; Zhao, Y | 1 |
| Domotenko, LV; Morozova, TP; Shemyakin, IG; Shepelin, AP | 1 |
| Cui, ZJ; Zhang, HY; Zhang, QY; Zhang, WT; Zhu, Q | 1 |
| Al Abri, S; Al Khalili, S; Kowada, A; Ndunda, N; Petersen, E; Yaqoubi, F | 1 |
| Agarwal, P; Aggarwal, AN; Chandna, J; Khaneja, R; Kumar, N; Sethi, S; Yadav, R | 1 |
| Ho, CS; Powell, KM; Schmit, KM; Wortham, JM | 1 |
| Kasinathan, A; Palanisamy, S; Serane, VK | 1 |
| Ahmadi, Q; Hayat, MS; Rahimi, BA; Rahimy, N; Wasiq, AW | 1 |
| Choi, J; Dawson, R; de Jager, VR; Diacon, AH; Hutchings, J; Kim, J; Nam, K; van der Merwe, L; van Niekerk, C; Vanker, N | 1 |
| Mushtaq, A | 1 |
| Banerji, JS | 1 |
| Mayanja-Kizza, H | 1 |
| Beattie, T; Chaisson, RE; Churchyard, GJ; Dooley, KE; Edward, VA; Fyvie, MJ; Gupte, A; Likoti, M; Marzinke, MA; Savic, R; Sebe, M; Shibambo, I; Wolf, L; Zhang, N | 1 |
| Huynh, J; Marais, BJ; Schaaf, HS; Thwaites, G | 1 |
| De Sessions, PF; Hibberd, ML; Kwan, PKW; Lin, W; Naim, ANM; Paton, NI; Periaswamy, B | 1 |
| Huang, D; Liang, Z; Wang, Y | 1 |
| Danna, BJ; Harvey, AW; Woc-Colburn, LE | 1 |
| Guan, CX; Guo, Q; Jiang, Y; Li, GL; Li, MC; Liu, HC; Liu, ZG; Wan, KL; Wan, L; Wei, JH; Zhao, LL; Zhao, XQ | 1 |
| Chesdachai, S; Katz, B; Sapkota, S | 1 |
| Bongomin, F; Khan, SA; Oravec, T | 1 |
| Gao, R; Guo, Y; Shen, X; Tan, G; Wang, H; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
| Chakrapani, G; Doble, M; Mitra, K; Ravindran, R | 1 |
| Bisognin, F; Dal Monte, P; Finelli, C; Lombardi, G; Re, MC | 1 |
| Blumberg, HM; Fekadu, A; Holland, DP; Manyazewal, T; Marconi, VC; Woldeamanuel, Y | 1 |
| Arriaga-Guerrero, AL; Bermúdez De León, M; Borrego-Loya, A; Contreras-Cordero, JF; Esquivel-Lucio, GJ; González-Escalante, LA; Granados-Tristán, AL; Hernández-Luna, CE; Márquez-Uribe, DY; Mercado Hernández, R; Peñuelas-Urquides, K; Rigal-Leal, J; Robles-González, RJ; Silva-Ramírez, B; Villarreal-Treviño, L | 1 |
| Akkerman, OW; Alffenaar, JC; Bolhuis, MS; Ghimire, S; Jongedijk, EM; Touw, DJ; van den Elsen, SHJ; van der Werf, TS; Wessels, M | 1 |
| Albério, CAA; da Paixão, TP; Fonseca, AAD; Galvão, FES; Pinto, ACG; Vieira, JLF | 1 |
| Kraft, WK; Lam, E; Schaefer, J; Zhan, T; Zheng, R | 1 |
| de Jong, BC; Decroo, T; Gumusboga, M; Hossain, MA; Kya Jai Maug, A; Lynen, L; Mulders, W; Ortuño-Gutiérrez, N; Rieder, HL; Van Deun, A | 1 |
| Chen, CY; Feng, JY; Huang, WC; Lee, SS; Li, CP; Lin, CB; Lin, SM; Pan, SW; Shu, CC; Su, WJ; Tung, CL; Wang, TY; Wei, YF | 1 |
| Bian, Y; Cao, J; Huang, C; Li, X; Liu, L; Liu, X; Miao, L; Qu, W | 1 |
| Aljohani, AKB; Alsalem, FMA; Broadhead, JL; Brown, AK; Gill, JH; Lu, Y; Sellars, JD | 1 |
| Kalita, J; Misra, UK; Pandey, PC; Singh, VK; Thomas, J | 1 |
| Chong, W; Lyu, M; Ming, L; Wang, D; Yang, Z; Ying, B; Zhao, J; Zhao, Z | 1 |
| Ghosh, A; N, S; Saha, S | 1 |
| Eller, P; Hackl, G; Hermann, J; Reisinger, AC; Vagena, FR | 1 |
| Adjobimey, M; Al-Jahdali, H; Apriani, L; Baah, JO; Bastos, ML; Benedetti, A; Campbell, JR; Elwood, K; Hoeppner, V; Kim, HJ; Long, R; Menzies, D; Oxlade, O; Ruslami, R; Schwartzman, K; Toelle, BG; Trajman, A | 1 |
| Balakrishnan, S; Das, M; Manu, MS; Mehta, K; Neena, PS; Rakesh, PS; Satyanarayana, S; Sindhu, MP; Sunil Kumar, M; Valamparampil, MJ | 1 |
| Desai, U; Doshi, K; Joshi, JM | 1 |
| Banerjee, D; Bhattacharyya, R; Kaur, S; Kumar, D; Kumari, M; Singh, S | 1 |
| Cai, LM; Hong, JJ; Huang, XT; Jiang, T; Lin, MY; Ling, Q; Liu, XF; Ma, CL; Mao, JC; Pan, KC; Peng, GQ; Ruan, QL; Shao, LY; Shen, YJ; Wang, XD; Wang, XZ; Wu, J; Wu, TZ; Yang, QL; Zhang, WH | 1 |
| Bark, S; Hunter, RL; Jagannath, C; Khan, A; Mani, A; Mishra, A; Singh, VK; Subbian, S | 1 |
| Kang, JY; Kim, HW; Kim, JS; Kim, JW; Kim, SK; Kim, YH; Lee, EG; Lee, SH; Min, J; Yoon, HK | 1 |
| Ci, R; Zang, W; Zhang, K; Zhu, A | 1 |
| Podany, AT | 1 |
| Berthier, C; Lellouch, AG; Lupon, E; Mansat, P; Martin-Blondel, G; Pollon, T | 1 |
| Brewer, CT; Chen, T; Kodali, K; Peng, J; Shaw, TI; Wu, J | 1 |
| Iwata, K; Miyakoshi, C; Morishita, N; Nishiwaki, M | 1 |
| Nishiura, H | 1 |
| Berger, T; Dean, P; Matt, M; Riney, L; Schlaudecker, E | 1 |
| Avsar, K; Beutler, M; Heiß-Neumann, M; Hoffmann, H; Hofmann-Thiel, S; Mihalic, M; Plesnik, S | 1 |
| Xiao, K; Zhong, L | 1 |
| Hesseling, AC; Hibma, JE; Radtke, KK; Savic, RM | 1 |
| Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M | 1 |
| Magazi, BT; Malinga, LA; Maningi, NE; Mbelle, NN; Pasipanodya, JG; Shey, BA; Sibandze, DB | 1 |
| Aseffa, A; Assefa, G; Bobosha, K; Hailu, T; Mekonnen, A; Shimelis, E; Tilahun, M; Wogayehu, T; Wondimagegn, G | 1 |
| Ahn, DJ; Kang, S; Kim, MK; Kim, SG; Kwon, JG; Lee, IH; Yang, CS | 1 |
| Al-Jahdali, H; Bah, B; Belo, M; Campbell, JR; Cook, VJ; Long, R; Menzies, D; Schwartzman, K; Trajman, A | 1 |
| Aghanya, IN; Akujobi, CN; E Ahiarakwem, II; Ekejindu, IM | 1 |
| Agdestein, A; Brynildsrud, O; Dejene, TA; Gebremichael, MW; Skjerve, E; Tessema, GT; Tønjum, T; Welekidan, LN; Yimer, SA | 1 |
| Baker, P; Bao, Y; Benson, CA; Chaisson, RE; Fletcher, CV; Gupta, A; Haas, DW; Mohapi, L; Mwelase, N; Podany, AT; Supparatpinyo, K; Swindells, S | 1 |
| Baumann, B; Campbell, JR; Chiang, LY; Cook, VJ; Djurdjev, O; Johnston, JC; Kumar, D; Levin, A; Morshed, M; Romanowski, K; Sekirov, I | 1 |
| Alva-Diaz, C; Esteban-Arias, D; López-Saavedra, A; Metcalf, T; Orellana-Tovar, I; Pacheco-Barrios, K; Rodriguez-López, E; Velásquez-Rimachi, V | 1 |
| Aung, KJM; de Jong, BC; Decroo, T; Hossain, MA; Lempens, P; Meehan, CJ; Rigouts, L; Van Deun, A | 1 |
| Kumar, A; Lidgren, L; Matheshwaran, S; Murugan, PA; Nair, NN; Qayoom, I; Raina, DB; Tägil, M; Teotia, AK; Verma, R | 1 |
| Denkinger, CM; Kohli, M; MacLean, E; Pai, M; Schumacher, SG | 1 |
| Calender, A; Israel-Biet, D; Pacheco, Y; Valeyre, D | 1 |
| Ahmad, E; Akhtar, ZM; Bukhari, NI; Haider, HMF; Ishtiaq, S; Jahangir, M; Mukhtar, H | 1 |
| Litterio, NJ; Lorenzutti, AM; Luciani-Giacobbe, LC; Olivera, ME; Ramírez-Rigo, MV | 1 |
| Aiona, K; Belknap, RW; Erlandson, KM; Haas, MK | 1 |
| Dowdy, DW; Hill, AN; Marks, SM; Menzies, NA; Parriott, A; Shete, PB; Shrestha, S | 1 |
| Ignatius, EH; Swindells, S | 1 |
| Baloch, AQ; Ghazal, A; Khanzada, FM; Mustafa, T; Qadir, M; Rizvi, AH; Tahseen, S | 1 |
| Mukherjee, G; Mukhopadhyay, B; Sil, AK | 1 |
| Xu, N; Yang, J; Yang, JX | 1 |
| Chen, M; Cheng, Y; Huang, C; Huang, T; Li, Y; Qin, C; Shi, B; Tang, W; Xia, Z; Xiao, S; Xu, H | 1 |
| Basol, G; Gonlugur, T; Gonlugur, U | 1 |
| Bottet, F; Calin, R; Gauthe, M; Jamme, M; Pialoux, G; Rondeau, E; Tamzali, Y | 1 |
| Ellappan, K; Joseph, NM; Krishnakumariamma, K; Kumar, SV; Muthuraj, M; Tamilarasu, K | 1 |
| Kaplan, N; Ozger, O | 1 |
| Abi-Chahla, ML; Dauchy, FA; Desclaux, A; Ducours, M; Dutronc, H; Pointillart, V; Wirth, G | 1 |
| Gálvez-López, R; García Salguero, AJ; Láinez-Ramos-Bossini, AJ; Pérez-García, MC; Rabadán-Caravaca, M; Ruiz-Carazo, E | 1 |
| Chaisson, RE; Churchyard, G; Dowdy, D; Ferguson, O; Jo, Y; Johnson, K; Pennington, J | 1 |
| Cao, J; Ma, S; Pan, Y; Song, Q; Tang, P; Zhang, J; Zhu, L | 1 |
| Chu, N; Du, Y; Guo, R; Han, X; Pang, Y; Wang, J; Wang, Q | 1 |
| Anton, C; Bernardi, RM; Freitas, AA; Lemos, CX; Machado, FD; Silva, DR | 1 |
| Dhochak, N; Kabra, SK; Lodha, R; Ram Jat, K; Sankar, J | 1 |
| Junaid, K; Kabir, S; Rehman, A | 1 |
| Ademe, Y; Bekele, T; de Jong, BC; Diro, E; Ejo, M; Gehre, F; Girma, Y; Kassa, M; Rigouts, L; Torrea, G; Uwizeye, C | 1 |
| González-Chávez, MM; Hernández-González, O; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-Vázquez, FJ; Portales-Pérez, DP; Rodríguez-Pinal, CJ; Romano-Moreno, S; Uresti-Rivera, EE; Veytia-Bucheli, JI; Zarazúa, S | 1 |
| Kuaban, C; Sander, M; Toukam, LDI | 1 |
| Imakiire, R; Imuta, N; Kawano, Y; Koriyama, T; Nishi, J; Nishikawa, T; Taniguchi, N; Tawaratsumida, H; Tominaga, H | 1 |
| Chen, TC; Cheng, MH; Chong, IW; Huang, CK; Huang, HL; Lai, PC; Lee, MR; Lu, PL; Sheu, CC; Wang, JY | 1 |
| Abreu, M; Machado, Á; Torres, T | 1 |
| Bhandari, B; Goldman, JD; Snyder, SA | 1 |
| Benson, CA; Chaisson, RE; Fletcher, CV; Gupta, A; Hakim, J; Kanyama, C; Langat, D; Leon-Cruz, J; Mwelase, N; Omoz-Oarhe, A; Podany, AT; Supparatpinyo, K; Swindells, S | 1 |
| Dube, D; Gautam, L; Sharma, R; Shrivastava, P; Vyas, S; Vyas, SP | 1 |
| Einbeck, CO; Hunter, CJ; Yasukawa, K | 1 |
| Angrish, N; Gupta, K; Kaur, S; Khare, G; Tyagi, AK | 1 |
| Becerra, MC; Hussain, H; Jaswal, M; Keshavjee, S; Khan, AJ; Lu, C; Majidulla, A; Malik, AA; Safdar, N; Yuen, CM | 1 |
| Gennery, A; Owens, S; Powell, S; Schim van der Loeff, I; Slatter, M; Tsilifis, C; Williams, E | 1 |
| Agejeva, A; Altraja, A; Klaos, K; Kummik, T; Laks, S; Remets, O; Sasi, S; Tann, A; Viiklepp, P | 1 |
| Kaur, R; Sharma, V; Sharma, VL | 1 |
| Achar, J; Azamat, I; Bayram, H; Gil, H; Gomez, D; Margaryan, H; Nazirov, P; Parpieva, N; Singh, J; Zayniddin, S; Ziba, B | 1 |
| Folkvardsen, DB; Lillebaek, T; Rasmussen, EM; Svensson, E | 1 |
| Cotton, MF; Greybe, L; Morrison, JL; Rabie, H; Schaaf, HS | 1 |
| Ji, Y; Li, Z; Liu, Q; Martinez, L; Qiu, B; Song, H; Wang, J; Yang, D | 1 |
| Abubakar, I; Charlett, A; Francis, M; Gosce, L; Hack, V; Kunst, H; Lipman, M; Muñoz, L; Rangaka, MX; Stagg, HR; Surey, J; White, PJ; Yates, TA | 1 |
| Bilek, N; Borate, B; Brumskine, W; Churchyard, G; Erasmus, M; Fiore-Gartland, A; Hadley, K; Hassan-Moosa, R; Hatherill, M; Hiemstra, A; Hikuam, C; Innes, C; Jaxa, L; Kaskar, M; Kimbung Mbandi, S; Malherbe, ST; Mendelsohn, SC; Mulenga, H; Musvosvi, M; Naidoo, K; Penn-Nicholson, A; Raphela, R; Scriba, TJ; Self, S; Sumner, T; Tameris, M; Walzl, G; White, RG | 1 |
| Cantillon, D; Cooper, I; Newport, MJ; Waddell, SJ; Wroblewska, J | 1 |
| Atuhumuza, E; Cattamanchi, A; Dowdy, D; Kamya, MR; Lim, RK; Muyindike, WR; Namakula-Katende, J; Sabiti, L; Semitala, FC | 1 |
| Aarnoutse, R; Bliven-Sizemore, E; Boeree, MJ; Dooley, KE; Heinrich, N; Hoelscher, M; Mac Kenzie, W; Morlock, G; Peloquin, CA; Phillips, PPJ; Posey, J; Savic, RM; Stout, JE; Weiner, M; Whitworth, W; Zhang, N | 1 |
| Andersson, DI; Bjarnemark, F; Brive, L; Glegola-Madejska, I; Godaly, G; Henderson, DI; Hjort, K; Krishnan, N; Millqvist Fureby, A; Puthia, M; Rao, KU; Robertson, BD; Sturegård, E; Tenland, E | 1 |
| Agerberth, B; Ahmed, S; Bergman, P; Brighenti, S; Groenheit, R; Kalsum, S; Rao Muvva, J; Rekha, RS; Schön, T | 1 |
| Apiwattanakul, N; Assawawiroonhakarn, S; Boonsathorn, S; Wiriyachai, T | 1 |
| Bobby, Z; Girish, C; Sanjay, S; Toi, PC | 2 |
| Ahmadi, P; Ansari, M; Balaei, F; Farhadian, N; Karami, C; Moradi, S; Shahlaei, M | 1 |
| Badal-Faesen, S; Churchyard, G; Demers, AM; Eisenach, K; Gupta, A; Hesseling, A; Hughes, M; Kim, S; McCallum, S; Mendoza-Ticona, A; Naini, L; Narunsky, K; Poongulali, S; Pradhan, N; Shah, NS; Smith, E; Swindells, S; Upton, C | 1 |
| Hao, W; Kuang, W; Liang, J; Liu, T; Su, Q; Tang, C; Wang, Y; Wu, L | 1 |
| Bajeli, S; Chakraborty, P; Kaushal, D; Kumar, A; Radotra, BD | 1 |
| Amare, M; Ameni, G; Erko, B; Gashaw, F; Gumi, B; Mekonnen, Y; Yenew, B | 1 |
| Babin, FX; Chedid, C; Francois, EM; Gebelin, J; Hoffmann, J; Joseph, P; Mabou, MM; Masetti, C; Mathon, JE; Ocheretina, O; Pape, JW; Raskine, L | 1 |
| Amanullah, F; Becerra, MC; Fareed, U; Farooq, S; Hussain, H; Jaswal, M; Keshavjee, S; Khan, AJ; Khan, H; Malik, AA; Nasir, K; Safdar, N; Shahbaz, S | 1 |
| Komukai, J; Kudoh, S; Matsumoto, K; Okado, A; Shimouchi, A; Yoshida, H; Yoshiyama, T | 1 |
| Alaverdyan, S; Gadoev, J; Kumar, A; Nabirova, D; Parpieva, N; Sayfutdinov, Z; Sultanov, S; Turaev, L | 1 |
| Agossah, C; Brossier, D; Goyer, I; Huynh, L; Lelong-Boulouard, V; Marie, J | 1 |
| Bishai, W; Dawson, R; De Jager, V; Diacon, A; Donahue, K; Fletcher, CV; Hafner, R; Hogg, E; Miyahara, S; Sun, X; Swindells, S; Urbanowski, M | 1 |
| Davies, GR; Peloquin, CA | 1 |
| Chen, Y; Huang, J; Lei, C; Li, Y; Lin, B; Lin, D; Liu, X; Wang, W; Wang, X; Yang, W; Yu, X; Zeng, J; Zhang, X; Zhou, J | 1 |
| Benevento, AF; Campos, J; Castello, F; Fernandez Do Porto, DA; López, B; Martí, M; Matteo, M; Monteserin, J; Pardo, A; Paul, R; Poklepovich, T; Ritacco, V; Serral, F; Simboli, N; Sosa, EJ; Turjanski, A; Wainmayer, I; Yokobori, N | 1 |
| Beylis, N; de Vos, M; Derendinger, B; Dippenaar, A; Dolby, T; Theron, G; van Helden, PD; Warren, RM | 1 |
| Ario, AR; Bahizi, G; Bulage, L; Kisaka, S; Kwesiga, B; Majwala, RK; Musisi, K; Nyombi, A; Turyahabwe, S | 1 |
| Boyce, C; Huang, FS; Khalil, N; Kohlrieser, CM; Peck, GM; Schlaudecker, EP; Staat, MA | 1 |
| Chen, L; He, C; Shao, R; Wang, Y | 1 |
| Alvarez, G; Finn, S; Habis, Y; Kilabuk, E; Mallick, R; Mulpuru, S; Patterson, M; Pease, C; Schwartzman, K; Zwerling, A | 1 |
| Abbadi, BL; Basso, LA; Bizarro, CV; Castelo Branco, APOT; Cibulski, S; Costa, TD; de Araújo, DM; Lock, GA; Macchi, F; Machado, P; Rodrigues-Junior, VS; Sidrônio, MGS; Silveira, MD | 1 |
| Akyuz, S; Altuner, D; Bedir, F; Dabanlioglu, B; Kocaturk, H; Ozgeris, FB; Sener, E; Suleyman, B; Suleyman, H; Turangezli, O | 1 |
| Bocharova, IV; Lepekha, LN; Nikonenko, BV | 1 |
| Hino, M; Imoto, W; Kakeya, H; Kawaguchi, T; Kuwabara, G; Oshima, K; Shibata, W; Shiraishi, S; Takagi, Y; Tazoe, K; Yamada, K; Yamairi, K | 1 |
| Akela, AK; Kumar, A | 1 |
| Alame Emane, AK; Guo, X; Liu, S; Takiff, HE | 1 |
| Andersson, B; Das, J; Kalsum, S; Lerm, M; Schön, T | 1 |
| Goyal, M; Modi, M; Ray, P; Sharma, A; Sharma, K; Sharma, M | 1 |
| Addo, KK; Heysell, SK; Mbelele, PM; Mfinanga, SG; Mohamed, SY; Mpagama, S; Mpolya, EA; Sauli, E | 1 |
| He, H; Li, J; Li, Q; Li, X; Shu, C; Wang, J | 1 |
| Hu, ZD; Li, T; Liu, XH; Lu, SH; Ma, JY; Xia, L; Yang, H; Yang, Y; Yu, X | 1 |
| Cohn, SE; Denti, P; Dooley, KE; Firnhaber, C; Francis, J; Godfrey, C; Kendall, MA; McIlleron, H; Mngqibisa, R; Wu, X | 1 |
| Chen, L; Chen, W; Gao, Q; Li, N; Li, Q; Liao, X; Liu, M; Luo, T; Xu, P | 1 |
| Abate, BB; Alemnew, B; Fourie, PB; Reta, MA | 1 |
| Al-Haj, NS; Al-Khatib, BY; D'souza, MR; Naji, KM | 1 |
| Álvarez-Maya, I; Ayala-Chavira, N; Rendón-Bautista, LA; Sandoval-Díaz, M; Villanueva-Arias, JC; Zenteno-Cuevas, R | 1 |
| Kawkitinarong, K; Laohapojanart, N; Ratanajamit, C; Srichana, T | 1 |
| Ali, RA; Anjum, AA; Arshad, U; Ashraf, M; Iqbal, A; Ishtiaq, S; Omer, MO; Rathore, AW; Zaman, M | 1 |
| Costa, ERD; da Silva, LV; da Silva, PEA; Dias, CF; Gómez, MAA; Kritski, AL; Perdigão, J; Portugal, I; Reis, AJ; Rossetti, MLR; Salvato, RS; Salvato, SS; Schiefelbein, SH; Unis, G; Viveiros, M; von Groll, A | 1 |
| Devezin, T; Dube, GS; Kay, AW; Lukhele, B; Mandalakas, AM; Mkhabela, M; Mtetwa, G; Ndlovu, B; Sandoval, M; Sibanda, J; Sikhondze, W; Stevens, RH; Vambe, D | 1 |
| Bradford, S; Britto, P; Chakhtoura, N; Chalermchockcharoentkit, A; Chipato, T; Dooley, KE; Gupta, A; Jayachandran, P; Kamthunzi, P; Langat, D; Mathad, JS; Montepiedra, G; Norman, J; Patil, S; Popson, S; Rouzier, V; Savic, R; Townley, E; Wiesner, L; Zhang, N | 1 |
| Angira, F; Badal-Faesen, S; Baker, P; Cohn, SE; Denti, P; Francis, J; Haas, DW; Kendall, MA; Mawlana, S; McIlleron, H; Mngqibisa, R; Omoz-Oarhe, A; Robinson, JA; Samaneka, WP | 1 |
| Aarnoutse, R; Chabala, C; Chirehwa, M; Choo, L; Gibb, D; Hesseling, AC; Hissar, S; Kapasa, M; Kinikar, A; LeBeau, K; Mave, V; McIlleron, H; Mulenga, V; Palmer, M; Turkova, A; van der Zalm, M; Wiesner, L; Wobudeya, E; Zimba, KM | 1 |
| Brumskine, W; Cárdenas, V; Chaisson, RE; Charalambous, S; Chihota, V; Churchyard, G; Cobelens, F; Fielding, KL; Garcia-Basteiro, AL; Grant, AD; Martinson, N; Masilela, L; Mngadi, K; Nguenha, D; Sebe, M; van den Hof, S; Waggie, Z; Wang, SH; Yimer, G | 1 |
| Dreyer, V; Egbe, NF; Kohl, TA; Kuaban, C; Merker, M; Ngangue, YR; Niemann, S; Noeske, J; Sander, MS; Vuchas, C | 1 |
| He, P; He, WC; Li, YM; Liu, CF; Liu, DX; Song, YM; Zhao, YL | 1 |
| Cui, X; Hao, Y; Li, G; Li, L; Li, Y; Ma, Y; Sha, X; Tang, PF; Wang, H; Wang, L; Zhang, K; Zhang, Z; Zhou, J | 1 |
| Mistry, N; Oswal, V; Rao, S; Shaikh, A; Sriraman, K; Vaswani, S | 1 |
| Feng, G; Han, W; Shi, J; Xia, R; Xu, J | 1 |
| Karthikeyan, K; Premjith, R; Vijayasankar, P | 1 |
| Barr, DA; Davies, G; Koch, A; Lalloo, DG; Mason, M; Meintjes, G; Mizrahi, V; Omollo, C; Warner, DF; Wilkinson, RJ | 1 |
| Chen, Z; Ge, Z; Liang, S; Liu, X; Ma, H; Ma, R; Wu, P; Zhang, J | 1 |
| Cossa, A; Faife, L; García-Basteiro, AL; Gomes, N; Langa, R; Mabunda, R; Mambuque, E; Manjate, F; Munguambe, S; Nguenha, D; Saavedra, B; Scott, L | 1 |
| Feng, L; Hu, J; Li, H; Li, L; Li, X; Wu, Q; Yu, H | 1 |
| Ammerman, NC; Belknap, R; Boyd, R; Ernest, JP; Nuermberger, E; Radtke, KK; Savic, RM; Sterling, TR; Zhang, N | 1 |
| Alemu, A; Diriba, G; Gamtesa, DF; Kebede, A; Tola, HH; Yenew, B | 1 |
| Bhalla, M; Ciobanu, N; Conradie, F; Crudu, V; David, A; Denkinger, CM; Georghiou, SB; Kazi, M; Myneedu, VP; Penn-Nicholson, A; Rodrigues, C; Ruhwald, M; Schumacher, SG; Scott, L | 1 |
| Ahmadi, A; Azizian, K; Kouhsari, E; Molaeipour, L; Ye, M; Yuan, W | 1 |
| Bekker, A; Davies, G; Denti, P; Gonzalez-Martinez, C; Hesseling, AC; McIlleron, HM; Rabie, H; Svensson, EM; van der Laan, LE; van Rie, A; Wasmann, RE; Wiesner, L; Winckler, J; Zar, HJ | 1 |
| Bollela, VR; Della Pasqua, O; Lanchote, VL; Nardotto, GHB; Rocha, A | 1 |
| Bianchi, L; Boiardi, G; Bortone, B; Cassetta, MI; Chiappini, E; Fallani, S; Galli, L; Montagnani, C; Novelli, A; Tersigni, C; Tofani, L; Venturini, E | 1 |
| Bandere, D; Cirule, A; Grinberga, S; Igumnova, V; Kivrane, A; Krams, A; Pole, I; Pugovics, O; Ranka, R; Sevostjanovs, E; Viksna, A | 1 |
| Chung, C; Jo, KW; Kim, YJ; Shim, TS | 1 |
| Atalay, MA; Sağıroğlu, P | 1 |
| Chew, R; Woods, ML | 1 |
| Bazira, J; Kassaza, K; Kinyi, H; Micheni, LN; Ntulume, I | 1 |
| Chan, TH; Huang, CS; Jou, R; Tu, C | 1 |
| Brombacher, F; Chia, JE; Guler, R; Hazra, R; Maine, RA; Mishra, BB; Ozturk, M; Parihar, SP; Saqib, M; Suzuki, H | 1 |
| Chang, TE; Huang, YH; Huang, YS; Perng, CL; Tseng, SY | 1 |
| Frampton, D; Gliddon, HD; Heaney, J; McKendry, RA; Munsamy, V; Nastouli, E; Pataillot-Meakin, T; Pillay, D; Pym, AS; Steyn, AJC | 1 |
| Cheng, CN; Chuang, YC; Hung, CC; Kuo, CH; Lin, KY; Lin, SW; Lin, YJ; Lin, YT; Liou, BH; Liu, WC; Sun, HY | 1 |
| Nolt, D; Starke, JR | 1 |
| Ariq, H; Habiburrahman, M; Handayani, RRD | 1 |
| Drain, PK; Hussain, H; Kendall, EA; Kubiak, RW; Kunkel, A; Menzies, R; Trajman, A | 1 |
| Gibbons, S; Khoo, S; Marzolini, C; van Oosterhout, JJ | 1 |
| Balloux, F; Bonilla, C; Coronel, J; Didelot, X; Gilman, RH; Grandjean, L; Kon, OM; Moore, DAJ; Torres Ortiz, A; Vidal, JR | 1 |
| Akello, L; Belknap, R; Berger, CA; Bishop, O; Cattamanchi, A; Dowdy, DW; Handley, MA; Kadota, JL; Kamya, MR; Katahoire, A; Katamba, A; Kiwanuka, N; Musinguzi, A; Nabunje, J; Nahid, P; Nakitende, A; Patel, D; Phillips, PPJ; Sammann, A; Semitala, FC; Welishe, F | 1 |
| Cetron, MS; Lambert, LA; Liu, Y; Maloney, SA; Marano, N; Ortega, LS; Phares, CR; Posey, DL; Weinberg, MS; Yang, Q | 1 |
| Egorova, A; Makarov, V; Salina, EG | 1 |
| Kumari, D; Perveen, S; Sharma, R; Singh, K | 1 |
| Cheng, MH; Chong, IW; Huang, HL; Huang, SH; Huang, YW; Lee, CH; Lee, JY; Lee, MR; Liu, IH; Lo, YS; Lu, PL; Wang, JY; Yang, JM | 1 |
| Ascher, DB; Denholm, JT; Karmakar, M; Ragonnet, R; Trauer, JM | 1 |
| Aaron, SD; Allen, C; Alsdurf, H; Alvarez, GG; Amaratunga, K; Brethour, K; Cameron, DW; Grimshaw, JM; Hui, C; Mallick, R; Mulpuru, S; Pakhale, S; Pease, C; Sullivan, K; Taljaard, M; Van Dyk, D; Zwerling, AA | 1 |
| Ahmad, FUD; Ahmed, H; Arafa, EA; Buabeid, MA; Hassan, W; Murtaza, G; Rani, T | 1 |
| Allen, L; Carr, W; Goswami, N; Kurbatova, E; Starks, A; Winston, C | 1 |
| Aznar, ML; Espiau, M; Espinosa-Pereiro, J; Sánchez-Montalvá, A | 1 |
| Benaissa, E; Benlahlou, Y; Bssaibis, F; Elouennass, M; Maleb, A | 1 |
| Hovhannesyan, A; Kozukeev, T; Labib, F; Rossi, R; Soltobekova, N; Yiehdego, G | 1 |
| Aarnoutse, R; Bhavani, PK; Chabala, C; Choo, L; Crook, AM; Demers, AM; Gibb, DM; Graham, SM; Hesseling, AC; Hissar, S; Joseph, B; Kapasa, M; Kinikar, A; LeBeau, K; Love-Koh, J; Mave, V; Mboizi, RB; McIlleron, H; Mulenga, V; Musoke, P; Palmer, M; Raichur, P; Seddon, JA; Thomason, MJ; Turkova, A; van der Zalm, MM; Welch, SB; Wills, GH; Wobudeya, E | 1 |
| Alffenaar, JC; Augustinsson, D; Bornefall, A; Carlsson, B; Ekqvist, D; Fredrikson, M; Niward, K; Nordvall, MJ; Paues, J; Sandstedt, M; Simonsson, USH; Sönnerbrandt, M | 1 |
| Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
| Chasweka, M; Chirambo, AP; Chitani, A; Corbett, EL; Davies, GR; Ghany, JF; Gordon, SB; Khoo, SH; Malamba, R; Mallewa, JE; McCallum, AD; Meghji, JZ; Mwandumba, HC; Pertinez, HE; Shani, D; Sheha, I; Sloan, DJ | 1 |
| Anderson, R; Cholo, MC; Mashele, SA; Matjokotja, MT; Rasehlo, SSM; Steel, HC | 1 |
| Centis, R; D'Ambrosio, L; Galvin, J; Migliori, GB; Tiberi, S; Utjesanovic, N; van den Boom, M; Zumla, A | 1 |
| Nachappa, SA; Neelambike, SM; Ramachandra, NB | 1 |
| Aono, A; Chikamatsu, K; Hiura, M; Hosoya, M; Igarashi, Y; Minegishi, M; Mitarai, S; Morishige, Y; Murase, Y; Ohtawa, S; Shimomura, Y; Takaki, A; Togashi, K; Yamada, H; Yano, M | 1 |
| Bongiorno, MR; Fabbrocini, G; Foti, C; Gambardella, A; Guarneri, C; Lembo, S; Loconsole, F; Megna, M; Patruno, C | 1 |
| Kon, OM; Lalvani, A; Park, M; Satta, G | 1 |
| Byabajungu, H; Ibanda, I; Joloba, ML; Kabugo, J; Kasemire, DL; Majwala, RK; Mujuni, D; Musisi, K; Nadunga, D; Nsawotebba, A; Nyombi, A; Orena, B; Phelan, JE; Ssengooba, W; Tugumisirize, D; Turyahabwe, I | 1 |
| Chandrasekaran, P; Kumar, N; Natrajan, M; Parkhill, J; Peacock, SJ; Rajendhiran, U; Ramalingam, SB; Ranganathan, UDK; Selvaraj, A; Sembulingam, T; Shanmugam, SK; Solaiyappan, S; Swaminathan, S; Tripathy, SP | 1 |
| Brilleman, R; Cotton, F; Deprez, G; Fage, D; Payen, MC | 1 |
| Byeon, SJ; Choi, JH; Chung, SJ | 1 |
| Cabibbe, AM; Cirillo, DM; Dohál, M; Dvořáková, V; Mokrý, J; Norman, A; Pinková, M; Porvazník, I; Rasmussen, EM; Škereňová, M; Solovič, I; Šperková, M; Spitaleri, A | 1 |
| Dinesh, V; Frederick, A; Lavanya, J; Mondal, R; Padmapriyadarsini, C; Palani, N; Premkumar, M; Shanmugam, S; Sivaramakrishnan, G; Sridhar, R; Thiruvengadam, K; Vaishnavee, V | 1 |
| Guo, Y; Huang, C; Sha, W; Tan, G; Wu, X; Yang, J; Yu, F | 1 |
| He, G; Jiang, X; Ning, H; Qiu, C; Shi, J; Wu, L; Wu, Z; Ye, X | 1 |
| Abouhareb, R; Alasadi, L; Alrstom, A; Alsuliman, T; Daher, N; Karam, B; Mohandes, AF; Rajab Bek, MW | 1 |
| Chaplin, M; Davies, GR; De Vos, M; Pillay, S; Schumacher, SG; Steingart, KR; Theron, G; Warren, R | 1 |
| Anderson, G; Vinnard, C | 1 |
| Bae, S; Choi, JY; Jeong, H; Kang, JY; Kim, HW; Kim, JS; Koo, HK; Lee, SS; Lee, Y; Min, J; Myong, JP; Park, JS; Shin, AY; Yim, HW | 1 |
| Anderson, K; Bian, A; Dheda, K; Pietersen, E; Shepherd, BE; Sterling, TR; van der Heijden, YF; Warren, R | 1 |
| Fan, Z; Jiang, Y; Zhao, X | 1 |
| Ahn, JH; Ha, JH; Jekarl, DW; Kim, HW; Kim, JS; Shin, AY | 1 |
| Gao, Q; Hong, C; Li, J; Tan, W; Wu, L; Yang, H; Yang, T; Yang, Z | 1 |
| Alshaer, MH; Gratz, J; Heysell, SK; Houpt, ER; Justine, M; Kosek, M; Liu, J; Maro, A; Mduma, E; Mpagama, SG; Mujaga, B; Peloquin, CA; Rogawski McQuade, ET; Thomas, TA; Van Aartsen, D | 1 |
| Chimbetete, T; Choshi, P; Lehloenya, R; Meintjes, G; Pedretti, S; Peter, J; Phillips, E; Porter, M; Smith, R | 1 |
| Al-Rabeai, DB; Khudhair, GS; Mohammed, KAS | 1 |
| Andia-Biraro, I; Chamba, N; Critchley, JA; Hill, PC; Kibirige, D; Kilonzo, K; Kyazze, AP; Laizer, S; Magombola, D; Mrema, L; Mwayula, IH; Ninsiima, S; Ntinginya, NE; Olomi, W; Romeo, R; Sabi, I; Sharples, K; Te Brake, L; van Crevel, R; van de Maat, J | 1 |
| Li, R; Luo, J; Song, P; Xie, NG; Zhang, DY; Zhang, K | 1 |
| Andersson, B; Jenmalm-Jensen, A; Kalsum, S; Lerm, M; Lundbäck, T; Otrocka, M; Schön, T; Welin, A | 1 |
| Falzon, D; Kanchar, A; Masini, T; Mirzayev, F; Viney, K; Yedilbayev, A; Zignol, M | 1 |
| Dhillon, MS; Sharma, A; Sharma, K; Sharma, M | 1 |
| de Vos, M; Derendinger, B; Dolby, T; Pillay, S; Scott, LA; Steinhobel, AD; Streicher, EM; Theron, G; Warren, RM | 1 |
| Chen, YW; Cui, TT; Guo, XG; Lan, QW; Li, YP; Li, YR; Lin, JY; Lin, M; Liu, JQ; Long, LJ; Qi, LY; Wu, GY; Wu, SY; Wu, T; Yang, YC; Yu, ZY; Yuan, WH | 1 |
| Wen, Y; Wu, X; Zhang, G | 1 |
| Chang, KC; Huang, SS | 1 |
| Derakhshan, M; Hoseini, SJ; Izadi, N; Jmehdar, SA; Kiani, F; Meshkat, Z; Nik, LB; Parsa, S; Rezaee, SA; Sabet, F; Samiei, A; Soleimanpour, S; Yaghoubi, A | 1 |
| Cole, J; Day, CL; Dick, EJ; Foreman, TW; Ganatra, SR; Gandhi, NR; Gonzalez, O; Hall-Ursone, S; Kaushal, D; Mehra, S; Peloquin, CA; Rengarajan, J; Schlesinger, LS; Sharan, R; Shivanna, V; Singh, DK; Thippeshappa, R | 1 |
| Arodola-Oladoyinbo, O; Chirehwa, M; Denti, P; Gengiah, TN; Kawuma, AN; Naidoo, A; Naidoo, K; Padayatchi, N; Perumal, R | 1 |
| Chen, X; Ding, Y; Fu, L; Guo, S; Liu, H; Lu, Y; Wang, B; Wang, N; Zhang, W; Zhu, H | 1 |
| Addise, D; Beyene, D; Merker, M; Mesfin, EA; Niemann, S; Shuaib, YA; Tesfaye, A; Tessema, B | 1 |
| Benson, CA; Chaisson, RE; Fletcher, CV; Gupta, A; Langat, D; Mohapi, L; Mwelase, N; Omoz-Oarhe, A; Pham, MM; Podany, AT; Samaneka, W; Supparatpinyo, K; Swindells, S | 1 |
| Adeyemi, SA; Choonara, YE; Kumar, P; Sumaila, M; Ubanako, P | 1 |
| Cheon, M; Hahn, S; Jeon, D; Kang, YA; Kim, HJ; Kim, KJ; Kim, YR; Kwak, N; Kwon, BS; Kwon, YS; Lee, JH; Lee, JK; Lee, JY; Mok, J; Park, J; Park, Y; Yim, JJ | 1 |
| Assefa, DG; Kassahun, A; Kifle, M; Sintayehu, K; Temesgen, B; Yimer, BT; Zeleke, ED; Zenebe, K | 1 |
| Bennie, M; Godman, B; Kruger, D; Kurdi, A; Meyer, JC; Schellack, N; Skosana, PP | 1 |
| Kang, JY; Kim, HW; Kim, JS; Kim, JW; Kim, SK; Kim, YH; Lee, SH; Min, J; Yoon, HK | 1 |
| Aung, WW; Cho, EJ; Kang, MR; Kim, JH; Lee, JI; Lee, JS; Park, CH; Son, ES | 1 |
| Farooq, S; Hussain, H; Jaswal, M; Khan, AJ; Khowaja, S; Malik, AA; Maniar, R; Safdar, N; Shumail, S | 1 |
| Barnes, GL; Chaisson, RE; Gupta, A; Martinson, NA; Moulton, LH; Msandiwa, R; Singh, P | 1 |
| Alarcón, MJ; Coronel, J; Cotrina, VV; Moore, DAJ; Puyén, ZM; Santos-Lázaro, D; Vigo, AN | 1 |
| Bryant, K; Chaisson, RE; Dawson, R; Dooley, KE; Dorman, SE; Johnson, JL; Kurbatova, E; Lalloo, UG; Mohapi, L; Muzanyi, G; Nahid, P; Pettit, AC; Phillips, PPJ; Podany, AT; Samaneka, W; Sanne, I; Savic, RM; Scott, N; Sizemore, E; Swindells, S; Vernon, A; Waja, Z | 1 |
| Bunchoo, S; Fukushima, Y; Hamada, S; Jekloh, N; Klayut, W; Nakajima, C; Phetsuksiri, B; Rudeeaneksin, J; Srisungngam, S; Suthachai, W; Suthum, K; Suzuki, Y; Tipkrua, N | 1 |
| Äbelö, A; Ashton, M; Bienvenu, E; Birgersson, S; Sundell, J | 1 |
| Bao, X; Deng, G; Deng, Y; Feng, T; Li, G; Suo, Y; Xu, H; Yang, J | 1 |
| Beraldi-Magalhães, F; Böger, B; Domingos, EL; Fachi, MM; Fernandez-Llimos, F; Imazu, P; Junker, AM; Pontarolo, R; Santos, JM; Tonin, FS | 1 |
| Doulla, B; Ershova, J; Heinrich, N; Hoelscher, M; Kilale, AM; Kingalu, A; Kisonga, R; Kondo, Z; Lema, Y; Lyamuya, E; Lyimo, J; Mfaume, SM; Mutayoba, BK; Ngowi, BJ; Nkiligi, E; Ntinginya, NE; Pletschette, M; Range, NS | 1 |
| Glenn, SM; Kell, DB; Makarov, V; Mukamolova, GV; Turapov, O | 1 |
| Ameni, G; Beyene, D; Blumberg, HM; Getahun, M; Kempker, RR | 1 |
| Gao, H; Gong, J; Hu, T; Qu, X; Song, Y; Tao, L; Zhai, J; Zhang, Y | 1 |
| George, S; Gerbo, RM; Hartman-Adams, H | 1 |
| Mlisana, KP; Mvelase, NR; Singh, R; Swe Swe-Han, K | 1 |
| Al-Zubaidi, A; Cheung, CY; Cook, GM; Dawes, SS; Lott, JS; Mizrahi, V; Taiaroa, G | 1 |
| Kilonzo, K; Lyamuya, F; Mremi, A; Sadiq, A; Temba, B; Urassa, D; Vara, P | 1 |
| Alfarisi, O; Barthwal, M; Deshmukh, S; Dharmshale, S; Dooley, KE; Gaikwad, S; Golub, JE; Gupta, A; Gupte, A; Gupte, N; Kagal, A; Lokhande, R; Mave, V; Pradhan, N; Raskar, S; Sahasrabudhe, T; Sane, M | 1 |
| Ahmed, S; Biswas, JP; Das, BR; Haque, N; Hasan, M; Hasan, MS; Hossain, MA; Islam, A; Khan, MK; Nasreen, SA; Paul, SK | 1 |
| Jiang, Y; Li, J; Shen, X; Wang, L; Xu, B; Yu, C; Zhang, Y; Zheng, X | 1 |
| Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N | 1 |
| Eze, FN; Srichana, T; Thawithong, E | 1 |
| Castel, S; Court, R; Joubert, A; Loveday, M; Norman, J; van der Merwe, M; Waitt, C; Wiesner, L; Zuma, P | 1 |
| Garg, S; Kumar, R; Kunimoto, D; Rayat, GR | 1 |
| da Silva, P; David, A; de Vos, M; Ruhwald, M; Schumacher, S; Scott, L; Stevens, W; Trollip, A | 1 |
| Ahmad, S; Al-Hajoj, S; Al-Mutairi, NM; Mokaddas, E | 1 |
| Anibarro, L; Barcala, JM; De Souza-Galvao, ML; Gijon, P; Grijota, MD; Luque, R; Perez-Recio, S; Sanchez, F; Santin, M | 1 |
| Bradbury, J; Lane, BC; McVeigh, LG; Voorhies, JM; Zaazoue, MA | 1 |
| Chatterjee, A; Hirani, N; Joshi, A; Kondabagil, K; Shah, S; Zade, A | 1 |
| Brankin, A; Colman, RE; Georghiou, SB; Seifert, M; Suresh, A; Uplekar, S; Walker, TM | 1 |
| Di Palma, M; Francis, JR; Globan, M; Hall, C; Hersch, N; Horan, K; Lopes, C; Meumann, EM; Pereira, HM; Ralph, AP; Sarmento, N | 1 |
| Chongsuvivatwong, V; Guo, S; Lei, S | 1 |
| Cáceres-Pérez, AR; Fariña, JB; Oliva, A; Santoveña-Estévez, A; Suárez-González, J | 1 |
| Al Moujahid, A; Bletsis, PP; de Jong, T; van den Elskamp, IJ; Wink, FR | 1 |
| Guo, T; Hou, Y; Jiang, T; Li, L; Song, K; Wang, Z; Xue, Y; Zhang, Q; Zhao, Z; Zu, X | 1 |
| Aarnoutse, RE; Agarwal, D; Alffenaar, JC; Antwi, S; Bang, ND; Bekker, A; Bell, DJ; Chabala, C; Choo, L; Davies, GR; Day, JN; Dayal, R; Denti, P; Donald, PR; Engidawork, E; Gafar, F; Garcia-Prats, AJ; Gibb, D; Graham, SM; Hesseling, AC; Heysell, SK; Idris, MI; Kabra, SK; Kinikar, A; Kumar, AKH; Kwara, A; Lodha, R; Magis-Escurra, C; Marais, BJ; Martinez, N; Mathew, BS; Mave, V; McIlleron, HM; Mduma, E; Mlotha-Mitole, R; Mpagama, SG; Mukherjee, A; Nataprawira, HM; Peloquin, CA; Pouplin, T; Ramachandran, G; Ranjalkar, J; Roy, V; Ruslami, R; Schaaf, HS; Shah, I; Singh, Y; Stevens, J; Sturkenboom, MGG; Svensson, EM; Swaminathan, S; Taxis, K; Thatte, U; Thee, S; Thomas, TA; Tikiso, T; Touw, DJ; Turkova, A; Velpandian, T; Verhagen, LM; Wasmann, RE; Winckler, JL; Yang, H; Yunivita, V | 1 |
| Gao, H; Gong, J; Hu, T; Ma, J; Qu, X; Song, Y; Zhai, J; Zhang, Y | 1 |
| Lou, C; Niu, N; Shi, Z; Wang, C; Wang, X; Yang, Z | 1 |
| Bisson, GP; Heysell, SK; Kreiswirth, BN; Kurepina, N; Mehta, K; Narayanan, N; Subbian, S; Vinnard, C | 1 |
| Bhadauria, M; Nirala, SK; Rakshit, S; Sahu, N | 1 |
| Asenjo-Redin, B; Mollov, A; Ojer-Zapata, M; Otano-Oroz, L | 1 |
| Lonati, D; Marano, M; Torroni, F | 1 |
| Cocoros, NM; Langer, AJ; Nguyen, M; Schmit, KM; Stojanovic, D; Talwar, A; Vonnahme, LA; Walker, WL; Welch, EC | 1 |
| Barnes, G; Dawson, R; Dooley, KE; Dorman, SE; Friedman, A; Gupte, N; Hendricks, B; Ignatius, EH; Narunsky, K; Smit, T; Whitelaw, C | 1 |
| Chen, L; Chen, X; Li, Y; Tan, Q; Wang, J; Wang, W; Wang, X; Wei, W; Wu, Z; Xu, L; Yu, M; Zeng, J; Zhang, C; Zhao, Y; Zhou, J | 1 |
| Kipper, K; Kloprogge, F; McHugh, TD; Ortiz Canseco, J; Phee, L; Sadouki, Z; Stoker, N; Witney, AA | 1 |
| Beltramino, S; Bravo, PM; Cornet, ML; Del Carmen Rial, M; Del Grosso, RC; Dotta, AC; Franzini, RL; Hunter, M; León, LR; Linares González, L; Pujato, NR; Radisic, MV; Uva, PD; Walther, J; Werber, G | 1 |
| Che, X; Cho, DC; Choi, JY; Eum, SY; Hong, MS; Kim, HJ; Lee, S; Lee, SK; Seo, YJ | 1 |
| He, W; Liu, D; Ou, X; Pei, S; Song, Z; Wang, S; Xia, H; Xing, R; Zhang, Z; Zhao, B; Zhao, Y | 1 |
| Béranger, A; Gegia, M; Linh, NN; Mirzayev, F; Mohamed, A; Nahid, P; Radtke, K; Savic, RM; Schumacher, SG; Solans, BP | 1 |
| Kim, B; Kim, N; Park, H; Roh, EY; Seok, KH; Shin, S; Yoon, JH | 1 |
| Campino, S; Clark, TG; Napier, G; Phelan, JE | 1 |
| Abubakar, I; Bern, H; Booth, HL; Calvert, J; Clarke, AL; Crook, A; Duong, T; Francis, M; Ghanouni, A; Griffiths, C; Hack, V; Hamada, Y; Horne, R; Kunst, H; Layton, C; Lipman, M; Mandelbaum, M; Owen-Powell, E; Rangaka, MX; Sanders, K; Surey, J; White, PJ; Zenner, D | 1 |
| Bao, J; Fu, H; Gao, S; He, Y; Hosyanto, FF; Li, A; Lu, N; Si, J; Tang, J; Tang, X; Xu, L; Yang, C | 1 |
| Alotaibi, SH | 1 |
| Hatano, M; Igarashi, M; Kinoshita, N; Matsumoto, S; Matsunaga, S; Ozeki, Y; Samukawa, N; Tokudome, K; Tomita, S; Yamaguchi, T | 1 |
| Gunasena, B; Madamarandawala, P; Madegedara, D; Magana-Arachchi, D; Rajapakse, S | 1 |
| Catanzaro, A; Catanzaro, DG; Chiles, P; Ciobanu, N; Codreanu, A; Colman, RE; Cooney, CG; Crudu, V; Hillery, N; Holmberg, RC; Kukhtin, AV; Linger, Y; Norville, R; Rodwell, TC; Seifert, M; Syed, RR | 1 |
| Avihingsanon, A; Balanag, VM; Burhan, E; Chew, KL; Cousins, C; Crook, AM; Dalay, VB; Djaharuddin, I; Kusmiati, T; Lee, SL; Lu, Q; Nunn, AJ; Papineni, P; Paton, NI; Pokharkar, Y; Ruslami, R; Sarin, R; Sekaggya-Wiltshire, C; Sugiri, JJR; Suresh, C; Veto, RS | 1 |
| Andrianomanana, FR; Crook, DW; Dingle, K; George, S; Grandjean Lapierre, S; Hall, MB; Hoosdally, S; Iqbal, Z; Mandal, A; Mishra, S; Mistry, N; Nilgiriwala, K; Patel, G; Rabodoarivelo, MS; Rakotosamimanana, N; Rodger, G; Walker, TM | 1 |
| Naidoo, A; Naidoo, K; Padayatchi, N; Perumal, R | 1 |
| Dartois, V; Mittereder, LR; Namasivayam, S; Oland, S; Sher, A; Wang, H; Zimmerman, M | 1 |
| Denholm, JT | 1 |
| He, C; Li, Y; Wu, W; Xu, K; Ying, C; Zhang, Y | 1 |
| Cai, S; Ma, N; Sun, Y; Zhang, Y | 1 |
| Allard-Gray, A; Boakye, I; Camara, A; Campbell, JR; Eisenbeis, L; Guimarães-Teixeira, E; Menzies, D; Sow, O; Zielinski, D | 1 |
| Armstrong, D; Fisher, S; Parrish, N; Totten, M | 1 |
| Belknap, R; Benedetti, A; Borisov, A; Campbell, JR; Chaisson, RE; Chan, PC; Martinson, N; Menzies, D; Nahid, P; Scott, NA; Sizemore, E; Sterling, TR; Villarino, ME; Wang, JY; Winters, N | 1 |
| Anderson, LF; Bonnet, M; Brode, SK; Campbell, JR; Cegielski, JP; Chan, ED; Fox, GJ; Guglielmetti, L; Kuksa, L; Menzies, D; Rodrigues, D; Singla, R; Skrahina, A; Viiklepp, P | 1 |
| Bender, JM; Bihm, D; Dasgupta-Tsinikas, S; Guevara, RE; Higashi, J; Jung, C; Kaneta, K; Kizzee, R; Lenz, A; Malhotra, S; Neely, M; Yumul, J | 1 |
| Aslan, G; Ersoy, L; Özgür, D; Tezcan Ülger, S; Ülger, M | 1 |
| Abebe, T; Amare, M; Blumberg, HM; Bobosha, K; Diriba, G; Fikadu, D; Kempker, RR; Moga, S; Zerihun, B | 1 |
| Asher, GN; Balio, C; Berry, AM; Coffey, CP; Jonas, DE; Kahwati, LC; Lee, LC; Riley, SR; Voisin, CE; Wang, SH; Williams, N | 1 |
| Chen, X; Feng, Z; Ge, S; Li, R; Li, Y; Miao, Y; Peng, Y; Song, L; Sun, F; Wang, X; Zhang, W; Zhang, Y | 1 |
| Ezhilarasan, D | 1 |
| Farshadzadeh, Z; Khoshnood, S; Khosravi, AD; Savari, M; Shahi, F | 1 |
| Griesel, R; Hill, AM; Keene, CM; Maartens, G; Meintjes, G; Omar, Z; Simmons, B; Wiesner, L; Zhao, Y | 1 |
| Chen, WY; Chen, YF; Huang, HM; Su, YC; Tsai, JM | 1 |
| Chen, S; Huang, Y; Long, Y; Qiu, Y; Shi, Y; Su, H; Wei, J; Wei, Y; Zhu, W | 1 |
| Agyemang, N; Badal-Faesen, S; Baker, P; Barr, E; Belaunzaran-Zamudio, PF; Cohn, SE; Gadama, L; Gatechompol, S; Godfrey, C; Haas, DW; Jalil, EM; Kayama, C; Mawlana, S; Mngqibisa, R; Olefsky, M; Pham, M; Podany, AT; Scarsi, KK; Smeaton, LM; Supparatpinyo, K; Van Schalkwyk, M; Woolley, E | 1 |
| Abad, CLR; Razonable, RR | 1 |
| Gadgil, CJ; Ramachandran, A | 1 |
| Newton, PN; Tabernero, P | 1 |
| Cho, YJ; Kim, HJ; Kim, YW; Kwon, BS; Lee, CT; Lee, JH; Lee, YJ; Lim, SY; Park, JS; Song, MJ | 1 |
| Arriaga-García, FJ; Herrera-Pérez, IG; Medellín-Garibay, SE; Milán-Segovia, RDC; Ortiz-Álvarez, A; Rodríguez-Báez, AS; Rodríguez-Pinal, CJ; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
| Çalışkantürk, G; Çeylan, K; Gazel, D; Karslıgil, T | 1 |
| Cao, H; Gao, Y; Huang, Z; Li, B; Li, T; Mo, S; Wu, J; Yang, C; Zhang, K; Zhang, R | 1 |
| Bauer, T; Bös, L; Breuer, C; Diel, R; Geerdes-Fenge, H; Günther, A; Häcker, B; Hannemann, J; Nienhaus, A; Priwitzer, M; Witte, P | 2 |
| Nair, S; Padmapriyadarsini, C; Rajendran, P; Sivakumar, S | 1 |
| Pecora Fulco, P; Taylor, A; Winthrop, E | 1 |
| Alffenaar, JW; Aryal, S; Boorgula, GD; Dheda, K; Gumbo, T; Malinga, L; Raj, P; Shankar, P; Singh, S; Srivastava, S; Thomas, TA | 1 |
| Huang, C; Lin, Y; Tong, J; Wang, Y; Xu, B; Xu, Q; Yang, X | 1 |
| Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A | 1 |
| Ai, LY; Bai, XX; Cheng, QL; Huang, YY; Jia, QJ; Li, QC; Wu, YF; Xie, L | 1 |
| Aalhoul, F; Cotton, F; Fage, D | 1 |
| Adeel, A; Ahmad, A; Ahmad, I; Aslam, H; Mushtaq, F; Raza, SM; Saleem, S | 1 |
| Achar, J; Dodd, PJ; Esmail, H; Hughes, J; Knight, GM; McQuaid, CF; Seddon, JA | 1 |
| Arzanlou, M; Esmaelizad, M; Habibzadeh, S; Hosseinali, Z; Mirzanejad-Asl, H; Mohammadshahi, J; Sadeghnezhad, M; Sohrabi, S; Teimourpour, A; Teimourpour, R | 1 |
| Aarnoutse, R; Chabala, C; Cotton, MF; Denti, P; Galileya, LT; Gibb, D; Hesseling, A; Lee, J; McIlleron, H; Njahira Mukui, I; Rabie, H; Turkova, A; Wasmann, RE; Zar, H | 1 |
| Anthwal, D; Bhalla, M; Choudhary, S; Gupta, RK; Haldar, S; Tyagi, JS | 1 |
342 review(s) available for isoniazid and rifampin
| Article | Year |
|---|---|
Tuberculosis: the drug development pipeline at a glance.
Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Drug Discovery; Humans; Tuberculosis | 2012 |
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Lung; Mycobacterium tuberculosis; Tuberculosis | 2013 |
Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications.
Topics: Molecular Structure; Quinazolines; Quinazolinones | 2014 |
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
Topics: Animals; Antitubercular Agents; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
Topics: Antitubercular Agents; Clinical Trials as Topic; DNA Gyrase; Drug Discovery; Humans; Mycobacterium tuberculosis; Topoisomerase II Inhibitors | 2016 |
Isoniazid derivatives and their anti-tubercular activity.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Triazole derivatives and their anti-tubercular activity.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2017 |
Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Molecular Structure; Mycobacterium tuberculosis; Pyrazoles; Structure-Activity Relationship; Tuberculosis | 2017 |
Recently reported biological activities of pyrazole compounds.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Pyrazoles | 2017 |
Fluoroquinolone derivatives and their anti-tubercular activities.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Recent advances of imidazole-containing derivatives as anti-tubercular agents.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Fluoroquinolone-isatin hybrids and their biological activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship | 2019 |
Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.
Topics: Animals; Antimalarials; Antitubercular Agents; Humans; Structure-Activity Relationship; Tetrazoles | 2019 |
Marine natural products as potential anti-tubercular agents.
Topics: Animals; Antitubercular Agents; Aquatic Organisms; Biological Products; Humans; Tuberculosis | 2019 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Drug-resistance in
Topics: | 2019 |
Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Models, Molecular; Mycobacterium tuberculosis; Oxadiazoles; Structure-Activity Relationship; Tuberculosis | 2021 |
Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
Topics: Antitubercular Agents; Carboxylic Ester Hydrolases; Drug Design; Enzyme Inhibitors; Humans; Lactones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Organophosphorus Compounds; Orlistat; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2021 |
An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review.
Topics: Animals; Antitubercular Agents; Drug Design; Drug Discovery; Humans; Mycobacterium tuberculosis; Piperazine; Structure-Activity Relationship; Tuberculosis | 2021 |
Antitubercular properties of thiazolidin-4-ones - A review.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Thiazolidines; THP-1 Cells; Vero Cells | 2021 |
The Mur Enzymes Chink in the Armour of Mycobacterium tuberculosis cell wall.
Topics: Antitubercular Agents; Cell Wall; Enzyme Inhibitors; Molecular Structure; Mycobacterium tuberculosis; Peptide Synthases; Peptidoglycan | 2021 |
Emerging impact of triazoles as anti-tubercular agent.
Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Treatment of tuberculosis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Child; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis; Viomycin | 1975 |
Advances in the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Urogenital | 1976 |
The chemotherapy of pulmonary tuberculosis: a review.
Topics: Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Patient Dropouts; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1979 |
Mode of action of anti-tubercular drugs.
Topics: Aminosalicylic Acid; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1977 |
Diagnosis and management of tuberculosis.
Topics: Adrenal Cortex Hormones; Ambulatory Care; Aminosalicylic Acid; Antitubercular Agents; BCG Vaccine; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium Infections; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary | 1979 |
[Antimicrobial therapy in pregnancy (author's transl)].
Topics: Abortion, Spontaneous; Antimalarials; Antiviral Agents; Central Nervous System; Cephalosporins; DNA Replication; Female; Humans; Isoniazid; Maternal-Fetal Exchange; Methemoglobinemia; Molecular Weight; Nalidixic Acid; Pregnancy; Pregnancy Complications, Infectious; Protein Binding; Rifampin; Sulfonamides; Teratogens; Urinary Tract Infections | 1979 |
[Tuberculosis in infancy nowadays (author's transl)].
Topics: BCG Vaccine; Child; Child, Preschool; Ethambutol; Germany, West; Humans; Infant; Infant, Newborn; Isoniazid; Rifampin; Risk; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1978 |
The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Acetylation; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver Function Tests; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1978 |
Tuberculosis: review of treatment failure, relapse and drug resistance.
Topics: Aminosalicylic Acid; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
[Desquamative interstitial pneumonia. Peripheral eosinophilia in DIP: a new clinical aspect (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Alveolitis, Extrinsic Allergic; Collagen Diseases; Diagnosis, Differential; Eosinophilia; Female; Histiocytosis, Langerhans-Cell; Humans; Isoniazid; Lung; Pneumonia; Pulmonary Eosinophilia; Radiography; Rifampin; Tetracycline | 1978 |
Drug treatment of tuberculous meningitis in childhood. A survey of current practices.
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1979 |
Hepatotoxicity: pathogenesis and therapeutic intervention.
Topics: Acetaminophen; Anabolic Agents; Androgens; Animals; Chemical and Drug Induced Liver Injury; Cysteamine; Cysteine; Erythromycin; Estrogens; Halothane; Humans; Isoniazid; Liver; Nitrofurantoin; Rifampin | 1979 |
Chemotherapy of tuberculosis.
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1976 |
Diagnosis, prevention and early therapy of tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Female; Humans; Hypersensitivity, Delayed; Isoniazid; Male; Mycobacterium tuberculosis; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Cardiovascular; Tuberculosis, Female Genital; Tuberculosis, Lymph Node; Tuberculosis, Male Genital; Tuberculosis, Meningeal; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Renal; United States | 1976 |
Case report and review of current treatment methods. Tuberculous spondylitis.
Topics: Adult; Debridement; Ethambutol; Humans; Isoniazid; Male; Rifampin; Spondylitis; Streptomycin; Tuberculosis, Spinal; Wound Healing | 1976 |
Failure of therapy for tuberculosis in human immunodeficiency virus infection.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis | 1992 |
[Chemoprophylaxis of tuberculosis (lecture)].
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; BCG Vaccine; Child; Ethambutol; Humans; Infant, Newborn; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1992 |
[Clinical pharmacology in optimization of therapy of lung diseases].
Topics: Antitubercular Agents; Asthma; Biotransformation; Ethionamide; Humans; Isoniazid; Metabolic Clearance Rate; Rifampin; Theophylline; Tuberculosis, Pulmonary | 1991 |
Toxic hepatitis with isoniazid and rifampin. A meta-analysis.
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Isoniazid; Meta-Analysis as Topic; Rifampin; Tuberculosis | 1991 |
Studies on the role of the mycobacterial cell envelope in the multiple drug resistance of atypical mycobacteria.
Topics: Calorimetry; Cell Membrane; Cell Wall; Drug Interactions; Drug Resistance, Microbial; Ethambutol; Isoniazid; Nontuberculous Mycobacteria; Rifampin; Streptomycin | 1991 |
[Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide].
Topics: Biological Availability; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1991 |
[Chemotherapy of extrapulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Isoniazid; Rifampin; Tuberculosis | 1991 |
[Short-term chemotherapy of leprosy using the combination rifampicin + cotrimoxazole + isoniazid].
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Female; Humans; Isoniazid; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 1991 |
[Genital tuberculosis in women].
Topics: Denmark; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Female; Humans; Infertility, Female; Isoniazid; Rifampin; Tuberculosis, Female Genital | 1990 |
Cutaneous tuberculosis. Current concepts.
Topics: BCG Vaccine; Humans; Isoniazid; Rifampin; Tuberculosis, Cutaneous | 1990 |
Pancreatic abscess due to mycobacterial infection associated with the acquired immunodeficiency syndrome.
Topics: Abscess; Acquired Immunodeficiency Syndrome; Adult; Amikacin; Female; Gentamicins; Humans; Isoniazid; Middle Aged; Mycobacterium Infections; Nafcillin; Pancreatic Diseases; Penicillins; Rifampin; Tomography, X-Ray Computed; Ultrasonography | 1990 |
[Therapy of tuberculosis].
Topics: Antitubercular Agents; Contraindications; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1990 |
Adverse cutaneous reactions to antituberculosis drugs.
Topics: Acne Vulgaris; Adult; Amikacin; Antitubercular Agents; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Pellagra; Pigmentation Disorders; Prothionamide; Pyrazinamide; Rifampin; Skin Diseases; Streptomycin; Thioacetazone | 1985 |
Chromatographic analysis of antituberculosis drugs in biological samples.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Chromatography; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Kinetics; Monitoring, Physiologic; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Viomycin | 1985 |
Treatment of extrapulmonary tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Rifampin; Tuberculosis | 1989 |
[Which treatment for primary tuberculosis?].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1989 |
[Short term treatment of infantile pulmonary tuberculosis].
Topics: Antitubercular Agents; BCG Vaccine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1989 |
[Adverse effects of antitubercular agents].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Hearing Loss, Bilateral; Humans; Immune Complex Diseases; Isoniazid; Neuritis; Rifampin; Streptomycin | 1985 |
Adverse reactions to drugs used in the treatment of tuberculosis.
Topics: Antitubercular Agents; Drug Hypersensitivity; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin | 1988 |
Antituberculosis agents.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1988 |
Teratology of the antituberculosis drugs.
Topics: Abnormalities, Drug-Induced; Animals; Antitubercular Agents; Female; Humans; Isoniazid; Pregnancy; Rifampin; Risk; Streptomycin; Teratogens | 1987 |
CNS tuberculosis.
Topics: Biopsy; Cerebral Ventricles; Cerebrospinal Fluid; Ethambutol; Humans; Hyaluronoglucosaminidase; Isoniazid; Nervous System Diseases; Prognosis; Pyrazinamide; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Meningeal | 1986 |
Respiratory pharmacology. Antituberculosis drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cyclosporins; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1986 |
Contact dermatitis to antituberculosis drugs.
Topics: Aminosalicylic Acid; Antitubercular Agents; Cross Reactions; Dermatitis, Contact; Desensitization, Immunologic; Ethambutol; Humans; Isoniazid; Kanamycin; Rifampin; Skin Tests; Streptomycin | 1986 |
Rifampin. No longer just for tuberculosis.
Topics: Adult; Bacterial Infections; Child; Drug Combinations; Humans; Isoniazid; Rifampin; Tuberculosis | 1985 |
[Treatment of pleuropulmonary tuberculosis in 1985].
Topics: Aminoglycosides; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Thioamides; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1985 |
[Toxic hepatitis induced by antibiotics].
Topics: Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Chloramphenicol; Erythromycin Estolate; Humans; Isoniazid; Rifampin; Tetracyclines; Troleandomycin | 1985 |
Tuberculosis--chemotherapy.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Rifampin; Self Medication; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1972 |
General considerations in intermittent drug therapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1971 |
Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Cycloserine; Drug Eruptions; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Pyrazinamide; Rifampin; Skin; Stomatitis; Streptomycin; Thioacetazone; Viomycin | 1972 |
Tuberculosis.
Topics: Aminosalicylic Acids; Bronchitis; Cough; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Mass Screening; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1973 |
[Ocular toxicity of ethambutol].
Topics: Aged; Aminosalicylic Acids; Capreomycin; Chemical Phenomena; Chemistry; Color Perception; Drug Therapy, Combination; Ethambutol; Eye; Eye Diseases; Female; Humans; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary; Visual Acuity; Visual Fields | 1971 |
[Proceedings: Tuberculosis therapy. Review on today's knowledge, developmental trends and still open problems].
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Germany, West; Humans; Isoniazid; Length of Stay; Rifampin; Streptomycin; Tuberculosis | 1973 |
New trends in the chemotherapy of tuberculosis--current aspects.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Tuberculosis | 1974 |
Acute forms of tuberculosis.
Topics: Acute Disease; Antitubercular Agents; Child; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Isoniazid; Lung; Middle Aged; Mycobacterium tuberculosis; Peritonitis, Tuberculous; Pneumonia; Radiography; Rifampin; Sputum; Tuberculosis; Tuberculosis, Cardiovascular; Tuberculosis, Meningeal; Tuberculosis, Miliary | 1973 |
The impact of chemotherapy on the care of patients with tuberculosis.
Topics: Antitubercular Agents; Aspirin; Bacteriological Techniques; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Hospitalization; Humans; Isoniazid; Length of Stay; Mycobacterium tuberculosis; Outpatient Clinics, Hospital; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
Neuro-tuberculosis, An unsolved problem.
Topics: Adrenal Cortex Hormones; Brain Edema; Cerebral Angiography; Developing Countries; Ethambutol; Humans; India; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thailand; Tuberculosis, Meningeal | 1974 |
[Modern treatment of skin tuberculosis].
Topics: Cycloserine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Skin; Streptomycin; Time Factors; Tuberculosis, Cutaneous | 1974 |
[Current status of the antitubercular chemotherapy].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Isonicotinic Acids; Microbial Sensitivity Tests; Prognosis; Prospective Studies; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Tuberculosis in Hong Kong ten years later.
Topics: Aminosalicylic Acids; BCG Vaccine; Child, Preschool; China; Cycloserine; Drug Resistance, Microbial; Ethionamide; Health Education; Hong Kong; Hospitalization; Humans; Hypersensitivity; Infant; Infant Mortality; Infant, Newborn; Isoniazid; Pyrazinamide; Racial Groups; Research; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
Topics: Alcoholism; Aminosalicylic Acids; Bilirubin; Drug Therapy, Combination; Humans; Isoniazid; Patient Dropouts; Rifampin; Streptomycin; Time Factors; Transaminases; Tuberculosis, Pulmonary | 1973 |
Genitourinary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethionamide; Female; Follow-Up Studies; Humans; Hypertension, Renal; Isoniazid; Kanamycin; Male; Nephrectomy; Pyridoxine; Radiography; Rifampin; Tuberculosis, Renal; Tuberculosis, Urogenital; United States | 1974 |
[Pregnancy and tuberculosis].
Topics: Abortion, Therapeutic; Adult; Antitubercular Agents; Birth Rate; Female; Fetal Diseases; Germany, West; Humans; Isoniazid; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Radiation Dosage; Recurrence; Rifampin; Streptomycin; Tuberculosis | 1974 |
[Chemoprevention and preventive chemotherapy of tuberculosis in adulthood (Review)].
Topics: Adult; Amides; Antitubercular Agents; Ethambutol; Evaluation Studies as Topic; False Negative Reactions; Female; Humans; Isoniazid; Isonicotinic Acids; Male; Placebos; Pregnancy; Recurrence; Rifampin; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
Topics: Adolescent; Adult; Age Factors; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Isoniazid; Leukocytosis; Lymphopenia; Male; Middle Aged; Purpura, Thrombocytopenic; Rifampin; Sex Factors; Tuberculosis, Pulmonary | 1974 |
Rifampin.
Topics: Adult; Aged; Animals; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Jaundice; Male; Mice; Middle Aged; Mycobacterium tuberculosis; Pregnancy; Rifampin; Thrombocytopenia; Tuberculosis, Pulmonary | 1972 |
Antituberculosis activity of rifampin. Report of studies performed and in progress (1966-1971).
Topics: Aminosalicylic Acids; Animals; Culture Media; Ethambutol; Follow-Up Studies; Guinea Pigs; Half-Life; Humans; Isoniazid; Mycobacterium tuberculosis; Rabbits; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Experimental chemotherapy of tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1969 |
[New drugs in antitubercular therapy].
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; RNA Nucleotidyltransferases; Tuberculosis; Tuberculosis, Pulmonary | 1969 |
[Drug therapy of tuberculosis in the child].
Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Female; Germany, West; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1969 |
[Current status of chemotherapy of pulmonary tuberculosis and its further prospectives].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Hemorrhagic Disorders; Humans; Isoniazid; Kanamycin; Phenylthiourea; Purpura, Thrombocytopenic; Pyrazines; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[New anti-tubercular agents--rifampicin and ethambutol].
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1971 |
Intermittent chemotherapy or improvement of initial treatment in tuberculosis.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Antitubercular Agents; Ethambutol; Guinea Pigs; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Clinical pharmacology of antitubercular drugs.
Topics: Antitubercular Agents; Child; Child, Preschool; Ethambutol; Humans; Infant; Isoniazid; Rifampin | 1983 |
[Nature of the hepatotoxic action of isoniazid (review of the literature)].
Topics: Acetyltransferases; Adult; Aged; Autoimmune Diseases; Biotransformation; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Enzyme Induction; Female; Humans; Isoniazid; Liver; Middle Aged; Pregnancy; Rifampin | 1984 |
Pregnancy and tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Female; Humans; Infant, Newborn; Isoniazid; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Prognosis; Rifampin; Risk; Streptomycin; Tuberculin Test; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1984 |
Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases.
Topics: Actinomyces; Actinomycosis; Actinomycosis, Cervicofacial; Adult; Age Factors; Aged; Anti-Bacterial Agents; Diagnosis, Differential; Female; Humans; Isoniazid; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Rifampin; Sex Factors; Sputum; United States | 1984 |
Aging and tuberculosis.
Topics: Aged; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Pyridoxine; Rifampin; Streptomycin; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Urogenital; United States | 1984 |
[New findings concerning the biochemical mechanisms of the tuberculous process and the correction of biochemical abnormalities using etiopathogenetic preparations].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethionamide; Fatty Acids; Humans; Isoniazid; Liver; Malates; Metabolic Diseases; Mitochondria; Oxidative Phosphorylation; Rifampin; Succinates; Succinic Acid; Tuberculosis | 1984 |
[Toxicity of pyrazinamide in antituberculous treatments (author's transl)].
Topics: Chemical and Drug Induced Liver Injury; Diarrhea; Drug Eruptions; Gout; Humans; Isoniazid; Nausea; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1980 |
[Treatment of tuberculous meningitis in adults: current trends and problems].
Topics: Aminosalicylic Acid; Antitubercular Agents; Blood-Brain Barrier; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Injections, Spinal; Isoniazid; Optic Neuritis; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1982 |
[Concept of the relapse of tuberculosis].
Topics: Animals; Humans; Isoniazid; Mice; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1982 |
Treatment of tuberculosis. The Mitchell lecture 1979.
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Bacteriologic basis of short-course chemotherapy for tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Guinea Pigs; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Antituberculous drugs.
Topics: Antitubercular Agents; Chemical Phenomena; Chemistry; Ethambutol; Humans; Isoniazid; Kinetics; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1982 |
Drug-induced pancreatitis: a critical review.
Topics: Acetaminophen; Adrenal Cortex Hormones; Amphetamines; Asparaginase; Azathioprine; Chlorthalidone; Cholestyramine Resin; Cimetidine; Cyproheptadine; Dextropropoxyphene; Diazoxide; Diuretics; Estrogens; Ethacrynic Acid; Furosemide; Histamine; Humans; Hypercalcemia; Indomethacin; Isoniazid; Mercaptopurine; Narcotics; Pancreatitis; Phenformin; Procainamide; Rifampin; Salicylates; Sodium Chloride Symporter Inhibitors; Sulfonamides; Tetracycline | 1980 |
Tuberculosis.
Topics: Alcohol Drinking; Carrier State; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1980 |
Treatment of tuberculosis during pregnancy.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; Hearing Disorders; Humans; Isoniazid; Limb Deformities, Congenital; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
What's new in tuberculosis?
Topics: Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Whither short-course chemotherapy?
Topics: Animals; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Mice; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1981 |
Antibiotics and hepatic disease.
Topics: Aminoglycosides; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Humans; Isoniazid; Kinetics; Lincomycin; Liver Diseases; Penicillins; Rifampin | 1982 |
[The therapeutic aspects of urogenital tuberculosis. Apropos of 86 cases].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Constriction, Pathologic; Endoscopy; Female; Humans; Isoniazid; Male; Middle Aged; Nephrectomy; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital; Ureter; Ureteral Diseases; Ureteroscopy | 1995 |
Hepatotoxicity: newer aspects of pathogenesis and treatment.
Topics: Acetaminophen; Acetylcysteine; Adenoma, Liver Cell; Adult; Amoxicillin; Anabolic Agents; Beverages; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Contraceptives, Oral; Female; Humans; Isoniazid; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Male; Nonprescription Drugs; Propylthiouracil; Rifampin | 1995 |
Fixed-dose combinations of antituberculous medications to prevent drug resistance.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Humans; Isoniazid; Pyrazinamide; Rifampin | 1995 |
Anti-infective agents and hepatic disease.
Topics: Anti-Infective Agents; Chloramphenicol; Clindamycin; Fluoroquinolones; Humans; Isoniazid; Liver Diseases; Metabolic Clearance Rate; Rifampin | 1995 |
Molecular genetics of drug resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Catalase; Drug Resistance, Microbial; Genes, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1994 |
Clinically significant drug interactions with antituberculosis agents.
Topics: Absorption; Antitubercular Agents; Biotransformation; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Enzyme Induction; Humans; Isoenzymes; Isoniazid; Quinolones; Rifabutin; Rifampin; Tissue Distribution; Tuberculosis | 1994 |
Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice.
Topics: AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Humans; Isoniazid; Research; Rifampin; Tuberculin Test; Tuberculosis | 1995 |
Tuberculous liver abscess treated by percutaneous infusion of antituberculous agents.
Topics: Administration, Cutaneous; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Liver Abscess; Middle Aged; Peritonitis, Tuberculous; Rifampin; Tuberculosis, Hepatic | 1994 |
Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Isoniazid; Liver Failure; Liver Transplantation; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1994 |
Pulmonary infection due to Mycobacterium xenopi.
Topics: Bacterial Typing Techniques; Clarithromycin; Cycloserine; DNA Probes; Drug Resistance, Microbial; Gastrectomy; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections; Respiratory Tract Infections; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations.
Topics: Antitubercular Agents; Culture Media; Drug Resistance, Microbial; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; World Health Organization | 1994 |
Multidrug-resistant tuberculosis and its control.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1993 |
Mode of action of antituberculous drugs and mechanisms of drug resistance in Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Cycloserine; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Mycobacterium tuberculosis; Rifampin | 1993 |
Outpatient management of tuberculosis.
Topics: Algorithms; Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mass Screening; Population Surveillance; Pyrazinamide; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary; United States | 1996 |
Feline tuberculosis: a literature review and discussion of 19 cases caused by an unusual mycobacterial variant.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Cat Diseases; Cats; Diagnosis, Differential; Dihydrostreptomycin Sulfate; Drug Therapy, Combination; Female; Incidence; Isoniazid; Male; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Skin; Tuberculosis; Tuberculosis, Cutaneous; United Kingdom; Weight Loss | 1996 |
Primary esophageal tuberculosis: a case report and 1996 update.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Esophageal Diseases; Female; Humans; Isoniazid; Rifampin; Tuberculosis | 1996 |
[Four cases of similar Hexheimer's reaction during the initial chemotherapy for tuberculosis bacillus].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Child, Preschool; Female; Humans; Isoniazid; Lymphadenitis; Male; Pleurisy; Rifampin; Tuberculosis, Pulmonary | 1995 |
Mechanisms of drug resistance in Mycobacterium tuberculosis.
Topics: Chromosome Mapping; Drug Resistance, Microbial; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin | 1996 |
Epidemiology, control and treatment of multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Developing Countries; Humans; Isoniazid; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Short-course chemoprophylaxis for tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antitubercular Agents; Chronic Disease; Clinical Trials as Topic; Disease Models, Animal; Drug Therapy, Combination; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1997 |
[Fulminant hepatitis during the therapy for tuberculous meningitis].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 1996 |
Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Rifampin | 1997 |
[Value of ciprofloxacin in the therapy of tuberculosis and other mycobacterioses].
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections; Ofloxacin; Rifampin | 1997 |
New horizons in the treatment of tuberculosis.
Topics: Animals; Drug Design; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycolic Acids; Pyrazinamide; Rifampin; Tuberculosis | 1997 |
[Emerging and drug-resistant infectious diseases--multi-drug resistant tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Multiple; Genes, MDR; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 1997 |
[The epidemiology of tuberculosis and of the resistance to antitubercular agents].
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Developed Countries; Developing Countries; Global Health; Health Promotion; HIV Infections; Humans; Incidence; Isoniazid; Population Growth; Poverty; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 1997 |
[Antitubercular chemotherapy].
Topics: Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Combinations; Ethambutol; Follow-Up Studies; HIV Seronegativity; Humans; Isoniazid; Patient Compliance; Patient Education as Topic; Pyrazinamide; Rifampin; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis--a molecular story.
Topics: Base Sequence; Drug Resistance, Microbial; Genes, MDR; Isoniazid; Microbial Sensitivity Tests; Molecular Biology; Mycobacterium tuberculosis; Phenotype; Polymerase Chain Reaction; Rifampin | 1998 |
[Chemotherapy for tuberculosis; yesterday, today, and tomorrow--basic and clinical studies].
Topics: Aminosalicylic Acid; Antitubercular Agents; Controlled Clinical Trials as Topic; Drug Delivery Systems; Drug Therapy, Combination; Forecasting; Humans; Immunologic Factors; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1998 |
[Pharyngeal tuberculosis: an analytical study and report of 10 cases].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Pharyngeal Diseases; Pyrazinamide; Rifampin; Tuberculosis | 1998 |
[Mechanisms of drug-resistance in mycobacteria].
Topics: Drug Resistance, Microbial; Isoniazid; Mycobacterium; Rifampin; Streptomycin | 1998 |
[Short-course chemotherapy of tuberculosis with pyrazinamide].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1998 |
Mycobacterium malmoense infection. An unusual cause of wrist swelling.
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy, Needle; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tenosynovitis; Wrist | 1998 |
The tuberculosis pandemic--which way now?
Topics: Adult; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Cattle; Child; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Microbial; HIV Infections; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis; World Health Organization | 1999 |
[Molecular mechanisms of drug resistance of Mycobacterium tuberculosis].
Topics: Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1999 |
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Drug Resistance, Multiple; Ethambutol; Ethionamide; Fluoroquinolones; Genes, Bacterial; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymorphism, Genetic; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Virulence | 1998 |
Shortening the duration of treatment for cervical tuberculous lymphadenitis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Neck; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node | 2000 |
Tuberculous subcutaneous abscesses developing during miliary tuberculosis therapy.
Topics: Abscess; Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Radiography; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Miliary | 2000 |
Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: case report and review.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis, Tuberculous; Pyrazinamide; Rifampin | 2000 |
Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Humans; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis | 2000 |
A current approach to the management of tuberculosis infection.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; BCG Vaccine; Ethambutol; Forecasting; Humans; Immunocompetence; Isoniazid; Mass Screening; Patient Compliance; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis | 2000 |
Role of individual drugs in the chemotherapy of tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Isoniazid; Microbial Sensitivity Tests; Primary Prevention; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis | 2000 |
Methicillin-resistant Staphylococcus aureus and multidrug resistant tuberculosis: Part 2.
Topics: Antibiotics, Antitubercular; Health Personnel; Humans; Isoniazid; Methicillin Resistance; Occupational Exposure; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tuberculosis, Multidrug-Resistant | 2000 |
[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2001 |
[Antitubercular drug-induced liver injuries].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Rifampin; Tuberculosis | 1998 |
A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Protocols; Female; Humans; Isoniazid; Male; Middle Aged; Recurrence; Retreatment; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam; World Health Organization | 2001 |
Tubercular laryngeal abscess.
Topics: Abscess; Adult; Antitubercular Agents; Cefotaxime; Diclofenac; Drainage; Ethambutol; Humans; Hydrocortisone; Isoniazid; Laryngoscopy; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Laryngeal | 2001 |
Antitubercular drugs (isoniazid, rifampin and pyrazinamide): hepatobiliary reactions.
Topics: Antitubercular Agents; Biliary Tract Diseases; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Pyrazinamide; Rifampin | 2001 |
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin | 2001 |
Tuberculous meningitis: is a 6-month treatment regimen sufficient?
Topics: Adult; Antitubercular Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Meningeal | 2001 |
Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
Topics: Antitubercular Agents; Government Programs; Humans; International Cooperation; Isoniazid; National Health Programs; Practice Guidelines as Topic; Rifampin; Tuberculosis, Multidrug-Resistant; World Health Organization | 2001 |
Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.
Topics: Africa South of the Sahara; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Government Programs; Humans; Isoniazid; Recurrence; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
A hoarse voice: atypical mycobacterial infection of the larynx.
Topics: Aged; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hoarseness; Humans; Isoniazid; Laryngeal Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyridoxine; Rifampin; Sputum; Staining and Labeling | 2001 |
Multidrug-resistant tuberculosis--can the tide be turned?
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Global Health; Humans; Isoniazid; Rifampin; Tuberculosis, Multidrug-Resistant | 2001 |
Chemotherapeutic treatment for spinal tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Spinal | 2002 |
Primary lingual tuberculosis: a case report with review of literature.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tongue Diseases; Tongue Neoplasms; Tuberculosis, Oral | 2002 |
Cervical lymphadenitis caused by Mycobacterium lentiflavum.
Topics: Abscess; Amoxicillin-Potassium Clavulanate Combination; Humans; Infant; Isoniazid; Lymph Nodes; Male; Mycobacterium; Mycobacterium Infections; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 2002 |
[Resistant tuberculosis: a molecular review].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2002 |
Clinical practice. Latent tuberculosis infection.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Male; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Risk Factors; Sensitivity and Specificity; Tuberculin Test; Tuberculosis | 2002 |
New guidelines: what to do about an unexpected positive tuberculin skin test.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Guideline Adherence; Humans; Isoniazid; Practice Guidelines as Topic; Rifampin; Risk Factors; Time Factors; Tuberculin Test; Tuberculosis | 2003 |
[Tuberculosis].
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Drug Therapy, Combination; Ethambutol; France; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary | 2002 |
Tuberculoma en plaque: a case report.
Topics: Adolescent; Antitubercular Agents; Brain Diseases; Drug Therapy, Combination; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculoma | 2002 |
[Diagnosed tuberculosis using specific DNA probe hybridization methods].
Topics: Bacterial Proteins; DNA Probes; DNA-Directed RNA Polymerases; Drug Resistance; Humans; Isoniazid; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Peroxidases; Polymerase Chain Reaction; Rifampin; Tuberculosis | 2002 |
[Tuberculous pneumonia in children].
Topics: Administration, Oral; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Diagnosis, Differential; Ethambutol; Humans; Injections, Intravenous; Isoniazid; Lithuania; Male; Mycobacterium tuberculosis; Radiography, Thoracic; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2003 |
[Nontuberculous mycobacteriosis].
Topics: Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pneumonia, Bacterial; Prognosis; Rifampin; Streptomycin | 2003 |
[Tuberculous epididymitis caused by Mycobacterium bovis].
Topics: Abscess; Aged; Animal Husbandry; Animals; Anti-Bacterial Agents; Antitubercular Agents; Cattle; Drug Therapy, Combination; Epididymitis; Humans; Isoniazid; Male; Mycobacterium bovis; Occupational Diseases; Pyrazinamide; Rifampin; Scrotum; Tuberculosis, Bovine; Tuberculosis, Male Genital | 2003 |
Latent tuberculosis in pregnancy: screening and treatment.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury, Chronic; Female; Hispanic or Latino; Humans; Isoniazid; Mass Screening; Patient Compliance; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Rifampin; Tuberculosis; United States; Withholding Treatment | 2003 |
[Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Topics: Aged; Agranulocytosis; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 2003 |
[Tuberculosis-current therapeutic principles].
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Practice Patterns, Physicians'; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2003 |
Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis, Pulmonary | 2004 |
Considering the role of four months of rifampin in the treatment of latent tuberculosis infection.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Costs and Cost Analysis; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Emigration and Immigration; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Patient Compliance; Rifampin; Time Factors; Tuberculosis; United States | 2004 |
[A case of successful desensitization therapy for isoniazid-induced pneumonitis].
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Desensitization, Immunologic; Ethambutol; Humans; Isoniazid; Male; Pneumonia; Rifampin; Tuberculosis, Pulmonary | 2004 |
Bacillus Calmette-Guérin-induced granulomatous hepatitis in a patient with a superficial bladder carcinoma.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Biopsy; Carcinoma, Transitional Cell; Drug Hypersensitivity; Drug Therapy, Combination; Hepatitis; Humans; Immunosuppressive Agents; Isoniazid; Liver; Male; Prednisolone; Rifampin; Transaminases; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis | 2005 |
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Developed Countries; Developing Countries; Humans; Isoniazid; Patient Compliance; Rifampin; Risk Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
[Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Notification; Drug Therapy, Combination; Ethambutol; Female; Germany; Humans; Immunocompromised Host; Isoniazid; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Patient Isolation; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Lymph Node | 2005 |
[Pulmonary tuberculosis in elderly patients].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Combined Modality Therapy; Drug Resistance, Multiple; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pneumonectomy; Postoperative Care; Rifampin; Tuberculosis, Pulmonary | 2005 |
[Resistance to antituberculous drugs].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2005 |
[Case of endometrial tuberculosis].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Endometrium; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis, Female Genital; Uterine Diseases; Vaginal Discharge | 2005 |
Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Antitubercular Agents; CD4 Lymphocyte Count; Developing Countries; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis | 2005 |
Routine surgery in addition to chemotherapy for treating spinal tuberculosis.
Topics: Aminosalicylic Acid; Antitubercular Agents; Combined Modality Therapy; Humans; Isoniazid; Kyphosis; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Tuberculosis, Spinal | 2006 |
Treatment of multidrug-resistant tuberculosis: evidence and controversies.
Topics: Antibiotics, Antitubercular; Case Management; Clinical Trials as Topic; Drug Administration Routes; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Comorbidity; Drug Therapy, Combination; HIV Infections; Humans; Isoniazid; Liver; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Risk Assessment; Tuberculosis | 2006 |
Antituberculosis drugs and hepatotoxicity.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunogenetics; Isoniazid; Liver; Pyrazinamide; Rifampin; Risk Factors; Tuberculosis | 2006 |
[Modern diagnosis of tuberculosis].
Topics: Adenosine Deaminase; Antibiotics, Antitubercular; Antitubercular Agents; Bacteriological Techniques; Culture Media; DNA Probes; DNA, Bacterial; Drug Resistance, Bacterial; Gene Amplification; Genes, Bacterial; Genotype; Humans; Immunologic Tests; Interferon-gamma; Isoniazid; Lymphocytes; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Sputum; Time Factors; Tuberculosis | 2006 |
[Trends in tuberculosis treatment duration].
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Isoniazid; Mice; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2006 |
Central nervous system infection and cutaneous lymphadenitis due to Mycobacterium kansasii in an immunocompetent patient.
Topics: Aged; Antitubercular Agents; Central Nervous System Bacterial Infections; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Lymphadenitis; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Skin Diseases, Bacterial | 2007 |
[Systematic review of anti-tuberculosis drug induced adverse reactions in China].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; China; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Isoniazid; Liver Diseases; Rifampin; Tuberculosis | 2007 |
Advances in the treatment of tuberculosis.
Topics: Adamantane; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Investigational; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin; Treatment Refusal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Incidence; Isoniazid; Liver Diseases; Pyrazinamide; Rifampin; Risk Factors; Tuberculosis | 2008 |
The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Rifampin; Sensitivity and Specificity; Tuberculosis | 2008 |
Diffuse pachymeningitis due to Mycobacterium tuberculosis: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Meningitis; Mycobacterium tuberculosis; Prednisone; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 2008 |
New approaches to the treatment of latent tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium tuberculosis; Patient Compliance; Rifampin; Treatment Outcome; Tuberculosis | 2008 |
Tuberculosis and silicosis: epidemiology, diagnosis and chemoprophylaxis.
Topics: Antibiotics, Antitubercular; Brazil; Humans; Isoniazid; Occupational Exposure; Pyrazinamide; Rifampin; Silicon Dioxide; Silicosis; Silicotuberculosis; Tuberculosis, Pulmonary | 2008 |
Pacemaker wire infection with Mycobacterium tuberculosis: a case report and literature review.
Topics: Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pacemaker, Artificial; Recurrence; Rifampin; Surgical Wound Infection; Tomography, X-Ray Computed; Tuberculosis | 2009 |
Primary gastric fundus tuberculosis in immunocompetent patient: a case report and literature review.
Topics: Adult; Antitubercular Agents; Follow-Up Studies; Gastric Fundus; Gastroscopy; Humans; Immunocompetence; Isoniazid; Male; Rifampin; Stomach Diseases; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal | 2008 |
Tuberculosis (HIV-negative people).
Topics: Antitubercular Agents; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Low-Level Light Therapy; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis.
Topics: Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; ROC Curve; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2009 |
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.
Topics: Antibiotics, Antitubercular; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Isoniazid; Randomized Controlled Trials as Topic; Recurrence; Regression Analysis; Rifampin; Risk Factors; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2009 |
4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Health Care Costs; Humans; Isoniazid; Liver; Medication Adherence; Rifampin; Tuberculosis | 2009 |
Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Isoniazid; Randomized Controlled Trials as Topic; Recurrence; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2009 |
Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.
Topics: Antitubercular Agents; Clarithromycin; Glucocorticoids; Humans; Immunocompromised Host; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Myelodysplastic Syndromes; Rifampin; Skin Diseases, Bacterial; Sputum; Sweet Syndrome | 2010 |
Tuberculous orchiepididymitis during 1978-2003 period: review of 34 cases and role of 16S rRNA amplification.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Combined Modality Therapy; Comorbidity; Epididymitis; Ethambutol; Exudates and Transudates; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Orchitis; Prostatitis; Pyrazinamide; Retrospective Studies; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Scrotum; Spain; Tuberculosis, Male Genital; Tuberculosis, Renal; Urine | 2010 |
Pediatric intracranial subdural empyema caused by Mycobacterium tuberculosis--a case report and review of literature.
Topics: Adolescent; Antibiotics, Antitubercular; Craniotomy; Dura Mater; Empyema, Subdural; Humans; Isoniazid; Male; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis | 2010 |
Bronchiectatic air bronchograms in pulmonary tuberculosis: a case report and literature review.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bronchiectasis; Bronchoalveolar Lavage; Bronchoscopy; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary | 2010 |
Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa.
Topics: Africa South of the Sahara; Antitubercular Agents; Asia; Europe, Eastern; Extensively Drug-Resistant Tuberculosis; HIV Infections; Humans; Isoniazid; Rifampin; South America; Tuberculosis, Multidrug-Resistant | 2010 |
Primary tuberculosis of the TMJ: presentation of a case and literature review.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Temporomandibular Joint; Temporomandibular Joint Disorders; Treatment Outcome; Tuberculosis, Osteoarticular; Young Adult | 2010 |
The chemotherapy of tuberculous lymphadenopathy in children.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Practice Guidelines as Topic; Rifampin; Tuberculosis, Lymph Node | 2010 |
Treatment of latent infection with Mycobacterium tuberculosis: update 2010.
Topics: Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Communicable Disease Control; Drug Design; Drug Resistance, Bacterial; Female; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Male; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome | 2011 |
Cerebrospinal fluid concentrations of antituberculosis agents in adults and children.
Topics: Adult; Antitubercular Agents; Child; Dose-Response Relationship, Drug; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 2010 |
The chemotherapy of tuberculous meningitis in children and adults.
Topics: Adult; Aminosalicylic Acid; Antibiotics, Antitubercular; Antitubercular Agents; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; History, 18th Century; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Severity of Illness Index; Streptomycin; Tuberculosis, Meningeal | 2010 |
Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection: a systematic review.
Topics: Age Factors; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Latent Tuberculosis; Rifampin; Risk Factors | 2010 |
Treatment of tuberculosis and optimal dosing schedules.
Topics: AIDS-Related Opportunistic Infections; Animals; Antitubercular Agents; Child; Disease Models, Animal; Drug Administration Schedule; Humans; Isoniazid; Rifampin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2011 |
Surgical treatment of an infant with Bacille Calmette-Guérin osteomyelitis extending across the growth plate.
Topics: Anti-Bacterial Agents; BCG Vaccine; Bone Substitutes; Curettage; Durapatite; Growth Plate; Humans; Infant; Isoniazid; Knee Joint; Male; Meta-Analysis as Topic; Osteomyelitis; Pyrazinamide; Recurrence; Reoperation; Rifampin; Tibia | 2011 |
Clinical practice. Latent tuberculosis infection in the United States.
Topics: Adult; Antigens, Bacterial; Antitubercular Agents; Drug Therapy, Combination; Female; Global Health; Humans; Interferon-gamma; Isoniazid; Mycobacterium tuberculosis; Practice Guidelines as Topic; Rifampin; Tuberculosis; Virus Latency | 2011 |
Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing.
Topics: Aminoglycosides; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethionamide; Genes, Bacterial; Isoniazid; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance.
Topics: Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Bacterial; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis | 2011 |
Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.
Topics: Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Body Fluids; Bronchoalveolar Lavage Fluid; Humans; Isoniazid; Lung; Respiratory Mucosa; Rifampin | 2011 |
[Lupus vulgaris caused by Mycobacterium bovis].
Topics: Aged; Antitubercular Agents; Axilla; Drug Therapy, Combination; Humans; Isoniazid; Lupus Vulgaris; Male; Mycobacterium bovis; Pyrazinamide; Rifampin; Tuberculoma; Tuberculosis, Lymph Node; Ultrasonography | 2012 |
[Not just a success story. On the history of tuberculosis treatment].
Topics: Antitubercular Agents; Ethambutol; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; History, Medieval; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculin; Tuberculosis | 2012 |
[Treatment of latent tuberculosis infection].
Topics: Antitubercular Agents; Cost of Illness; Drug Combinations; Humans; Incidence; Isoniazid; Latent Tuberculosis; Medication Adherence; Rifampin; Treatment Outcome | 2012 |
Treatment of latent tuberculosis infection in HIV: shorter or longer?
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Rifampin; Time Factors; Treatment Outcome; Tuberculin Test; Tuberculosis, Multidrug-Resistant | 2012 |
Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
Topics: Adolescent; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gynecomastia; Humans; Isoniazid; Male; Pyrazinamide; Retreatment; Rifampin; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2011 |
Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing.
Topics: Animals; Antitubercular Agents; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2013 |
Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.
Topics: Adult; Brazil; Coinfection; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-12; Isoniazid; Leprosy; Male; Middle Aged; Prednisone; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pleural; Tuberculosis, Pulmonary; White People | 2013 |
Contacts of infectious tuberculosis patients: monitor those at highest risk of developing tuberculosis.
Topics: Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Risk Factors; Tuberculosis | 2012 |
Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2013 |
Rifampicin pharmacokinetics in extreme prematurity to treat congenital tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Infectious Disease Transmission, Vertical; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Miliary | 2013 |
Treating BCG-induced disease in children.
Topics: Abscess; Adjuvants, Immunologic; Antibiotics, Antitubercular; BCG Vaccine; Child; Child, Preschool; Erythromycin; Humans; Infant; Isoniazid; Lymphadenitis; Mycobacterium bovis; Randomized Controlled Trials as Topic; Rifampin; Suction | 2013 |
Treatment of latent tuberculosis infection.
Topics: Antitubercular Agents; Disease Progression; Drug Resistance, Bacterial; Drug Therapy, Combination; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Rifampin; Tumor Necrosis Factor-alpha | 2013 |
[Tubercular abscess of the chest wall in the child].
Topics: Abscess; Adolescent; Antitubercular Agents; Biopsy; Combined Modality Therapy; Diagnosis, Differential; Drainage; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompetence; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sternum; Thoracic Neoplasms; Thoracic Wall; Tomography, X-Ray Computed; Tuberculosis, Cutaneous; Tuberculosis, Osteoarticular | 2013 |
[Pseudotumor form of primary nasopharyngeal tuberculosis: apropos of 2 new cases and review of the literature].
Topics: Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Nasal Obstruction; Nasopharyngeal Diseases; Nasopharyngeal Neoplasms; Pyrazinamide; Rifampin; Smoking; Tuberculosis; Tuberculosis, Lymph Node; Young Adult | 2013 |
Tuberculous meningitis.
Topics: Antitubercular Agents; Child; Humans; Isoniazid; Magnetic Resonance Imaging; Prognosis; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2013 |
Question 1: what are the options for treating latent TB infection in children?
Topics: Antitubercular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Isoniazid; Latent Tuberculosis; Randomized Controlled Trials as Topic; Rifampin | 2013 |
Rapid diagnosis of Mycobacterium tuberculosis infection and drug susceptibility testing.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Coinfection; Comorbidity; DNA, Bacterial; Drug Resistance, Bacterial; Female; Global Health; HIV; Humans; Infant; Isoniazid; Meta-Analysis as Topic; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis; Women's Health | 2013 |
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Topics: Adult; Antibiotics, Antitubercular; Child; Directly Observed Therapy; Drug Administration Schedule; HIV Seronegativity; Humans; Isoniazid; Latent Tuberculosis; Randomized Controlled Trials as Topic; Rifabutin; Rifampin; Tuberculosis, Pulmonary | 2013 |
Routine surgery in addition to chemotherapy for treating spinal tuberculosis.
Topics: Aminosalicylic Acid; Antitubercular Agents; Combined Modality Therapy; Humans; Isoniazid; Kyphosis; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Tuberculosis, Spinal | 2006 |
Treatment of latent tuberculosis infection.
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Rifampin; Time Factors; Tuberculosis | 2013 |
Isolated tuberculous liver abscess in an immunocompetent adult patient: A case report and literature review.
Topics: Aged; Antitubercular Agents; Biopsy; Blood Chemical Analysis; Drug Combinations; Ethambutol; Humans; Isoniazid; Laparotomy; Liver; Liver Abscess; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis.
Topics: Antitubercular Agents; Arylamine N-Acetyltransferase; Cytochrome P-450 CYP2E1; Gene Frequency; Genetic Predisposition to Disease; Genotype; Hepatocytes; Humans; Isoniazid; Liver Failure, Acute; Odds Ratio; Polymorphism, Genetic; Pyrazinamide; Rifampin; Tuberculosis | 2014 |
Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.
Topics: Antitubercular Agents; Europe; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Population Surveillance; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; World Health Organization | 2013 |
Treatment guidelines for latent tuberculosis infection.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; HIV Infections; Humans; Immunosuppressive Agents; Isoniazid; Japan; Latent Tuberculosis; Patient Education as Topic; Practice Guidelines as Topic; Rifampin; Risk Factors; Tuberculosis Societies | 2014 |
Antitubercular therapy in patients with cirrhosis: challenges and options.
Topics: Antitubercular Agents; Ethambutol; Humans; Immune System Diseases; Isoniazid; Latent Tuberculosis; Liver; Liver Cirrhosis; Liver Diseases; Liver Failure; Liver Function Tests; Liver Transplantation; Prevalence; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2014 |
Trends in discovery of new drugs for tuberculosis therapy.
Topics: Alcohol Oxidoreductases; Animals; Antitubercular Agents; Bacterial Proteins; Drug Discovery; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Treatment of latent tuberculosis infection: a network meta-analysis.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Pyrazinamide; Rifampin | 2014 |
Mycobacterium bovid infection of total knee arthroplasty after bacille Calmette-Guérin therapy for bladder cancer.
Topics: Administration, Intravesical; Aged; Antitubercular Agents; Arthroplasty, Replacement, Knee; BCG Vaccine; Cancer Vaccines; Humans; Isoniazid; Male; Mycobacterium bovis; Mycobacterium Infections; Prosthesis-Related Infections; Rifampin; Urinary Bladder Neoplasms | 2015 |
Tuberculous meningitis: advances in diagnosis and treatment.
Topics: Antitubercular Agents; Drug Therapy, Combination; Host-Pathogen Interactions; Humans; Isoniazid; Mycobacterium tuberculosis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2015 |
Multidrug resistant tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Forecasting; Genotype; Global Health; Humans; Isoniazid; Microbial Sensitivity Tests; Palliative Care; Phenotype; Prognosis; Public Health; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant | 2015 |
Getting it right for children: improving tuberculosis treatment access and new treatment options.
Topics: Antitubercular Agents; BCG Vaccine; Child; Global Health; Health Knowledge, Attitudes, Practice; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vaccination | 2015 |
Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
Topics: Antitubercular Agents; Diarylquinolines; Drug Design; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Evolution, Chemical; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
Topics: Africa South of the Sahara; Antitubercular Agents; Bacteriological Techniques; Ethambutol; Humans; Isoniazid; Prevalence; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Child; Coinfection; Community Health Services; Drug Administration Schedule; Drug Design; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Global Health; HIV Infections; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis.
Topics: Antitubercular Agents; Bacteriological Techniques; Cost-Benefit Analysis; Drug Resistance, Microbial; Humans; Isoniazid; Models, Econometric; Nucleic Acid Amplification Techniques; Patient Acceptance of Health Care; Quality-Adjusted Life Years; Rifampin; Sequence Analysis; State Medicine; Technology Assessment, Biomedical; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; United Kingdom | 2015 |
Latent Mycobacterium tuberculosis infection.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Practice Guidelines as Topic; Rifampin; Risk Factors | 2015 |
Systematic review of the prevalence of Mycobacterium tuberculosis resistance in Saudi Arabia.
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Prevalence; Rifampin; Saudi Arabia; Streptomycin; Tuberculosis, Multidrug-Resistant | 2015 |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
Topics: Antirheumatic Agents; Antitubercular Agents; Coinfection; Comorbidity; Disease Management; Drug Users; Emigrants and Immigrants; Evidence-Based Medicine; Health Personnel; HIV Infections; Humans; Ill-Housed Persons; Interferon-gamma Release Tests; Isoniazid; Kidney Failure, Chronic; Latent Tuberculosis; Mass Screening; Practice Guidelines as Topic; Prisoners; Public Health; Radiography, Thoracic; Renal Dialysis; Rifampin; Risk Assessment; Silicosis; Substance-Related Disorders; Transplant Recipients; Tuberculin Test; Tumor Necrosis Factor-alpha; World Health Organization | 2015 |
Improving Treatment Completion Rates for Latent Tuberculosis Infection: A Review of Two Treatment Regimens at a Community Health Center.
Topics: Community Health Centers; Directly Observed Therapy; Drug Therapy, Combination; Hispanic or Latino; Humans; Isoniazid; Latent Tuberculosis; Medication Adherence; Poverty; Rifampin; Wisconsin | 2015 |
Clinical research in the treatment of tuberculosis: current status and future prospects.
Topics: Antitubercular Agents; Biomedical Research; Clinical Trials as Topic; Drug Therapy, Combination; Fluoroquinolones; Humans; Isoniazid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 2015 |
Updates on the risk factors for latent tuberculosis reactivation and their managements.
Topics: Antitubercular Agents; Disease Management; Female; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Male; Rifampin; Risk Factors; Transplant Recipients; World Health Organization | 2016 |
GenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-Analysis.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; ROC Curve; Tuberculosis, Multidrug-Resistant | 2016 |
Distribution and association of Mycobacterium tuberculosis CAS lineage with multidrug resistance in North India.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genetic Loci; Genotyping Techniques; Humans; India; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Databases, Factual; Dose-Response Relationship, Drug; Drug Monitoring; Ethambutol; Humans; Isoniazid; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Six-month therapy for abdominal tuberculosis.
Topics: Abdomen; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Pyrazinamide; Randomized Controlled Trials as Topic; Recurrence; Rifampin; Time Factors; Tuberculosis, Gastrointestinal | 2016 |
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Canada; Humans; Isoniazid; Recurrence; Retreatment; Rifampin; Treatment Failure; Tuberculosis, Pulmonary | 2017 |
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment.
Topics: Adolescent; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Ethambutol; Feasibility Studies; Female; Fluoroquinolones; Graft Rejection; Humans; Isoniazid; Liver Failure, Acute; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prognosis; Rifampin; Treatment Outcome; Tuberculosis | 2017 |
Optimizing the management of children with latent tuberculosis infection.
Topics: Antitubercular Agents; Biomarkers; Chemokine CXCL10; Child; Disease Management; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Humans; Interferon-gamma; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Rifampin; Tuberculin Test; Tuberculosis Vaccines; Tuberculosis, Pulmonary | 2017 |
Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.
Topics: Antitubercular Agents; DNA Probes; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Anti-tuberculosis drug resistance in Ethiopia: systematic review.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Humans; Isoniazid; Prevalence; Public Health; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2017 |
Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Ethiopia; Humans; Isoniazid; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant | 2017 |
Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Male; Network Meta-Analysis; Rifampin; Time Factors | 2017 |
Treatment of Latent Tuberculosis Infection.
Topics: Antitubercular Agents; Humans; Isoniazid; Latent Tuberculosis; Medication Adherence; Mycobacterium tuberculosis; Rifampin; Treatment Outcome | 2017 |
Systematic review and meta-analysis of the nitrate reductase assay for drug susceptibility testing of Mycobacterium tuberculosis and the detection limits in liquid medium.
Topics: Antitubercular Agents; Colorimetry; Humans; Isoniazid; Limit of Detection; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2017 |
Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Combinations; Humans; Isoniazid; Latent Tuberculosis; Network Meta-Analysis; Pyrazinamide; Rifampin | 2017 |
The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran.
Topics: Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.
Topics: Antitubercular Agents; Bayes Theorem; Comorbidity; Cost-Benefit Analysis; Decision Trees; Emigrants and Immigrants; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Markov Chains; Quality-Adjusted Life Years; Rifampin; Tuberculin Test; United States | 2017 |
Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Bacterial; Humans; Isoniazid; Models, Biological; Pharmacogenetics; Rifampin; Tuberculosis | 2018 |
A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Incidence; Isoniazid; Latent Tuberculosis; Respiratory Tract Diseases; Rifampin | 2018 |
Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high human immunodeficiency virus and tuberculosis burden countries: A systematic review.
Topics: Africa; Anti-HIV Agents; Antitubercular Agents; Asia; Body Weight; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Coinfection; Cost of Illness; Cytochrome P-450 CYP2B6; Drug Interactions; Female; HIV Infections; Humans; Isoniazid; Latin America; Male; Polymorphism, Single Nucleotide; Rifampin; Sex Factors; Treatment Outcome; Tuberculosis | 2018 |
3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review.
Topics: Adolescent; Antitubercular Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2018 |
A comprehensive review on Primary gallbladder tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Female; Gallbladder Diseases; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis; Young Adult | 2018 |
Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
Topics: Directly Observed Therapy; Humans; Isoniazid; Latent Tuberculosis; Rifampin; Time Factors; United States | 2018 |
Updates in the Treatment of Active and Latent Tuberculosis.
Topics: Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Randomized Controlled Trials as Topic; Rifampin | 2018 |
[Design of Spray-dried Porous Particles for Sugar-based Dry Powder Inhaler Formulation].
Topics: Administration, Inhalation; Antitubercular Agents; Carboxylic Acids; Dextrins; Drug Compounding; Drug Delivery Systems; Drug Design; Dry Powder Inhalers; Ethanol; Excipients; Humans; Hydrophobic and Hydrophilic Interactions; Isoniazid; Maltose; Naphthalenes; Particle Size; Porosity; Powders; Rifampin; Solutions; Sucrose | 2018 |
[Diagnostic accuracy of line probe assays for drug-resistant tuberculosis: a Meta-analysis].
Topics: Antitubercular Agents; Biological Assay; China; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2018 |
Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Child; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; HIV Seronegativity; Humans; Isoniazid; Latent Tuberculosis; Rifampin; Tuberculosis, Pulmonary | 2018 |
Development of new drug-regimens against multidrug-resistant tuberculosis.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Development; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Ethylenediamines; Humans; Isoniazid; Macrolides; Medication Adherence; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Abbott RealTime MTB and MTB RIF/INH assays for the diagnosis of tuberculosis and rifampicin/isoniazid resistance.
Topics: Anti-Bacterial Agents; Diagnostic Techniques and Procedures; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2019 |
Pharmacokinetics of First-Line Anti-Tubercular Drugs.
Topics: Age Factors; Antitubercular Agents; Child; Drug Overdose; Ethambutol; Food; Genotype; HIV Infections; Humans; Isoniazid; Malnutrition; Nutritional Status; Polymorphism, Genetic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2019 |
Female genital tuberculosis: Revisited.
Topics: Biopsy; Endoscopy; Ethambutol; Fallopian Tubes; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Rifampin; Tuberculosis, Female Genital | 2018 |
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature.
Topics: Antitubercular Agents; Drug Hypersensitivity Syndrome; False Negative Reactions; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Young Adult | 2019 |
Severe disseminated tuberculosis in HIV-negative refugees.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Ethambutol; Fluorine Radioisotopes; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Pyrazinamide; Refugees; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2019 |
Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Geography; Humans; Isoniazid; Mycobacterium tuberculosis; Predictive Value of Tests; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Electroanalysis of isoniazid and rifampicin: Role of nanomaterial electrode modifiers.
Topics: Antitubercular Agents; Biosensing Techniques; Electrochemical Techniques; Electrodes; Equipment Design; Graphite; Humans; Isoniazid; Nanostructures; Nanotechnology; Polymers; Rifampin | 2019 |
Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Developing Countries; Drug Therapy, Combination; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Rifampin; Young Adult | 2020 |
Metabolomics describes previously unknown toxicity mechanisms of isoniazid and rifampicin.
Topics: Animals; Antitubercular Agents; Biomarkers; Biotransformation; Drug-Related Side Effects and Adverse Reactions; Humans; Isoniazid; Metabolomics; Rifampin; Risk Assessment; Toxicity Tests | 2020 |
Tuberculosis treatment in children: The changing landscape.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Central Nervous System; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2020 |
The impact of diabetes mellitus on drug resistance in patients with newly diagnosed tuberculosis: a systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Comorbidity; Diabetes Complications; Drug Resistance; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |
Diagnostic Challenges and Dilemmas in Tuberculous Meningitis.
Topics: Adult; Antitubercular Agents; Asthma; Ethambutol; Female; Headache; Hospitalization; Humans; Hydrocephalus; Isoniazid; Leukocytosis; Magnetic Resonance Imaging; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Somalia; Spinal Puncture; Tuberculosis, Meningeal; United States; Vision Disorders | 2020 |
A novel risk factor for predicting anti-tuberculosis drug resistance in patients with tuberculosis complicated with type 2 diabetes mellitus.
Topics: Adult; Aged; Antitubercular Agents; Diabetes Mellitus, Type 2; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Glycated Hemoglobin; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Rifampin; Risk Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |
Tuberculosis in 2019.
Topics: Antitubercular Agents; Ethambutol; Health Policy; Humans; India; Isoniazid; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Practice Guidelines as Topic; Pulmonologists; Pyrazinamide; Rifampin; Surveys and Questionnaires; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2020 |
Multiple tuberculomas in an immunocompetent patient and their diagnostic challenge in a high prevalence country: Case report and literature review.
Topics: Antitubercular Agents; Blindness; Brain; Brain Diseases; Cerebellar Ataxia; Dexamethasone; Drug Therapy, Combination; Endemic Diseases; Ethambutol; Female; Glucocorticoids; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Nausea; Nystagmus, Pathologic; Peru; Pyrazinamide; Quadriplegia; Rifampin; Tomography, X-Ray Computed; Tuberculoma, Intracranial; Tuberculosis, Pulmonary; Vomiting; Young Adult | 2020 |
Diagnostic accuracy of centralised assays for TB detection and detection of resistance to rifampicin and isoniazid: a systematic review and meta-analysis.
Topics: Antibiotics, Antitubercular; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis | 2021 |
Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Autophagy; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Host-Pathogen Interactions; Humans; Isoniazid; Lung; Pandemics; Pneumonia, Viral; Pulmonary Edema; Rifampin; Sarcoidosis; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severity of Illness Index | 2020 |
Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB.
Topics: Anti-HIV Agents; Antitubercular Agents; Drug Interactions; Extensively Drug-Resistant Tuberculosis; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2020 |
Thinking Outside the Lungs: A Case of Disseminated Abdominal Tuberculosis.
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Lung; Middle Aged; Pyrazinamide; Rifampin | 2020 |
A rare case of primary sinonasal tuberculosis presented with phlyctenular keratoconjunctivitis in a pediatric patient: A case report and literature review.
Topics: Antibiotics, Antitubercular; Child; Child, Preschool; Female; Humans; Isoniazid; Keratoconjunctivitis; Male; Mycobacterium tuberculosis; Orbit; Paranasal Sinus Diseases; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2021 |
The Treatment of Tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Monitoring; Drug Therapy, Combination; Humans; Isoniazid; Levofloxacin; Rifampin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2021 |
Adverse events associated with weekly short course isoniazid and rifapentine therapy in pediatric patients with latent tuberculosis: A chart and literature review.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Retrospective Studies; Rifampin; Young Adult | 2021 |
Emerging progress on diagnosis and treatment of female genital tuberculosis.
Topics: Antitubercular Agents; Female; Humans; Infertility, Female; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Rifampin; Tuberculosis, Female Genital | 2021 |
Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genetic Fitness; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2021 |
Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis.
Topics: Drug Resistance; Ethiopia; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant | 2021 |
Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis.
Topics: Ethiopia; Humans; Isoniazid; Prevalence; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant | 2021 |
Antibiotic heteroresistance in Mycobacterium tuberculosis isolates: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2021 |
Hepatotoxicity, efficacy and completion rate between 3 months of isoniazid plus rifapentine and 9 months of isoniazid in treating latent tuberculosis infection: A systematic review and meta-analysis.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Latent Tuberculosis; Medication Adherence; Middle Aged; Rifampin; Young Adult | 2021 |
Combining LAMP and Au-Nanoprobe to detect INH-RIF resistance accurately in tuberculosis: an evidence-based review.
Topics: Antibiotics, Antitubercular; DNA, Bacterial; Humans; Isoniazid; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2021 |
Targeting Non-Replicating
Topics: Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2021 |
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance.
Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin | 2022 |
MDR Tuberculosis Treatment.
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Drug resistant TB - latest developments in epidemiology, diagnostics and management.
Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients.
Topics: Antitubercular Agents; Drug Resistance; Ethambutol; Humans; Isoniazid; Lasers; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Topics: Adult; Amikacin; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis.
Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2022 |
Systematic review with network meta-analysis on the treatments for latent tuberculosis infection in children and adolescents.
Topics: Adolescent; Antitubercular Agents; Bayes Theorem; Child; Humans; Isoniazid; Latent Tuberculosis; Network Meta-Analysis; Rifampin | 2022 |
Management and outcomes of surgical site tuberculosis infection due to infected bone graft in spine surgery: a single-institution experience and 1-year postoperative follow-up.
Topics: COVID-19; Follow-Up Studies; Humans; Isoniazid; Retrospective Studies; Rifampin; Surgical Wound Infection; Treatment Outcome; Tuberculosis | 2023 |
Comparison on Major Gene Mutations Related to Rifampicin and Isoniazid Resistance between Beijing and Non-Beijing Strains of
Topics: Antitubercular Agents; Bacterial Proteins; Bayes Theorem; DNA, Intergenic; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin | 2022 |
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin | 2023 |
Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Ethambutol; HIV; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Network Meta-Analysis; Rifampin; Tuberculosis | 2023 |
Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Latent Tuberculosis; Mass Screening; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Rifampin; United States | 2023 |
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Humans; Isoniazid; Pyrazinamide; Rifampin | 2023 |
Multi-drug resistant and rifampin-resistant tuberculosis in transplant recipients.
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Transplant Recipients; Tuberculosis, Multidrug-Resistant; Young Adult | 2023 |
484 trial(s) available for isoniazid and rifampin
| Article | Year |
|---|---|
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
Topics: Amino Acid Sequence; Animals; Antitubercular Agents; Bacterial Proton-Translocating ATPases; Diarylquinolines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Male; Mice; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium smegmatis; Mycobacterium tuberculosis; Point Mutation; Protein Subunits; Quinolines; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2005 |
Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Antitubercular Agents; Area Under Curve; Diarylquinolines; Dose-Response Relationship, Drug; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Mycobacterium tuberculosis; Quinolines; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1975 |
Short-course treatment in pulmonary tuberculosis.
Topics: Adolescent; Adult; Africa, Eastern; Antitubercular Agents; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1975 |
Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
Topics: Adolescent; Adult; Clinical Trials as Topic; Culture Techniques; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Singapore; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1975 |
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Middle Aged; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1976 |
Ethambutol plus isoniazid compared with rifampicin plus isoniazid in antituberculosis continuation treatment.
Topics: Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1977 |
Short-course chemotherapy in pulmonary tuberculosis.
Topics: Clinical Trials as Topic; Developing Countries; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1977 |
Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: first report: Third East African/British Medical Research Councils study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Isoniazid; Kenya; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tanzania; Thioacetazone; Time Factors; Tuberculosis, Pulmonary; Uganda; Zambia | 1978 |
Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. First report of 4th study. East African and British Medical Research Councils.
Topics: Adolescent; Adult; Africa, Eastern; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary; Zambia | 1978 |
Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1979 |
The chemotherapy of pulmonary tuberculosis: a review.
Topics: Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Patient Dropouts; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1979 |
Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Infant, Newborn; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1978 |
U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary; United States; United States Public Health Service | 1979 |
Trial of two intermittent short-course regimens (78 doses) in the initial treatment of pulmonary tuberculosis.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1977 |
[Hepatoxic side-effects of rifampicin. A comparative clinical study].
Topics: Alanine Transaminase; Alcoholism; Alkaline Phosphatase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1977 |
The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Acetylation; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver Function Tests; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1978 |
Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Alanine Transaminase; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1979 |
[Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Hong Kong; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: the results up to 24 months.
Topics: Adolescent; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1979 |
Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months.
Topics: Adolescent; Adult; Antibodies; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Singapore; Thrombocytopenia; Tuberculosis, Pulmonary | 1977 |
[Treatment of open cavernous pulmonary tuberculosis (author's transl)].
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1979 |
[A pilot and a controlled study of the influence of ethambutol on serum urate concentration and uric acid clearance (author's transl)].
Topics: Alcoholism; Body Weight; Creatinine; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Uric Acid | 1979 |
Lymph node tuberculosis: a comparison of various methods of treatment.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 1977 |
Short-duration treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Ambulatory Care; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Dropouts; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1977 |
[Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1977 |
Serum concentrations and bioavailability of rifampicin and isoniazid in combination.
Topics: Adolescent; Adult; Biological Availability; Drug Combinations; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Rifampin | 1976 |
Some aspects of tuberculous meningitis in Surabaya.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Indonesia; Infant; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1976 |
Treatment of leprosy with rifampicin and isoprodian (L73A).
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Prothionamide; Rifampin | 1975 |
Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Mycobacterium leprae; Prothionamide; Rifampin | 1975 |
Rifampicin and isoprodian in combination in the treatment of leprosy.
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Malta; Prothionamide; Rifampin | 1975 |
Preliminary experience with rifampicin and isoprodian (L73A)--combination in lepromatous leprosy.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprosy; Male; Middle Aged; Prothionamide; Rifampin | 1975 |
Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothionamide; Rifampin | 1975 |
Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
Topics: Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethiopia; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Prothionamide; Rifampin | 1975 |
Proceedings: Short course chemotherapy in pulmonary tuberculosis: a controlled trial by the British Thoracic and Tuberculosis Association. (A report from one of the three clinical co-ordinators).
Topics: Clinical Trials as Topic; Drug Evaluation; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1975 |
Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Dapsone; Double-Blind Method; Drug Combinations; Female; Humans; Incidence; Isoniazid; Leprostatic Agents; Leprosy, Lepromatous; Liver Function Tests; Male; Middle Aged; Prospective Studies; Prothionamide; Rifampin | 1992 |
Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection).
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis, Pulmonary | 1992 |
The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Hong Kong; Humans; Isoniazid; Mycobacterium tuberculosis; Rifabutin; Rifampin; Rifamycins; Sputum; Tuberculosis, Pulmonary | 1992 |
A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
Topics: Adult; Aged; Antitubercular Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1992 |
Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration.
Topics: Adult; Antithrombin III; Blood Coagulation; Drug Combinations; Enzymes; Female; Fibrinogen; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1992 |
Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Prospective Studies; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1992 |
Intensive short course chemotherapy for treatment of Greek children with tuberculosis.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Greece; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 1992 |
Six-months versus nine-months chemotherapy for tuberculosis of lymph nodes: preliminary results. British Thoracic Society Research Committee.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1992 |
Comparative efficacy of drug regimens in skin tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Thioacetazone; Tuberculosis, Cutaneous | 1991 |
A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
Topics: Adult; Aged; Alanine Transaminase; Disease Susceptibility; Double-Blind Method; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Silicosis; Tuberculosis, Pulmonary | 1992 |
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Colony Count, Microbial; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1991 |
Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hon
Topics: Adolescent; Adult; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1991 |
Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Topics: Adolescent; Adult; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1991 |
[Complex treatment of patients with destructive pulmonary tuberculosis including intramuscular administration of isoniazid].
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Humans; Injections, Intramuscular; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1991 |
Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Algerian Working Group/British Medical Research Council Cooperative Study.
Topics: Adolescent; Adult; Aged; Algeria; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1991 |
[Nine month chemotherapy with INH and rifampicin for non-cavitary pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1991 |
[A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment].
Topics: Drug Combinations; Drug Resistance, Microbial; Follow-Up Studies; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Random Allocation; Rifampin; Tuberculosis, Pulmonary | 1990 |
Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Follow-Up Studies; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1990 |
USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results.
Topics: Adult; Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Data Interpretation, Statistical; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Multicenter Studies as Topic; Patient Compliance; Proportional Hazards Models; Pyrazinamide; Randomized Controlled Trials as Topic; Recurrence; Rifampin; Sputum; Survival Rate; Tuberculosis, Pulmonary; United States | 1990 |
Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Tablets; Tuberculosis, Pulmonary | 1990 |
The treatment of superficial tuberculous lymphadenitis.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lymph Nodes; Prospective Studies; Rifampin; Tuberculosis, Lymph Node | 1990 |
Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Isoniazid; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Randomized Controlled Trials as Topic; Rifampin | 1990 |
[Tisamide in the complex treatment of tuberculosis].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1990 |
A randomized trial of fully intermittent vs. daily followed by intermittent short course chemotherapy for childhood tuberculosis.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Male; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1990 |
Six-month combination chemotherapy for cervical tuberculous lymphadenitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Reoperation; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 1990 |
Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment.
Topics: Adolescent; Adult; Dapsone; Drug Combinations; Drug Resistance; Humans; Isoniazid; Leprosy; Recurrence; Rifampin; Sex Factors; Thioacetazone | 1985 |
Pyrazinamide as a part of combination therapy for BL and LL patients--a preliminary report.
Topics: Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Mice; Middle Aged; Muscle, Smooth; Pyrazinamide; Rifampin; Scrotum; Skin; Thioacetazone | 1988 |
Intracranial tuberculomas. An assessment of a therapeutic 4-drug trial in 35 children.
Topics: Adolescent; Antitubercular Agents; Brain Diseases; Child; Child, Preschool; Combined Modality Therapy; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pyrazinamide; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Tuberculoma | 1989 |
Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis.
Topics: Administration, Oral; Brazil; Costs and Cost Analysis; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Patient Compliance; Randomized Controlled Trials as Topic; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1989 |
Acceptability, compliance, and adverse reactions when isoniazid, rifampin, and pyrazinamide are given as a combined formulation or separately during three-times-weekly antituberculosis chemotherapy.
Topics: Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1989 |
Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar.
Topics: Antiprotozoal Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Leishmaniasis, Visceral; Male; Metronidazole; Random Allocation; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
[A controlled survey comparing 2 short-term therapeutic regimes in lymph node tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Lymph Node | 1989 |
[Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Tuberculosis, Pulmonary | 1989 |
A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Hong Kong; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1989 |
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Multicenter Studies as Topic; Patient Compliance; Prospective Studies; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1989 |
Treatment of extrapulmonary tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Rifampin; Tuberculosis | 1989 |
[Short term treatment of infantile pulmonary tuberculosis].
Topics: Antitubercular Agents; BCG Vaccine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1989 |
[Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
Topics: Adult; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Ketoconazole; Male; Middle Aged; Rifampin; Tuberculosis | 1989 |
Random variation in tuberculin sensitivity in schoolchildren. Serial skin testing before and after preventive treatment for tuberculosis.
Topics: Adolescent; Child; Dapsone; Drug Combinations; Ethambutol; Female; Humans; Hypersensitivity, Delayed; Isoniazid; Male; Placebos; Prothionamide; Random Allocation; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1989 |
Short course chemotherapy for tuberculosis of lymph nodes: a controlled trial. British Thoracic Society Research Committee.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Random Allocation; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1985 |
Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1985 |
Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Clinical Trials as Topic; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1986 |
A controlled trial of six-month and nine-month regimens of chemotherapy in patients undergoing radical surgery for tuberculosis of the spine in Hong Kong. Tenth report of the Medical Research Council Working Party on Tuberculosis of the Spine.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Hong Kong; Humans; Isoniazid; Middle Aged; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Spinal | 1986 |
Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1988 |
Adrenal function in tuberculosis.
Topics: Acute Disease; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Child; Child, Preschool; Ethambutol; Female; Humans; Hydrocortisone; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1988 |
Short course chemotherapy for lymph node tuberculosis: final report at 5 years. British Thoracic Society Research Committee.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Random Allocation; Rifampin; Tuberculosis, Lymph Node | 1988 |
Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.
Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Prothionamide; Pyrazinamide; Radiography; Recurrence; Rifampin; Sputum; Tuberculosis, Pulmonary | 1987 |
Short-course chemotherapy of pulmonary tuberculosis in pneumoconiotic patients.
Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Pneumoconiosis; Prospective Studies; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1987 |
[Results of a shortened (6 months) schedule of treatment of pulmonary tuberculosis using INH, RMP and PZA].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1987 |
United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide.
Topics: Clinical Trials as Topic; Drug Combinations; Female; Humans; Isoniazid; Male; Patient Compliance; Pyrazinamide; Random Allocation; Rifampin; Tuberculosis, Pulmonary | 1987 |
Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Dizziness; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; India; Isoniazid; Joint Diseases; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1986 |
[Actual condition and chemotherapy of extrapulmonary tuberculosis in national sanatoria. (An observation in intestinal tuberculosis and tuberculous peritonitis)--report of the B series of 26th controlled trials of chemotherapy. Cooperative Study Unit of C
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Female; Hospitals, Special; Humans; Isoniazid; Japan; Male; Middle Aged; Peritonitis, Tuberculous; Prognosis; Rifampin; Tuberculosis, Gastrointestinal | 1986 |
A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1986 |
[Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Controlled clinical trial of three short-course regimens of chemotherapy for pulmonary tuberculosis in Nigeria--a preliminary report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study.
Topics: Adult; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Prospective Studies; Prothionamide; Random Allocation; Rifampin | 1986 |
Three chemotherapy studies of tuberculous meningitis in children.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; India; Infant; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1986 |
Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Tanzania/British Medical Research Council Study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tanzania; Tuberculosis, Pulmonary | 1985 |
[Actual condition and chemotherapy of extrapulmonary tuberculosis in national sanatoria. An observation in tuberculous lymphadenitis. Report of the B series of 26th controlled trials of chemotherapy].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Female; Hospitals, Special; Humans; Infant; Isoniazid; Japan; Male; Middle Aged; Rifampin; Tuberculosis, Lymph Node | 1985 |
Operational evaluation of treatment for tuberculosis. Results of 8- and 12-month regimens in Peru.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1985 |
[The short course therapies by Ryoken's method. 9 month and 12 month regimens including rifampicin (RFP) plus isoniazid (INH) in bacteriologically proved pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1985 |
[Which is the best drug combination for the short-term therapy of tuberculosis? A prospective randomized study with 190 patients].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Prospective Studies; Pyrazinamide; Random Allocation; Rifampin; Tuberculosis, Pulmonary | 1985 |
[Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1985 |
Pharmacokinetics of oral and intravenous rifampicin during chronic administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Parenteral; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1985 |
General considerations in intermittent drug therapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1971 |
Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Evaluation Studies as Topic; Female; Humans; Injections, Intramuscular; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Pyrazinamide; Radiography; Recurrence; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1972 |
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils.
Topics: Adolescent; Adult; Africa, Eastern; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1974 |
Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. I. Role of individual antituberculous drugs in drug regimens used in the chemotherapy of human tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Cycloserine; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1974 |
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Africa; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1974 |
[Short-term treatment of pulmonary tuberculosis].
Topics: Adolescent; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1974 |
Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Radiography; Rifampin; Skin Diseases; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary; United Kingdom | 1973 |
Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
Topics: Adolescent; Adult; Alanine Transaminase; Bacteriological Techniques; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leukocyte Count; Liver; Male; Middle Aged; Mycobacterium tuberculosis; Radiography; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thioc
Topics: Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Gastrointestinal Diseases; Humans; Isoniazid; Mycobacterium tuberculosis; Phenylthiourea; Pyridoxine; Recurrence; Rifampin; Streptomycin; Thrombocytopenia; Time Factors; Tuberculosis, Pulmonary | 1974 |
Drug-induced heart failure in advanced pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Heart Failure; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Rifampicin in the treatment of lung and kidney tuberculosis].
Topics: Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Tuberculosis, Renal | 1972 |
Rifampicin blood serum levels and half-life during prolonged administration in tuberculous patients.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Analysis of Variance; Clinical Trials as Topic; Drug Combinations; Ethambutol; Female; Half-Life; Humans; Isoniazid; Kinetics; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1972 |
Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Argentina; Clinical Trials as Topic; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prognosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1972 |
Rifampin in original treatment of pulmonary tuberculosis. A United States Public Health Service cooperative therapy trial.
Topics: Administration, Oral; Adult; Age Factors; Alanine Transaminase; Clinical Trials as Topic; Drug Combinations; Drug Tolerance; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Rifampin; Sex Factors; Time Factors; Tuberculosis, Pulmonary; United States; United States Public Health Service | 1972 |
[Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives].
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Estriol; Estrogens; Estrone; Ethambutol; Ethinyl Estradiol; Female; Humans; Isoniazid; Menstruation Disturbances; Pregnancy; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Drug Combinations; Ethambutol; Humans; Isoniazid; Methods; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
Topics: Alcoholism; Aminosalicylic Acids; Bilirubin; Drug Therapy, Combination; Humans; Isoniazid; Patient Dropouts; Rifampin; Streptomycin; Time Factors; Transaminases; Tuberculosis, Pulmonary | 1973 |
Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1974 |
Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Headache; Humans; Isoniazid; Male; Purpura, Thrombocytopenic; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Topics: Antibody Formation; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kidney Function Tests; Liver Function Tests; Purpura, Thrombocytopenic; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly.
Topics: Antibody Formation; Binding Sites, Antibody; Blood Cell Count; Clinical Trials as Topic; Erythrocytes; Female; Humans; Iproniazid; Isoniazid; Leukocyte Count; Male; Purpura, Thrombocytopenic; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Preliminary results of a therapeutic trial concerning the administration of isoniazid + rifampicin once a week, immediately or after an initial period of continuous treatment].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Comparative study (in a controlled therapeutic trial) of 3 intermittent regimens, after an initial period of daily administration, in the repeated treatment of pulmonary tuberculosis (results)].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1973 |
Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
Topics: Adult; Aminosalicylic Acids; Blood Proteins; Blood Sedimentation; Body Weight; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Mycobacterium bovis; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1974 |
[Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
Topics: Adult; Antitubercular Agents; Brazil; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Male; Pilot Projects; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1974 |
Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin.
Topics: Alkaline Phosphatase; Aminosalicylic Acids; Aspartate Aminotransferases; Bilirubin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isocitrate Dehydrogenase; Isoniazid; Liver; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
Comparative controlled trial of rimactane in pulmonary tuberculosis.
Topics: Adolescent; Adult; Blood Sedimentation; Body Weight; Clinical Trials as Topic; Drug Synergism; Female; Hemoglobins; Humans; Isoniazid; Male; Middle Aged; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1969 |
Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
Topics: Clinical Trials as Topic; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1969 |
Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
Topics: Body Weight; Clinical Trials as Topic; Drug Synergism; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1969 |
A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1969 |
[Initial provisional record of a controlled trial of isoniazid-rifomycin-thiocarlide versus isoniazid-streptomycin-thiocarlide in active pulmonary tuberculosis not yet treated].
Topics: Clinical Trials as Topic; Drug Synergism; Humans; Isoniazid; Phenylthiourea; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1969 |
Capreomycin, ethambutol and rifampicin. Clinical experience in Manchester.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Hypersensitivity; Drug Resistance, Microbial; England; Ethambutol; Humans; Hypocalcemia; Hypokalemia; Isoniazid; Kidney Diseases; Labyrinth Diseases; Magnesium; Rifampin; Streptomycin; Vision Disorders; Water-Electrolyte Balance | 1969 |
[56 recent pulmonary tuberculosis cases treated with combined rifampicin-isoniazid in a controlled experiment].
Topics: Adult; Clinical Trials as Topic; Drug Synergism; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1969 |
[Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Drug Synergism; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1969 |
[Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1970 |
Computer-aided procedures in a multi-centre co-operative controlled clinical trial in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Computers; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Laboratories; Medical Records; Methods; Organization and Administration; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary; United Kingdom | 1971 |
A metabolic and kinetic study on the association rifampicin-isoniazid.
Topics: Bilirubin; Chronic Disease; Clinical Trials as Topic; Drug Combinations; Drug Interactions; Humans; Isoniazid; Liver; Liver Diseases; Rifampin; Time Factors | 1971 |
Results and tolerance of prolonged rifampicin treatment in recent and chronic forms of pulmonary tuberculosis.
Topics: Chronic Disease; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Liver; Pilot Projects; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1971 |
[Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1968 |
Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
Topics: Administration, Oral; Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Clinical Trials as Topic; Ethambutol; Female; Hospitalization; Humans; Isoniazid; Leukocyte Count; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Pain; Rifampin; Streptomycin; Tuberculosis, Pulmonary; United States; United States Public Health Service; Vertigo | 1971 |
The Australian rifampicin trial.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Clinical Trials as Topic; Eosinophilia; Humans; In Vitro Techniques; Intestinal Absorption; Isoniazid; Jaundice; L-Lactate Dehydrogenase; Liver; Liver Function Tests; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Thrombocytopenia; Transaminases; Tuberculosis, Pulmonary | 1971 |
Results of rifampicin in 25 treated patients.
Topics: Clinical Trials as Topic; Drug Combinations; Humans; Isoniazid; Mycobacterium tuberculosis; Preoperative Care; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1971 |
Rifampicin.
Topics: Adenoviridae; Administration, Oral; Animals; Bacteria; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Conjunctivitis; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Eye Diseases; Haemophilus Infections; Humans; Isoniazid; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Vaccinia; Vaccinia virus | 1971 |
Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.
Topics: Adult; Bilirubin; Chronic Disease; Half-Life; Humans; Isoniazid; Kinetics; Liver Cirrhosis; Male; Rifampin; Statistics as Topic; Time Factors | 1972 |
Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Body Weight; Ethambutol; Ethionamide; Female; Hemoglobins; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1972 |
[Preliminary observations on the therapeutic effect of rifampycin associated with streptomycin or isoniazid].
Topics: Adolescent; Adult; Drug Synergism; Humans; Isoniazid; Male; Radiography; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1968 |
A comparative trial with combinations of rifampicin, ethambutol and isoniazid (Hydronsan) in previously untreated cases of pulmonary tuberculosis.
Topics: Adolescent; Adult; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Liver Function Tests; Male; Rifampin; Tuberculosis, Pulmonary | 1971 |
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic Association (third report).
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Recurrence; Remission, Spontaneous; Rifampin; Societies, Medical; Streptomycin; Time Factors; Tuberculosis, Pulmonary; United Kingdom | 1980 |
Limited therapeutic action of rifampicin/isoniazid against Leishmania aethiopica.
Topics: Drug Therapy, Combination; Ethiopia; Humans; Isoniazid; Leishmaniasis; Rifampin | 1981 |
Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1980 |
Comparison of a conventional and an initial 2-month intensive drug regimen for treating pulmonary tuberculosis in Swaziland.
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Eswatini; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1984 |
Short-term chemotherapy of tuberculosis.
Topics: Clinical Trials as Topic; Drug Administration Schedule; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1983 |
Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India.
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Prednisolone; Pyrazinamide; Random Allocation; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1983 |
Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
[Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1983 |
[Long-term results of a trial of short-term chemotherapy. French study 6.9.12].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1983 |
[Short-term chemotherapy of tuberculosis. Cooperative French trial].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Random Allocation; Rifampin; Tuberculosis, Pulmonary; United States | 1984 |
Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
Topics: Adolescent; Adult; Algeria; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Rural Population; Streptomycin; Tuberculosis, Pulmonary | 1984 |
[A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tubercu
Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1984 |
A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1984 |
[Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study].
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1983 |
A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1982 |
[Short-term chemotherapy of pulmonary tuberculosis. Bacteriologic results].
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1980 |
A controlled trial of individually-adapted short-course chemotherapy versus two-year scheme in original treatment of pulmonary tuberculosis. Report after a five-year follow-up.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1982 |
[Intravenous rifampicin therapy in open tuberculosis].
Topics: Administration, Oral; Adult; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Injections, Intravenous; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1980 |
Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
[Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Intensive chemotherapy of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acid; Antibiotics, Antitubercular; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
[Complex hospital treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Hospitalization; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Rifampin-isoniazid therapy of alcoholic and nonalcoholic tuberculous patients in a U.S. Public Health Service Cooperative Therapy Trial.
Topics: Alcoholism; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
Chemotherapy of tuberculosis for the 1980's.
Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1980 |
Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Poland; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
[Urgent problems of antibacterial treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Pyrazinamide; Random Allocation; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. British Thoracic Association.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1981 |
BTA short-course chemotherapy studies.
Topics: Clinical Trials as Topic; Ethambutol; Female; Hepatitis; Humans; Isoniazid; Liver Function Tests; Male; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary; United Kingdom | 1981 |
Short-course chemotherapy. The Arkansas experience.
Topics: Adolescent; Adult; Aged; Arkansas; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1981 |
A study of the characteristics and course of sputum smear-negative pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Radiography; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Nine-month chemotherapy for pulmonary tuberculosis.
Topics: Adult; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Self Administration; Tuberculosis, Pulmonary | 1982 |
Short-course chemotherapy for pulmonary tuberculosis. A 100-day interrupted regimen.
Topics: Adult; Antibiotics, Antitubercular; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Topics: Adolescent; Adult; Aged; Alcoholism; Clinical Trials as Topic; Denmark; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1982 |
Chemotherapy for tuberculosis today.
Topics: Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1982 |
[Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].
Topics: Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Male; Middle Aged; Prothionamide; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1982 |
Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Rifampin; Tuberculosis, Pulmonary | 1980 |
Factors influencing the effects of the initial phase of tuberculosis chemotherapy.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Clinical trial of a combination of three drugs in fixed proportions in the treatment of tuberculosis. Groupe de Travail sur la Chimiothérapie de la Tuberculose].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1995 |
Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Survival Rate; Thioacetazone; Tuberculosis, Pulmonary; Uganda | 1994 |
A comparison of two short course tuberculosis chemotherapy regimens, both using Rifater during an intensive phase, with a 3 year follow-up.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Combinations; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Thailand; Treatment Outcome; Tuberculosis, Pulmonary | 1995 |
A controlled clinical trial of short-course chemotherapy for tuberculoma of the brain.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculoma, Intracranial | 1995 |
[Treatment of pleural tuberculosis with a short 4-month regimen: preliminary results].
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pleural | 1995 |
[Analysis of course and treatment results after treatment of pulmonary tuberculosis with early introduction of interrupted observation--preliminary report].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Uric Acid | 1995 |
Antituberculosis treatment-induced hepatotoxicity: role of predictive factors.
Topics: Adolescent; Adult; Antitubercular Agents; Body Mass Index; Case-Control Studies; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Male; Middle Aged; Nutrition Disorders; Pyrazinamide; Rifampin | 1995 |
[Contemporary methods in the diagnosis and treatment of intrathoracic tuberculosis in children].
Topics: Administration, Oral; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Injections, Intramuscular; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1994 |
Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Patient Compliance; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis | 1994 |
Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prospective Studies; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1995 |
Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide.
Topics: Adolescent; Adult; Biological Availability; Cross-Over Studies; Dietary Carbohydrates; Dietary Fats; Female; Food; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1995 |
[Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood--a pilot project].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Pilot Projects; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1994 |
[Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
Clinically significant drug interactions with antituberculosis agents.
Topics: Absorption; Antitubercular Agents; Biotransformation; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Enzyme Induction; Humans; Isoenzymes; Isoniazid; Quinolones; Rifabutin; Rifampin; Tissue Distribution; Tuberculosis | 1994 |
[BCG vaccination and increasing the effectiveness of treatment of post-vaccination complications by the use of rifampicin and dimexide].
Topics: Abscess; BCG Vaccine; Child; Dimethyl Sulfoxide; Drug Combinations; Humans; Infant, Newborn; Isoniazid; Lymphadenitis; Rifampin; Solutions; Time Factors | 1994 |
[Pathogenetic therapy of pulmonary tuberculosis in adolescents].
Topics: Administration, Oral; Adolescent; Antibiotics, Antitubercular; Antioxidants; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Isoniazid; Lipid Peroxidation; Male; Phenyl Ethers; Prednisolone; Rifampin; Streptomycin; T-Lymphocytes; Treatment Outcome; Tuberculin; Tuberculosis, Pulmonary | 1994 |
A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV-1; Humans; Isoniazid; Los Angeles; Male; Mycobacterium tuberculosis; Patient Compliance; Prospective Studies; Pyrazinamide; Remission Induction; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1994 |
[Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
Early diagnosis of spinal tuberculosis by MRI.
Topics: Abscess; Adolescent; Adult; Biopsy, Needle; Cervical Vertebrae; Child; Discitis; Drainage; Female; Humans; Image Interpretation, Computer-Assisted; Isoniazid; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteitis; Reproducibility of Results; Rifampin; Thoracic Vertebrae; Time Factors; Tuberculosis, Spinal | 1994 |
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment.
Topics: Adolescent; Adult; Colony Count, Microbial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifabutin; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1993 |
Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease.
Topics: Adolescent; Adult; Aged; Crohn Disease; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prednisolone; Rifampin; Time Factors; Treatment Outcome | 1994 |
[A comparative study of rifapentine treatment and three years follow-up on initial pulmonary tuberculous].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethionamide; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1993 |
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
Topics: Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1993 |
Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 1993 |
[Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
Topics: Antitubercular Agents; Dosage Forms; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1993 |
[Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1993 |
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy.
Topics: Adult; Biological Availability; Capsules; Drug Administration Schedule; Drug Combinations; Half-Life; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tablets; Tuberculosis, Pulmonary | 1993 |
Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Recurrence; Retrospective Studies; Rifampin; Sputum; Tuberculosis, Pulmonary | 1993 |
Controlled trial of short-course regimens of chemotherapy in the ambulatory treatment of spinal tuberculosis. Results at three years of a study in Korea. Twelfth report of the Medical Research Council Working Party on Tuberculosis of the Spine.
Topics: Adolescent; Adult; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Humans; Infant; Isoniazid; Longitudinal Studies; Middle Aged; Rifampin; Time Factors; Tuberculosis, Spinal | 1993 |
Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa.
Topics: Adolescent; Adult; Africa, Western; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Seronegativity; HIV Seropositivity; HIV-1; HIV-2; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Treatment Failure; Tuberculosis, Pulmonary | 1995 |
[The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Female; Humans; Isoniazid; Life Style; Male; Middle Aged; Prognosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.
Topics: Administration, Oral; Adult; Analysis of Variance; Antimalarials; Antitubercular Agents; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Synergism; Humans; Isoniazid; Male; Quinine; Rifampin; Thailand | 1995 |
Randomised trial of corticosteroids in the treatment of tuberculous pleurisy.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Isoniazid; Male; Middle Aged; Prednisolone; Prospective Studies; Rifampin; Treatment Failure; Tuberculosis, Pleural | 1995 |
Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters.
Topics: Adult; Aged; Aging; Antitubercular Agents; Female; Homeostasis; Humans; Isoniazid; Male; Middle Aged; Osmolar Concentration; Rifampin; Tuberculosis | 1995 |
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Female; HIV-1; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1996 |
[Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Spain; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Short course chemoprophylaxis with rifampicin, isoniazid and pyrazinamide for tuberculosis evaluated in gold miners with chronic silicosis: a double-blind placebo controlled trial.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Gold; Humans; Isoniazid; Male; Middle Aged; Mining; Pyrazinamide; Rifampin; Silicotuberculosis | 1996 |
Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1996 |
A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Black People; Body Weight; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1996 |
Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Capsules; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Rifampin; Single-Blind Method; Tablets | 1995 |
Treatment of multidrug-resistant tuberculosis in Indonesia.
Topics: Adult; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Indonesia; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Nausea; Ofloxacin; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 1996 |
Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy.
Topics: Administration, Oral; Adult; Antibiotics, Antitubercular; Biopsy, Needle; Female; Humans; Injections, Intramuscular; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Neck; Prospective Studies; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Lymph Node | 1997 |
[Compliance, efficacy and tolerability of the therapeutic regimen recommended by National Consensus on Tuberculosis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Isoniazid; Male; Middle Aged; Patient Compliance; Prospective Studies; Pyrazinamide; Recurrence; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 1997 |
Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Biological Availability; Diarrhea; Female; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 1997 |
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Risk; Treatment Outcome; Tuberculin Test; Tuberculosis, Pulmonary | 1997 |
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinica
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sputum; Tuberculosis | 1997 |
Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide.
Topics: Absorption; Adult; Analysis of Variance; Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, High Pressure Liquid; Cross-Over Studies; Dose-Response Relationship, Drug; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin | 1997 |
Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Prognosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Gastrointestinal | 1997 |
A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Sputum; Tuberculosis, Pulmonary | 1997 |
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1998 |
Prospective study of corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bronchoscopy; Chi-Square Distribution; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Glucocorticoids; Humans; Isoniazid; Lung; Male; Middle Aged; Prednisolone; Prospective Studies; Pyrazinamide; Radiography; Respiratory Function Tests; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1997 |
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Recurrence; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
A 15-year assessment of controlled trials of the management of tuberculosis of the spine in Korea and Hong Kong. Thirteenth Report of the Medical Research Council Working Party on Tuberculosis of the Spine.
Topics: Adolescent; Adult; Ambulatory Care; Aminosalicylic Acid; Antibiotics, Antitubercular; Antitubercular Agents; Bed Rest; Bone Transplantation; Casts, Surgical; Child; Child, Preschool; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Hong Kong; Hospitalization; Humans; Infant; Isoniazid; Korea; Longitudinal Studies; Male; Middle Aged; Paraplegia; Randomized Controlled Trials as Topic; Rifampin; Spinal Diseases; Streptomycin; Treatment Outcome; Tuberculosis, Spinal | 1998 |
Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.
Topics: Administration, Oral; Adult; Antibiotics, Antitubercular; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Reference Values; Rifampin | 1998 |
[Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Prospective Studies; Rifampin; Time Factors; Tuberculosis | 1998 |
[Results of examination in healthy volunteers of rifampicin and isoniazid bioavailability from Polish two-drug combination capsules of rifamazid used for tuberculosis treatment].
Topics: Adult; Antitubercular Agents; Cross-Over Studies; Drug Combinations; Female; Humans; Isoniazid; Male; Middle Aged; Reference Values; Rifampin | 1998 |
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Antitubercular Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Isoniazid; Male; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculin Test; Tuberculosis, Pulmonary; Zambia | 1998 |
Hepatic enzyme abnormalities in children on triple therapy for tuberculosis.
Topics: Adolescent; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Isoniazid; Liver; Liver Function Tests; Male; Monitoring, Physiologic; Prognosis; Pyrazinamide; Rifampin; Tuberculosis | 1999 |
[Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1997 |
Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1999 |
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1999 |
Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council W
Topics: Adolescent; Adult; Ambulatory Care; Aminosalicylic Acid; Antitubercular Agents; Bone Transplantation; Child; Child, Preschool; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Osteotomy; Radiography; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Spinal | 1999 |
Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Male; Reference Values; Rifampin; Therapeutic Equivalency | 1999 |
Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172).
Topics: Adjuvants, Immunologic; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Argentina; BCG Vaccine; Drug Therapy, Combination; Female; Humans; Immunotherapy; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1999 |
Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
Topics: Adult; Antitubercular Agents; Cross-Over Studies; Drug Combinations; Humans; In Vitro Techniques; Isoniazid; Male; Rifampin; Therapeutic Equivalency; Time Factors | 1999 |
Bioavailability of rifampicin in a separate formulation and fixed dose combination with isoniazid NIH: a case for a fixed dose combination (FDC) for the treatment of tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Metabolic Clearance Rate; Rifampin; Single-Blind Method; Time Factors; Tuberculosis | 1999 |
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health O
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Proportional Hazards Models; Pyrazinamide; Rifampin; Statistics, Nonparametric; Tuberculin Test; Tuberculosis | 2000 |
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase.
Topics: Acetylation; Antitubercular Agents; Arylamine N-Acetyltransferase; Drug Therapy, Combination; Genotype; Hong Kong; Humans; Isoniazid; Polymorphism, Restriction Fragment Length; Rifampin; Tuberculosis, Pulmonary | 2000 |
Twice weekly vs. daily chemotherapy for childhood tuberculosis.
Topics: Antitubercular Agents; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Isoniazid; Male; Patient Compliance; Pyrazinamide; Rifampin; South Africa; Treatment Outcome; Tuberculosis, Pulmonary | 2000 |
A multicentre study of the early bactericidal activity of anti-tuberculosis drugs.
Topics: Adult; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Hong Kong; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; South Africa; Sputum; Tuberculosis, Pulmonary | 2000 |
A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis.
Topics: Adult; Antitubercular Agents; Community Health Workers; Drug Combinations; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; South Africa; Tuberculosis | 2000 |
Short-course chemotherapy for tuberculosis of the spine. A comparison between ambulant treatment and radical surgery--ten-year report.
Topics: Adolescent; Adult; Ambulatory Care; Antitubercular Agents; Bone Transplantation; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Kyphosis; Male; Rifampin; Spinal Fusion; Treatment Outcome; Tuberculosis, Spinal | 1999 |
[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group].
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Incidence; Isoniazid; Liver; Male; Prospective Studies; Rifampin; Time Factors; Tuberculin Test; Tuberculosis | 2000 |
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Opportunistic Infections; Prospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2001 |
[Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Isoniazid; Japan; Male; Middle Aged; Practice Guidelines as Topic; Prospective Studies; Rifampin; Tuberculosis; Tuberculosis Societies | 2000 |
Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis; Zambia | 2001 |
Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis antigen 85 in sputum: potential surrogate marker in tuberculosis chemotherapy trials.
Topics: Acyltransferases; Antibiotics, Antitubercular; Antigens, Bacterial; Antitubercular Agents; Biomarkers; Colony Count, Microbial; Humans; Isoniazid; Kinetics; Recurrence; Rifampin; Rifamycins; Sputum; Tuberculosis | 2001 |
Substandard tuberculosis drugs on the global market and their simple detection.
Topics: Antitubercular Agents; Asia; Chromatography, Thin Layer; Colombia; Drug Combinations; Europe, Eastern; Humans; Isoniazid; Predictive Value of Tests; Quality Control; Reference Standards; Rifampin; Sensitivity and Specificity; Tuberculosis | 2001 |
Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Topics: Adolescent; Adult; Antitubercular Agents; Developing Countries; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Urban Health; World Health Organization | 2000 |
[Controlled clinical study on efficacy of fixed-dose compounds rifater/rifinah in antituberculous chemotherapy].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1998 |
The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
Topics: Antibiotics, Antitubercular; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Colorimetry; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Quality Control; Reference Values; Rifampin; Therapeutic Equivalency; Tuberculosis; Urinalysis | 2001 |
Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological Availability; Calibration; Chromatography, Thin Layer; Drug Combinations; Drug Interactions; Humans; Isoniazid; Male; Regression Analysis; Rifampin; Solutions | 2001 |
Reintroducing antituberculosis therapy after Stevens-Johnson syndrome in human immunodeficiency virus-infected patients with tuberculosis: role of desensitization.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Desensitization, Immunologic; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Stevens-Johnson Syndrome; Treatment Outcome; Tuberculosis | 2001 |
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculin Test; Tuberculosis, Pulmonary | 2001 |
Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy.
Topics: Adolescent; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Therapy, Combination; Female; Hong Kong; Humans; Isoniazid; Life Tables; Male; Middle Aged; Prognosis; Proportional Hazards Models; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Protocols; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Nigeria; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2002 |
A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.
Topics: Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Reference Values; Rifampin; Treatment Outcome; Tuberculosis | 2002 |
Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Radiography, Thoracic; Rifampin; Sputum; Treatment Outcome | 2002 |
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
Topics: Antibiotics, Antitubercular; Drug Administration Schedule; Drug Therapy, Combination; Ethnicity; Female; Humans; Isoniazid; Male; Middle Aged; Radiography, Thoracic; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Prospective Studies; Pyrazinamide; Rifampin | 2002 |
Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
Topics: Analysis of Variance; Antibiotics, Antitubercular; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Therapeutic Equivalency; Time Factors; Tuberculosis | 2002 |
Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
Topics: Adult; Antitubercular Agents; Drug Combinations; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Rifampin; Sputum; Taiwan; Tuberculosis, Pulmonary | 2002 |
Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine.
Topics: Adult; Analysis of Variance; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Probability; Recurrence; Reference Values; Rifampin; Severity of Illness Index; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary | 2003 |
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Comparative evaluation of efficacy and safety profile of three anti-tuberculous regimens in Mangalore.
Topics: Adult; Antitubercular Agents; Dizziness; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Gastritis; Humans; Hypesthesia; Isoniazid; Male; Nausea; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; HIV Seronegativity; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Radiography; Recurrence; Rifampin; Sputum; Survival Analysis; Treatment Outcome | 2003 |
The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Topics: Adult; Aged; Antitubercular Agents; Bronchodilator Agents; Drug Interactions; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Theophylline; Time Factors; Tuberculosis, Pulmonary | 2003 |
A novel method for evaluating the antimicrobial activity of tuberculosis treatment regimens.
Topics: Antitubercular Agents; Cell Survival; Ciprofloxacin; Drug Administration Schedule; Humans; Isoniazid; Microbial Sensitivity Tests; Models, Statistical; Rifampin; Sputum; Tuberculosis, Pulmonary | 2003 |
Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol.
Topics: Administration, Oral; Adult; Analysis of Variance; Antitubercular Agents; Area Under Curve; Chemistry, Pharmaceutical; Clinical Protocols; Cross-Over Studies; Dosage Forms; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Ethambutol; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Therapeutic Equivalency; World Health Organization | 2003 |
The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Aza Compounds; Female; Fluoroquinolones; Humans; Inhibitory Concentration 50; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin; Sputum; Tuberculosis, Pulmonary | 2003 |
Use of Rhu-GM-CSF in pulmonary tuberculosis patients: results of a randomized clinical trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antitubercular Agents; Double-Blind Method; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2003 |
Initial experience on rifampin and pyrazinamide vs isoniazid in the treatment of latent tuberculosis infection among patients with silicosis in Hong Kong.
Topics: Aged; Antitubercular Agents; Drug Administration Schedule; Female; Hong Kong; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Risk Factors; Silicosis; Tuberculosis | 2003 |
[Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 2003 |
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
Topics: Adolescent; Adult; Antitubercular Agents; Cost Savings; Cost-Benefit Analysis; Costs and Cost Analysis; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2004 |
[Treatment of latent tuberculosis among homeless population. Comparison between wo therapeutic approaches].
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Ill-Housed Persons; Isoniazid; Male; Patient Compliance; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2004 |
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
Topics: Adult; Antibiotics, Antitubercular; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Fluoroquinolones; Gatifloxacin; Isoniazid; Linezolid; Mice; Mice, Inbred C57BL; Oxazolidinones; Rifampin; Time Factors; Tuberculosis | 2004 |
Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
Topics: Administration, Oral; Adult; Antitubercular Agents; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Drug Combinations; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Therapeutic Equivalency | 2004 |
Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Risk Factors; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Pyridoxine; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2004 |
Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months.
Topics: Adult; Antitubercular Agents; Costs and Cost Analysis; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Isoniazid; Male; Outcome and Process Assessment, Health Care; Patient Compliance; Rifampin; Tuberculosis | 2004 |
Disposition of uric acid upon administration of ofloxacin alone and in combination with other anti-tuberculosis drugs.
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Humans; Isoniazid; Male; Ofloxacin; Pyrazinamide; Rifampin; Uric Acid | 2004 |
Recurrent tuberculosis in the United States and Canada: relapse or reinfection?
Topics: Adult; Antitubercular Agents; Canada; Female; Genotype; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prospective Studies; Recurrence; Rifampin; Tuberculosis, Pulmonary; United States | 2004 |
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.
Topics: Acetylation; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Ethambutol; Feces; Female; HIV Infections; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Phenotype; Pyrazinamide; Rifampin; Tuberculosis | 2004 |
Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Pleural Effusion; Psoas Abscess; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2004 |
[Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
Topics: Administration, Oral; Antitubercular Agents; Diabetes Complications; Ethambutol; Humans; Hypoglycemic Agents; Injections, Intralymphatic; Injections, Intramuscular; Insulin; Isoniazid; Liver Diseases; Lymphatic System; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2004 |
Evaluation of modified short course chemotherapy in active pulmonary tuberculosis patients with human immunodeficiency virus infection in University College Hospital, Ibadan, Nigeria--a preliminary report.
Topics: Acne Vulgaris; Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary | 2004 |
Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Infant; Isoniazid; Pyrazinamide; Rifampin; Statistics, Nonparametric; Tuberculosis, Pulmonary | 2005 |
Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatment.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Cross-Over Studies; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Therapeutic Equivalency; Tuberculosis | 2005 |
[Randomized control study on domestic fixed-dose combinations in the initial treatment of smears positive tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2004 |
Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Child; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Lymph Nodes; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Self Administration; Treatment Outcome; Tuberculin Test; Tuberculosis, Lymph Node | 2005 |
Clinical trial of rifampicin in the treatment of pulmonary tuberculosis in Lagos.
Topics: Adult; Antibiotics, Antitubercular; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Nigeria; Rifampin; Tuberculosis, Pulmonary | 1973 |
Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens.
Topics: Adult; Antigens, Bacterial; Antitubercular Agents; Cells, Cultured; Female; Humans; Interferon-gamma; Isoniazid; Longitudinal Studies; Lymphocyte Count; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; T-Lymphocytes; Treatment Outcome; Tuberculosis | 2006 |
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Isoniazid; Male; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2006 |
Lack of weight gain and relapse risk in a large tuberculosis treatment trial.
Topics: Adult; Antitubercular Agents; Body Mass Index; Body Weight; Female; Humans; Isoniazid; Male; Middle Aged; Prognosis; Recurrence; Rifampin; Risk Factors; Thinness; Tuberculosis; Weight Gain | 2006 |
[Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
Topics: Adult; DNA Mutational Analysis; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Point Mutation; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis, Pulmonary | 2006 |
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological Availability; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Radiography, Thoracic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
[Short-course isoniazid and rifampin compared with isoniazid for latent tuberculosis infection: a randomized clinical trial].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Virus Latency | 2007 |
[Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Virus Latency | 2007 |
Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Linear Models; Male; Mass Spectrometry; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 2007 |
The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Prospective Studies; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2007 |
Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Aza Compounds; Drug Interactions; Female; Fluoroquinolones; Humans; Indonesia; Isoniazid; Male; Middle Aged; Moxifloxacin; Plasma; Quinolines; Rifampin; Tuberculosis, Pulmonary | 2007 |
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Colony Count, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Male; Middle Aged; Moxifloxacin; Nonlinear Dynamics; Ofloxacin; Pyrazinamide; Quinolines; Rifampin; Sputum | 2008 |
Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antitubercular Agents; Body Composition; Drug Therapy, Combination; Ethambutol; HIV Infections; HIV Seronegativity; Humans; Hypoalbuminemia; India; Isoniazid; Malnutrition; Nutritional Status; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
[Effectiveness of prophylaxis against tuberculosis in patients infected with HIV].
Topics: Adult; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Cohort Studies; Comorbidity; Female; HIV Seropositivity; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Rifampin; Survival Rate; Treatment Outcome; Tuberculosis; Viral Load | 2007 |
Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Educational Status; Employment; Ethambutol; Humans; Isoniazid; Middle Aged; Pakistan; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2008 |
[Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Self Administration; Tuberculosis, Pulmonary | 2008 |
Pyrazinamide serum levels in childhood tuberculosis.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2008 |
Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach.
Topics: Adult; Antitubercular Agents; Blood Sedimentation; Body Weight; Chemical and Drug Induced Liver Injury; Curcuma; Drug Therapy, Combination; Ethambutol; Female; Hemoglobins; Humans; Isoniazid; Liver Diseases; Male; Middle Aged; Patient Compliance; Plant Preparations; Pyrazinamide; Rifampin; Tinospora; Treatment Outcome; Tuberculosis | 2008 |
Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Female; Humans; Isoniazid; Liver; Male; Patient Compliance; Patient Dropouts; Prospective Studies; Rifampin; Transaminases; Tuberculosis; Young Adult | 2008 |
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Topics: Adult; Antitubercular Agents; Aza Compounds; Brazil; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Kaplan-Meier Estimate; Logistic Models; Male; Moxifloxacin; Multivariate Analysis; Pyrazinamide; Quinolines; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Patient Satisfaction; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Mycobacterium tuberculosis; Proportional Hazards Models; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Prospective randomized trial of six-month versus nine-month therapy for intestinal tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Gastrointestinal; Young Adult | 2009 |
Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Pyrazinamide; Rifampin; Tuberculosis; Viral Load | 2010 |
Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study.
Topics: Adult; Antitubercular Agents; Cohort Studies; Directly Observed Therapy; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tanzania; Treatment Outcome; Tuberculosis; Young Adult | 2009 |
Tailored release drug delivery system for rifampicin and isoniazid for enhanced bioavailability of rifampicin.
Topics: Adult; Antitubercular Agents; Biological Availability; Cross-Over Studies; Delayed-Action Preparations; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 2011 |
Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Young Adult | 2010 |
Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; Ethambutol; Female; Flow Cytometry; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis; Uganda; Viral Load; Young Adult | 2010 |
Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis.
Topics: Antiretroviral Therapy, Highly Active; Antitubercular Agents; Child, Preschool; Drug Therapy, Combination; Ethionamide; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Isoniazid; Kaplan-Meier Estimate; Lopinavir; Male; Pyrimidinones; Rifampin; Ritonavir; RNA, Viral; South Africa; Tuberculosis, Pulmonary; Viral Load | 2010 |
Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Brazil; Canada; Female; Follow-Up Studies; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Prospective Studies; Rifampin; Risk; Saudi Arabia; Time Factors; Young Adult | 2010 |
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Therapy, Combination; Ethambutol; Female; Free Radical Scavengers; Humans; Isoniazid; Liver; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2010 |
Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB.
Topics: Adult; Antibiotics, Antitubercular; Brazil; Canada; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Health Care Costs; Health Services; Humans; Isoniazid; Latent Tuberculosis; Rifampin; Saudi Arabia | 2010 |
Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania.
Topics: Adult; Antitubercular Agents; Calcifediol; Female; Hospitalization; Humans; Isoniazid; Male; Parathyroid Hormone; Rifampin; Sunlight; Tanzania; Tuberculosis, Pulmonary; Vitamin D; Vitamin D Deficiency; Vitamins | 2010 |
Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents.
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Culture Media; Diarylquinolines; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Quinolines; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2010 |
Relative bioavailability of rifampicin in a three-drug fixed-dose combination formulation.
Topics: Adult; Antitubercular Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drugs, Generic; Humans; Isoniazid; Mexico; Pyrazinamide; Rifampin; Therapeutic Equivalency; Young Adult | 2010 |
Genital tuberculosis among infertile women and fertility outcome after antitubercular therapy.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Fertilization; Humans; Infertility, Female; Isoniazid; Laparoscopy; Polymerase Chain Reaction; Pregnancy; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Female Genital | 2011 |
Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2011 |
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intramuscular; Isoniazid; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Young Adult | 2011 |
Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Humans; Intention to Treat Analysis; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Treatment Failure; Tuberculosis, Pulmonary; World Health Organization; Young Adult | 2011 |
New regimens to prevent tuberculosis in adults with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Cause of Death; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Mycobacterium tuberculosis; Patient Compliance; Proportional Hazards Models; Rifampin; Risk; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2011 |
Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations.
Topics: Antitubercular Agents; Area Under Curve; Child, Preschool; Coinfection; Female; HIV Infections; Humans; Isoniazid; Male; Nutritional Status; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; World Health Organization | 2011 |
Three months of rifapentine and isoniazid for latent tuberculosis infection.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Intention to Treat Analysis; Isoniazid; Male; Middle Aged; Prospective Studies; Rifampin; Risk Factors; Self Administration; Tuberculosis; Virus Latency | 2011 |
Potential cost-effectiveness of rifampin vs. isoniazid for latent tuberculosis: implications for future clinical trials.
Topics: Adult; Antitubercular Agents; Brazil; Canada; Cost-Benefit Analysis; Decision Support Techniques; Drug Administration Schedule; Drug Costs; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Models, Economic; Research Design; Rifampin; Saudi Arabia; Time Factors; Treatment Outcome; Young Adult | 2011 |
Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Follow-Up Studies; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Prisoners; Rifampin; Taiwan; Treatment Outcome; Tuberculin Test; Young Adult | 2012 |
Isoniazid vs. rifampin for latent tuberculosis infection in jail inmates: toxicity and adherence.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Female; Humans; Isoniazid; Latent Tuberculosis; Liver Function Tests; Male; Medication Adherence; Prisons; Rifampin; Socioeconomic Factors | 2012 |
Phase II dose-ranging trial of the early bactericidal activity of PA-824.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nitroimidazoles; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2012 |
Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis.
Topics: Adult; Antitubercular Agents; Female; Genotype; HIV Infections; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Young Adult | 2012 |
Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Organophosphonates; Oxazines; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture.
Topics: Antimalarials; Bacterial Load; Bacteriological Techniques; Diagnostic Techniques, Respiratory System; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Tuberculous lymphadenopathy: a multicentre operational study of 6-month thrice weekly directly observed treatment.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Directly Observed Therapy; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node; Young Adult | 2013 |
Rifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population.
Topics: Adolescent; Adult; Antitubercular Agents; Chi-Square Distribution; Child; Drug Administration Schedule; Emigrants and Immigrants; Female; Humans; Isoniazid; Latent Tuberculosis; Logistic Models; Male; Medication Adherence; Multivariate Analysis; Odds Ratio; Prevalence; Prospective Studies; Rifampin; Risk Assessment; Risk Factors; Socioeconomic Factors; Spain; Time Factors; Treatment Outcome; Young Adult | 2013 |
Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
Topics: Adult; Antitubercular Agents; Area Under Curve; China; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tandem Mass Spectrometry; Therapeutic Equivalency | 2013 |
Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
Topics: Adult; Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1 Inhibitors; Drug Combinations; Excipients; Female; Humans; Isoniazid; Male; Mannitol; Mice; Mice, Inbred Strains; Microsomes, Liver; Middle Aged; Mycobacterium tuberculosis; Rats; Rats, Sprague-Dawley; Rifampin; Young Adult | 2013 |
Changes in QuantiFERON®-TB Gold In-Tube results during treatment for tuberculous infection.
Topics: Adult; Antitubercular Agents; Brazil; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Rifampin; Time Factors; Treatment Outcome; Tuberculin Test; Young Adult | 2013 |
Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulations.
Topics: Adult; Antitubercular Agents; Area Under Curve; Coinfection; Drug Administration Schedule; Drug Dosage Calculations; Drug Synergism; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; HIV Infections; Humans; Isoniazid; Male; Monte Carlo Method; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2013 |
Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
Topics: Adult; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Dietary Supplements; Drug Therapy, Combination; Ethambutol; Female; Guinea-Bissau; HIV Core Protein p24; HIV Infections; HIV-1; HIV-2; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazinamide; Rifampin; RNA, Viral; Tuberculosis, Pulmonary; Vitamin D; Young Adult | 2013 |
Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Apolipoproteins A; Apolipoproteins B; Biomarkers; Female; Humans; Isoniazid; Latent Tuberculosis; Lipid Metabolism; Lipids; Male; Middle Aged; Rifampin; Young Adult | 2013 |
Dependence of efavirenz- and rifampicin-isoniazid-based antituberculosis treatment drug-drug interaction on CYP2B6 and NAT2 genetic polymorphisms: ANRS 12154 study in Cambodia.
Topics: Alkynes; Anti-HIV Agents; Antitubercular Agents; Aryl Hydrocarbon Hydroxylases; Arylamine N-Acetyltransferase; Benzoxazines; Cambodia; Chromatography, Liquid; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug Interactions; HIV Infections; Humans; Isoniazid; Lamivudine; Plasma; Polymorphism, Single Nucleotide; Rifampin; Spectrophotometry, Ultraviolet; Stavudine; Tuberculosis | 2014 |
Bioequivalence of fixed-dose combination Myrin®-P Forte and reference drugs in loose combination.
Topics: Adult; Antitubercular Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Ethambutol; Fasting; Female; Healthy Volunteers; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Singapore; Therapeutic Equivalency; Young Adult | 2013 |
Relative bioavailability of isoniazid in a fixed-dose combination product in healthy Mexican subjects.
Topics: Administration, Oral; Adult; Antitubercular Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Drug Combinations; Drugs, Generic; Female; Half-Life; Healthy Volunteers; Humans; Isoniazid; Male; Metabolic Clearance Rate; Pyrazinamide; Rifampin; Therapeutic Equivalency; Young Adult | 2014 |
Short-course treatment of latent tuberculosis infection in patients with rheumatic conditions proposed for anti-TNF therapy.
Topics: Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Rheumatic Diseases; Rifampin; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.
Topics: Adult; Alkynes; Antitubercular Agents; Benzoxazines; Coinfection; Cyclopropanes; Female; Half-Life; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Rifampin; Treatment Outcome; Tuberculosis; Young Adult | 2014 |
The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus).
Topics: Administration, Oral; Administration, Rectal; Animals; Antitubercular Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Elephants; Ethambutol; Female; Isoniazid; Male; Pyrazinamide; Rifampin | 2014 |
Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Aspirin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Prednisolone; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2014 |
Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
Topics: Adult; Ambulatory Care Facilities; Antitubercular Agents; Canada; Directly Observed Therapy; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis; United States | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis.
Topics: Africa; Antitubercular Agents; Asia; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Latin America; Male; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Area Under Curve; Disinfection; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Sterilization; Treatment Outcome; Tuberculosis; Young Adult | 2015 |
Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial.
Topics: Adolescent; Antitubercular Agents; Body Height; Body Mass Index; Body Weight; Child; Child, Preschool; Dietary Supplements; Double-Blind Method; Ethambutol; Female; Humans; India; Infant; Isoniazid; Male; Micronutrients; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Zinc | 2014 |
A four-month gatifloxacin-containing regimen for treating tuberculosis.
Topics: Adult; Antitubercular Agents; Blood Glucose; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Intention to Treat Analysis; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2014 |
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Female; HIV Infections; Humans; India; Infant; Isoniazid; Male; Pyrazinamide; Regression Analysis; Rifampin; Treatment Outcome; Tuberculosis | 2015 |
Comparative bioavailability of rifampicin and isoniazid in fixed-dose combinations and single-drug formulations.
Topics: Administration, Oral; Adolescent; Adult; Antitubercular Agents; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; China; Cross-Over Studies; Drug Combinations; Drug Interactions; Half-Life; Healthy Volunteers; Humans; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; Tablets; Therapeutic Equivalency; Young Adult | 2014 |
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Rifampin; Treatment Outcome | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2015 |
A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Drug Users; Ethambutol; Ethnicity; Female; Humans; Isoniazid; Male; Patient Compliance; Pyrazinamide; Rifampin; Socioeconomic Factors; Substance-Related Disorders; Treatment Outcome; Tuberculosis | 2015 |
Bioequivalence of fixed-dose combination RIN®-150 to each reference drug in loose combination.
Topics: Adult; Antitubercular Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Healthy Volunteers; Humans; Isoniazid; Male; Middle Aged; Rifampin; Singapore; Tablets; Therapeutic Equivalency; Tuberculosis; Young Adult | 2015 |
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pul
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Moxifloxacin; Nitroimidazoles; Pyrazinamide; Rifampin; South Africa; Sputum; Tanzania; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.
Topics: Adolescent; Adult; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Prospective Studies; Respiratory Tract Diseases; Rifampin | 2015 |
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; South Africa; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.
Topics: Administration, Oral; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Isoniazid; Male; Reverse Transcriptase Inhibitors; Rifampin; RNA, Viral; Tuberculosis | 2015 |
Effects on type 2 diabetes complicated with pulmonary tuberculosis: regiment of insulin, isoniazid, rifampicin, pyrazinamide and ethambutol versus the regiment plus Qi-boosting and Yin-nourishing decoction of Traditional Chinese Medicine.
Topics: Adult; Aged; Antitubercular Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethambutol; Female; Humans; Hypoglycemic Agents; Insulin; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2015 |
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Malawi; Male; Middle Aged; Pyrazinamide; Rifampin; Young Adult | 2015 |
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.
Topics: Adult; Antitubercular Agents; Aspartate Aminotransferases; Brazil; Canada; Case-Control Studies; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Multivariate Analysis; Rifampin; Risk Factors; Spain; United States | 2015 |
Population pharmacokinetics of rifampicin and 25-deacetyl-rifampicin in healthy Asian adults.
Topics: Adult; Antitubercular Agents; Asian People; Cross-Over Studies; Female; Healthy Volunteers; Humans; Isoniazid; Male; Middle Aged; Plasma; Prospective Studies; Rifampin; Young Adult | 2015 |
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.
Topics: Adult; Antitubercular Agents; Area Under Curve; CD4 Lymphocyte Count; Coinfection; Ethambutol; Female; Gene Expression; HIV Infections; Humans; Isoniazid; Liver-Specific Organic Anion Transporter 1; Male; Monte Carlo Method; Organic Anion Transporters; Polymorphism, Single Nucleotide; Pyrazinamide; Rifabutin; Rifampin; Sex Factors; Tuberculosis, Pulmonary | 2016 |
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
Topics: Anti-Bacterial Agents; Area Under Curve; Coinfection; Drug Dosage Calculations; Ethambutol; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2016 |
A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Contact Tracing; Drug Administration Schedule; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Predictive Value of Tests; Prospective Studies; Republic of Korea; Rifampin; Tertiary Care Centers; Time Factors; Treatment Outcome; Tuberculin Test; Tuberculosis, Pulmonary; Young Adult | 2016 |
Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
Topics: Antitubercular Agents; Decision Support Techniques; Ethambutol; Humans; Isoniazid; Markov Chains; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2016 |
Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Disability Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Pilot Projects; Proportional Hazards Models; Pyrazinamide; Rifampin; Seizures; Time Factors; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2016 |
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Case-Control Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Moxifloxacin; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2016 |
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
Topics: Adolescent; Adult; Americas; Antitubercular Agents; Asia; Child; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Isoniazid; Male; Prospective Studies; Rifampin; Treatment Outcome; Tuberculosis; Young Adult | 2016 |
Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.
Topics: Adult; Africa; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects.
Topics: Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Ethambutol; Female; Healthy Volunteers; Humans; Isoniazid; Male; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin | 2016 |
Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus.
Topics: Adult; Antitubercular Agents; Diabetes Mellitus; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 2017 |
Evaluation of Proinflammatory Cytokines and Adverse Events in Healthy Volunteers upon Inhalation of Antituberculosis Drugs.
Topics: Administration, Inhalation; Adult; Antitubercular Agents; Cross-Over Studies; Double-Blind Method; Dry Powder Inhalers; Female; Healthy Volunteers; Humans; Interleukin-1beta; Isoniazid; Levofloxacin; Liposomes; Male; Peak Expiratory Flow Rate; Pyrazinamide; Rifampin; Sputum; Tumor Necrosis Factor-alpha; Young Adult | 2016 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Ethylenediamines; Female; Fluoroquinolones; Humans; Isoniazid; Male; Moxifloxacin; Pyrazinamide; Rifampin; South Africa; Tanzania; Tuberculosis, Pulmonary | 2017 |
HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glycated Hemoglobin; HIV; Humans; Isoniazid; Male; Middle Aged; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2017 |
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han.
Topics: Adult; Antitubercular Agents; Asian People; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Genetic Predisposition to Disease; Glucuronosyltransferase; Humans; Isoniazid; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrazinamide; Rifampin; Risk; Tuberculosis, Pulmonary; Young Adult | 2017 |
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.
Topics: Adult; Aged; Antitubercular Agents; Biomarkers; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Reminder Systems; Rifampin; Self Administration; Text Messaging | 2017 |
SIRCLE: a randomised controlled cost comparison of self-administered short-course isoniazid and rifapentine for cost-effective latent tuberculosis eradication.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Australia; Cost-Benefit Analysis; Disease Eradication; Drug Administration Schedule; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; New Zealand; Prospective Studies; Rifampin; Self Administration; Young Adult | 2017 |
A Randomized, Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Tolerability of Risorine with Conventional Rifampicin in the Treatment of Newly Diagnosed Pulmonary Tuberculosis Patients.
Topics: Adult; Alkaloids; Antibiotics, Antitubercular; Benzodioxoles; Drug Combinations; Female; Humans; Isoniazid; Male; Piperidines; Polyunsaturated Alkamides; Rifampin; Sputum; Tuberculosis, Pulmonary | 2017 |
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.
Topics: Adolescent; Adult; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Isoniazid; Latent Tuberculosis; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rifampin; Young Adult | 2018 |
Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Cytokines; Drug Administration Schedule; Drug Interactions; Female; Healthy Volunteers; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Rifampin; Young Adult | 2018 |
The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial.
Topics: Adult; Antitubercular Agents; British Columbia; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Quality of Life; Rifampin; Text Messaging; Treatment Adherence and Compliance | 2018 |
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; CD4 Lymphocyte Count; Directly Observed Therapy; Drug Administration Schedule; Ethambutol; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Male; Middle Aged; Patient Dropouts; Proportional Hazards Models; Rifampin; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viral Load | 2018 |
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Male; Prospective Studies; Rifampin; Risk Factors; Sputum; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary; Uganda | 2018 |
Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Taiwan; Time Factors; Treatment Outcome; Young Adult | 2018 |
Safety and Side Effects of Rifampin versus Isoniazid in Children.
Topics: Adolescent; Antibiotics, Antitubercular; Child; Child, Preschool; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Intention to Treat Analysis; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Patient Safety; Rifampin; Treatment Outcome | 2018 |
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Rifampin | 2018 |
Bacterial Factors That Predict Relapse after Tuberculosis Therapy.
Topics: Adult; Antitubercular Agents; Area Under Curve; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Recurrence; Rifampin; ROC Curve; Treatment Failure; Tuberculosis | 2018 |
Clinical effect of lamivudine in treating liver function lesion caused by hepatitis B combined with Anti-TB drugs.
Topics: Adult; Aged; Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Humans; Isoniazid; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Rifampin; Treatment Outcome; Tuberculosis; Withholding Treatment; Young Adult | 2018 |
Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazid.
Topics: Adolescent; Adult; Africa, Western; Aged; Aged, 80 and over; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Benzoxazines; Blood Chemical Analysis; Cyclopropanes; Drug Interactions; Female; HIV Infections; Humans; Inactivation, Metabolic; Isoniazid; Male; Middle Aged; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis; Young Adult | 2019 |
Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study.
Topics: Aged; Antibiotics, Antitubercular; China; Communicable Disease Control; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Mycobacterium tuberculosis; Proportional Hazards Models; Rifampin; Risk Factors; Rural Population; Treatment Outcome | 2018 |
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Linezolid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
Topics: Adolescent; Adult; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Levofloxacin; Male; Middle Aged; Peru; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India.
Topics: Adolescent; Age Factors; Antitubercular Agents; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; India; Infant; Isoniazid; Male; Metabolic Clearance Rate; Models, Biological; Rifampin; Tuberculosis | 2019 |
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
Topics: Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Nitroimidazoles; Oxazoles; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2019 |
Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial.
Topics: Adult; Antibiotics, Antitubercular; Contact Tracing; Cost-Benefit Analysis; Ethambutol; Family Characteristics; Female; Global Burden of Disease; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Vietnam | 2019 |
Efficacy and safety of cholecalciferol-augmented anti-tuberculosis therapy for treatment of naïve patients with pulmonary tuberculosis: A randomized, controlled, clinical study.
Topics: Adult; Antitubercular Agents; Cholecalciferol; Drug Therapy, Combination; Egypt; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary; Vitamins; Young Adult | 2019 |
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Topics: Adult; Antibiotics, Antitubercular; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; India; Isoniazid; Metformin; Multicenter Studies as Topic; Mycobacterium tuberculosis; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis, Pulmonary | 2019 |
Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ill-Housed Persons; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; United States | 2019 |
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Rifampin; Tuberculosis | 2019 |
Safety of pyrazinamide-including regimen in late elderly patients with pulmonary tuberculosis: A prospective randomized open-label study.
Topics: Age Factors; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2019 |
Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; India; Isoniazid; Microscopy, Fluorescence; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2019 |
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; Linear Models; Male; Multivariate Analysis; Prospective Studies; Pyrazinamide; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Pulmonary; United Kingdom | 2019 |
Clinical predictors of drug-resistant tuberculosis in Mexico.
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Male; Mexico; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2019 |
Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; California; Directly Observed Therapy; Drug Administration Schedule; Drug Monitoring; Female; Humans; Isoniazid; Male; Medication Adherence; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Self Administration; Treatment Outcome; Tuberculosis; Wireless Technology; Young Adult | 2019 |
Transmissibility and potential for disease progression of drug resistant
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Disease Progression; Female; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Isoniazid; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Peru; Prospective Studies; Rifampin; Sputum; Tuberculin Test; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Preventive tuberculosis treatment effect on QuantiFERON TB-Gold in-tube testing in a high tuberculosis-endemic country: A clinical trial.
Topics: Antigens, Bacterial; Antitubercular Agents; China; Diagnostic Tests, Routine; Endemic Diseases; Female; Follow-Up Studies; Humans; Interferon-gamma; Interferon-gamma Release Tests; Isoniazid; Male; Middle Aged; Prospective Studies; Rifampin; Tuberculin Test; Tuberculosis | 2020 |
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Linezolid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; South Africa; Sputum; Tuberculosis, Pulmonary | 2020 |
Dynamic changes of interferon gamma release assay results with latent tuberculosis infection treatment.
Topics: Antitubercular Agents; Biomarkers; China; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Interferon-gamma; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Rifampin; Treatment Outcome | 2020 |
Telacebec (Q203), a New Antituberculosis Agent.
Topics: Administration, Oral; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Imidazoles; Isoniazid; Mycobacterium tuberculosis; Piperidines; Pyrazinamide; Pyridines; Rifampin; Tuberculosis, Pulmonary | 2020 |
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.
Topics: Adult; Drug Administration Schedule; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Rifampin; South Africa; Treatment Outcome; Tuberculosis; Viral Load | 2020 |
Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Directly Observed Therapy; Electrical Equipment and Supplies; Equivalence Trials as Topic; Ethambutol; Ethiopia; Female; Follow-Up Studies; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Mycobacterium tuberculosis; Patient Acceptance of Health Care; Prospective Studies; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Self Administration; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2020 |
Twice-Daily Doravirine Overcomes the Interaction Effect from Once-Weekly Rifapentine and Isoniazid in Healthy Volunteers.
Topics: Adolescent; Adult; Antitubercular Agents; Area Under Curve; Drug Administration Schedule; Drug Interactions; Female; Healthy Volunteers; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyridones; Reverse Transcriptase Inhibitors; Rifampin; Triazoles; Tuberculosis; Young Adult | 2020 |
Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings.
Topics: Adult; Antitubercular Agents; Child; Costs and Cost Analysis; Developed Countries; Developing Countries; Drug Administration Schedule; Female; Health Care Costs; Humans; Isoniazid; Latent Tuberculosis; Male; Rifampin | 2020 |
Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial.
Topics: Antitubercular Agents; Area Under Curve; China; Drug Administration Schedule; Half-Life; Humans; Isoniazid; Male; Medication Adherence; Middle Aged; Rifampin; Silicosis; Tuberculosis, Pulmonary | 2021 |
Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Arylamine N-Acetyltransferase; Benzoxazines; Cyclopropanes; Drug Synergism; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nevirapine; Pharmacogenetics; Rifampin; Young Adult | 2021 |
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antitubercular Agents; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nevirapine; Rifampin; Young Adult | 2021 |
An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; London; Male; Middle Aged; Pilot Projects; Rifampin; Self Administration; Treatment Outcome; Young Adult | 2021 |
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.
Topics: Adult; Antitubercular Agents; Biomarkers; Drug Administration Schedule; Female; HIV Seronegativity; Humans; Incidence; Isoniazid; Male; Mycobacterium tuberculosis; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Bacterial; South Africa; Treatment Outcome; Tuberculosis; Young Adult | 2021 |
Optimising pyrazinamide for the treatment of tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2021 |
Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017-2018.
Topics: Antitubercular Agents; Cohort Studies; Humans; Isoniazid; Prospective Studies; Rifampin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uzbekistan | 2021 |
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Moxifloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2020 |
Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial.
Topics: Dry Powder Inhalers; Humans; Isoniazid; Levofloxacin; Powders; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2021 |
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
Topics: Adult; Antitubercular Agents; Child; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Male; Pregnancy; Pregnant Women; Rifampin; Tuberculosis | 2022 |
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Drug Interactions; Female; HIV Infections; Humans; Isoniazid; Medroxyprogesterone Acetate; Pharmacogenetics; Rifampin; Tuberculosis | 2022 |
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.
Topics: Adolescent; Adult; Anti-HIV Agents; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Male; Mozambique; Rifampin; South Africa; Tuberculosis, Pulmonary; Young Adult | 2021 |
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis; Uganda | 2021 |
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
Topics: Adolescent; Africa; Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; India; Infant; Intention to Treat Analysis; Isoniazid; Male; Patient Acuity; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2022 |
Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP).
Topics: Adult; Antitubercular Agents; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Randomized Controlled Trials as Topic; Recurrence; Rifampin; Tuberculosis | 2022 |
Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial.
Topics: Adult; Antitubercular Agents; Cohort Studies; Diabetes Mellitus, Type 2; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Randomized Controlled Trials as Topic; Rifampin; Tanzania | 2022 |
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Multicenter Studies as Topic; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2022 |
Pregnancy in Women With HIV in a Tuberculosis Preventive Therapy Trial.
Topics: Antitubercular Agents; Contraceptive Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Isoniazid; Latent Tuberculosis; Pregnancy; Rifampin; Rifamycins; Tuberculosis | 2022 |
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Topics: Antitubercular Agents; Drug Therapy, Combination; HIV; HIV Infections; Humans; Isoniazid; Moxifloxacin; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 2023 |
Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Kidney Failure, Chronic; Latent Tuberculosis; Prospective Studies; Randomized Controlled Trials as Topic; Rifampin | 2022 |
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Isoniazid; Mice; Nitroimidazoles; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2023 |
Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Humans; Isoniazid; Latent Tuberculosis; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; State Medicine; United Kingdom; Young Adult | 2022 |
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Topics: Antitubercular Agents; Diarylquinolines; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Linezolid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2023 |
Factors Associated With Discontinuation of Tuberculosis Preventive Treatment: Post Hoc Analysis of 2 Randomized, Controlled Trials.
Topics: Antitubercular Agents; Clinical Protocols; Drug Administration Schedule; Humans; Isoniazid; Rifampin; Tuberculosis | 2023 |
Optimizing (O) rifapentine-based (RI) regimen and shortening (EN) the treatment of drug-susceptible tuberculosis (T) (ORIENT) using an adaptive seamless design: study protocol of a multicenter randomized controlled trial.
Topics: Clinical Trials, Phase II as Topic; Humans; Isoniazid; Moxifloxacin; Multicenter Studies as Topic; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis | 2023 |
Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial.
Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Infant; Isoniazid; Lamivudine; Rifampin; RNA; South Africa; Tenofovir; Tuberculosis; Viral Load | 2023 |
4276 other study(ies) available for isoniazid and rifampin
| Article | Year |
|---|---|
Synthesis and antibacterial activity of 2,2'-dithiobis(benzamide) derivatives against Mycobacterium species.
Topics: Animals; Benzamides; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Mice; Mycobacterium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Structure-Activity Relationship; Sulfides | 1985 |
Norditerpenoids and diterpenoids from Salvia multicaulis with antituberculous activity.
Topics: Antitubercular Agents; Chromatography, Liquid; Diterpenes; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plants, Medicinal; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Turkey | 1997 |
New pyrrole derivatives as antimycobacterial agents analogs of BM212.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium; Piperazines; Pyrroles | 1999 |
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9.
Topics: Antitubercular Agents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Organometallic Compounds; Structure-Activity Relationship | 2000 |
Antimycobacterial activity of ionic fullerene derivatives.
Topics: Anti-Bacterial Agents; Carbon; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Pyrrolidines; Solubility; Structure-Activity Relationship | 2000 |
A new class of antituberculosis agents.
Topics: Amides; Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfones | 2000 |
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10.
Topics: Animals; Antitubercular Agents; Cell Division; Chlorocebus aethiops; Cobalt; Combinatorial Chemistry Techniques; Drug Stability; Ligands; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Organometallic Compounds; Structure-Activity Relationship; Vero Cells | 2001 |
Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Chlorocebus aethiops; Crystallography, X-Ray; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization; Spiro Compounds; Steroids; Structure-Activity Relationship; Vero Cells | 2002 |
Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azepines; Enzyme Inhibitors; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium; Structure-Activity Relationship; Transferases | 2003 |
Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds.
Topics: Acylation; Aminoglycosides; Anti-Bacterial Agents; Enzyme Inhibitors; Inhibitory Concentration 50; Isomerism; Microbial Sensitivity Tests; Mycobacterium; Prodrugs; Structure-Activity Relationship; Transferases | 2003 |
Novel pyridazino[4,3-b]indoles with dual inhibitory activity against Mycobacterium tuberculosis and monoamine oxidase.
Topics: Animals; Antitubercular Agents; Indoles; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Mycobacterium tuberculosis; Pyridazines; Rats | 2004 |
Antituberculous activity of some aryl semicarbazone derivatives.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Semicarbazones; Structure-Activity Relationship | 2004 |
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones.
Topics: Animals; Anti-Bacterial Agents; Cobalt; Copper; Drug Evaluation, Preclinical; Fluorine; Hydrazones; Isoniazid; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2004 |
Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.
Topics: Antitubercular Agents; Isonicotinic Acids; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2005 |
Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
Topics: Amines; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2005 |
Synthesis and antitubercular activity of 2-hydroxy-aminoalkyl derivatives of diaryloxy methano phenanthrenes.
Topics: Antitubercular Agents; Methane; Mycobacterium tuberculosis; Phenanthrenes; Structure-Activity Relationship | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oleanolic Acid; Plants, Medicinal; Triterpenes; Vero Cells | 2006 |
Discovery of new antitubercular oxazolyl thiosemicarbazones.
Topics: Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiosemicarbazones | 2006 |
Search of antitubercular activities in tetrahydroacridines: synthesis and biological evaluation.
Topics: Acridines; Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship | 2006 |
Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Microbial Sensitivity Tests; Models, Molecular; Morpholines; Mycobacterium tuberculosis; Piperazines; Pyrroles; Quantitative Structure-Activity Relationship; Vero Cells | 2006 |
Integerrimides A and B, cyclic heptapeptides from the latex of Jatropha integerrima.
Topics: Animals; Antineoplastic Agents, Phytogenic; Candida albicans; Chickens; Drug Screening Assays, Antitumor; Herpesvirus 1, Human; Humans; Jatropha; Latex; Molecular Structure; Neurites; Peptides, Cyclic; Plants, Medicinal; Plasmodium falciparum; Spinal Cord; Thailand | 2006 |
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Topics: Animals; Antitubercular Agents; Blood; Cell Line; Humans; In Vitro Techniques; Intracellular Membranes; Macrophages; Mammals; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium; Mycobacterium bovis; Mycolic Acids; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis | 2006 |
Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Diarylquinolines; Drug Synergism; Female; Lung; Mice; Organ Size; Pyrazinamide; Quinolines; Spleen; Survival Analysis; Tuberculosis, Pulmonary | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents.
Topics: Alkylation; Antitubercular Agents; Chemical Phenomena; Chemistry, Physical; Computer Simulation; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazoles; Pyrimidines; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship | 2007 |
N-Hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity.
Topics: Agar; Animals; Antitubercular Agents; Chemistry, Pharmaceutical; Chlorocebus aethiops; Drug Design; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Chemical; Molecular Conformation; Mycobacterium tuberculosis; Semicarbazides; Semicarbazones; Temperature; Vero Cells | 2007 |
Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Carbohydrate Conformation; Carbohydrate Sequence; Carbohydrates; Chemistry, Pharmaceutical; Drug Design; Molecular Sequence Data; Mycobacterium avium; Mycobacterium tuberculosis; Plant Extracts; Stachys; Staphylococcus aureus | 2007 |
Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Colony Count, Microbial; Culture Media; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Serial Passage | 2007 |
Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines.
Topics: Animals; Antitubercular Agents; Cells, Cultured; Chemical Phenomena; Chemistry, Physical; Chlorocebus aethiops; Humans; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship | 2007 |
Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Topics: Animals; Arabinofuranosyluracil; Cell Line; Cell Survival; Chlorocebus aethiops; Drug Resistance, Bacterial; Floxuridine; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Rifampin; Structure-Activity Relationship | 2007 |
Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens.
Topics: Alkyl and Aryl Transferases; Anti-Bacterial Agents; Benzophenones; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Mycobacterium; Naphthols; Staphylococcus aureus; Staphylococcus epidermidis | 2007 |
Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Benzothiadiazines; Indicators and Reagents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship | 2007 |
Design, synthesis and antitubercular activity of diarylmethylnaphthol derivatives.
Topics: Antitubercular Agents; Drug Design; Methylation; Molecular Structure; Mycobacterium tuberculosis; Naphthols; Structure-Activity Relationship | 2007 |
Preparation and antitubercular activities of alkylated amino alcohols and their glycosylated derivatives.
Topics: Alkylation; Amino Alcohols; Antitubercular Agents; Cell Proliferation; Cells, Cultured; Glycosylation; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2007 |
Pyrrolidine dithiocarbamate and diethyldithiocarbamate are active against growing and nongrowing persister Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Ditiocarb; Female; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Pyrrolidines; Rifampin; Thiocarbamates | 2007 |
Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives.
Topics: Antitubercular Agents; Hydrazines; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Spectrophotometry, Infrared | 2008 |
Synthesis and biological evaluation of N-(aryl)-2-thiophen-2-ylacetamides series as a new class of antitubercular agents.
Topics: Acetamides; Animals; Antitubercular Agents; Cell Line; Macrophages; Mice; Molecular Structure; Structure-Activity Relationship; Thiophenes | 2007 |
Thiophene containing triarylmethanes as antitubercular agents.
Topics: Alkylation; Antitubercular Agents; Drug Design; Methane; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thiophenes; Trityl Compounds | 2008 |
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Ethambutol; Georgia (Republic); Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Prevalence; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2008 |
Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo.
Topics: Animals; Antitubercular Agents; Biological Availability; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridones; Quinolones; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.
Topics: Antitubercular Agents; Bacterial Proteins; Codon; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Rifampin | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Piperazines; Pyrroles; Structure-Activity Relationship | 2008 |
Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives.
Topics: Antitubercular Agents; Azoles; Binding Sites; Computer Simulation; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Humans; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium; Phenyl Ethers; Protein Binding | 2009 |
Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Female; Guinea Pigs; Isoniazid; Lung; Metronidazole; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spleen; Tuberculosis, Pulmonary | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
A facile synthesis, antibacterial, and antitubercular studies of some piperidin-4-one and tetrahydropyridine derivatives.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Design; Drug Resistance, Microbial; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Chemical; Models, Molecular; Piperidines; Piperidones; Pyridines; Rifampin | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives.
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Guinea Pigs; Histamine H1 Antagonists; Humans; Microbial Sensitivity Tests; Piperidines | 2008 |
5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species.
Topics: Antitubercular Agents; Combinatorial Chemistry Techniques; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Structure-Activity Relationship; Thiosemicarbazones; Tuberculosis | 2009 |
Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents.
Topics: Antitubercular Agents; Dihydropyridines; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Structure-Activity Relationship | 2009 |
Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Vero Cells | 2009 |
Biomimetic transformation and biological activities of Globiferin, a terpenoid benzoquinone from Cordia globifera.
Topics: Antifungal Agents; Antimalarials; Antitubercular Agents; Benzoquinones; Biotransformation; Candida albicans; Cordia; Drug Resistance, Multiple; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Roots; Plants, Medicinal; Plasmodium falciparum; Terpenes; Thailand | 2009 |
Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides.
Topics: Antitubercular Agents; Cell Line; Drug Design; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2009 |
A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Indoles; Microwaves; Mycobacterium tuberculosis; Stereoisomerism; Structure-Activity Relationship | 2009 |
Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations.
Topics: Antitubercular Agents; Bacterial Proteins; Computer Simulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Protein Binding; Sterol 14-Demethylase; Thermodynamics; Tuberculosis | 2009 |
Synthesis, spectral and biological evaluation of some new thiazolidinones and thiazoles based on t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Fungi; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazoles; Thiazolidines | 2009 |
Macrophyllin-type bicyclo[3.2.1]octanoid neolignans from the leaves of Pleurothyrium cinereum.
Topics: Animals; Antitubercular Agents; Bridged Bicyclo Compounds, Heterocyclic; Colombia; Lauraceae; Lignans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Leaves; Plants, Medicinal; Platelet Activating Factor; Rabbits; Stereoisomerism | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Hydrazones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Vero Cells | 2009 |
Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents.
Topics: Alkanes; Animals; Antitubercular Agents; Cattle; Cell Line; Cell Survival; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Prenylation | 2009 |
New approach for drug susceptibility testing: monitoring the stress response of mycobacteria.
Topics: Electric Impedance; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Stress, Physiological | 2009 |
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
Topics: Antitubercular Agents; Carboxylic Acids; Esters; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship | 2009 |
L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Catalysis; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; Proline; Thiazines | 2009 |
Natural product leads for drug discovery: isolation, synthesis and biological evaluation of 6-cyano-5-methoxyindolo[2,3-a]carbazole based ligands as antibacterial agents.
Topics: Anti-Bacterial Agents; Bacillus anthracis; Biological Products; Carbazoles; Drug Discovery; Drug Evaluation, Preclinical; Ligands; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2009 |
Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.
Topics: Antimalarials; Antitubercular Agents; Benzothiazoles; Drug Design; Isoxazoles; Models, Molecular; Mycobacterium tuberculosis; Phenylacetates; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents | 2009 |
Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.
Topics: Alleles; Antitubercular Agents; Codon; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Ethambutol; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Operon; Pentosyltransferases; Plasmids; Rifampin | 2010 |
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Carbohydrates; Chemistry, Pharmaceutical; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfides | 2009 |
1,3-Dipolar cycloaddition of C-aryl-N-phenylnitrones to (R)-1-(1-phenylethyl)-3-[(E)-arylmethylidene]tetrahydro-4(1H)-pyridinones: synthesis and antimycobacterial evaluation of enantiomerically pure spiroisoxazolidines.
Topics: Anti-Bacterial Agents; Drug Discovery; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Nitrogen Oxides; Oxazoles; Pyridones; Stereoisomerism | 2010 |
A highly atom economic, chemo-, regio- and stereoselective synthesis and evaluation of spiro-pyrrolothiazoles as antitubercular agents.
Topics: Antitubercular Agents; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Molecular Conformation; Mycobacterium tuberculosis; Pyrroles; Spiro Compounds; Stereoisomerism; Thiazoles | 2010 |
Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Microbial Sensitivity Tests; Pyridines; Vero Cells | 2010 |
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Design; Drug Resistance, Bacterial; Esters; Isoxazoles; Mycobacterium tuberculosis; Structure-Activity Relationship; Vero Cells | 2010 |
Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China.
Topics: Antitubercular Agents; Bacterial Proteins; China; Cohort Studies; Culture Media; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs.
Topics: Antitubercular Agents; Carboxylic Acids; Esters; Humans; Isoxazoles; Mefloquine; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prodrugs | 2010 |
New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Crystallography, X-Ray; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Oxazoles; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 2010 |
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones.
Topics: Alkynes; Antimalarials; Antitubercular Agents; Chalcones; Mycobacterium tuberculosis; Plasmodium falciparum | 2010 |
Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents.
Topics: Anti-Bacterial Agents; Drug Design; Hydrazones; Mycobacterium; Quinolines | 2010 |
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Discovery; Ethambutol; Fluoroquinolones; Immunocompetence; Inhalation Exposure; Isoniazid; Linezolid; Mice; Mice, Inbred C57BL; Moxifloxacin; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Rifampin; Tuberculosis, Pulmonary | 2010 |
Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons.
Topics: Animals; Antitubercular Agents; Blood Proteins; Brain; Carbon Radioisotopes; Humans; Isoniazid; Papio; Positron-Emission Tomography; Pyrazinamide; Rifampin; Thorax; Tissue Distribution | 2010 |
A note to the biological activity of benzoxazine derivatives containing the thioxo group.
Topics: Anti-Bacterial Agents; Benzoxazines; Cell Proliferation; HeLa Cells; Humans; Microbial Sensitivity Tests; Mycobacterium | 2010 |
Anti-infective discorhabdins from a deep-water alaskan sponge of the genus Latrunculia.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Hepacivirus; Heterocyclic Compounds, 4 or More Rings; Mice; Microbial Sensitivity Tests; Molecular Structure; Oceans and Seas; Plasmodium berghei; Plasmodium falciparum; Porifera; Quinones; Spiro Compounds | 2010 |
3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Arabinonucleosides; Cell Line; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Monocytes; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Rifampin; Stereoisomerism; Structure-Activity Relationship | 2010 |
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Topics: Anti-Bacterial Agents; Erythromycin; Luminescent Proteins; Microbial Sensitivity Tests; Models, Genetic; Mycobacterium ulcerans; Reserpine; Tetracycline | 2010 |
In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.
Topics: Antitubercular Agents; DNA Gyrase; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolones; Thiazoles; Topoisomerase II Inhibitors; Tuberculosis | 2010 |
New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties.
Topics: Antitubercular Agents; Bacteria; Crystallography, X-Ray; Microbial Sensitivity Tests; Quinolines | 2010 |
A new class of potential anti-tuberculosis agents: Synthesis and preliminary evaluation of novel acrylic acid ethyl ester derivatives.
Topics: Acrylates; Antitubercular Agents; Benzothiazoles; Catalysis; Copper; Microbial Sensitivity Tests; Mycobacterium; Sulfides | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs.
Topics: Animals; Antitubercular Agents; Benzofurans; Chlorocebus aethiops; Drug Design; Drug Resistance, Multiple; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Vero Cells | 2010 |
5-Nitro-2-furoic acid hydrazones: design, synthesis and in vitro antimycobacterial evaluation against log and starved phase cultures.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Catalytic Domain; Chlorocebus aethiops; Computer Simulation; Drug Design; Enzyme Inhibitors; Furans; Hydrazines; Hydrazones; Isocitrate Lyase; Microbial Sensitivity Tests; Mycobacterium; Vero Cells | 2010 |
Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
Topics: Antitubercular Agents; Curcuma; Curcumin; Humans; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2010 |
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2010 |
Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models.
Topics: Alkynes; Animals; Antitubercular Agents; Cell Line, Tumor; Deoxycytidine; Deoxyribonucleosides; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Pyridines; Pyrimidines; Structure-Activity Relationship; Tuberculosis; Uracil | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Drug Resistance, Bacterial; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Purines; Vero Cells | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of novel spiro-pyrrolothiazolyloxindoles and their antitubercular evaluation.
Topics: Antitubercular Agents; Cyclization; Indoles; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Oxindoles; Spiro Compounds; Stereoisomerism | 2010 |
A facile 1,3-dipolar cycloaddition of azomethine ylides to 2-arylidene-1,3-indanediones: synthesis of dispiro-oxindolylpyrrolothiazoles and their antimycobacterial evaluation.
Topics: Antitubercular Agents; Azo Compounds; Crystallography, X-Ray; Indans; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Spiro Compounds; Stereoisomerism; Thiazoles; Thiosemicarbazones | 2010 |
Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Cell Line; HIV; HIV Infections; HIV Reverse Transcriptase; Isocitrate Lyase; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Thiosemicarbazones; Tuberculosis | 2011 |
Synthesis and in vitro antimycobacterial activity of 8-OCH(3) ciprofloxacin methylene and ethylene isatin derivatives.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Ciprofloxacin; Isatin; Microbial Sensitivity Tests; Mycobacterium; Oximes; Semicarbazones; Vero Cells | 2011 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents.
Topics: Animals; Antimalarials; Antitubercular Agents; Benzimidazoles; Cell Line, Tumor; Drug Resistance, Multiple; Hemin; Hemoglobins; Humans; Hydrazines; Hydrolysis; Mice; Plasmodium | 2011 |
Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents.
Topics: Animals; Antimalarials; Antitubercular Agents; Isatin; Lactones; Mycobacterium tuberculosis; Plasmodium falciparum; Structure-Activity Relationship | 2011 |
Dihydro-β-agarofuran sesquiterpenes isolated from Celastrus vulcanicola as potential anti-Mycobacterium tuberculosis multidrug-resistant agents.
Topics: Antitubercular Agents; Celastrus; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Furans; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Sesquiterpenes; Structure-Activity Relationship | 2011 |
New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agents.
Topics: Amides; Antitubercular Agents; Crystallography, X-Ray; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Piperazines; Pseudomonas; Quinolines; Stereoisomerism; Streptococcus; Structure-Activity Relationship; Triazoles | 2011 |
A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Thiones | 2011 |
Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa.
Topics: Acetylcholinesterase; Alkaloids; Animals; Antitubercular Agents; Butyrylcholinesterase; Cholinesterase Inhibitors; Electrophorus; Horses; Indole Alkaloids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Pentacyclic Triterpenes; Plant Extracts; Plant Leaves; Spiro Compounds; Structure-Activity Relationship; Voacanga; Xanthenes | 2011 |
Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles.
Topics: Animals; Antitubercular Agents; Benzimidazoles; Chlorocebus aethiops; Imidazoles; Indoles; Mycobacterium tuberculosis; Purines; Pyridines; Vero Cells | 2011 |
Antimycobacterial activity of novel 1,2,4-oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1,3-dipolar cycloadditions of nitrile oxides.
Topics: Antibiotics, Antitubercular; Benzopyrans; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Nitriles; Oxadiazoles; Oxides; Pyridines; Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Galactose; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrans; Structure-Activity Relationship | 2011 |
Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.
Topics: | 2011 |
Synthesis and antitubercular evaluation of novel dibenzo[b,d]furan and 9-methyl-9H-carbazole derived hexahydro-2H-pyrano[3,2-c]quinolines via Povarov reaction.
Topics: Antitubercular Agents; Carbazoles; Humans; Imines; Models, Molecular; Mycobacterium tuberculosis; Pyrans; Quinolines; Structure-Activity Relationship; Tuberculosis | 2011 |
Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
Topics: Amides; Antitubercular Agents; Drug Design; Drug Resistance, Bacterial; Indenes; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazoles | 2011 |
Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
Topics: Antitubercular Agents; Carcinoma, Hepatocellular; Cell Proliferation; Click Chemistry; Humans; Isoniazid; Liver Neoplasms; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Triazoles; Tumor Cells, Cultured | 2011 |
Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.
Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2011 |
Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Indenes; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrazoles; Stereoisomerism; Structure-Activity Relationship; Thioamides; Vero Cells | 2011 |
Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cells, Cultured; Drug Resistance, Microbial; Isoniazid; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Phenazines; Quinones; Rifampin; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; X-Ray Diffraction | 2011 |
A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation.
Topics: Antitubercular Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Pyrazolones; Water | 2011 |
Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
Topics: Animals; Antitubercular Agents; Humans; Mice; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; NIH 3T3 Cells; Quinolines; Structure-Activity Relationship; Thiadiazoles; Tuberculosis | 2011 |
Stereochemical analysis of leubethanol, an anti-TB-active serrulatane, from Leucophyllum frutescens.
Topics: Antitubercular Agents; Circular Dichroism; Diterpenes; Mexico; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Plant Bark; Plant Roots; Scrophulariaceae | 2011 |
Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Catalytic Domain; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Humans; Models, Molecular; Mycobacterium tuberculosis; Oxazolidinones; Protein Binding; Quinolines; Tuberculosis | 2011 |
Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin.
Topics: Antitubercular Agents; Escherichia coli; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazoles; Rifampin; Rifamycins; Tuberculosis | 2011 |
Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents.
Topics: Antitubercular Agents; Bacteria; Drug Design; Hydrazines; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Quinolines | 2011 |
Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Chemistry Techniques, Synthetic; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; Humans; Indoles; Mice; Microtubules; Models, Molecular; Protein Multimerization; Protein Structure, Quaternary; Pyrazoles; Tubulin; Tumor Suppressor Protein p53 | 2011 |
A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies.
Topics: Anti-Bacterial Agents; Azoles; Candida albicans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
One-pot syntheses of pseudopteroxazoles from pseudopterosins: a rapid route to non-natural congeners with improved antimicrobial activity.
Topics: Anti-Bacterial Agents; Diterpenes; Enterococcus faecium; Glycosides; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazoles; Staphylococcus aureus; Stereoisomerism; Vancomycin | 2011 |
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
Topics: Antifungal Agents; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Fungi; Indoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Topics: Antitubercular Agents; China; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oligopeptides; Streptomyces; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uridine | 2011 |
Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity.
Topics: Antitubercular Agents; Benzimidazoles; Cell Line; Heterocyclic Compounds; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Propionates | 2012 |
Camphorsulfonic acid catalysed facile tandem double Friedlander annulation protocol for the synthesis of phenoxy linked bisquinoline derivatives and discovery of antitubercular agents.
Topics: Animals; Antitubercular Agents; Camphor; Catalysis; Chemistry Techniques, Synthetic; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Phenols; Quinolines; Structure-Activity Relationship | 2012 |
Design, synthesis of some new (2-aminothiazol-4-yl)methylester derivatives as possible antimicrobial and antitubercular agents.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Crystallography, X-Ray; Fungi; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Mycoses; Thiazoles; Tuberculosis | 2012 |
Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
Topics: Acetates; Antitubercular Agents; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rhodanine; Thiadiazoles; Tuberculosis | 2012 |
Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives.
Topics: 2,2'-Dipyridyl; Anions; Antitubercular Agents; Calixarenes; Guanidine; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenols; Quaternary Ammonium Compounds; Tuberculosis | 2012 |
Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.
Topics: Antitubercular Agents; Isomerism; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazoles; Pyridines; Structure-Activity Relationship; Thiazoles | 2012 |
Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.
Topics: Alkaloids; Antitubercular Agents; Benzylisoquinolines; Drug Resistance, Multiple, Bacterial; Humans; Magnetic Resonance Spectroscopy; Menispermaceae; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Extracts; Plant Roots; Tuberculosis, Multidrug-Resistant | 2012 |
Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis.
Topics: Alkyl and Aryl Transferases; Anaerobiosis; Antitubercular Agents; Bacterial Proteins; Electron Transport; Enzyme Inhibitors; Escherichia coli; Hydroxylamines; Mycobacterium tuberculosis; Quinolones; Stereoisomerism; Vitamin K 2 | 2012 |
Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases.
Topics: Animals; Antibiotics, Antitubercular; Benzoxazines; DNA-Directed RNA Polymerases; Drug Design; Drug Resistance, Bacterial; Mice; Mycobacterium tuberculosis; Rifampin; Rifamycins | 2012 |
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
Topics: Alpinia; Antibiotics, Antitubercular; Antitubercular Agents; Diarylheptanoids; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Plant Extracts; Seeds | 2012 |
Synthesis, structure-activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives.
Topics: Anti-Bacterial Agents; Berberine; Chemistry Techniques, Synthetic; Drug Resistance, Bacterial; Mycobacterium tuberculosis; Structure-Activity Relationship | 2012 |
Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents.
Topics: Antifungal Agents; Antitubercular Agents; Bacteria; Benzothiazoles; Chemistry Techniques, Synthetic; Fungi; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A solvent free, four-component synthesis and 1,3-dipolar cycloaddition of 4(H)-pyrans with nitrile oxides: synthesis and discovery of antimycobacterial activity of enantiomerically pure 1,2,4-oxadiazoles.
Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Drug Discovery; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitriles; Oxadiazoles; Oxides; Piperidines; Pyrans; Stereoisomerism | 2012 |
Synthesis and antimycobacterial activity of novel 1,3-dimethylisocyanurate derivatives.
Topics: Amides; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rats; Structure-Activity Relationship; Sulfonic Acids; Triazines | 2012 |
New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
Topics: Antimalarials; Antitubercular Agents; Chemistry Techniques, Synthetic; Electrons; Fungi; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines | 2012 |
Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Topics: Antitubercular Agents; Cell Line, Tumor; Cell Survival; Drug Resistance, Bacterial; Humans; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Pentoxyl; Pyrimidine Nucleosides; Uracil | 2012 |
Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Female; Isomerism; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Nitroimidazoles; Oxides; Quinoxalines; Rats; Tirapazamine; Triazines; Tuberculosis; Vero Cells | 2012 |
Construction and functionalization of fused pyridine ring leading to novel compounds as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Ligands; Models, Molecular; Molecular Structure; Pyridines; Structure-Activity Relationship; Vero Cells | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Three new 12-carbamoylated streptothricins from Streptomyces sp. I08A 1776.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Dose-Response Relationship, Drug; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Stereoisomerism; Streptomyces; Streptothricins | 2012 |
1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Azoles; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Imidazoles; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Naphthoquinones; Oxazoles; Structure-Activity Relationship | 2012 |
The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Stereoisomerism; Uracil; Vero Cells | 2012 |
The design, synthesis, in silico ADME profiling, antiplasmodial and antimycobacterial evaluation of new arylamino quinoline derivatives.
Topics: Aminoquinolines; Antiprotozoal Agents; Antitubercular Agents; Biological Assay; Blood-Brain Barrier; Computer Simulation; Drug Design; Erythrocytes; Humans; Inhibitory Concentration 50; Mefloquine; Microbial Sensitivity Tests; Models, Biological; Mycobacterium tuberculosis; Plasmodium falciparum; Quinine; Structure-Activity Relationship; Tetrazoles | 2012 |
Microwave-assisted synthesis, molecular docking and antitubercular activity of 1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives.
Topics: Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Microwaves; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Nitriles; Oxidoreductases; Pyrimidines; Structure-Activity Relationship | 2012 |
Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Cell Proliferation; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles | 2012 |
A facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines acting as antimycobacterial agents.
Topics: Anti-Bacterial Agents; Cycloaddition Reaction; High-Throughput Screening Assays; Microbial Sensitivity Tests; Pyrrolidines | 2013 |
Synthesis and biological evaluation of a new class of 4-aminoquinoline-rhodanine hybrid as potent anti-infective agents.
Topics: Aminoquinolines; Animals; Anti-Infective Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Rhodanine; Structure-Activity Relationship; Vero Cells | 2013 |
Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents.
Topics: Animals; Anti-Infective Agents; Antioxidants; Antitubercular Agents; Artemia; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluorine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Ovum; Quinolines; Structure-Activity Relationship | 2013 |
Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Artemia; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Motor Activity; Quinolones; Structure-Activity Relationship; Tuberculosis | 2013 |
Synthesis of novel isothiazolopyridines and their in vitro evaluation against Mycobacterium and Propionibacterium acnes.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Crystallography, X-Ray; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium; Mycobacterium tuberculosis; Propionibacterium acnes; Pyridines; Structure-Activity Relationship; Thiazoles; Vero Cells | 2013 |
Synthesis and antimycobacterial activity of analogues of the bioactive natural products sampangine and cleistopholine.
Topics: Alkaloids; Anthraquinones; Anti-Bacterial Agents; Aza Compounds; Biological Products; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Naphthyridines; Structure-Activity Relationship | 2013 |
Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides.
Topics: Animals; Antitubercular Agents; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; Humans; Jurkat Cells; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Structure-Activity Relationship; Vero Cells | 2013 |
Advancement of Imidazo[1,2-
Topics: | 2013 |
Design and synthesis of positional isomers of 5 and 6-bromo-1-[(phenyl)sulfonyl]-2-[(4-nitrophenoxy)methyl]-1H-benzimidazoles as possible antimicrobial and antitubercular agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Benzimidazoles; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Klebsiella pneumoniae; Models, Molecular; Molecular Structure; Mycobacterium; Rhizopus; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Studies on substituted benzo[h]quinazolines, benzo[g]indazoles, pyrazoles, 2,6-diarylpyridines as anti-tubercular agents.
Topics: Antitubercular Agents; Cell Line; Humans; Indazoles; Mycobacterium tuberculosis; Pyrazoles; Pyridines; Quinazolines; Tuberculosis | 2013 |
Phomapyrrolidones A-C, antitubercular alkaloids from the endophytic fungus Phoma sp. NRRL 46751.
Topics: Actinidiaceae; Alkaloids; Animals; Antitubercular Agents; Ascomycota; Chlorocebus aethiops; Drug Screening Assays, Antitumor; Female; Humans; Male; Molecular Structure; Mycelium; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Succinimides; Vero Cells | 2013 |
Inhibitory effect of oxygenated cholestan-3β-ol derivatives on the growth of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cholestanols; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidation-Reduction; Stereoisomerism; Structure-Activity Relationship | 2013 |
Chlorinated coumarins from the polypore mushroom Fomitopsis officinalis and their activity against Mycobacterium tuberculosis.
Topics: Agaricales; Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Cytotoxins; Hydrocarbons, Chlorinated; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Vero Cells | 2013 |
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; DNA Gyrase; Dose-Response Relationship, Drug; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tuberculosis; Urea | 2013 |
Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Fatty Acids; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2013 |
Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis.
Topics: Bacterial Proteins; Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; Structure-Activity Relationship; Thiazoles | 2013 |
Antimycobacterial labdane diterpenes from Leucas stelligera.
Topics: Antitubercular Agents; Crystallography, X-Ray; Diterpenes; Drug Screening Assays, Antitumor; Flavones; Hep G2 Cells; Humans; India; Inhibitory Concentration 50; Lamiaceae; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular | 2013 |
Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Click Chemistry; Drug Design; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenanthridines; Piperazine; Piperazines; Structure-Activity Relationship; Triazoles | 2013 |
Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Heterocyclic Compounds; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship | 2013 |
Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Antimycobacterial activity of nitrogen heterocycles derivatives: bipyridine derivatives. Part III.
Topics: Antitubercular Agents; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Nitrogen; Pyridines | 2014 |
Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Benzofurans; Click Chemistry; HEK293 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2014 |
A novel indigoid anti-tuberculosis agent.
Topics: Antitubercular Agents; Crystallography, X-Ray; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2014 |
Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase.
Topics: Anti-Bacterial Agents; High-Throughput Screening Assays; Inorganic Pyrophosphatase; Mycobacterium tuberculosis; Staphylococcus aureus; Structure-Activity Relationship; Triazines | 2014 |
Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles; Tuberculosis; Vero Cells | 2014 |
Synthesis and characterization of new N-(4-(4-chloro-1H-imidazol-1-yl)-3-methoxyphenyl)amide/sulfonamide derivatives as possible antimicrobial and antitubercular agents.
Topics: Amides; Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Structure-Activity Relationship; Sulfonamides | 2014 |
Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
Topics: Acridines; Animals; Antitubercular Agents; Cell Line; Cyclization; Drug Design; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines | 2014 |
Microwave induced three-component synthesis and antimycobacterial activity of benzopyrazolo[3,4-b]quinolindiones.
Topics: Antitubercular Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Mycobacterium; Quinolones; Species Specificity; Spectrometry, Mass, Electrospray Ionization | 2014 |
Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues.
Topics: Animals; Antitubercular Agents; Cell Line; Crystallography, X-Ray; Macrophages; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenanthridines; Spectrometry, Mass, Electrospray Ionization | 2014 |
Sulfur rich 2-mercaptobenzothiazole and 1,2,3-triazole conjugates as novel antitubercular agents.
Topics: Antitubercular Agents; Benzothiazoles; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Spectrometry, Mass, Electrospray Ionization; Sulfur | 2014 |
Convenient one-pot synthesis, anti-mycobacterial and anticancer activities of novel benzoxepinoisoxazolones and pyrazolones.
Topics: Antineoplastic Agents; Antitubercular Agents; Benzoxepins; Crystallography, X-Ray; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyrazolones; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared | 2014 |
1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Proliferation; Comet Assay; DNA Damage; Drug Design; Drug Resistance, Multiple; Macrophages; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Phenanthridines; Structure-Activity Relationship; Tuberculosis | 2014 |
Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Hydrazones; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles | 2014 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Facile synthesis of benzonitrile/nicotinonitrile based s-triazines as new potential antimycobacterial agents.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nicotinic Acids; Nitriles; Structure-Activity Relationship; Triazines | 2014 |
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological Availability; Chronic Disease; DNA Gyrase; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Humans; Macrophages; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Piperidines; Protein Subunits; Rats; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tuberculosis, Pulmonary | 2014 |
Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Catalytic Domain; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pyrazoles; Pyridones; Structure-Activity Relationship | 2014 |
Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Isoniazid; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis, Pulmonary | 2014 |
Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
Topics: Animals; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Imidazoles; Macrophages; Mice; Microsomes, Liver; Mycobacterium tuberculosis; Pyridines; Rats, Sprague-Dawley; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2014 |
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
Topics: Alcohol Oxidoreductases; Amides; Animals; Antitubercular Agents; Bacterial Proteins; Catalytic Domain; Cell Line, Tumor; Drug Resistance, Bacterial; Genome, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Piperidines; Protein Binding; Quinolones; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship | 2014 |
Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
Topics: Antitubercular Agents; Bridged Bicyclo Compounds; Dose-Response Relationship, Drug; Heterocyclic Compounds; Hydrocarbons, Aromatic; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyridines; Pyrimidines; Structure-Activity Relationship | 2014 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues.
Topics: Antitubercular Agents; Bacterial Proteins; Molecular Structure; Mycobacterium tuberculosis; Oligopeptides; Peptide Synthases; Streptomyces; Substrate Specificity; Uridine | 2014 |
Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; High-Throughput Screening Assays; Humans; Mice; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Protein Kinases; Small Molecule Libraries; Structure-Activity Relationship; Thiazoles | 2014 |
Ultrasound-assisted one-pot four-component synthesis of novel 2-amino-3-cyanopyridine derivatives bearing 5-imidazopyrazole scaffold and their biological broadcast.
Topics: Antioxidants; Antitubercular Agents; Chemistry Techniques, Synthetic; Fungi; Mycobacterium tuberculosis; Pyrazoles; Pyridines; Structure-Activity Relationship; Ultrasonics | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
Topics: Acetates; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrroles; Structure-Activity Relationship | 2014 |
Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.
Topics: | 2014 |
Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Piperazines; Structure-Activity Relationship | 2014 |
Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents.
Topics: Adamantane; Antitubercular Agents; Chemistry Techniques, Synthetic; Hydrazines; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Quinolines; Semicarbazides | 2014 |
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.
Topics: Acetamides; Animals; Bacterial Proteins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; Quinazolines; Structure-Activity Relationship; Tuberculosis | 2014 |
Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Structure; Oximes; Structure-Activity Relationship | 2014 |
2-Phenylindole and Arylsulphonamide: Novel Scaffolds Bactericidal against Mycobacterium tuberculosis.
Topics: | 2014 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.
Topics: Animals; Antitubercular Agents; Cell Proliferation; Cells, Cultured; Crystallography, X-Ray; Drug Design; Isoxazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Piperazines; Structure-Activity Relationship; Tuberculosis | 2014 |
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Benzoxazoles; Cell Line; Humans; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Structure-Activity Relationship; Tuberculosis | 2014 |
Tetrahydroxanthene-1,3(2H)-dione derivatives from Uvaria valderramensis.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Leukemia, Myeloid; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Philippines; Plant Leaves; Stereoisomerism; Uvaria; Xanthones | 2014 |
Design, synthesis and molecular docking of substituted 3-hydrazinyl-3-oxo-propanamides as anti-tubercular agents.
Topics: Amides; Antitubercular Agents; Binding Sites; Drug Design; Humans; Hydrazines; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Protein Structure, Secondary; Protein Structure, Tertiary | 2014 |
An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition.
Topics: Animals; Antitubercular Agents; Benzofurans; Benzothiazoles; Cell Line; DNA Gyrase; Dose-Response Relationship, Drug; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Piperazines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2014 |
Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Biological Products; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Quinolines; Structure-Activity Relationship | 2015 |
Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
Topics: Animals; Antitubercular Agents; Benzimidazoles; Cell Line; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium bovis; Mycobacterium tuberculosis; Structure-Activity Relationship; Swine | 2015 |
Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
Topics: Antitubercular Agents; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Imidazoles; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship | 2015 |
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Phenazines; Pyrrolidines; Quinolizidines; Structure-Activity Relationship; Tuberculosis; Vero Cells | 2014 |
Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors.
Topics: Alanine Dehydrogenase; Animals; Cell Line; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Macrophages; Mice; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2015 |
Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Topics: Amides; Animals; Antitubercular Agents; Cell Line; Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrolases; Macrophages; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Phenanthridines; Piperazines; Structure-Activity Relationship | 2015 |
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Proton-Translocating ATPases; Quinolines; Rats, Sprague-Dawley; Sulfonamides; Tuberculosis | 2015 |
Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043.
Topics: | 2015 |
Eremophilane Sesquiterpenes and Diphenyl Thioethers from the Soil Fungus Penicillium copticola PSU-RSPG138.
Topics: Animals; Antimalarials; Antineoplastic Agents; Biphenyl Compounds; Chlorocebus aethiops; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Molecular Structure; Penicillium; Plasmodium falciparum; Sesquiterpenes; Soil Microbiology; Sulfides; Thailand; Vero Cells | 2015 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents.
Topics: Antitubercular Agents; Chemistry Techniques, Synthetic; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Quinolines | 2015 |
Synthesis, in vitro anticancer and antimycobacterial evaluation of new 5-(2,5-dimethoxyphenyl)-1,3,4-thiadiazole-2-amino derivatives.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HEK293 Cells; HT29 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium smegmatis; Structure-Activity Relationship | 2015 |
Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain.
Topics: Antitubercular Agents; DNA Gyrase; Drug Discovery; Humans; Mycobacterium smegmatis; Mycobacterium tuberculosis | 2015 |
Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase.
Topics: Acetolactate Synthase; Antitubercular Agents; Benzoates; Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Quinazolinones; Structure-Activity Relationship | 2015 |
Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure-activity relationship.
Topics: Animals; Antitubercular Agents; Benzimidazoles; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Mice; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2015 |
Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors.
Topics: Animals; Anti-Bacterial Agents; DNA Gyrase; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; Piperidines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors; Zebrafish | 2015 |
Synthesis and antimycobacterial properties of ring-substituted 6-hydroxynaphthalene-2-carboxanilides.
Topics: Anilides; Anti-Bacterial Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Naphthols; Structure-Activity Relationship | 2015 |
Thiophene containing trisubstituted methanes [TRSMs] as identified lead against Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Methane; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rats; Thiophenes; Vero Cells | 2015 |
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
Topics: Antitubercular Agents; Binding Sites; Combinatorial Chemistry Techniques; Distamycins; DNA Footprinting; DNA, Bacterial; Ligands; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Nylons; Small Molecule Libraries; Structure-Activity Relationship; Thiophenes | 2015 |
Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
Topics: Animals; Antimalarials; Antitubercular Agents; Cell Line, Tumor; Humans; Indoles; Inhibitory Concentration 50; Plasmodium falciparum; Pyrimidines; Quantitative Structure-Activity Relationship; Sulfonamides | 2015 |
Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Click Chemistry; Halogenation; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Pyrazoles; Structure-Activity Relationship; Triazoles | 2015 |
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Drug Discovery; Drug Repositioning; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2015 |
Left-Hand Side Exploration of Novel Bacterial Topoisomerase Inhibitors to Improve Selectivity against hERG Binding.
Topics: | 2015 |
Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents.
Topics: | 2015 |
Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity.
Topics: Animals; Antitubercular Agents; Callyspongia; Drug Screening Assays, Antitumor; Humans; Marine Biology; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic | 2015 |
The effect of complexation of 3-formylrifamycin SV macrocyclic ether derivatives with metal cations and small nitrogen-containing organic molecules on antibacterial activity against S. aureus and S. epidermidis.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Ethers; Lithium; Macrocyclic Compounds; Microbial Sensitivity Tests; Molecular Conformation; Nitrogen; Organometallic Compounds; Rifamycins; Sodium; Staphylococcus aureus; Staphylococcus epidermidis; Structure-Activity Relationship | 2015 |
Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Spiro Compounds; Structure-Activity Relationship; Thiazoles | 2015 |
Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nalidixic Acid; Proteus vulgaris; Structure-Activity Relationship | 2015 |
Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
Topics: Antitubercular Agents; Bile Acids and Salts; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2015 |
4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.
Topics: Aminoquinolines; Antitubercular Agents; DNA Gyrase; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2015 |
Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrrolidines; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2015 |
Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB.
Topics: Antitubercular Agents; Dioxanes; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; HEK293 Cells; Humans; Mycobacterium tuberculosis; Oxazoles; Structure-Activity Relationship | 2015 |
Synthesis, antimycobacterial and antibacterial activity of l-[(1R,2S)-2-fluorocyclopropyl]naphthyridone derivatives containing an oxime-functionalized pyrrolidine moiety.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Levofloxacin; Moxifloxacin; Naphthyridines; Oximes; Pyrrolidines; Stereoisomerism | 2015 |
Hybrid triazoles: Design and synthesis as potential dual inhibitor of growth and efflux inhibition in tuberculosis.
Topics: Antitubercular Agents; Cells, Cultured; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Triazoles | 2016 |
Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Chlorocebus aethiops; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrazoles; Pyrimidines; Triazoles; Tuberculosis; Vero Cells | 2015 |
Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent.
Topics: Alcohol Oxidoreductases; Antineoplastic Agents; Antitubercular Agents; Bacterial Proteins; Cell Line, Tumor; Click Chemistry; Free Radical Scavengers; Humans; Hydrogen Bonding; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Thiazines; Triazoles | 2016 |
Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Isoniazid; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Structure, Tertiary; Pyrimidines; Schiff Bases; Structure-Activity Relationship | 2016 |
Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors.
Topics: Acridines; Animals; Antitubercular Agents; Bacterial Proteins; Cell Line; Cell Survival; Chlorobenzoates; DNA Gyrase; Dose-Response Relationship, Drug; Embryo, Nonmammalian; Ether-A-Go-Go Potassium Channels; Gene Expression; Heart Rate; Macrophages; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Piperidines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors; Zebrafish; Zebrafish Proteins | 2016 |
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Peptide Synthases; Structure-Activity Relationship; Thiazoles; Zebrafish | 2016 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship; Tuberculosis | 2016 |
Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Combinatorial Chemistry Techniques; Green Chemistry Technology; Humans; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidines; Tuberculosis | 2016 |
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacteria; Cell Line; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Fungi; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Microsomes; Mutagens; Mycobacterium tuberculosis; Oxazoles; Primary Cell Culture; Rifampin; Structure-Activity Relationship; Thiadiazoles | 2016 |
Novel nicotine analogues with potential anti-mycobacterial activity.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Nicotine; Rats; Rats, Wistar; Structure-Activity Relationship | 2016 |
2-(Quinolin-4-yloxy)acetamides Are Active against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains.
Topics: | 2016 |
Investigation of 4-amino-5-alkynylpyrimidine-2(1H)-ones as anti-mycobacterial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrimidinones; Structure-Activity Relationship; Tuberculosis | 2016 |
Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis.
Topics: Antitubercular Agents; Molecular Docking Simulation; Pyrazines; Thiazolidines | 2016 |
Synthesis, antimycobacterial and antibacterial activity of 1-(6-amino-3,5-difluoropyridin-2-yl)fluoroquinolone derivatives containing an oxime functional moiety.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Fluoroquinolones; Oximes | 2016 |
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant | 2016 |
Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies.
Topics: Animals; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Piperazine; Piperazines; Quantitative Structure-Activity Relationship; RAW 264.7 Cells | 2016 |
Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
Topics: Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship | 2016 |
Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes.
Topics: A549 Cells; Anti-Bacterial Agents; Antitubercular Agents; Cells; Coordination Complexes; Copper; Humans; Hydrazones; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship | 2016 |
Lovastatin Analogues from the Soil-Derived Fungus Aspergillus sclerotiorum PSU-RSPG178.
Topics: Animals; Aspergillus; Chlorocebus aethiops; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inhibitory Concentration 50; KB Cells; Lovastatin; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium scrofulaceum; Nuclear Magnetic Resonance, Biomolecular; Plasmodium falciparum; Soil Microbiology; Thailand; Vero Cells | 2016 |
Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Disease Models, Animal; Drug Design; Female; Humans; Indoles; Membrane Transport Proteins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Molecular Targeted Therapy; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2016 |
Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors.
Topics: Adenosine Triphosphatases; Antitubercular Agents; DNA Gyrase; Drug Discovery; Engineering; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Protein Conformation | 2016 |
Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cysteine Synthase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synthesis and antibacterial evaluation of macrocyclic diarylheptanoid derivatives.
Topics: Amines; Anti-Bacterial Agents; Antitubercular Agents; Gram-Positive Bacteria; Heptanes; Macrocyclic Compounds; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfonamides; Urea | 2016 |
Dehydrozingerone Inspired Styryl Hydrazine Thiazole Hybrids as Promising Class of Antimycobacterial Agents.
Topics: | 2016 |
A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Click Chemistry; Coumarins; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles | 2016 |
Design and development of new class of Mycobacterium tuberculosisl-alanine dehydrogenase inhibitors.
Topics: Alanine Dehydrogenase; Antitubercular Agents; Carbon-13 Magnetic Resonance Spectroscopy; Crystallography, X-Ray; Drug Design; Molecular Structure; Mycobacterium tuberculosis; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2016 |
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Design; Humans; Mycobacterium tuberculosis; Oxadiazoles | 2016 |
Amphiphilic xanthones as a potent chemical entity of anti-mycobacterial agents with membrane-targeting properties.
Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Biological Availability; Cell Membrane; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Hydrophobic and Hydrophilic Interactions; Kinetics; Mycobacterium tuberculosis; Rats; Xanthones | 2016 |
Synthesis and Antitubercular Activity of New Benzo[b]thiophenes.
Topics: | 2016 |
Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity.
Topics: Animals; Antitubercular Agents; Cell Death; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridines | 2017 |
Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cell Line; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium Infections; Nucleosides; Pyrimidines; Structure-Activity Relationship | 2016 |
Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis.
Topics: Alanine Dehydrogenase; Antitubercular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Structure-Activity Relationship; Thiophenes | 2016 |
Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Resistance, Bacterial; Drug Resistance, Multiple; Hep G2 Cells; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Structure-Activity Relationship; Thiadiazines; Triazoles; Vero Cells | 2017 |
Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Discovery of new chemical entities as potential leads against Mycobacterium tuberculosis.
Topics: Administration, Oral; Animals; Antitubercular Agents; Biological Availability; Chlorocebus aethiops; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Mice; Molecular Structure; Mycobacterium tuberculosis; Rats; Structure-Activity Relationship; Tuberculosis; Vero Cells | 2016 |
Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
Topics: Antitubercular Agents; Catechols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2017 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Drug Resistance, Bacterial; Drug Synergism; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; RAW 264.7 Cells; Structure-Activity Relationship | 2017 |
Synthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis.
Topics: Antitubercular Agents; Cell Line; Chemistry Techniques, Synthetic; Drug Design; Drug Resistance, Multiple; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Thioridazine | 2017 |
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines | 2017 |
Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.
Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Ethers; Humans; Mice; Mice, Inbred BALB C; Models, Molecular; Mycobacterium tuberculosis; Pyridines; Quinine; Tuberculosis | 2017 |
Anti-tuberculosis activity and structure-activity relationships of oxygenated tricyclic carbazole alkaloids and synthetic derivatives.
Topics: Alkaloids; Animals; Antitubercular Agents; Carbazoles; Cell Survival; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Vero Cells | 2017 |
Flavonoids from Erythrina schliebenii.
Topics: Antitubercular Agents; Drug Screening Assays, Antitumor; Erythrina; Flavonoids; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Plant Bark; Plant Roots; Tanzania | 2017 |
Synthesis, antimycobacterial and cytotoxic activity of α,β-unsaturated amides and 2,4-disubstituted oxazoline derivatives.
Topics: Amides; Animals; Antitubercular Agents; Liver; Microbial Sensitivity Tests; Microscopy; Mycobacterium tuberculosis; Oxazoles; Rats; Structure-Activity Relationship | 2017 |
A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Indazoles; Isoniazid; Mycobacterium tuberculosis; Rifampin; Structure-Activity Relationship | 2017 |
Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Species Specificity; Structure-Activity Relationship; Tetrazoles | 2017 |
Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors.
Topics: Antitubercular Agents; Bacterial Proteins; Benzothiazoles; Binding Sites; Catalytic Domain; Drug Design; Enzyme Inhibitors; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship; Transaminases | 2017 |
Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections.
Topics: Anti-Bacterial Agents; Biological Transport; Cell Line; Cord Factors; Humans; Indoles; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Mycolic Acids | 2017 |
Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship | 2017 |
QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
Topics: Animals; Antitubercular Agents; Chalcone; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Drug Discovery; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant; Vero Cells | 2017 |
Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.
Topics: | 2017 |
Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium bovis; Mycobacterium tuberculosis; Quinolones; Structure-Activity Relationship | 2017 |
The antitrypanosomal and antitubercular activity of some nitro(triazole/imidazole)-based aromatic amines.
Topics: Amines; Antitubercular Agents; Dose-Response Relationship, Drug; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Parasitic Sensitivity Tests; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2017 |
Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
Topics: Antitubercular Agents; Caco-2 Cells; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Solubility; Structure-Activity Relationship; Tetrazoles; Water | 2017 |
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.
Topics: Animals; Antitubercular Agents; Biological Availability; Caco-2 Cells; Heterocyclic Compounds; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxides; Spectrum Analysis | 2017 |
The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Humans; Imidazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Structure-Activity Relationship; Triazoles | 2017 |
Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
Topics: Antitubercular Agents; Cell Survival; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship; Triazoles | 2017 |
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.
Topics: Administration, Oral; Animals; Antitubercular Agents; Blood Proteins; Drug Stability; High-Throughput Screening Assays; Humans; Male; Mice, Inbred C57BL; Microsomes, Liver; Mycobacterium tuberculosis; Proteomics; Pyrimidines; Small Molecule Libraries; Structure-Activity Relationship | 2017 |
Indolylalkyltriphenylphosphonium Analogues Are Membrane-Depolarizing Mycobactericidal Agents.
Topics: | 2017 |
Synthesis and antimycobacterial activity of triterpeni≿ A-ring azepanes.
Topics: Antitubercular Agents; Azepines; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triterpenes | 2018 |
Primaquine hybrids as promising antimycobacterial and antimalarial agents.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Plasmodium berghei; Primaquine; Rats; Structure-Activity Relationship | 2018 |
Lead identification and optimization of bacterial glutamate racemase inhibitors.
Topics: Amino Acid Isomerases; Animals; Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; RAW 264.7 Cells; Structure-Activity Relationship | 2018 |
Antitubercular Nitroimidazoles Revisited: Synthesis and Activity of the Authentic 3-Nitro Isomer of Pretomanid.
Topics: | 2017 |
Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors.
Topics: Amino Acid Isomerases; Animals; Anti-Bacterial Agents; Benzoxazoles; Biofilms; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kinetics; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium; RAW 264.7 Cells; Structure-Activity Relationship; Zebrafish | 2018 |
New hydrazides derivatives of isoniazid against Mycobacterium tuberculosis: Higher potency and lower hepatocytotoxicity.
Topics: Animals; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Hydrazines; Isoniazid; Macrophages; Mice; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2018 |
Synthesis and evaluation of 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrans; Spiro Compounds; Structure-Activity Relationship; Thiophenes | 2018 |
Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole.
Topics: Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2018 |
Synthesis, evaluation and CoMFA/CoMSIA study of nitrofuranyl methyl N-heterocycles as novel antitubercular agents.
Topics: Antitubercular Agents; Drug Design; Furans; Heterocyclic Compounds; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Static Electricity | 2018 |
Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
Topics: Animals; Antitubercular Agents; Drug Design; Female; Humans; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Piperidines; Thiazines; Tuberculosis | 2018 |
Indolyl Azaspiroketal Mannich Bases Are Potent Antimycobacterial Agents with Selective Membrane Permeabilizing Effects and in Vivo Activity.
Topics: Animals; Antitubercular Agents; Aza Compounds; Cell Death; Cell Membrane Permeability; Indoles; Mannich Bases; Mice; Molecular Structure; Mycobacterium tuberculosis; Spiro Compounds | 2018 |
Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
Topics: Animals; Antitubercular Agents; Carbanilides; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; RAW 264.7 Cells; Structure-Activity Relationship; Thiazoles | 2018 |
Design, synthesis and antimycobacterial activity of 3,5-dinitrobenzamide derivatives containing fused ring moieties.
Topics: Anti-Bacterial Agents; Benzamides; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2018 |
Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
Topics: Antitubercular Agents; Caco-2 Cells; Drug Design; HEK293 Cells; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
Topics: Animals; Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines; RAW 264.7 Cells; Structure-Activity Relationship | 2018 |
A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity.
Topics: Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Binding Sites; Body Weight; DNA Gyrase; Imidazoles; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Structure, Tertiary; Structure-Activity Relationship | 2018 |
The synthesis, biological evaluation and structure-activity relationship of 2-phenylaminomethylene-cyclohexane-1,3-diones as specific anti-tuberculosis agents.
Topics: | 2017 |
Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones.
Topics: | 2017 |
Benzylsulfanyl benzo-heterocycle amides and hydrazones as new agents against drug-susceptible and resistant
Topics: | 2017 |
Synthesis and
Topics: | 2018 |
Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold.
Topics: | 2018 |
Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents.
Topics: Amides; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Oximes; Structure-Activity Relationship | 2018 |
Design, synthesis and antibacterial properties of pyrimido[4,5-b]indol-8-amine inhibitors of DNA gyrase.
Topics: Anti-Bacterial Agents; Cell Survival; DNA Gyrase; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2018 |
An antimycobacterial pleuromutilin analogue effective against dormant bacilli.
Topics: Administration, Oral; Animals; Antitubercular Agents; Area Under Curve; Biological Availability; Caco-2 Cells; Diterpenes; Female; Half-Life; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pleuromutilins; Polycyclic Compounds | 2018 |
Design, synthesis, and biological evaluation of
Topics: | 2018 |
Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Drug Design; Drug Resistance, Multiple; Female; Guinea Pigs; Macrophages; Male; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Protein Conformation; Protein Tyrosine Phosphatases; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2018 |
Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinazolinones; Staphylococcal Infections; Structure-Activity Relationship; Triazoles | 2018 |
Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Dose-Response Relationship, Drug; Female; HEK293 Cells; Hep G2 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazines; Vero Cells | 2018 |
Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2019 |
Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Pyrroles; Structure-Activity Relationship; Triazoles | 2019 |
Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Morpholines; Mycobacterium tuberculosis; Piperazine; Quinolines; Structure-Activity Relationship | 2019 |
Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; Triazoles | 2019 |
Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Topics: Antitubercular Agents; Area Under Curve; Drug Resistance, Multiple; Hydrophobic and Hydrophilic Interactions; Imidazoles; Mycobacterium tuberculosis; Piperazine; Piperazines; Pyridines; Structure-Activity Relationship; Thiazines | 2019 |
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
Topics: Amides; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Design; Female; Imidazoles; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship; Vero Cells | 2019 |
Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrophenols; Pyridines; Structure-Activity Relationship; Thiadiazoles; Tuberculosis, Multidrug-Resistant; Vero Cells | 2019 |
Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis.
Topics: Amination; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Furans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship | 2019 |
Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2019 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Quinolone-isoniazid hybrids: synthesis and preliminary
Topics: | 2019 |
Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Female; Imidazoles; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship | 2019 |
hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents.
Topics: Antitubercular Agents; Benzothiazoles; Dose-Response Relationship, Drug; Drug Discovery; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2019 |
Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Isatin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Vero Cells | 2019 |
5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation.
Topics: Antitubercular Agents; Antiviral Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Orthomyxoviridae; Structure-Activity Relationship | 2019 |
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Dinitrobenzenes; Dose-Response Relationship, Drug; Drug Development; Hydrocarbons, Fluorinated; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2019 |
Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Topics: Antitubercular Agents; Carbamates; Hep G2 Cells; Humans; Isocitrate Lyase; Mycobacterium tuberculosis; Phenols; Salicylanilides; Tuberculosis | 2019 |
Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
Topics: Animals; Antitubercular Agents; Drug Design; Female; Humans; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oximes; Piperazines; Thiazines; Tuberculosis | 2019 |
Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach.
Topics: Antitubercular Agents; Cell Line, Tumor; Cell Survival; Click Chemistry; Crystallization; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Quinolines; Structure-Activity Relationship; Triazoles | 2019 |
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.
Topics: | 2019 |
Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agents.
Topics: Amines; Antitubercular Agents; Cell Death; Cell Line; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Tetrazoles | 2020 |
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacillus subtilis; Benzofurans; Lichens; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles | 2020 |
Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity.
Topics: Acrylonitrile; Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2020 |
Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Hydrazones; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; RAW 264.7 Cells; Structure-Activity Relationship; Thiadiazoles | 2020 |
Synthesis and antimycobacterial activity of thiazolidine-2,4-dione based derivatives with halogenbenzohydrazones and pyridinecarbohydrazones substituents.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Design; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Thiazolidinediones; Vero Cells | 2020 |
Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis.
Topics: Animals; Antitubercular Agents; Benzofurans; Benzopyrans; Drug Design; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2020 |
Antimycobacterial Rufomycin Analogues from
Topics: Antitubercular Agents; Crystallography, X-Ray; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oligopeptides; Streptomyces | 2020 |
Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
Topics: Animals; Antitubercular Agents; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Hep G2 Cells; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; RAW 264.7 Cells; Structure-Activity Relationship; Tuberculosis; Vero Cells | 2020 |
Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
Topics: Amides; Animals; Antitubercular Agents; Biofilms; Cell Line; Dose-Response Relationship, Drug; Drug Development; Enzyme Inhibitors; HEK293 Cells; Humans; Ketol-Acid Reductoisomerase; Macrophages; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2020 |
Synthesis, antitubercular and anticancer activity of new Baylis-Hillman adduct-derived
Topics: | 2014 |
Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis.
Topics: Amino Acid Sequence; Animals; Antitubercular Agents; Cell Line; Cell Survival; Chalcones; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fatty Acid Synthase, Type II; Humans; Indoles; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2020 |
Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; RAW 264.7 Cells; Structure-Activity Relationship; Thiourea | 2020 |
Improving the Potency of
Topics: | 2020 |
Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents.
Topics: Alkanes; Animals; Antitubercular Agents; Drug Design; Drug Resistance; Mice; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazines; Tuberculosis, Multidrug-Resistant | 2020 |
Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening.
Topics: Bacterial Proteins; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fatty Acid Synthases; Molecular Structure; Mycobacterium tuberculosis; ortho-Aminobenzoates; Structure-Activity Relationship | 2020 |
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Synergism; Enzyme Inhibitors; HEK293 Cells; Humans; Microsomes, Liver; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; NADH Dehydrogenase; Organoselenium Compounds; Parasitic Sensitivity Tests; Phenothiazines; Protein Binding; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Vero Cells | 2020 |
The synthesis and antituberculosis activity of 5-alkynyl uracil derivatives.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium bovis; Mycobacterium tuberculosis; Structure-Activity Relationship; Uracil | 2020 |
Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis.
Topics: Animals; Chlorocebus aethiops; Drug Design; Female; Hep G2 Cells; Humans; Mice; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Oxazolidinones; Safety; Tuberculosis, Multidrug-Resistant; Vero Cells | 2020 |
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Topics: Animals; Antifungal Agents; Antitubercular Agents; Aspergillus niger; Bacterial Proteins; Drug Design; Gram-Negative Bacteria; Isoniazid; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; RAW 264.7 Cells; Triazoles | 2020 |
Synthesis and evaluation of thiophene based small molecules as potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Synergism; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Protein Binding; Structure-Activity Relationship; Thiophenes; THP-1 Cells | 2020 |
Design, synthesis and biological evaluation of diamino substituted cyclobut-3-ene-1,2-dione derivatives for the treatment of drug-resistant tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Cycloparaffins; Drug Design; Drug Resistance, Bacterial; Drug Stability; Humans; Inhibitory Concentration 50; Male; Mice; Microbial Sensitivity Tests; Mitochondrial Proton-Translocating ATPases; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Conformation | 2020 |
New one-pot synthesis of anti-tuberculosis compounds inspired on isoniazid.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Chlorocebus aethiops; Hydrazones; Isoniazid; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; Structure-Activity Relationship; Tosyl Compounds; Vero Cells | 2020 |
Design, synthesis, and evaluation of substituted 2-acylamide-1,3-benzo[d]zole analogues as agents against MDR- and XDR-MTB.
Topics: Animals; Antitubercular Agents; Drug Design; Female; Halogenation; HEK293 Cells; Humans; Male; Mice; Mycobacterium tuberculosis; Oxazoles; Rats, Sprague-Dawley; Thiadiazoles; Tuberculosis, Multidrug-Resistant | 2021 |
Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.
Topics: Amination; Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Schiff Bases; Thiazoles; Tuberculosis | 2020 |
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
2-((3,5-Dinitrobenzyl)thio)quinazolinones: Potent Antimycobacterial Agents Activated by Deazaflavin (F
Topics: Antitubercular Agents; High-Throughput Screening Assays; Microbial Sensitivity Tests; Mutagenicity Tests; Mycobacterium tuberculosis; Nitroreductases; Quinazolinones; Riboflavin; Structure-Activity Relationship | 2021 |
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
Topics: Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Polyketide Synthases; Quinolones; Structure-Activity Relationship | 2021 |
Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Quinolones; Structure-Activity Relationship | 2021 |
Discovery of novel N
Topics: A549 Cells; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cytidine; Drug Discovery; Fungi; Humans; Microbial Sensitivity Tests | 2021 |
Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Piperazine; Structure-Activity Relationship; Thiazines | 2021 |
Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Chalcone; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esters; Isoxazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2021 |
Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis.
Topics: Amides; Antitubercular Agents; Benzopyrans; Dose-Response Relationship, Drug; Esters; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2021 |
Benzoheterocyclic Oxime Carbamates Active against
Topics: Antitubercular Agents; Carbamates; Dose-Response Relationship, Drug; Heterocyclic Compounds; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oximes; Structure-Activity Relationship | 2021 |
Design and synthesis of novel 5-alkynyl pyrimidine nucleosides derivatives: Influence of C-6-substituent on antituberculosis activity.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Structure-Activity Relationship | 2021 |
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in
Topics: Antitubercular Agents; Cell Wall; Drug Discovery; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfonamides | 2021 |
Novel C-3-(N-alkyl-aryl)-aminomethyl rifamycin SV derivatives exhibit activity against rifampicin-resistant Mycobacterium tuberculosis RpoB
Topics: Antitubercular Agents; Binding Sites; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Rifamycins; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2021 |
Exploring disordered loops in DprE1 provides a functional site to combat drug-resistance in Mycobacterium strains.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2022 |
Antimicrobial and Cytotoxic Angucyclic Quinones from
Topics: Actinomadura; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolones | 2021 |
Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Oxadiazoles; Structure-Activity Relationship | 2022 |
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Calcium Channel Blockers; Ion Transport; Iron Chelating Agents; Male; Membrane Transport Proteins; Mycobacterium tuberculosis; Oxazoles; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tuberculosis; Verapamil | 2022 |
Structural Rigidification of
Topics: | 2022 |
Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis.
Topics: Animals; Antitubercular Agents; Benzenesulfonamides; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfonamides; Thiophenes; Tuberculosis, Multidrug-Resistant | 2022 |
Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 Based on the Depsipeptide Natural Products Ecumicin and Ohmyungsamycin A.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Biological Products; Depsipeptides; Molecular Chaperones; Mycobacterium tuberculosis; Peptides, Cyclic; Zebrafish | 2022 |
Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
Topics: Animals; Anti-Bacterial Agents; Hydrazines; Hydroxamic Acids; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship | 2022 |
Tapping into the antitubercular potential of 2,5-dimethylpyrroles: A structure-activity relationship interrogation.
Topics: Animals; Antitubercular Agents; Humans; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrroles; Structure-Activity Relationship | 2022 |
Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.
Topics: Amines; Animals; Antitubercular Agents; Benzoxazoles; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vero Cells | 2022 |
Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.
Topics: Animals; Antitubercular Agents; Long QT Syndrome; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant
Topics: | 2022 |
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Antitubercular Activity of Novel 2-(Quinoline-4-yloxy)acetamides with Improved Drug-Like Properties.
Topics: | 2022 |
Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection.
Topics: Animals; Chagas Disease; Disease Models, Animal; Mice; Mycobacterium tuberculosis; Nitroimidazoles; Nitroreductases; Trypanosoma cruzi; Tuberculosis | 2022 |
Discovery of biphenyls bearing thiobarbiturate fragment by structure-based strategy as Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitors.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Biphenyl Compounds; Enzyme Inhibitors; Mice; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Tyrosine Phosphatases; Thiobarbiturates; Tuberculosis; Virulence Factors | 2022 |
Synthesis, biological evaluation and computational studies of pyrazole derivatives as
Topics: | 2022 |
[Monitoring of antitubercular treatments. Value of the determination of serum gamma-glutamyl transpeptidase (gamma-GT)].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; gamma-Glutamyltransferase; Humans; Isoniazid; Liver; Rifampin | 1977 |
Elevation of plasma levels of lysosomal enzymes during treatment with rifampicin and isoniazid.
Topics: Acetylglucosaminidase; Alanine Transaminase; Female; gamma-Glutamyltransferase; Glucuronidase; Hexosaminidases; Humans; Isoniazid; Lysosomes; Male; Rifampin; Sex Factors; Tuberculosis, Pulmonary | 1978 |
Tuberculosis in the 1980s: a case for short-course chemotherapy.
Topics: Animals; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Isoniazid; Mice; New Zealand; Pyrazinamide; Rifampin; Tuberculosis | 1979 |
Results of treatment of spinal tuberculosis by "middle-path" regime.
Topics: Abscess; Aminosalicylic Acids; Antitubercular Agents; Convalescence; Debridement; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Postoperative Care; Recurrence; Rest; Rifampin; Spinal Cord Compression; Spinal Fusion; Streptomycin; Thioacetazone; Tuberculosis, Spinal | 1975 |
Short-course chemotherapy for pulmonary tuberculosis.
Topics: Africa, Eastern; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Follow-Up Studies; Isoniazid; Mycobacterium tuberculosis; Prognosis; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1975 |
Letter: Short-course triple chemotherapy for tuberculosis.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Peritonitis, Tuberculous; Rifampin; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1975 |
Side effects of drugs used to treat tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Capreomycin; Chemical and Drug Induced Liver Injury; Cycloserine; Deafness; Drug Hypersensitivity; Ethambutol; Ethionamide; Gastrointestinal Diseases; Goiter; Humans; Isoniazid; Kanamycin; Liver; Mental Disorders; Mice; Nervous System Diseases; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1975 |
Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
Topics: Capreomycin; Culture Media; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Streptomycin; Temperature; Thiosemicarbazones; Viomycin | 1975 |
Short-course chemotherapy for pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1975 |
Letter: Short-course triple chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1975 |
The treatment of tuberculosis.
Topics: Aminosalicylic Acids; Capreomycin; Ethambutol; Ethionamide; Humans; Isoniazid; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis | 1975 |
Editorial: Treatment of tuberculous meningitis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1976 |
Initial resistance of Mycobacterium tuberculosis in Northern Nigeria.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Nigeria; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1976 |
Letter: Induction of hepatic cortisol-6-hydroxylase by rifampicin.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Antagonism; Drug Therapy, Combination; Enzyme Induction; Female; Humans; Hydrocortisone; Isoniazid; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Rifampin; Tuberculosis, Pulmonary | 1976 |
Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Patient Dropouts; Recurrence; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1977 |
Short-course treatment in pulmonary tuberculosis.
Topics: Adolescent; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1977 |
Short-course (6-month) treatment of pulmonary tuberculosis (Second East African/British Medical Research Council Study).
Topics: Africa, Eastern; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1976 |
Short-course chemotherapy for tuberculosis.
Topics: Adult; Ambulatory Care; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; South Africa; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1979 |
Basic mechanisms of chemotherapy.
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Humans; In Vitro Techniques; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1979 |
Antituberculous drugs.
Topics: Abnormalities, Drug-Induced; Antitubercular Agents; Dihydrostreptomycin Sulfate; Ethambutol; Ethionamide; Female; Fetus; Hearing Disorders; Humans; Infant, Newborn; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Identification and drug sensitivity of tubercle bacilli from Addis Ababa, Ethiopia.
Topics: Aminosalicylic Acid; Ethiopia; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thiosemicarbazones | 1978 |
Primary antituberculous drug resistance in Hawaii, 1957 to 1977.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Hawaii; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1978 |
[The use of mycobacteria in the estimation of the concentration of antibiotics, antimycotics and antituberculotics (author's transl)].
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Bacitracin; Drug Resistance, Microbial; Ethambutol; Ethionamide; Gentamicins; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Neomycin; Rifampin; Streptomycin; Time Factors | 1978 |
[Short course chemotherapy for pulmonary tuberculosis with duration for 6 months after sputum negative conversion. (Report 1)--Report of the 19--20th A series of controlled trial of chemotherapy--(author's transl)].
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Daily short course (6 months) chemotherapy for treatment of pulmonary tuberculosis in Nigerians: a preliminary report.
Topics: Adolescent; Adult; Drug Combinations; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1978 |
Thoracic tuberculosis: clinical aspects.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Child; Child, Preschool; Drug Interactions; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Mass Chest X-Ray; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary; United States | 1979 |
[The bacteriological principles of tuberculosis treatments].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1979 |
The cost of antituberculous drug regimens.
Topics: Antitubercular Agents; Biological Availability; Drug Administration Schedule; Drug Therapy; Humans; Isoniazid; Long-Term Care; Pyrazinamide; Rifampin; Tuberculosis | 1979 |
[Short term chemotherapy of tuberculosis. Bactericidal mechanisms in short term chemotherapy].
Topics: Animals; Antitubercular Agents; Guinea Pigs; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Temperature; Tuberculosis | 1978 |
[Ultrastructural change in Mycobacterium tuberculosis under the influence of antibacterial preparations (a review of the literature)].
Topics: Antitubercular Agents; Cell Nucleus; Cell Wall; Cycloserine; Cytoplasm; Ethambutol; Intracellular Membranes; Isoniazid; Kanamycin; Microscopy, Electron; Microscopy, Electron, Scanning; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1979 |
Tuberculosis: genitourinary tuberculosis.
Topics: Cystoscopy; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Methods; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital; Urine | 1979 |
Drug resistance in newly discovered untreated tuberculosis patients in Poland, 1974-1977.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Poland; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong.
Topics: Aminosalicylic Acids; Arthritis; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Therapy, Combination; Gastrointestinal Diseases; Hong Kong; Humans; Isoniazid; Labyrinth Diseases; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
[Pott's disease. Medical treatment or medico-surgical treatment. Round-table discussion].
Topics: Abscess; Ethambutol; Humans; Intervertebral Disc; Isoniazid; Paraplegia; Rifampin; Spinal Fusion; Tuberculosis, Spinal | 1975 |
[Reactive metabolites of xenobiotics : their role in the hepatotoxicity of drugs].
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Glutathione; Glycolates; Humans; Hydrazines; Isoniazid; Monoamine Oxidase Inhibitors; Pharmaceutical Preparations; Rifampin | 1979 |
Analysis of metabolic changes in revertants of antibiotic-resistant micobacteria.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Extrachromosomal Inheritance; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Neomycin; Rifampin; Streptomycin; Viomycin | 1975 |
[Surveillance and complications of antituberculosis chemotherapy].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Hematologic Diseases; Humans; Isoniazid; Liver; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Rheumatic Diseases; Rifampin; Streptomycin; Tuberculosis | 1979 |
[Treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1978 |
Tuberculosis in Britain today.
Topics: Emigration and Immigration; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary; United Kingdom | 1979 |
Gynecological tuberculosis in the west of Scotland.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Rifampin; Scotland; Streptomycin; Tuberculosis, Female Genital | 1979 |
Pulmonary tuberculosis initial treatment.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1978 |
Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Poland; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1978 |
Mycobacterium marinum infections treated with tetracycline.
Topics: 4-Aminobenzoic Acid; Adult; Ethambutol; Granuloma; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious; Streptomycin; Tetracycline | 1977 |
Recent advances in antituberculosis chemotherapy.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Leprosy eradication project of Malta. First published report after 5 years running.
Topics: Adolescent; Adult; Aged; Bacteriological Techniques; Child; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Malta; Middle Aged; Prothionamide; Rifampin; Time Factors | 1977 |
[Tasks and possibilities in the near future of consultation bureaus for the prevention of tuberculosis].
Topics: Community Health Services; Ethambutol; History, 20th Century; Humans; Isoniazid; Netherlands; Rifampin; Transients and Migrants; Tuberculosis | 1978 |
In vitro resistance test of human leprosy bacilli to anti-leprous drugs.
Topics: Dapsone; Drug Resistance, Microbial; Humans; Isoniazid; Leprostatic Agents; Leprosy; Microbial Sensitivity Tests; Mycobacterium leprae; Rifampin; Streptomycin | 1977 |
[Current short-term chemotherapy of tuberculosis. Fundamentals, assumptions, drug combinations, plan of treatment and prospects].
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1978 |
Tuberculosis in renal transplant patients.
Topics: Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Postoperative Complications; Rifampin; Transplantation, Homologous; Tuberculosis | 1979 |
Tuberculosis in renal transplant recipients.
Topics: Adult; Drug Administration Schedule; Female; Humans; Isoniazid; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Rifampin; Transplantation, Homologous; Tuberculosis, Pulmonary | 1979 |
Stability of bacteriophage type of Mycobacterium tuberculosis: absence of variation caused by experimental chemotherapy in mice and analysis of spontaneous variation.
Topics: Analysis of Variance; Animals; Bacteriophage Typing; Drug Resistance, Microbial; Isoniazid; Mice; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1977 |
A rapid radiometric method for determining the sensitivity of clinical isolates of Mycobacterium tuberculosis to several chemotherapeutic agents.
Topics: Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; RNA, Bacterial; Streptomycin; Tritium; Uracil | 1977 |
Synergy and rifampicin.
Topics: Drug Synergism; Escherichia coli; Humans; Isoniazid; Novobiocin; Proteus vulgaris; Pseudomonas aeruginosa; Rifampin; Salmonella typhi; Salmonella typhimurium; Shigella dysenteriae; Tetracycline; Tuberculosis, Pulmonary | 1977 |
[Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1977 |
[Action of isoniazid and rifampicin on viability and ultrastructure of M. tuberculosis].
Topics: Isoniazid; Mycobacterium tuberculosis; Rifampin | 1977 |
Occult tuberculous infection in children.
Topics: Adolescent; Aminosalicylic Acid; Child; Child, Preschool; Europe; Humans; Infant; Isoniazid; Mycobacterium tuberculosis; New Zealand; Polynesia; Rifampin; Tuberculosis, Pulmonary | 1977 |
[Research in the campaign against leprosy (author's transl)].
Topics: Animals; Armadillos; Dapsone; Drug Therapy, Combination; Humans; Isoniazid; Leprosy; Mice; Models, Biological; Mycobacterium; Prothionamide; Rifampin | 1977 |
Treatment of tuberculosis in alcoholic patients.
Topics: Alcoholism; Hospitalization; Humans; Isoniazid; Long-Term Care; Patient Compliance; Rifampin; Social Work; Tuberculosis | 1977 |
[Changes in the indication of surgical treatment for pulmonary tuberculosis in accordance with the introduction of rifampicin based on bacteriological findings on culture of resected specimens (author's transl)].
Topics: Humans; Isoniazid; Lung; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1977 |
Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Topics: Drug Interactions; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin | 1977 |
[On the possibility of a rapid method for sensitivity testing of mycobacteria by determination of H3-uracil incorporation (author's transl)].
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium phlei; Mycobacterium tuberculosis; Rifampin; Tritium; Uracil | 1977 |
[Evaluation criteria of antitubercular drugs from microbiological view].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1977 |
[Bacterial isolation during chemotherapy of patients with pulmonary tuberculosis].
Topics: Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1977 |
Rapid radiometric susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Carbon Dioxide; Carbon Radioisotopes; Ethambutol; Formates; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidation-Reduction; Rifampin; Streptomycin | 1978 |
Antimicrobial activity of antituberculosis agents against anaerobic bacteria.
Topics: Actinomyces; Antitubercular Agents; Bacteria; Bacteroides; Bacteroides fragilis; Clostridium; Ethambutol; Eubacterium; Fusobacterium; Humans; Isoniazid; Microbial Sensitivity Tests; Peptococcus; Peptostreptococcus; Rifampin; Tuberculosis, Pulmonary | 1979 |
Defective leukotaxis in monocytes from patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Chemotaxis, Leukocyte; Chronic Disease; Dose-Response Relationship, Immunologic; Ethambutol; Female; Humans; Immunity, Cellular; In Vitro Techniques; Isoniazid; Lung Diseases; Lymphokines; Male; Middle Aged; Monocytes; Rifampin; Tuberculosis, Pulmonary; Zymosan | 1979 |
Short-course chemotherapy for tuberculosis.
Topics: Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1979 |
Short-course chemotherapy of tuberculosis with largely twice-weekly isoniazid-rifampin.
Topics: Adolescent; Adult; Aged; Drug Hypersensitivity; Humans; Isoniazid; Jaundice; Middle Aged; Rifampin; Thrombocytopenia; Time Factors; Tuberculosis, Pulmonary; Vomiting | 1979 |
Tuberculous meningitis.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Finland; Humans; Isoniazid; Male; Middle Aged; Prognosis; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1979 |
Five cases of intracranial tuberculoma followed by serial computerised tomography.
Topics: Adult; Brain Diseases; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tomography, X-Ray Computed; Tuberculoma | 1979 |
[Therapy of tuberculosis].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Modified short-course (nine months) chemotherapy for pulmonary tuberculosis suitable for Developing Countries.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Developing Countries; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Middle Aged; Nigeria; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Genitourinary tuberculosis: a 7-year review.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Forecasting; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Urogenital | 1979 |
Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 1979 |
Long-term results of medical treatment in Mycobacterium intracellulare infection.
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Mycobacterium Infections, Nontuberculous; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
[Pharmacokinetics and metabolism of the principal antubercular drugs].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin | 1979 |
[Indications, dosage and combinations of the major antitubercular drugs].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1979 |
Practical application of short-course (6 month) regimens of chemotherapy for pulmonary tuberculosis in Kenyan nomads.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Kenya; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Blood levels of rifampicin, desacetylrifampicin and isoniazid during combined therapy.
Topics: Biotransformation; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Kinetics; Models, Biological; Rifampin; Time Factors | 1979 |
[Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
Topics: Aged; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver; Liver Diseases; Peritonitis, Tuberculous; Rifampin | 1979 |
Modern management of tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acid; Child; Cycloserine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1979 |
[A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)].
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin | 1979 |
[A study on short-course chemotherapy for pulmonary tuberculosis (Report 2)--6--9 month short-course chemotherapy (author's transl)].
Topics: Adult; Antibiotics, Antitubercular; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1979 |
[Two cases of pulmonary tuberculosis having evolved after the first attack with triple therapy of isoniazid, rifampicin and ethambutol].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1979 |
The side effects and interactions of antituberculosis drugs.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Child; Drug Interactions; Ethambutol; Female; Humans; Immunosuppression Therapy; Isoniazid; Optic Neuritis; Phenytoin; Pregnancy; Rifampin; Streptomycin; Thrombocytopenia | 1979 |
Pulmonary disease caused by Mycobacterium xenopi in an Australian man.
Topics: Australia; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyridoxine; Rifampin; Sputum; Tuberculosis, Pulmonary | 1979 |
[New information on the metabolism of isoniazide and rifampicin. Their therapeutical consequences (author's transl)].
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1979 |
The treatment of tuberculous meningitis in children with a combination of isoniazid, rifampicin and streptomycin--preliminary report.
Topics: Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1979 |
[Pregnancy and pulmonary tuberculosis].
Topics: BCG Vaccine; Ethambutol; Female; Humans; Infant, Newborn; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Prognosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
[Biotransformation of rifampicin in pulmonary tuberculosis patients].
Topics: Adolescent; Adult; Animals; Biotransformation; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1977 |
Principles of the chemotherapy of tuberculosis.
Topics: Aminosalicylic Acid; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1977 |
Twenty-five years experience of the drug treatment of tuberculosis of the female genital tract.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Female Genital | 1977 |
[Toxicological evaluation criteria (secondary action aspects)].
Topics: Anti-Infective Agents; Cephalosporins; Chloramphenicol; Erythromycin; Ethambutol; Gentamicins; Humans; Isoniazid; Lincomycin; Nalidixic Acid; Neomycin; Nitrofurantoin; Penicillins; Rifampin; Streptomycin; Sulfonamides; Tetracyclines | 1977 |
[Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
Topics: Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Liver Diseases; Male; Prospective Studies; Rifampin; Time Factors; Transaminases; Tuberculosis, Pulmonary | 1977 |
[Toxic hepatitis (liver and antitubercular drugs)].
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Liver; Rifampin | 1977 |
Pharmacodynamic interference between rifampicin and isoniazid.
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Prothrombin; Rifampin | 1978 |
The treatment of tuberculous meningitis.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1978 |
Diseases of the respiratory system: tuberculosis.
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Patient Compliance; Rifampin; Streptomycin; Tuberculosis | 1978 |
[New guidelines for pulmonary tuberculosis therapy].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
Treatment of renal tuberculosis. I. Clinical and bacteriological patterns and results.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Radiography; Rifampin; Tuberculosis, Renal; Urine | 1978 |
Rifampin in treatment of tuberculous meningitis in children.
Topics: Child; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Meningeal | 1978 |
Mycobacterium gordonae infection of a prosthetic aortic valve.
Topics: Aortic Valve; Endocarditis, Bacterial; Ethambutol; Heart Valve Prosthesis; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin | 1978 |
Short-term intensive initial chemotherapy for pulmonary tuberculosis--preliminary report--can the duration of TB treatment be even shorter?
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1978 |
Choosing the correct drug combinations against tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
Current status of the chemotherapy of tuberculosis. Part II.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1978 |
Treatment of tuberculosis.
Topics: Attitude of Health Personnel; Humans; Isoniazid; Rifampin; Tuberculosis | 1978 |
[Isoniazid-rifampicin: an exemplary hepatotoxicity].
Topics: Animals; Biotransformation; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Liver; Microsomes, Liver; Necrosis; Rifampin | 1978 |
[Therapy of urogenital tuberculosis].
Topics: Ambulatory Care; Ethambutol; Female; Humans; Isoniazid; Kidney Failure, Chronic; Pregnancy; Pregnancy Complications; Prothionamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Urogenital | 1978 |
[The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Phospholipids; Rifampin; Tuberculosis, Pulmonary | 1978 |
How safe is isoniazid?
Topics: Adult; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Hepatitis, Viral, Human; Humans; Isoniazid; Liver Diseases; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1978 |
Hepatitis from isoniazid and rifampin.
Topics: Adult; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Rifampin | 1978 |
Antituberculosis chemotherapy.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Neuritis; Rifampin; Streptomycin | 1978 |
Combined therapy in leprosy. Background and findings.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Leprostatic Agents; Leprosy; Prothionamide; Rifampin | 1978 |
[Comparative studies on therapeutic effect of rifampicin and isoniazid on experimental mouse tuberculosis (author's transl)].
Topics: Animals; Drug Evaluation, Preclinical; Isoniazid; Male; Mice; Rifampin; Tuberculosis | 1978 |
[The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
Topics: Acetylation; Adolescent; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Drug Interactions; Humans; Isoniazid; Liver; Middle Aged; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1978 |
Treatment of renal tuberculosis. II. Microbiological study of 271 renal tuberculous cavities.
Topics: Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Kidney; Rifampin; Tuberculosis, Renal | 1978 |
[Tuberculosis of the peripheral lymph nodes].
Topics: Adolescent; Adult; Ethambutol; Female; Germany, West; Humans; Inguinal Canal; Isoniazid; Male; Middle Aged; Neck; Rifampin; Tuberculin Test; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1978 |
More adverse reactions to rifampicin.
Topics: Female; Humans; Infant; Isoniazid; Rifampin; Tuberculosis, Meningeal | 1978 |
[Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis (preliminary report) (author's transl)].
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
[An attempt to work out highly efficient short-course regimens by model experiments in mouse tuberculosis (author's transl)].
Topics: Animals; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Rifampin; Streptomycin; Tuberculosis | 1978 |
[Anemia with hypersideroblastosis during anti-tuberculosis therapy. Cure with vitamin therapy].
Topics: Aged; Anemia, Sideroblastic; Antitubercular Agents; Ascorbic Acid; Female; Humans; Isoniazid; Pyridoxine; Rifampin; Tuberculosis, Pulmonary | 1978 |
A case of probable congenital tuberculosis successfully treated with rifampicin and INH.
Topics: Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1978 |
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
Topics: Acetylation; Adult; Age Factors; Alanine Transaminase; Alcoholism; Aspartate Aminotransferases; Biliary Tract Diseases; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver; Male; Middle Aged; Phenotype; Rifampin; Risk; Sex Factors; Time Factors; Tuberculosis, Pulmonary | 1978 |
Will short-term TB therapy regimens work?
Topics: Antitubercular Agents; Arkansas; Drug Therapy, Combination; Humans; Isoniazid; Patient Compliance; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1978 |
[Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
[Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
Topics: Drug Evaluation; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
Granulomatous hepatitis and pleuritis after ileal bypass for obesity.
Topics: Ethambutol; Female; Hepatitis; Humans; Ileum; Intestinal Absorption; Isoniazid; Jejunum; Middle Aged; Obesity; Phagocyte Bactericidal Dysfunction; Pleurisy; Rifampin | 1978 |
Tuberculosis in East Africans presenting with intra-thoracic lymphadenopathy.
Topics: Adult; Africa, Eastern; Asia; Emigration and Immigration; Ethambutol; Female; Humans; Isoniazid; Male; Mediastinum; Middle Aged; Rifampin; Tuberculosis, Lymph Node; United Kingdom | 1978 |
Mycobacterium fortuitum infections: a review with two illustrative cases.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Rifampin; Surgical Wound Infection | 1978 |
[Pharmacokinetics and clinical importance of the interactions of rifampicin with phenprocoumone and isoniazide].
Topics: 4-Hydroxycoumarins; Adolescent; Adult; Aged; Child; Drug Interactions; Female; Humans; Isoniazid; Male; Middle Aged; Phenprocoumon; Rifampin | 1978 |
[Tuberculosis of hematopoietic organs in the child. 2 cases with pulmonary involvement].
Topics: Adolescent; Child, Preschool; Drug Tolerance; Ethambutol; Female; Humans; Isoniazid; Male; Prognosis; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary; Tuberculosis, Splenic | 1978 |
[Results of a cooperative international questionnaire on the cost of antitubercular drugs].
Topics: Antitubercular Agents; Costs and Cost Analysis; Ethambutol; Ethionamide; Isoniazid; Pyrazinamide; Rifampin; Streptomycin | 1978 |
[Absorption of anti-tuberculous drugs after gastric surgery (author's transl)].
Topics: Antitubercular Agents; Biological Availability; Ethambutol; Humans; Intestinal Absorption; Isoniazid; Postgastrectomy Syndromes; Rifampin | 1979 |
[Present status and treatment of urogenital tuberculosis].
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Germany, West; Humans; Isoniazid; Long-Term Care; Male; Pregnancy; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1975 |
The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1975 |
Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1975 |
Tuberculous meningitis developing after six months of treatment of pulmonary tuberculosis. Complication of infection with a drug-resistant strain in a two-year-old child.
Topics: Blood Glucose; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Glucose; Humans; Isoniazid; Lung; Male; Mycobacterium tuberculosis; Radiography; Rifampin; Salicylates; Tuberculin Test; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1975 |
Growth inhibition of tubercle bacilli after pulsed exposures to combinations of antituberculous drugs.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 1975 |
[In-vitro study of the effects of 4,4-diamino-diphenylsulphone in combination with isoniazid and rifampicin (author's transl)].
Topics: Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; In Vitro Techniques; Isoniazid; Mycobacterium leprae; Mycobacterium tuberculosis; Rifampin | 1975 |
Emergence of rifampin-resistant Mycobacterium tuberculosis in Massachusetts.
Topics: Drug Resistance, Microbial; Female; Humans; In Vitro Techniques; Isoniazid; Male; Massachusetts; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1976 |
Mutational studies of the drug-resistance of M. tuberculosis with special reference to p-aminosalicylic acid, ethambutol, isoniazid and rifampicin.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Extrachromosomal Inheritance; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin | 1975 |
[Current status of conservative and surgical treatment of tuberculosis arthritis in adults (author's transl)].
Topics: Adult; Age Factors; Ankle Joint; Elbow Joint; Hip Joint; Humans; Isoniazid; Joints; Knee Joint; Radiography; Rifampin; Sacroiliac Joint; Shoulder Joint; Streptomycin; Tuberculosis, Osteoarticular; Wrist Joint | 1975 |
[Sensitivity tests of mycobacteria to INH, SM, EMB and RMP in a semi-liquid serum-sauton-agar (author's transl)].
Topics: Antitubercular Agents; Culture Media; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1976 |
Light-chain proteinuria and reversible renal failure in rifampin-treated patients with tuberculosis.
Topics: Acute Kidney Injury; Aged; Ethambutol; Female; Humans; Immunoglobulin Light Chains; Isoniazid; Male; Middle Aged; Proteinuria; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Renal | 1976 |
Comparative studies on the influence of dimethylsulfoxide (DMSO) on reversion to sensitivity to isonicotinic acid hydrazide (INH) and rifampicin (RMP) in resistant strains of tubercle bacilli.
Topics: Dimethyl Sulfoxide; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin | 1976 |
Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.
Topics: Animals; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1976 |
Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Enzyme Induction; Female; Humans; Isoniazid; Liver; Male; Microsomes, Liver; Rifampin | 1977 |
Modern medical management of pulmonary tuberculosis.
Topics: Alcoholism; Ethambutol; Fever; Humans; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1977 |
Why tuberculosis is still a health problem in the aged.
Topics: Age Factors; Aged; Ethambutol; Humans; Isoniazid; Nursing Homes; Patient Isolation; Radiography; Rifampin; Sputum; Tuberculin Test; Tuberculosis, Pulmonary | 1977 |
[Anticoagulants in tuberculostatic therapy].
Topics: 4-Hydroxycoumarins; Aged; Drug Antagonism; Epididymitis; Ethambutol; Humans; Isoniazid; Male; Phenprocoumon; Rifampin; Thrombophlebitis; Tuberculosis, Male Genital | 1977 |
Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
Topics: Adult; Antipyrine; Drug Interactions; Enzyme Induction; Female; Half-Life; Humans; Isoniazid; Liver; Male; Microsomes, Liver; Middle Aged; Oxidation-Reduction; Oxidoreductases; Rifampin | 1977 |
Management of tuberculosis: altered role of the primary care physician.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1977 |
[A study on short-course chemotherapy for pulmonary tuberculosis. (Report I) (author's transl)].
Topics: Adult; Aminosalicylic Acid; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1977 |
Reactivation of tuberculosis in old age.
Topics: Adult; Aged; Child; Ethambutol; Female; Humans; Isoniazid; Male; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1977 |
[Antagonistic action of rifampicin and isoniazid on the metabolism of oral contraceptives].
Topics: Contraceptives, Oral; Contraceptives, Oral, Hormonal; Drug Antagonism; Isoniazid; Rifampin | 1977 |
Tuberculosis.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1977 |
[Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)].
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Child; Diagnosis, Differential; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 1977 |
[Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Biotransformation; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1977 |
[A case of circumcision tuberculosis].
Topics: Child; Circumcision, Male; Ethambutol; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Lymph Node; Tuberculosis, Male Genital | 1977 |
Drug interactions with isoniazid metabolism in rats.
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Aspirin; Drug Interactions; Ethambutol; Ethanol; Injections, Intravenous; Isoniazid; Male; Phenobarbital; Rats; Rifampin; Time Factors; Tissue Distribution | 1977 |
[A study on the intensive chemotherapy for previously untreated pulmonary tuberculosis--comparison of two regimens, SM-INH-RFP and SM-INH-EB (author's transl)].
Topics: Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1977 |
Antituberculous therapy in pregnancy. Risks to the fetus.
Topics: Ethambutol; Female; Humans; Isoniazid; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Risk; Streptomycin; Tuberculosis, Pulmonary | 1977 |
[Halothane and antituberculous drugs--a hepatotoxic combination? (author's transl)].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Halothane; Hepatic Encephalopathy; Humans; Isoniazid; Middle Aged; Rifampin; Time Factors | 1977 |
[Clinical efficacy of intermittent chemotherapy with initial intensive regimen in original treatment for pulmonary tuberculosis. Report of the 18th series of controlled trial of chemotherapy (author's transl)].
Topics: Adult; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1977 |
[INH and rifampicin dosage at the beginning of tuberculosis treatment].
Topics: Drug Tolerance; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1977 |
[Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination (author's transl)].
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Rifampin; Tuberculosis | 1977 |
[Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)].
Topics: Acetylation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Male; Optic Neuritis; Rifampin; Tuberculosis | 1977 |
The binding of antituberculous drugs to normal and kwashiorkor serum.
Topics: Aminosalicylic Acid; Antitubercular Agents; Blood Proteins; Child; Ethambutol; Ethionamide; Humans; In Vitro Techniques; Isoniazid; Kwashiorkor; Protein Binding; Rifampin; Streptomycin | 1977 |
Antituberculosis agents: isoniazid, rifampin, streptomycin, ethambutol.
Topics: Antibiotics, Antitubercular; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1977 |
Practical management and control of tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1977 |
Tuberculosis chemoprophylaxis.
Topics: Asia, Southeastern; Drug Resistance; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1977 |
Letter: Tuberculosis care in general hospitals: Arizona's experience.
Topics: Economics, Medical; Hospitalization; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
Scleral tuberculosis.
Topics: Administration, Topical; Aged; Female; Fluorescein Angiography; Humans; Isoniazid; Necrosis; Radiography; Rifampin; Sclera; Streptomycin; Tuberculosis, Ocular; Wound Healing | 1976 |
Genitourinary tuberculosis: a study of short course regimens.
Topics: Adult; Aged; Antitubercular Agents; Calcinosis; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kidney Diseases; Male; Middle Aged; Rifampin; Tuberculosis, Urogenital | 1976 |
Tuberculosis management in the mid-1970s.
Topics: Ambulatory Care; Antitubercular Agents; Drug Resistance; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Patient Compliance; Rifampin; Self Medication; Sputum; Streptomycin; Time Factors; Tuberculosis; United States | 1976 |
Influence of immunosuppression on the action of antimycobacterial drugs in experimental tuberculosis. I. Effects of isoniazid, rifampicin and streptomycin on the survival of tuberculous mice immunosuppressed by azathioprine (Imuran).
Topics: Animals; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Immunosuppression Therapy; Isoniazid; Mice; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
Chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
[Treatment of severe open cavitary pulmonary tuberculosis with a combination of rifampicin and isoprodian (author's transl)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Male; Middle Aged; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Rifampicin in the treatment of chronic pulmonary tuberculosis].
Topics: Antitubercular Agents; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1976 |
Two cases of ethambutol nephrotoxicity.
Topics: Acute Kidney Injury; Aged; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Tuberculosis of peripheral lymph nodes (author's transl)].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 1976 |
[Frequency, diagnosis, and course of hepatotoxic side effects of Rifampicin (author's transl)].
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Isoniazid; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 1976 |
New concepts in diagnosis and treatment of tuberculosis. Part II: current trends in treatment and management.
Topics: Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1976 |
[Remote results of prophylactic examination of patients with chronic destructive pulmonary tuberculosis].
Topics: Adult; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1976 |
Hepatic toxicity of antituberculous drugs in children.
Topics: Adult; Chemical and Drug Induced Liver Injury; Child; Female; Humans; Isoniazid; Liver; Male; Rifampin | 1976 |
[Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Isoniazid; Liver; Male; Rats; Rifampin | 1976 |
Intermittent short course treatment of pulmonary tuberculosis: preliminary report.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
A Singapore study of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis (1).
Topics: Adult; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Singapore; Tuberculosis, Pulmonary | 1976 |
Intermittent treatment using isoniazid and rifampicin once a week: final results of a controlled trial.
Topics: Drug Therapy, Combination; Follow-Up Studies; Germany, West; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1976 |
Two-three years follow up study of pulmonary tuberculosis treated 6 months with rifampicin-containing regimens.
Topics: Adult; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Poland; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
Response to chemotherapy of pulmonary infection due to mycobacterium kansasii.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Texas | 1976 |
Short-course chemotherapy in pulmonary tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1976 |
Short course treatment with two drugs, isoniazid plus rifampicin for six months: a controlled clinical trial with two treatment regimens.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1976 |
Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1976 |
[New drugs in the treatment of leprosy].
Topics: Dapsone; Drug Combinations; Drug Evaluation; Humans; Isoniazid; Isonicotinic Acids; Leprosy; Prothionamide; Rifampin; Tablets | 1976 |
[Bronchoscopy in tuberculosis before and after treatment with NA 872].
Topics: Bromhexine; Bronchoscopy; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1975 |
Hepatotoxicity of rifampicin and isoniazid in children.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Hepatic Encephalopathy; Humans; Isoniazid; Liver; Liver Function Tests; Male; Rifampin; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1975 |
[Current aspects in treatment of tuberculosis].
Topics: Adult; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1976 |
Letter: Epanutin and isoniazid interaction.
Topics: Adult; Carbamazepine; Drug Interactions; Electroencephalography; Epilepsy; Ethambutol; Ethosuximide; Female; Humans; Isoniazid; Phenobarbital; Phenytoin; Rifampin | 1975 |
[New aspects of tuberculosis therapy].
Topics: Contraceptives, Oral; Ethambutol; Female; Humans; Isoniazid; Menstruation; Methods; Pulmonary Heart Disease; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1975 |
The course of untreated Mycobacterium kansasii disease.
Topics: Adult; Ethambutol; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Rifampin; Vital Capacity | 1975 |
Mycobacterium kansasii tendinitis and fasciitis. Report of a case treated successfully with drug therapy alone.
Topics: Ethambutol; Fascia; Humans; Inflammation; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Rifampin; Tendinopathy | 1975 |
[Launois-Bensaude disease; etiopathogenic discussion in a patient treated with tuberculostatic agents].
Topics: Adult; Antitubercular Agents; Ethambutol; Functional Laterality; Humans; Isoniazid; Lipomatosis; Male; Rifampin; Syndrome; Tuberculosis, Pulmonary | 1975 |
Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii.
Topics: Adult; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Mycobacterium; Mycobacterium Infections; Recurrence; Rifampin; Sputum; Streptomycin; Time Factors | 1975 |
Editorial: Isoniazid-associated hepatitis. Reconsideration of the indications for administration of isoniazid.
Topics: Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Ethambutol; Humans; Isoniazid; Rifampin; Risk; Tuberculosis, Pulmonary; United States | 1975 |
Medical grand rounds from Touro Infirmary. Mycobacterium kansasii, aortic stenosis and antimicrobial related hepatitis.
Topics: Aged; Aortic Valve Stenosis; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Liver; Lung Diseases; Lung Diseases, Obstructive; Male; Mycobacterium Infections; Rifampin | 1975 |
An evaluation of the current therapeutic regimen for renal tuberculosis.
Topics: Aminosalicylic Acids; Bilirubin; Color Perception; Cycloserine; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kidney; Liver; Lung Diseases; Male; Rifampin; Tuberculosis, Renal; Visual Perception | 1975 |
Lesions of bone in disseminated infection due to the mycobacterium avium-intracellulare group. Report of a case.
Topics: Adolescent; Bone Diseases; Bone Neoplasms; Child; Diagnosis, Differential; Ethambutol; Hodgkin Disease; Humans; Isoniazid; Kanamycin; Male; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Radiography; Rifampin; Time Factors | 1975 |
Tuberculosis. Chemoprophylaxis and treatment.
Topics: Chemical and Drug Induced Liver Injury; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Patient Compliance; Rifampin; Streptomycin; Tuberculosis | 1975 |
Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Prothionamide; Rifampin | 1975 |
Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
Topics: Adolescent; Adult; Child; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothionamide; Rifampin | 1975 |
Topics in tuberculosis.
Topics: Ambulatory Care; Female; Humans; Isoniazid; Maryland; Patient Care Planning; Pregnancy; Rifampin; Tuberculosis | 1975 |
Ethanol-antibiotic interactions at hepatic level.
Topics: Acute Disease; Alcoholic Intoxication; Animals; Anti-Bacterial Agents; Chronic Disease; Drug Interactions; Ethanol; Gentamicins; Humans; Isoniazid; Kanamycin; Liver; Male; Rats; Rifampin; Streptomycin; Sulfobromophthalein | 1975 |
Proceedings: Latest results of East African/British Medical Research Council short course chemotherapy studies.
Topics: Drug Evaluation; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis | 1975 |
The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves.
Topics: Animals; Dapsone; Dogs; Isoniazid; Peripheral Nerves; Pyrazinamide; Rifampin; Sciatic Nerve; Sheep; Time Factors | 1975 |
Editorial: Rifampin in tuberculous meningitis.
Topics: Child; Child, Preschool; Drug Hypersensitivity; Drug Interactions; Drug Therapy, Combination; Humans; Infant; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1975 |
Evaluation of rifampicin in the treatment of tuberculous meningitis in children.
Topics: Adolescent; Aminosalicylic Acids; Blindness; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Hemiplegia; Humans; Hydrocephalus; Infant; Infant, Newborn; Intellectual Disability; Isoniazid; Rifampin; Tuberculosis, Meningeal | 1975 |
Pregnancy and pulmonary tuberculosis.
Topics: Antitubercular Agents; BCG Vaccine; Birth Weight; Delivery, Obstetric; Ethambutol; Female; Humans; Isoniazid; New York City; Parity; Pneumothorax, Artificial; Pregnancy; Pregnancy Complications, Infectious; Rest; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1975 |
Mycobacteria fortuitum in the urinary tract: a case report.
Topics: Adult; Diagnosis, Differential; Female; Humans; Isoniazid; Mycobacterium; Mycobacterium Infections; Rifampin; Tuberculosis, Urogenital; Urinary Tract Infections | 1975 |
Rifampicin in clinical use.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; England; Humans; Isoniazid; Rifampin; Staphylococcal Infections; Streptomycin; Substance-Related Disorders; Tuberculosis | 1975 |
[Isoprodian in combination with ethambutol and rifampicin in the treatment of tuberculosis (author's transl)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Rifampin; Sulfones; Tuberculosis | 1975 |
[Treatment of tuberculosis].
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1975 |
Genitourinary tuberculosis: study of 20 patients.
Topics: Adult; Aged; Calcinosis; Ethambutol; Female; Humans; Isoniazid; Kidney Diseases; Male; Middle Aged; Nephrectomy; Rifampin; Tuberculosis, Urogenital | 1976 |
Mycobacterium kansasii infection in the deep structures of the hand. Report of two cases.
Topics: Adult; Ethambutol; Female; Hand; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Rifampin; Synovectomy | 1976 |
[The course of pulmonary tuberculosis in the initial phase of various intensive therapy combinations].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
[The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
Rifampin-induced methadone withdrawal.
Topics: Adult; Aged; Drug Interactions; Heroin Dependence; Humans; Isoniazid; Male; Methadone; Middle Aged; Rifampin; Substance Withdrawal Syndrome; Tuberculosis, Pulmonary | 1976 |
[Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis].
Topics: Adult; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
[The validation of the adequacy of chemotherapy in bladder tuberculosis based on a study of bacteriostatic activity].
Topics: Blood Bactericidal Activity; Cycloserine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tissue Distribution; Tuberculosis, Urogenital; Urinary Bladder; Urinary Bladder Diseases | 1992 |
Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan.
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Sex Factors; Taiwan; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1992 |
Clinical significance of adrenal computed tomography in Addison's disease.
Topics: Addison Disease; Adrenal Glands; Adult; Aged; Atrophy; Female; Humans; Hydrocortisone; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 1992 |
Rationale for chemotherapy of tuberculosis and current recommendations.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1992 |
Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver Function Tests; Male; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1992 |
[Activity of ethambutol, isoniazid and rifampicin on Corynebacterium urealyticum and Corynebacterium jeikeium].
Topics: Corynebacterium; Dose-Response Relationship, Drug; Ethambutol; France; Humans; In Vitro Techniques; Isoniazid; Rifampin | 1992 |
Effects of rifampicin on pharmacokinetics of isoniazid and its metabolite acetylhydrazine in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Drug Interactions; Hydrazines; Isoniazid; Male; Rats; Rats, Wistar; Rifampin | 1992 |
Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1992 |
Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension.
Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Drug Interactions; Ethambutol; Female; Humans; Hypertension; Isoniazid; Nicardipine; Nifedipine; Propranolol; Quinazolines; Rifampin | 1992 |
Drug-resistant TB may bring epidemic.
Topics: Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifampin; Tuberculosis, Pulmonary | 1992 |
Drug interaction between rifampicin, isoniazid and cotrimoxazole in rabbits.
Topics: Animals; Drug Interactions; Half-Life; Isoniazid; Rabbits; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Prospective analysis of short course chemotherapy in female genital tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Female Genital | 1992 |
Development of effective drug combinations for the inhibition of multiply resistant mycobacteria, especially of the Mycobacterium avium complex.
Topics: Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium Complex; Rifampin; Thioacetazone | 1992 |
Case holding in patients with tuberculosis in Botswana.
Topics: Botswana; Drug Therapy, Combination; Humans; Isoniazid; National Health Programs; Patient Compliance; Primary Health Care; Pyrazinamide; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1992 |
[Evaluation of the treatment of adult tuberculous meningitis].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Intracranial Pressure; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Survival Rate; Tuberculosis, Meningeal | 1992 |
Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases.
Topics: Antitubercular Agents; Cell Division; Enviomycin; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium Complex; Rifampin; Streptomycin | 1992 |
Simultaneous microdetermination of rifampin, deacetylrifampin, isoniazid, and acetylisoniazid in plasma by liquid chromatography with dual electrochemical and spectrophotometric detection.
Topics: Chromatography, Liquid; Electrochemistry; Isoniazid; Microchemistry; Rifampin; Spectrophotometry | 1992 |
Bioavailability of rifampin in experimental murine tuberculosis.
Topics: Animals; Biological Availability; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1992 |
[Therapy of pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Inpatients; Isoniazid; Male; Outpatients; Pregnancy; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1992 |
Clinical application of the polymerase chain reaction for a rapid diagnosis of Mycobacterium tuberculosis infection.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Base Sequence; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV-1; Humans; Isoniazid; Male; Molecular Sequence Data; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis | 1992 |
[Effect of plasmapheresis on the course of experimental tuberculosis and the tolerance of chemotherapy by patients with renal tuberculosis].
Topics: Animals; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Disease Models, Animal; Drug Tolerance; Humans; Isoniazid; Mycobacterium bovis; Plasmapheresis; Rabbits; Rifampin; Tuberculosis, Pulmonary; Tuberculosis, Renal | 1992 |
Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum.
Topics: Catalase; Chromatography, Thin Layer; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; In Vitro Techniques; Isoniazid; Kanamycin; Mutagenesis; Mycobacterium; Mycolic Acids; Peroxidases; Rifampin; Streptomycin | 1992 |
Polymerase chain reaction for detection of Mycobacterium tuberculosis.
Topics: Acute Disease; Child; Diagnosis, Differential; DNA, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Lymph Nodes; Lymphadenitis; Male; Mycobacterium tuberculosis; Neck; Polymerase Chain Reaction; Rifampin; Tuberculosis, Lymph Node | 1992 |
Culture-positive tuberculosis in Western Australia.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance, Microbial; Emigration and Immigration; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Pleural; Tuberculosis, Pulmonary; Western Australia | 1992 |
[A case of pulmonary tuberculosis associated with severe skin eruption, prominent eosinophilia, and liver dysfunction induced by streptomycin].
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Therapy, Combination; Eosinophilia; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1992 |
Treatment of early rheumatoid arthritis with rifampicin.
Topics: Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors | 1992 |
[Cold tuberculous retropharyngeal abscess].
Topics: Abscess; Brachial Plexus Neuritis; Deglutition Disorders; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Neck; Rifampin; Tuberculosis | 1992 |
Pancreatic tuberculosis following renal transplantation.
Topics: Ethambutol; Female; Humans; Immunosuppression Therapy; Isoniazid; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Pancreatic Diseases; Postoperative Complications; Rifampin; Transplantation, Homologous; Tuberculosis | 1992 |
Intensive short course chemotherapy for tuberculous meningitis.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Meningeal | 1992 |
Reactivation of tuberculous lymphadenitis during pregnancy.
Topics: Adult; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Recurrence; Rifampin; Risk Factors; Tuberculosis, Lymph Node; United Kingdom | 1992 |
[Leprosy in Africa. Current status and epidemiological significance].
Topics: Adolescent; Adult; Africa; Child; Cross-Sectional Studies; Drug Therapy, Combination; Humans; Isoniazid; Leprosy; Leprosy, Lepromatous; Leprosy, Tuberculoid; Prothionamide; Rifampin; Trimethoprim | 1992 |
Peritonitis caused by Mycobacterium kansasii in a patient undergoing continuous ambulatory peritoneal dialysis.
Topics: Drug Therapy, Combination; Female; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rifampin | 1992 |
Tuberculous pleural effusion: 6-month therapy with isoniazid and rifampin.
Topics: Arkansas; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Time Factors; Tuberculosis, Pleural | 1992 |
Resistance to antituberculosis drugs in treated patients in Lagos, Nigeria.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Nigeria; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1992 |
[Pulmonary infection caused by Mycobacterium gordonae (M. gordonae) in a healthy middle-aged male].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis, Pulmonary | 1992 |
Tuberculosis in the 1990's: resurgence, regimens, and resources.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Child; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; False Negative Reactions; Humans; Isoniazid; Pyrazinamide; Radiography, Thoracic; Rifampin; Risk Factors; Streptomycin; Tuberculosis; United States | 1992 |
[Renal tuberculosis treated with rifampicin, isoniazid and ofloxacin].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Rifampin; Tuberculosis, Renal | 1992 |
Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.
Topics: Animals; Colony Count, Microbial; Drug Combinations; Female; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spleen; Tuberculosis | 1992 |
[A radiographic progression during and after initial chemotherapy for pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Radiography, Thoracic; Rifampin; Tuberculosis, Pulmonary | 1992 |
Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
From the Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement.
Topics: Black or African American; Black People; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; South Africa; Streptomycin; Tuberculosis | 1992 |
High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia.
Topics: Adolescent; Adult; Age Factors; Aged; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Saudi Arabia; Sex Factors; Streptomycin; Tuberculosis, Pulmonary | 1992 |
The treatment of diffuse cutaneous leishmaniasis: a report of two cases.
Topics: Adolescent; Adult; Antimony Sodium Gluconate; Biopsy; Female; Humans; Isoniazid; Ketoconazole; Leishmaniasis; Levamisole; Male; Rifampin; Ultraviolet Therapy | 1991 |
HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; CD4-Positive T-Lymphocytes; Drug Resistance, Microbial; Female; HIV Seropositivity; HIV Seroprevalence; Humans; Immune Tolerance; Isoniazid; Leukocyte Count; Male; Middle Aged; Mycobacterium tuberculosis; New York City; Rifampin; T-Lymphocytes, Regulatory; Tuberculosis | 1991 |
Contemporary management of cervical tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Biopsy, Needle; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Neck; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Sputum; Streptomycin; Tuberculin Test; Tuberculosis, Lymph Node | 1992 |
Mycobacterium bovis (BCG) vaccination. Progressive disease in a patient asymptomatically infected with the human immunodeficiency virus.
Topics: Adult; BCG Vaccine; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Mycobacterium bovis; Rifampin; Tuberculosis | 1992 |
Stability of isoniazid, rifampin and pyrazinamide in suspensions used for the treatment of tuberculosis in children.
Topics: Ascorbic Acid; Child; Chromatography, High Pressure Liquid; Drug Stability; Humans; Isoniazid; Pyrazinamide; Rifampin; Suspensions; Temperature; Tuberculosis | 1991 |
AIDS and tuberculosis in Spain. A report of 140 cases.
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Prospective Studies; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Spain; Streptomycin; Substance Abuse, Intravenous; Tuberculosis; Tuberculosis, Pulmonary | 1991 |
[Anti-tuberculosis antibodies in the immunoenzyme test in relation to the effectiveness of chemotherapy of tuberculosis].
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Drug Therapy, Combination; Female; Humans; Immunoenzyme Techniques; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1991 |
[Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
Topics: Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary; Wound Healing | 1991 |
[Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Ethambutol; Isoniazid; Liver; Liver Function Tests; Male; Rats; Rifampin | 1991 |
Erythema induratum (Bazin's disease).
Topics: Aged; Erythema Induratum; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculin Test | 1991 |
A new short-term combination therapy of leprosy.
Topics: Adult; Aged; Drug Therapy, Combination; Erythema Nodosum; Female; Follow-Up Studies; Humans; Isoniazid; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Recurrence; Rifampin; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 1991 |
[Standardized controlled antitubercular therapy and results in 755 patients].
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1991 |
Disseminated intravascular coagulopathy associated with rifampicin.
Topics: Adult; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1991 |
Hepatitis and antitubercular therapy.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Rifampin; Risk Factors | 1991 |
[Tuberculosis of the larynx, oral cavity and pharynx].
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy; Ethambutol; Humans; Isoniazid; Male; Pharyngeal Diseases; Pharyngeal Neoplasms; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Laryngeal; Tuberculosis, Oral | 1991 |
Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991.
Topics: Acquired Immunodeficiency Syndrome; Cross Infection; Drug Resistance, Microbial; Ethambutol; Florida; HIV Infections; Humans; Isoniazid; New York City; Rifampin; Tuberculosis, Pulmonary | 1991 |
[A differential method of pharmacological prevention of tuberculosis in children in a sanatorium].
Topics: Adolescent; Carrier State; Child; Ethambutol; Health Resorts; Humans; Isoniazid; Respiratory Tract Infections; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary; Ukraine | 1991 |
[Effectiveness of tocopherol and anti-hypoxic agents in liver damage caused by antitubercular agents].
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hepatitis, Animal; Inosine Diphosphate; Isoniazid; Male; Piracetam; Pyrazinamide; Rats; Rifampin; Vitamin E | 1991 |
[Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Topics: Adult; Aged; Drug Therapy, Combination; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1991 |
From the Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991.
Topics: Acquired Immunodeficiency Syndrome; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Ethambutol; Florida; HIV Infections; Humans; Isoniazid; Middle Aged; New York City; Rifampin; Tuberculosis, Pulmonary | 1991 |
A maternal death caused by AIDS. Case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Eflornithine; Female; Humans; Isoniazid; Opportunistic Infections; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Prognosis; Rifampin | 1991 |
[Adverse effect of etiotropic agents in patients with tuberculosis].
Topics: Alcohol Drinking; Drug Hypersensitivity; Ethionamide; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1991 |
Skeletal tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Risk Factors; Spinal Diseases; Time Factors; Tuberculosis, Osteoarticular | 1991 |
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1991 |
[Effects of isoniazid and rifampicin on cell elements of cultured intact pulmonary tissue from experimental animals].
Topics: Animals; Culture Techniques; Dogs; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1991 |
Memory T cell-mediated resistance to Mycobacterium tuberculosis infection in innately susceptible and resistant mice.
Topics: Animals; Cyclophosphamide; Immunity, Cellular; Immunization, Passive; Immunologic Memory; Immunotherapy, Adoptive; Isoniazid; Male; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Rifampin; T-Lymphocyte Subsets; T-Lymphocytes; Tuberculosis | 1991 |
Hepatotoxicity of rifampin and isoniazid. Is it all drug-induced hepatitis?
Topics: Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Female; Hepatitis A; Hepatitis B; Hepatitis C; Humans; Infant; Isoniazid; Liver; Male; Rifampin; Tuberculosis | 1991 |
Short course chemotherapy for pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Self Administration; Time Factors; Tuberculosis, Pulmonary | 1991 |
The management of pulmonary tuberculosis in adults notified in England and Wales in 1988. The British Thoracic Society Research Committee and the Medical Research Council Cardiothoracic Epidemiology Group.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; England; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Wales | 1991 |
Six-months isoniazid-rifampin treatment for pulmonary tuberculosis in children.
Topics: Child; Costs and Cost Analysis; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1991 |
The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite.
Topics: Acetylation; Adult; Aged; Aged, 80 and over; Aging; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1991 |
The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide.
Topics: Adult; Aged; Aged, 80 and over; Aging; Female; Humans; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1991 |
Radiometric and conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Carbon Radioisotopes; Ethambutol; Isoniazid; Isotope Labeling; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1991 |
Short course chemotherapy for endometrial tuberculosis in infertile women.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Rifampin; Tuberculosis, Female Genital | 1990 |
Cutaneous tuberculosis: atypical skin lesions in immunodepressed patients.
Topics: Adult; Colitis, Ulcerative; Ethambutol; Humans; Isoniazid; Prednisone; Rifampin; Sulfasalazine; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 1990 |
Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis.
Topics: Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Steroids; Streptomycin; Tuberculosis, Meningeal | 1991 |
Chromosomal aberrations in tuberculosis patients before and after treatment with short-term chemotherapy.
Topics: Chromosome Aberrations; Drug Therapy, Combination; Humans; Isoniazid; Mutagens; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1991 |
[Pitfalls in the diagnosis of tuberculous arthritis].
Topics: Adolescent; Adult; Aged; Arthritis, Infectious; Arthritis, Rheumatoid; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Joint Prosthesis; Male; Middle Aged; Rifampin; Tuberculosis, Osteoarticular | 1991 |
[Three cases of localized pleural tuberculosis which looked exacerbated during antituberculous chemotherapy].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pleural | 1991 |
[Two cases of appearance of a new intrapulmonary lesion during antituberculous chemotherapy in tuberculous pleuritis].
Topics: Adult; Antitubercular Agents; Bronchoscopy; Drug Therapy, Combination; Female; Humans; Isoniazid; Lung; Male; Rifampin; Streptomycin; Tuberculosis, Pleural | 1991 |
[Laryngeal tuberculosis today. A case report].
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Laryngoscopy; Larynx; Rifampin; Tuberculosis, Laryngeal | 1991 |
Hepatoxic reaction to antituberculous drugs: Adjustments to therapeutic regimen.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Protocols; Humans; Isoniazid; Liver Diseases; Pyrazinamide; Rifampin | 1991 |
Tuberculosis of the lacrimal gland.
Topics: Adolescent; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lacrimal Apparatus; Rifampin; Streptomycin; Tuberculosis, Ocular | 1991 |
Determination of in vivo and in vitro drug effects of mycobacteria from the mass spectrometric analysis of single organisms.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Isoniazid; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Mass Spectrometry; Mycobacterium; Mycobacterium leprae; Polymyxin B; Potassium; Rifampin; Sodium; Trimethoprim | 1991 |
[Drug therapy of intractable Mycobacterium infections].
Topics: Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin; Tuberculosis | 1990 |
A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Aspartate Aminotransferases; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1990 |
Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Bacteriological Techniques; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1990 |
The pathogenicity of Mycobacterium tuberculosis during chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Fluorescent Antibody Technique; Guinea Pigs; Humans; Injections, Subcutaneous; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1990 |
[Short- and long-term results of tuberculosis therapy with a fixed combination of isoniazide, prothionamide and diaminodiphenylsulfone combined with rifampicin].
Topics: Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Isonicotinic Acids; Long-Term Care; Male; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1990 |
[In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1990 |
Cutaneous inoculation tuberculosis in laboratory personnel.
Topics: Accidents, Occupational; Adolescent; Adult; Ethambutol; Female; Humans; Injections; Isoniazid; Laboratory Infection; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Cutaneous | 1990 |
The mycobacteriology of pulmonary tuberculosis in South African gold miners.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Male; Mining; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Recurrence; Rifampin; South Africa; Streptomycin; Tuberculosis, Pulmonary | 1990 |
Antituberculous drug resistance in central Haiti.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Haiti; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1990 |
In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1990 |
Use of a radiometric technique for rapid sensitivity testing of mycobacteria in Scotland: the first year's experience.
Topics: Carbon Radioisotopes; Culture Media; Drug Resistance, Microbial; Egg Proteins; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Radiometry; Rifampin; Scotland | 1990 |
[Tuberculosis: a disease that is difficult to eradicate. Description of a case].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Lymph Node | 1990 |
Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine.
Topics: Acetylation; Arthritis, Rheumatoid; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Peripheral Nervous System Diseases; Pyridoxine; Rifampin; Tuberculosis, Pulmonary | 1990 |
[Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enviomycin; Ethambutol; Humans; Isoniazid; Mycobacterium; Mycobacterium Infections; Ofloxacin; Rifampin; Viomycin | 1990 |
[The treatment of primary tuberculosis].
Topics: Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1990 |
[An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical].
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Guinea Pigs; Heterocyclic Compounds; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1990 |
Any questions? How should a patient be managed who is being treated for sputum positive pulmonary tuberculosis and becomes jaundiced in the third week of chemotherapy?
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Jaundice; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1990 |
Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population.
Topics: Alanine Transaminase; Alkaline Phosphatase; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Zimbabwe | 1990 |
Effectiveness of multidrug therapies in tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1990 |
Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1990 |
Brain stem tuberculoma in adult patients: diagnosis and treatment.
Topics: Adult; Brain Diseases; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculoma | 1990 |
Rapid oral desensitization to isoniazid and rifampin.
Topics: Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Isoniazid; Middle Aged; Rifampin; Skin Tests | 1990 |
[Preliminary report of short-course tuberculosis of the spine].
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Spinal | 1990 |
Tuberculous meningitis. Short course of chemotherapy.
Topics: Adolescent; Adult; Aged; Child; Drug Combinations; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 1990 |
Antituberculous drug susceptibility testing of Mycobacterium bovis BCG strain Montréal.
Topics: Aminosalicylic Acid; Antitubercular Agents; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium bovis; Rifampin; Streptomycin | 1990 |
[Treatment of tuberculosis. Drug combinations, therapeutic problems and results in a 10-year case load].
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1990 |
Drug combinations and the bioavailability of rifampicin.
Topics: Antitubercular Agents; Biological Availability; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1990 |
Tuberculous meningitis. 23 cases from a 12-year period (1976-1987).
Topics: Adolescent; Adult; Blood Cell Count; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prednisone; Pyridoxine; Retrospective Studies; Rifampin; Tuberculosis, Meningeal | 1990 |
[Clinico-laboratory diagnosis of adverse reactions in children to antitubercular drugs in different combinations].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1990 |
[Transamination processes in mycobacteria with different biological properties].
Topics: Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Drug Resistance, Microbial; Isoniazid; Mycobacterium; Mycobacterium phlei; Nontuberculous Mycobacteria; Rifampin; Streptomycin | 1990 |
[Drugs used in tuberculosis and leprosy].
Topics: Administration, Oral; Antibiotics, Antitubercular; Clofazimine; Dapsone; Humans; Injections, Intramuscular; Isoniazid; Leprostatic Agents; Leprosy; Rifampin; Streptomycin; Tuberculosis | 1990 |
Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
Topics: Carrier State; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Hepatitis B; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1990 |
[Chemoprophylaxis of tuberculosis].
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Humans; Infant; Isoniazid; Rifampin; Tuberculosis | 1990 |
[Therapeutic drug monitoring of antituberculosis drugs].
Topics: Age Factors; Aminosalicylic Acid; Antitubercular Agents; Biological Availability; Dosage Forms; Drug Interactions; Humans; Isoniazid; Kidney Diseases; Liver Diseases; Rifampin; Streptomycin | 1990 |
Tuberculosis control and the AIDS epidemic in developing countries.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Developing Countries; Diagnosis, Differential; Disease Outbreaks; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1990 |
[Clinico-pharmacokinetic interactions of rifampicin, pyrazinamide and isoniazide].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Infusions, Intravenous; Isoniazid; Metabolic Clearance Rate; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1990 |
[Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
Topics: Acetylation; Administration, Oral; Ethambutol; Humans; Isoniazid; Metabolic Clearance Rate; Mixed Function Oxygenases; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1990 |
[Six-month treatment of pulmonary tuberculosis in children. Review of 11 cases].
Topics: Antitubercular Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Rifampin; Spain; Tuberculosis, Pulmonary | 1990 |
Salivary levels of isoniazid and rifampicin in tuberculous patients.
Topics: Adolescent; Adult; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Saliva; Tuberculosis; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 1990 |
Failure of tuberculosis chemotherapy in a human immunodeficiency virus-infected patient.
Topics: Adult; HIV Infections; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 1990 |
[The efficacy of the treatment of newly diagnosed patients with destructive tuberculosis of the lungs using rifampicin in combination with other drugs].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1990 |
Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Confidence Intervals; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Prognosis; Pyrazinamide; Radiography; Regression Analysis; Retrospective Studies; Rifampin; Survival Rate; Time Factors; Tuberculosis, Miliary | 1990 |
[Approach to chemotherapy of vertebral tuberculosis].
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Streptomycin; Tuberculosis, Spinal | 1990 |
Choroidal tuberculomas without evidence of extraocular tuberculosis.
Topics: Adult; Choroiditis; Fundus Oculi; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Ocular; Visual Acuity | 1990 |
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Evaluation; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1986 |
Cost savings from alternative treatments for tuberculosis.
Topics: Ambulatory Care; Antitubercular Agents; Botswana; Cost-Benefit Analysis; Ethambutol; Humans; Isoniazid; Patient Compliance; Retrospective Studies; Rifampin; Thioacetazone; Tuberculosis | 1986 |
180 doses in 26 weeks vs 56 doses in 24 weeks of chemotherapy in pulmonary tuberculosis: a preliminary report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Thioacetazone; Tuberculosis, Pulmonary | 1988 |
MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Culture Media; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1988 |
Macular subretinal neovascularization in choroidal tuberculosis.
Topics: Choroid; Ethambutol; Female; Fluorescein Angiography; Fundus Oculi; Humans; Isoniazid; Macula Lutea; Middle Aged; Neovascularization, Pathologic; Photography; Retina; Retinal Diseases; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Ocular; Visual Acuity | 1989 |
Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Tuberculosis | 1989 |
Problems of tuberculosis treatment in Thailand.
Topics: Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Female; Humans; Isoniazid; Male; National Health Programs; Pyrazinamide; Rifampin; Streptomycin; Thailand; Thioacetazone; Tuberculosis | 1989 |
Determination of isoniazid in pharmaceutical preparations by reaction with radiochloramine-B.
Topics: Aminosalicylic Acid; Ascorbic Acid; Chloramines; Indicators and Reagents; Isoniazid; Rifampin | 1989 |
Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig.
Topics: Animals; BCG Vaccine; Guinea Pigs; Immunity; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1989 |
Accidental poisoning with isoniazid and rifampicin in an infant: role of peritoneal dialysis.
Topics: Accidents, Home; Female; Humans; Infant; Isoniazid; Peritoneal Dialysis; Rifampin; Seizures | 1989 |
Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.
Topics: Animals; Anti-Bacterial Agents; Disease Susceptibility; Drug Therapy, Combination; Female; Immunity, Innate; Isoniazid; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mycobacterium bovis; Mycobacterium tuberculosis; Recurrence; Rifampin; Tuberculosis | 1989 |
Mycobacterium tuberculosis cervical adenitis. Diagnosis and management.
Topics: Adolescent; Child; Diagnosis, Differential; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Neck; Rifampin; Tuberculin Test; Tuberculosis, Lymph Node | 1989 |
[Two cases of long-lasting SPCN status].
Topics: Adult; Drug Resistance; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1989 |
[The etiopathogenetic treatment of experimental tuberculosis using preparations with immunomodulating action].
Topics: Adjuvants, Immunologic; Animals; Drug Evaluation, Preclinical; Drug Therapy, Combination; Guinea Pigs; Immunity; Isoniazid; Levamisole; Male; Mycobacterium tuberculosis; Ribonucleases; Rifampin; Succinates; Succinic Acid; Time Factors; Tuberculosis | 1989 |
Resistance to antituberculosis drugs in Riyadh, Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Saudi Arabia; Streptomycin | 1989 |
Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
Topics: Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Libya; Male; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1989 |
Superiority of enviomycin or streptomycin over ethambutol in initial treatment of lung disease caused by Mycobacterium avium complex.
Topics: Clinical Protocols; Drug Combinations; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Sputum; Streptomycin; Viomycin | 1989 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1989 |
Antimycobacterial chemotherapy in inflammatory bowel disease.
Topics: Adult; Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium; Rifampin; Sulfasalazine | 1989 |
[Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Miliary | 1989 |
Combination chemotherapy with ciprofloxacin for infection with Mycobacterium tuberculosis in mouse models.
Topics: Animals; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Isoniazid; Male; Mice; Rifampin; Tuberculosis | 1989 |
[Quantitative determination of isoniazid and rifampicin in the urine of patients treated with combination of drugs].
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin | 1989 |
[Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
Topics: Adolescent; Africa; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Combinations; Female; Hepatitis B; Humans; Infant; Isoniazid; Liver; Male; Nutrition Disorders; Rifampin; Transaminases; Tuberculosis, Pulmonary | 1989 |
Six months' chemotherapy for lymph node tuberculosis.
Topics: Adolescent; Adult; Drug Administration Schedule; Female; Humans; India; Isoniazid; Male; Middle Aged; Prognosis; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Lymph Node; United Kingdom | 1989 |
Isoniazid-related hepatotoxicity: a study of the effect of rifampicin administration on the metabolism of acetylisoniazid in man.
Topics: Acetylation; Adult; Carcinogens; Humans; Hydrazines; Isoniazid; Liver; Male; Rifampin | 1989 |
Mycobacterium simiae as a cause of intra-abdominal disease: a case report.
Topics: Abdomen; Adult; Ascitic Fluid; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Pyrazinamide; Rifampin | 1989 |
Application of the least-squares method in the matrix form: simultaneous spectrophotometric determination of rifampicin and isoniazid in binary pharmaceutical formulations.
Topics: Isoniazid; Least-Squares Analysis; Rifampin; Spectrophotometry, Ultraviolet | 1989 |
Multiple cold abscesses in a borderline lepromatous patient on multidrug therapy.
Topics: Abscess; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Ethambutol; Hip Joint; Humans; Isoniazid; Leprosy, Borderline; Leprosy, Lepromatous; Male; Rifampin; Tuberculosis, Osteoarticular | 1989 |
[Tuberculosis in children in 1989].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Age Factors; Anti-Bacterial Agents; BCG Vaccine; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1989 |
Non-surgical treatment of tuberculomas of the brain.
Topics: Adult; Antitubercular Agents; Brain Diseases; Drug Combinations; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tomography, X-Ray Computed; Tuberculoma | 1989 |
Hepatic function in relation to acetylator phenotype in children treated with antitubercular drugs.
Topics: Acetylation; Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Liver; Male; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1989 |
[Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Gentamicins; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Species Specificity | 1989 |
[A short course of chemotherapy in newly diagnosed and retreatment of smear-positive pulmonary tuberculosis in a rural area].
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Rifampin; Rural Population; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1989 |
[Tuberculous ulcer of the tongue: clinical case].
Topics: Adult; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tongue Diseases; Tuberculosis; Tuberculosis, Oral; Tuberculosis, Pulmonary; Ulcer | 1989 |
Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Mycobacterium leprae; Paraguay; Patient Compliance; Prothionamide; Rifampin; Time Factors | 1989 |
Tuberculous meningitis in children: treatment with isoniazid and rifampicin for twelve months.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrocephalus; Infant; Intellectual Disability; Isoniazid; Male; Rifampin; Tuberculosis, Meningeal | 1989 |
Prolonged use of intravenous isoniazid and rifampin.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Isoniazid; Middle Aged; Rifampin; Tuberculosis, Miliary | 1989 |
Isoniazid-rifampicin-induced submassive hepatic necrosis.
Topics: Chemical and Drug Induced Liver Injury; Female; Hepatic Encephalopathy; Humans; Isoniazid; Liver; Middle Aged; Necrosis; Rifampin | 1989 |
Treatment of tuberculous meningitis in adults with a combination of isoniazid, rifampicin and streptomycin: a prospective study.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nervous System Diseases; Prospective Studies; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1989 |
Importance of rifampicin in combined daily/intermittent chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prothionamide; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1989 |
[Tuberculous meningitis].
Topics: Child; Drug Therapy, Combination; Female; Humans; Isoniazid; Middle Aged; Rifampin; Time Factors; Tuberculosis, Meningeal | 1989 |
[Hepatotoxic effect of a combination of pyrazinamide with isoniazid and rifampicin].
Topics: Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Synergism; Isoniazid; Liver; Male; Pyrazinamide; Rats; Rifampin | 1989 |
Human bioavailability studies.
Topics: Biological Availability; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin | 1989 |
Hypercalcaemia in a child with miliary tuberculosis.
Topics: Calcium; Humans; Hypercalcemia; Infant; Isoniazid; Male; Prednisone; Rifampin; Streptomycin; Tuberculosis, Miliary; Vitamin D | 1989 |
Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer.
Topics: Administration, Intravesical; Aged; BCG Vaccine; Carcinoma, Transitional Cell; Humans; Isoniazid; Male; Prednisolone; Rifampin; Time Factors; Tuberculosis; Urinary Bladder Neoplasms | 1989 |
Internuclear ophthalmoplegia in tuberculous meningitis.
Topics: Adult; Brain Stem; Cerebral Infarction; Dexamethasone; Drug Therapy, Combination; Endarteritis; Humans; Isoniazid; Male; Middle Aged; Ophthalmoplegia; Prognosis; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 1989 |
[Treatment efficacy in destructive forms of pulmonary tuberculosis in relation to the methods of administering rifadin and isoniazid].
Topics: Administration, Inhalation; Administration, Oral; Adult; Bronchi; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1989 |
Progression of kyphosis in tuberculosis of the spine treated by anterior arthrodesis.
Topics: Adolescent; Adult; Bone Transplantation; Child; Child, Preschool; Debridement; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Kyphosis; Male; Random Allocation; Rifampin; Spinal Fusion; Tuberculosis, Spinal | 1989 |
[Effectiveness of INH-rifampicin treatment of lymph node tuberculosis].
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Rifampin; Tuberculosis, Lymph Node | 1989 |
[Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1989 |
Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254.
Topics: Animals; Antitubercular Agents; Culture Media; Hydrogen-Ion Concentration; In Vitro Techniques; Isoniazid; Macrophages; Mice; Mice, Inbred BALB C; Mycobacterium Infections; Pyrazinamide; Rifampin; Streptomycin; Time Factors | 1989 |
Less is more: short-course preventive therapy of tuberculosis.
Topics: Animals; Humans; Isoniazid; Mice; Rifampin; Tuberculosis | 1989 |
Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.
Topics: Animals; BCG Vaccine; Colony Count, Microbial; Drug Administration Schedule; Drug Therapy, Combination; Isoniazid; Mice; Pyrazinamide; Rifampin; Spleen; Time Factors; Tuberculosis | 1989 |
[Original treatment of pulmonary tuberculosis by enviomycin (EVM)].
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Enviomycin; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary; Viomycin | 1987 |
Antimycobacterial drugs and the production of reactive oxidants by polymorphonuclear leucocytes in vitro.
Topics: Antitubercular Agents; Ethambutol; In Vitro Techniques; Isoniazid; Luminescent Measurements; Neutrophils; Oxidation-Reduction; Peroxidase; Pyrazinamide; Rifampin; Streptomycin | 1988 |
Neurotoxicity of antituberculous drugs in a patient without active tuberculosis.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Optic Atrophy; Peripheral Nervous System Diseases; Rifampin | 1988 |
Treatment of nontuberculous mycobacterial infections in pediatric patients.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-Infective Agents; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium Infections; Rifabutin; Rifampin; Rifamycins; Streptomycin | 1988 |
Pulmonary problems of pregnancy.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Asthma; Drug Therapy, Combination; Ethambutol; Female; Heparin; Humans; Infant, Newborn; Isoniazid; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Infectious; Pulmonary Embolism; Rifampin; Theophylline; Tuberculosis, Pulmonary | 1985 |
Hepatic toxicity during chemotherapy for severe tuberculosis meningitis.
Topics: Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Child, Preschool; Drug Combinations; Ethionamide; gamma-Glutamyltransferase; Humans; Infant; Isoniazid; Liver Diseases; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 1987 |
[Sequential development of vitamin D metabolites under isoniazid and rifampicin therapy].
Topics: Adolescent; Adult; Alkaline Phosphatase; Calcitriol; Child; Child, Preschool; Female; gamma-Glutamyltransferase; Humans; Hydroxycholecalciferols; Isoniazid; Male; Parathyroid Hormone; Rifampin; Tuberculosis, Pulmonary | 1988 |
Smear- and culture-negative pulmonary tuberculosis: four-month short-course chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Arkansas; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Rifampin; Sputum; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary | 1989 |
Pulmonary tuberculosis, cryoglobulinemia and immunecomplex glomerulonephritis.
Topics: Adult; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis; Humans; Immune Complex Diseases; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1987 |
[Routine use of 6-month antitubercular treatment in 300 patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 1986 |
Isoniazid, rifampin, and hepatotoxicity.
Topics: Acetylation; Asian; Chemical and Drug Induced Liver Injury; Drug Combinations; Drug Interactions; Humans; Isoniazid; Peripheral Nervous System Diseases; Rifampin; Risk; Time Factors; Tuberculosis | 1986 |
The role of host factors for the chemotherapy of BCG infection in inbred strains of mice.
Topics: Animals; Cyclosporins; Immunity; Isoniazid; Mice; Mice, Inbred Strains; Mycobacterium bovis; Rifampin; Time Factors; Tuberculosis | 1988 |
Evaluation of streptomycin and ethambutol concentrations for susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional procedures.
Topics: Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiometry; Rifampin; Streptomycin | 1986 |
Nonweekend schedule for BACTEC drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Dose-Response Relationship, Drug; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 1986 |
Effect of dose formulation on isoniazid absorption in two young children.
Topics: Administration, Oral; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infant; Injections, Intramuscular; Intestinal Absorption; Isoniazid; Kinetics; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Meningeal | 1986 |
Tuberculosis in Korea. The relationship between prior therapy and drug resistance.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Korea; Microbial Sensitivity Tests; Military Personnel; Mycobacterium tuberculosis; Rifampin; Risk; Streptomycin; Tuberculosis, Pulmonary; United States | 1986 |
Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis.
Topics: Animals; Drug Therapy, Combination; Interferon-gamma; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Rifampin; Spleen; Time Factors; Tuberculosis | 1986 |
[Comparative therapeutic activity of rifampicin and isoniazid in different densities of microbial population in the lungs of experimental animals].
Topics: Animals; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1986 |
Primary drug-resistant tuberculosis in children. Emergence of primary drug-resistant strains of M. tuberculosis to rifampin.
Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Humans; Infant; Infant, Newborn; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Pulmonary | 1986 |
Drug-resistant tuberculosis in Sierra Leone.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sierra Leone; Streptomycin; Tuberculosis | 1986 |
The Birmingham Tuberculosis Drug Resistance Register, 1956-1983.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Emigration and Immigration; England; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Registries; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Topics: Anti-Bacterial Agents; Clofazimine; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Streptomycin; Sulfamethoxazole | 1986 |
Effects of recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin on infections of mouse peritoneal macrophages with Listeria monocytogenes and Mycobacterium microti in vitro.
Topics: Animals; Bacterial Infections; Cells, Cultured; Drug Therapy, Combination; Interferon-gamma; Isoniazid; Listeriosis; Lymphokines; Macrophages; Mice; Mice, Inbred BALB C; Mycobacterium Infections; Recombinant Proteins; Rifampin | 1986 |
A rapid method for the evaluation of new antituberculous agents.
Topics: Antitubercular Agents; Carbon Dioxide; Ethambutol; Guanidines; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Scintillation Counting; Streptomycin; Succinimides; Thiazoles; Time Factors | 1987 |
[Theoretical basis for the treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Resistance; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1986 |
[Detection of pulmonary tuberculosis in adolescents in institutions of the general medical network and efficacy of its treatment].
Topics: Adolescent; Antitubercular Agents; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculin Test; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1987 |
[Prospective study on the preliminary evaluation of a tuberculosis susceptibility test with the micro-culture dish method using native products].
Topics: Aminosalicylic Acid; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Streptomycin | 1987 |
In vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic: RU-28965.
Topics: Antibiotics, Antitubercular; Drug Combinations; Drug Evaluation, Preclinical; Isoniazid; Leucomycins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 1987 |
Augmentation of hepatic uridine-diphosphate glucuronyl transferase activity by antituberculous drugs in hamsters in vivo.
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Bilirubin; Cricetinae; Enzyme Activation; Glucuronosyltransferase; Hydrocortisone; Isoniazid; Liver; Male; Rifampin; Time Factors | 1987 |
In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazines; Rifampin | 1987 |
The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy.
Topics: Dapsone; Drug Resistance, Microbial; Humans; Isoniazid; Leprosy; Mycobacterium leprae; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1987 |
[Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Outpatient Clinics, Hospital; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1987 |
[Long-term results of short-course chemotherapy in pulmonary tuberculosis (final report). The third study: comparative study of two regimens, 6RHZ and -6RHS (treatment was continued for 6 months after negative conversion of sputum by culture)].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1988 |
Direct antimicrobial drug susceptibility testing of Mycobacterium tuberculosis by the radiometric method.
Topics: Bacteriological Techniques; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiometry; Rifampin; Sputum; Streptomycin | 1988 |
Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1988 |
Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP.
Topics: Adenosine Triphosphate; Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Isoniazid; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Radiometry; Rifampin; Streptomycin; Time Factors | 1988 |
Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan.
Topics: Antitubercular Agents; China; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Osmolar Concentration; Rifampin; Streptomycin; Tuberculosis; United States | 1988 |
The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; San Francisco; Sputum; Time Factors; Tuberculosis, Pulmonary | 1988 |
Airway obstruction secondary to tuberculosis lymph node erosion into the trachea: drainage via bronchoscopy.
Topics: Airway Obstruction; Bronchoscopy; Drainage; Female; Humans; Infant; Isoniazid; Pyrazinamide; Radiography; Rifampin; Tracheal Diseases; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1988 |
Identification and control of paratuberculosis in a large goat herd.
Topics: Animals; Disease Outbreaks; Ethambutol; Female; Goats; Immunodiffusion; Isoniazid; Male; Paratuberculosis; Rifampin; Sex Factors; Weight Loss | 1988 |
In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin | 1988 |
[New and future drugs in pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1988 |
Complex interaction of rifampin and warfarin.
Topics: Adult; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Isoniazid; Lung Diseases, Obstructive; Prothrombin Time; Rifampin; Stimulation, Chemical; Tuberculosis, Pulmonary; Warfarin | 1988 |
Management and outcome of pulmonary tuberculosis in adults notified in England and Wales in 1983. Medical Research Council Tuberculosis and Chest Diseases Unit.
Topics: Adolescent; Adult; Antitubercular Agents; Bangladesh; Drug Administration Schedule; England; Ethambutol; Female; Follow-Up Studies; Hospitalization; Humans; India; Isoniazid; Male; Pakistan; Patient Acceptance of Health Care; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Wales | 1988 |
Rifampicin-isoniazid and delayed elimination of theophylline: a case report.
Topics: Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Lung Diseases, Obstructive; Male; Middle Aged; Recurrence; Rifampin; Theophylline; Time Factors; Tuberculosis, Pulmonary | 1988 |
Failure of ketoconazole treatment of Blastomyces dermatitidis [corrected] due to interaction of isoniazid and rifampin.
Topics: Blastomycosis; Drug Interactions; Female; Humans; Isoniazid; Ketoconazole; Middle Aged; Rifampin | 1988 |
Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording device.
Topics: Adult; Drug Therapy, Combination; Electronics, Medical; Female; Humans; Isoniazid; Male; Patient Compliance; Rifampin; Tuberculosis, Pulmonary | 1988 |
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. I. Single-dose study.
Topics: Adult; Antitubercular Agents; Biological Availability; Drug Administration Schedule; Drug Combinations; Female; Humans; Isoniazid; Male; Middle Aged; Osmolar Concentration; Pyrazinamide; Rifampin | 1988 |
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Biological Availability; Drug Administration Schedule; Drug Combinations; Female; Humans; Isoniazid; Male; Middle Aged; Osmolar Concentration; Pyrazinamide; Rifampin | 1988 |
[Pharmacokinetics of isoniazid and rifampicin in an experiment and in clinical practice].
Topics: Animals; Female; Half-Life; Humans; Isoniazid; Male; Rats; Rifampin | 1988 |
Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
Topics: Acetylation; Adult; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Nutrition Disorders; Phenotype; Rifampin; Spectrometry, Fluorescence; Tuberculosis | 1988 |
[A case of Mycobacterium kansasii lung infection developed after treatment of Mycobacterium gordonae lung infection].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Tuberculosis, Pulmonary | 1988 |
[Synergistic effects of davercin, rifampicin, ethambutol and isonicotinic acid hydrazide on selected standard strains of Mycobacterium in the in-vitro and in-vivo experiments].
Topics: Animals; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; In Vitro Techniques; Isoniazid; Mice; Mycobacterium; Mycobacterium Infections; Rifampin | 1988 |
Drug induced hepatic damage.
Topics: Acetaminophen; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Hypersensitivity; Humans; Infant; Isoniazid; Rifampin | 1988 |
Tuberculous lymphadenitis in Singapore.
Topics: Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; Singapore; Tuberculosis, Lymph Node | 1988 |
A retrospective comparison of two drug regimens RHE2/RH10 and RHZ2/RH10 in the treatment of tuberculous mediastinal lymphadenopathy.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mediastinal Diseases; Middle Aged; Pyrazinamide; Radiography; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1988 |
Psoas abscess due to retroperitoneal tuberculous lymphadenopathy.
Topics: Abscess; Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Muscular Diseases; Retroperitoneal Space; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1988 |
[Short-course chemotherapy for tuberculosis in children and the partial follow-up study].
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Follow-Up Studies; Humans; Infant; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1988 |
[A crossed pharmacokinetic assay of two presentations of HRZ: one with combined components and one with isolated components H+R+Z].
Topics: Administration, Oral; Adult; Drug Combinations; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin | 1988 |
Multidrug chemotherapy of tuberculosis in rhesus monkeys.
Topics: Animals; Antitubercular Agents; Disease Outbreaks; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Macaca; Macaca mulatta; Male; Monkey Diseases; Mycobacterium bovis; Radiography; Rifampin; Tuberculosis | 1988 |
Comparison of antituberculosis drug regimens for lung disease caused by Mycobacterium avium complex.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Enviomycin; Female; Humans; Isoniazid; Male; Mycobacterium avium; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1988 |
Effects of rifampicin with and without isoniazid in rheumatoid arthritis.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin | 1988 |
Drugs for tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 1988 |
Tuberculosis presenting as laryngeal stridor in a child.
Topics: Child, Preschool; Humans; Injections, Intramuscular; Injections, Spinal; Isoniazid; Larynx; Lung; Male; Pyrazinamide; Respiratory Sounds; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculosis, Laryngeal; Tuberculosis, Miliary | 1988 |
Tuberculosis verrucosa cutis: clinical picture and response to short-course chemotherapy.
Topics: Adult; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Cutaneous | 1988 |
[Clinico-pharmacological approach to rifampicin and isoniazid dosage].
Topics: Administration, Oral; Adolescent; Adult; Half-Life; Humans; Infusions, Intravenous; Isoniazid; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1987 |
Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Nontuberculous Mycobacteria; Rifampin; Streptomycin | 1987 |
[Peritoneal tuberculosis. Apropos of a case report].
Topics: Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Peritonitis, Tuberculous; Rifampin; Tomography, X-Ray Computed | 1987 |
Effect of rifampicin induced S9 fraction on the mutagenicity of isoniazid in the Salmonella assay system.
Topics: Animals; Drug Synergism; Isoniazid; Male; Mice; Mice, Inbred Strains; Mutagenicity Tests; Rifampin; Salmonella | 1987 |
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.
Topics: Adult; Antitubercular Agents; Child; Culture Media; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Rifampin; Streptomycin | 1987 |
Conservative treatment of tuberculosis of the thoracic and lumbar spine in adults and children.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Lumbar Vertebrae; Male; Middle Aged; Rifampin; Thoracic Vertebrae; Tuberculosis, Spinal | 1987 |
BCG osteitis: a case report.
Topics: BCG Vaccine; Child, Preschool; Drug Therapy, Combination; Fibula; Humans; In Vitro Techniques; Isoniazid; Male; New Zealand; Osteomyelitis; Rifampin; Tibia; Vaccination | 1986 |
[Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Ofloxacin; Oxazines; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children.
Topics: Acetylation; Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Isoniazid; Liver Function Tests; Male; Phenotype; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1986 |
[Effect of rifampin, isoniazid and streptomycin on E receptors of T cells].
Topics: Adult; Humans; Isoniazid; Rifampin; Rosette Formation; Streptomycin; T-Lymphocytes | 1986 |
[Use of inhalation of ultrasonic aerosols and galvanic current in the treatment of patients with pulmonary tuberculosis].
Topics: Administration, Inhalation; Aerosols; Combined Modality Therapy; Electric Stimulation Therapy; Humans; Isoniazid; Pulmonary Circulation; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1987 |
American Thoracic Society. Medical Section of the American Lung Association: Treatment of tuberculosis and tuberculosis infection in adults and children.
Topics: Adult; Age Factors; Blood Cell Count; Blood Urea Nitrogen; Child; Creatinine; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Lactation; Liver; Mycobacterium bovis; Pregnancy; Pyrazinamide; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculin; Tuberculosis | 1986 |
[Lupoid syndrome in "BCG-itis." Report of a case].
Topics: Adult; BCG Vaccine; Female; Humans; Isoniazid; Lupus Vulgaris; Prednisolone; Pyrazinamide; Rifampin | 1986 |
Pott's paraplegia.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Paraplegia; Pyrazinamide; Rifampin; Spinal Canal; Spinal Fusion; Streptomycin; Tuberculosis, Spinal | 1987 |
[Atypical mycobacterial pulmonary infections. Apropos of a case in a newborn infant].
Topics: Humans; Infant; Isoniazid; Male; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Rifampin; Tuberculosis, Pulmonary | 1987 |
New approach to treatment of pulmonary and extrapulmonary tuberculosis. Possible ramifications of cutaneous mycobacterial infections.
Topics: Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 1987 |
[Prognosis of isoniazid-resistant patients of pulmonary tuberculosis].
Topics: Adult; Aged; Drug Resistance; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Prognosis; Rifampin; Tuberculosis, Pulmonary | 1987 |
[A case of allergic shock caused by readministration of rifampicin].
Topics: Adult; Drug Hypersensitivity; Female; Humans; Isoniazid; Rifampin; Shock, Septic; Tuberculosis, Pulmonary | 1987 |
The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothionamide; Rifampin | 1986 |
First assessment of the Malta Leprosy Eradication Project.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Malta; Prothionamide; Recurrence; Rifampin | 1986 |
Report of the joint leprosy-tuberculosis project in Paraguay.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Leprostatic Agents; Leprosy; Paraguay; Prothionamide; Rifampin; Tuberculosis | 1986 |
The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Isonicotinic Acids; Leprostatic Agents; Leprosy; Male; Prothionamide; Rifampin; Tanzania | 1986 |
Effect of rifampin, phenobarbital pretreatment, and acetylator phenotype on acetylisoniazid metabolism in the rabbit.
Topics: Acetylation; Animals; Isoniazid; Kinetics; Liver; Male; Phenobarbital; Phenotype; Protein Binding; Rabbits; Rifampin; Tissue Distribution | 1987 |
In vitro susceptibility of Mycobacterium avium to a new macrolide (RU-28965).
Topics: Anti-Bacterial Agents; Drug Interactions; Isoniazid; Leucomycins; Microbial Sensitivity Tests; Mycobacterium avium; Rifampin; Sulfamethoxypyridazine | 1987 |
From the Centers for Disease Control. Conference on new approaches for tuberculosis preventive therapy.
Topics: Antitubercular Agents; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1987 |
Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Osmolar Concentration; Radiometry; Rifampin; Streptomycin | 1987 |
[Chemotherapy of pulmonary tuberculosis. Sputum culture conversion in 8 weeks in 84% of patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Isoniazid; Lung; Male; Middle Aged; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1987 |
[Investigation on bacteriological relapses in cases of pulmonary tuberculosis treated with INH and RFP--report of the 27th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan
Topics: Adult; Aged; Female; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1987 |
Remission of pulmonary alveolar proteinosis during antituberculous chemotherapy.
Topics: Antitubercular Agents; Humans; Isoniazid; Male; Middle Aged; Pulmonary Alveolar Proteinosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1987 |
[Comparative evaluation of the effectiveness of treatment with rifampicin and isoniazid administered at various intervals].
Topics: Drug Administration Schedule; Humans; Injections, Intravenous; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1987 |
Treatment of tuberculous meningitis: role of short-course chemotherapy.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1987 |
Mycobacterium malmoense--report of a case in Switzerland.
Topics: Bronchoalveolar Lavage Fluid; Erythromycin; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pneumonectomy; Rifampin; Sputum; Switzerland | 1987 |
Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1987 |
Tuberculous pleural effusion and lymphadenitis treated with rifampin-containing regimen.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pleural Effusion; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Pleural | 1987 |
[Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients].
Topics: Acetylation; Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1987 |
Is medical therapy effective for regional lymphadenitis following BCG vaccination?
Topics: BCG Vaccine; Erythromycin; Humans; Infant; Infant, Newborn; Isoniazid; Lymphadenitis; Rifampin | 1987 |
Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; England; Humans; India; Infant; Infant, Newborn; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis | 1987 |
Pharmacokinetics of antituberculosis drugs in patients.
Topics: Adult; Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1987 |
Antituberculous agents.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1987 |
Effects of rifampin and isoniazid on the isolated perfused rat liver.
Topics: Animals; Aspartate Aminotransferases; Bile Ducts, Intrahepatic; Isoniazid; Liver; Male; Rats; Rifampin; Sulfobromophthalein | 1986 |
Stenotic tuberculous tracheitis treated with resection and anastomosis.
Topics: Constriction, Pathologic; Female; Humans; Isoniazid; Middle Aged; Rifampin; Tracheitis; Tuberculosis, Pulmonary | 1986 |
[Present status and chemotherapy of extrapulmonary tuberculosis in national sanatoria--urinary tuberculosis. Report of the B series of 26th Controlled Trials of Chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in
Topics: Adolescent; Adult; Aged; Child; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Urogenital | 1986 |
[Short course chemotherapy in pulmonary tuberculosis on individual basis--final report].
Topics: Adult; Aged; Antibiotics, Antitubercular; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Middle Aged; Radiography; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
[Studies of short-term chemotherapy of tuberculosis. III. Early and late results of 6 months' treatment of tuberculosis. Analysis of failures and recurrences during 1-5 years' observation].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Patient Dropouts; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1986 |
Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.
Topics: Acetylation; Chemical and Drug Induced Liver Injury; Drug Combinations; Humans; Hydrazines; Isoniazid; Rifampin; Tuberculosis | 1986 |
The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.
Topics: Acetylation; Adolescent; Adult; Biological Availability; Drug Combinations; Humans; Isoniazid; Middle Aged; Osmolar Concentration; Phenotype; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1986 |
Short-course chemotherapy for pleural tuberculosis. Nine years' experience in routine treatment service.
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pleural | 1986 |
[Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
Topics: Adult; Algeria; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Transients and Migrants; Tuberculosis, Pulmonary | 1986 |
[Antitubercular therapeutic regimens routinely prescribed in Bas-Rhin and results of treatment].
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; France; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Short-course tuberculosis therapy--a new combination product.
Topics: Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1986 |
Serum haloperidol levels of schizophrenics receiving treatment for tuberculosis.
Topics: Adult; Drug Interactions; Haloperidol; Humans; Isoniazid; Metabolic Clearance Rate; Middle Aged; Rifampin; Schizophrenia; Tuberculosis, Pulmonary | 1986 |
Toxic overdose of isoniazid, rifampicin and ethambutol.
Topics: Acidosis; Adult; Alanine Transaminase; Aspartate Aminotransferases; Ethambutol; Female; Humans; Isoniazid; Renal Dialysis; Rifampin; Seizures | 1986 |
Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians.
Topics: Antipyrine; Diet, Vegetarian; Drug Therapy, Combination; Enzyme Induction; Female; Half-Life; Humans; Hydrocortisone; India; Isoniazid; Liver; Male; Mixed Function Oxygenases; Quinine; Rifampin; Streptomycin; Tuberculosis | 1986 |
[Clinical course and effectiveness of treatment of destructive pulmonary tuberculosis in adolescents].
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Prothionamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Rifampin-induced acute renal failure.
Topics: Acute Kidney Injury; Antibodies; Blood Urea Nitrogen; Complement C3; Creatinine; Drug Therapy, Combination; Humans; Isoniazid; Kidney Glomerulus; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1986 |
[Studies on sputum conversion of smear-positive, previously untreated pulmonary tuberculosis: a comparison of short-course and standard chemotherapy regimens].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1986 |
[Recent-term therapeutic effects of short-course chemotherapy in rural outpatients with smear positive tuberculosis].
Topics: Adolescent; Adult; Ambulatory Care; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Rural Population; Sputum; Tuberculosis, Pulmonary | 1986 |
Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature.
Topics: Adult; Antitubercular Agents; Blood Sedimentation; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Respiratory Distress Syndrome; Rifampin; Tuberculosis, Pulmonary | 1986 |
Pyrazinamide in treatment of tuberculous meningitis.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 1986 |
[Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
Topics: Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1986 |
A simple technique for entrapping rifampicin and isoniazid into liposomes.
Topics: Hot Temperature; Isoniazid; Lipids; Liposomes; Methods; Rifampin; Sonication; Technology, Pharmaceutical | 1986 |
The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis.
Topics: Animals; Drug Therapy, Combination; Isoniazid; Liposomes; Lung; Male; Mice; Mice, Inbred Strains; Pharmaceutical Vehicles; Rifampin; Stem Cells; Tuberculosis, Pulmonary | 1986 |
Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Humans; Infant; Isoniazid; Jaundice; Liver; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Tuberculosis, Spinal | 1986 |
Tuberculous aortitis with associated necrosis and perforation: treatment and options.
Topics: Aged; Aortitis; Combined Modality Therapy; Female; Humans; Isoniazid; Necrosis; Rifampin; Rupture, Spontaneous; Tuberculosis, Cardiovascular | 1986 |
[Studies of serum rifampicin concentrations].
Topics: Adolescent; Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1986 |
Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase.
Topics: Antitubercular Agents; Body Weight; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Tablets; Time Factors; Tuberculosis, Pulmonary | 1986 |
Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
Topics: Antipyrine; Enzyme Induction; Female; Glucaric Acid; Glucuronidase; Half-Life; Humans; Isoniazid; Liver; Male; Mixed Function Oxygenases; Rifampin; Streptomycin; Sugar Acids; Time Factors | 1986 |
[Effect of antituberculosis therapy on the course of syphilitic infection].
Topics: Adult; Drug Therapy, Combination; Humans; Isoniazid; Male; Rifampin; Syphilis; Tuberculosis, Pulmonary | 1986 |
[Preventive chemotherapy in tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1986 |
Skin lesions caused by Mycobacterium scrofulaceum.
Topics: Abscess; Adult; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Lupus Erythematosus, Systemic; Male; Mycobacterium avium; Rifampin; Tuberculosis, Cutaneous | 1987 |
Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism.
Topics: Adult; Aged; Calcifediol; Calcitriol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary; Vitamin D | 1985 |
Package inserts for antituberculosis drugs and tuberculins.
Topics: Antitubercular Agents; Child; Child, Preschool; Contraceptives, Oral; Drug Interactions; Drug Labeling; Drug Synergism; Humans; Isoniazid; Mycobacterium Infections; Outpatients; Pyrazinamide; Rifampin; Tuberculin; United States; United States Food and Drug Administration | 1985 |
Safety of thrice-weekly rifampicin for tuberculosis in South-East Asian refugees.
Topics: Adolescent; Adult; Aged; Asia, Southeastern; Australia; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Prospective Studies; Pyrazinamide; Refugees; Rifampin; Tuberculosis, Pulmonary | 1985 |
Gynaecological tuberculosis: analysis of a personal series of 710 cases.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Ethambutol; Fallopian Tube Diseases; Female; Humans; Isoniazid; Middle Aged; Ovarian Diseases; Rifampin; Tuberculosis, Female Genital; Uterine Diseases | 1985 |
Recent trends in chemotherapy of leprosy.
Topics: Clofazimine; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Leprostatic Agents; Leprosy; Mycobacterium leprae; Prothionamide; Rifampin | 1985 |
Isoniazid-induced pure red cell aplasia.
Topics: Aged; Bone Marrow; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Red-Cell Aplasia, Pure; Rifampin; Tuberculosis | 1985 |
Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis.
Topics: Culture Media; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Streptomycin | 1985 |
Short course chemotherapy for tuberculosis of lymph nodes.
Topics: Adolescent; Adult; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Lymph Node | 1985 |
The action of antituberculosis drugs in short-course chemotherapy.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Models, Biological; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sterilization; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1985 |
Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods.
Topics: Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiometry; Rifampin; Streptomycin | 1985 |
Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria.
Topics: Adenosine Triphosphate; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Fluorescent Antibody Technique; Isoniazid; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1985 |
[The latest topics concerning pyrazinamide].
Topics: Adolescent; Adult; Animals; Child; Drug Resistance, Microbial; Drug Synergism; Female; Humans; Isoniazid; Male; Mice; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 1985 |
[Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid].
Topics: Adult; Animals; Chronic Disease; Drug Resistance, Microbial; Guinea Pigs; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Pulmonary; Virulence | 1985 |
Short-course chemotherapy for extrapulmonary tuberculosis. Nine years' experience.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1986 |
Tuberculosis control practices in major metropolitan health departments in the United States. 3. Standard of practice in 1984.
Topics: Adolescent; Adult; Child; Drug Therapy; Drug Therapy, Combination; Ethambutol; Health Facilities; Health Policy; Health Surveys; Humans; Isoniazid; Public Health Administration; Rifampin; Tuberculosis; United States | 1985 |
Treatment of pulmonary tuberculosis in patients notified in England and Wales in 1978-9: chemotherapy and hospital admission. Medical Research Council Tuberculosis and Chest Diseases Unit.
Topics: Adolescent; Adult; Drug Therapy, Combination; England; Ethambutol; Female; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary; Wales | 1985 |
Interaction of ketoconazole with rifampin and isoniazid.
Topics: Child, Preschool; Drug Interactions; Humans; Isoniazid; Ketoconazole; Male; Rifampin | 1985 |
The impact of treatment programmes on the epidemiology of tuberculosis.
Topics: China; Chronic Disease; Developing Countries; Humans; India; Isoniazid; Netherlands; Patient Compliance; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1985 |
Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failure.
Topics: Adult; Antitubercular Agents; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Patient Compliance; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1985 |
Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes.
Topics: Aged; Arkansas; Cross Infection; Humans; Isoniazid; Length of Stay; Nursing Homes; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1985 |
Should the dose of antituberculosis drugs be reduced in patients with liver disease?
Topics: Humans; Isoniazid; Liver Diseases; Rifampin; Tuberculosis | 1985 |
Legionella pneumonia in chronic granulomatous disease.
Topics: Bacterial Infections; Child; Erythromycin; Female; Granulomatous Disease, Chronic; Humans; Isoniazid; Legionella; Rifampin; Sulfamethoxazole | 1985 |
[Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
Topics: Absorption; Adolescent; Adult; Child; Female; Humans; Isoniazid; Lung; Lymph Nodes; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1985 |
[Tuberculosis: some current problems].
Topics: Belgium; Humans; Isoniazid; Rifampin; Tuberculosis | 1985 |
[Course of serum alkaline phosphatase during treatment with isoniazid and rifampicin].
Topics: Adolescent; Alkaline Phosphatase; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Retrospective Studies; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1985 |
A study of the effects of rifampicin on isoniazid metabolism in human volunteer subjects.
Topics: 17-Hydroxycorticosteroids; Acetylation; Adult; Biotransformation; Creatinine; Humans; Hydrazines; Hydrocortisone; Isoniazid; Liver Function Tests; Male; Phenotype; Rifampin | 1985 |
Effects of rifampicin and phenobarbital on the fate of isoniazid and hydrazine in vivo in rats.
Topics: Acetylation; Animals; Drug Interactions; Hydrazines; Isoniazid; Liver; Male; Oxidation-Reduction; Phenobarbital; Rats; Rats, Inbred Strains; Rifampin | 1985 |
[Synergistic effect of rifampicin on hepatotoxicity of isoniazid].
Topics: Animals; Bile; Chemical and Drug Induced Liver Injury; Depression, Chemical; Drug Synergism; Free Radicals; Isoniazid; Lipid Peroxides; Liver; Male; Rats; Rifampin | 1985 |
Tuberculosis of the female genital tract.
Topics: Adult; Aminosalicylic Acid; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Female Genital | 1985 |
Chemotherapeutic agents in pulmonary tuberculosis with special reference to isoniazid-ethambutol continuation therapy.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1985 |
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study.
Topics: Absorption; Antitubercular Agents; Humans; Isoniazid; Kinetics; Male; Pyrazinamide; Rifampin; Streptomycin | 1985 |
Six-month chemotherapy for urogenital tuberculosis.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Urogenital | 1985 |
[Immunologic reactivity and healing reactions in animals with experimental tuberculosis as affected by chemotherapy].
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Guinea Pigs; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1985 |
Tuberculosis in an Indochinese refugee camp: epidemiology, management and therapeutic results.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Middle Aged; Patient Compliance; Pregnancy; Pyrazinamide; Refugees; Rifampin; Streptomycin; Thailand; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1985 |
Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Patient Compliance; Rifampin; Sputum; Tuberculosis, Pulmonary | 1985 |
Successful nonsurgical treatment of tuberculous empyema in an irreducible pleural space.
Topics: Administration, Oral; Aged; Antitubercular Agents; Empyema, Tuberculous; Ethambutol; Female; Humans; Isoniazid; Punctures; Rifampin; Tuberculosis, Pleural | 1985 |
Field trial of short course chemotherapy for pulmonary tuberculosis: results at 30 months.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Thailand; Time Factors; Tuberculosis, Pulmonary | 1985 |
Clinical experience with short-course chemotherapy in patients with tubercular pleural effusion and lymphadenitis.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymphadenitis; Male; Middle Aged; Pleural Effusion; Rifampin; Time Factors; Tuberculosis | 1985 |
[Pharmacokinetics of isoniazid, rifampicin and streptomycin in tuberculosis patients with chronic cor pulmonale].
Topics: Administration, Oral; Adult; Chronic Disease; Female; Humans; Infusions, Parenteral; Isoniazid; Kinetics; Male; Pulmonary Heart Disease; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1985 |
Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Random Allocation; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1985 |
Failure of a prothionamide-containing oral antituberculosis regimen.
Topics: Administration, Oral; Antitubercular Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Isonicotinic Acids; Male; Patient Compliance; Prothionamide; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1985 |
[Clinico-experimental studies of therapy optimization in kidney tuberculosis].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Isoniazid; Kidney; Male; Middle Aged; Rifampin; Tuberculosis, Renal | 1985 |
Influence of rifampicin and isoniazid on the kinetics of phenytoin.
Topics: Acetylation; Adult; Aged; Ethambutol; Female; Half-Life; Humans; Isoniazid; Kinetics; Male; Middle Aged; Phenotype; Phenytoin; Rifampin; Tuberculosis, Pulmonary | 1985 |
Tuberculosis of the knee.
Topics: Adolescent; Adult; Child; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immobilization; Isoniazid; Knee Joint; Male; Pyrazinamide; Radiography; Rifampin; Streptomycin; Tuberculosis, Osteoarticular | 1985 |
Sarcoidosis of the larynx in a child.
Topics: Adolescent; Diagnosis, Differential; Epiglottis; Female; Humans; Isoniazid; Laryngeal Diseases; Laryngeal Mucosa; Prednisone; Rifampin; Sarcoidosis; Tuberculosis | 1985 |
Tuberculosis of the orbit.
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Humans; Isoniazid; Male; Orbital Diseases; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Ocular | 1985 |
Cerebellar tuberculoma: a rare disease in an industrialized country.
Topics: Cerebellar Diseases; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Radiography; Rifampin; Tuberculoma | 1985 |
Adult tuberculous meningitis: comparative study of different chemotherapeutic regimens.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1985 |
Tuberculous infection.
Topics: Adolescent; Adult; Africa, Eastern; Aged; Costs and Cost Analysis; Delayed-Action Preparations; Developing Countries; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Rural Population; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1971 |
Laboratory aspects of intermittent drug therapy.
Topics: Animals; Ethionamide; Growth; Guinea Pigs; Humans; Isoniazid; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis | 1971 |
[Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1971 |
Shorter chemotherapy in tuberculosis.
Topics: Developing Countries; Drug Combinations; Economics; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1972 |
Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey.
Topics: Adolescent; Adult; Africa, Northern; Age Factors; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Ethnicity; Female; France; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary; Viomycin | 1972 |
[Allergy to antitubercular agents; with special reference to new drugs].
Topics: Adult; Aged; Agranulocytosis; Anaphylaxis; Antitubercular Agents; Capreomycin; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Thrombocytopenia; Viomycin | 1973 |
[New findings in the biotransformation and pharmacokinetics of antitubercular agents].
Topics: Animals; Biotransformation; Capreomycin; Dogs; Ethionamide; Humans; Isoniazid; Kinetics; Rifampin | 1973 |
Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin.
Topics: Alcoholism; Aminosalicylic Acids; Bilirubin; Dihydrostreptomycin Sulfate; Humans; Isoniazid; Rifampin; Sputum; Transaminases; Tuberculosis; Tuberculosis, Pulmonary | 1973 |
Pyrazinamide and other drugs in tuberculous meningitis.
Topics: Adult; Blood-Brain Barrier; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1973 |
Supervised ambulatory treatment of tuberculosis with brief initial hospitalization.
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Aminosalicylic Acids; Capreomycin; Convalescence; Disability Evaluation; Drug Therapy, Combination; Ethambutol; Female; Finland; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Self Medication; Sex Factors; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1973 |
PAS.
Topics: Aminosalicylic Acids; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1973 |
[Proceedings: Ambulatory chemotherapy of tuberculosis in Finland (organization)].
Topics: Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Ethambutol; Ethionamide; Finland; Humans; Isoniazid; Patient Dropouts; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1973 |
[Tuberculosis drug therapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors | 1973 |
Rifampicin hepatitis. A clinical and histological study.
Topics: Adult; Aged; Alcoholism; Biopsy; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Prednisolone; Rifampin; Staining and Labeling; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Therapy of urogenital tuberculosis. Urological aspects].
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Cycloserine; Drug Synergism; Endoscopy; Ethambutol; Female; Humans; Isoniazid; Male; Radiography; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1974 |
Short-course treatment in pulmonary tuberculosis.
Topics: Adolescent; Adult; Africa, Eastern; Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1973 |
Nontuberculous mycobacterial infections of man.
Topics: Capreomycin; Child; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Lung Diseases; Lymphadenitis; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious; Sputum; Streptomycin | 1974 |
Letter: Rifampicin and drug metabolism.
Topics: Aminosalicylic Acids; Contraceptives, Oral; Ethambutol; Female; Growth Hormone; Half-Life; Humans; Isoniazid; Liver; Rifampin; Streptomycin; Tolbutamide | 1974 |
[Drug therapy of tuberculosis].
Topics: Amides; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tetracycline; Thiosemicarbazones; Tuberculosis; Viomycin | 1974 |
Letter: Acneiform lesions in combined rifampicin treatment in Africans.
Topics: Acne Vulgaris; Adult; Drug Eruptions; Female; Humans; Isoniazid; Male; Rifampin; Thioacetazone; Tuberculosis, Urogenital; Zambia | 1974 |
Letter: Rifampicin and cortisone replacement therapy.
Topics: Addison Disease; Aged; Cortisone; Drug Interactions; Female; Humans; Isoniazid; Recurrence; Rifampin; Streptomycin; Tuberculosis | 1974 |
Letter: In-vitro detection of hypersensitivity to antituberculous drugs.
Topics: Aminosalicylic Acids; Cell Migration Inhibition; Drug Hypersensitivity; Drug Therapy, Combination; Humans; Immunity, Cellular; In Vitro Techniques; Isoniazid; Macrophages; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Tuberculosis, Renal | 1974 |
Binding of rifampicin by human plasma proteins.
Topics: Adult; Aged; Aminosalicylic Acids; Blood Proteins; Carbon Radioisotopes; Chromatography, Thin Layer; Dialysis; Ethambutol; Female; Fibrinogen; gamma-Globulins; Humans; Isoniazid; Male; Middle Aged; Protein Binding; Rifampin; Serum Albumin; Streptomycin; Tuberculosis | 1974 |
Treatment of pulmonary tuberculosis.
Topics: Capreomycin; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cycloserine; Depression; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Hospitalization; Humans; Isoniazid; Kanamycin; Kidney Diseases; Optic Neuritis; Patient Education as Topic; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
Changes in cortisol metabolism following rifampicin therapy.
Topics: Addison Disease; Adipates; Adrenal Glands; Adult; Cortisone; Dose-Response Relationship, Drug; Drug Antagonism; Drug Therapy, Combination; Fludrocortisone; Half-Life; Humans; Hydrocortisone; Isoniazid; Male; Rifampin; Streptomycin; Sugar Acids; Tuberculosis, Pulmonary | 1974 |
[Comparative determinations of Mycobacterium resistance using the vertical diffusion test and the proportion method (economical test)].
Topics: Aminosalicylic Acids; Capreomycin; Diffusion; Drug Resistance, Microbial; Ethambutol; Ethionamide; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Streptomycin | 1974 |
Treatment of isoniazid-resistant pulmonary tuberculosis with ethambutol, rifampicin and capreomycin: a co-operative study in England and Wales.
Topics: Adult; Aged; Capreomycin; Drug Resistance, Microbial; Drug Therapy, Combination; England; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary; Wales | 1974 |
Chemotherapy in Japan.
Topics: Aminosalicylic Acids; Antitubercular Agents; Congresses as Topic; Drug Interactions; Humans; Isoniazid; Japan; Rifampin; Tuberculosis, Pulmonary | 1972 |
[2d day of round-table conference on "perfected methods of antibacillary treatment of pulmonary tuberculosis"].
Topics: Aminosalicylic Acids; Chronic Disease; Congresses as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Poland; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
New drugs against tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mice; Rifampin; Tuberculosis, Pulmonary | 1969 |
New drugs against tuberculosis.
Topics: Animals; Antitubercular Agents; Cortisone; Isoniazid; Mice; Pyrazinamide; Rifampin | 1969 |
The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
Topics: Animals; Ethambutol; Ethionamide; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thioacetazone; Tuberculosis | 1969 |
Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.
Topics: Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kinetics; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Steroid-responsive hypercalcemia in disseminated bone tuberculosis.
Topics: Acute Disease; Adult; Clavicle; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Hypercalcemia; Isoniazid; Male; Military Medicine; Mycobacterium tuberculosis; Phosphates; Prednisone; Radiography; Rifampin; Streptomycin; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary | 1973 |
Toxicologic and pharmacologic aspects of rifampin.
Topics: Administration, Oral; Drug Interactions; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1973 |
A survey of mycobacterial isolates from the Randwick Chest Hospital, Sydney, in an 18-month period, 1970 to 1971.
Topics: Adult; Aged; Aminosalicylic Acids; Australia; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1973 |
Endobronchial tuberculosis.
Topics: Aged; Bronchial Diseases; Bronchoscopy; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Radiography; Rifampin; Sputum; Tracheal Diseases; Tuberculosis | 1973 |
Exogenous reinfection with Mycobacterium tuberculosis confirmed by phage typing.
Topics: Aminosalicylic Acids; Bacteriophage Typing; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Male; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary; Urease | 1973 |
[Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phosphorus Radioisotopes; Rifampin; Streptomycin | 1973 |
Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Topics: Aged; Aminosalicylic Acids; Diarrhea; Drug Resistance, Microbial; England; Ethambutol; Headache; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Tuberculosis in a patient after renal transplantation.
Topics: Adult; Azathioprine; Bacteriuria; Ethambutol; Humans; Isoniazid; Kidney Transplantation; Male; Mycobacterium tuberculosis; Postoperative Complications; Prednisone; Rifampin; Sputum; Transplantation, Homologous; Tuberculin Test; Tuberculosis, Pulmonary | 1973 |
[Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
Topics: Animals; Drug Resistance, Microbial; Ethambutol; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Tuberculosis in Acukland.
Topics: Adult; Age Factors; Aged; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethnicity; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium bovis; Mycobacterium tuberculosis; New Zealand; Rifampin; Sex Factors; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1973 |
The effect of chemotherapy for tuberculosis on immunity to tuberculosis.
Topics: Animals; BCG Vaccine; Drug Resistance, Microbial; Female; Immunity, Maternally-Acquired; Immunization, Passive; Isoniazid; Lymphocyte Transfusion; Lymphocytes; Mycobacterium tuberculosis; Rats; Rifampin; Thoracic Duct; Transplantation, Homologous; Tuberculosis | 1974 |
Therapeutic efficacy of rifampin in newly detected pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1974 |
Supratentorial tuberculoma: a case report and review.
Topics: Adult; Brain Diseases; Cerebral Angiography; Dexamethasone; Diagnosis, Differential; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Phenytoin; Rifampin; Streptomycin; Tuberculoma | 1974 |
Restoration of mycolate synthetase activity in Mycobacterium tuberculosis exposed to isoniazid.
Topics: Acetates; Amino Acids; Carbon Radioisotopes; Cell Survival; Fatty Acid Synthases; Fatty Acids; Isoniazid; Mycobacterium tuberculosis; Mycolic Acids; Protein Biosynthesis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1974 |
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary; United States | 1974 |
Primary drug resistance in children. Drug susceptibility of strains of M. tuberculosis isolated from children during the years 1969 to 1972 at the Kings County Hospital Medical Center of Brooklyn.
Topics: Antitubercular Agents; Child; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; New York City; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acids; Child; Cycloserine; Drug Resistance, Microbial; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Morocco; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Residence Characteristics; Rifampin; Sex Factors; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. II. The role of rifampicin and other drugs in the dependent or independent action of drug associations in vitro.
Topics: Antitubercular Agents; Aspirin; Culture Media; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Microbial; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1974 |
[Signes of adaptation under long-term combined antituberculous therapy (author's transl)].
Topics: Adaptation, Physiological; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Long-Term Care; Rifampin; Streptomycin; Transaminases; Tuberculosis | 1974 |
Antibiotics, antiseptics and tubercle bacilli.
Topics: Aminosalicylic Acids; Anti-Infective Agents, Local; Antitubercular Agents; DNA-Directed RNA Polymerases; Drug Therapy, Combination; Ethambutol; Folic Acid; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; RNA, Messenger; RNA, Transfer; Streptomycin | 1974 |
Primary isoniazid-resistant tuberculosis in children. Clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972.
Topics: Adolescent; Aminosalicylic Acids; Antibiotics, Antitubercular; Child; Child, Preschool; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiography; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
The effect of radiation on microbiologic characteristics of M tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cell Survival; Chromosomes, Bacterial; Cycloserine; Dose-Response Relationship, Radiation; Drug Resistance, Microbial; Ethambutol; Ethionamide; Freezing; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Preservation, Biological; Pyrazinamide; Radiation Genetics; Rifampin; Streptomycin | 1974 |
Ambulatory management of tuberculosis.
Topics: Adult; Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Resistance, Microbial; Ethambutol; Humans; Infant; Isoniazid; Kidney Function Tests; Liver Function Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Change in drug resistance of Mycobacterium tuberculosis in experimental studies].
Topics: Animals; Anti-Bacterial Agents; Culture Techniques; Drug Resistance, Microbial; Ethambutol; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Nitrofurans; Rifampin; Streptomycin | 1974 |
Immunological memory in tuberculosis. I. Influence of persisting viable organisms.
Topics: Animals; BCG Vaccine; Cortisone; Female; Hypersensitivity, Delayed; Immunity, Maternally-Acquired; Immunologic Memory; Isoniazid; Liver; Lung; Lymphocytes; Mycobacterium bovis; Mycobacterium tuberculosis; Rats; Rats, Inbred BN; Rats, Inbred Lew; Rifampin; Spleen; Time Factors; Tuberculin; Tuberculosis | 1974 |
[Cooperative study of short-term antibacillary treatments in 14 French centers].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pregnancy; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1974 |
[Algodystrophy associated with antitubercular chemotherapy: 22 cases].
Topics: Adult; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Niacinamide; Pyrazinamide; Reflex Sympathetic Dystrophy; Rifampin; Tuberculosis; Vitamin B Deficiency | 1969 |
Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
Topics: Adolescent; Adult; Aged; Bilirubin; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Transaminases | 1971 |
Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
Topics: Bilirubin; Drug Eruptions; Drug Hypersensitivity; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Transaminases; Tuberculosis, Pulmonary | 1972 |
[Physico-chemical and bacterio-cytological studies using tuberculostatic drugs and compounds of polymethylmetacrylate].
Topics: Antitubercular Agents; Arthroplasty; Chemical Phenomena; Chemistry, Physical; Diffusion; Drug Combinations; Isoniazid; Joint Prosthesis; Methylmethacrylates; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis, Osteoarticular | 1972 |
Isoniazid administration and liver injury.
Topics: Aminosalicylic Acids; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Child; Drug Eruptions; Ethambutol; Fever; Humans; Isoniazid; Liver; Male; Pain; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Facial paralysis caused by tubercular otitis. Current therapeutic possibilities].
Topics: Adult; Ethambutol; Facial Paralysis; Female; Humans; Isoniazid; Male; Otitis; Rifampin; Tuberculosis | 1974 |
The susceptibility of mycobacteria to rifamide and rifampicin.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Viomycin | 1967 |
[Drug sensitivity of the so-called atypical mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Morpholines; Mycobacterium; Pyrazinamide; Pyrazines; Rifampin; Streptomycin; Viomycin | 1968 |
[How to oversee the treatment of tuberculosis?].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Long-Term Care; Male; Medication Errors; Middle Aged; Rifampin; Streptomycin; Tuberculosis | 1970 |
Non-photochromogenic mycobacteria serotype Davis. The inhomogeneity within the serological group and the relationship to Mycobacterium avium.
Topics: Aminosalicylic Acids; Animals; Chickens; Cycloserine; Erythromycin; Guinea Pigs; Hot Temperature; Humans; In Vitro Techniques; Isoniazid; Mice; Microbial Sensitivity Tests; Mycobacterium; Penicillins; Rabbits; Rifampin; Streptomycin; Viomycin | 1970 |
[Thoughts on pulmonary tuberculosis in the aged].
Topics: Age Factors; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Jaundice and rifampicin].
Topics: Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Imipramine; Isoniazid; Jaundice; Liver; Male; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Miliary | 1971 |
[Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Depression, Chemical; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
Treatment of drug-resistant tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Eruptions; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Humans; Hypothyroidism; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Advances and principles in tuberculostatic therapy].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
Topics: Antitubercular Agents; Bacteriological Techniques; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Viomycin | 1971 |
[Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Topics: Adult; Aged; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Tuberculostatics. General adverse effects].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Neomycin; Oxytetracycline; Rifampin; Streptomycin; Thiosemicarbazones; Viomycin | 1972 |
[Electroencephalographic changes and antitubercular treatments].
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Aminosalicylic Acids; Antitubercular Agents; Drug Interactions; Electroencephalography; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Sex Factors; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Duration of the after-control of the tuberculous patients following the termination of the treatment].
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Thiosemicarbazones; Time Factors; Tuberculosis, Pulmonary; Viomycin | 1972 |
Treatment of tuberculosis today in Nebraska.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Pyridoxine; Rifampin; Sputum; Streptomycin; Tuberculosis; Viomycin | 1973 |
[Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
Topics: Adult; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug Tolerance; Female; Hepatitis A; Humans; Isoniazid; Jaundice; Liver; Male; Middle Aged; Rifampin; Tuberculosis | 1973 |
[Cold thoracic abscess due to Histoplasma duboisii. Treatment using rifampicin].
Topics: Abscess; Adult; Diagnosis, Differential; Ethambutol; Fluorescent Antibody Technique; Histoplasma; Histoplasmosis; Humans; Isoniazid; Male; Rifampin; Skin Tests; Thorax; Tuberculosis | 1973 |
New antituberculosis drugs and concepts of prophylaxis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Arthritis; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Liver; Lupus Vulgaris; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Viomycin | 1974 |
[Encapsulating peritonitis: diagnostic and etiologic problems].
Topics: Adrenal Cortex Hormones; Adult; Ethambutol; Female; Humans; Isoniazid; Laparotomy; Middle Aged; Peritonitis; Peritonitis, Tuberculous; Radiography, Abdominal; Radiography, Thoracic; Rifampin; Tuberculosis, Gastrointestinal | 1973 |
[The liver and rifampicin].
Topics: Bilirubin; Biopsy; Chemical and Drug Induced Liver Injury; Drug Interactions; Ethambutol; Humans; Isoniazid; Liver; Phosphoric Monoester Hydrolases; Rifampin; Transaminases; Tuberculosis | 1973 |
[Use of a isoniozid-rifompicin drug hepatotoxicity screening technic in tuberculosis therapy].
Topics: Adult; Bilirubin; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoenzymes; Isoniazid; Jaundice; L-Lactate Dehydrogenase; Male; Oxidoreductases; Rifampin; Transaminases; Tuberculosis | 1974 |
Recent trends in tuberculosis care.
Topics: Aftercare; Alcoholism; Aminosalicylic Acids; Ethambutol; Hospitals, Special; Humans; Isoniazid; Occupational Health Services; Patient Education as Topic; Population Surveillance; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Virginia | 1974 |
[Metabolic behavior of Mycobacterium tuberculosis strain H37 Ra under action of rifampicin, comparison with isoniazid].
Topics: Adenosine Triphosphate; Fructose-Bisphosphate Aldolase; Glycolysis; Isoniazid; Mycobacterium tuberculosis; NAD; NADP; Pyruvate Kinase; Rifampin; Transaminases | 1971 |
[Modification of ovulation in the chicken. A new toxicology method].
Topics: Animals; Biological Assay; Chickens; Dose-Response Relationship, Drug; Egg Proteins; Eggs; Female; Isoniazid; Lethal Dose 50; Ovulation; Rifampin; Time Factors | 1974 |
Atypical mycobacteriosis of the urinary tract. A case report of extensive disease caused by the Battey bacillus.
Topics: Ethambutol; Female; Humans; Isoniazid; Middle Aged; Minnesota; Mycobacterium; Mycobacterium Infections; Radiography, Abdominal; Rifampin; Streptomycin; Urinary Tract Infections; Urography; Urologic Diseases | 1974 |
[Survey of the tuberculosis problem in the Nordic countries. Are BCG vaccination and mass screening necessary?].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; BCG Vaccine; Ethambutol; Female; Humans; Iceland; Infant, Newborn; Isoniazid; Male; Mass Chest X-Ray; Middle Aged; Registries; Retrospective Studies; Rifampin; Scandinavian and Nordic Countries; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1974 |
[The experimental study on the transmission of the antituberculous drugs to fetuses (author's transl)].
Topics: Animals; Antitubercular Agents; Carbon Radioisotopes; Female; Glucose; Isoniazid; Maternal-Fetal Exchange; Mice; Pregnancy; Rifampin | 1974 |
Intermittent chemotherapy for adults with tuberculosis.
Topics: Administration, Oral; Adult; Drug Resistance, Microbial; Ethambutol; Humans; Injections, Intramuscular; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1974 |
Resected lung after an abbreviated rifampin regimen.
Topics: Adult; Aspergillosis; Hemoptysis; Humans; Isoniazid; Lung; Lung Diseases, Fungal; Male; Radiography; Rifampin; Tuberculosis, Pulmonary | 1974 |
[The effects of antituberculosis drugs on the pharmacokinetics of digitoxin (author's transl)].
Topics: Administration, Oral; Adult; Antitubercular Agents; Digitoxin; Drug Therapy, Combination; Ethambutol; Humans; Hydroxylation; Intestinal Absorption; Isoniazid; Kidney Tubules; Kinetics; Liver; Middle Aged; Protein Binding; Radioimmunoassay; Rifampin; Tuberculosis | 1974 |
[Current therapy of pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Convalescence; Drug Therapy, Combination; Ethambutol; Hospitals, Special; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Hematopoietic tuberculosis].
Topics: Bone Marrow; Bone Marrow Examination; Cholestasis; Erythema; Ethambutol; Humans; Isoniazid; Leukopenia; Male; Middle Aged; Neutropenia; Peritonitis, Tuberculous; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Osteoarticular; Tuberculosis, Splenic; Vitamin B Complex | 1974 |
On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
Topics: Adolescent; Adult; Aged; Chromatography, Thin Layer; Drug Therapy, Combination; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Rifampin; Spectrophotometry; Time Factors; Tuberculosis, Pulmonary | 1974 |
The activities of aminotransferases, malate- and lactate dehydrogenases in plasma of children with epilepsy.
Topics: Acetylation; Biotransformation; Colorimetry; Drug Combinations; Isoniazid; Polarography; Rifampin | 1974 |
Pulmonary tuberculosis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Drug Therapy, Combination; Emigration and Immigration; Female; Humans; India; Isoniazid; Male; Middle Aged; Pakistan; Pyridoxine; Rifampin; Streptomycin; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary; United Kingdom | 1974 |
[Determinations of concentration of tuberculostatics].
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Methods; Rifampin; Streptomycin | 1974 |
[Rifampycine in the treatment of chronic pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Evaluation; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1974 |
[Relationship between rate of inactivation of isoniazid and changes in transaminase levels during combined isoniazid-rifampicin therapy (author's transl)].
Topics: Acetylation; Drug Therapy, Combination; Female; Humans; Isoniazid; Rifampin; Time Factors; Transaminases; Tuberculosis, Pulmonary | 1974 |
Experimental evaluation of antituberculous compounds, with special reference to the effect of combined treatment.
Topics: Animals; Antitubercular Agents; Drug Resistance; Drug Therapy, Combination; Humans; Isoniazid; Rifampin | 1974 |
[Icterus caused by rifampicin and isoniazide].
Topics: Adult; Aged; Autopsy; Biopsy; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Jaundice; Liver; Middle Aged; Rifampin | 1974 |
[A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Proposals for a standard therapy of cutaneous tuberculosis].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Cutaneous | 1974 |
[Delayed results of treatment of pulmonary tuberculosis with rifampicin].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1974 |
The impact of rifampicin on the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1974 |
Treatment of pulmonary tuberculosis in a patient on maintenance haemodialysis.
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Humans; Isoniazid; Kidney Failure, Chronic; Male; Renal Dialysis; Rifampin; Tuberculosis, Pulmonary | 1974 |
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1974 |
Poncet's disease--fact or fiction? A re-appraisal of tuberculous rheumatism.
Topics: Adult; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Hepatic; Tuberculosis, Ocular; Tuberculosis, Osteoarticular | 1974 |
Hyperlipidaemia as a complication of rifampicin treatment.
Topics: Alanine Transaminase; Alcoholism; Aminosalicylic Acids; Aspartate Aminotransferases; Cholesterol; Chylomicrons; Drug Therapy, Combination; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; Isoniazid; Male; Middle Aged; Rifampin; Triglycerides; Tuberculosis, Pulmonary | 1974 |
[Proceedings: Rifampicin in initial therapy of pulmonary tuberculosis].
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Pilot Projects; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Proceedings: Rifampicin adverse effects in intermittent therapy].
Topics: Adult; Aged; Aminosalicylic Acids; Drug Combinations; Drug Hypersensitivity; Female; Humans; Isoniazid; Male; Middle Aged; Purpura; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Rapid visual test for the determination of drug resistance in comparison with the economic test].
Topics: Culture Media; Drug Resistance, Microbial; Ethambutol; Ethionamide; Evaluation Studies as Topic; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Streptomycin; Suspensions; Time Factors | 1974 |
[A case of mandibular tuberuclosis].
Topics: Biopsy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Mandibular Diseases; Middle Aged; Rifampin; Sarcoidosis; Tuberculosis, Osteoarticular | 1972 |
The predictability of hypersensitivity to anti-tuberculous drugs.
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Blood Sedimentation; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Leukocyte Count; Lymphocytes; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Side effects of rifampicin. A clinical study.
Topics: Acute Disease; Acute Kidney Injury; Adult; Ambulatory Care; Amylases; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hematologic Diseases; Humans; Isoniazid; Liver; Male; Pancreatitis; Prednisolone; Recurrence; Rifampin; Stimulation, Chemical; Streptomycin; Transaminases; Tuberculosis, Pulmonary | 1973 |
Side effects observed during intermittent rifampicin therapy.
Topics: Antibody Formation; Antigen-Antibody Reactions; Drug Therapy, Combination; Fever; Headache; Humans; Isoniazid; Nausea; Purpura, Thrombocytopenic; Pyridoxine; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Intermittent rifampicin treatment of tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Fever; Headache; Humans; Isoniazid; Kidney Diseases; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1973 |
[Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Combinations; Humans; Infant; Isoniazid; Liver; Rifampin; Transaminases; Tuberculosis, Pulmonary | 1972 |
Characterization and mycobacteriophage typing of Mycobacterium xenopi.
Topics: Bacteriological Techniques; Bacteriophage Typing; Isoniazid; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium; Rifampin; Streptomycin | 1972 |
[Rhinoscleroma with tracheobronchial spread].
Topics: Antitubercular Agents; Diagnosis, Differential; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Klebsiella pneumoniae; Middle Aged; Rhinitis; Rhinoscleroma; Rifampin; Streptomycin; Vitamin D | 1973 |
[Comparative study of hepatic bilirubin and paranitrophenol glucuronyl transferase activity. 3. Effect of rifampicin alone or associated with streptomycin and isoniazid in man].
Topics: Bilirubin; Enzyme Induction; Glucuronates; Humans; Isoniazid; Liver; Liver Function Tests; Microscopy, Electron; Nitrophenols; Rifampin; Streptomycin; Transferases; Tuberculosis | 1973 |
Intermittent rifampicin treatment in experimental tuberculosis.
Topics: Administration, Oral; Agglutination Tests; Animals; Antibodies, Bacterial; Blood Bactericidal Activity; Coombs Test; Disease Models, Animal; Fluorescent Antibody Technique; Guinea Pigs; Isoniazid; Rifampin; Spleen; Time Factors; Tuberculin Test; Tuberculosis | 1973 |
Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
Topics: Administration, Oral; Animals; Drug Therapy, Combination; Female; Germ-Free Life; Injections, Subcutaneous; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium bovis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses.
Topics: Animals; Chronic Disease; Drug Therapy, Combination; Female; Isoniazid; Lung; Mice; Mycobacterium bovis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Assessment of the bacteriological effect of combined treatment with rifadin, sulfamethoxypyrazine, and isoniazide in lepromatous leprosy.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Leprosy; Microbial Sensitivity Tests; Muscle, Smooth; Mycobacterium leprae; Pyrazines; Rifampin; Skin; Sulfanilamides; Time Factors | 1973 |
Fundamental data, methods and goals of present research on the treatment of leprosy.
Topics: Animals; Animals, Laboratory; Antitubercular Agents; Clofazimine; Dapsone; Ethionamide; Humans; In Vitro Techniques; Isoniazid; Leprosy; Mice; Mycobacterium lepraemurium; Rifampin; Sulfonamides; Trimethoprim | 1973 |
[BCG infection of hematopoietic organs with cellular immune deficiency].
Topics: Adolescent; Adrenal Cortex Hormones; Anemia; Antibodies; BCG Vaccine; Biopsy; Bone Marrow Diseases; Ethambutol; Female; Fever; Hepatomegaly; Humans; Immunity, Cellular; Immunoglobulins; Immunologic Deficiency Syndromes; Iron; Isoniazid; Leukocyte Count; Lymph Nodes; Lymphocytes; Lymphopenia; Mycobacterium bovis; Mycobacterium Infections; Rifampin; Splenic Diseases; Splenomegaly; Tuberculin Test | 1974 |
Observations on the action of rifampin and ethambutol alone and in combination with other antituberculous drugs.
Topics: Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1972 |
[Isotope clearance examinations in patients with urogenital tuberculosis].
Topics: Chromium Isotopes; Diuresis; Edetic Acid; Ethambutol; Female; Humans; Iodohippuric Acid; Isoniazid; Radioisotope Renography; Rifampin; Time Factors; Tuberculosis, Urogenital | 1972 |
A study of 200 cases of active, recent pulmonary tuberculosis treated with rifampin-isoniazid. A follow-up history of one and one-half to three years.
Topics: Adolescent; Adult; Aged; Bilirubin; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Jaundice; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Tuberculosis, Pulmonary | 1972 |
Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Bilirubin; Blood Proteins; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Radiography; Rifampin; Sputum; Transaminases; Tuberculosis, Pulmonary | 1972 |
The antituberculosis efficacy of rifampin in 136 patients.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1972 |
Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
Topics: Adolescent; Adult; Aged; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Isoniazid; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1972 |
Intermittent chemotherapy in pulmonary tuberculosis--current aspects.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Long-Term Care; Methods; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Critical concentration for definition of rifampicin resistance of tubercle bacilli].
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1972 |
[Rifampicine in tuberculosis. Peculiarity of its experimental activity and new therapeutic prospects].
Topics: Animals; Drug Resistance, Microbial; Humans; Isoniazid; Mice; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1972 |
[Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C].
Topics: Adolescent; Adult; Aged; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pneumonectomy; Postoperative Complications; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Chemotherapy of tuberculosis demonstrated on the model-example of exudative tubercular pleurisy].
Topics: Adrenal Cortex Hormones; Ethambutol; Humans; Isoniazid; Long-Term Care; Models, Biological; Pleurisy; Rifampin; Tuberculosis, Pleural | 1973 |
Rifampin in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1972 |
[Treatment of INH resistant tuberculo-pneumoconiosis with the rifampicin-ethambutol combination].
Topics: Drug Combinations; Drug Resistance, Microbial; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Rifampin; Silicotuberculosis; Sputum | 1972 |
[Treatment of tuberculosis in childhood].
Topics: Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1972 |
[Modern view on drug therapy of tuberculosis].
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1972 |
The Australian rifampicin trial.
Topics: Adult; Aged; Costs and Cost Analysis; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Rifampin; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1972 |
Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Topics: Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1972 |
A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Preventive treatment of tuberculosis].
Topics: Antitubercular Agents; Communicable Disease Control; Disease Reservoirs; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1972 |
[Ambulatory chemotherapy of tuberculosis].
Topics: Ambulatory Care; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Outpatient Clinics, Hospital; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1972 |
Shorter treatment.
Topics: Animals; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1972 |
[Therapy of tuberculosis].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1972 |
[4 cases of cutaneous tuberculosis. Possible role of atypic mycobacteria].
Topics: Adult; Aged; Biopsy; Female; Humans; Isoniazid; Leg; Male; Penis; Rifampin; Skin Tests; Tuberculosis, Cutaneous | 1972 |
[Automatic data processing during a controlled therapeutic trial in multiple tuberculosis units (survey 6.9.12)].
Topics: Computers; Electronic Data Processing; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1972 |
The treatment of tuberculosis of the skin with a combination of rifampicin, ethambutol and isoniazid.
Topics: Aged; Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Cutaneous | 1972 |
A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
Topics: Aniline Compounds; Animals; Dapsone; Disease Models, Animal; Drug Combinations; Ethionamide; Humans; Isoniazid; Leprosy; Mice; Models, Biological; Mycobacterium Infections; Phenazines; Pyrazines; Rabbits; Rifampin; Sulfonamides; Trimethoprim | 1972 |
[Toxicity of antitubercular agents for the liver].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin | 1973 |
Tuberculosis complicated by pregnancy.
Topics: Adolescent; Adult; Aminosalicylic Acids; Anesthesia, General; Cross Infection; Delivery, Obstetric; Female; Fetus; Humans; Infant, Newborn; Isoniazid; Labor, Obstetric; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1973 |
[Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin].
Topics: Animals; Drug Synergism; Ethambutol; Guinea Pigs; Isoniazid; Methods; Rifampin; Tuberculosis | 1973 |
In vitro and in vivo cellular immunity in anergic miliary tuberculosis.
Topics: Adult; Antigens; Cell Migration Inhibition; Chlorine; Deoxyuridine; Herpes Zoster; Humans; Immunity, Cellular; Iodine Isotopes; Isoniazid; Lymphocyte Activation; Male; Nitrobenzenes; Prednisone; Rifampin; Skin; Skin Tests; Tuberculin Test; Tuberculosis, Miliary | 1973 |
[Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination].
Topics: Animals; Chemical and Drug Induced Liver Injury; Isoniazid; Liver; Rats; Rifampin; Time Factors | 1973 |
[Two cases of auricular tuberculosis with facial paralysis].
Topics: Adolescent; Adult; Ear Diseases; Facial Paralysis; Female; Humans; Isoniazid; Labyrinth Diseases; Rifampin; Tuberculosis; Tuberculosis, Pulmonary; Vertigo | 1973 |
[Treatment of pulmonary, pleural and vertebral tuberculosis].
Topics: Dexamethasone; Drug Hypersensitivity; Ethambutol; Glomerular Filtration Rate; Humans; Isoniazid; Pleural Effusion; Pyridoxine; Rifampin; Tuberculosis, Pulmonary; Tuberculosis, Spinal | 1973 |
Transfer factor therapy in a patient with progressive primary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Anemia, Aplastic; Cell Migration Inhibition; Ethambutol; Female; Humans; Immunity, Cellular; Immunity, Maternally-Acquired; Isoniazid; Lectins; Lymphocytes; Macrophages; Pyrazinamide; Radiography; Rifampin; Splenectomy; Streptodornase and Streptokinase; Streptomycin; Thymidine; Tritium; Tuberculin Test; Tuberculosis, Pulmonary | 1973 |
[Current aspects of the therapy of lymph node tuberculosis].
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Lymphadenitis; Male; Rifampin; Tuberculosis, Lymph Node | 1973 |
[Early results of sputum-positive patients with newly-detected pulmonary tuberculosis with rifampicin combined with isoniazid and SM (preliminary report)].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Synergism; Evaluation Studies as Topic; Humans; Isoniazid; Middle Aged; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1973 |
[A clinical experience of rifampicin on renal tuberculosis].
Topics: Adult; Aminosalicylic Acids; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Renal | 1973 |
[Treatment of laryngeal tuberculosis (author's transl)].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis, Laryngeal | 1973 |
An evaluation of the fluorometric determination of serum isoniazid with pentanedione.
Topics: Aminosalicylic Acids; Blood Preservation; Doxycycline; Evaluation Studies as Topic; Humans; Hydrazones; Isoniazid; Ketoglutarate Dehydrogenase Complex; Ketones; Methods; Minocycline; Pyruvates; Rifampin; Spectrometry, Fluorescence; Streptomycin | 1973 |
[Rifampicin in the treatment of tuberculosis].
Topics: Administration, Oral; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1973 |
[Letter: Acute kidney failure due to rifampicin].
Topics: Acute Kidney Injury; Diarrhea; Ethionamide; Female; Humans; Isoniazid; Middle Aged; Renal Dialysis; Rifampin; Skin Manifestations; Tuberculosis, Pulmonary; Vomiting | 1973 |
Initial treatment of tuberculosis with rifampicin.
Topics: Adult; Aminosalicylic Acids; Drug Therapy, Combination; Eosinophils; Ethambutol; Female; Humans; Isoniazid; Leukocyte Count; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1973 |
[Case of miliary tuberculosis complicated by severe pneumomediastinum and pneumothorax].
Topics: Child, Preschool; Drainage; Ethambutol; Humans; Isoniazid; Male; Mediastinal Emphysema; Pneumothorax; Rifampin; Streptomycin; Tuberculosis, Miliary | 1973 |
[Modern tuberculosis therapy].
Topics: Aminosalicylic Acids; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mass Screening; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Skin tuberculosis].
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyridoxine; Rifampin; Tuberculosis, Cutaneous; Ultraviolet Therapy | 1973 |
[Letter: Sleeping pills].
Topics: Adult; Contraceptives, Oral; Drug Interactions; Female; Humans; Isoniazid; Pregnancy; Rifampin | 1973 |
Lupus vulgaris with tuberculous prostatitis.
Topics: Aminosalicylic Acids; Humans; Isoniazid; Lupus Vulgaris; Male; Middle Aged; Prostatitis; Rifampin; Streptomycin; Tuberculosis, Male Genital | 1973 |
A pilot study of leprosy treatment with a combination of various antileprosy drugs. Preliminary report.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Leprosy; Male; Pilot Projects; Pyrazines; Rifampin; Sulfanilamides; Sulfonamides; Time Factors; Trimethoprim; Uganda | 1973 |
[Administration of a new antimycobacterial combined therapy in leprosy in East Africa].
Topics: Africa, Eastern; Antitubercular Agents; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Prognosis; Pyrazines; Rifampin; Sulfanilamides; Time Factors | 1973 |
The leprosy eradication-project of Malta.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ethionamide; Female; Humans; Infant; Infant, Newborn; Isoniazid; Leprosy; Male; Mediterranean Islands; Middle Aged; Public Health; Rifampin; Sulfonamides | 1973 |
[Statement on tuberculosis treatment].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones | 1973 |
[Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Modern treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Recurrence; Rifampin; Streptomycin; Sweden; Tuberculosis | 1973 |
[Short-term chemotherapy of pulmonary tuberculosis without previous treatment (results up to July 20th, 1972)].
Topics: Drug Therapy, Combination; Ethambutol; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Side effects of tuberculostatics (author's transl)].
Topics: Adult; Antitubercular Agents; Drug Hypersensitivity; Ear; Ethambutol; Female; Humans; Isoniazid; Liver; Male; Polyneuropathies; Rifampin; Streptomycin; Thrombocytopenia | 1973 |
Tuberculous arthropathy.
Topics: Adult; Female; Fever; Humans; Isoniazid; Radiography; Rifampin; Sacroiliac Joint; Streptomycin; Tuberculosis, Miliary; Tuberculosis, Osteoarticular | 1974 |
Editorial: Rifampin in the treatment of tuberculosis.
Topics: Canada; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1974 |
[Modern treatment of renal tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Renal | 1974 |
Upper respiratory tract tuberculosis. Sixteen cases in a general hospital.
Topics: Aged; Diagnosis, Differential; Epiglottis; Esophageal Neoplasms; Hospitals, General; Humans; Ileocecal Valve; Isoniazid; Laryngeal Neoplasms; Laryngoscopy; Male; Otitis Media; Pharyngitis; Radiography; Respiratory Tract Infections; Rifampin; Tongue Diseases; Tonsillitis; Tuberculosis; Tuberculosis, Gastrointestinal; Tuberculosis, Laryngeal; Tuberculosis, Oral; Tuberculosis, Pulmonary | 1974 |
Letter: Rifampin in initial treatment of pulmonary tuberculosis: a U.S. Public Health Service tuberculosis therapy trial.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary; United States; United States Public Health Service | 1974 |
Sensitivity to rifampicin: incidence, mechanism, and prevention.
Topics: Antibodies; Antibody Formation; Binding Sites, Antibody; Biological Assay; Cell Membrane; Coombs Test; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Tolerance; Erythrocytes; Humans; Isoniazid; Lymphocyte Activation; Rifampin; Time Factors; Tuberculosis | 1974 |
[Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Cholestasis; Clinical Enzyme Tests; Drug Therapy, Combination; Ethambutol; Fatty Liver; Female; Humans; Isoniazid; Liver Diseases; Liver Function Tests; Male; Middle Aged; Necrosis; Rifampin; Sulfobromophthalein; Tuberculosis, Pulmonary | 1974 |
[Detection of the effects of the rifampin-isoniazid combination on the human liver].
Topics: Chemical and Drug Induced Liver Injury; Drug Combinations; Drug Interactions; Female; Humans; Isoniazid; Liver; Male; Rifampin; Statistics as Topic; Transaminases; Tuberculosis | 1974 |
[Jaundice and rifampicin. Critical study].
Topics: Antigen-Antibody Reactions; Chemical and Drug Induced Liver Injury; Drug Interactions; Female; Humans; Hyperbilirubinemia; Isoniazid; Male; Prognosis; Rifampin; Statistics as Topic; Transaminases; Tuberculosis | 1974 |
Three patients with intracranial tuberculomas with unusual features.
Topics: Adolescent; Aminosalicylic Acids; Brain Diseases; Dexamethasone; Diabetic Coma; Electroencephalography; Emigration and Immigration; Ethambutol; Female; Headache; Humans; Hydrocephalus; India; Isoniazid; Male; Papilledema; Pyrazinamide; Radionuclide Imaging; Rifampin; Streptomycin; Technetium; Tuberculoma; United Kingdom | 1974 |
[Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1974 |
Ethambutol in pregnancy.
Topics: Abnormalities, Drug-Induced; Animals; Child; Child, Preschool; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Fetus; Follow-Up Studies; Growth; Humans; Infant; Infant, Newborn; Isoniazid; Mice; Pregnancy; Pregnancy Complications, Infectious; Rabbits; Rats; Rifampin; Tuberculosis, Pulmonary | 1974 |
Mycobacterium tuberculosis infection of the middle ear.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Otitis Media; Pyridoxine; Rifampin; Tuberculosis; Tuberculosis, Meningeal | 1974 |
A ten-year clinical experience with Mycobacterium kansasii.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Child; Cycloserine; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Pneumonectomy; Pyrazinamide; Rifampin; Sputum; Streptomycin | 1974 |
[Treatment of primary tuberculosis].
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Antibody Formation; Antitubercular Agents; BCG Vaccine; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Immunity, Cellular; Infant; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1974 |
Blood levels of rifampicin in liver diseases.
Topics: Ethambutol; Humans; Isoniazid; Jaundice; Liver; Liver Diseases; Rifampin; Sulfobromophthalein; Tuberculosis, Pulmonary | 1974 |
Tuberculosis of the nose and paranasal sinuses.
Topics: Female; Humans; Isoniazid; Maxillary Sinus; Middle Aged; Nasal Mucosa; Nasal Polyps; Nose Diseases; Radiography; Rifampin; Streptomycin; Tuberculosis; Turbinates | 1974 |
[Treatment of tuberculous praevesical ureteral strictures (author's transl)].
Topics: Adult; Antitubercular Agents; Cortisone; Ethambutol; Female; Humans; Isoniazid; Methods; Middle Aged; Rifampin; Tuberculosis, Urogenital; Ureteral Diseases; Ureteral Obstruction | 1974 |
A pilot study concerning the early immunosuppressive effects of rifampin in man.
Topics: Adult; Antibody Formation; Bacteriophages; DNA Viruses; Histoplasmin; Humans; Immunity; Immunity, Cellular; Immunoglobulin G; Immunosuppressive Agents; Isoniazid; Middle Aged; Mitosporic Fungi; Mumps virus; Neutralization Tests; Pilot Projects; Rifampin; Skin Tests; Time Factors; Trichophyton; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
Incidence of resistant pulmonary tuberculosis in relation to initial bacterial load, Rifampicin and INH in experimental tuberculosis.
Topics: Animals; Drug Resistance, Microbial; Female; Isoniazid; Mice; Mutation; Mycobacterium bovis; Rifampin; Tuberculosis, Pulmonary | 1970 |
The antimycobacterial activity of rifampin.
Topics: Animals; Antitubercular Agents; In Vitro Techniques; Isoniazid; Mice; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin | 1968 |
The rifamycins with other drugs in the treatment of pulmonary tuberculosis: a report of nine cases.
Topics: Adult; Blood Proteins; Drug Resistance, Microbial; Humans; Injections, Intravenous; Isoniazid; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1967 |
Activity of rifampicin in experimental tuberculosis of the guinea pig.
Topics: Animals; Antitubercular Agents; Guinea Pigs; Isoniazid; Lung Diseases; Lymph Nodes; Mycobacterium tuberculosis; Organ Size; Rifampin; Skin Ulcer; Spleen; Splenic Diseases; Tuberculin Test; Tuberculosis | 1967 |
[Mode of action of "tuverculostatics". Consequences for the therapy].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1968 |
Rifampin--a major new chemotherapeutic agent for the treatment of tuberculosis.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Streptomyces; Streptomycin; Tuberculosis | 1969 |
[On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
Topics: Animals; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Spleen; Tuberculosis | 1967 |
Some comparative aspects of rifampicin and isoniazid.
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin | 1968 |
In vitro effect of rifampin on mycobacteria.
Topics: Aminosalicylic Acids; Culture Media; Drug Resistance, Microbial; Isoniazid; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1969 |
Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; United States; United States Department of Veterans Affairs | 1969 |
Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions.
Topics: Antitubercular Agents; Dialysis; Drug Resistance, Microbial; Drug Stability; Drug Storage; Isoniazid; Models, Biological; Mycobacterium; Mycobacterium tuberculosis; Rifampin | 1969 |
[Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Germany, West; Hospitals, Convalescent; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1969 |
[Rifamicin in the studies of the Scuola Tisiologica in Naples].
Topics: Adult; Aminosalicylic Acids; Animals; Drug Resistance, Microbial; Drug Synergism; Female; Guinea Pigs; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1968 |
[Experimental evaluation of the antimycobacterial activity of rifampicin].
Topics: Animals; Drug Synergism; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1968 |
Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.
Topics: Animals; Ethambutol; Ethionamide; Follow-Up Studies; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Spleen; Streptomycin; Tuberculosis | 1969 |
Rifampicin in treatment of experimental tuberculosis in mice.
Topics: Animals; Drug Synergism; Isoniazid; Lung; Male; Mice; Mycobacterium tuberculosis; Rifampin; Spleen; Tuberculosis | 1969 |
In vivo bactericidal activity of rifampicin in combination with other antimycobacterial agents.
Topics: Animals; Antitubercular Agents; Ethambutol; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Spleen; Streptomycin | 1969 |
Mechanism of rifampicin action on mycobacterial cells. Consideration to the potentiation problem of antimycobacterial treatment.
Topics: Drug Synergism; Isoniazid; Mycobacterium tuberculosis; Rifampin; RNA Nucleotidyltransferases | 1969 |
Rifampicin activity "in vitro" and in established tuberculosis in mice.
Topics: Animals; Drug Resistance, Microbial; Drug Synergism; In Vitro Techniques; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1969 |
The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 1969 |
[Incidence and significance of positive fluorescent bacilloscopy associated with negative cultures during treatment based on isoniazid or rifomycin in tubercular patients treated in the sanatorium].
Topics: Drug Synergism; Hospitals, Special; Humans; Isoniazid; Microbial Sensitivity Tests; Microscopy, Fluorescence; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1969 |
[Rifomycin in treatment of tuberculosis with polyresistant mycobacteria: clinical and laboratory observations].
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1969 |
[On the comparative effectiveness of rifampicin and INI treatment in guinea pigs inoculated with repeated microdoses of bacilli].
Topics: Animals; Drug Resistance, Microbial; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1968 |
Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1970 |
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969.
Topics: Aminosalicylic Acids; Antitubercular Agents; Dosage Forms; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Population Surveillance; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary; Veterans | 1970 |
Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.
Topics: Culture Media; Drug Resistance, Microbial; Ethambutol; Genetics, Microbial; Isoniazid; Mutation; Mycobacterium tuberculosis; Probability; Rifampin; Streptomycin | 1970 |
Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.
Topics: Analysis of Variance; Animals; Drug Resistance, Microbial; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Spleen; Streptomycin; Tuberculosis; Tuberculosis, Hepatic | 1970 |
Rifampicin in the treatment of experimental tuberculosis in mice: sterilization of tubercle bacilli in the tissues.
Topics: Animals; Cortisone; Drug Synergism; Isoniazid; Lung; Male; Mice; Mycobacterium tuberculosis; Rifampin; Spleen; Tuberculosis | 1970 |
[Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
Topics: Animals; Cortisone; Drug Synergism; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Splenic | 1970 |
[Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
Topics: Adult; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1970 |
[Internal medicine treatment of pulmonary tuberculosis].
Topics: Ambulatory Care; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Long-Term Care; Prednisolone; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1970 |
[Comparative study of the development of rifomycin blood levels in humans by 2 different microbiologic methods].
Topics: Adult; Drug Synergism; Female; Humans; Immunodiffusion; Isoniazid; Male; Methods; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1970 |
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. IX. September 1969-September 1970.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Military Personnel; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[Bacteriological problems presented by 3 cardiac transplantations].
Topics: Escherichia coli; Heart Transplantation; Humans; Infection Control; Isoniazid; Male; Penicillin G; Proteus; Rifampin; Streptococcal Infections; Streptomycin; Transplantation; Tuberculosis, Pulmonary | 1969 |
Genito-urinary tuberculosis. A study of the disease in one unit over a period of 24 years.
Topics: Aminosalicylic Acids; Calcinosis; Drug Synergism; Epididymitis; Ethambutol; Female; Humans; Hypertension, Renal; Isoniazid; Kidney Calculi; Male; Mycobacterium tuberculosis; Nephrectomy; Prednisolone; Rifampin; Streptomycin; Tuberculosis, Urogenital; Ureteral Obstruction; Urinary Bladder; Urinary Diversion; Urine | 1971 |
Rifampin: characteristics and role in the chemotherapy of tuberculosis.
Topics: Animals; Haplorhini; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Research; Rifampin; Tuberculosis | 1971 |
Rifampicin with ethambutol for drug-resistant tuberculosis.
Topics: Adult; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[An experimental study on the antituberculous activity of rifampicin].
Topics: Animals; Antitubercular Agents; Autoradiography; Guinea Pigs; Isoniazid; Liver; Mice; Microscopy, Electron; Mycobacterium tuberculosis; Rifampin | 1971 |
[Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Culture Media; Depression, Chemical; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1971 |
[Activity of rifampicin on experimental tuberculosis in mice. The development of resistance to rifampicin. Therapeutic effects of combinations of different drugs with rifampicin].
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Evaluation Studies as Topic; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1970 |
Rifampicin in experimental investigations on mice.
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Evaluation Studies as Topic; Injections, Subcutaneous; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Spleen; Time Factors; Tuberculosis | 1970 |
Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs.
Topics: Administration, Oral; Adolescent; Adult; Aminosalicylic Acids; Animals; Culture Media; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Guinea Pigs; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium tuberculosis; Organ Size; Rifampin; Spleen; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
Experimental and clinical studies of rifampicin in tuberculosis.
Topics: Adult; Animals; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Mice; Middle Aged; Mycobacterium tuberculosis; Rifampin; Shock, Septic; Tuberculosis, Pulmonary | 1970 |
[Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy].
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Systemic chemotherapy in mice experimentally infected with Mycobacterium marinum.
Topics: Administration, Oral; Animals; Dapsone; Demeclocycline; Ethionamide; Female; Isoniazid; Mice; Mice, Inbred Strains; Mycobacterium Infections; Phenylthiourea; Pyrazines; Rifampin; Sulfonamides | 1971 |
Rifampicin in the treatment of previously untreated pulmonary tuberculosis.
Topics: Age Factors; Drug Combinations; Ethambutol; Female; Gastric Juice; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1971 |
Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Animals; Drug Resistance, Microbial; Ethambutol; Female; Humans; Injections, Intramuscular; Isoniazid; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Pyridoxine; Radiography; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Mode of action of antituberculous agents and ultrastructure of mycobacteria.
Topics: Animals; Antitubercular Agents; Cycloserine; Ethambutol; Isoniazid; Kanamycin; Mice; Microscopy, Electron; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1971 |
Rifampin and isoniazid in previously untreated patients with pulmonary tuberculosis.
Topics: Bilirubin; Blood Pressure; Female; Humans; Isoniazid; Male; Middle Aged; Radiography, Thoracic; Rifampin; Transaminases; Tuberculosis, Pulmonary | 1972 |
Effect of rifampicin and isoniazid on liver function.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Bilirubin; Child; Female; Humans; Isoniazid; Liver; Male; Middle Aged; Phenotype; Rifampin; Sulfamethazine; Tuberculosis, Pulmonary | 1972 |
Rifampin in treatment of advanced pulmonary tuberculosis. Report of a VA cooperative pilot study.
Topics: Adult; Agranulocytosis; Alkaline Phosphatase; Antitubercular Agents; Aspartate Aminotransferases; Bilirubin; Drug Resistance, Microbial; Eosinophilia; Female; Humans; Isoniazid; Leukopenia; Male; Middle Aged; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary; Uric Acid | 1972 |
Rifampicin and isoniazid and liver function.
Topics: Alanine Transaminase; Alkaline Phosphatase; Anorexia Nervosa; Bilirubin; Child; Humans; Isoniazid; Liver; Nausea; Rifampin; Vomiting | 1972 |
[Therapy of acute pericarditis].
Topics: Adrenal Cortex Hormones; Analgesics; Cardiac Tamponade; Drainage; Ethambutol; Humans; Isoniazid; Pericarditis; Punctures; Rifampin; Tuberculosis, Cardiovascular | 1972 |
Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
Topics: Drug Synergism; Evaluation Studies as Topic; Humans; Isoniazid; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1972 |
Dusting off and polishing up the control of tuberculosis.
Topics: Animals; Guinea Pigs; Humans; Isoniazid; Mice; Rabbits; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1972 |
Rifampin: its role in the treatment of tuberculosis.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary; United States; United States Public Health Service | 1972 |
Changing concepts in treatment of tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Hospitals, Special; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary; United States | 1972 |
The place of rifampin.
Topics: Aminosalicylic Acids; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
Metabolic study and controlled clinical trials of rifampin.
Topics: Adult; Aged; Amides; Aminosalicylic Acids; Ethambutol; Female; Humans; Hydrogen-Ion Concentration; Isoniazid; Isonicotinic Acids; Male; Middle Aged; Rifampin; Saliva; Streptomycin; Sulfides | 1972 |
Rifampin-isoniazid compared with PAS-isoniazid-streptomycin in initial treatment of pulmonary tuberculosis. A controlled cooperative trial.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Aminosalicylic Acids; Aspartate Aminotransferases; Bilirubin; Female; Humans; Injections, Intramuscular; Isoniazid; Male; Middle Aged; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1972 |
Rifampin in initial treatment of advanced pulmonary tuberculosis.
Topics: Administration, Oral; Adult; Aged; Ethambutol; Female; Humans; Injections, Intramuscular; Isoniazid; Male; Middle Aged; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1972 |
Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
Topics: Alkaline Phosphatase; Bilirubin; Blood Proteins; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug Synergism; Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Rifampin; Transaminases; Tuberculosis, Pulmonary | 1972 |
Rifampin: clinical experience with a new anti-tuberculosis drug.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Therapy of female genital tuberculosis].
Topics: Ethambutol; Female; Glucocorticoids; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Salpingitis; Tuberculosis, Female Genital | 1972 |
[Efficiency of interrupted therapy of tuberculosis (experimental study)].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Methods; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1972 |
[Has the intermittent therapy of pulmonary tuberculosis a future in industrialised countries?].
Topics: Animals; Antitubercular Agents; Belgium; Congo; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Methods; Mice; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Drug therapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Ethambutol; Humans; Isoniazid; Rest; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1972 |
Rifampin with disulfiram.
Topics: Disulfiram; Drug Combinations; Humans; Isoniazid; Liver; Male; Middle Aged; Rifampin | 1972 |
[Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
Topics: Chemical and Drug Induced Liver Injury; Child, Preschool; Cholestasis; Humans; Isoniazid; Jaundice; Liver; Male; Rifampin; Tuberculosis, Miliary | 1972 |
[Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chronic Disease; Drug Combinations; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1972 |
Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Drug Combinations; Drug Resistance, Microbial; Humans; Isoniazid; Liver Diseases; Liver Function Tests; Male; Middle Aged; Radiography; Rifampin; Tuberculosis, Pulmonary | 1972 |
Recent developments in the treatment of infectious diseases. V. Management of tuberculosis in the community hospital.
Topics: Aminosalicylic Acids; Cross Infection; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sanitation; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Disseminated tuberculosis complicated by pancytopenia.
Topics: Anemia, Aplastic; Biopsy; Ethambutol; Female; Humans; Isoniazid; Liver; Middle Aged; Rifampin; Tuberculosis, Miliary | 1971 |
Rifampin alone and combined with other drugs in Mycobacterium kansasii and Mycobacterium intracellulare infections of mice.
Topics: Animals; Drug Resistance, Microbial; Drug Synergism; Ethionamide; Female; Heart; Isoniazid; Kidney; Mice; Mice, Inbred Strains; Mycobacterium Infections; Rifampin; Streptomycin | 1971 |
[Comparative study: Streptomycin, Isoniazid (Ethambutol) vs. Rifampicin, Isoniazid (Ethambutol)].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1971 |
[Newer therapeutic possibilities in the treatment of chronic open pulmonary tuberculosis].
Topics: Antitubercular Agents; Chronic Disease; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Rifampicin and liver].
Topics: Humans; Isoniazid; Jaundice; Liver; Rifampin; Tuberculosis, Pulmonary | 1971 |
Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Topics: Aminosalicylic Acids; Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Folate deficiency in pulmonary tuberculosis: relationship to treatment and to serum vitamin A and beta-carotene.
Topics: Adult; Aged; Aminosalicylic Acids; Carotenoids; Erythrocytes; Ethionamide; Female; Folic Acid; Folic Acid Deficiency; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Vitamin A | 1971 |
[Hepatitis induced by combination of rifampicin and isoniazid].
Topics: Adult; Aged; Animals; Biopsy; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Mice; Middle Aged; Rifampin | 1971 |
[Hepatic tolerance in man of rifampicin-isoniazid association].
Topics: Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Topics: Adult; Aminosalicylic Acids; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[A case of icterus in the course of treatment with rifampicin. Histological records].
Topics: Aged; Biopsy; Chemical and Drug Induced Liver Injury; Ethionamide; Female; Humans; Isoniazid; Jaundice; Liver; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[Hepatitis induced by combined rifomycin and isoniazid].
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Synergism; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary; Tuberculosis, Splenic | 1971 |
Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. II. Bilirubin levels and other biochemical determinations.
Topics: Alanine Transaminase; Analysis of Variance; Aspartate Aminotransferases; Bilirubin; Drug Combinations; Ethambutol; Humans; Isoniazid; Liver; Liver Diseases; Liver Function Tests; Rifampin; Time Factors | 1971 |
Serum levels after administration of rifampicin.
Topics: Drug Combinations; Ethambutol; Food Deprivation; Humans; Isoniazid; Rifampin; Sarcina; Time Factors | 1971 |
Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. I. Variation of the rifampicin serum levels (947 determinations).
Topics: Analysis of Variance; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Sarcina; Time Factors; Tuberculosis, Pulmonary | 1971 |
[Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment].
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1971 |
[International Symposium on Rifampicin. Morning discussion].
Topics: Bilirubin; Drug Combinations; Humans; Isoniazid; Liver; Rifampin | 1971 |
The effect of pyrazinamide, rifampicin and cycloserine on the blood levels and urinary excretion of isoniazid.
Topics: Cycloserine; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1971 |
Potentially serious side-effects of high-dose twice-weekly rifampicin.
Topics: Acute Kidney Injury; Adolescent; Adult; Antibodies; Child; Complement Fixation Tests; Epistaxis; Female; Fever; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis | 1971 |
New approach for the evaluation of antimycobacterial drug combinations in vitro (the laboratory model man).
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Synergism; Erythromycin; Ethionamide; Humans; Isoniazid; Methenamine; Models, Biological; Mycobacterium; Oxacillin; Penicillin Resistance; Rifampin | 1969 |
[Activity of Rifampicin associated with other drugs on experimental tuberculosis in guinea pigs].
Topics: Animals; Guinea Pigs; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1967 |
[Rifampicin in tuberculosis. Summary of the observations and discussion].
Topics: Drug Synergism; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1968 |
[Diphasic treatment of pulmonary tuberculosis in children using rifamycin, ethambutol and isoniazid].
Topics: Child; Child, Preschool; Drug Synergism; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1970 |
Pharmacokinetic interactions between the tuberculostatics rifampicin, para-aminosalicylic acid and isoniazid.
Topics: Aminosalicylic Acids; Drug Synergism; Half-Life; Humans; Isoniazid; Rifampin | 1970 |
Potentially serious side effects of high-dose twice-weekly rifampicin.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Antibodies; Child; Coombs Test; Epistaxis; Female; Fever; Humans; Isoniazid; Lip; Male; Middle Aged; Oral Hemorrhage; Rifampin; Streptomycin; Thrombocytopenia; Tongue Diseases; Tuberculosis, Pulmonary | 1971 |
An experimental attempt of intensified chemotherapy with rifampicin combined with other drugs.
Topics: Administration, Oral; Animals; Drug Synergism; Ethambutol; Ethionamide; Female; Isoniazid; Mice; Mice, Inbred Strains; Rifampin; Tuberculosis | 1971 |
Rifampicin.
Topics: Bronchitis; Chronic Disease; Drug Resistance, Microbial; Drug Synergism; Economics, Medical; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1969 |
Drugs in the treatment of tuberculosis--1969.
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1969 |
[Rifomycin in continuous and intermittent combined treatment of experimental tuberculosis in mice].
Topics: Animals; Drug Synergism; Isoniazid; Mice; Rifampin; Streptomycin; Tuberculosis | 1969 |
[Clinical results obtained by rifomycin treatment of patients with recent tuberculosis].
Topics: Drug Synergism; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1969 |
[Treatment of recent pulmonary tuberculosis with combined rifomycin-isoniazid].
Topics: Adult; Drug Synergism; Female; Humans; Isoniazid; Male; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1969 |
[Treatment of pulmonary tuberculosis by combined rifampicin-isoniazid-streptomycin, and return to work after the 45th day].
Topics: Absenteeism; Adult; Drug Synergism; Humans; Isoniazid; Male; Middle Aged; Prognosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1969 |
Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Lung; Mice; Rifampin; Spleen; Tuberculosis, Pulmonary | 1969 |
[Rifampicin and isoniazid in the intermittent treatment of experimental tuberculosis in guinea-pigs].
Topics: Animals; Drug Synergism; Guinea Pigs; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis | 1969 |
[Conservative treatment of renal tuberculosis].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Renal | 1969 |
[Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
[Rifampicin, a new antitubercular bactericide].
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Female; Guinea Pigs; Humans; In Vitro Techniques; Isoniazid; Male; Mice; Pregnancy; Rifampin | 1970 |
Jaundice after rifampicin.
Topics: Aged; Aspartate Aminotransferases; Humans; Isoniazid; Jaundice; Liver Function Tests; Male; Rifampin; Tuberculosis, Pulmonary | 1970 |
Rifampin, new hope in the fight against tuberculosis.
Topics: Humans; Isoniazid; Rifampin; Tuberculosis | 1970 |
The action of rifampin alone and in combination with other antituberculous drugs.
Topics: Drug Resistance, Microbial; Drug Synergism; Ethambutol; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1970 |
[Drug therapy of urogenital tuberculosis].
Topics: Aminosalicylic Acids; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1970 |
[Modern chemotherapy of tuberculosis].
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; Berlin; Child; Child, Preschool; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Infant; Isoniazid; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis | 1970 |
[Pharmacogenetic and interaction-model with some usual antitubercular agents].
Topics: Aminosalicylic Acids; Humans; Isoniazid; Rifampin; Tuberculosis | 1970 |
[New drugs in the treatment of primary tuberculosis].
Topics: Aminosalicylic Acids; Child; Child, Preschool; Ethambutol; Female; France; Humans; Isoniazid; Male; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
[Research on the protective action of rifampicin administered intermittently in experimental tuberculosis in guinea pigs].
Topics: Animals; Guinea Pigs; Isoniazid; Rifampin; Tuberculosis | 1970 |
[Current views on drug treatment of tuberculosis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1970 |
Present position of urinary tuberculosis.
Topics: Adolescent; Adult; Age Factors; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Renal; Tuberculosis, Urogenital; Urinary Bladder | 1970 |
Results of treatment in a large series of cases of genito-urinary tuberculosis and the changing pattern of the disease.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Female; Humans; Hypertension, Renal; Isoniazid; Male; Nephrectomy; Rifampin; Streptomycin; Tuberculosis, Renal; Tuberculosis, Urogenital; Ureter; Ureteral Diseases; Urinary Bladder | 1970 |
Jaundice associated with rifampicin.
Topics: Aged; Alkaline Phosphatase; Chemical and Drug Induced Liver Injury; Drug Synergism; Female; Humans; Isoniazid; Liver; Liver Function Tests; Middle Aged; Rifampin; Tuberculosis | 1970 |
[A new and powerful anti-tubercular drug: rifampicin].
Topics: Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Humans; Infusions, Parenteral; Isoniazid; Rifampin; Streptomyces; Tuberculosis | 1970 |
[Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide].
Topics: Adult; Drug Synergism; Female; Humans; Hypoprothrombinemias; Isoniazid; Isonicotinic Acids; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Vitamin K Deficiency | 1970 |
[Jaundice epidemiology in 1,974 hospitalized tubercular patients, treated or untreated by rifampicin].
Topics: Drug Synergism; Humans; Isoniazid; Jaundice; Rifampin; Tuberculosis; Tuberculosis, Hepatic | 1970 |
[A new and powerful anti-tubercular drug: rifampicin].
Topics: Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Humans; Infusions, Parenteral; Isoniazid; Rifampin; Streptomyces; Tuberculosis | 1970 |
[Increase in transaminases and jaundice during treatment with rifampicin combined with isoniazid].
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Jaundice; Liver; Rifampin; Transaminases | 1970 |
[Jaundice and cytolysis in patients receiving rifampicin and isoniazid at the same time].
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Jaundice; Liver; Male; Middle Aged; Rifampin | 1970 |
[Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
Topics: Adolescent; Adult; Aged; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1970 |
Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies.
Topics: Administration, Oral; Animals; Drug Combinations; Ethambutol; Ethionamide; Evaluation Studies as Topic; Isoniazid; Mice; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1970 |
Rifampicin in retreatment and original treatment cases of pulmonary tuberculosis.
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1970 |
Consequences of the development of new antituberculous drugs for the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis | 1970 |
[Case report on the treatment of bone tuberculosis with rifampicin (Rimactan)].
Topics: Adrenal Cortex Hormones; Bronchitis; Humans; Isoniazid; Male; Middle Aged; Prognosis; Rifampin; Spondylitis; Streptomycin; Tuberculosis, Pulmonary; Tuberculosis, Spinal | 1970 |
Experimental therapy with rifampicin.
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Isoniazid; Mice; Mycobacterium Infections; Phenylthiourea; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1970 |
[Standard therapy of tuberculosis].
Topics: Antitubercular Agents; Body Weight; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1971 |
[Symposium: chemotherapy including new antitubercular agents].
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1971 |
[Changing picture of tuberculosis during a decade].
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1971 |
The combination of rifampicin and other antituberculous agents in chronic murine tuberculosis.
Topics: Animals; Cell Count; Chronic Disease; Disease Models, Animal; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Lung; Mice; Placebos; Rifampin; Streptomycin; Tuberculosis | 1971 |
[The rational basis for the treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis | 1971 |
[Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1971 |
"Control of tuberculosis" up-to-date.
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1971 |
[Experimental study of rifampicin and ethambutol].
Topics: Animals; Blood Bactericidal Activity; Ethambutol; Guinea Pigs; Humans; In Vitro Techniques; Isoniazid; Mice; Microbial Sensitivity Tests; Rabbits; Rifampin; Tuberculosis | 1971 |
Trial of rifampicin in the treatment of pulmonary tuberculosis. A preliminary report.
Topics: Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
Topics: Culture Techniques; Cycloserine; Ethambutol; Humans; Isoniazid; Monocytes; Phenylthiourea; Pyrazines; Rifampin; Tuberculosis, Pulmonary | 1967 |
Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
Topics: Adolescent; Adult; Aminosalicylic Acids; Animals; Guinea Pigs; Humans; Isoniazid; Mice; Middle Aged; Mycobacterium; Protein Binding; Rifampin; Streptomycin; Tuberculosis | 1967 |
[Rifampicin in experimental tuberculosis].
Topics: Animals; Ethambutol; Ethionamide; Isoniazid; Mice; Models, Biological; Rifampin; Tuberculosis, Pulmonary | 1968 |
[Intermittent rifomycin therapy of experimental tuberculosis in guinea pigs].
Topics: Animals; Body Weight; Drug Synergism; Ethambutol; Guinea Pigs; Isoniazid; Rifampin; Tuberculosis | 1968 |
Sensitivity of some mycobacteria to Rifocin-M.
Topics: Drug Resistance, Microbial; Isoniazid; Mycobacterium; Rifampin; Species Specificity | 1969 |
Addendum on serum levels.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Phenazines; Pyrazinamide; Rifampin; Streptomycin | 1967 |
Addison's disease with adrenal enlargement on computed tomographic scanning. Report on two cases of tuberculosis and review of the literature.
Topics: Addison Disease; Adrenal Glands; Adrenocorticotropic Hormone; Aged; Cortisone; Drug Therapy, Combination; Fludrocortisone; Humans; Isoniazid; Male; Middle Aged; Prednisone; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Male Genital | 1984 |
Interaction of ketoconazole with rifampin and isoniazid.
Topics: Drug Interactions; Drug Therapy, Combination; Humans; Infant; Isoniazid; Ketoconazole; Kinetics; Rifampin; Tinea Capitis; Tuberculosis, Lymph Node | 1984 |
[Effect of rifampicin on gamma-glutamyl-transferase in guinea-pigs (author's transl)].
Topics: Animals; gamma-Glutamyltransferase; Guinea Pigs; Isoniazid; Rifampin | 1980 |
Tuberculosis in chronic renal failure.
Topics: Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Mycobacterium avium; Rifampin; Tuberculosis | 1980 |
Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis.
Topics: Brazil; Drug Synergism; Humans; Isoniazid; Leishmania; Leishmaniasis; Male; Rifampin; Tuberculosis | 1981 |
Acute isoniazid/ethambutol/rifampicin overdosage.
Topics: Acute Disease; Adult; Drug Synergism; Ethambutol; Humans; Isoniazid; Male; Rifampin | 1982 |
Adverse drug reaction to sunset-yellow in rifampicin-isoniazid tablet.
Topics: Azo Compounds; Excipients; Female; Gastrointestinal Diseases; Humans; Isoniazid; Middle Aged; Rifampin; Tablets; Tuberculosis | 1982 |
Spinal tuberculosis: remember streptomycin.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Spinal | 1983 |
Urinary D-glucaric acid excretion during rifampicin/isoniazid and anticonvulsant enzyme induction.
Topics: Adolescent; Adult; Aged; Enzyme Induction; Female; gamma-Glutamyltransferase; Glucaric Acid; Glucuronidase; Glutethimide; Humans; Isoniazid; Liver; Male; Middle Aged; Phenytoin; Rifampin; Sugar Acids | 1984 |
Positive histological tuberculous findings despite stable sterility of the urine on culture: results of 111 nephrectomies and partial nephrectomies.
Topics: Capreomycin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Nephrectomy; Retrospective Studies; Rifampin; Tuberculosis, Renal | 1980 |
Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases.
Topics: Adolescent; Adult; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Middle Aged; Rifampin; Thioacetazone | 1981 |
Brain-stem tuberculoma: an unusual presentation.
Topics: Adult; Brain Diseases; Brain Stem; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Rifampin; Tomography, X-Ray Computed; Tuberculoma | 1982 |
Drug-resistant Mycobacterium tuberculosis in Korean isolates.
Topics: Adult; Capreomycin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Korea; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1982 |
Evaluation of drug regimen in lepromatous leprosy--II.
Topics: Adult; Animals; Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Humans; Isoniazid; Leprostatic Agents; Leprosy; Male; Mice; Middle Aged; Rifampin; Thioacetazone | 1983 |
[Antitubercular agents].
Topics: Antimetabolites; Antitubercular Agents; DNA; Ethambutol; Ethionamide; Folic Acid Antagonists; Humans; Isoniazid; Rifampin; RNA; Tuberculosis, Pulmonary | 1984 |
[Therapeutic results in lung diseases caused by atypical mycobacteria].
Topics: Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Erythromycin; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
Tuberculosis in hospital.
Topics: Adult; BCG Vaccine; Child; Cross Infection; Disease Outbreaks; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Occupational Diseases; Patient Isolation; Rifampin; Specimen Handling; Sterilization; Tuberculosis; Tuberculosis, Pulmonary; United Kingdom; Vaccination; Ventilators, Mechanical | 1984 |
[Acute adrenal insufficiency induced by antitubercular treatment in an addisonian woman. Possible role of the rifampicin-isoniazid combination].
Topics: Addison Disease; Adrenal Insufficiency; Drug Therapy, Combination; Female; Humans; Isoniazid; Middle Aged; Rifampin | 1983 |
[Toxicity in the current treatment of pulmonary tuberculosis in children].
Topics: Adolescent; Antitubercular Agents; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Eruptions; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Isoniazid; Nausea; Nervous System Diseases; Rifampin; Tuberculosis, Pulmonary | 1984 |
[Current treatment of pulmonary tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1984 |
Guidelines for short-course tuberculosis chemotherapy. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control Atlanta, Ga.
Topics: Centers for Disease Control and Prevention, U.S.; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis; United States | 1980 |
Activity of oral drugs against Leishmania tropica in human macrophages in vitro.
Topics: Antiprotozoal Agents; Cells, Cultured; Drug Interactions; Humans; Isoniazid; Ketoconazole; Leishmania; Macrophages; Metronidazole; Nitrofurans; Phenothiazines; Quinacrine; Rifampin; Sulfamethoxazole; Trimethoprim | 1983 |
[Activity of rifampicin administered daily and intermittently on experimental tuberculosis in mice].
Topics: Animals; Drug Administration Schedule; Female; Isoniazid; Mice; Rifampin; Time Factors; Tuberculosis | 1983 |
Compliance of patients and physicians: experience and lessons from tuberculosis-II.
Topics: Attitude of Health Personnel; Drug Administration Schedule; Drug Information Services; Drug Therapy, Combination; Education, Medical, Graduate; Family Practice; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary; United Kingdom | 1983 |
Antituberculosis drug resistance in south Texas.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Female; Hispanic or Latino; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sex Factors; Streptomycin; Texas; Tuberculosis, Pulmonary | 1983 |
[Resistance of the Koch bacillus to antibacillary agents in the Department of the Lower Rhine].
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1983 |
Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
Topics: Administration, Oral; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kinetics; Male; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Results of intermittent treatment of tuberculosis and Mycobacteria shedding in children].
Topics: Adolescent; Child; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Pharmacokinetics of antitubercular agents in man].
Topics: Absorption; Antitubercular Agents; Half-Life; Humans; Isoniazid; Kinetics; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1984 |
[Resistance to antitubercular drugs in Chile].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Immunity; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1984 |
Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Patient Compliance; Recurrence; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1984 |
Treatment of septic arthritis due to Mycobacterium kansasii.
Topics: Adult; Arthritis, Infectious; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin | 1984 |
The usefulness of phage typing Mycobacterium tuberculosis isolates.
Topics: Adolescent; Adult; Aged; Animal Diseases; Animals; Bacteriophage Typing; Child; Child, Preschool; Disease Outbreaks; Elephants; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Recurrence; Rifampin; Tuberculosis | 1984 |
[The present status of pneumoconiosis in Japan and the results of chemotherapy of silico-tuberculosis].
Topics: Adult; Aged; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Silicotuberculosis | 1984 |
[Resistant strains of Mycobacterium tuberculosis in the Gizan Area, Saudi Arabia].
Topics: Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Saudi Arabia; Streptomycin | 1984 |
Drug-resistance encountered in the retreatment of Mycobacterium tuberculosis infections.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Patient Readmission; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; beta-Lactamases; Cephalosporins; Chloramphenicol; Clindamycin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Penicillins; Rifampin; Spectinomycin; Tetracyclines | 1980 |
Effect of chemotherapy on suppressor T cells in BCG-infected mice.
Topics: Animals; Drug Combinations; Isoniazid; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mice; Mycobacterium bovis; Rifampin; Specific Pathogen-Free Organisms; Spleen; T-Lymphocytes, Regulatory; Tuberculosis | 1980 |
Treatment of tuberculous masses in the neck.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Emigration and Immigration; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Neck; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 1984 |
Rifampicin in tuberculous meningitis: a retrospective assessment.
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Tuberculosis, Meningeal | 1984 |
Hepatotoxicity of isoniazid and rifampin in children.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Isoniazid; Nutrition Disorders; Rifampin | 1984 |
[Short-course chemotherapy for tuberculosis in Chile. Operational considerations].
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Patient Dropouts; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
[Short-course treatment of tuberculosis on a 7-month schedule with an initial intensive phase of 1 month (TA-81)].
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
Serum total bile acid levels in patients receiving rifampicin and isoniazid.
Topics: Adolescent; Adult; Bile Acids and Salts; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1984 |
[Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
Topics: Animals; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Guinea Pigs; Injections, Intramuscular; Injections, Intravenous; Isoniazid; Lung; Necrosis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1984 |
Contralateral pleural effusion during chemotherapy for tuberculous pleurisy.
Topics: Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pleural Effusion; Prednisone; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pleural | 1984 |
[A case of pulmonary tuberculosis followed by interesting clinical findings].
Topics: Child; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Isoniazid; Mediastinal Neoplasms; Radiography; Rifampin; Tuberculosis, Pulmonary | 1984 |
[Five year follow-up study on the short-course chemotherapy for pulmonary tuberculosis in Niigata Prefecture].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1984 |
Preliminary observations on short-course chemotherapy in tuberculous serositis.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyridoxamine; Rifampin; Serositis; Time Factors; Tuberculosis | 1984 |
A successful supervised outpatient short-course tuberculosis treatment program in an open refugee camp on the Thai-Cambodian border.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Antitubercular Agents; Cambodia; Child; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Refugees; Rifampin; Streptomycin; Thailand; Time Factors; Tuberculosis, Pulmonary | 1984 |
Pemphigus foliaceus induced by rifampicin.
Topics: Humans; Isoniazid; Male; Middle Aged; Pemphigus; Pyridoxine; Rifampin; Tuberculosis, Pulmonary | 1984 |
Lupus vulgaris responding to double antituberculous therapy.
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Lupus Vulgaris; Middle Aged; Pyridoxine; Rifampin | 1984 |
Appearance of tuberculoma during the course of TB meningitis.
Topics: Adolescent; Brain Stem; Female; Humans; Isoniazid; Prednisolone; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Meningeal | 1984 |
[Tuberculosis treatment today].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
[Carbamazepine-tuberculostatics interaction].
Topics: Carbamazepine; Child; Drug Interactions; Female; Humans; Isoniazid; Rifampin | 1984 |
The management of genito-urinary tuberculosis--a review.
Topics: Angiography; Antitubercular Agents; Developing Countries; Drug Therapy, Combination; Endoscopy; Epididymis; Female; Humans; Isoniazid; Male; Nephrectomy; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital; Urinary Diversion; Urography | 1984 |
[Studies on short-course chemotherapy of tuberculosis. II. Liver function during 6-month chemotherapy of tuberculosis with hydrazide, rifampicin and pyrazinamide].
Topics: Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1984 |
The management of urinary tuberculosis--a logical approach.
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Urogenital | 1984 |
Genitourinary tuberculosis. A study of 1117 cases over a period of 34 years.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital; Urine | 1984 |
Management of tuberculosis in elderly persons.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Urogenital | 1984 |
Tuberculosis of the greater trochanteric bursa.
Topics: Aged; Bursa, Synovial; Female; Gallium Radioisotopes; Hip Joint; Humans; Isoniazid; Rifampin; Technetium; Tuberculosis, Osteoarticular | 1983 |
Drug treatment of tuberculosis.
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1984 |
Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis.
Topics: Adolescent; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Isoniazid; Liver Function Tests; Retrospective Studies; Rifampin; Time Factors; Tuberculosis, Pulmonary; United States | 1983 |
Short-course chemotherapy for tuberculosis in children.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Lung; Male; Patient Compliance; Radiography; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Changes in the isoniazid inactivation index during antituberculosis treatment in children].
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Erythromycin; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Rifampin in the treatment of children with newly detected intrathoracic tuberculosis].
Topics: Aminosalicylic Acid; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
Fatal hepatitis after treatment with isoniazid and rifampicin in a patient on anticonvulsant therapy.
Topics: Anticonvulsants; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1983 |
Undesirable side effects of isoniazid and rifampin in largely twice-weekly short-course chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Hematologic Diseases; Humans; Isoniazid; Male; Middle Aged; Rifampin; Skin Diseases; Tuberculosis, Pulmonary | 1983 |
The tolerability and efficacy of a 6-month antituberculosis regimen containing rifampicin, isoniazid and pyrazinamide.
Topics: Adolescent; Adult; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1983 |
[Use of the antioxidant ionol to prevent damage to the heart from prolonged administration of antitubercular preparations].
Topics: Animals; Antioxidants; Antitubercular Agents; Butylated Hydroxytoluene; Heart Diseases; Isoniazid; Male; Prothionamide; Rats; Rifampin; Time Factors | 1983 |
Spiking fever induced by isoniazid.
Topics: Drug Hypersensitivity; Fever; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors | 1983 |
[Immunologic aspects of myocardial damage during long-term administration of antitubercular preparations].
Topics: Animals; Cardiomyopathies; Drug Combinations; Isoniazid; Isonicotinic Acids; Myocardium; Prothionamide; Rats; Rifampin | 1983 |
[Phospholipids and their complexes as correctors of the combined hepatotropic action of ethanol and tuberculostatic drugs].
Topics: Animals; Chemical and Drug Induced Liver Injury; Drug Interactions; Ethanol; Isoniazid; Male; Phospholipids; Rats; Rifampin | 1983 |
[Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
Topics: Administration, Oral; Drug Therapy, Combination; Humans; Isoniazid; Kidney Failure, Chronic; Kidney Function Tests; Kinetics; Rifampin; Time Factors; Tuberculosis, Renal | 1983 |
Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
[Comparison of 3 6-month chemotherapy regimes in pulmonary tuberculosis in routine practice in Algiers. 18th-month results].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse].
Topics: Animals; DNA-Directed RNA Polymerases; Drug Therapy, Combination; Female; Isoniazid; Mice; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1983 |
[Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
Topics: Ambulatory Care; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Hospitalization; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1983 |
[Short-term chemotherapy for juvenile tuberculosis].
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis; Tuberculosis, Lymph Node | 1983 |
Is isoniazid-hepatotoxicity induced by the metabolite, hydrazine?
Topics: Animals; Cytochrome P-450 Enzyme System; Hydrazines; Isoniazid; Liver; Male; Microsomes, Liver; Rabbits; Rifampin | 1983 |
[Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
An overview of tuberculosis in the 1980s.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Patient Education as Topic; Pregnancy; Rifampin; Tuberculosis | 1983 |
Tuberculoid granuloma of the pharynx.
Topics: Adult; Female; Granuloma; Humans; Isoniazid; Pharyngeal Diseases; Rifampin; Tuberculosis | 1984 |
The treatment of urinary tuberculosis.
Topics: Adult; Aged; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Kidney; Male; Methods; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Urogenital; Ureter; Urinary Bladder; Urinary Tract; Urography | 1984 |
[Sensitizing effect of rifampicin in combination with isoniazid and streptomycin on microcirculation].
Topics: Adolescent; Adult; Capillaries; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Vasculitis, Leukocytoclastic, Cutaneous | 1984 |
[Evolution of the treatment of tuberculosis].
Topics: Ambulatory Care; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Hospitalization; Humans; Isoniazid; Patient Compliance; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1984 |
[Female genital tuberculosis, a changing reality].
Topics: Amenorrhea; Ethambutol; Female; Humans; Infertility, Female; Isoniazid; Rifampin; Tuberculosis, Female Genital | 1984 |
[Urinary tuberculosis today].
Topics: Calcinosis; Diagnosis, Differential; Endoscopy; Ethambutol; Female; Humans; Isoniazid; Italy; Male; Pyelonephritis; Rifampin; Tuberculosis, Urogenital; Ureteral Calculi; Ureteral Obstruction; Urinary Tract Infections; Urine | 1984 |
[Efficacy of different methods of treating experimental cavernous tuberculosis of a single kidney].
Topics: Animals; Drug Therapy, Combination; Ethambutol; Isoniazid; Rabbits; Rifampin; Tuberculosis, Renal | 1984 |
Shortest possible acceptable effective chemotherapy in ambulatory patients with pulmonary tuberculosis. Part II. Results during the 24 months after the end of chemotherapy.
Topics: Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethionamide; Follow-Up Studies; Humans; India; Isoniazid; Patient Compliance; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1984 |
[A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
The first infant to survive a generalized BCG infection.
Topics: Antibodies, Bacterial; B-Lymphocytes; Child, Preschool; Humans; Infant; Isoniazid; Lymphocyte Activation; Male; Mitogens; Mycobacterium bovis; Prognosis; Rifampin; Streptomycin; T-Lymphocytes; Tuberculosis; Viral Plaque Assay | 1982 |
Skin lesions caused by Mycobacterium haemophilum.
Topics: Adult; Female; Humans; Isoniazid; Kidney Transplantation; Leg Dermatoses; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious | 1982 |
[Comparative study of two microbiological assay methods of serum isoniazid].
Topics: Anti-Bacterial Agents; Biological Assay; Humans; Isoniazid; Mycobacterium; Rifampin | 1982 |
[Meningitis of uncertain etiology].
Topics: Adult; Cryptococcus; Cryptococcus neoformans; Ethambutol; Female; Humans; Isoniazid; Meningitis; Mycobacterium tuberculosis; Rifampin | 1980 |
[L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; L Forms; Male; Middle Aged; Mycobacterium tuberculosis; Prothionamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Short-course treatment regimens for patients with tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Resistant mycobacterium tuberculosis: report of a family in Connecticut.
Topics: Adolescent; Connecticut; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1980 |
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
The efficacy of short-course chemotherapy for tuberculosis.
Topics: Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1980 |
Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique.
Topics: Adolescent; Child; Child, Preschool; Cost-Benefit Analysis; Decision Making; Delphi Technique; Drug Resistance, Microbial; Drug Therapy; Drug Therapy, Combination; Humans; Infant; Isoniazid; Mycobacterium tuberculosis; Rifampin; Surveys and Questionnaires; Tuberculosis | 1980 |
[Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
Topics: Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.
Topics: Culture Media; Humans; Hydrogen-Ion Concentration; Isoniazid; Mycobacterium tuberculosis; Rifampin; Temperature; Tuberculosis, Pulmonary | 1981 |
Rapid drug-susceptibility testing of Mycobacterium tuberculosis.
Topics: Aminosalicylic Acid; Carbon Dioxide; Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1981 |
[Changes in the primary resistance to Mycobacterium tuberculosis in Piedmont 1965-1979].
Topics: Antibiotics, Antitubercular; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Italy; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis.
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Species Specificity; Tuberculosis | 1981 |
Studies in short-course chemotherapy for tuberculosis. Basis for short-course chemotherapy.
Topics: Animals; Drug Therapy, Combination; Humans; Isoniazid; Mice; Mice, Inbred Strains; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1981 |
Tuberculosis: who should prescribe?
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Medication Errors; Middle Aged; Rifampin; Streptomycin | 1982 |
Survey of pulmonary tuberculosis in south and west Wales (1976-8).
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Wales | 1982 |
Cutaneous tuberculosis.
Topics: Adult; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Cutaneous; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1982 |
[Use of agar diffusion method for separate determination of concentration of streptomycin and rifampicin in the blood in the presence of isoniazid].
Topics: Bacillus; Culture Media; Drug Interactions; Humans; Immunodiffusion; In Vitro Techniques; Isoniazid; Kinetics; Microbial Sensitivity Tests; Rifampin; Streptomycin | 1982 |
[Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
Topics: Animals; Antibiotics, Antitubercular; Drug Therapy, Combination; Female; Humans; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spleen; Streptomycin; Tuberculosis | 1982 |
Genitourinary tuberculosis revisited.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Urogenital | 1982 |
Present chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1982 |
[Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mice; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Sputum; Tuberculosis, Pulmonary | 1982 |
Disseminated cutaneous Mycobacterium marinum infection.
Topics: Ethambutol; Female; Humans; Infant; Isoniazid; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Skin Diseases, Infectious | 1983 |
[Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence].
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1983 |
Tuberculosis therapy.
Topics: Chemical and Drug Induced Liver Injury; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1983 |
[Fatal liver cell necrosis following short-term administration of isoniazid and rifampicin to a patient already under treatment with antiepileptics].
Topics: Anticonvulsants; Chemical and Drug Induced Liver Injury; Drug Interactions; Hepatic Encephalopathy; Humans; Isoniazid; Liver; Male; Middle Aged; Necrosis; Rifampin | 1983 |
Incidence of chromosomal aberrations in patients under combined tuberculostatic chemotherapy.
Topics: Antitubercular Agents; Chromosome Aberrations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lymphocytes; Metaphase; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
[A clinical study on the chemotherapy for pulmonary tuberculosis in diabetics].
Topics: Adult; Aged; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1983 |
Calcium metabolism during rifampicin and isoniazid therapy.
Topics: Calcium Metabolism Disorders; Drug Therapy, Combination; Female; Humans; Isoniazid; Rifampin; Tuberculosis | 1983 |
Short course chemotherapy for tuberculosis: treatment of choice?
Topics: Costs and Cost Analysis; Drug Combinations; Humans; Isoniazid; Patient Compliance; Rifampin; Tuberculosis, Pulmonary | 1983 |
Tuberculosis and its control: lessons to be learned from past experience, and implications for leprosy control programmes.
Topics: Adolescent; Adult; BCG Vaccine; Child; Child, Preschool; Developing Countries; Drug Resistance, Microbial; Humans; Infant; Isoniazid; Leprosy; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1983 |
Reactivated musculoskeletal tuberculosis with concomitant asymptomatic genitourinary infection.
Topics: Arthrodesis; Ethambutol; Female; Hip Joint; Humans; Isoniazid; Joint Diseases; Knee Joint; Middle Aged; Radionuclide Imaging; Recurrence; Rifampin; Shoulder Joint; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular; Tuberculosis, Renal | 1983 |
Hepatic complications of antituberculosis therapy revisited.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1983 |
Modern issues in the therapy of tuberculosis.
Topics: Drug Resistance; Female; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Fatal liver cell necrosis after short-term administration of isoniazid and rifampicin to a patient already under treatment with anti-epileptic agents].
Topics: Adult; Carbamazepine; Female; Hepatic Encephalopathy; Humans; Isoniazid; Liver; Necrosis; Rifampin | 1983 |
[Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
Topics: Adolescent; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1983 |
Therapy of tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Child; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1983 |
Chemotherapy for pulmonary tuberculosis. A short-course regimen and its rationale.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Risk; Time Factors; Tuberculosis, Pulmonary; United States | 1983 |
Chemotherapy of tuberculosis: TB or not TB?
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1981 |
[Treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1982 |
Adverse effects of antituberculosis drugs causing changes in treatment.
Topics: Antitubercular Agents; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1982 |
Isoniazid-rifampin--induced fulminant liver disease in an infant.
Topics: Chemical and Drug Induced Liver Injury; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1980 |
Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Humans; Infant; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
Circulating immune complexes in tuberculosis.
Topics: Adolescent; Adult; Aged; Antigen-Antibody Complex; Child; Child, Preschool; Complement Activating Enzymes; Complement C1q; Female; Humans; Immunoglobulin G; Immunoglobulin M; Isoniazid; Longitudinal Studies; Male; Middle Aged; Rifampin; Tuberculosis | 1981 |
[Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
Topics: Acetylation; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium; Rifampin; Tuberculosis | 1982 |
[Liver damage following antituberculous therapy].
Topics: Adult; Alcoholism; Chemical and Drug Induced Liver Injury; Ethambutol; Fatty Liver; Humans; Isoniazid; Male; Rifampin | 1982 |
Increased incidence of hepatitis induced by isoniazid-rifampin combination in children.
Topics: Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Humans; Isoniazid; Rifampin | 1982 |
[Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
Topics: Adolescent; Adult; Aged; Blood Cells; Drug Therapy, Combination; Female; Free Radicals; Humans; Isoniazid; Male; Middle Aged; Plasma; Pyridoxine; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1982 |
Short-course chemotherapy for tuberculosis.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Self Administration; Tuberculosis, Pulmonary | 1982 |
Cavitary lung infection caused by Mycobacterium flavescens.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Melanoma; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis, Pulmonary | 1982 |
[Dynamics of various immunobiochemical and encephalographic indices during polychemotherapy of pulmonary tuberculosis patients].
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1982 |
Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Middle Aged; Poland; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1982 |
Tuberculous pericarditis developing during chemotherapy.
Topics: Child; Ethambutol; Humans; Isoniazid; Male; Pericarditis, Tuberculous; Prednisone; Rifampin; Streptomycin; Tuberculosis, Cardiovascular; Tuberculosis, Pulmonary | 1982 |
[Duration of the treatment of tuberculosis in 1981].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1982 |
[Clinically primary tuberculosis of the tongue].
Topics: Ethambutol; Humans; Isoniazid; Lung; Male; Middle Aged; Mouth Mucosa; Radiography; Rifampin; Tongue Diseases; Tuberculosis; Tuberculosis, Oral | 1982 |
Short-course chemotherapy for pulmonary tuberculosis. Points of interest.
Topics: Adult; Ambulatory Care; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1982 |
Present views on isoniazid and isoniazid-rifampicin hepatitis.
Topics: Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Rifampin | 1982 |
[Glycolysis components and carbohydrate metabolic enzyme activity of the blood under long-term action of rifampicin and isoniazid].
Topics: Animals; Carbohydrates; Drug Synergism; Drug Therapy, Combination; Enzyme Activation; Erythrocytes; Glycolysis; Isoniazid; Male; Rats; Rifampin; Time Factors | 1982 |
Adverse drug reactions in TB therapy: risks and recommendations.
Topics: Adult; Age Factors; Aged; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug Evaluation; Ethambutol; Humans; Isoniazid; Kidney Diseases; Middle Aged; Optic Neuritis; Rifampin; Risk; Streptomycin; Tuberculosis | 1982 |
Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis.
Topics: Adolescent; Adult; Calcium; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Osteomalacia; Rifampin; Tuberculosis; Vitamin D | 1982 |
Postmenopausal tuberculosis of the female genital tract.
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Menopause; Middle Aged; Rifampin; Tuberculosis, Female Genital | 1982 |
[Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].
Topics: Acetylation; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1982 |
Medical management of gastrointestinal tuberculosis.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Gastrointestinal | 1982 |
[Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver].
Topics: Acetylation; Antitubercular Agents; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Liver; Rifampin; Transaminases; Tuberculosis | 1982 |
Effect of rifampicin and isoniazid on vitamin D metabolism.
Topics: Adult; Aged; Antipyrine; Calcium; Drug Interactions; Female; Humans; Isoniazid; Kinetics; Male; Middle Aged; Parathyroid Hormone; Rifampin; Tuberculosis, Pulmonary; Vitamin D | 1982 |
Pulmonary disease due to Mycobacterium xenopi. Report of two cases.
Topics: Aged; Alcoholism; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pulmonary Emphysema; Rifampin; Tuberculosis, Pulmonary | 1982 |
[Fulminant hepatitis in patients with mixed connective tissue disease under antitubercular treatment with hydrazide and rifampicin].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Mixed Connective Tissue Disease; Rifampin | 1982 |
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Rifampin; Streptomycin | 1982 |
Antituberculosis drug levels after jejunoileal bypass.
Topics: Antitubercular Agents; Ethambutol; Female; Humans; Ileum; Isoniazid; Jejunum; Middle Aged; Obesity; Postoperative Complications; Rifampin; Tuberculosis, Pulmonary | 1982 |
[Hepatotoxic action of rifampicin and isonicotinic acid hydrazide].
Topics: Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kinetics; Liver; Rifampin; Transaminases | 1982 |
[Acute toxic action of combinations of antibiotics with isoniazid].
Topics: Animals; Drug Synergism; Drug Therapy, Combination; Female; Isoniazid; Lethal Dose 50; Male; Mice; Rifampin; Streptomycin; Time Factors | 1982 |
Modern treatment of tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1982 |
Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis.
Topics: Calcium; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis | 1982 |
[The effect of rifampicin and INH on the mouse liver].
Topics: Animals; Isoniazid; Liver; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Rifampin | 1982 |
Determination of rifampicin, desacetylrifampicin, isoniazid and acetylisoniazid by high-performance liquid chromatography: application to human serum extracts, polymorphonucleocytes and alveolar macrophages.
Topics: Chromatography, High Pressure Liquid; Humans; Isoniazid; Macrophages; Neutrophils; Rifampin; Tuberculosis, Pulmonary | 1982 |
[Microbiological evaluation of the abacillary state in the combined therapy of destructive pulmonary tuberculosis in experimental animals].
Topics: Aminosalicylic Acid; Animals; Dogs; Drug Therapy, Combination; Isoniazid; Lung; Lymph Nodes; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1982 |
[The treatment of bone tuberculosis with special reference to tuberculous spondylitis].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Radiography; Rifampin; Spondylitis; Streptomycin; Tuberculosis, Spinal | 1982 |
[Clinical description of the relapse of tuberculosis].
Topics: Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1982 |
In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
Topics: Antitubercular Agents; Dimethyl Sulfoxide; Drug Interactions; Ethambutol; Ethionamide; Isoniazid; Mycobacterium; Mycobacterium avium; Nontuberculous Mycobacteria; Rifampin; Streptomycin | 1982 |
[Hepatitis caused by drugs. 4].
Topics: Adult; Aminosalicylic Acid; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Halothane; Humans; Iproniazid; Isoniazid; Middle Aged; Nitrofurantoin; Phenytoin; Prognosis; Rifampin; Sulfonamides | 1982 |
[Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
Topics: Acetylation; Acetyltransferases; Adult; Aged; Drug Therapy, Combination; Enzyme Induction; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1980 |
The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women.
Topics: Adolescent; Adult; Ethambutol; Ethinyl Estradiol; Female; Humans; Isoniazid; Kinetics; Norethindrone; Norethindrone Acetate; Rifampin; Sex Hormone-Binding Globulin; Tuberculosis | 1980 |
The treatment of tuberculosis of the female genital tract with rifampicin, ethambutol, and isoniazid.
Topics: Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Female Genital | 1981 |
[Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Diazepam interaction with antituberculosis drugs.
Topics: Adult; Antitubercular Agents; Blood Proteins; Diazepam; Drug Interactions; Ethambutol; Female; Humans; Isoniazid; Kinetics; Male; Protein Binding; Rifampin | 1981 |
[Short-term intensive therapy of destructive pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Plasma concentrations of isoniazid in children with tuberculous infections.
Topics: Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Injections, Intramuscular; Isoniazid; Male; Phenytoin; Rifampin; Tuberculin Test; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1981 |
[Reparative processes during treatment of destructive pulmonary tuberculosis by maximum drug concentrations].
Topics: Animals; Antitubercular Agents; Dogs; Isoniazid; Lung; Prednisolone; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Wound Healing | 1981 |
Current concept of short-term chemotherapy of tuberculosis.
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1981 |
[Liver damage from tuberculosis treatment].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Liver; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1981 |
[Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
[Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
Topics: Adolescent; Adult; Antitubercular Agents; Blood Coagulation; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1981 |
[Ways of increasing chemotherapy effectiveness in pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Evaluation; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1981 |
Pulmonary actinomycosis. Rapid improvement with isoniazid and rifampin.
Topics: Actinomycosis; Adult; Diagnosis, Differential; Humans; Isoniazid; Lung Diseases; Male; Rifampin; Tuberculosis, Pulmonary | 1981 |
[Metabolic disorders in acute poisoning and their correction by sodium succinate].
Topics: Animals; Antitubercular Agents; Ethionamide; Guinea Pigs; Isoniazid; Phenobarbital; Poisoning; Rifampin; Succinates | 1981 |
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity.
Topics: Acetylation; Adult; Antipyrine; Calcium; Humans; Isoniazid; Kidney; Liver; Male; Mixed Function Oxygenases; Oxygenases; Parathyroid Hormone; Phenotype; Phosphates; Rifampin; Tuberculosis, Pulmonary; Vitamin D | 1981 |
Short course chemotherapy for tuberculosis.
Topics: Costs and Cost Analysis; Drug Therapy, Combination; Humans; Isoniazid; Patient Compliance; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1981 |
Shortest possible acceptable, effective ambulatory chemotherapy in pulmonary tuberculosis: preliminary report I.
Topics: Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Ethionamide; Female; Humans; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Short-course (6-month) cooperative tuberculosis study in Poland: results 30 months after completion of treatment.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Poland; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1981 |
Isoniazid-rifampin regimens for tuberculosis.
Topics: Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1981 |
[Problems in treatment of pulmonary tuberculosis: in terms of bacteriologic relapse (author's transl)].
Topics: Drug Therapy, Combination; Humans; Isoniazid; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Effect of administration of various antibacterial drugs on hydroxyproline concentration in the rat lung].
Topics: Animals; Cephalosporins; Cephradine; Hydroxyproline; Isoniazid; Lung; Male; Rats; Rifampin; Time Factors | 1981 |
Acetylhydrazine hepatotoxicity.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Hydrazines; Isoniazid; Liver; Male; Phenobarbital; Rats; Rats, Inbred Strains; Rifampin | 1981 |
Isoniazid metabolism in the rabbit, and the effect of rifampin pretreatment.
Topics: Animals; Biotransformation; Drug Interactions; Isoniazid; Male; Rabbits; Rifampin; Time Factors | 1981 |
Preliminary results of six-month regimens studied in the United States and in Poland.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Poland; Rifampin; Time Factors; Tuberculosis, Pulmonary; United States | 1981 |
[Hepatotoxicity of the rifampicin-isoniazid combination in children].
Topics: Chemical and Drug Induced Liver Injury; Child, Preschool; Humans; Isoniazid; Liver; Male; Parotid Diseases; Rifampin; Tuberculosis; Tuberculosis, Oral | 1981 |
Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex.
Topics: Adult; Aged; Aminosalicylic Acid; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Isoniazid; Mice; Microbial Sensitivity Tests; Rifampin; Tuberculosis | 1981 |
[Histological characteristics of tuberculous cavity treated with rifampicin--a comparative study with cases treated by primary drugs (author's transl)].
Topics: Adolescent; Adult; Aminosalicylic Acid; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
[A case of rifampicin-induced acute renal failure and review of 47 cases with liver dysfunction induced by isoniazid and rifampicin (author's transl)].
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Male; Middle Aged; Rifampin | 1981 |
[Adverse reactions to short-course anti-tuberculous therapy (author's transl)].
Topics: Antitubercular Agents; Drug Hypersensitivity; Drug Tolerance; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin | 1981 |
[Hydrazide-rifampicin: hepatotoxicity in children].
Topics: Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1981 |
[Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
Topics: Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Hepatomegaly; Humans; Infant; Isoniazid; Liver Diseases; Rifampin; Transaminases; Tuberculosis, Meningeal | 1981 |
[Light and electron microscopy studies of the liver in tuberculosis patients receiving rifampin and isoniazid].
Topics: Drug Therapy, Combination; Humans; Isoniazid; Liver; Rifampin; Tuberculosis, Pulmonary | 1981 |
[A report on 10 cases of enlargement of mediastinal lymph nodes occurring during RFP and INH treatment (author's transl)].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Hyperplasia; Isoniazid; Lymph Nodes; Male; Mediastinum; Rifampin | 1981 |
[Clinically apparent liver damage during brief tuberculosis therapy].
Topics: Acute Disease; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin | 1981 |
Tuberculosis in patients with end-stage renal disease.
Topics: Adult; Aged; Ethambutol; Female; Humans; Immunity, Cellular; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Pyrazinamide; Renal Dialysis; Rifampin; Risk; Tuberculosis | 1980 |
Nontuberculous mycobacterial endobronchitis in children.
Topics: Bronchitis; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis, Pulmonary | 1980 |
Tuberculosis in the elderly: treating the "white plague".
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Risk; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary; United States | 1980 |
Short-course chemotherapy for tuberculosis with largely twice weekly isoniazid-rifampin.
Topics: Drug Administration Schedule; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
Rifampin and AFB: yes or no?
Topics: Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
Congenital miliary tuberculosis proved by open lung biopsy specimen and successfully treated.
Topics: Biopsy; Female; Humans; Infant, Newborn; Isoniazid; Lung; Male; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Streptomycin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1980 |
[Patterns of the healing processes of the tuberculotic lung cavern].
Topics: Animals; Dogs; Isoniazid; Pyridoxine; Rifampin; Time Factors; Tuberculosis, Pulmonary; Wound Healing | 1980 |
[Evaluation of the nature of the hepatotoxic action of isoniazid, rifamicin, ethambutol and their combinations against a background of prolonged alcohol administration].
Topics: Animals; Drug Interactions; Ethambutol; Ethanol; Isoniazid; Lipid Metabolism; Liver; Male; Rats; Rifampin; Seasons; Time Factors | 1980 |
Leishmaniasis: a case history and treatment failure with rifampin.
Topics: Adult; Ethambutol; Humans; Isoniazid; Leishmaniasis; Male; Rifampin | 1980 |
Tuberculosis therapy and enzyme induction in man.
Topics: Acetylation; Adult; Aged; Antipyrine; Antitubercular Agents; Enzyme Induction; Ethambutol; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Side effects of antitubercular drugs leading to discontinuation of drug therapy].
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acid; Antitubercular Agents; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Rifampin; Sex Ratio; Streptomycin | 1980 |
Neutropenia with each standard antituberculosis drug in the same patient.
Topics: Aged; Agranulocytosis; Antibiotics, Antitubercular; Ethambutol; Humans; Isoniazid; Leukocyte Count; Male; Neutropenia; Neutrophils; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Pulmonary tuberculosis in 3 Swedish children].
Topics: Adolescent; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Radiography; Rifampin; Sweden; Tuberculosis, Pulmonary | 1980 |
[Effectiveness of chemotherapy of chronic forms of pulmonary tuberculosis under hospital conditions].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Follow-Up Studies; Hospitalization; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Serum and cerebrospinal fluid proteins in tuberculous meningitis.
Topics: Adolescent; Adult; Blood Proteins; Cerebrospinal Fluid Proteins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Prognosis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Meningeal | 1980 |
[Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Epilepsy; Female; Hepatic Encephalopathy; Humans; Isoniazid; Phenobarbital; Rifampin; Tuberculosis, Miliary | 1980 |
[Acute liver insufficiency caused by rifampicin-isoniazid].
Topics: Child; Hepatic Encephalopathy; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Humans; Isoniazid; Lung; Middle Aged; Pneumonectomy; Rifampin; Time Factors; Tissue Distribution; Tuberculosis, Pulmonary | 1980 |
Monitoring regularity of drug intake in tuberculous patients by means of simple urine tests.
Topics: Color; Drug Administration Schedule; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary; Urine | 1980 |
Short-course chemotherapy with isoniazid and rifampin.
Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
Short course chemotherapy--use of combination tablets of isoniazid and rifampin.
Topics: Drug Combinations; Drug Resistance, Microbial; Humans; Isoniazid; Rifampin | 1980 |
An advance in treatment of tuberculosis.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Principles of rational tuberculosis chemotherapy].
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Drug Evaluation; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Humans; Isoniazid; Mice; Prothionamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Short course chemotherapy in tuberculous meningitis: a pilot trial.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Child; Child, Preschool; Ethambutol; Humans; Infant; Isoniazid; Pilot Projects; Rifampin; Streptomycin; Time Factors; Tuberculosis, Meningeal | 1980 |
[A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1980 |
[New aspects of chemotherapy of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
[Experimental study of therapeutic effect of various antibacterial drug combinations].
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Guinea Pigs; Isoniazid; Prothionamide; Rabbits; Rats; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
American Thoracic Society. Medical Section of the American Lung Association. Guidelines for short-course tuberculosis chemotherapy.
Topics: Adult; Child; Humans; Isoniazid; Rifampin; Tuberculosis | 1980 |
A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Heroin Dependence; Hong Kong; Humans; Isoniazid; Male; Opioid-Related Disorders; Opium; Prisoners; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1980 |
Controlled double-blind study of the effect of rifampin on humoral and cellular immune responses in patients with pulmonary tuberculosis and in tuberculosis contacts.
Topics: Adolescent; Adult; Antibody Formation; Double-Blind Method; Female; Humans; Immunity, Cellular; Isoniazid; Leukocytes; Lymphocyte Activation; Male; Middle Aged; Pyrazinamide; Rifampin; Skin Tests; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Clinical approach to the choice of antimicrobial therapy, case #20, Part B: Fever in pregnancy.
Topics: Adult; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Epidemiology, diagnosis, and treatment of renal tuberculosis. A report of 213 cases].
Topics: Ethambutol; Female; Humans; Isoniazid; Male; Nephrectomy; Prothionamide; Rifampin; Streptomycin; Tuberculosis, Renal; Urine; Urography | 1980 |
[Report on 13 cases (including 3 deaths) of liver damage induced by rifampicin (author's transl)].
Topics: Adult; Chemical and Drug Induced Liver Injury; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1980 |
Update on chemotherapy of renal tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyridoxine; Rifampin; Time Factors; Tuberculosis, Renal | 1980 |
[Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Short course chemotherapy.
Topics: Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid.
Topics: Acetylation; Drug Interactions; Humans; Isoniazid; Kinetics; Phenotype; Prednisolone; Rifampin | 1980 |
Rifampicin.
Topics: Animals; Antipyrine; Enzyme Induction; Humans; Isoniazid; Rifampin | 1980 |
Study on drug interactions.
Topics: Adult; Clofazimine; Dapsone; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Leprosy; Male; Middle Aged; Rifampin | 1980 |
Fever response of patients on therapy for pulmonary tuberculosis.
Topics: Alcoholism; Antitubercular Agents; Bacterial Infections; Drug Therapy, Combination; Ethambutol; Female; Fever; Humans; Isoniazid; Lung; Male; Middle Aged; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1981 |
Short-course chemotherapy for tuberculosis.
Topics: Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1981 |
Hepatotoxicity from isoniazid and rifampin in inner-city AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Alanine Transaminase; Alcoholism; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Female; Humans; Incidence; Isoniazid; Liver Function Tests; Male; New York City; Poverty Areas; Rifampin; Risk Factors; Time Factors; Tuberculosis, Pulmonary | 1995 |
Tuberculosis of the breast.
Topics: Adult; Aged; Antitubercular Agents; Combined Modality Therapy; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Mastectomy, Segmental; Mastitis; Middle Aged; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 1995 |
Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colorimetry; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1995 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Female; Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Oxidative stress during antituberculous therapy in young and elderly patients.
Topics: Adult; Age Factors; Aged; Allantoin; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Oxidative Stress; Pyrazinamide; Rifampin; Thiobarbituric Acid Reactive Substances; Time Factors; Tuberculosis, Pulmonary; Uric Acid | 1995 |
Toxicity of isoniazid and rifampicin combination.
Topics: Drug Combinations; Humans; Isoniazid; Rifampin | 1995 |
Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1995 |
Relapse rates in tuberculosis patients.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1995 |
Fulminant isoniazid-induced hepatitis: the hazards of ex-adiuvantibus treatment in the elderly.
Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Hepatic Encephalopathy; Humans; Isoniazid; Rifampin; Risk Factors | 1994 |
An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda.
Topics: Ambulatory Care; Cost of Illness; Cost-Benefit Analysis; Drug Packaging; Guidelines as Topic; Humans; Isoniazid; Patient Education as Topic; Program Development; Program Evaluation; Rifampin; Rural Health; Time Factors; Treatment Outcome; Tuberculosis; Uganda | 1995 |
Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Flow Cytometry; Fluoresceins; Formaldehyde; Humans; Hydrolysis; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 1995 |
Drugs for tuberculosis.
Topics: Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
[Tuberculous splenic abscess in an immunocompetent patient].
Topics: Abscess; Adolescent; Ethambutol; Female; Humans; Isoniazid; Rifampin; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Splenic | 1995 |
L5 luciferase reporter mycobacteriophages: a sensitive tool for the detection and assay of live mycobacteria.
Topics: Bacterial Typing Techniques; Base Sequence; Drug Resistance, Microbial; Ethambutol; Genes, Insect; Genes, Reporter; Genetic Vectors; Genome, Viral; Isoniazid; Luciferases; Lysogeny; Molecular Sequence Data; Mycobacteriophages; Mycobacterium; Promoter Regions, Genetic; Rifampin; Sensitivity and Specificity; Streptomycin; Transcription, Genetic | 1995 |
Brief report: meningitis due to iatrogenic BCG infection in two immunocompromised children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Child, Preschool; Drug Contamination; Ethionamide; Female; Humans; Iatrogenic Disease; Immunocompromised Host; Isoniazid; Male; Meningitis, Bacterial; Mycobacterium bovis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1995 |
Primary hyperparathyroidism and vitamin D deficiency.
Topics: Humans; Hyperparathyroidism; Isoniazid; Rifampin; Vitamin D Deficiency | 1995 |
Tuberculosis drug resistance in the Western Cape.
Topics: Adolescent; Adult; Aged; Drug Resistance, Multiple; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; South Africa; Tuberculosis | 1995 |
[Analysis of restriction fragment length polymorphism (RFLP) in epidemiology of tuberculosis].
Topics: Antitubercular Agents; Bacteriological Techniques; Colombia; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Models, Genetic; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prospective Studies; Rifampin; Rural Population; Streptomycin; Tuberculosis, Pulmonary; Urban Population | 1995 |
Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement.
Topics: Aged; Drug Eruptions; Drug Therapy, Combination; Eosinophilia; Ethambutol; Female; Humans; Isoniazid; Pulmonary Eosinophilia; Pyrazinamide; Radiography; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis, Miliary | 1995 |
[Pathogenesis and control of tuberculosis in the era of AIDS].
Topics: Acquired Immunodeficiency Syndrome; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Base Sequence; DNA, Bacterial; Drug Resistance, Microbial; Fatal Outcome; Humans; Isoniazid; Male; Middle Aged; Molecular Sequence Data; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Hepatotoxicity caused by the combined action of isoniazid and rifampicin.
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Rifampin; Tuberculosis, Miliary | 1995 |
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Isoniazid; Liver Transplantation; Male; Middle Aged; Pyrazinamide; Rifampin; Survival Rate | 1995 |
Anti tubercular treatment induced hepatotoxicity: does acetylator status matter?
Topics: Acetylation; Adult; Antitubercular Agents; Biomarkers; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Phenotype; Pyrazinamide; Rifampin | 1995 |
Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Drug Resistance, Multiple; Genes, Bacterial; Genetic Markers; Humans; Isoniazid; Molecular Sequence Data; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Peroxidases; Polymorphism, Single-Stranded Conformational; Ribosomal Proteins; Rifampin; RNA, Ribosomal, 16S; Streptomycin | 1995 |
Mycobacterial testing in clinical laboratories that participate in the College of American Pathologists' Mycobacteriology E survey: results of a 1993 questionnaire.
Topics: Centers for Disease Control and Prevention, U.S.; Drug Resistance, Multiple; Humans; Isoniazid; Laboratories; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Societies, Scientific; Surveys and Questionnaires; Tuberculosis, Pulmonary; United States | 1995 |
[Lupus vulgaris. Treatment with 3 drugs].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Lupus Vulgaris; Male; Pyrazinamide; Rifampin | 1995 |
Short-course chemotherapy for tuberculous pleural effusion and culture-negative pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pleural Effusion; Pyrazinamide; Rifampin; Self Administration; Tuberculosis, Pulmonary | 1995 |
Silicotuberculosis: long-term outcome after short-course chemotherapy.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Silicotuberculosis; Streptomycin; Tuberculosis, Pulmonary | 1995 |
Antituberculous therapy and acute liver failure.
Topics: Adult; Antitubercular Agents; Drug Hypersensitivity; Female; Humans; Isoniazid; Liver Failure, Acute; Liver Function Tests; Male; Middle Aged; Pyrazinamide; Rifampin | 1995 |
Antituberculous therapy and acute liver function.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Hong Kong; Humans; Isoniazid; Liver Function Tests; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1995 |
[Tuberculous dacryocystitis].
Topics: Acute Disease; Child, Preschool; Dacryocystitis; Dacryocystorhinostomy; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 1995 |
Drug therapy of bacillus Calmette-Guérin sepsis.
Topics: Animals; Body Weight; Cycloserine; Drug Combinations; Isoniazid; Mice; Mice, Inbred C3H; Mycobacterium bovis; Prednisone; Rifampin; Survival Analysis; Tuberculosis | 1995 |
Mycobacterial cervical adenitis.
Topics: Adult; Cervical Vertebrae; Clavicle; Female; Humans; Isoniazid; Lymphadenitis; Mycobacterium scrofulaceum; Mycobacterium tuberculosis; Rifampin; Tomography, X-Ray Computed; Ultrasonography | 1995 |
Multiple drug interactions with cyclosporine in a heart transplant patient.
Topics: Cyclosporine; Drug Interactions; Drug Monitoring; Erythromycin; Heart Transplantation; Humans; Immunosuppression Therapy; Isoniazid; Male; Middle Aged; Rifampin | 1995 |
Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study. The Italian Tuberculosis Drug Resistance Study Group.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; HIV Infections; Humans; Isoniazid; Italy; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1995 |
[Therapy of tuberculosis in the adult].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxide.
Topics: Cell Line; Cell Wall; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Ethambutol; Isoniazid; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Permeability; Rifampin; Streptomycin | 1995 |
Replacement of one lung by a large bulla in active tuberculosis.
Topics: Aged; Drug Therapy, Combination; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1995 |
Antituberculous therapy and acute liver function.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Isoniazid; Liver Function Tests; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1995 |
Anti-tuberculous therapy and acute liver failure.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Immunosuppression Therapy; Isoniazid; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1995 |
[Tuberculous abscess of the liver. Apropos of 2 cases].
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver Abscess; Pyrazinamide; Rifampin; Tuberculosis, Hepatic | 1994 |
Transient exacerbation of tuberculous lymphadenitis during chemotherapy in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Leukocyte Count; Male; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 1994 |
Comprehensive assay for pyrazinamide, rifampicin and isoniazid with its hydrazine metabolites in human plasma by column liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Female; Humans; Hydrazines; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Spectrophotometry, Ultraviolet | 1994 |
Treating tuberculosis with one combination drug.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis | 1994 |
Tuberculous pleural effusion: experience with six months of treatment with isoniazid and rifampicin.
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pleural | 1994 |
Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis.
Topics: Acute Kidney Injury; Adult; Biopsy; Drug Therapy, Combination; Glomerulonephritis; Humans; Isoniazid; Kidney Glomerulus; Male; Microscopy, Electron; Rifampin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1994 |
Serum alfa-one antitrypsin (AAT) in tubercular lymphadenitis.
Topics: alpha 1-Antitrypsin; Blood Sedimentation; Ethambutol; Isoniazid; Prognosis; Rifampin; Tuberculosis, Lymph Node | 1994 |
Acute tubular necrosis following endosulphan insecticide poisoning.
Topics: Aged; Anti-Bacterial Agents; Endosulfan; Fatal Outcome; Humans; Isoniazid; Kidney Tubular Necrosis, Acute; Male; Rifampin; Suicide, Attempted; Tuberculosis, Pulmonary | 1995 |
Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model.
Topics: Animals; Antibiotics, Antitubercular; Drug Therapy, Combination; Female; Isoniazid; Mice; Pyrazinamide; Rifabutin; Rifampin; Rifamycins; Tuberculosis | 1994 |
High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Child; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Turkey | 1994 |
Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fever; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 1994 |
[Pulmonary tuberculosis in infants. Apropos of 6 cases].
Topics: BCG Vaccine; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary | 1994 |
Tuberculosis in human immunodeficiency virus-exposed or -infected United States children.
Topics: Adult; Child; Child, Preschool; Drug Resistance, Multiple; HIV Infections; Humans; Infant; Isoniazid; Retrospective Studies; Rifampin; Surveys and Questionnaires; Tuberculosis; United States | 1994 |
Rifampin-induced severe thrombocytopenia in a patient with pulmonary tuberculosis.
Topics: Adult; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Male; Rifampin; Thrombocytopenia; Tuberculosis, Pulmonary | 1994 |
Mycobacterium tuberculosis: drug-resistance mechanisms.
Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin | 1994 |
[Effects of antibacterial preparations on growth of Mycobacterium tuberculosis in a model of primary tuberculous infection in tissue culture].
Topics: Animals; Bacteriological Techniques; Culture Media; Culture Techniques; Isoniazid; Lung; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors | 1994 |
Cytogenetic study of tuberculosis patients before and after tuberculostatic drug treatment.
Topics: Adult; Antitubercular Agents; Cell Division; Chromosome Aberrations; Drug Combinations; Female; Humans; Isoniazid; Lymphocytes; Male; Middle Aged; Mitotic Index; Mutagens; Pyrazinamide; Rifampin; Sister Chromatid Exchange; Tuberculosis, Pulmonary | 1995 |
Isoniazid and acetylisoniazid kinetics in serum and urine in pulmonary primary complex with intermittent regimen.
Topics: Adolescent; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis | 1994 |
Antituberculous therapy and acute liver failure.
Topics: Chemical and Drug Induced Liver Injury; Fever of Unknown Origin; Humans; Isoniazid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Function Tests; Male; Middle Aged; Rifampin; Time Factors | 1995 |
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance, Microbial; Ethionamide; Female; Genes, Bacterial; Humans; Isoniazid; Male; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1994 |
Dissolution test method for rifampicin-isoniazid fixed dose formulations.
Topics: Capsules; Chromatography, High Pressure Liquid; Drug Combinations; Humans; Indicators and Reagents; Isoniazid; Rifampin; Solubility; Spectrophotometry, Ultraviolet | 1994 |
Tuberculosis and drug resistance in Tennessee-preliminary data, 1993.
Topics: Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tennessee; Tuberculosis, Multidrug-Resistant | 1994 |
4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 1994 |
Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice.
Topics: Animals; Antitubercular Agents; Colony-Forming Units Assay; Drug Therapy, Combination; Female; Immunity; Isoniazid; Mice; Mice, Nude; Pyrazinamide; Rifampin; Tuberculosis | 1994 |
[Sacral tuberculous osteitis].
Topics: Child, Preschool; Drug Therapy, Combination; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Osteitis; Pyrazinamide; Rifampin; Sacrum; Tuberculosis, Spinal | 1994 |
[Possibilities and prospects of intravascular irradiation of blood by helium-neon laser in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Blood; Female; Humans; Isoniazid; Lasers; Liver; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1993 |
[Endoscopic diagnosis of colonic tuberculosis].
Topics: Aged; Cecum; Colon; Colonic Diseases; Colonoscopy; Drug Therapy, Combination; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1994 |
TB treatment: yesterday, today and ... tomorrow.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Monitoring; Ethambutol; Humans; Infant; Isoniazid; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
[Two pulmonary tuberculosis cases with HIV infection].
Topics: Adult; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
Clinical features, diagnosis, and treatment of tuberculosis in infants.
Topics: Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1994 |
[Tuberculous meningitis caused by resistant microorganisms. Therapeuticfailure in 2 patients with HIV infection and disseminated tuberculosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fatal Outcome; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Zidovudine | 1994 |
Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting.
Topics: Adult; AIDS-Related Opportunistic Infections; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin; Superinfection; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
[Rapidly growing tumor of the hand--is tuberculosis as differential diagnosis gaining increased importance?].
Topics: Bone Regeneration; Child, Preschool; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Metacarpus; Rifampin; Tuberculosis, Osteoarticular | 1994 |
From the Food and Drug Administration.
Topics: Antitubercular Agents; Blood Donors; Drug Approval; Drug Combinations; Electromagnetic Phenomena; Equipment and Supplies; Equipment Failure; HIV Infections; HIV Seronegativity; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis; United States; United States Food and Drug Administration; Wheelchairs | 1994 |
Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: changing seroprevalence and evaluation of a thioacetazone-free regimen.
Topics: Adolescent; Child; Child, Preschool; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV Seroprevalence; HIV-1; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary; Zambia | 1994 |
Papulonecrotic tuberculide and erythema induratum as presenting manifestations of tuberculosis.
Topics: Adult; Asia; Drug Therapy, Combination; Erythema Induratum; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; United Kingdom | 1994 |
Tuberculosis in liver transplant patients.
Topics: Adult; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoniazid; Liver Transplantation; Male; Middle Aged; Rifampin; Tuberculin Test; Tuberculosis | 1994 |
Mycobacterial cervical lymphadenitis. A clinicopathological study of 3 cases.
Topics: Aged; Diagnosis, Differential; Ethambutol; Female; Follow-Up Studies; Humans; Hyperplasia; Isoniazid; Lymph Nodes; Middle Aged; Neck; Rifampin; Tuberculosis, Lymph Node | 1994 |
Tuberculosis in renal transplant recipients.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kidney Transplantation; Lymph Nodes; Male; Middle Aged; Mycobacterium tuberculosis; Postoperative Complications; Rifampin; Sputum; Tuberculosis, Pulmonary | 1994 |
Rifampin-resistant Mycobacterium kansasii.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Ciprofloxacin; Clinical Protocols; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Texas; Treatment Outcome; Tuberculosis | 1994 |
Nationwide survey of drug-resistant tuberculosis in the United States.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Demography; Female; Health Surveys; Humans; Incidence; Infant; Isoniazid; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; New York City; Population Surveillance; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; United States | 1994 |
Rapid resolution of tuberculous pericardial effusions with high dose prednisone and anti-tuberculous drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Female; HIV Seronegativity; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pericardial Effusion; Pericarditis, Tuberculous; Prednisone; Rifampin | 1994 |
[Tuberculosis of the spine in children. Personal experience].
Topics: Abscess; Child, Preschool; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Mycobacterium tuberculosis; Rifampin; Spinal Cord; Streptomycin; Tomography, X-Ray Computed; Tuberculosis, Spinal | 1994 |
Follow-up of tuberculosis patients undergoing standard anti-tuberculosis chemotherapy by using a polymerase chain reaction.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1994 |
Characteristics of patients with drug resistant and drug sensitive tuberculosis in East London between 1984 and 1992.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Isoniazid; London; Lung; Male; Middle Aged; Prevalence; Radiography; Recurrence; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis.
Topics: AIDS-Related Opportunistic Infections; Cross Infection; DNA, Bacterial; Drug Resistance; Hospitals, Urban; Humans; Isoniazid; Mycobacterium tuberculosis; New York City; Polymorphism, Restriction Fragment Length; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1993 |
Genito-urinary tuberculosis--experience with 52 urology inpatients.
Topics: Adolescent; Adult; Aged; Child; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Urogenital; Ureteral Obstruction | 1993 |
Serum concentrations of rifampicin and isoniazid in tuberculosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Half-Life; Humans; Infant; Isoniazid; Male; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1993 |
[Cephalosporins as possible methods of etiotropic therapy of tuberculosis].
Topics: Animals; Cefazolin; Cefotaxime; Cells, Cultured; Cephalosporins; Culture Media; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mice; Microbial Sensitivity Tests; Rifampin; Tuberculosis | 1993 |
Short course chemotherapy for tuberculosis in children.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Pyrazinamide; Rifampin; Skin Diseases; Streptomycin; Tuberculosis; Vomiting | 1993 |
An outbreak of tuberculosis in a captive herd of Arabian oryx (Oryx leucoryx): management.
Topics: Animals; Antelopes; Disease Outbreaks; Ethambutol; Female; Isoniazid; Male; Pregnancy; Rifampin; Saudi Arabia; Tuberculosis, Pulmonary | 1994 |
Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis.
Topics: Acute Disease; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin | 1994 |
An epidemic of tuberculosis in an elementary school, Sanremo, Italy, 1993.
Topics: Adult; Child; Contact Tracing; Disease Outbreaks; Drug Therapy, Combination; Epidemiologic Methods; Female; Humans; Isoniazid; Italy; Male; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1994 |
Anti-tuberculous initial drug resistance of Mycobacterium tuberculosis in Kenya: a ten-year review.
Topics: Drug Resistance, Microbial; Humans; Incidence; Isoniazid; Kenya; Microbial Sensitivity Tests; Population Surveillance; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1993 |
[Incidence of resistance of tuberculosis bacteria in Switzerland].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Resistance, Microbial; Ethambutol; Humans; Incidence; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Rifampin; Switzerland; Tuberculosis, Multidrug-Resistant | 1993 |
Treatment of tuberculosis in patients with pre-existing liver disease or following hepatotoxic drug reactions.
Topics: Chemical and Drug Induced Liver Injury; Clinical Protocols; Contraindications; Humans; Isoniazid; Liver Diseases; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1993 |
[Tuberculosis of the parotid gland].
Topics: Demyelinating Diseases; Electromyography; Facial Nerve; Facial Paralysis; Female; Functional Laterality; Hemiplegia; Humans; Hypoglossal Nerve; Isoniazid; Middle Aged; Parotid Diseases; Parotid Gland; Pyridoxine; Rifampin; Sialography; Tuberculosis | 1993 |
[Tuberculosis of the central nervous system: value of early polychemotherapy. Apropos of 2 cases].
Topics: Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Prednisolone; Rifampin; Tuberculosis, Meningeal | 1993 |
[Hepatic toxicity of antitubercular agents. Role of different drugs. 199 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 1993 |
Successful treatment of erythema induratum of bazin following rapid detection of mycobacterial DNA by polymerase chain reaction.
Topics: DNA, Bacterial; Erythema Induratum; Ethambutol; Female; Humans; Isoniazid; Leg Dermatoses; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin | 1993 |
Drug resistant tuberculosis: problems on the horizon.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 1993 |
Turning intermittent regimens into daily regimens using blister-packs. An exploration in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Packaging; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Pyrazinamide; Rifampin; Tuberculosis | 1993 |
[Tuberculosis of the female urethra: a case report].
Topics: Drug Therapy, Combination; Female; Humans; Isoniazid; Middle Aged; Rifampin; Tuberculosis, Urogenital; Urethral Diseases | 1993 |
Determination of iron by the Ferrochem II: interference by tuberculostatics.
Topics: Antitubercular Agents; Drug Combinations; Electrochemistry; Humans; Iron; Isoniazid; Pyrazinamide; Rifampin; Spectrophotometry, Atomic | 1993 |
[Lupus vulgaris. Cutaneous tuberculosis in a Vietnamese refugee].
Topics: Adolescent; Humans; Isoniazid; Lupus Vulgaris; Male; Norway; Rifampin; Vietnam | 1993 |
Drug-resistant tuberculosis.
Topics: Drug Resistance, Microbial; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 1993 |
The third epidemic--multidrug-resistant tuberculosis.
Topics: Adult; Age Factors; Comorbidity; Disease Outbreaks; Drug Resistance, Microbial; Ethambutol; Female; HIV Seropositivity; Humans; Ill-Housed Persons; Isoniazid; Male; Minority Groups; Mycobacterium tuberculosis; New York City; Rifampin; Sex Factors; Streptomycin; Substance Abuse, Intravenous; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Unemployment | 1994 |
Ocular lesions of tuberculosis.
Topics: Adolescent; Choroid Diseases; Drug Combinations; Female; Humans; Infant; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Tuberculosis, Ocular | 1993 |
[The microbiological diagnosis of tuberculosis in areas under strict radiation control].
Topics: Air Pollution, Radioactive; Animals; Bronchoalveolar Lavage Fluid; Drug Resistance, Microbial; Guinea Pigs; Humans; Isoniazid; Mycobacterium tuberculosis; Republic of Belarus; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Virulence | 1993 |
Phenytoin toxicity due to rifampicin induced hepatic dysfunction.
Topics: Chemical and Drug Induced Liver Injury; Child; Drug Interactions; Epilepsy; Female; Humans; Isoniazid; Phenytoin; Rifampin; Tuberculosis | 1993 |
[Clinical aspects and outcome of recurrent pulmonary tuberculosis].
Topics: Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1993 |
Chemotherapy of tuberculosis for patients with renal impairment.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1993 |
Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau.
Topics: Drug Resistance, Microbial; Ethambutol; Guinea-Bissau; Humans; In Vitro Techniques; Isoniazid; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1993 |
Isoniazid and rifampin therapy for tuberculosis: what patients need to know.
Topics: Drug Interactions; Food; Humans; Isoniazid; Patient Education as Topic; Rifampin; Tuberculosis | 1993 |
Cost-effectiveness analysis of three short-course anti-tuberculosis programmes compared with a standard regimen in Thailand.
Topics: Adolescent; Adult; Antitubercular Agents; Cost-Benefit Analysis; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Thailand; Tuberculosis, Pulmonary | 1993 |
[BCGitis as a cause of mediastinal tumor].
Topics: Bacteriological Techniques; BCG Vaccine; Combined Modality Therapy; Female; Humans; Infant; Isoniazid; Mediastinal Diseases; Mediastinum; Rifampin; Thoracotomy; Tuberculoma | 1993 |
Cervical tuberculous vertebral osteomyelitis: case report and discussion of the literature.
Topics: Adult; Cervical Vertebrae; Drug Therapy, Combination; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Spinal | 1993 |
Antituberculous drugs in kidney transplant recipients treated with cyclosporine.
Topics: Aged; Antitubercular Agents; Cyclosporine; Drug Interactions; Ethambutol; Humans; Isoniazid; Kidney Transplantation; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1993 |
From the Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1993 |
Isolated tuberculous pericarditis still exists: a case history.
Topics: Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pericarditis, Tuberculous; Rifampin | 1993 |
[Analysis of drug sensitivity of M. tuberculosis strains isolated from patients treated for tuberculosis in 1982-1991].
Topics: Adult; Child; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Species Specificity; Streptomycin; Tuberculosis | 1993 |
A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Malaysia; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1993 |
[Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
Topics: Benin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1993 |
[Retreatment of pulmonary tuberculosis--duration of chemotherapy].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Drug Resistance; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Recurrence; Retrospective Studies; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1993 |
[A case of oral tuberculosis suspected malignancy].
Topics: Diagnosis, Differential; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Oral | 1993 |
Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis.
Topics: Administration, Oral; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Models, Biological; Prognosis; Rifampin; Spinal Puncture; Streptomycin; Time Factors; Tuberculosis, Meningeal | 1993 |
Current status of mycobacterial testing in clinical laboratories. Results of a questionnaire completed by participants in the College of American Pathologists Mycobacteriology E survey.
Topics: Bacteriological Techniques; Drug Resistance, Microbial; Humans; Isoniazid; Laboratories; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Surveys and Questionnaires; Time Factors; Tuberculosis | 1993 |
Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; India; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Retrospective Studies; Rifampin; Sputum; Tuberculosis, Pulmonary | 1993 |
The emergence of drug-resistant tuberculosis in New York City.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Drug Resistance, Microbial; Female; Health Surveys; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; New York City; Rifampin; Substance Abuse, Intravenous; Tuberculosis; Tuberculosis, Pulmonary; United States | 1993 |
CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
Topics: Adult; Centers for Disease Control and Prevention, U.S.; Child; Drug Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; United States | 1993 |
Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital.
Topics: Adolescent; Adult; Drug Resistance; Ethambutol; Female; Hospitals, Special; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1993 |
Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors | 1993 |
Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1993 |
Antibiotic-resistant tuberculous choroiditis.
Topics: Aged; Anti-Bacterial Agents; Choroiditis; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Prednisone; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Ocular; Uveitis; Visual Acuity | 1993 |
Imaging in children with spinal tuberculosis. A comparison of radiography, computed tomography and magnetic resonance imaging.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Diagnostic Imaging; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Rifampin; Spinal Cord Compression; Thoracic Vertebrae; Tomography, X-Ray; Tomography, X-Ray Computed; Tuberculosis, Spinal | 1993 |
Preventive therapy for the patient with both universal indication and contraindication for isoniazid.
Topics: Adult; Contraindications; Delphi Technique; Drug Therapy, Combination; Ethambutol; Female; Hepatic Encephalopathy; Humans; Isoniazid; Liver Transplantation; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1993 |
Pelvic-peritoneal tuberculosis with elevated serum and peritoneal fluid Ca-125 levels. A report of two cases.
Topics: Adnexal Diseases; Adult; Antigens, Tumor-Associated, Carbohydrate; Ascitic Fluid; Diagnosis, Differential; Ethambutol; Female; Humans; Infertility, Female; Isoniazid; Menopause; Middle Aged; Peritonitis, Tuberculous; Pyrazinamide; Rifampin; Tuberculosis, Female Genital; Uterine Diseases | 1993 |
Acute and long-term efficacy of antituberculous treatment in HIV-seropositive patients with tuberculosis: a study of 36 cases.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antitubercular Agents; Bisexuality; CD4-CD8 Ratio; Ethambutol; Female; HIV Seropositivity; Homosexuality; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Time Factors; Treatment Failure; Treatment Outcome; Tuberculosis | 1993 |
Intracellular levels and extracellular release of lysosomal enzymes from peripheral blood monocytes in pulmonary tuberculosis patients.
Topics: Acetylglucosaminidase; Adolescent; Drug Therapy, Combination; Ethambutol; Female; Glucuronidase; Humans; Isoniazid; Latex; Lysosomes; Male; Middle Aged; Monocytes; Reference Values; Rifampin; Tuberculosis, Pulmonary | 1993 |
[Tuberculosis treatment in 1992].
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1993 |
Utilization of antituberculosis drugs expressed in defined daily doses in Klenovnik Hospital in the period between 1983 and 1987.
Topics: Antitubercular Agents; Croatia; Drug Therapy, Combination; Drug Utilization; Ethambutol; Hospitals, Special; Humans; Isoniazid; Pulmonary Medicine; Pyridoxine; Rifampin; Tuberculosis, Pulmonary | 1993 |
Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India.
Topics: Adolescent; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1993 |
Optochiasmatic tuberculoma causing progressive visual failure: when has medical treatment failed?
Topics: Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Humans; Isoniazid; Mental Disorders; Optic Chiasm; Optic Nerve Diseases; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Tuberculoma, Intracranial; Vision Disorders | 1993 |
Increased insulin requirement in a patient with type 1 diabetes on rifampicin.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Humans; Insulin; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1993 |
Mycobacterial infections in renal allograft recipients.
Topics: Drug Therapy, Combination; Ethambutol; HIV Seropositivity; Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Mycobacterium Infections; New York; Postoperative Complications; Pyrazinamide; Rifampin; Transplantation, Homologous | 1993 |
A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antitubercular Agents; Dopa Decarboxylase; Homovanillic Acid; Humans; Isoniazid; Levodopa; Male; Middle Aged; Parkinson Disease; Rifampin; Tuberculosis, Pulmonary | 1995 |
[Interesting case of pulmonary alveolar proteinosis].
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Bronchoalveolar Lavage; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pulmonary Alveolar Proteinosis; Rifampin; Tuberculosis, Pulmonary | 1995 |
Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
Topics: Antitubercular Agents; Bacteriological Techniques; Culture Media; Drug Resistance, Microbial; Evaluation Studies as Topic; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 1995 |
Antituberculosis activity of clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Female; Isoniazid; Macrophages; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1995 |
In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and alpha-1-acid glycoprotein.
Topics: Aging; Blood Proteins; Humans; In Vitro Techniques; Isoniazid; Orosomucoid; Plasma; Protein Binding; Pyrazinamide; Rifampin; Serum Albumin | 1996 |
Rifampin-resistant, isoniazid-susceptible TB in HIV patients.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Genes, Bacterial; HIV Infections; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Washington | 1995 |
Management of primary chest wall tuberculosis.
Topics: Abscess; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Combined Modality Therapy; Debridement; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Suppuration; Thoracic Diseases; Thoracic Neoplasms; Treatment Outcome; Tuberculosis | 1995 |
Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; South Africa; Sputum; Tuberculosis, Pulmonary | 1996 |
Presumed ocular and central nervous system tuberculosis in a patient with the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Chorioretinitis; Drug Therapy, Combination; Ethambutol; Female; Fundus Oculi; HIV-1; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Meningeal; Tuberculosis, Ocular; Visual Acuity | 1996 |
[Primary tuberculosis of the oral cavity].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Middle Aged; Mouth Mucosa; Mycobacterium tuberculosis; Pyrazinamide; Radiography, Panoramic; Rifampin; Time Factors; Tooth Extraction; Tuberculosis, Oral | 1996 |
Abdominal tuberculosis in children: review of 26 cases.
Topics: Adolescent; Anti-Bacterial Agents; Antitubercular Agents; California; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Peritonitis, Tuberculous; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Gastrointestinal | 1996 |
[Resistance of Mycobacterium tuberculosis in the province of Castellón].
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Microbial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Spain; Streptomycin | 1996 |
[Efficacy and tolerance of the treatment of tuberculosis in the aged].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Isoniazid; Male; Rifampin; Risk Factors; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1996 |
Alternatives to INH chemoprophylaxis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Chemoprevention; Child; Child, Preschool; Drug Resistance, Multiple; Humans; India; Isoniazid; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 1995 |
Drug susceptibility of Mycobacterium tuberculosis isolates from a cohort of Haitian migrants evaluated in 1994.
Topics: Antitubercular Agents; Cohort Studies; Haiti; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Transients and Migrants | 1995 |
Hepatotoxic effects of tuberculosis therapy. A practical approach to a tricky management problem.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Liver; Liver Diseases; Pyrazinamide; Rifampin; Risk Factors; Tuberculosis | 1996 |
[Oxidative metabolism changes in respiratory tract cells of guinea pigs during natural development of experimental tuberculosis and under specific chemotherapy].
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Catalase; Cells, Cultured; Guinea Pigs; Isoniazid; Lung; Macrophages, Alveolar; Malondialdehyde; Oxidoreductases; Rifampin; Superoxide Dismutase; Time Factors; Tuberculosis | 1996 |
[Biological characteristics of mycobacterial agent in homeless patients with pulmonary tuberculosis].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Ill-Housed Persons; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Remission of hypercalciuria in patients with tuberculosis after treatment.
Topics: Adult; Calcitriol; Calcium; Female; Humans; Isoniazid; Male; Parathyroid Hormone; Remission Induction; Rifampin; Tuberculosis; Vitamin D | 1996 |
Total hip arthroplasty complicated by tuberculous infection.
Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Hip Joint; Hip Prosthesis; Humans; Isoniazid; Mycobacterium tuberculosis; Prosthesis Failure; Prosthesis-Related Infections; Pyrazinamide; Radiography; Range of Motion, Articular; Reoperation; Rifampin; Tuberculosis, Osteoarticular | 1996 |
[Pleural tuberculosis with negative ADA].
Topics: Adenosine Deaminase; Adolescent; Antibiotics, Antitubercular; Antitubercular Agents; Clinical Enzyme Tests; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Isoniazid; Pyrazinamide; Radiography, Thoracic; Rifampin; Tuberculosis, Pleural | 1996 |
Whither the roles of rifater and rifamate?
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Trimethoprim; Tuberculosis | 1996 |
[Antitubercular agents].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; History, 20th Century; Humans; Isoniazid; Rifampin; Streptomycin | 1996 |
Effect of antituberculous drugs, isoniazid, pyrazinamide and rifampicin, on chemiluminescence of the human polymorphonuclear leukocytes.
Topics: Antitubercular Agents; Humans; Isoniazid; Luminescent Measurements; Neutrophils; Pyrazinamide; Reactive Oxygen Species; Rifampin | 1995 |
Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Reporter gene technology to assess activity of antimycobacterial agents in macrophages.
Topics: Anti-Bacterial Agents; Genes, Reporter; Humans; Isoniazid; Luciferases; Luminescent Measurements; Macrophages; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Recombination, Genetic; Rifampin | 1996 |
Probable BCG osteomyelitis of the hard palate: a case report.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Child, Preschool; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Osteomyelitis; Palate; Rifampin; Tuberculosis, Oral; Tuberculosis, Osteoarticular | 1996 |
New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Time Factors | 1996 |
Short-course therapy of pulmonary tuberculosis: doctor's compliance.
Topics: Adult; Alcoholism; Ambulatory Care; Antitubercular Agents; Clinical Competence; Drug Combinations; Family Practice; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Switzerland; Tuberculosis, Pulmonary | 1996 |
Multidrug resistant tuberculosis outbreak in Buenos Aires. DNA fingerprinting analysis of isolates.
Topics: Acquired Immunodeficiency Syndrome; Adult; Argentina; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Hospital transmission of multidrug-resistant Mycobacterium tuberculosis in Rosario, Argentina.
Topics: Acquired Immunodeficiency Syndrome; Adult; Argentina; Chronic Disease; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
[Is multidrug-resistant tuberculosis an emergent infection in Buenos Aires?].
Topics: Acquired Immunodeficiency Syndrome; Argentina; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 1996 |
[Effectiveness of regional lymphotropic therapy in combined treatment of tuberculosis in adolescents].
Topics: Adolescent; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Guinea Pigs; Humans; Injections, Intralymphatic; Isoniazid; Kanamycin; Male; Radiography; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1996 |
Mycobacterial tenosynovitis of the flexor tendons of the hand. A report of five cases.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Carpal Tunnel Syndrome; Combined Modality Therapy; Ethambutol; Female; Hand; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Tenosynovitis; Tuberculosis | 1996 |
Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1996 |
Liver injury during antituberculosis treatment: an 11-year study.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Antitubercular Agents; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Jaundice; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin | 1996 |
Rectal stricture: a complication of tuberculosis.
Topics: Antitubercular Agents; Child; Colectomy; Constriction, Pathologic; Ethambutol; Female; Humans; Isoniazid; Rectal Diseases; Rifampin; Sigmoid Diseases; Tuberculosis, Gastrointestinal | 1996 |
The duration of excretion of viable bacilli in elderly patients on treatment for cavitating pulmonary tuberculosis.
Topics: Aged; Antitubercular Agents; Black People; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1996 |
Diagnosis and outcome of isolated rectal tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Biopsy; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Proctoscopy; Rectal Diseases; Rifampin; Treatment Outcome; Tuberculosis, Gastrointestinal | 1996 |
Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and alpha-interferon immunotherapy.
Topics: Adjuvants, Immunologic; Adult; Anti-Bacterial Agents; Antitubercular Agents; Bone Marrow Transplantation; Combined Modality Therapy; Disease Susceptibility; Drug Therapy, Combination; Fistula; Hodgkin Disease; Humans; Immunocompromised Host; Interferon-alpha; Interleukin-2; Isoniazid; Male; Opportunistic Infections; Oral Ulcer; Pyrazinamide; Recombinant Proteins; Rifampin; Risk Factors; Transplantation Conditioning; Transplantation, Autologous; Tuberculosis, Oral | 1996 |
Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model.
Topics: Animals; Antibiotics, Antitubercular; Colony Count, Microbial; Drug Therapy, Combination; Female; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Rifamycins; Spleen; Time Factors; Tuberculosis | 1996 |
In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Isoniazid; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Rifamycins; Tuberculosis | 1996 |
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Blotting, Southern; Cause of Death; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Ethambutol; Female; HIV Infections; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; New York City; Polymorphism, Restriction Fragment Length; Proportional Hazards Models; Rifampin; Sputum; Streptomycin; Survival Analysis; Tuberculosis, Multidrug-Resistant | 1996 |
Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Culture Media; Drug Combinations; Drug Interactions; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Pyrazinamide; Rats; Rifampin; Spleen; Tuberculosis | 1996 |
Antituberculosis activities of clofazimine and its new analogs B4154 and B4157.
Topics: Animals; Antitubercular Agents; Cell Line; Clofazimine; Drug Resistance, Multiple; Female; Isoniazid; Macrophages; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rats; Rifampin; Tuberculosis | 1996 |
Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain.
Topics: Adult; Antitubercular Agents; Brain; Drug Resistance, Microbial; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Interferon-gamma; Isoniazid; Magnetic Resonance Imaging; Mycobacterium tuberculosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Refractory Period, Electrophysiological; Rifampin; Tuberculosis, Multidrug-Resistant | 1996 |
Human immunodeficiency virus infection in children with tuberculosis in Santo Domingo, Dominican Republic: prevalence, clinical findings, and response to antituberculosis treatment.
Topics: AIDS Serodiagnosis; Antibiotics, Antitubercular; Antitubercular Agents; Child, Preschool; Dominican Republic; Female; HIV Infections; HIV Seroprevalence; Humans; Infant; Isoniazid; Male; Prevalence; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1996 |
Focal tuberculosis of the liver with local hemorrhage in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Ethambutol; Granuloma; Histocytochemistry; Homosexuality, Male; Humans; Isoniazid; Liver; Male; Mycobacterium; Pyrazinamide; Rifampin; Tuberculosis | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Simultaneous determination of rifampicin, isoniazid and pyrazinamid by high performance thin layer chromatography.
Topics: Antitubercular Agents; Chromatography, Thin Layer; Drug Combinations; Isoniazid; Pyrazinamide; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Tablets | 1996 |
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Penicillins; Rifampin; Sulbactam | 1996 |
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Arthralgia; Child; Child, Preschool; Exanthema; Female; Hepatitis; Hospitalization; Humans; Incidence; Infant; Isoniazid; Liver; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1996 |
[Cytokine production during the development and correction of an immunodeficiency in experimental tuberculosis].
Topics: Adjuvants, Immunologic; Animals; Antitubercular Agents; Concanavalin A; Drug Evaluation, Preclinical; Drug Therapy, Combination; Immunity, Cellular; Immunologic Deficiency Syndromes; Interleukin-2; Interleukin-6; Isoniazid; Mice; Mycobacterium bovis; Rifampin; Thymus Hormones; Tuberculosis; Tumor Necrosis Factor-alpha | 1996 |
Multiple small bowel perforations in a patient on treatment of tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Combinations; Female; Humans; Intestinal Perforation; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 1996 |
Concurrent mucosal leishmaniasis and pulmonary tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Contraindications; Drug Therapy, Combination; Humans; Immunity, Cellular; Isoniazid; Leishmania; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1996 |
Disseminated infection due to multidrug-resistant Mycobacterium bovis in a patient who was seropositive for human immunodeficiency virus.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium bovis; Mycobacterium Infections; Pyrazinamide; Rifampin | 1996 |
The 5-year outcome of multidrug resistant tuberculosis patients in the Cape Province of South Africa.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Outcome Assessment, Health Care; Pyrazinamide; Retrospective Studies; Rifampin; South Africa; Surveys and Questionnaires; Time Factors; Tuberculosis, Multidrug-Resistant | 1996 |
Rifampin preventive therapy for tuberculosis in Boston's homeless.
Topics: Adult; Antibiotics, Antitubercular; Boston; Cohort Studies; Disease Outbreaks; Drug Therapy, Combination; Female; Humans; Ill-Housed Persons; Incidence; Isoniazid; Male; Rifampin; Tuberculin Test; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Four-drug initial therapy for TB is standard treatment.
Topics: Aminosalicylic Acid; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1996 |
Unusual presentation of intra-abdominal tuberculosis.
Topics: Antitubercular Agents; Child; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Peritonitis, Tuberculous; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1996 |
Tuberculosis control programme guidelines--treatment regimens.
Topics: Antitubercular Agents; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Optic Neuritis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; South Africa; Streptomycin; Tuberculosis | 1996 |
Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
Topics: Adult; Antibiotics, Antitubercular; Drug Interactions; Ethambutol; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Isoniazid; Liver Transplantation; Living Donors; Mycobacterium tuberculosis; Postoperative Complications; Rifampin; Streptomycin; Tacrolimus; Tuberculosis | 1996 |
Tuberculosis and renal transplantation.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Kidney Transplantation; Male; Postoperative Complications; Pyrazinamide; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 1996 |
Tuberculous perianal ulcers.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Fissure in Ano; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1996 |
Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis.
Topics: Antitubercular Agents; Chronic Disease; Drug Resistance; Fever; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1996 |
Changes in the size of adrenal glands in acute pulmonary tuberculosis with therapy.
Topics: Adolescent; Adrenal Glands; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 1996 |
Successful treatment of atypical mycobacterial meningitis by fluoroquinolone.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Ethambutol; Humans; Injections, Spinal; Isoniazid; Male; Meningitis; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Ofloxacin; Polymerase Chain Reaction; Rifampin; Streptomycin | 1996 |
Osteomalacia during rifampicin and isoniazid therapy is rare in Hong Kong.
Topics: Antitubercular Agents; Hong Kong; Hospitals, Teaching; Humans; Isoniazid; Osteomalacia; Rifampin; Tuberculosis | 1996 |
[Severe hepatotoxicity of tuberculostatic agents. Increase in the incidence].
Topics: Acute Disease; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female; Hepatic Encephalopathy; Humans; Isoniazid; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Pyrazinamide; Rifampin | 1996 |
[Tuberculosis of the middle ear: a rare extrapulmonary manifestation].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Ear Diseases; Ear, Middle; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1996 |
Periodontal indices of patients taking isoniazid and rifampin: a pilot study.
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Male; Military Personnel; Periodontal Index; Pilot Projects; Rifampin; Tuberculosis, Pulmonary; United States | 1997 |
Tuberculosis of the long bone in children.
Topics: Antitubercular Agents; Biopsy; Child, Preschool; Curettage; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Male; Radiography; Rifampin; Tuberculosis, Osteoarticular | 1997 |
Rifampicin and isoniazid increase acetaminophen and isoniazid cytotoxicity in human HepG2 hepatoma cells.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antitubercular Agents; Carcinoma, Hepatocellular; Cell Survival; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Humans; Isoniazid; Liver Neoplasms; Methylcholanthrene; Rifampin; Tumor Cells, Cultured | 1997 |
Esophagomediastinal fistula as a complication of tuberculous mediastinal lymphadenitis.
Topics: Adult; Antibiotics, Antitubercular; Esophageal Fistula; Ethambutol; Female; Fistula; Humans; Isoniazid; Mediastinal Diseases; Pyrazinamide; Radiography, Thoracic; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 1996 |
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacteriological Techniques; Base Sequence; DNA Primers; Drug Resistance, Microbial; Genes, Bacterial; Genotype; Humans; Isoniazid; Laboratories; Molecular Sequence Data; Mutation; Mycobacterium tuberculosis; Phenotype; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Rifampin; Sensitivity and Specificity | 1997 |
Tuberculous meningitis.
Topics: Antitubercular Agents; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1997 |
Initial screening for antituberculous drug resistance at an inpatient facility in Leon, Nicaragua.
Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Nicaragua; Prevalence; Pyrazinamide; Radiometry; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 1997 |
A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; New York City; Odds Ratio; Rifampin; Risk Factors; Treatment Failure; Tuberculosis, Pulmonary | 1997 |
[Osteoarticular tuberculosis during infancy: the reality in our environment].
Topics: Antitubercular Agents; Child, Preschool; Female; Femur; Humans; Infant; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Osteoarticular | 1997 |
Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Microbial; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1997 |
Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Amylopectin; Animals; Antitubercular Agents; Bilirubin; Cholesterol; Drug Delivery Systems; Isoniazid; Liposomes; Liver; Lung; Macrophages; Mice; Phosphatidylcholines; Rifampin; Transaminases; Tuberculosis | 1997 |
Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple; Humans; Isoniazid; Molecular Sequence Data; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 1997 |
Cervical tuberculous lymphadenitis in a frequent traveler to endemic areas of tuberculosis.
Topics: Antitubercular Agents; Biopsy; Humans; Isoniazid; Lymph Nodes; Male; Middle Aged; Neck; Rifampin; Travel; Tuberculosis, Lymph Node | 1997 |
'Multidrug'-resistant tuberculosis. It is time to focus on the private sector of medicine.
Topics: Antitubercular Agents; Clinical Protocols; Drug Combinations; Drug Resistance, Microbial; Humans; Internal Medicine; International Cooperation; Isoniazid; Patient Compliance; Private Practice; Retreatment; Rifampin; Societies, Medical; Terminology as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes.
Topics: Adult; Aged; Antitubercular Agents; Cause of Death; Clinical Protocols; Cohort Studies; Female; Forecasting; HIV Seronegativity; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Patient Compliance; Prospective Studies; Recurrence; Remission Induction; Retreatment; Rifampin; Risk Factors; Sputum; Treatment Outcome; Treatment Refusal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents.
Topics: Adolescent; Adult; Alanine Transaminase; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Prospective Studies; Rifampin; Tuberculosis, Pulmonary | 1997 |
Multiple drug resistant tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Patient Compliance; Rifampin; Tuberculosis, Multidrug-Resistant; United Kingdom | 1997 |
Persistent fever in pulmonary tuberculosis. Several factors were not considered.
Topics: Antitubercular Agents; Fever; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1997 |
Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Dose-Response Relationship, Drug; Isoniazid; Liposomes; Lung; Mice; Mice, Inbred Strains; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis | 1997 |
Vulvovaginal tuberculosis: a case report.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Female Genital; Vulvovaginitis | 1997 |
Pancreatic insufficiency due to antituberculous therapy.
Topics: Antitubercular Agents; Chronic Disease; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Exocrine Pancreatic Insufficiency; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin | 1997 |
[Oral desensitization to antitubercular agents].
Topics: Administration, Oral; Adult; Antitubercular Agents; Desensitization, Immunologic; Drug Combinations; Female; Humans; Isoniazid; Pyrazinamide; Rifampin | 1997 |
beta-Galactosidase reporter system in mycobacteria and its application in rapid antimycobacterial drug screening.
Topics: Anti-Bacterial Agents; Antitubercular Agents; beta-Galactosidase; Escherichia coli; Genes, Reporter; Isoniazid; Kinetics; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Plasmids; Pyrazinamide; Recombinant Proteins; Rifampin; Streptomycin | 1997 |
[Liver injury under tuberculostatic treatment].
Topics: Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1997 |
Resolution of a brainstem abscess through antituberculous therapy.
Topics: Adult; Antitubercular Agents; Brain Abscess; Brain Stem; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rifampin | 1997 |
Tuberculosis: old lessons unlearnt?
Topics: Antitubercular Agents; Drug Combinations; Drug Monitoring; Global Health; Health Priorities; Humans; Isoniazid; Patient Compliance; Research; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 1997 |
Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method.
Topics: Amikacin; Antitubercular Agents; Cell Division; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Radiometry; Rifampin | 1997 |
Rifampicin and isoniazid in the treatment of leprous nerve abscesses.
Topics: Abscess; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Male; Nervous System Diseases; Rifampin; Treatment Outcome | 1997 |
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection.
Topics: Adult; Aged; Antitubercular Agents; Case-Control Studies; Diarrhea; Ethambutol; Female; HIV Infections; HIV Seropositivity; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin | 1997 |
[The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Combinations; Female; Humans; Isoniazid; Male; Mali; Middle Aged; Patient Compliance; Pyrazinamide; Recurrence; Retreatment; Retrospective Studies; Rifampin; Sex Factors; Sputum; Streptomycin; Thioacetazone; Treatment Outcome; Tuberculosis, Pulmonary; World Health Organization | 1997 |
Study of oxidative-stress in isoniazid-rifampicin induced hepatic injury in young rats.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Isoniazid; Lipid Peroxidation; Liver Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Rifampin | 1997 |
Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Sensitivity and Specificity | 1997 |
Tuberculosis of the ankle in childhood: clinical, roentgenographic and computed tomography findings.
Topics: Ankle Joint; Arthritis; Biopsy; Child; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Osteomyelitis; Pyrazinamide; Radiography; Rifampin; Tomography, Emission-Computed; Tuberculosis, Osteoarticular | 1997 |
Administration of anti-tuberculosis drugs through patient empowerment.
Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Drug Therapy, Combination; Female; Hospitals, District; Humans; Isoniazid; Malawi; Male; Middle Aged; Patient Compliance; Patient Education as Topic; Patient Participation; Rifampin; Tuberculosis | 1997 |
Autoimmune haemolytic anaemia responding to anti-tuberculous treatment.
Topics: Adult; Anemia, Hemolytic; Antitubercular Agents; Autoimmune Diseases; Biopsy; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 1997 |
Rapid method for testing susceptibility of Mycobacterium tuberculosis by using DNA probes.
Topics: Analysis of Variance; Cell Division; DNA Probes; Drug Resistance, Multiple; Isoniazid; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Photometry; Reagent Kits, Diagnostic; Rifampin; RNA, Ribosomal; Species Specificity | 1997 |
[Isolation obligation and therapy in tuberculosis].
Topics: Antitubercular Agents; Bronchoalveolar Lavage Fluid; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Patient Isolation; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1997 |
[Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1996 |
[CT scanning and treatment of intracranial tuberculoma].
Topics: Adolescent; Animals; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Parietal Lobe; Pyrazinamide; Rabbits; Retrospective Studies; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculoma, Intracranial | 1996 |
Pneumonitis and eosinophilia induced by ethambutol.
Topics: Aged; Antitubercular Agents; Eosinophilia; Ethambutol; Humans; Isoniazid; Lymphocyte Activation; Male; Pneumonia; Rifampin | 1997 |
[A case of tuberculous abscess in the chest wall close to the thickening pleural lesion following tuberculous pleuritis].
Topics: Abscess; Adult; Antitubercular Agents; Female; Humans; Isoniazid; Rifampin; Thoracic Diseases; Tuberculosis; Tuberculosis, Pleural | 1997 |
Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Patient Compliance; Rifampin; Tuberculosis | 1997 |
[A severe form of urinary tuberculosis in children].
Topics: Adolescent; Antitubercular Agents; Atrophy; Bacteriuria; BCG Vaccine; Child; Cystitis; Hematuria; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Nephrectomy; Pyrazinamide; Rifampin; Sclerosis; Tuberculosis, Pulmonary; Tuberculosis, Renal; Tuberculosis, Urogenital; Ureter; Urinary Bladder; Urinary Bladder Diseases | 1997 |
Outbreak of drug-resistant tuberculosis with second-generation transmission in a high school in California.
Topics: Adolescent; California; Cohort Studies; Disease Outbreaks; Drug Resistance, Multiple; Ethambutol; Ethionamide; Female; Humans; Infectious Disease Transmission, Vertical; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Schools; Skin Tests; Sputum; Streptomycin; Tuberculosis | 1997 |
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
Topics: Antitubercular Agents; Clinical Laboratory Information Systems; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Population Surveillance; Quality Assurance, Health Care; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 1997 |
Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Immunoassay; Isoniazid; Latex Fixation Tests; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 1997 |
Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia.
Topics: Antitubercular Agents; Cross-Sectional Studies; Developing Countries; Drug Resistance, Multiple; Drug Therapy, Combination; Ethambutol; Ethiopia; Humans; Isoniazid; Microbial Sensitivity Tests; Multicenter Studies as Topic; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant | 1997 |
Short-course chemoprophylaxis evaluated in gold miners with chronic silicosis.
Topics: Antitubercular Agents; Gold; Humans; Isoniazid; Mining; Patient Compliance; Pyrazinamide; Rifampin; Silicosis; Treatment Outcome; Tuberculosis | 1997 |
Unusual miliary tuberculosis presenting with generalized lymphadenopathy and abdominal involvement.
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Lymph Nodes; Lymphatic Diseases; Male; Neck; Pleural Effusion; Prednisolone; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal; Tuberculosis, Miliary | 1997 |
Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacteriological Techniques; Coloring Agents; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Peru; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis; Xanthenes | 1998 |
[Immunologic memory induced by Mycobacterium bovis in the inbred mice].
Topics: Animals; Antitubercular Agents; Female; Fluorescent Antibody Technique, Direct; Immunologic Memory; Ionomycin; Isoniazid; Mice; Mice, Inbred CBA; Mycobacterium bovis; Phenotype; Rifampin; Spleen; T-Lymphocytes; Tuberculosis; Vaccination | 1997 |
Attendance versus compliance with tuberculosis treatment in an occupational setting--a pilot study.
Topics: Antibiotics, Antitubercular; Chi-Square Distribution; Cross-Sectional Studies; Drug Monitoring; False Positive Reactions; Gold; Humans; Isoniazid; Mining; Patient Compliance; Pilot Projects; Prevalence; Rifampin; South Africa; Tuberculosis, Pulmonary | 1997 |
[Tuberculosis of the breast].
Topics: Abscess; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Breast Diseases; Female; Follow-Up Studies; Humans; Isoniazid; Mammography; Prognosis; Radiography, Thoracic; Rifampin; Time Factors; Tomography, X-Ray Computed; Tuberculosis | 1997 |
[Reasons for chronic expectoration--case reports].
Topics: Adult; Aged; Antitubercular Agents; Capreomycin; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Secondary Prevention; Sputum; Streptomycin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Surgical treatment of patients with multi-resistant pulmonary tuberculosis--case reports].
Topics: Adult; Antitubercular Agents; Bronchial Fistula; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Humans; Isoniazid; Male; Middle Aged; Pleural Diseases; Pneumonectomy; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Drug-resistant tuberculosis in Singapore, 1995 to 1996.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antitubercular Agents; Case-Control Studies; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Singapore; Streptomycin; Tuberculosis, Multidrug-Resistant | 1997 |
[Tuberculosis in hemodialysis].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Renal Dialysis; Retrospective Studies; Rifampin; Tuberculosis | 1997 |
Risk factors for hepatotoxicity induced by antituberculosis drugs.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Streptomycin | 1997 |
[Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Hypersensitivity; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Purpura; Pyrazinamide; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis, Pulmonary | 1995 |
[Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tunisia | 1996 |
[Isolated colonic tuberculosis].
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Colonic Diseases; Colonoscopy; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1997 |
[Urogenital tuberculosis. Apropos of 40 cases].
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Combined Modality Therapy; Constriction, Pathologic; Cystitis; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Nephrectomy; Prostatic Diseases; Pyrazinamide; Rifampin; Stents; Tuberculosis, Male Genital; Tuberculosis, Renal; Tuberculosis, Spinal; Tuberculosis, Urogenital; Ureteral Diseases; Urinary Bladder Diseases; Urography | 1997 |
Acid-fast bacilli persisting in the genitourinary tract 3 years after intravesical bacille Calmette-Guérin therapy for bladder carcinoma.
Topics: Adjuvants, Immunologic; Aged; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Carcinoma in Situ; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Male Genital; Urinary Bladder Neoplasms | 1998 |
Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Medical Records; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1998 |
Physician compliance with national tuberculosis treatment guidelines: a university hospital study.
Topics: Antitubercular Agents; Cerebrospinal Fluid; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Hospitals, University; Humans; Isoniazid; Mycobacterium tuberculosis; Pakistan; Physicians; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Sputum; Surveys and Questionnaires; Tuberculosis; World Health Organization | 1998 |
A resected case of Mycobacterium szulgai pulmonary disease.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[A case of prostatic tuberculosis: usefulness of transrectal ultrasound in diagnosis].
Topics: Anemia, Refractory, with Excess of Blasts; Antibiotics, Antitubercular; Antitubercular Agents; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prostatic Diseases; Rifampin; Tuberculosis, Urogenital; Ultrasonography | 1998 |
Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis.
Topics: Antibiotics, Antitubercular; Drug Therapy, Combination; Glomerulonephritis; Humans; Isoniazid; Leprostatic Agents; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1998 |
[Case of chronic kidney failure with thrombotic thrombocytopenic purpura due to miliary tuberculosis].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Kidney Failure, Chronic; Purpura, Thrombotic Thrombocytopenic; Rifampin; Streptomycin; Tuberculosis, Miliary | 1998 |
[Treatment of tuberculous meningitis: marker of cure].
Topics: Adenosine Deaminase; Antitubercular Agents; Biomarkers; Gadolinium DTPA; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1998 |
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; HIV Seropositivity; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Topics: Adult; Ambulatory Care; Antibiotics, Antitubercular; Antitubercular Agents; Cohort Studies; Confidence Intervals; Drug Administration Schedule; Female; Follow-Up Studies; Forecasting; Humans; Isoniazid; Male; Medical History Taking; Predictive Value of Tests; Pyrazinamide; Recurrence; Retreatment; Rifampin; Risk Factors; Safety; Sensitivity and Specificity; South Africa; Sputum; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 1998 |
Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
Topics: Adult; Age Distribution; Aged; Antitubercular Agents; Confidence Intervals; Ethambutol; Female; Humans; Incidence; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; New Jersey; Odds Ratio; Population Surveillance; Pyrazinamide; Rifampin; Risk Factors; Sex Distribution; Streptomycin; Tuberculosis, Multidrug-Resistant | 1998 |
Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium.
Topics: Bacterial Proteins; Cell Division; Drug Design; Drug Resistance, Microbial; Isoniazid; Kinetics; Microscopy, Electron; Molecular Sequence Data; Mutagenesis; Mycobacterium avium; Mycobacterium tuberculosis; Mycolic Acids; Permeability; Peroxidases; Phenotype; Rifampin | 1998 |
Drug resistant tuberculosis in prisons in Azerbaijan: case study.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Azerbaijan; Humans; Isoniazid; Mycobacterium tuberculosis; Prisoners; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 1998 |
Tuberculous Addison's disease: lack of normalization of adrenocortical function after anti-tuberculous chemotherapy.
Topics: Addison Disease; Adrenal Cortex; Adrenal Cortex Function Tests; Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; Aldosterone; Anti-Inflammatory Agents; Antitubercular Agents; Drug Therapy, Combination; Fludrocortisone; Humans; Hydrocortisone; Isoniazid; Male; Middle Aged; Prednisolone; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Endocrine | 1998 |
Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Chi-Square Distribution; Child; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 1998 |
Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 1998 |
Concomitant lichen scrofulosorum and erythema induratum.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Erythema Induratum; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Skin; Tuberculin Test; Tuberculosis, Cutaneous | 1998 |
Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
[Analysis of short-term effects of short-course intermittent chemotherapies of the World Bank Loaned Project].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1996 |
[A case of intracranial tuberculoma followed by MRI].
Topics: Antitubercular Agents; Brain; Female; Follow-Up Studies; Humans; Isoniazid; Magnetic Resonance Imaging; Middle Aged; Necrosis; Rifampin; Streptomycin; Time Factors; Tuberculoma, Intracranial | 1998 |
A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death.
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Isoniazid; Mycobacterium bovis; Rabbits; Rifampin; Thalidomide; Tuberculosis, Meningeal | 1998 |
[Pulmonary tuberculosis in children: its age-dependent aspects].
Topics: Adolescent; Age Distribution; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Male; Mycobacterium Infections; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 1998 |
[Epidemiologic followup of cases of tuberculosis in the medical-social centers of Paris for the year 1994].
Topics: Adolescent; Adult; Africa; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Medically Uninsured; Middle Aged; Paris; Population Surveillance; Rifampin; Social Security; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Unemployment; Vaccination | 1998 |
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Microbial; Ethambutol; Global Health; Humans; Isoniazid; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 1998 |
Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.
Topics: Agar; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Flow Cytometry; Fluoresceins; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin | 1998 |
Red (wo)man syndrome.
Topics: Adolescent; Antibiotics, Antitubercular; Antitubercular Agents; Disease-Free Survival; Drug Overdose; Female; Humans; Isoniazid; Rifampin; Suicide, Attempted; Syndrome | 1998 |
Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment.
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Amoxicillin; Antitubercular Agents; BCG Vaccine; Carcinoma, Transitional Cell; Cystitis; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Immunotherapy; Isoniazid; Male; Middle Aged; Prospective Studies; Rifampin; Urinary Bladder Neoplasms; Urinary Tract Infections | 1998 |
Isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Developing Countries; Drug Therapy, Combination; HIV-1; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1998 |
Central nervous system tuberculosis after resolution of miliary tuberculosis.
Topics: Antitubercular Agents; Central Nervous System Infections; Dexamethasone; Drug Therapy, Combination; Ethionamide; Glucocorticoids; Humans; Immunocompetence; Infant; Isoniazid; Male; Prednisolone; Pyrazinamide; Rifampin; Streptomycin; Treatment Failure; Tuberculoma; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Multidrug-Resistant | 1998 |
[Recurrent tuberculosis in a psychiatric hospital, recurrent outbreaks during 1987-1996].
Topics: Antitubercular Agents; Disease Outbreaks; Drug Therapy, Combination; Follow-Up Studies; Hospitals, Psychiatric; Humans; Incidence; Isoniazid; Israel; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1998 |
Survey of drug-resistant tuberculosis in northwestern Russia from 1984 through 1994.
Topics: Antibiotics, Antitubercular; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Russia; Tuberculosis, Pulmonary | 1998 |
Effectiveness of short-course, intermittent chemotherapy for tuberculosis in young infants aged less than 6 months.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1998 |
[Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide].
Topics: Aged; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethambutol; Exanthema; Female; Humans; Isoniazid; Male; Middle Aged; Pruritus; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1998 |
Oxidative-hepatic injury of isoniazid-rifampicin in young rats subjected to protein and energy malnutrition.
Topics: Animals; Antioxidants; Antitubercular Agents; Glutathione; Glutathione Transferase; Isoniazid; Lipid Peroxidation; Liver; Male; Protein-Energy Malnutrition; Rats; Rats, Wistar; Rifampin | 1998 |
Mycobacterium tuberculosis drug resistance: a call to action.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Health Surveys; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 1998 |
Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Thailand; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Does AIDS impair the absorption of antituberculosis agents?
Topics: Absorption; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antitubercular Agents; Biological Availability; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 1998 |
Sequential evaluation of serum adenosine deaminase in patients treated for tuberculosis.
Topics: Adenosine Deaminase; Adolescent; Adult; Antitubercular Agents; Biomarkers; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1998 |
Phenomenon of rifampicin-induced discolouration of body fluids.
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Chromogenic Compounds; Drug Interactions; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1993 |
Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy.
Topics: Adolescent; Adult; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; BCG Vaccine; Cell Division; Cells, Cultured; Epitopes, T-Lymphocyte; Ethambutol; Female; Humans; Interferon-gamma; Interleukin-10; Isoniazid; Leukocytes, Mononuclear; Lipoproteins; Male; Middle Aged; Mycobacterium tuberculosis; Peptides; Pleural Effusion; Pyrazinamide; Rifampin; T-Lymphocytes; Tuberculin; Tuberculosis | 1998 |
Prevention of tuberculosis in HIV-1.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance, Microbial; HIV-1; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 1998 |
Scrofuloderma.
Topics: Biopsy; DNA, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Skin; Tuberculosis, Cutaneous | 1998 |
Optic disk tubercle.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fluorescein Angiography; Fundus Oculi; Granuloma; Humans; Isoniazid; Male; Optic Disk; Papilledema; Rifampin; Tuberculosis, Ocular; Vision Disorders | 1998 |
A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia.
Topics: Bacterial Proteins; Drug Resistance, Multiple; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Peroxidases; Rifampin | 1998 |
Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
Topics: Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Culture Media; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Streptomycin; United States | 1998 |
[Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
[Multi-organ tuberculosis in a child: diagnosis and therapeutic problems].
Topics: Antitubercular Agents; Child, Preschool; Fatal Outcome; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 1998 |
Intensive short course chemotherapy in the management of tuberculous meningitis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethionamide; Humans; Infant; Isoniazid; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 1998 |
Drug-resistant tuberculosis in Budapest.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Hungary; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
[Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP].
Topics: Adenosine Triphosphate; Antitubercular Agents; Ethambutol; Evaluation Studies as Topic; Isoniazid; Kanamycin; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1998 |
Primary tuberculous tracheitis.
Topics: Antitubercular Agents; Cough; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Respiratory Sounds; Rifampin; Tracheal Stenosis; Tracheitis; Tuberculosis, Pulmonary | 1998 |
Short-term tuberculosis prophylaxis is effective in persons with HIV.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis | 1998 |
[Cutaneous leukocytoclastic vasculitis in a patient with pulmonary tuberculosis].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Skin Diseases, Vascular; Tuberculosis, Pulmonary; Vasculitis, Leukocytoclastic, Cutaneous | 1998 |
[Treatment of newly diagnosed patients with infiltrative and disseminated pulmonary tuberculosis].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1998 |
[Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
Topics: Adolescent; Adult; Antitubercular Agents; Cameroon; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Disease Notification; Drug Administration Schedule; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pregnancy; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1998 |
Diagnosing multidrug resistant tuberculosis in Britain. Clinical suspicion should drive rapid diagnosis.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Humans; Isoniazid; Rifampin; Tuberculosis, Multidrug-Resistant; United Kingdom | 1998 |
Action of metronidazole in combination with isoniazid & rifampicin on persisting organisms in experimental murine tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Female; Isoniazid; Metronidazole; Mice; Mice, Inbred BALB C; Rifampin; Tuberculosis | 1998 |
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Antitubercular Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; HIV Infections; Humans; Isoniazid; Liver Function Tests; Pyrazinamide; Rifampin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1995 |
Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Infant; Isoniazid; Liver; Male; Middle Aged; Mycobacterium tuberculosis; Opportunistic Infections; Organ Transplantation; Retrospective Studies; Rifampin; Risk Factors; Tuberculosis | 1998 |
Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus.
Topics: Adult; Anaphylaxis; Antibiotics, Antitubercular; Antitubercular Agents; Cerebral Infarction; Drug Hypersensitivity; Drug Therapy, Combination; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1998 |
Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cost-Benefit Analysis; Decision Trees; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Quality-Adjusted Life Years; Rifampin; Survival Rate; Tuberculosis | 1998 |
[Efficacy of a short 6 month therapeutic coursefor HIV infected tuberculosis patients in Abidjan, Côte d'Ivoire].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antitubercular Agents; Cohort Studies; Cote d'Ivoire; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 1998 |
Subchronic toxicity of human immunodeficiency virus and tuberculosis combination therapies in B6C3F1 mice.
Topics: Animals; Anti-HIV Agents; Antibiotics, Antitubercular; Blood Platelets; Bone Marrow; Drug Interactions; Erythrocytes; Female; Hemoglobins; Isoniazid; Male; Mice; Pyrazinamide; Rifampin; Toxicity Tests; Zidovudine | 1998 |
Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
Topics: Adult; Aged; Antitubercular Agents; Cohort Studies; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Tuberculosis of the pyriform fossa--a rare entity.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Laryngoscopy; Male; Pharyngeal Diseases; Pharyngeal Neoplasms; Pyrazinamide; Radiography; Rifampin; Tuberculosis; Tuberculosis, Laryngeal; Tuberculosis, Pulmonary | 1998 |
[Hepatic tuberculosis: a case with pseudotumours form].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Hepatic | 1998 |
Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.
Topics: Antitubercular Agents; Bacteriological Techniques; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1999 |
[Tuberculosis among hemodialysis patients in Dakar, apropos of 2 cases].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Hallucinations; Humans; Isoniazid; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Renal Dialysis; Rifampin; Senegal; Streptomycin; Tuberculosis | 1998 |
Management of presumed intraocular tuberculosis: possible role of the polymerase chain reaction.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Aqueous Humor; Child; DNA Primers; DNA, Bacterial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Ocular; Uveitis | 1998 |
Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis.
Topics: Acyltransferases; Antibiotics, Antitubercular; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Culture Media; DNA Transposable Elements; Drug Resistance, Microbial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Bacterial; RNA, Messenger; RNA, Ribosomal, 16S; Time Factors | 1999 |
Brainstem tuberculoma mimicking glioma: the role of antituberculous drugs as a diagnostic tool.
Topics: Antitubercular Agents; Brain Neoplasms; Diagnosis, Differential; Female; Glioma; Humans; Isoniazid; Magnetic Resonance Imaging; Middle Aged; Pyrazinamide; Rifampin; Tuberculoma | 1999 |
Tuberculosis of the sternoclavicular joint. Report of two cases.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sternoclavicular Joint; Tomography, X-Ray Computed; Treatment Outcome; Tuberculin Test; Tuberculosis, Osteoarticular | 1998 |
Tuberculous meningitis and co-infection with HIV.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; HIV Seronegativity; HIV Seropositivity; Humans; Infant; Isoniazid; Mycobacterium tuberculosis; Radiography; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 1998 |
Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Isoniazid; Pyrazinamide; Reproducibility of Results; Rifampin; Spectrophotometry, Ultraviolet | 1999 |
The management of pulmonary tuberculosis in adults notified in Scotland in 1993.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clinical Protocols; Disease Notification; Humans; Isoniazid; Middle Aged; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Scotland; Tuberculosis, Pulmonary | 1998 |
Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; United Kingdom | 1999 |
Characterization of Mycobacterium smegmatis mutants defective in 1-d-myo-inosityl-2-amino-2-deoxy-alpha-d-glucopyranoside and mycothiol biosynthesis.
Topics: Culture Media; Cysteine; Disaccharides; Drug Resistance, Microbial; Genetic Complementation Test; Glucosides; Glycopeptides; Hydrogen Peroxide; Inositol; Isoniazid; Mutagenesis; Mycobacterium smegmatis; Pyrazoles; Rifampin; Sulfhydryl Compounds | 1999 |
Therapeutic dilemma: crescentic mesangiocapillary glomerulonephritis type 1 in a patient on antituberculous therapy with rifampicin.
Topics: Aged; Antitubercular Agents; Clarithromycin; Female; Glomerulonephritis, Membranoproliferative; Humans; Isoniazid; Methylprednisolone; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1999 |
Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; Antitubercular Agents; Bromodeoxyuridine; Cells, Cultured; Chemical and Drug Induced Liver Injury; DNA Replication; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunity, Cellular; Isoniazid; Kidney Diseases; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nervous System Diseases; Rifampin; Tuberculosis | 1999 |
[Clinical and pathological analysis of liver injury resulting from rifampin and isoniazid].
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Chemical and Drug Induced Liver Injury; Female; Hepatitis B Antigens; Humans; Isoniazid; Liver; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1997 |
Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997).
Topics: Alleles; Antitubercular Agents; Bacterial Proteins; Base Sequence; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple; Genes, Bacterial; Humans; Isoniazid; Molecular Epidemiology; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Peroxidases; Peroxiredoxins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Rifampin; Scotland; Tuberculosis, Pulmonary | 1999 |
Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box.
Topics: Antitubercular Agents; Bacteriophages; Drug Resistance, Microbial; Evaluation Studies as Topic; Firefly Luciferin; Genes, Reporter; Humans; Isoniazid; Luciferases; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 1999 |
Isoniazid and rifampicin rarely cause acute pancreatitis in patients with tuberculosis.
Topics: Acute Disease; Antitubercular Agents; Humans; Isoniazid; Pancreatitis; Rifampin; Tuberculosis, Pulmonary | 1999 |
Good news and not such good news.
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1999 |
Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics.
Topics: Adult; Antitubercular Agents; Biological Availability; Cross-Over Studies; Drug Combinations; Humans; Isoniazid; Male; Pyrazinamide; Rifampin | 1999 |
Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Topics: Adolescent; Adult; Antitubercular Agents; Botswana; Child; Comorbidity; Disease Outbreaks; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Prevalence; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1999 |
[Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
Topics: Adenosine Triphosphate; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Isoniazid; Kanamycin; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1999 |
[Tuberculous osteoarthritis revealed by ankle injury].
Topics: Accidental Falls; Aged; Ankle Injuries; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Ganglionic Blockers; Humans; Isoniazid; Osteoarthritis; Pempidine; Rifampin; Time Factors; Tuberculosis, Osteoarticular | 1999 |
Multidrug resistant tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Chemoprevention; Humans; India; Isoniazid; Mycobacterium tuberculosis; Patient Compliance; Rifampin; Tuberculosis, Multidrug-Resistant | 1998 |
Treatment of childhood tuberculosis.
Topics: Adult; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Child; Child, Preschool; Humans; Infant, Newborn; Isoniazid; Lymphadenitis; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1998 |
A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro.
Topics: Alkaline Phosphatase; beta-Naphthoflavone; Caffeine; Carbamazepine; Carcinoma, Hepatocellular; Clofibrate; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gene Expression Regulation; Genes, Reporter; Glucocorticoids; Hormone Antagonists; Humans; Isoniazid; Mifepristone; Mixed Function Oxygenases; Phenobarbital; Phenylbutazone; Phenytoin; Receptors, Glucocorticoid; Recombinant Proteins; Rifampin; Tumor Cells, Cultured; Xenobiotics | 1999 |
The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Renal Dialysis; Rifampin | 1999 |
Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Mycobacterium bovis; Osteomyelitis; Pyrazinamide; Rifampin; Tuberculosis, Spinal; Urinary Bladder Neoplasms | 1999 |
-Skin eruption after the first dose of antitubercular quadri-therapy: consideration of pyrazinamide-.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethambutol; Exanthema; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1998 |
Intramedullary cervical tuberculoma.
Topics: Adolescent; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Antitubercular Agents; Brain; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Medulla Oblongata; Methylprednisolone; Radiography; Rifampin; Spinal Cord; Tuberculoma, Intracranial | 1999 |
[Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Diabetes Complications; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Acceptance of Health Care; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1999 |
Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Predictive Value of Tests; Prospective Studies; Pyrazinamide; Rifampin; South Africa; Sputum; Treatment Outcome; Tuberculosis | 1999 |
[Improvements in the treatment and management of control the occurrence of multidrug-resistance tuberculosis].
Topics: Antitubercular Agents; Humans; Isoniazid; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Study on the molecular mechanism of multi-drug resistance in clinical isolates of Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Genes, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1997 |
[Efficacy of unfixed continuation phase short-course chemotherapy].
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1997 |
[A case of peritoneal tuberculosis. Contribution of mini-endoscopy].
Topics: Adolescent; Female; Humans; Isoniazid; Laparoscopes; Peritoneum; Peritonitis, Tuberculous; Rifampin; Treatment Outcome; Tuberculosis, Female Genital | 1999 |
Drug-resistant tuberculosis in the Philippines.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Philippines; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 1999 |
Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1999 |
Cutaneous tuberculosis: efficient therapeutic response in a case with multiple lesions.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Foot Dermatoses; Hand Dermatoses; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous | 1999 |
Discrimination of multidrug-resistant Mycobacterium tuberculosis IS6110 fingerprint subclusters by rpoB gene mutation analysis.
Topics: DNA Fingerprinting; DNA Transposable Elements; DNA-Directed RNA Polymerases; Drug Resistance, Multiple; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Plant Proteins; Polymorphism, Restriction Fragment Length; Rifampin; Streptomycin | 1999 |
First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Azerbaijan; Dietary Supplements; Ethambutol; Humans; Isoniazid; Logistic Models; Male; Mycobacterium tuberculosis; Patient Compliance; Pilot Projects; Prisoners; Prisons; Rifampin; Sputum; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 1999 |
The threat of multidrug resistance: is tuberculosis ever untreatable or uncontrollable?
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Humans; Isoniazid; Patient Compliance; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; United Kingdom; United States | 1999 |
Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Stem Cells; Tuberculosis | 1999 |
In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants.
Topics: Acetone; Antitubercular Agents; Drug Interactions; Drug Resistance, Microbial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plants, Medicinal; Radiometry; Rifampin; South Africa | 1999 |
Tuberculous pseudoaneurysm of the femoral artery: a case report.
Topics: Aged; Aged, 80 and over; Anastomosis, Surgical; Aneurysm, False; Aneurysm, Ruptured; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Femoral Artery; Humans; Isoniazid; Magnetic Resonance Angiography; Male; Rifampin; Tuberculosis, Cardiovascular | 1999 |
Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
Topics: Antitubercular Agents; Developing Countries; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization | 1999 |
Case report: percutaneous balloon dilatation and ureteral stenting for tuberculous renal infundibular and ureteral strictures.
Topics: Adult; Antitubercular Agents; Catheterization; Constriction, Pathologic; Female; Follow-Up Studies; Humans; Isoniazid; Kidney Calices; Kidney Pelvis; Nephrostomy, Percutaneous; Pyridoxine; Rifampin; Stents; Tuberculosis, Renal; Ureteral Diseases | 1999 |
Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis | 1999 |
Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Ethambutol; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis | 1999 |
Pulmonary nodule mimicking lung cancer in a human immunodeficiency virus type-1 infected patient.
Topics: Acquired Immunodeficiency Syndrome; Adenocarcinoma; Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; HIV-1; Humans; Isoniazid; Lung Neoplasms; Male; Pyrazinamide; Rifampin; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 1999 |
Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Base Sequence; DNA Primers; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli Proteins; Evaluation Studies as Topic; HSP70 Heat-Shock Proteins; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Bacterial; RNA, Messenger; Tuberculosis | 1999 |
Stability of rifampicin in dissolution medium in presence of isoniazid.
Topics: Antitubercular Agents; Chromatography, Thin Layer; Drug Compounding; Drug Stability; Hydrochloric Acid; Hydrogen-Ion Concentration; Isoniazid; Regression Analysis; Reproducibility of Results; Rifampin; Rifamycins; Sensitivity and Specificity; Solubility; Spectrophotometry, Ultraviolet | 1999 |
Drug-induced lupus nephritis in HIV infection.
Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Lupus Nephritis; Rifampin; Tuberculosis, Gastrointestinal | 1999 |
[Current aspects of spinal tuberculosis: apropos of 16 case reports].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Spinal | 1999 |
The threat of multidrug-resistant tuberculosis: results of 1 yr of surveillance in the Lombardy region of Italy.
Topics: Antitubercular Agents; Humans; Isoniazid; Italy; Population Surveillance; Rifampin; Tuberculosis, Multidrug-Resistant | 1999 |
Immunoglobulin A nephropathy complicating pulmonary tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Creatinine; Drug Therapy, Combination; Fluorescent Antibody Technique, Direct; Glomerulonephritis, IGA; Hematuria; Humans; Immunoglobulin A; Isoniazid; Male; Proteinuria; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 1999 |
[Multidrug-resistant tuberculosis associated with AIDS (kinetics of nosocomial epidemics of multidrug-resistant tuberculosis associated with AIDS. Possible transformation into endemic disease].
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Argentina; Cohort Studies; Cross Infection; Disease Outbreaks; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Multidrug-Resistant | 1999 |
[Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Spain; Streptomycin | 1999 |
[A case of pulmonary infectious disease due to Mycobacterium szulgai].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 1999 |
Tuberculosis in renal transplant recipients.
Topics: Adult; Female; Humans; Isoniazid; Kidney Transplantation; Liver; Male; Middle Aged; Retrospective Studies; Rifampin; Tuberculosis | 1999 |
Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; DNA, Bacterial; Humans; In Situ Hybridization; Isoniazid; Lichenoid Eruptions; Male; Mycobacterium avium Complex; Polymerase Chain Reaction; Rifampin; Thorax; Tuberculosis, Cutaneous | 1999 |
Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Humans; Isoniazid; Pyrazinamide; Rifampin; Sensitivity and Specificity | 1999 |
The colorimetric analysis of anti-tuberculosis fixed-dose combination tablets and capsules.
Topics: Antitubercular Agents; Capsules; Chemistry, Pharmaceutical; Colorimetry; Drug Combinations; Ethambutol; Isoniazid; Pyrazinamide; Rifampin; Tablets | 1999 |
[A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin].
Topics: Acute Kidney Injury; Aged; Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1999 |
[Disseminated extrapulmonary tuberculosis with skin, lymph node and bone involvement].
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Fibula; Follow-Up Studies; HIV Seronegativity; Humans; Isoniazid; Male; Osteomyelitis; Pyrazinamide; Rifampin; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Cutaneous; Tuberculosis, Lymph Node; Tuberculosis, Osteoarticular | 1999 |
Chronic ulceration of the tongue and laryngitis: first clinical sign of asymptomatic pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Laryngitis; Male; Pyrazinamide; Rifampin; Tongue; Tuberculosis, Pulmonary; Ulcer | 1999 |
Mycobacterial infections in solid organ transplant recipients.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium Infections; Organ Transplantation; Postoperative Complications; Pyrazinamide; Retrospective Studies; Rifampin; Rural Population; Socioeconomic Factors; Time Factors; Turkey | 1999 |
Unusual clinical manifestation of tuberculosis in a renal transplant recipient.
Topics: Adult; Antitubercular Agents; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Kidney Transplantation; Liver; Liver Function Tests; Postoperative Complications; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis | 1999 |
Evaluation of the BBL MGIT (Mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs.
Topics: Antitubercular Agents; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Streptomycin | 2000 |
Early results from indirect drug susceptibility test for tubercle bacilli.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrobenzoates; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1999 |
Cutaneous tuberculosis and pyoderma gangrenosum.
Topics: Antibiotics, Antitubercular; Diagnosis, Differential; Female; Foot Dermatoses; Humans; Isoniazid; Middle Aged; Multiple Myeloma; Pyoderma Gangrenosum; Rifampin; Tuberculosis, Cutaneous | 2000 |
Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin | 1999 |
Prevalence and risk factors of drug-resistant tuberculosis along the Mexico-Texas border.
Topics: Adult; Antitubercular Agents; Female; Hispanic or Latino; Humans; Isoniazid; Male; Mexico; Middle Aged; Odds Ratio; Prevalence; Regression Analysis; Rifampin; Risk Factors; Texas; Tuberculosis, Multidrug-Resistant | 2000 |
Reply to Davis and colleagues: Twice weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; South Africa; Tuberculosis, Pulmonary | 1999 |
Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru.
Topics: Antitubercular Agents; Bacterial Typing Techniques; Costs and Cost Analysis; Drug Resistance, Microbial; Humans; Inpatients; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Polymerase Chain Reaction; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis | 2000 |
Simultaneous determination of rifampicin, isoniazid and pyrazinamide in tablet preparations by multivariate spectrophotometric calibration.
Topics: Antitubercular Agents; Isoniazid; Multivariate Analysis; Pyrazinamide; Rifampin; Spectrophotometry; Tablets | 1999 |
[Clinical and epidemiological characteristics of patients with drug-resistant tuberculosis].
Topics: Antitubercular Agents; Colony Count, Microbial; Humans; Incidence; Isoniazid; Mycobacterium tuberculosis; Republic of Belarus; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1999 |
[Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Isoniazid; Middle Aged; Quinolones; Respiratory Tract Infections; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1999 |
[Intradermal reaction to tuberculin: application, interpretation and therapeutic implications].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Humans; Injections, Intradermal; Isoniazid; Mass Screening; Rifampin; Risk Factors; Tuberculin; Tuberculin Test; Tuberculosis, Pulmonary | 2000 |
[Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Proteins; Colony Count, Microbial; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Oxidoreductases; Peroxidases; Point Mutation; Polymerase Chain Reaction; Rifampin; Tuberculosis | 2000 |
Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance; Drug Therapy, Combination; Female; HIV Seronegativity; HIV Seroprevalence; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Streptomycin; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary; Uganda | 1999 |
Anti-tuberculosis drug resistance in Portugal.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Population Surveillance; Portugal; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.
Topics: Adult; Aged; Antitubercular Agents; Arylamine N-Acetyltransferase; Asian People; Chemical and Drug Induced Liver Injury; Female; Genotype; Humans; Isoniazid; Japan; Male; Middle Aged; Prospective Studies; Rifampin; Tuberculosis, Pulmonary | 2000 |
The first occurrence of a multi-drug resistant tuberculosis epidemic in the Czech Republic caused by genetically closely related Mycobacterium tuberculosis strains.
Topics: Adult; Antitubercular Agents; Czech Republic; Disease Outbreaks; DNA Fingerprinting; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifampin; Risk Factors; Sex Factors; Tuberculosis, Multidrug-Resistant | 2000 |
Evaluation of the invader assay, a linear signal amplification method, for identification of mutations associated with resistance to rifampin and isoniazid in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Evaluation Studies as Topic; Isoniazid; Mutation; Mycobacterium tuberculosis; Peroxidases; Polymerase Chain Reaction; Rifampin | 2000 |
Clinical relevance of reduced bioavailability of rifampicin.
Topics: Adverse Drug Reaction Reporting Systems; Antitubercular Agents; Biological Availability; Drug Interactions; Drug Therapy, Combination; Humans; India; Isoniazid; Rifampin | 1999 |
Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis.
Topics: Antimalarials; Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2000 |
Diagnosis and treatment of cervical tuberculous lymphadenitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Biopsy, Needle; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Neck Dissection; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node | 2000 |
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spleen; Streptomycin; Tuberculosis | 2000 |
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
Topics: Antitubercular Agents; Dominican Republic; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Global Health; Hong Kong; Humans; Isoniazid; Italy; Korea; Peru; Program Evaluation; Retrospective Studies; Rifampin; Risk; Russia; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2000 |
Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels.
Topics: Absorption; Antibiotics, Antitubercular; Antitubercular Agents; Critical Care; Critical Illness; Fatal Outcome; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2000 |
Criteria for the control of drug-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Isoniazid; Models, Theoretical; Practice Guidelines as Topic; Rifampin; Tuberculosis, Pulmonary; World Health Organization | 2000 |
[Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Cote d'Ivoire; Ethambutol; Female; Humans; Isoniazid; Male; Medical History Taking; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
Spinal intramedullary tuberculous lesion: medical management. Report of four cases.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Clinical Protocols; Female; Follow-Up Studies; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rifampin; Spinal Cord Diseases; Streptomycin; Tuberculoma; Tuberculosis, Central Nervous System; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 2000 |
Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.
Topics: Antitubercular Agents; Humans; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis | 2000 |
Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody-Producing Cells; Antigen-Antibody Complex; Antitubercular Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Predictive Value of Tests; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2000 |
[Treatment of multidrug resistant tuberculosis in Santakiskes tuberculosis hospital].
Topics: Adult; Aged; Antitubercular Agents; Chronic Disease; Female; Hospitals, State; Humans; Incidence; Isoniazid; Lithuania; Male; Middle Aged; Pneumonectomy; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
[Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2000 |
Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; France; Hospitals, University; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
[Intracranial tuberculomas developing during treatment of pulmonary tuberculosis: case report].
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculoma, Intracranial; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 2000 |
Treatment of large macular choroidal tubercle improves vision.
Topics: Antitubercular Agents; Choroid Diseases; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Fluorescein Angiography; Fundus Oculi; Humans; Isoniazid; Macula Lutea; Middle Aged; Rifampin; Tuberculosis, Miliary; Tuberculosis, Ocular; Vision, Ocular | 2000 |
Interaction of gliclazide and rifampicin.
Topics: Aged; Antibiotics, Antitubercular; Clarithromycin; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Ethambutol; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2000 |
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Malawi; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2000 |
Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Costs and Cost Analysis; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Netherlands; Rifampin; Sputum; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2000 |
Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Mass Index; Body Weight; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leptin; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 1999 |
Tubercular involvement of the thyroid gland: a report of two cases.
Topics: Abscess; Aged; Aged, 80 and over; Antitubercular Agents; Biopsy, Needle; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Mycobacterium tuberculosis; Rifampin; Thyroid Diseases; Tuberculosis, Endocrine | 1999 |
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluorometry; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Peroxidases; Pilot Projects; Polymerase Chain Reaction; Rifampin; Temperature; Time Factors; Tuberculosis, Pulmonary | 2000 |
[Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Data Interpretation, Statistical; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Incidence; Isoniazid; Mycobacterium tuberculosis; Ontario; Rifampin; Tuberculosis, Pulmonary | 2000 |
Twice weekly isoniazid and rifampin treatment of latent tuberculosis infection in Canadian plains Aborigines.
Topics: Adolescent; Adult; American Indian or Alaska Native; Antitubercular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Male; Rifampin; Saskatchewan; Tuberculosis, Pulmonary | 2000 |
Primary and acquired resistance of Mycobacterium tuberculosis in Western Mexico.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Isoniazid; Mexico; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Recurrence; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Topics: Agar; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin | 2000 |
The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Indonesia; Isoniazid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2000 |
Pelvic tuberculosis: an uncommon gynaecological problem presenting as ovarian mass.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Female; Humans; Isoniazid; Ovarian Diseases; Pelvis; Rifampin; Tuberculosis, Female Genital; Tuberculosis, Miliary; Uterine Neoplasms | 2000 |
Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Carbon Dioxide; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Streptomycin; Time Factors | 2000 |
Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Colony-Forming Units Assay; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis | 2000 |
Second episode of tuberculosis in an HIV-infected child: relapse or reinfection?
Topics: AIDS-Related Opportunistic Infections; Amoxicillin-Potassium Clavulanate Combination; Antibiotics, Antitubercular; Antitubercular Agents; Child, Preschool; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; HIV; HIV Infections; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Pyrazinamide; Radiography, Thoracic; Rifampin; Secondary Prevention; South Africa; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis; Tuberculosis, Meningeal | 2000 |
[Primary and acquired drug resistance of tuberculosis bacilli in Poland].
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Child; Ethambutol; Female; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Poland; Rifampin; Sex Distribution; Species Specificity; Tuberculosis, Multidrug-Resistant | 1999 |
Treatment of tuberculosis: a well-standardised protocol.
Topics: Adult; Child; Clinical Protocols; Ethambutol; France; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis; United Kingdom; United States; World Health Organization | 2000 |
[Desensitization therapy for antituberculous drugs].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Desensitization, Immunologic; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Tuberculosis | 2000 |
Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Health Care Costs; Humans; Isoniazid; Life Expectancy; Male; Middle Aged; Outcome Assessment, Health Care; Patient Compliance; Radiography; Recurrence; Rifampin; San Francisco; Tuberculosis, Pulmonary | 2000 |
Chromosomal aberrations and micronuclei in lymphocytes of patients before and after exposure to anti-tuberculosis drugs.
Topics: Adolescent; Adult; Age Factors; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Case-Control Studies; Cell Nucleus; Chromosome Aberrations; Ethambutol; Female; Humans; Isoniazid; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Middle Aged; Pyrazinamide; Rifampin; Streptomycin | 2000 |
[The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Isoniazid; Lung; Microscopy, Electron; Rabbits; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2000 |
Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method.
Topics: Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 2000 |
Tuberculous abscess of the graft in a renal transplant recipient after chronic rejection: case report.
Topics: Abscess; Adult; Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Graft Rejection; Humans; Isoniazid; Kidney Transplantation; Nephrectomy; Pyrazinamide; Reoperation; Rifampin; Tuberculosis | 2000 |
Tuberculosis after renal transplantation.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Incidence; India; Isoniazid; Kidney Transplantation; Living Donors; Male; Postoperative Complications; Pyrazinamide; Pyridoxine; Retrospective Studies; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 2000 |
Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient.
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Living Donors; Mycobacterium tuberculosis; Postoperative Complications; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2000 |
Therapeutic efficacy of Poly(DL-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Biocompatible Materials; Drug Combinations; Drug Compounding; Isoniazid; Lactic Acid; Mice; Mycobacterium tuberculosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Tissue Distribution; Tuberculosis | 2001 |
[The effectiveness of pyrazinamide-containing six-month short course chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Risk Factors; Time Factors; Tuberculosis, Pulmonary | 2000 |
Tumor-like tuberculosis of the sacrum.
Topics: Adult; Antitubercular Agents; Chordoma; Diagnosis, Differential; Female; Humans; Isoniazid; Osteolysis; Rifampin; Sacrum; Spinal Cord Neoplasms; Tomography, X-Ray Computed; Tuberculosis, Spinal | 2000 |
Atlantoaxial tuberculosis: three cases.
Topics: Adult; Aged; Antitubercular Agents; Atlanto-Axial Joint; Drug Therapy, Combination; Female; Humans; Immobilization; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculosis, Spinal | 2000 |
[Early anterolateral surgery for tuberculosis of the lower cervical spine with neurological complications in adult. Our experience in Gabon].
Topics: Adult; Antitubercular Agents; Cervical Vertebrae; Combined Modality Therapy; Debridement; Emergencies; Ethambutol; Follow-Up Studies; Gabon; Humans; Isoniazid; Kyphosis; Paraplegia; Physical Therapy Modalities; Pyrazinamide; Quadriplegia; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Spinal | 2000 |
[Evolution of drug-resistant Mycobacterium tuberculosis in the province of Castellón. 1992-1998].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Risk Factors; Spain; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
A comparison of the E-test and proportion methods for susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 2000 |
Active BCG mycobacterial infection of lymph nodes following vaccination in two paediatric patients: is surgery indicated?
Topics: Antitubercular Agents; BCG Vaccine; Female; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis, Lymph Node; Vaccination | 2000 |
Facial granulomatous diseases: a study of four cases tested for the presence of Mycobacterium tuberculosis DNA using nested polymerase chain reaction.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Face; Female; Granulomatous Disease, Chronic; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Rosacea; Tuberculosis, Cutaneous | 2001 |
Effect of preoperative chemotherapy on the outcome of surgical treatment of vertebral tuberculosis: retrospective analysis of 434 cases.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Selection; Premedication; Preoperative Care; Recurrence; Retrospective Studies; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Spinal | 2001 |
Sternal tuberculosis in a 9-month-old infant after BCG vaccination.
Topics: Antitubercular Agents; BCG Vaccine; Humans; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Radiography; Rifampin; Sternum; Tuberculosis, Osteoarticular | 2000 |
Contralateral pleural effusion during chemotherapy for tuberculous pleural effusion.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Pleural Effusion; Pyrazinamide; Radiography, Thoracic; Rifampin; Tuberculosis | 2000 |
Isoniazid- and rifampicin-induced oxidative hepatic injury--protection by N-acetylcysteine.
Topics: Acetylcysteine; Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Catalase; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Drug Interactions; Injections, Intraperitoneal; Isoniazid; Lipid Peroxidation; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Rifampin; Superoxide Dismutase | 2000 |
Comparison of two rapid colorimetric methods for determining resistance of mycobacterium tuberculosis to rifampin, isoniazid, and streptomycin in liquid medium.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colorimetry; Coloring Agents; Drug Resistance, Microbial; Isoniazid; Mycobacterium tuberculosis; Oxidation-Reduction; Rifampin; Sensitivity and Specificity; Streptomycin; Time Factors; Tuberculosis, Multidrug-Resistant | 2001 |
Surgical management of multidrug-resistant tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Pneumonectomy; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
A whole blood bactericidal assay for tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Blood; Blood Bactericidal Activity; Culture Media; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Quinolines; Rifampin | 2001 |
[Analysis of reasons failed focal debridement in 109 patients with spinal tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Debridement; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Spinal | 1998 |
Tuberculosis treatment: dangerous regimens?
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 2001 |
Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Hospitals, State; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prisons; Rifampin; Sensitivity and Specificity; Siberia; Sputum; Tuberculosis, Pulmonary | 2001 |
[Central nervous system tuberculosis in children: 2. Treatment and outcome].
Topics: Adolescent; Adrenal Cortex Hormones; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrocephalus; Hyponatremia; Infant; Isoniazid; Male; Prognosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Central Nervous System | 2001 |
Osteoarticular tuberculosis: current diagnosis and treatment.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Mycobacterium; Osteoarthritis, Knee; Pyrazinamide; Rifampin; Streptomycin; Synovial Fluid; Tuberculosis, Osteoarticular | 2000 |
[Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Aminosalicylic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Streptomycin; Treatment Refusal | 2001 |
Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Pyrazinamide; Rifampin; Saudi Arabia; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Efficacy of chemotherapy for prostatic tuberculosis-a clinical and histologic follow-up study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Biopsy; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Palpation; Prostate-Specific Antigen; Prostatic Diseases; Rifampin; Treatment Outcome; Tuberculosis, Male Genital | 2001 |
Routine use of rapid molecular methods to detect antibiotic resistance in Mycobacterium tuberculosis.
Topics: Drug Resistance, Microbial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin | 2001 |
Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid.
Topics: Administration, Oral; Animals; Antibiotics, Antitubercular; Chemistry, Pharmaceutical; Colony Count, Microbial; Delayed-Action Preparations; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Isoniazid; Mice; Microspheres; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2001 |
Molecular basis of rifampin and isoniazid resistance in Mycobacterium bovis strains isolated in Sardinia, Italy.
Topics: Animals; Antibiotics, Antitubercular; Cattle; DNA Fingerprinting; Drug Resistance, Microbial; Isoniazid; Italy; Mutation; Mycobacterium bovis; Phenotype; Polymerase Chain Reaction; Rifampin | 2001 |
Multifocal extensive spinal tuberculosis (Pott's disease) involving cervical, thoracic and lumbar vertebrae.
Topics: Antitubercular Agents; Cervical Vertebrae; Ethambutol; Female; Humans; Isoniazid; Lumbar Vertebrae; Middle Aged; Pyrazinamide; Quadriplegia; Rifampin; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Spinal | 2001 |
New TB drug approved.
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1995 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
Medical advances with international impact.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clinical Trials as Topic; Developing Countries; Drug Therapy, Combination; Female; Health Services Accessibility; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Reagent Kits, Diagnostic; Rifampin; RNA, Viral; Tuberculosis; Viral Load; Zidovudine | 1998 |
New TB therapy works for HIV-positive patients.
Topics: Antitubercular Agents; Clinical Trials as Topic; Disease Progression; HIV Infections; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis | 1998 |
Short course preventive therapy for tuberculosis is successful in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 1998 |
Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Capsules; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Therapy, Combination; Female; Isoniazid; Lactic Acid; Male; Mice; Mycobacterium tuberculosis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Treatment Outcome; Tuberculosis | 2001 |
Comparison of MB/BacT system and agar proportion method in drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Biosensing Techniques; Carbon Dioxide; Colony Count, Microbial; Colorimetry; Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2001 |
Familial outbreak of disseminated multidrug-resistant tuberculosis and meningitis.
Topics: Adolescent; Adult; Antitubercular Agents; Culture Media; Fatal Outcome; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Rifampin; Survival Rate; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant | 2001 |
Mycolic acid index susceptibility method for Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Pulmonary | 2001 |
Protective effect of Hemidesmus indicus against rifampicin and isoniazid-induced hepatotoxicity in rats.
Topics: Administration, Oral; Animals; Chemical and Drug Induced Liver Injury; Isoniazid; Magnoliopsida; Male; Medicine, Ayurvedic; Mitochondria, Liver; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Rifampin | 2000 |
[Clinical study on the cases in which INH or RFP was discontinued during treatment for pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Female; Fever; Humans; Isoniazid; Male; Middle Aged; Rifampin; Sex Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
The treatment of multidrug-resistant tuberculosis in Turkey.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Ofloxacin; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Turkey | 2001 |
[Comparison of three antituberculous drugs in serum and cold abscesses of patients with spinal tuberculosis].
Topics: Abscess; Adult; Anti-Infective Agents; Antitubercular Agents; Female; Humans; Isoniazid; Male; Ofloxacin; Rifampin; Tuberculosis, Spinal | 1998 |
[Efficacy of regimens containing INH, RFP with varied chemotherapy courses on retreated culture positive pneumoconio-tuberculosis].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Silicotuberculosis; Streptomycin | 1998 |
[Analysis on quality control of drug susceptibility testing in the surveillance of drug resistance in tuberculosis in Henan].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Streptomycin | 1998 |
Tuberculous otitis media -- a diagnostic dilemma.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ear Diseases; Facial Paralysis; Female; Hearing Loss; Hearing Loss, Conductive; Humans; Isoniazid; Mycobacterium Infections; Otitis Media; Pyrazinamide; Rifampin; Tinnitus; Tuberculosis | 2001 |
[Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Monitoring; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium bovis; Mycobacterium kansasii; Mycobacterium tuberculosis; Rifampin; Russia; Streptomycin | 2001 |
[Improved technology of chemotherapy of pulmonary tuberculosis complicated by other diseases].
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Gastrointestinal Diseases; Humans; Isoniazid; Phonophoresis; Rabbits; Respiratory Tract Diseases; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2001 |
[A study on resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan: comparison of results in the local facilities and in the reference laboratory, in 1997].
Topics: Ethambutol; Humans; Isoniazid; Japan; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Streptomycin | 2001 |
[Determination of drug resistance of Mycobacterium tuberculosis by methods of proportions and absolute concentrations].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2001 |
[Lymphotropic therapy with antitubercular agents in the treatment of tuberculous epididymitis].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Epididymitis; Ethambutol; Humans; Injections, Intralymphatic; Injections, Intramuscular; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Male Genital; Ultrasonography | 2001 |
Modulating effect of Liv.100, an ayurvedic formulation on antituberculosis drug-induced alterations in rat liver microsomes.
Topics: Animals; Antitubercular Agents; Ascorbic Acid; Cytochrome b Group; Cytochrome P-450 Enzyme System; Cytochrome Reductases; Cytochrome-B(5) Reductase; Drug Interactions; Glucose-6-Phosphatase; Herbal Medicine; India; Isoniazid; Lipid Peroxidation; Magnoliopsida; Male; Medicine, Ayurvedic; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Phytotherapy; Plant Extracts; Plants, Medicinal; Protective Agents; Pyrazinamide; Rats; Rats, Wistar; Rifampin | 2001 |
Rifampicin allergy confirmed by an intradermal test, but with a negative patch test.
Topics: Antitubercular Agents; Diagnosis, Differential; Drug Eruptions; Ethambutol; False Negative Reactions; Female; Humans; Intradermal Tests; Isoniazid; Middle Aged; Patch Tests; Peritonitis, Tuberculous; Pyrazinamide; Pyridoxine; Rifampin | 2001 |
Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Female; Hong Kong; Humans; Isoniazid; Longitudinal Studies; Male; Middle Aged; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Retrospective Studies; Rifampin; Sex Distribution; Streptomycin; Time Factors; Tuberculosis, Multidrug-Resistant | 2001 |
Treatment of tuberculosis in Haiti.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Haiti; Health Services Research; Humans; Isoniazid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2001 |
Adverse reaction to antimycobacterials administered as a combination tablet with no reaction to the same drugs in isolation.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; Humans; Isoniazid; Male; Rifampin; Tablets; Tuberculosis | 2001 |
[Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data].
Topics: Adolescent; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 2001 |
[Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Culture Media; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin | 2001 |
[Molecular medicine and treatment of tuberculosis].
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Female; Genetic Engineering; Humans; Isoniazid; Male; Mice; Mutation; Mycobacterium tuberculosis; Polymorphism, Genetic; Rifampin; Risk Factors; Tuberculosis | 2001 |
[Effects of rifampin and isoniazid on the pharmacokinetics of diazepam in rabbits].
Topics: Animals; Cytochrome P-450 Enzyme System; Diazepam; Isoniazid; Male; Microsomes, Liver; Rabbits; Random Allocation; Rifampin | 1997 |
Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifampin; Streptomycin | 1999 |
Liposomes and PLG microparticles as sustained release antitubercular drug carriers--an in vitro-in vivo study.
Topics: Alkaline Phosphatase; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Aspartate Aminotransferases; Bilirubin; Delayed-Action Preparations; Drug Carriers; Female; Isoniazid; Lactic Acid; Liposomes; Liver; Male; Mice; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rifampin; Tissue Distribution | 2001 |
Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Delivery Systems; Flow Cytometry; Hydrogen-Ion Concentration; Isoniazid; Macrophages, Alveolar; Mice; Microspheres; Particle Size; Phagocytosis; Rats; Rifampin; Tuberculosis, Pulmonary | 2001 |
Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Chaperonin 60; Chaperonins; Clarithromycin; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Polymerase Chain Reaction; Rifampin; Skin Diseases, Bacterial | 2001 |
Drug resistance of strains of Mycobacterium tuberculosis isolated in Brazil.
Topics: Antitubercular Agents; Brazil; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2001 |
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Aza Compounds; Colony Count, Microbial; Drug Resistance, Microbial; Female; Fluoroquinolones; Isoniazid; Lung; Mice; Moxifloxacin; Mycobacterium tuberculosis; Organ Size; Quinolines; Rifampin; Spleen; Streptomycin; Survival Rate; Tuberculosis | 2001 |
Derivative spectrophotometry as a tool for the determination of drug partition coefficients in water/dimyristoyl-L-alpha-phosphatidylglycerol (DMPG) liposomes.
Topics: Chlordiazepoxide; Dibucaine; Hydrogen-Ion Concentration; Isoniazid; Lipid Bilayers; Phosphatidylglycerols; Rifampin; Spectrophotometry; Static Electricity | 2001 |
Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Clinical Protocols; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Mass Screening; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Population Surveillance; Qatar; Retrospective Studies; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Revised treatment and testing guidelines for latent tuberculosis infection.
Topics: Adolescent; Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Humans; Isoniazid; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Risk Factors; Societies, Medical; Tuberculosis; United States | 2000 |
Management of tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Humans; Isoniazid; Patient Compliance; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis; Urinalysis | 2001 |
[Observations of properties of the L-form of M. tuberculosis induced by the antituberculosis drugs].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; L Forms; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Norfloxacin; Rifampin; Streptomycin | 2001 |
Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.
Topics: Adult; Alopecia; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lichenoid Eruptions; Pyrazinamide; Rifampin; Scalp Dermatoses; Tuberculosis, Gastrointestinal | 2001 |
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
Topics: Aminosalicylic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Chlorocebus aethiops; Clofazimine; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Hydrazones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Vero Cells | 2002 |
Liquid chromatographic determination of isoniazid, pyrazinamide and rifampicin from pharmaceutical preparations and blood.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Humans; Isoniazid; Pharmaceutical Preparations; Pyrazinamide; Rifampin; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2002 |
Tuberculosis presenting as immune thrombocytopenic purpura.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Autoimmune Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Middle Aged; Mycobacterium tuberculosis; Purpura, Thrombocytopenic, Idiopathic; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis | 2002 |
Can serial qualitative polymerase chain reaction monitoring predict outcome of pulmonary tuberculosis treatment?
Topics: Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 2001 |
[Efficacy of the sparfloxacin-ethambutol combination in a case of cerebral tuberculosis].
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Rifampin; Tuberculosis, Central Nervous System | 2002 |
[Dissolved ozone treatment-induced change in the resistance of multi-resistant mycobacterial strain to isoniazid and rifampicin].
Topics: Antitubercular Agents; Cells, Cultured; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Ozone; Rifampin; Tuberculosis, Pulmonary | 2002 |
[A case of polymyositis complicated with pulmonary tuberculosis concerned with steroid resistance due to rifampin administration].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Polymyositis; Prednisolone; Rifampin; Tuberculosis, Pulmonary | 2001 |
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Base Sequence; Drug Resistance, Bacterial; Genotype; Isoniazid; Molecular Sequence Data; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin | 2002 |
Sample survey of drug-resistant tuberculosis in Henan, China, 1996.
Topics: Adult; Aged; China; Data Collection; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2002 |
Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levels.
Topics: Analysis of Variance; Antitubercular Agents; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Combinations; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Therapeutic Equivalency | 2002 |
Tuberculous meningoencephalitis in HIV-seronegative patients: variety of clinical presentation and impact on diagnostics and treatment.
Topics: Adult; Aged; Antitubercular Agents; Brain; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 2001 |
[The basic disease had already been diagnosed. Abdominal pain increased].
Topics: Abdominal Pain; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Humans; Isoniazid; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prognosis; Radiography, Abdominal; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Miliary | 2002 |
Another step on the path to better TB therapies.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Hong Kong; Humans; Isoniazid; Prognosis; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis, Pulmonary | 2002 |
Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain.
Topics: DNA, Bacterial; Drug Resistance, Multiple; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Rifampin; Sensitivity and Specificity; Spain; Tuberculosis, Multidrug-Resistant | 2002 |
Tuberculosis in Thai prisons: magnitude, transmission and drug susceptibility.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Cross-Sectional Studies; DNA Fingerprinting; DNA, Bacterial; Drug Resistance; HIV Infections; Humans; Incidence; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Prisoners; Radiography, Thoracic; Rifampin; Risk Factors; Thailand; Tuberculosis, Pulmonary | 2002 |
Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Child; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Retrospective Studies; Rifampin; Serologic Tests; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
[Latent tuberculosis infection: diagnosis and treatment].
Topics: Antitubercular Agents; BCG Vaccine; Humans; Isoniazid; Predictive Value of Tests; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis | 2002 |
Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in Zambia.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Diarrhea; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Incidence; Isoniazid; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis; Zambia | 2002 |
Noncompliance with tuberculosis treatment by patients at a tuberculosis and AIDS reference hospital in midwestern Brazil.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Antitubercular Agents; Brazil; Child; Child, Preschool; Female; Hospitals; Humans; Infant; Infant, Newborn; Isoniazid; Male; Medical Records; Middle Aged; Patients; Pyrazinamide; Rifampin; Risk Factors; Treatment Refusal; Tuberculosis | 2002 |
Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Isoniazid; Japan; Male; Middle Aged; Prospective Studies; Rifampin; Tuberculin Test; Tuberculosis, Ocular; Uveitis; Visual Acuity | 2002 |
Tuberculous pericarditis in an infant evolving during triple chemotherapy.
Topics: Antitubercular Agents; Child, Preschool; Drug Therapy, Combination; Echocardiography; Female; Humans; Isoniazid; Pericardial Effusion; Pericarditis, Tuberculous; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
Erythema nodosum associated with reactivation tuberculous lymphadenitis (scrofula).
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leg; Mycobacterium tuberculosis; Neck; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 2002 |
MDR-TB: a challenge for the 21st century.
Topics: Aminosalicylic Acid; Drug Resistance, Bacterial; Drug Therapy, Combination; Forecasting; Humans; Isoniazid; Mycobacterium tuberculosis; Public Health Practice; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2002 |
Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
Topics: Antitubercular Agents; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2002 |
Diagnostic criteria for Tuberculous Meningitis.
Topics: Antitubercular Agents; Child; Child, Preschool; Humans; Isoniazid; Mycobacterium tuberculosis; Prognosis; Pyrazinamide; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculin Test; Tuberculosis, Meningeal | 2002 |
Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Risk Factors; Russia; Socioeconomic Factors; Streptomycin; Tuberculosis, Pulmonary | 2002 |
Molecular analysis of drug resistant TB.
Topics: Adolescent; Adult; Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Clarithromycin; Cyclophosphamide; Ethambutol; Female; Humans; Immunosuppressive Agents; Isoniazid; Leg; Lupus Erythematosus, Systemic; Muscle, Skeletal; Mycobacterium haemophilum; Mycobacterium Infections; Mycophenolic Acid; Rifampin | 2002 |
Complete resolution of cervical spinal tuberculosis with paraplegia in pregnancy.
Topics: Adult; Antitubercular Agents; Cervical Vertebrae; Diagnosis, Differential; Female; Humans; Infant, Newborn; Isoniazid; Magnetic Resonance Imaging; Paraplegia; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis, Spinal | 2002 |
Role of poly [DL-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s).
Topics: Administration, Oral; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biocompatible Materials; Capsules; Delayed-Action Preparations; Drug Compounding; Female; Half-Life; Isoniazid; Lactic Acid; Male; Mice; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazinamide; Rifampin; Solubility | 2002 |
Tuberculosis of the pancreas diagnosed with needle aspiration.
Topics: Adult; Biopsy, Needle; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Male; Pancreas; Pancreatic Diseases; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2002 |
Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Automation; Bacteriophages; Cell Culture Techniques; Drug Resistance, Multiple; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reference Values; Reproducibility of Results; Rifampin; Sensitivity and Specificity | 2002 |
Biochemical and histochemical changes pertaining to active and healed cutaneous tuberculosis.
Topics: Antitubercular Agents; Biopsy; Collagen; Elastin; Fibronectins; Fibrosis; Humans; Immunohistochemistry; Isoniazid; Rifampin; Transforming Growth Factor beta; Tuberculosis, Cutaneous; Zinc | 2002 |
Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Typing Techniques; DNA Fingerprinting; Drug Administration Schedule; Drug Resistance, Bacterial; Ethambutol; Female; Genetics, Microbial; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2002 |
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis.
Topics: Humans; Isoniazid; Kidney Transplantation; Liver; Rifampin; Tuberculin Test; Tuberculosis | 2002 |
Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Topics: Adult; Antibiotics, Antitubercular; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Saudi Arabia; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Validation of a RP-LC method for the simultaneous determination of isoniazid, pyrazinamide and rifampicin in a pharmaceutical formulation.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Isoniazid; Pharmaceutical Preparations; Pyrazinamide; Reproducibility of Results; Rifampin; Sensitivity and Specificity | 2002 |
Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Colorimetry; Drug Resistance, Microbial; Humans; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Peru; Rifampin; Tuberculosis; Xanthenes | 2002 |
Will tuberculosis become resistant to all antibiotics?
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Models, Biological; Mycobacterium tuberculosis; Prevalence; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Perianal ulceration in a "healthy" Chinese man with disseminated tuberculosis.
Topics: Aged; Antitubercular Agents; Anus Diseases; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous | 2002 |
Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Citrulline; Drug Administration Schedule; Enzyme Inhibitors; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Nitric Oxide; Nitrites; Pyrazinamide; Rifampin; T-Lymphocyte Subsets; Tuberculosis | 2002 |
[A case of tuberculosis pleuritis developing contralateral pleural effusion during anti-tuberculosis chemotherapy, falling into chronic respiratory failure].
Topics: Aged; Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Humans; Isoniazid; Male; Pleural Effusion; Pyrazinamide; Respiratory Insufficiency; Rifampin; Tuberculosis, Pleural | 2002 |
Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients.
Topics: Adolescent; Analysis of Variance; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Isoniazid; Japan; Liver; Male; Medical Records; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors | 2002 |
Pulmonary alveolar proteinosis and tuberculosis in a diabetic patient: a rare or a seldom diagnosed association?
Topics: Adult; Diabetes Complications; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pulmonary Alveolar Proteinosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2002 |
Long-term follow up of childhood tuberculous meningitis.
Topics: Acetazolamide; Anti-Inflammatory Agents; Antitubercular Agents; Brain; Child; Cognition Disorders; Diuretics; Drug Therapy, Combination; Ethionamide; Female; Follow-Up Studies; Furosemide; Humans; Hydrocephalus; Isoniazid; Male; Mycobacterium tuberculosis; Prednisolone; Pyrazinamide; Quality of Life; Rifampin; Tuberculosis, Meningeal; Ventriculoperitoneal Shunt; Wechsler Scales | 2002 |
Bacteriological conversion in twenty urinary tuberculosis patients treated with ofloxacin, rifampin and isoniazid: a 10-year follow-up study.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Treatment Outcome; Tuberculosis; Urinary Tract Infections | 2002 |
[Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2002 |
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
Topics: Antitubercular Agents; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin; World Health Organization | 2002 |
[Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Japan; Pyrazinamide; Reference Standards; Rifampin; Surveys and Questionnaires; Tuberculosis, Pulmonary | 2002 |
Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light. 1. Pure anti-tuberculosis drugs and their combinations.
Topics: Adsorption; Antitubercular Agents; Darkness; Drug Combinations; Drug Stability; Ethambutol; Excipients; Isoniazid; Light; Pyrazinamide; Rifampin; Temperature; Water | 2002 |
[Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Poland; Prevalence; Prospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Solitary pontine tuberculoma.
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Pons; Radiography; Rifampin; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Pulmonary | 2002 |
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Russia; Streptomycin; Time Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2002 |
The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda.
Topics: 1-Butanol; Adult; Antitubercular Agents; Child; False Negative Reactions; False Positive Reactions; Humans; Isoniazid; Patient Compliance; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Tuberculosis; Uganda; Urinalysis | 2002 |
Determination of antitubercular drugs by micellar electrokinetic capillary chromatography (MEKC).
Topics: Antitubercular Agents; Chromatography, Micellar Electrokinetic Capillary; Isoniazid; Pyrazinamide; Rifampin | 2002 |
Summaries for patients. Short-course treatment for latent tuberculosis is associated with more frequent liver injury than long-course treatment is.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Pyrazinamide; Rifampin | 2002 |
Tuberculosis re-treatment outcomes within the public service in Nairobi, Kenya.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Isoniazid; Kenya; Male; Middle Aged; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Folic Acid Antagonists; Genetic Complementation Test; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Saccharomyces cerevisiae; Tetrahydrofolate Dehydrogenase; Triazines | 2002 |
Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Carriers; Drug Therapy, Combination; Female; Isoniazid; Liposomes; Lung; Male; Mice; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis | 2002 |
[Pulmonary tuberculosis presenting as tubercular lupus].
Topics: Adolescent; Antitubercular Agents; Biopsy; Drug Combinations; Female; Humans; Isoniazid; Lupus Vulgaris; Luxembourg; Philippines; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2002 |
The triad of weight loss, fever and night sweating: isolated bone marrow tuberculosis, a case report.
Topics: Antitubercular Agents; Bone Marrow; Diagnosis, Differential; Fever; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Sweating; Tuberculosis, Miliary; Weight Loss | 2002 |
[Effect of levofloxacine on cell elements of the lung tissue and on the growth of drug resistant Mycobacteria tuberculosis].
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Cell Movement; Culture Techniques; Drug Interactions; Drug Resistance, Multiple, Bacterial; Isoniazid; Levofloxacin; Lung; Lymphocytes; Macrophages; Mice; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2002 |
[Myrin P in the combined treatment of tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2002 |
Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the mycobacteria growth indicator tube (MGIT) system.
Topics: Antitubercular Agents; Bacteriological Techniques; Culture Media; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2002 |
Two cases of pulmonary tuberculosis caused by Mycobacterium tuberculosis subsp canetti.
Topics: Adult; Antitubercular Agents; Bacterial Typing Techniques; DNA Fingerprinting; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 2002 |
Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Microscopy; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2002 |
Cerebral hemorrhage associated with vitamin K deficiency in congenital tuberculosis treated with isoniazid and rifampin.
Topics: Cerebral Hemorrhage; Humans; Infant; Infectious Disease Transmission, Vertical; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis; Vitamin K; Vitamin K Deficiency | 2002 |
Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci).
Topics: Amikacin; Animals; Antelopes; Antitubercular Agents; Area Under Curve; Ethambutol; Female; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2002 |
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
[Treatment of patients with destructive pulmonary tuberculosis with concomitant diabetes mellitus].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Diabetes Complications; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pneumonectomy; Rifampin; Risk Factors; Thoracoplasty; Time Factors; Tuberculoma; Tuberculosis, Pulmonary | 2002 |
[The evolution of threshold values of air conduction in the extended high frequency range (9-18 kHz) in patients suffering from the pulmonary tuberculosis treated with combination of SM, INH, RFM, and PZA].
Topics: Adult; Antitubercular Agents; Audiometry, Pure-Tone; Auditory Threshold; Case-Control Studies; Deafness; Dose-Response Relationship, Drug; Humans; Isoniazid; Male; Middle Aged; Poland; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2002 |
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Confidence Intervals; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Probability; Pyrazinamide; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2003 |
Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Prospective Studies; Pyrazinamide; Rifampin; Severity of Illness Index; Tuberculosis, Pulmonary | 2003 |
Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antifungal Agents; Antitubercular Agents; Antiviral Agents; Binding Sites; Chemical Phenomena; Chemistry, Physical; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Morpholines; Mycobacterium; Piperazines; Pyrroles; Rifampin; Streptomycin; Structure-Activity Relationship | 2003 |
Prognosis of tuberculous meningitis in adults in the era of modern antituberculous chemotherapy.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Leukocyte Count; Male; Mycobacterium tuberculosis; Prognosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Meningeal | 2002 |
Role of early endourologic management of tuberculous ureteral strictures.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Chi-Square Distribution; Constriction, Pathologic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nephrectomy; Nephrostomy, Percutaneous; Rifampin; Stents; Time Factors; Treatment Outcome; Tuberculosis, Renal; Ureter; Ureteral Obstruction | 2002 |
Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Follow-Up Studies; Humans; India; Isoniazid; Retrospective Studies; Rifampin; Streptomycin; Time Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors | 2002 |
Drug resistance and genotypes of strains of Mycobacterium tuberculosis isolated from human immunodeficiency virus-infected and non-infected tuberculosis patients in Bauru, São Paulo, Brazil.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Brazil; DNA Fingerprinting; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Risk Factors; Tuberculosis, Pulmonary | 2002 |
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Rifampin; Risk Factors; Tuberculosis, Pulmonary | 2003 |
Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis.
Topics: Agar; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Probability; Rifampin; ROC Curve; Sensitivity and Specificity; Streptomycin | 2003 |
Interaction of rifampicin and isoniazid with large unilamellar liposomes: spectroscopic location studies.
Topics: Antibiotics, Antitubercular; Dimyristoylphosphatidylcholine; Fluorometry; Hydrophobic and Hydrophilic Interactions; Isoniazid; Lipid Bilayers; Liposomes; Magnetic Resonance Spectroscopy; Molecular Probes; Phosphatidylglycerols; Rifampin; Static Electricity | 2003 |
Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar.
Topics: AIDS-Related Opportunistic Infections; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Myanmar; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Ethambutol; Isoniazid; Pharmacopoeias as Topic; Pyrazinamide; Reference Standards; Rifampin; Tablets; United States | 2003 |
Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics.
Topics: Amidohydrolases; Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Benzene Derivatives; Catalase; Cell Division; Culture Media; Cysteine; Disaccharides; Drug Resistance, Multiple, Bacterial; Glycopeptides; Inositol; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium smegmatis; Mycobacterium tuberculosis; Oleic Acid; Oxidants; Pyrazoles; Rifampin; Sulfhydryl Compounds | 2003 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes.
Topics: Aryl Hydrocarbon Hydroxylases; beta-Naphthoflavone; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Induction; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Hepatocytes; Humans; Isoniazid; Liver; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Phenobarbital; Rifampin | 2003 |
[Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Madagascar; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Mycobacterium tuberculosis; National Health Programs; Population Surveillance; Prospective Studies; Recurrence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Urban Health | 2002 |
Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2003 |
Choroidal tuberculoma in miliary tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Ethambutol; Fluorescein Angiography; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Miliary; Tuberculosis, Ocular; Ultrasonography | 2003 |
Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.
Topics: Administration, Oral; Alginates; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Drug Compounding; Excipients; Guinea Pigs; Half-Life; Hydrogels; Isoniazid; Pneumococcal Infections; Pyrazinamide; Rifampin; Solubility | 2003 |
Massive spontaneous perirenal hematoma and accelerated hypertension in a patient with polyarteritis nodosa.
Topics: Adult; Antitubercular Agents; Hematoma; Humans; Hypertension, Renal; Isoniazid; Kidney; Kidney Diseases; Male; Mycobacterium Infections, Nontuberculous; Nephrectomy; Polyarteritis Nodosa; Rifampin | 2003 |
Treatment of latent tuberculosis infection.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis | 2003 |
Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Combinations; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tablets; Tuberculosis | 2003 |
Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
Topics: Administration, Oral; Antibiotics, Antitubercular; Antitubercular Agents; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Combinations; Drug Compounding; Ethambutol; Excipients; Feasibility Studies; Humans; Isoniazid; Powders; Pyrazinamide; Rifampin; Tuberculosis | 2003 |
A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Drug Combinations; Drug Labeling; Drug Packaging; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Pilot Projects; Pyrazinamide; Rifampin; Tablets; Time Factors; Tuberculosis | 2003 |
Improved real-time PCR for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
Topics: Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2003 |
Treatment outcome of tuberculosis among Saudi nationals: role of drug resistance and compliance.
Topics: Antibiotics, Antitubercular; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Pyrazinamide; Retrospective Studies; Rifampin; Saudi Arabia; Treatment Failure; Treatment Outcome; Treatment Refusal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Effect of rifampicin & isoniazid on cytochrome P-450 in mycobacteria.
Topics: Antitubercular Agents; Cytochrome P-450 Enzyme System; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Rifampin | 2002 |
[Tuberculous peripheral multifocal choroiditis].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antitubercular Agents; Choroiditis; Drug Therapy, Combination; Female; Humans; Isoniazid; Macular Edema; Middle Aged; Pyrazinamide; Radiography; Rifampin; Tuberculin Test; Tuberculosis, Ocular; Tuberculosis, Pulmonary | 2003 |
Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results.
Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Moxifloxacin; Quinolines; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2003 |
[Tuberculous otitis media. Report of 3 cases].
Topics: Adult; Aged; Amoxicillin; Antitubercular Agents; Cerebrospinal Fluid Otorrhea; Drug Combinations; Ear Diseases; Female; Humans; Isoniazid; Male; Mycobacterium Infections; Mycobacterium tuberculosis; Otitis Media; Penicillins; Proteus Infections; Proteus mirabilis; Pyrazinamide; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tuberculosis | 2003 |
[Pulmonary cryptococcosis combined with pulmonary tuberculosis].
Topics: Cryptococcosis; Diabetes Complications; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Rifampin; Thoracic Surgery, Video-Assisted; Tuberculosis, Pulmonary | 2003 |
Control of anti-tuberculosis drug resistance in Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2003 |
Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico.
Topics: Antitubercular Agents; Bacterial Proteins; Codon; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Electrophoresis, Agar Gel; Isoniazid; Mexico; Mutation; Mycobacterium tuberculosis; Peroxidases; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifampin | 2003 |
Quality of anti-tuberculosis drugs offered to patients.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Chromatography, Thin Layer; Consumer Product Safety; Drug Storage; Humans; India; Isoniazid; Quality Control; Rifampin; Risk Assessment | 2003 |
Evaluation of susceptibility of Mycobacterium bovis to antituberculous drugs by radiometric BACTEC 460TB system.
Topics: Animals; Antitubercular Agents; Cattle; Isoniazid; Microbial Sensitivity Tests; Mycobacterium bovis; Radiometry; Reproducibility of Results; Rifampin; Tuberculosis, Bovine | 2003 |
Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2003 |
[Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Ethambutol; Female; Humans; Incidence; Isoniazid; Japan; Male; Middle Aged; Retrospective Studies; Rifampin; Risk Factors; Time Factors | 2003 |
Rapid oral desensitization to isoniazid, rifampin, and ethambutol.
Topics: Administration, Oral; Antibiotics, Antitubercular; Antitubercular Agents; Child; Desensitization, Immunologic; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Rifampin; Time Factors | 2003 |
Follow-up of compliance with tuberculosis treatment in children: monitoring by urine tests.
Topics: Antitubercular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Isoniazid; Male; Monitoring, Physiologic; Patient Compliance; Prospective Studies; Pyrazinamide; Rifampin; Sensitivity and Specificity; Treatment Outcome; Tuberculosis, Pulmonary; Turkey; Urinalysis; Urine | 2003 |
[The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
[Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2003 |
Mycobacterial infection after renal transplantation in a Western population.
Topics: Adult; Aged; Belgium; Female; Humans; Immunosuppression Therapy; Isoniazid; Kidney Transplantation; Male; Middle Aged; Mycobacterium Infections; Mycobacterium tuberculosis; Opportunistic Infections; Retrospective Studies; Rifampin; Treatment Outcome | 2003 |
[An adult case of tuberculous meningitis].
Topics: Adult; Antitubercular Agents; Cytokines; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Prognosis; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Miliary | 2003 |
[Remission of pulmonary alveolar proteinosis during antituberculosis chemotherapy].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pulmonary Alveolar Proteinosis; Remission Induction; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2003 |
Bilateral bone loss of the maxilla.
Topics: Adult; Alveolar Bone Loss; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Maxillary Diseases; Pyrazinamide; Rifampin; Tuberculosis, Oral | 2003 |
[Therapy strategy in the treatment of patients with drug-resistant pulmonary tuberculosis].
Topics: Antibiotics, Antitubercular; Antiviral Agents; Aprotinin; Humans; Isoniazid; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Behavior of decomposition of rifampicin in the presence of isoniazid in the pH range 1-3.
Topics: Capsules; Chromatography, High Pressure Liquid; Drug Combinations; Drug Incompatibility; Drug Stability; Hydrogen-Ion Concentration; In Vitro Techniques; Isoniazid; Rifampin; Tablets; Time Factors | 2003 |
Regional gastrointestinal permeability of rifampicin and isoniazid (alone and their combination) in the rat.
Topics: Animals; Antitubercular Agents; Digestive System; Drug Combinations; Gastric Mucosa; Intestinal Mucosa; Intestine, Small; Isoniazid; Rats; Rats, Sprague-Dawley; Rifampin | 2003 |
[Accelerated determination of the Mycobacterium tuberculosis drug resistance with a semiliquid culture medium].
Topics: Antitubercular Agents; Culture Media; Drug Resistance, Microbial; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2003 |
Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biocompatible Materials; Biological Availability; Capsules; Drug Combinations; Drug Compounding; Isoniazid; Lactic Acid; Mice; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazinamide; Rifampin; Tissue Distribution; Tuberculosis, Pulmonary | 2003 |
Reactivation of latent tuberculosis infection in TNF-deficient mice.
Topics: Animals; Cell Migration Inhibition; Chemokines; Down-Regulation; Granuloma; Isoniazid; Lymphocyte Activation; Lymphocyte Subsets; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mycobacterium tuberculosis; Necrosis; Pneumonia, Bacterial; Recurrence; Rifampin; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2003 |
Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Genes, Reporter; Humans; Isoniazid; Luciferases; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Photography; Rifampin; Tuberculosis, Multidrug-Resistant | 2003 |
Frequency and antibiotic susceptibility pattern of mycobacterial isolates from extra-pulmonary tuberculosis cases.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Lymph Nodes; Mycobacterium tuberculosis; Pleural Effusion; Rifampin; Streptomycin; Suppuration; Tuberculosis | 2003 |
[Quality control of culture media for mycobacterium drug sensitivity tests].
Topics: Antitubercular Agents; Culture Media; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Quality Control; Rifampin; Streptomycin | 2003 |
Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Point Mutation; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Rifampin; Sensitivity and Specificity | 2003 |
Characterization of clinical isolates of Mycobacterium tuberculosis resistant to drugs and detection of RpoB mutation in multidrug-resistant tuberculosis in the Philippines.
Topics: Codon; DNA-Directed RNA Polymerases; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Phenotype; Philippines; Retrospective Studies; Rifampin; Seroepidemiologic Studies | 2003 |
Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures.
Topics: Antitubercular Agents; Colorimetry; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrites; Reproducibility of Results; Rifampin; Time Factors; Tuberculosis | 2003 |
In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antibiotics, Antitubercular; Antitubercular Agents; Capreomycin; Cycloserine; Drug Combinations; Ethambutol; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rifampin | 2003 |
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
Topics: Administration, Inhalation; Aerosols; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological Availability; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry, Physical; Colony Count, Microbial; Drug Carriers; Drug Combinations; Drug Compounding; Female; Guinea Pigs; Half-Life; Injections, Intravenous; Isoniazid; Lactic Acid; Lung; Male; Microspheres; Mycobacterium tuberculosis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazinamide; Rifampin; Tuberculosis | 2003 |
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.
Topics: Administration, Oral; Animals; Antitubercular Agents; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Glycolates; Isoniazid; Lactic Acid; Liver; Lung; Male; Mice; Mycobacterium tuberculosis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazinamide; Rifampin; Spleen; Tuberculosis | 2003 |
[A 27-year-old patient with recurrent Fever].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Fever; Humans; Isoniazid; Lymph Nodes; Male; Mediastinoscopy; Mycobacterium tuberculosis; Radiography, Thoracic; Recurrence; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 2003 |
Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
Topics: Academic Medical Centers; Adult; Alberta; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Disease Progression; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk Factors; Sputum; Time Factors; Tuberculosis, Pulmonary | 2003 |
The close association of Lymphadenitis tuberculosa and Erythema induratum of Bazin in Japanese patients.
Topics: Adult; Antitubercular Agents; Erythema Induratum; Female; Humans; Isoniazid; Japan; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Lymph Node | 2003 |
[Identification of Mycobacterium tuberculosis strains and a simultaneous identification of their drug resistance by the hybridization method on oligonucleotide microchips].
Topics: Bacterial Proteins; Catalase; Drug Resistance, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oligonucleotides; Oxidoreductases; Rifampin | 2003 |
Typing of Mycobacterium tuberculosis strains resistant to rifampicin and isoniazid by molecular biological methods.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Typing Techniques; Codon; DNA; Drug Resistance, Microbial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Nucleic Acid Heteroduplexes; Oligonucleotide Array Sequence Analysis; Polymorphism, Single-Stranded Conformational; Rifampin; Tuberculosis | 2003 |
[Severe course and contingent risk factors in optic neuropathy and myelopathy after tuberculostatics].
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Optic Nerve Diseases; Photophobia; Pyrazinamide; Rifampin; Risk Factors; Risk Management; Spinal Cord Diseases; Treatment Outcome; Tuberculosis, Lymph Node | 2003 |
Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Diagnostic Errors; Dose-Response Relationship, Drug; Female; Humans; Infant; Isoniazid; Male; Medical History Taking; Medication Errors; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant | 2003 |
Effect of drug resistance on the generation of secondary cases of tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Confidence Intervals; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Incidence; Isoniazid; Mycobacterium tuberculosis; Rifampin; San Francisco; Streptomycin; Tuberculosis | 2003 |
In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Drug Combinations; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin | 2004 |
Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; HIV Infections; Humans; Intestinal Absorption; Isoniazid; Malabsorption Syndromes; Male; Middle Aged; Rifampin; Tuberculosis; Xylose | 2004 |
Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Area Under Curve; Body Weight; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Staphylococcus aureus; Time Factors | 2003 |
Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Interviews as Topic; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Peru; Prevalence; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2003 |
Laryngeal tuberculosis.
Topics: Acetylcysteine; Adult; Antitubercular Agents; Epiglottis; Ethambutol; Female; Granuloma, Laryngeal; Humans; Isoniazid; Mycobacterium; Rifampin; Tuberculosis, Laryngeal | 2004 |
Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis | 2004 |
[Septic loosening of a Wagner revision stem provoked by Mycobacterium tuberculosis].
Topics: Acetabulum; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Arthroplasty, Replacement, Hip; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prosthesis Failure; Prosthesis-Related Infections; Pyrazinamide; Radioimmunoassay; Reoperation; Rifampin; Synovial Fluid; Time Factors; Titanium; Tuberculosis | 2003 |
Pancytopenia due to extensive hemophagocytosis following anti-tubercular treatment.
Topics: Adult; Antitubercular Agents; Biopsy, Needle; Bone Marrow; Hepatomegaly; Histiocytosis; Humans; Isoniazid; Male; Pancytopenia; Pyrazinamide; Rifampin; Tuberculosis | 2004 |
[Clinical forms of new cases of tuberculosis at Kaunas Romainiai Tuberculosis Hospital in 1998-2001].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Resistance, Bacterial; Hemorrhage; Humans; Incidence; Isoniazid; Lithuania; Mycobacterium tuberculosis; Pulmonary Heart Disease; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 2004 |
Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
Topics: Antitubercular Agents; Developing Countries; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Recurrence; Registries; Retrospective Studies; Rifampin; Risk Factors; Sputum; Thailand; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2004 |
Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Excipients; Isoniazid; Kinetics; Membranes, Artificial; Microscopy, Electron, Scanning; Osmosis; Permeability; Rifampin | 2004 |
Cavitatory pulmonary tuberculosis in a 52-day-old infant.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Asia; Drug Therapy, Combination; Female; Humans; Infant; Infectious Disease Transmission, Vertical; Isoniazid; Male; Pregnancy; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant | 2004 |
[Cardiac tamponade with paroxysmal atrial flutter controlled by antituberculous therapy].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Atrial Flutter; Cardiac Tamponade; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 2004 |
[Molecular genetic characteristics of rifampicin-resistant Mycobacterium tuberculosis isolates in Novosibirsk].
Topics: Antitubercular Agents; Codon; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium tuberculosis; Point Mutation; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Retrovesical tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Biopsy, Fine-Needle; Child; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Laparotomy; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Urogenital; Ultrasonography, Interventional; Urination Disorders | 2004 |
[Unexpected complication in an elderly lady suffering from rheumatoid arthritis].
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Pyridoxine; Radiography, Abdominal; Rifampin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Urogenital; Urine | 2004 |
Antimicrobial susceptibility determined by the E test, Löwenstein-Jensen proportion, and DNA sequencing methods among Mycobacterium tuberculosis isolates discrepancies, preliminary results.
Topics: Antitubercular Agents; Base Sequence; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2004 |
Drug susceptibility testing of Mycobacterium tuberculosis by the broth microdilution method with 7H9 broth.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin | 2004 |
Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR.
Topics: Antitubercular Agents; Benzophenoneidum; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Polymerase Chain Reaction; Rhodamines; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary | 2004 |
Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Guinea Pigs; Humans; Isoniazid; Liposomes; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutropenia.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Granulocyte Colony-Stimulating Factor; Humans; Iatrogenic Disease; Isoniazid; Male; Neutropenia; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 2004 |
Cranial-epidural tuberculosis presenting as a scalp swelling.
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Edema; Epidural Space; Ethambutol; Frontal Bone; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Parietal Bone; Pyrazinamide; Rifampin; Scalp; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2004 |
Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Drug Combinations; Drug Compounding; Injections, Subcutaneous; Isoniazid; Lactic Acid; Lung; Mice; Microspheres; Mycobacterium tuberculosis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazinamide; Rifampin; Spleen; Tissue Distribution; Tuberculosis | 2004 |
Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibiotics, Antitubercular; Chemistry, Pharmaceutical; Cholesterol; Delayed-Action Preparations; Drug Combinations; Isoniazid; Liposomes; Phosphatidylcholines; Rifampin; Solubility; Spectrophotometry, Ultraviolet | 2004 |
Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid.
Topics: Antitubercular Agents; Brazil; Coloring Agents; Flow Cytometry; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Rifampin; Xanthenes | 2004 |
Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected children.
Topics: Animals; Antitubercular Agents; BCG Vaccine; Cattle; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; HIV Infections; Humans; Infant; Isoniazid; Mutation; Mycobacterium bovis; Rifampin; Tuberculosis, Pulmonary | 2004 |
CYP2E1 mediated isoniazid-induced hepatotoxicity in rats.
Topics: Alanine Transaminase; Animals; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; Down-Regulation; Hydrazines; Isoniazid; Liver; Male; Rats; Rifampin; RNA, Messenger | 2004 |
Prognostic indicators in patients with intracranial tuberculoma: a review of 102 cases.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Brain Diseases; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculoma, Intracranial | 2004 |
Empirical treatment for tuberculosis: survey of cases treated over 2 years in a London area.
Topics: Adult; Antibiotic Prophylaxis; Antitubercular Agents; BCG Vaccine; Blood Sedimentation; Ethnicity; Female; Humans; Isoniazid; Logistic Models; London; Male; Middle Aged; Retrospective Studies; Rifampin; Risk Factors; Sputum; Tuberculosis, Pulmonary | 2004 |
Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reproducibility of Results; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2004 |
[Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
Topics: Adolescent; Anti-Bacterial Agents; Genotype; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Treatment of latent TB infection for close contacts as a complementary TB control strategy in Singapore.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antitubercular Agents; BCG Vaccine; Carrier State; Child; Child, Preschool; Contact Tracing; Health Policy; Humans; Isoniazid; Lung; Outcome and Process Assessment, Health Care; Radiography; Rifampin; Singapore; Tuberculin Test; Tuberculosis, Pulmonary | 2004 |
Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens.
Topics: Antitubercular Agents; Carrier State; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Patient Compliance; Prisons; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis | 2004 |
Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Peru; Pyrazinamide; Registries; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis | 2004 |
Antituberculosis drugs and hepatotoxicity.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Risk Factors; Tuberculosis | 2004 |
The in vitro antibacterial/synergistic activities of Withania somnifera extracts.
Topics: Anti-Bacterial Agents; Drug Synergism; Escherichia coli; Humans; Isoniazid; Microbial Sensitivity Tests; Phytotherapy; Plant Extracts; Plant Leaves; Plant Roots; Rifampin; Salmonella typhimurium; Withania | 2004 |
Rifapentine for the treatment of tuberculosis: is it all it can be?
Topics: Antibiotics, Antitubercular; Dose-Response Relationship, Drug; Drug Combinations; Half-Life; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 2004 |
Finding gold in the muddy waters of public health reports.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Communicable Disease Control; Drug Combinations; Drug Utilization; Humans; Isoniazid; Public Health Practice; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 2004 |
Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
Topics: Administration, Oral; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Weight; Communicable Disease Control; Drug Therapy, Combination; Drug Utilization Review; Ethambutol; Female; Guideline Adherence; Hospital Records; Hospitals, Public; Humans; Isoniazid; Malawi; Male; Middle Aged; Pyrazinamide; Registries; Rifampin; Tuberculosis, Pulmonary | 2004 |
Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Drug Combinations; Drug Utilization; Humans; Isoniazid; Los Angeles; Mycobacterium tuberculosis; Recurrence; Rifampin; Self Administration; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland.
Topics: Bacterial Proteins; Catalase; DNA Fingerprinting; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Polymerase Chain Reaction; Rifampin | 2004 |
[Current aspects of laryngeal tuberculosis].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Laryngeal Diseases; Mycobacterium tuberculosis; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2004 |
A 32-year-old man with tuberculosis, fever, and rash.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Hypersensitivity; Ethambutol; Exanthema; Fever; Humans; Isoniazid; Liver; Liver Failure; Male; Pyrazinamide; Pyridoxine; Rifampin; Skin; Tuberculosis, Pulmonary | 2004 |
[Leukopenia due to anti-tuberculous chemotherapy including rifampicin and isoniazid].
Topics: Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Leukopenia; Male; Middle Aged; Rifampin | 2004 |
Tuberculous epididymitis with extensive retroperitoneal and mediastinal involvement.
Topics: Adult; Antitubercular Agents; Diagnostic Imaging; District of Columbia; Drug Therapy, Combination; Epididymitis; Humans; Isoniazid; Male; Mediastinum; Pyrazinamide; Retroperitoneal Space; Rifampin; Sierra Leone; Tuberculosis, Male Genital | 2004 |
Lung specific stealth liposomes as antitubercular drug carriers in guinea pigs.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Carriers; Drug Therapy, Combination; Guinea Pigs; Infusions, Intravenous; Isoniazid; Liposomes; Lung; Rifampin; Time Factors; Tuberculosis | 2004 |
Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.
Topics: Adenosine Triphosphatases; Anaerobiosis; Antitubercular Agents; Colony Count, Microbial; Electron Transport; Energy Metabolism; Enzyme Inhibitors; Isoniazid; Mycobacterium tuberculosis; Nitrates; Oxygen; Pyrazinamide; Rifampin | 2004 |
[Study on the epidemiology and determinants of drug-resistant tuberculosis in northern rural area of Jiangsu province].
Topics: Adult; Antitubercular Agents; China; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Humans; Incidence; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Rifampin; Rural Health; Streptomycin; Surveys and Questionnaires; Tuberculosis, Pulmonary | 2004 |
[The use of gene chip in detecting Mycobacterium tuberculosis resistant to rifampin and isoniazid].
Topics: Drug Resistance, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2004 |
Cervical spine tuberculosis.
Topics: Adolescent; Antitubercular Agents; Cervical Vertebrae; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Spinal | 2004 |
Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay.
Topics: Antitubercular Agents; Color; Ethambutol; Ethylenediamines; Free Radical Scavengers; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Nitrate Reductases; Nitrates; Nitrites; Oxidation-Reduction; Potassium Compounds; Rifampin; Sensitivity and Specificity; Streptomycin; Sulfanilamides; Time Factors | 2004 |
[Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
Topics: Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Diabetes Complications; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Sputum; Tuberculosis, Pulmonary; World Health Organization | 2004 |
[Bactericidal therapy in patients with tuberculosis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Chlortetracycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2004 |
[Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 2004 |
Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice.
Topics: Animals; Cell Survival; Disease Models, Animal; Female; Gene Expression Regulation, Bacterial; Granuloma; Isoniazid; Mice; Mice, Hairless; Mice, Inbred BALB C; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Phenotype; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Time Factors; Up-Regulation | 2004 |
Tuberculosis: medical management update.
Topics: Adult; Antitubercular Agents; Child; Dental Staff; Ethambutol; Humans; Infectious Disease Transmission, Patient-to-Professional; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Oral; Tuberculosis, Pulmonary | 2004 |
Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Chemical and Drug Induced Liver Injury; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Netherlands; Prospective Studies; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis | 2004 |
Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?
Topics: Adolescent; Adult; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Female; HIV Infections; Humans; Isoniazid; Liver; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Pyrazinamide; Randomized Controlled Trials as Topic; Regression Analysis; Rifampin; Tuberculosis | 2004 |
Multifocal osteoarticular tuberculosis: a case report.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Joints; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Osteoarticular | 2005 |
Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy.
Topics: alpha-Defensins; Animals; Anti-Infective Agents; Antitubercular Agents; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Isoniazid; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2004 |
[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ozone; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB).
Topics: Antibiotics, Antitubercular; Ascitic Fluid; Bronchoalveolar Lavage Fluid; Cerebrospinal Fluid; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Pleural Effusion; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Urine | 2004 |
Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidoreductases; Polymerase Chain Reaction; Rifampin; Russia; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Topics: Antitubercular Agents; Colony Count, Microbial; Culture Media; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sampling Studies; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2004 |
Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis.
Topics: Adult; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Drug Interactions; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Oxazines; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2004 |
[The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Turkey | 2004 |
The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Retrospective Studies; Rifampin; Siberia; Tuberculosis, Pulmonary | 2004 |
Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Mycobacterium tuberculosis; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Sputum; Tuberculosis | 2004 |
Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2002: a report of the Australian Mycobacterium Reference Laboratory Network.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Australia; Bronchoscopy; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; False Negative Reactions; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Predictive Value of Tests; Rifampin; Sputum; Tuberculosis | 2003 |
[Quantitative analysis of sigma genes expression in Mycobacterium tuberculosis cultures exposed to rifampicin and isoniazid].
Topics: Antibiotics, Antitubercular; Drug Resistance, Microbial; Gene Expression Regulation, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Bacterial; RNA, Messenger; Sigma Factor | 2004 |
Interference of isonicotinyl hydrazone in the microbiological analysis of rifampicin from anti-tuberculosis FDC products containing isoniazid.
Topics: Antitubercular Agents; Bacillus subtilis; Chemistry, Pharmaceutical; Drug Interactions; Hydrazones; Isoniazid; Isonicotinic Acids; Microbiological Techniques; Rifampin | 2004 |
Overestimation of rifampicin during colorimetric analysis of anti-tuberculosis products containing isoniazid due to formation of isonicotinyl hydrazone.
Topics: Antitubercular Agents; Colorimetry; Hydrazones; Isoniazid; Rifampin; Spectrophotometry, Ultraviolet | 2004 |
The transpedicular approach in the management of thoracic spine tuberculosis: a short-term follow up study.
Topics: Abscess; Adolescent; Adult; Aged; Antitubercular Agents; Braces; Combined Modality Therapy; Curettage; Debridement; Decompression, Surgical; Disease Progression; Drainage; Ethambutol; Female; Follow-Up Studies; Humans; Immobilization; Isoniazid; Kyphosis; Male; Middle Aged; Movement Disorders; Pyrazinamide; Radiography; Recovery of Function; Retrospective Studies; Rifampin; Severity of Illness Index; Spinal Cord Compression; Thoracic Vertebrae; Treatment Outcome; Tuberculosis, Spinal | 2004 |
In vitro analysis of rifampicin and its effect on quality control tests of rifampicin containing dosage forms.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Chromatography, High Pressure Liquid; Dosage Forms; Drug Combinations; Filtration; Isoniazid; Quality Control; Rifampin; Solubility; Tablets | 2004 |
Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Female; Isoniazid; Lung; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mycobacterium tuberculosis; Rifampin; Spleen; Tuberculosis; Weight Loss | 2004 |
Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 2003 |
Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 2003 |
Successful kidney re-transplantation in a patient with previous allograft kidney tuberculosis.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Immunosuppression Therapy; Isoniazid; Kidney Transplantation; Male; Opportunistic Infections; Pyrazinamide; Reoperation; Rifampin; Tuberculosis, Renal | 2004 |
Tuberculosis control and the private health sector in Bolivia: a survey of pharmacies.
Topics: Antitubercular Agents; Bolivia; Communicable Disease Control; Community Pharmacy Services; Cooperative Behavior; Drug Prescriptions; Ethambutol; Humans; Isoniazid; Pharmacies; Prescription Fees; Private Sector; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2004 |
Safe susceptibility testing of Mycobacterium tuberculosis by flow cytometry with the fluorescent nucleic acid stain SYTO 16.
Topics: Antibiotics, Antitubercular; DNA, Bacterial; Ethambutol; Flow Cytometry; Fluorescent Dyes; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2005 |
Drug-resistant tuberculosis in HIV-infected persons: Italy 1999-2000.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; HIV Infections; Hospitals, Public; Humans; Isoniazid; Italy; Male; Middle Aged; Prevalence; Prospective Studies; Rifampin; Risk Factors; Tuberculosis, Pulmonary | 2004 |
Macular edema as the only ocular finding of tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Macular Edema; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Sputum; Tuberculin Test; Tuberculosis, Ocular | 2004 |
[Case of pulmonary tuberculosis in late stage of pregnancy].
Topics: Adult; Antitubercular Agents; Cesarean Section; Cross Infection; Drug Therapy, Combination; Ethambutol; Female; Hospitals, General; Humans; Infant, Newborn; Infection Control; Isoniazid; Patient Isolation; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2004 |
[Pulmonary Mycobacterium fortuitum infection with multiple nodular shadows in a healthy man].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Radiography, Thoracic; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan.
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Bacterial Typing Techniques; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prevalence; Rifampin; Taiwan; Tuberculosis | 2005 |
Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand.
Topics: Adult; Age Factors; Contraindications; Digoxin; Drug Interactions; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Female; Furosemide; Hospitals, University; Humans; Isoniazid; Male; Middle Aged; Outpatients; Pharmacoepidemiology; Pharmacy Service, Hospital; Regression Analysis; Retrospective Studies; Rifampin; Thailand; Time Factors | 2005 |
Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.
Topics: Animals; Antibodies, Bacterial; Antitubercular Agents; Colony Count, Microbial; Combined Modality Therapy; Disease Models, Animal; Female; Immunoglobulin G; Immunotherapy; Interferon-gamma; Isoniazid; Lung; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mycobacterium tuberculosis; Rifampin; Spleen; Tuberculosis; Tuberculosis Vaccines; Tumor Necrosis Factor-alpha | 2005 |
Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Fluoroquinolones; Gatifloxacin; Isoniazid; Mycobacterium tuberculosis; Rifampin | 2005 |
Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
Topics: Antitubercular Agents; Bacterial Proteins; Brazil; Catalase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Polymorphism, Single-Stranded Conformational; Prevalence; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2005 |
New PCR-based assay for detection of common mutations associated with rifampin and isoniazid resistance in Mycobacterium tuberculosis.
Topics: Drug Resistance, Multiple, Bacterial; Isoniazid; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2005 |
Melatonin prevents the free radical and MADD metabolic profiles induced by antituberculosis drugs in an animal model.
Topics: Animals; Antioxidants; Antitubercular Agents; Carboxylic Acids; Death Domain Receptor Signaling Adaptor Proteins; Drug Combinations; Free Radicals; Guanine Nucleotide Exchange Factors; Hydroxybenzoates; Isoniazid; Melatonin; Oxidative Stress; Pyrazinamide; Rats; Rats, Sprague-Dawley; Rifampin | 2005 |
[Tuberculoma and tuberculous meningeal-radiculitis with paradoxical progression during treatment].
Topics: Aged; Anti-Inflammatory Agents; Antitubercular Agents; Confusion; Disease Progression; Drug Therapy, Combination; Female; Fever; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Ofloxacin; Prednisone; Radiculopathy; Rifampin; Spinal Puncture; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma; Tuberculoma, Intracranial; Tuberculosis, Meningeal | 2005 |
Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Norway; Patient Compliance; Pyrazinamide; Registries; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary | 2005 |
Drug-resistance tuberculosis among the foreign-born in Canada.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Canada; Drug Resistance, Bacterial; Emigration and Immigration; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 2005 |
Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates--a retrospective study from a chest-disease institute in India.
Topics: Adult; Aged; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; Rifampin; Sputum; Treatment Failure; Tuberculosis, Pulmonary | 2005 |
[Effectiveness of an intensive chemotherapy stage in new cases of pulmonary tuberculosis and diabetes mellitus].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Radiography, Thoracic; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2004 |
Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.
Topics: Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2005 |
Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Formazans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Nitrate Reductases; Oxazines; Rifampin; Sensitivity and Specificity; Streptomycin; Tetrazolium Salts; Xanthenes | 2005 |
Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.
Topics: Capreomycin; Cycloserine; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam | 2005 |
High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ethambutol; Female; Humans; Isoniazid; Lithuania; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2005 |
Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru.
Topics: Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Multidrug-Resistant | 2005 |
Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Prisons; Pyrazinamide; Rifampin; Tuberculosis | 2005 |
[Process of acquiring drug resistance: retrospective review of records of MDR TB].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Treatment Refusal; Tuberculosis, Multidrug-Resistant | 2004 |
Optimal latent TB control methods.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2005 |
Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Codon; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Multifocal osteoarticular tuberculosis.
Topics: Adult; Antitubercular Agents; Bone and Bones; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Knee; Male; Pain; Pyrazinamide; Radiography; Radius; Rifampin; Treatment Outcome; Tuberculosis, Osteoarticular; Weight Loss; Wrist | 2005 |
Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.
Topics: Agar; Antitubercular Agents; Blood; Culture Media; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.
Topics: Antitubercular Agents; Ethambutol; Flow Cytometry; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Tuberculosis | 2005 |
Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
Topics: Adult; Antitubercular Agents; Carrier State; Case-Control Studies; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Incidence; Isoniazid; Male; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors | 2005 |
Tuberculous peritonitis developing during chemotherapy for pulmonary and intestinal tuberculosis: a case report.
Topics: Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Laparoscopy; Male; Middle Aged; Peritonitis, Tuberculous; Rifampin; Time Factors; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 2005 |
[Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prognosis; Retrospective Studies; Rifampin; Risk; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2005 |
Spoligotyping of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mumbai, India.
Topics: Adult; Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; India; Isoniazid; Male; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifampin; Sputum; Tuberculosis, Pulmonary | 2005 |
Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Colony Count, Microbial; Drug Resistance, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifabutin; Rifampin | 2005 |
Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; California; Child; Female; Humans; Isoniazid; Male; Multivariate Analysis; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; United States | 2005 |
Results of a national study on anti-mycobacterial drug resistance in El Salvador.
Topics: Age Distribution; Antibiotics, Antitubercular; Directly Observed Therapy; El Salvador; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Fluorescent Dyes; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity | 2005 |
Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
Topics: Acetamides; Animals; Antitubercular Agents; Cell Line; Drug Antagonism; Furans; Isoniazid; Linezolid; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxazoles; Oxazolidinones; Rifampin | 2005 |
[Case report: cutaneous tuberculosis and tuberculous osteomyelitis].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Humans; Immunocompetence; Isoniazid; Male; Osteomyelitis; Pyrazines; Rifampin; Tibia; Tomography, X-Ray Computed; Tuberculosis, Cutaneous; Tuberculosis, Osteoarticular | 2005 |
Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey.
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; Catalase; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin | 2005 |
Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin | 2005 |
Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Area Under Curve; Biological Availability; Drug Carriers; Drug Delivery Systems; Guinea Pigs; Isoniazid; Lipids; Nanostructures; Pyrazinamide; Rifampin; Tuberculosis | 2005 |
Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against anti-tuberculosis drugs induced liver toxicity.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Fruit; Hepatocytes; Humans; Isoniazid; Male; Phyllanthus emblica; Phytotherapy; Plant Extracts; Protective Agents; Pyrazinamide; Rats; Rats, Wistar; Rifampin; Tuberculosis, Pulmonary | 2005 |
Multidrug resistance among persons with tuberculosis in California, 1994-2003.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; California; Child; Child, Preschool; Emigration and Immigration; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Risk Factors; Socioeconomic Factors; Tuberculosis, Multidrug-Resistant | 2005 |
Solitary choroidal tuberculoma in an immunocompetent patient.
Topics: Adult; Antitubercular Agents; Choroid Diseases; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fluorescein Angiography; Humans; Immunocompetence; Isoniazid; Male; Rifampin; Tuberculin Test; Tuberculoma; Tuberculosis, Ocular | 2005 |
Rifampicin resistance in tuberculosis outbreak, London, England.
Topics: Antitubercular Agents; Base Sequence; Disease Outbreaks; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; Isoniazid; London; Molecular Sequence Data; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Time Factors | 2005 |
[Medicine and television: a diagnosis history].
Topics: Adult; Antitubercular Agents; Cholestasis, Intrahepatic; Diagnostic Errors; Hepatitis B; Hepatitis C; HIV Infections; Humans; Isoniazid; Male; Medicine in the Arts; Mercury Poisoning; Pyrazinamide; Rifampin; Television; Tuberculosis | 2005 |
Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.
Topics: Amides; Antibiotics, Antitubercular; Antitubercular Agents; Catalysis; Chromatography, High Pressure Liquid; Drug Combinations; Ethambutol; Isoniazid; Picolinic Acids; Pyrazinamide; Rifampin; Spectrophotometry, Ultraviolet | 2005 |
Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Topics: Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Ethambutol; Flow Cytometry; Gels; Humans; Isoniazid; Microbial Sensitivity Tests; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Microspheres; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2005 |
Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru.
Topics: Colorimetry; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium tuberculosis; Peru; Prospective Studies; Rifampin; Sensitivity and Specificity | 2005 |
[Anti-drug pattern of drug-resistant Mycobacterium tuberculosis and analysis of mutation in drug-target genes].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin | 2005 |
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana.
Topics: Adult; Antitubercular Agents; Botswana; Comorbidity; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2005 |
Isoniazid and rifampicin treatment on phospholipids and their subfractions in liver tissue of rabbits.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, Thin Layer; Drug Interactions; Isoniazid; Liver; Male; Phosphates; Phospholipids; Rabbits; Rifampin | 2005 |
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Multiple, Bacterial; Genotype; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Sequence Analysis, DNA | 2005 |
Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection.
Topics: Anti-HIV Agents; Antitubercular Agents; BCG Vaccine; Child; Female; HIV Infections; Humans; Infant; Isoniazid; Rifampin; Tuberculosis, Lymph Node | 2005 |
In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv.
Topics: Anti-Bacterial Agents; Clotrimazole; Colony Count, Microbial; Drug Synergism; Econazole; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
The use of macroarrays for the identification of MDR Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Rifampin; Tuberculosis, Multidrug-Resistant | 2006 |
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.
Topics: Aerosols; Alginates; Animals; Antitubercular Agents; Drug Carriers; Drug Evaluation, Preclinical; Female; Glucuronic Acid; Guinea Pigs; Hexuronic Acids; Inhalation; Isoniazid; Liver; Lung; Male; Mycobacterium tuberculosis; Nanostructures; Pyrazinamide; Rifampin; Spleen; Time Factors; Tuberculosis | 2005 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
[Two pregnant immigrant women with tuberculous peritonitis].
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Fetal Death; Humans; Isoniazid; Peritonitis, Tuberculous; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrazinamide; Rifampin | 2005 |
[Tuberculoma complicating tuberculous meningitis: description of one paediatric case].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Magnetic Resonance Imaging; Prednisone; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Meningeal | 2005 |
Simultaneous determination of rifampicin and isoniazid by continuous-flow chemiluminescence with artificial neural network calibration.
Topics: Algorithms; Antitubercular Agents; Calibration; Complex Mixtures; Drug Combinations; Flow Injection Analysis; Isoniazid; Luminescent Measurements; Neural Networks, Computer; Pattern Recognition, Automated; Reproducibility of Results; Rifampin; Sensitivity and Specificity | 2005 |
[The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Tuberculous meningitis in BCG vaccinated and unvaccinated children.
Topics: Antitubercular Agents; BCG Vaccine; Child, Preschool; Female; Humans; Injections, Intramuscular; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Meningeal; Vaccination | 2005 |
Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan.
Topics: Antitubercular Agents; Bacterial Proteins; Codon; Genotype; Humans; Isoniazid; Kazakhstan; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2005 |
Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay.
Topics: Alleles; Antitubercular Agents; Culture Media; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA | 2005 |
Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey.
Topics: Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Base Sequence; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; In Vitro Techniques; Isoniazid; Mycobacterium tuberculosis; Oxidoreductases; Point Mutation; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Turkey | 2005 |
Paraneoplastic limbic encephalitis presenting as acute viral encephalitis.
Topics: Acute Disease; Acyclovir; Anti-Bacterial Agents; Anticonvulsants; Carcinoma, Renal Cell; Cerebrospinal Fluid; Diagnosis, Differential; Drug Therapy, Combination; Electroencephalography; Encephalitis, Viral; Enoxaparin; Ethambutol; Follow-Up Studies; Herpesvirus 1, Human; Humans; Isoniazid; Limbic Encephalitis; Limbic System; Magnetic Resonance Imaging; Male; Meningoencephalitis; Methylprednisolone; Middle Aged; Nephrectomy; Neuropsychological Tests; Paraneoplastic Syndromes, Nervous System; Phenytoin; Rifampin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2005 |
Concurrence of granular cell tumor and Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bronchoscopy; Ethambutol; Granular Cell Tumor; Humans; Isoniazid; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2005 |
Monitoring the ingestion of anti-tuberculosis drugs by simple non-invasive methods.
Topics: Antitubercular Agents; Drug Monitoring; Humans; Isoniazid; Isonicotinic Acids; Microbial Sensitivity Tests; Patient Compliance; Reproducibility of Results; Retrospective Studies; Rifampin; Self Administration; Staphylococcus aureus | 2006 |
[Cervical spondylodiscitis: one pathogen may hide another].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Cervical Vertebrae; Cholecystitis; Discitis; Disease Progression; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Ethambutol; Fluoroquinolones; France; Humans; Immobilization; Isoniazid; Male; Middle Aged; Morocco; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Radiography; Rifampin; Tuberculosis, Spinal | 2006 |
Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Reagent Strips; Rifampin; Streptomycin | 2005 |
Reactivation of tuberculosis after apparently adequate chemoprophylaxis.
Topics: Adolescent; Antitubercular Agents; Chemoprevention; Contact Tracing; Disease Transmission, Infectious; Ethambutol; Female; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 2005 |
[The combined effect of isoniazid and rifampicin on the activities of CYP4501A2 and CYP4503A4 in primary hepatocytes from healthy human adults].
Topics: Adult; Cells, Cultured; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Hepatocytes; Humans; Isoniazid; Rifampin | 2005 |
Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chitosan; Cholesterol; Fatty Acids, Nonesterified; Isoniazid; Lipid Peroxidation; Lipid Peroxides; Liver; Liver Function Tests; Male; Rats; Rats, Wistar; Rifampin; Triglycerides | 2006 |
A 2-year-old girl with an abnormal gait.
Topics: Antitubercular Agents; Child, Preschool; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Gait Ataxia; Humans; Isoniazid; Osteomyelitis; Physical Examination; Pyrazinamide; Rifampin; Tuberculosis, Spinal | 2005 |
High frequency of multidrug-resistant Mycobacterium tuberculosis isolates in Georgetown, Guyana.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Guyana; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Risk Factors; Sputum; Tuberculosis, Multidrug-Resistant | 2005 |
Drug-drug interaction studies on first-line anti-tuberculosis drugs.
Topics: Antitubercular Agents; Chromatography, Liquid; Drug Combinations; Drug Compounding; Drug Incompatibility; Drug Stability; Drug Storage; Ethambutol; Hot Temperature; Humidity; Isoniazid; Mass Spectrometry; Pyrazinamide; Rifampin | 2005 |
[Bilateral tuberculous epididymitis after intravesical Bacillus Calmette-Guerin therapy].
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Drug Therapy, Combination; Epididymitis; Humans; Isoniazid; Male; Orchiectomy; Rifampin; Tuberculosis, Male Genital; Urinary Bladder Neoplasms | 2005 |
Comparison of redox and D29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Costs and Cost Analysis; Drug Resistance, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Oxazines; Oxidation-Reduction; Rifampin; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Xanthenes | 2006 |
Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Bacterial Proteins; Catalase; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Phenotype; Reagent Kits, Diagnostic; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2006 |
Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Codon; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis | 2006 |
Adherence to anti-tuberculosis chemoprophylaxis and treatment in children.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Drug Therapy, Combination; Family Health; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Patient Compliance; Rifampin; South Africa; Tuberculosis, Pulmonary | 2006 |
Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2006 |
In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection.
Topics: Adult; Antitubercular Agents; Carrier State; Cohort Studies; Directly Observed Therapy; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Patient Compliance; Rifampin; Tuberculosis | 2005 |
Artificial neural networks to optimize formulation components of a fixed-dose combination of rifampicin, isoniazid and pyrazinamide in a microemulsion.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Caprylates; Chemistry, Pharmaceutical; Child; Drug Combinations; Drug Stability; Emulsions; Humans; Isoniazid; Neural Networks, Computer; Polyethylene Glycols; Polysorbates; Pyrazinamide; Rifampin; Solubility; Sorbitol; Triglycerides | 2005 |
Effect of garlic on isoniazid and rifampicin-induced hepatic injury in rats.
Topics: Animals; Glutathione; Isoniazid; Lipid Peroxidation; Liver; Rats; Rats, Wistar; Rifampin; Sulfhydryl Compounds | 2006 |
[Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Humans; Incidence; Isoniazid; Moscow; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Adverse drug reactions observed during DOTS.
Topics: Adolescent; Adult; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; India; Isoniazid; Male; Middle Aged; National Health Programs; Patient Compliance; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 2004 |
Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin; Tuberculosis, Pulmonary | 2006 |
[BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2006 |
Mycobacterium tuberculosis in a Saudi Arabian hospital.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Saudi Arabia; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2006 |
Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice.
Topics: Animals; Disease Models, Animal; Fatty Liver; Glutathione; Isoniazid; Liver; Male; Mice; Mice, Inbred BALB C; Mitochondria, Liver; Mitochondrial Membranes; Oxidative Stress; Permeability; Rifampin | 2006 |
Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidoreductases; Promoter Regions, Genetic; Regulatory Sequences, Nucleic Acid; Rifampin; Tuberculosis | 2006 |
[Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Male; Rifampin; Stevens-Johnson Syndrome; Togo; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 2005 |
The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation.
Topics: Adult; Antitubercular Agents; Cohort Studies; Directly Observed Therapy; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Prevalence; Prisons; Prospective Studies; Recurrence; Rifampin; Risk Factors; Russia; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2006 |
Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
Topics: Adult; Antitubercular Agents; Area Under Curve; Cohort Studies; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2006 |
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Isoniazid; Mice; Mice, Inbred BALB C; Moxifloxacin; Pyrazinamide; Quinolines; Rifampin; Tuberculosis, Pulmonary | 2006 |
Effect of different oral doses of isoniazid-rifampicin in rats.
Topics: Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Body Weight; Isoniazid; Liver; Male; Rats; Rats, Wistar; Rifampin | 2006 |
Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
Topics: Agar; Antitubercular Agents; Blood; Culture Media; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2006 |
Study of the interaction between rifapentine and isoniazid under acid conditions.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Interactions; Hydrogen-Ion Concentration; Isoniazid; Rifampin | 2006 |
Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses.
Topics: Alginates; Animals; Antitubercular Agents; Area Under Curve; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Ethambutol; Female; Glucuronic Acid; Hexuronic Acids; Isoniazid; Male; Mice; Nanostructures; Pyrazinamide; Rifampin; Tissue Distribution | 2006 |
Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Drug Combinations; Fruit; Hepatocytes; Isoniazid; Lipid Peroxidation; Oxidative Stress; Pyrazinamide; Rats; Rifampin; Terminalia | 2006 |
Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Proteins; Base Sequence; Catalase; DNA Probes; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidoreductases; Polymerase Chain Reaction; Rifampin | 2006 |
Effect of oral administration of crude aqueous extract of garlic on pharmacokinetic parameters of isoniazid and rifampicin in rabbits.
Topics: Administration, Oral; Animals; Antitubercular Agents; Garlic; Herb-Drug Interactions; Isoniazid; Plant Extracts; Rabbits; Rifampin | 2006 |
Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice.
Topics: Animals; Antibodies, Bacterial; Antitubercular Agents; Disease Models, Animal; Female; Humans; Immune Sera; Immunization, Passive; Isoniazid; Lung; Mice; Mice, Inbred DBA; Mice, SCID; Mycobacterium tuberculosis; Rifampin; Secondary Prevention; Specific Pathogen-Free Organisms; Tuberculosis | 2006 |
Resistance of Mycobacterium tuberculosis isolates in different populations in Greece during 1993-2002.
Topics: Antitubercular Agents; Chi-Square Distribution; Drug Resistance, Bacterial; Emigration and Immigration; Female; Greece; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; USSR | 2006 |
Multidrug-resistant tuberculosis in military recruits.
Topics: Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Military Personnel; Pyrazinamide; Radiography, Thoracic; Rifampin; Tuberculin Test; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; United States | 2006 |
Rapid susceptibility test for Mycobacterium tuberculosis to isoniazid and rifampin with resazurin method in screw-cap tubes.
Topics: Antitubercular Agents; Drug Resistance, Microbial; False Positive Reactions; Humans; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Xanthenes | 2006 |
In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.
Topics: Antitubercular Agents; Cells, Cultured; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Oxazolidinones; Rifampin | 2006 |
[Tuberculosis of the submandibular gland: a case report].
Topics: Antitubercular Agents; Combined Modality Therapy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Submandibular Gland Diseases; Tuberculosis, Oral | 2006 |
Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
Topics: Adamantane; Antitubercular Agents; Drug Resistance, Bacterial; Drug Synergism; Ethylenediamines; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2006 |
[Evaluation of reasons of the MDR M. tuberculosis strains dissemination by analysis of the rifampicin and/or isoniazid resistant isolates].
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Phylogeny; Rifampin; Russia; Siberia; Tuberculosis, Multidrug-Resistant | 2006 |
[Characteristics of Mycobacterium tuberculosis clinical strains genotype A1].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 2006 |
Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacteriological Techniques; Culture Media; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Reference Standards; Rifampin; Sensitivity and Specificity | 2006 |
Application of the resazurin microtitre assay for detection of multidrug resistance in Mycobacterium tuberculosis in Algiers.
Topics: Algeria; Antibiotics, Antitubercular; Antitubercular Agents; Colorimetry; Humans; Indicators and Reagents; Isoniazid; Mycobacterium tuberculosis; Oxazines; Rifampin; Tuberculosis, Multidrug-Resistant; Xanthenes | 2006 |
Validation of a rapid method for detection of M. tuberculosis resistance to INH and RMP in Lima, Peru.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Time Factors | 2006 |
[Isoniazid induced neuropathy: consider prevention].
Topics: Acetylation; Achilles Tendon; Adult; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Ethambutol; Female; Guinea; Hepatitis B, Chronic; HIV Infections; Humans; Hypesthesia; Inactivation, Metabolic; Isoniazid; Peripheral Nervous System Diseases; Reflex, Abnormal; Rifampin; Tuberculosis, Pulmonary; Vitamin B 6; Vitamin B 6 Deficiency | 2006 |
A boy undergoing maintenance hemodialysis who developed mediastinal lymph node tuberculosis.
Topics: Child; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Humans; Isoniazid; Lymph Nodes; Male; Mediastinum; Mycobacterium tuberculosis; Pyrazinamide; Renal Dialysis; Rifampin; Tuberculosis, Lymph Node | 2006 |
Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam.
Topics: Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Hospitals; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Promoter Regions, Genetic; Recombination, Genetic; Rifampin; Sequence Analysis, DNA; Tuberculosis; Vietnam | 2006 |
Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates.
Topics: Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Polymerase Chain Reaction; Recombination, Genetic; Rifampin; Sensitivity and Specificity; Tuberculosis; Turkey | 2006 |
Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Italy; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sequence Analysis, DNA; Tuberculosis | 2006 |
Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Body Fluids; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Tuberculosis, Multidrug-Resistant | 2006 |
The use of real-time polymerase chain reaction for rapid diagnosis of skeletal tuberculosis.
Topics: Antitubercular Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Femur; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Osteolysis; Pyrazinamide; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Tuberculosis, Osteoarticular | 2006 |
Tuberculous cervical lymphadenitis: an unusual case.
Topics: Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Granuloma, Giant Cell; Humans; Isoniazid; Lymphadenitis; Middle Aged; Neck; Rifampin; Tuberculosis, Lymph Node | 2006 |
Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia.
Topics: Adult; Antitubercular Agents; DNA Fingerprinting; Drug Resistance, Bacterial; Georgia (Republic); Hospitals; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prisoners; Prospective Studies; Quality Control; Rifampin; Sputum; Streptomycin; Tuberculosis | 2006 |
Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
Topics: Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Isoniazid; Lamivudine; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 2006 |
Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
Topics: Animals; Antitubercular Agents; Guinea Pigs; Humans; Isoniazid; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mycobacterium tuberculosis; Rabbits; Rifampin; Tuberculosis, Pulmonary | 2007 |
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Pyrazinamide; Rifampin; Secondary Prevention; Time Factors; Tuberculosis, Pulmonary | 2006 |
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
Topics: Alleles; Antibiotics, Antitubercular; Antitubercular Agents; Biological Evolution; DNA Mutational Analysis; DNA, Bacterial; DNA, Intergenic; Ethambutol; Gene Deletion; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2006 |
Molecular characterization of mutation associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates.
Topics: Adolescent; Adult; Antitubercular Agents; Bacterial Proteins; Catalase; Codon; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Humans; Isoniazid; Middle Aged; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; RNA Polymerase II; Tuberculosis | 2006 |
Anti-tuberculosis drug inducd hepatitis - a Sri Lankan experience.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Prospective Studies; Rifampin; Risk Assessment; Risk Factors; Sri Lanka; Streptomycin; Tuberculosis | 2006 |
Moving forward with evidence and controversies: the challenges of MDR-TB.
Topics: Antibiotics, Antitubercular; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient?
Topics: Antibiotics, Antitubercular; Confounding Factors, Epidemiologic; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Sputum; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Topics: Adolescent; Adult; Age Factors; Aged; Analysis of Variance; Anti-Bacterial Agents; Antibiotics, Antitubercular; British Columbia; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Emigration and Immigration; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti.
Topics: Antitubercular Agents; Cost of Illness; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Haiti; Health Care Costs; Humans; Isoniazid; Program Evaluation; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; World Health Organization | 2006 |
Ocular tuberculosis in acquired immunodeficiency syndrome.
Topics: Abscess; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Child; Conjunctival Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Panophthalmitis; Pyrazinamide; Retinal Diseases; Retrospective Studies; Rifampin; Tuberculosis, Central Nervous System; Tuberculosis, Ocular; Tuberculosis, Pulmonary | 2006 |
Use of nonlinear mixed-effects analysis for improved precision of early pharmacodynamic measures in tuberculosis treatment.
Topics: Antitubercular Agents; Humans; Isoniazid; Models, Biological; Nonlinear Dynamics; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 2006 |
[Addisonian crises induced by rifampicin].
Topics: Addison Disease; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Miliary | 2006 |
Penile tuberculosis associated with monoclonal gammopathy of undetermined significance.
Topics: Aged; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Paraproteinemias; Penile Diseases; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Male Genital | 2006 |
Unusual presentation of tuberculosis as a splenic mass.
Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Humans; Isoniazid; Liver; Lymph Nodes; Male; Rifampin; Spleen; Splenectomy; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis, Splenic | 2006 |
Application of the Genotype MTBDR assay directly on sputum specimens.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum | 2006 |
Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Isoniazid; Male; Patient Compliance; Retrospective Studies; Rifampin; Socioeconomic Factors; Treatment Outcome; Tuberculosis | 2006 |
Comprehensive findings on clinical, bacteriological, histopathological and therapeutic aspects of cutaneous tuberculosis.
Topics: Adult; Age Distribution; Antibiotics, Antitubercular; Antitubercular Agents; Child; Extremities; Female; Humans; Isoniazid; Lupus Vulgaris; Male; Middle Aged; Rifampin; Sex Distribution; Skin; Treatment Outcome; Tuberculosis, Cutaneous; Tuberculosis, Lymph Node | 2006 |
Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia.
Topics: Adult; Antibiotics, Antitubercular; Bacterial Typing Techniques; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Hospitals, Special; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prisoners; Rifampin; Risk Factors; Russia; Species Specificity; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2006 |
Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients.
Topics: Adult; Afghanistan; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant | 2006 |
Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance.
Topics: Antitubercular Agents; Bacteriological Techniques; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Genotype; Isoniazid; Mycobacterium tuberculosis; Rifampin | 2006 |
Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
Topics: Adult; Antitubercular Agents; Bacteriophages; Biological Assay; Culture Media; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Prospective Studies; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 2007 |
Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Sputum; Tuberculosis | 2006 |
Latent pelvic tuberculosis reactivating in a postmenopausal woman: a case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Hepatitis, Autoimmune; Humans; Hysterectomy; Isoniazid; Ovariectomy; Recurrence; Rifampin; Tuberculosis, Female Genital | 2006 |
National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Cross-Sectional Studies; Ethambutol; Female; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Myanmar; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antitubercular Agents; Arthritis; Arthritis, Rheumatoid; Comorbidity; Etanercept; Female; Greece; Humans; Immunoglobulin G; Incidence; Infliximab; Isoniazid; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Retrospective Studies; Rifampin; Spondylitis, Ankylosing; Tuberculosis; Tuberculosis, Pulmonary | 2006 |
Within-host population dynamics of antibiotic-resistant M. tuberculosis.
Topics: Algorithms; Anti-Bacterial Agents; Computer Simulation; Drug Resistance, Microbial; Drug Therapy, Combination; Granuloma; Humans; Isoniazid; Models, Biological; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 2007 |
Dissolution testing of marketed rifampicin containing fixed dose combination formulations using a new discriminative media: a post marketing retrospective study.
Topics: Antitubercular Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Combinations; Isoniazid; Kinetics; Pyrazinamide; Reference Standards; Retrospective Studies; Rifampin; Solubility; Spectrophotometry, Ultraviolet | 2006 |
Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin | 2006 |
Tuberculid of the glans penis.
Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Penile Diseases; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous | 2006 |
Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Topics: Adamantane; Antitubercular Agents; Chromatography, Thin Layer; Computer Simulation; Isoniazid; Least-Squares Analysis; Ligands; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Quinolines; Rifampin; Spectrometry, Mass, Electrospray Ionization | 2007 |
Rapid and low-cost colorimetric method using 2,3,5-triphenyltetrazolium chloride for detection of multidrug-resistant Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Bacteriological Techniques; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tetrazolium Salts; Tuberculosis | 2006 |
Sir, I turned much darker!
Topics: Addison Disease; Adult; Antitubercular Agents; Ethambutol; Germany; Humans; Hydrocortisone; Hyperpigmentation; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Endocrine | 2006 |
Mycobacterium tuberculosis presenting as chronic red eye.
Topics: Adolescent; Antitubercular Agents; Chronic Disease; Conjunctivitis, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Ocular | 2006 |
Treatment failure in tuberculosis.
Topics: Adolescent; BCG Vaccine; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Health Surveys; Humans; Isoniazid; Male; Mass Chest X-Ray; Rifampin; Treatment Failure; Tuberculin Test; Tuberculosis, Pulmonary | 2007 |
[Acquired ichthyosis revealing hepatic and lymph node tuberculosis].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Ichthyosis; Isoniazid; Laparotomy; Liver; Lymph Nodes; Male; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Lymph Node | 2006 |
Consider rifampin BUT be cautious.
Topics: Antitubercular Agents; Humans; Isoniazid; Multicenter Studies as Topic; Patient Compliance; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2006 |
Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Cohort Studies; Drug Administration Schedule; Drug Interactions; Emigration and Immigration; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Practice Guidelines as Topic; Retrospective Studies; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; United States | 2006 |
Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure.
Topics: Adult; Antitubercular Agents; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Hemianopsia; Humans; Isoniazid; Kidney Failure, Chronic; Male; Optic Neuritis; Renal Dialysis; Rifampin; Tuberculosis | 2006 |
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis.
Topics: Antitubercular Agents; Data Collection; Global Health; Humans; Isoniazid; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant | 2006 |
[The mycolic acids analysis with HPLC technique in drug susceptibility testing of Mycobacterium tuberculosis strains].
Topics: Antitubercular Agents; Bacteriological Techniques; Biomarkers; Chromatography, High Pressure Liquid; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Rifampin; Sensitivity and Specificity | 2006 |
Tuberculous gumma in a patient with cervical lymphadenitis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis, Cutaneous; Tuberculosis, Lymph Node | 2006 |
Rapid antibiotic susceptibility testing of Mycobacterium tuberculosis: its utility in resource poor settings.
Topics: Antitubercular Agents; Colorimetry; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Poverty; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Absence of an association between Mycobacterium tuberculosis genotype and clinical features in children with tuberculous meningitis.
Topics: Adolescent; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Ethionamide; Female; Genotype; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2007 |
Evaluation of an intracellular pharmacokinetic in vitro infection model as a tool to assess tuberculosis therapy.
Topics: Antitubercular Agents; Cell Line; Half-Life; Humans; Isoniazid; Levofloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin | 2007 |
Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Capreomycin; Clinical Trials as Topic; Drug Administration Routes; Humans; Isoniazid; Microbial Sensitivity Tests; New York City; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Moxifloxacin-induced arthropathy.
Topics: Aged, 80 and over; Antitubercular Agents; Arthritis; Aza Compounds; Drug Therapy, Combination; Fluoroquinolones; Humans; Isoniazid; Male; Moxifloxacin; Pyrazinamide; Quinolines; Rifampin; Tuberculosis, Pulmonary | 2007 |
PCR identification of Mycobacterium tuberculosis complex in a clinical sample from a patient with symptoms of tuberculous spondylodiscitis.
Topics: Adult; Antitubercular Agents; Biopsy; Discitis; Drug Therapy, Combination; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Thoracic Vertebrae; Tuberculin Test; Tuberculosis, Spinal | 2007 |
Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra.
Topics: Administration, Inhalation; Animals; Cytokines; Isoniazid; Macrophages; Mice; Microspheres; Mycobacterium tuberculosis; Phagocytosis; Reactive Nitrogen Species; Reactive Oxygen Species; Rifampin | 2007 |
Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Time Factors; Tuberculosis, Multidrug-Resistant | 2007 |
Optimization of a stability-indicating HPLC method for the simultaneous determination of rifampicin, isoniazid, and pyrazinamide in a fixed-dose combination using artificial neural networks.
Topics: Biological Availability; Chromatography, High Pressure Liquid; Drug Combinations; Hydrogen-Ion Concentration; Isoniazid; Neural Networks, Computer; Pyrazinamide; Reproducibility of Results; Rifampin; Sensitivity and Specificity | 2007 |
Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Topics: Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Cells, Cultured; Colorimetry; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Indicators and Reagents; Isoniazid; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Phagocytosis; Quinolines; Rifampin; Spectrometry, Fluorescence; Tuberculosis; Xanthenes | 2007 |
CHIH-DFT determination of the molecular structure infrared spectra, UV spectra and chemical reactivity of three antitubercular compounds: Rifampicin, Isoniazid and Pyrazinamide.
Topics: Antitubercular Agents; Isoniazid; Pyrazinamide; Rifampin; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet | 2007 |
Modification to improve efficiency of sampling schedules for BA/BE testing of FDC anti-tuberculosis drugs.
Topics: Antitubercular Agents; Area Under Curve; Biological Availability; Blood Specimen Collection; Ethambutol; Humans; Isoniazid; Pyrazinamide; Quality Assurance, Health Care; Rifampin; South Africa; Therapeutic Equivalency | 2007 |
Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Rwanda; Streptomycin; Tuberculosis, Pulmonary; Warfare | 2007 |
Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; Colony Count, Microbial; Drug Synergism; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Isoniazid; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Time Factors | 2006 |
Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Infant; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2007 |
Outcome and management of spinal tuberculosis according to the severity of disease: a retrospective study of 137 adult patients at Korean teaching hospitals.
Topics: Adult; Antitubercular Agents; Combined Modality Therapy; Decompression, Surgical; Drug Therapy, Combination; Ethambutol; Female; Hospitals, Teaching; Humans; Isoniazid; Korea; Male; Middle Aged; Retrospective Studies; Rifampin; Severity of Illness Index; Spinal Fusion; Treatment Outcome; Tuberculosis, Spinal | 2007 |
[A case of tuberculosis showing immune reconstitution syndrome after the initiation of antiretroviral therapy for HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; HIV-1; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Zidovudine | 2007 |
Evaluation of rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis by a mycobacteriophage D29-based assay.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity | 2007 |
Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine.
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Male; Molecular Epidemiology; Mutation; Mycobacterium tuberculosis; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Ukraine | 2007 |
Primary and acquired drug resistance in childhood tuberculosis.
Topics: Adolescent; Afghanistan; Antitubercular Agents; Child; Child Welfare; Ethambutol; Female; Gastric Juice; Humans; Iran; Isoniazid; Male; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Refugees; Retrospective Studies; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
[Isoniazid-induced acute pancreatitis].
Topics: Acute Disease; Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Female; Femoral Neck Fractures; Fractures, Spontaneous; Humans; Isoniazid; Pancreatitis; Pyrazinamide; Rifampin; Tuberculosis, Osteoarticular | 2007 |
Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.
Topics: Antitubercular Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Complex Mixtures; Humans; Isoniazid; Rifampin; Spectrometry, Mass, Electrospray Ionization | 2007 |
[Aseptic cerebral venous thrombosis and multiple cerebral tuberculomas associated with pulmonary miliary tuberculosis].
Topics: Acenocoumarol; Aged; Anticoagulants; Antitubercular Agents; Confusion; Drug Therapy, Combination; Female; Heparin; Humans; Immunocompromised Host; Isoniazid; Lateral Sinus Thrombosis; Pyrazinamide; Radiography; Rifampin; Streptomycin; Thrombophilia; Tuberculoma, Intracranial; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 2007 |
Tuberculous uveitis after treatment with etanercept.
Topics: Antirheumatic Agents; Antitubercular Agents; Aqueous Humor; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Granuloma; Humans; Immunoglobulin G; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Panuveitis; Pyrazinamide; Receptors, Tumor Necrosis Factor; Retrospective Studies; Rifampin; Tuberculosis, Ocular | 2007 |
[Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2007 |
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium tuberculosis; Ozone; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Female; Humans; Intestinal Absorption; Isoniazid; Lactulose; Male; Mannitol; Middle Aged; Permeability; Rifampin; Tuberculosis, Pulmonary | 2006 |
[Case report: tuberculosis of parotid gland].
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Lymph Node Excision; Male; Parotid Diseases; Parotid Gland; Pyrazinamide; Radiography; Rifampin; Tuberculosis | 2007 |
Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Korea; Middle Aged; Prevalence; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.
Topics: Antitubercular Agents; Codon; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Isoniazid; Mass Spectrometry; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Russia; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tuberculosis | 2007 |
Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacteriological Techniques; Culture Media; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2007 |
[Case of liver tuberculosis requiring differentiation from liver metastasis of cancer].
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Liver Neoplasms; Lymphatic Metastasis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Lymph Node | 2007 |
XDR-TB--danger ahead.
Topics: Antitubercular Agents; Global Health; Humans; Incidence; Isoniazid; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant | 2007 |
[Centrofacial granulomatous inflammation].
Topics: Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lupus Vulgaris; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Skin; Time Factors; Treatment Outcome; Tuberculin Test | 2007 |
Haemorheological variables in Nigeria pulmonary tuberculosis patients undergoing therapy.
Topics: Adult; Blood Sedimentation; Blood Viscosity; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Isoniazid; Leukocyte Count; Male; Middle Aged; Nigeria; Platelet Count; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 2007 |
Short-course regimens for latent tuberculosis: what is ready for prime time?
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Virus Latency | 2007 |
Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Diarylquinolines; Female; Granuloma; Guinea Pigs; Hypoxia; Isoniazid; Lung; Mycobacterium tuberculosis; Nitroimidazoles; Pyrazinamide; Quinolines; Radiation-Sensitizing Agents; Rifampin; Spleen; Tuberculosis | 2007 |
Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar.
Topics: Antitubercular Agents; Colorimetry; Feasibility Studies; Humans; Indicators and Reagents; Isoniazid; Madagascar; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Predictive Value of Tests; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Xanthenes | 2007 |
Drug resistance in tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis | 2007 |
Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA Transposable Elements; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin | 2007 |
Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis | 2007 |
Clinical characteristics of tuberculosis in patients with liver cirrhosis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver; Liver Cirrhosis; Male; Middle Aged; Prognosis; Rifampin; Tuberculosis, Pulmonary | 2007 |
[Tuberculosis caused by XDR resistant Mycobacterium tuberculosis in Poland. Microbiological and molecular analysis].
Topics: Antitubercular Agents; Capreomycin; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Epidemiology; Mycobacterium tuberculosis; Poland; Population Surveillance; Prevalence; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2007 |
A new Multi-PCR-SSCP assay for simultaneous detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA | 2007 |
Gatifloxacin in combination with rifampicin in a murine tuberculosis model.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Combinations; Female; Fluoroquinolones; Gatifloxacin; Isoniazid; Lung; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2007 |
The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Hydrazines; Intubation, Gastrointestinal; Isoniazid; Male; Pyrazinamide; Rats; Rats, Wistar; Rifampin; Time Factors | 2007 |
Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.
Topics: Adolescent; Adult; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Comorbidity; Female; Humans; Isoniazid; Liver Cirrhosis; Liver Transplantation; Male; Postoperative Complications; Preoperative Care; Rifampin; Safety; Treatment Outcome; Tuberculin Test; Tuberculosis | 2007 |
Effects of four Indian medicinal herbs on Isoniazid-, Rifampicin- and Pyrazinamide-induced hepatic injury and immunosuppression in guinea pigs.
Topics: Animals; Guinea Pigs; Immune Tolerance; India; Isoniazid; Liver; Neutrophils; Plants, Medicinal; Pyrazinamide; Rifampin | 2007 |
Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antitubercular Agents; Comorbidity; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Streptomycin; Thailand; Tuberculosis, Multidrug-Resistant | 2007 |
Tuberculous sacro-ileitis: two cases and radiological findings.
Topics: Abscess; Adult; Antitubercular Agents; Arthritis, Infectious; Brucellosis; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Sacroiliac Joint; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Ultrasonography | 2007 |
Mass-spectrometry based minisequencing method for the rapid detection of drug resistance in Mycobacterium tuberculosis.
Topics: Bacterial Proteins; Catalase; Databases, Nucleic Acid; DNA Probes; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Genetic Markers; Humans; Isoniazid; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Promoter Regions, Genetic; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tuberculosis, Multidrug-Resistant | 2007 |
Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats.
Topics: Analysis of Variance; Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chitosan; Isoniazid; Lipid Peroxidation; Liver; Liver Function Tests; Male; Protective Agents; Rats; Rats, Wistar; Rifampin | 2007 |
Patient choice promotes adherence in preventive treatment for latent tuberculosis.
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antitubercular; Antineoplastic Agents; Attitude to Health; Child; Female; Humans; Isoniazid; Male; Patient Compliance; Patient Satisfaction; Regression Analysis; Rifampin; Risk; Time Factors; Treatment Outcome; Tuberculosis | 2007 |
Drug resistance to tuberculosis in a tertiary care setting in Karachi.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cohort Studies; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pakistan; Rifampin; Tuberculosis, Multidrug-Resistant | 2007 |
Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.
Topics: Administration, Oral; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Isoniazid; Ketoconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
[Analysis of mutations of multidrug-resistant M. tuberculosis strains in patients with tuberculosis in the Kyrghyz Republic].
Topics: Adult; Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Catalase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Peroxidases; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
[Reasons for drug-resistant tuberculosis emergence].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Evaluation of a tool to benchmark hospital antibiotic prescribing in the United Kingdom.
Topics: Anti-Bacterial Agents; Benchmarking; Cefuroxime; Ciprofloxacin; Cohort Studies; Data Collection; Drug Prescriptions; Drug Utilization; Hospitals; Humans; Isoniazid; Medication Systems, Hospital; Pharmacy Service, Hospital; Pilot Projects; Practice Guidelines as Topic; Practice Patterns, Physicians'; Rifampin; United Kingdom | 2008 |
Clinical and operational value of the extensively drug-resistant tuberculosis definition.
Topics: Antitubercular Agents; Communicable Diseases; Drug Resistance, Multiple; Extensively Drug-Resistant Tuberculosis; Global Health; Humans; Isoniazid; Population Surveillance; Public Health; Rifampin; Risk; Russia; Time Factors; Treatment Outcome | 2007 |
Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin | 2007 |
Urine levels of rifampicin & isoniazid in asymptomatic HIV-positive individuals.
Topics: Adult; Antitubercular Agents; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Resistance; HIV Infections; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Middle Aged; Models, Biological; Rifampin; Tuberculosis; Xylose | 2007 |
Adverse drug reactions associated with first-line anti-tuberculosis drug regimens.
Topics: Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2007 |
Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Autoanalysis; Culture Media; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Streptomycin | 2007 |
Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
Topics: Antitubercular Agents; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Isoniazid; Lupus Erythematosus, Systemic; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 2007 |
[Use of a mini-sequencing test, followed by the MALDI-TOF mass-spectrometric analysis to evaluate rifampicin and izoniazid resistance in Mycobacterium tuberculosis circulating in the Russian Federation].
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Phenotype; Reproducibility of Results; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tuberculosis | 2007 |
The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Chromatography, High Pressure Liquid; Drug Interactions; Half-Life; Isoniazid; Male; Pyrazinamide; Rats; Rats, Wistar; Rifampin | 2007 |
Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Rifampin; Tuberculosis | 2007 |
[Loculated ascitis by peritoneal tuberculosis].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Ascites; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Peritonitis, Tuberculous; Pyrazinamide; Radiography, Abdominal; Rifampin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Formulation and statistical optimization of a novel crosslinked polymeric anti-tuberculosis drug delivery system.
Topics: Administration, Oral; Antitubercular Agents; Chemistry, Pharmaceutical; Citrates; Cross-Linking Reagents; Drug Carriers; Drug Combinations; Gastric Juice; Hydrogen-Ion Concentration; Isoniazid; Kinetics; Least-Squares Analysis; Models, Chemical; Models, Statistical; Plasticizers; Polymers; Rifampin; Solubility; Spectrophotometry, Ultraviolet; Surface Properties; Technology, Pharmaceutical; Zinc Sulfate | 2008 |
Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Health Services Accessibility; Humans; India; Isoniazid; Male; Middle Aged; Public Health; Rifampin; Rural Population; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Urban Population | 2007 |
A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array.
Topics: Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oligonucleotide Probes; Phenotype; Point Mutation; Polymerase Chain Reaction; Rifampin | 2007 |
Comparative evaluation of BACTEC 460TB system and Lowenstein-Jensen medium for the isolation of M. tuberculosis from cerebrospinal fluid samples of tuberculous meningitis patients.
Topics: Bacteriological Techniques; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Meningeal | 2007 |
A novel solid dosage form of rifampicin and isoniazid with improved functionality.
Topics: Antitubercular Agents; Capsules; Chemistry, Pharmaceutical; Drug Delivery Systems; Isoniazid; Rifampin; Solubility; Tablets; Tablets, Enteric-Coated | 2007 |
[Ascites by peritoneal tuberculosis].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Ascites; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Peritonitis, Tuberculous; Pyrazinamide; Radiography, Abdominal; Rifampin; Time Factors; Tomography, X-Ray Computed | 2007 |
[Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Turkey | 2007 |
Elevated gatifloxacin and reduced rifampicin concentrations in a single-dose interaction study amongst healthy volunteers.
Topics: Aged; Antibiotics, Antitubercular; Area Under Curve; Cross-Over Studies; Drug Interactions; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin | 2007 |
[Case of fatal liver failure due to anti-tuberculous therapy].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Liver Failure; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2007 |
Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa.
Topics: Antitubercular Agents; Biological Assay; Genes, Reporter; Humans; Isoniazid; Luciferases; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Prospective Studies; Rifampin; South Africa; Tuberculosis | 2008 |
[Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Cross-Sectional Studies; Democratic Republic of the Congo; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
[Case of pulmonary infection with Mycobacterium chelonae in healthy breast-feeding woman].
Topics: Adult; Antitubercular Agents; Breast Feeding; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
Neurological picture. Dorsal intramedullary tuberculoma.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Mycobacterium tuberculosis; Rifampin; Spinal Cord Diseases; Tuberculoma; Tuberculosis, Spinal | 2007 |
Nationwide survey on the prevalence of anti-tuberculosis drug resistance in the Republic of Yemen, 2004.
Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Yemen | 2007 |
Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
Topics: Antitubercular Agents; BCG Vaccine; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium bovis; Rifampin; Streptomycin; Tuberculosis | 2007 |
[Multiresistant tuberculosis in Brazil: history and control].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Brazil; Health Surveys; History, 20th Century; History, 21st Century; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2007 |
Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
Topics: Adolescent; Antibiotic Prophylaxis; Antitubercular Agents; Contact Tracing; Female; Humans; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2007 |
Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures.
Topics: Adult; Aged; Albumins; Animals; Antitubercular Agents; Catechols; Cell Culture Techniques; Cell Survival; Cells, Cultured; Cytochrome P-450 CYP2E1; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Female; Glutathione; Hepatocytes; Humans; Isoniazid; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Rifampin; RNA, Messenger; Species Specificity | 2008 |
[Mycobacterium ulcerans infection treated by Rifater, pyrazynamide, Myambutol, and surgery: a case report with a 6-year follow-up].
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Chloramines; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Mastectomy; Metronidazole; Mycobacterium ulcerans; Nitrofurantoin; Pleurisy; Prednisolone; Pyrazinamide; Recurrence; Rifampin; Skin Transplantation | 2008 |
Evaluation of antitubercular drug insertion into preformed dipalmitoylphosphatidylcholine monolayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antitubercular Agents; Drug Combinations; Drug Compounding; Ethambutol; Excipients; Isoniazid; Membranes, Artificial; Rifampin; Surface Properties | 2008 |
Tuberculosis peritonitis.
Topics: Aged; Antitubercular Agents; Dominican Republic; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Peritonitis; Rhode Island; Rifampin; Tuberculosis | 2007 |
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluoroquinolones; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Secondary Prevention; Time Factors; Tuberculosis | 2007 |
Isoniazid-rifampicin induced lipid changes in rats.
Topics: Administration, Oral; Animals; Antitubercular Agents; Female; Isoniazid; Lipids; Liver; Male; Rats; Rats, Wistar; Rifampin | 2008 |
Drug susceptibility profiling of tuberculous meningitis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Infant; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant | 2008 |
Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Biomarkers; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity | 2007 |
[Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan].
Topics: Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Japan; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
[A surgically treated case of ileus caused by small intestinal tuberculosis during treatment for pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Ileal Diseases; Ileus; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 2007 |
Multifocal osteomyelitis due to Mycobacterium szulgai in a patient with chronic lymphocytic leukemia.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leukemia, Lymphocytic, Chronic, B-Cell; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Osteomyelitis; Rifampin | 2008 |
Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.
Topics: Antitubercular Agents; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Probe Techniques; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; South Africa; Sputum; Time Factors; Tuberculosis, Multidrug-Resistant | 2008 |
Treatment of isoniazid-resistant pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Medical Audit; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
Cerebral vacuolation induced in rats by the administration of LUP-3FDC, an anti-tuberculosis cocktail.
Topics: Administration, Oral; Animals; Antitubercular Agents; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Isoniazid; Male; Microscopy, Electron; Pyrazinamide; Rats; Rats, Wistar; Rifampin; Toxicity Tests, Chronic; Ultrasonography; Vacuoles | 2008 |
Hepatoprotective effect of tocopherol against isoniazid and rifampicin induced hepatotoxicity in albino rabbits.
Topics: Animals; Antioxidants; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cimetidine; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Isoniazid; Liver Diseases; Rabbits; Rifampin; Tocopherols | 2007 |
[Case of bladder tuberculosis with onset at the age of nineteen--treatment of urinary tract tuberculosis in accordance with the new Japanese Tuberculosis Treatment Guidelines].
Topics: Adult; Antitubercular Agents; Diagnostic Imaging; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoniazid; Japan; Male; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Urogenital; Urinary Bladder Diseases | 2008 |
[Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female; Hepatitis, Chronic; Humans; Isoniazid; Liver; Male; Middle Aged; Retrospective Studies; Rifampin; Tuberculosis | 2008 |
Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2008 |
Molecular genetics of drug-resistant Mycobacterium tuberculosis isolates in Finland, 1995-2004.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Finland; Genotype; Humans; Isoniazid; Mycobacterium tuberculosis; Point Mutation; Rifampin; Seroepidemiologic Studies; Tuberculosis, Multidrug-Resistant | 2008 |
[A case of development of acute miliary tuberculosis].
Topics: Acute Disease; Adult; Antitubercular Agents; Humans; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Miliary | 2008 |
Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR.
Topics: Alkyl and Aryl Transferases; Antitubercular Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Bacterial Typing Techniques; Drug Resistance, Multiple, Bacterial; Gene Expression; Humans; Isoniazid; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; Rifampin | 2008 |
[Tuberculosis dactylis: a case report].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Child; Drug Therapy, Combination; Ethambutol; Female; Fingers; Humans; Isoniazid; Pyrazinamide; Radiography; Rifampin; Time Factors; Treatment Outcome; Tuberculin Test; Tuberculosis, Osteoarticular | 2008 |
Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity.
Topics: Antitubercular Agents; Cell Line, Tumor; Cell Survival; Chemical and Drug Induced Liver Injury; Humans; Hydrazines; Isoniazid; Liver; Pyrazinamide; Rifampin | 2008 |
Hepatotoxicity of pyrazinamide: cohort and case-control analyses.
Topics: Adult; Aged; Antitubercular Agents; Case-Control Studies; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Logistic Models; Male; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Pyrazinamide; Rifampin; Tuberculosis | 2008 |
Protective effect of Tinospora cordifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: an experimental study.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Isoniazid; Liver Cirrhosis; Liver Diseases; Male; Necrosis; Phyllanthus emblica; Phytotherapy; Plant Extracts; Pyrazinamide; Rats; Rats, Wistar; Rifampin; Tinospora | 2008 |
Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.
Topics: Adult; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Case-Control Studies; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Glutathione Transferase; Homozygote; Humans; Isoniazid; Male; Middle Aged; Mutation; Polymorphism, Genetic; Prospective Studies; Pyrazinamide; Rifampin; White People | 2008 |
An ounce of tuberculosis prevention.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Humans; Isoniazid; Patient Compliance; Rifampin; Risk Factors; Tuberculosis | 2008 |
An unusual case of chylothorax complicating childhood tuberculosis.
Topics: Antitubercular Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chest Tubes; Chylothorax; Diagnosis, Differential; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Octreotide; Pyrazinamide; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis, Pulmonary | 2008 |
Evaluation of the GenoCard as a tool for transport and storage of samples for tuberculosis molecular drug susceptibility testing.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Minisatellite Repeats; Mycobacterium tuberculosis; Rifampin; Specimen Handling; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
[Exposure to multiresisant tuberculosis: study and follow-up of nine children].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Environmental Exposure; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2008 |
Papulonecrotic tuberculids associated with uveitis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Glucocorticoids; Humans; Isoniazid; Male; Ophthalmic Solutions; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Cutaneous; Tuberculosis, Ocular; Uveitis | 2008 |
Tuberculosis of transverse testicular ectopic testis associated with persistent mullerian duct syndrome.
Topics: Abnormalities, Multiple; Antitubercular Agents; Choristoma; Cryptorchidism; Drug Therapy, Combination; Hernia, Inguinal; Humans; Infant; Isoniazid; Male; Mullerian Ducts; Pyrazinamide; Rifampin; Syndrome; Testicular Diseases; Tuberculosis, Male Genital; Urologic Surgical Procedures, Male | 2008 |
A comparison of conventional and radiometric methods for the assessment of anti-tubercular activity of drugs against Mycobacterium tuberculosis in mice and macrophage models.
Topics: Animals; Antibiotics, Antitubercular; Bacteriological Techniques; Cells, Cultured; Colony Count, Microbial; Female; Humans; Isoniazid; Lung; Macrophages; Male; Mice; Microbial Sensitivity Tests; Morphine; Mycobacterium tuberculosis; Narcotics; Radiometry; Rifampin; Spleen | 2008 |
Psoriasiform lupus vulgaris.
Topics: Adolescent; Antitubercular Agents; Biopsy; Buttocks; Child; Disease Progression; Ethambutol; Female; Humans; Isoniazid; Lupus Vulgaris; Pyrazinamide; Pyridoxine; Rifampin; Tuberculin Test; Vitamin B Complex | 2008 |
Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.
Topics: Animals; Antigens, Bacterial; Antitubercular Agents; BCG Vaccine; Female; Guinea Pigs; Humans; Interferon-gamma; Isoniazid; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Rifampin; Specific Pathogen-Free Organisms; T-Lymphocytes; Time Factors; Treatment Outcome; Tuberculosis Vaccines; Tuberculosis, Pulmonary | 2008 |
Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation, Missense; Mycobacterium tuberculosis; Oxidoreductases; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2008 |
Spinal tuberculosis in pregnancy.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Labor, Induced; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Thoracic Vertebrae; Thoracotomy; Tuberculosis, Spinal | 2008 |
Diagnostic challenges of intestinal tuberculosis in a patient with chronic diarrhoea: case report.
Topics: Adult; Antitubercular Agents; Chronic Disease; Diarrhea; Ethambutol; Humans; Isoniazid; Laparotomy; Male; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 2008 |
One to make the diagnosis. A case of non tuberculous mycobacterial mastoiditis in a nine year old female.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Ethambutol; Female; Humans; Ireland; Isoniazid; Mastoiditis; Nontuberculous Mycobacteria; Pyrazinamide; Rifampin | 2008 |
[Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Protein Array Analysis; Reagent Kits, Diagnostic; Rifampin | 2008 |
Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; DNA Probes; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reproducibility of Results; Rifampin; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2009 |
Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Topics: Antitubercular Agents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Pyrimidines; Rifampin; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant; Xanthenes | 2008 |
Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2008 |
Long-term course and treatment of a cutaneous BCG infection.
Topics: Accidents, Occupational; Adult; Antitubercular Agents; BCG Vaccine; Ethambutol; Female; Humans; Isoniazid; Leg; Mycobacterium bovis; Rifampin; Treatment Outcome; Tuberculosis, Cutaneous; Wrist | 2008 |
Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations.
Topics: Administration, Oral; Antitubercular Agents; Delayed-Action Preparations; Drug Combinations; Isoniazid; Rifampin; Solubility; Tablets; Technology, Pharmaceutical | 2008 |
Genitourinary tuberculosis in pediatric urological practice.
Topics: Antibiotics, Antitubercular; Child; Drug Therapy, Combination; Education, Medical, Continuing; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pediatrics; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Urogenital; Urology | 2008 |
Impact of the interaction of R207910 with rifampin on the treatment of tuberculosis studied in the mouse model.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Diarylquinolines; Disease Models, Animal; Drug Interactions; Female; Humans; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Spleen; Tuberculosis, Pulmonary | 2008 |
Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Codon; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Polymerase Chain Reaction; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Turkey | 2008 |
Molecular characterization of drug-resistant mycobacterium tuberculosis isolates from Sichuan Province in china.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; China; Codon; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Rifampin | 2008 |
Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, Uganda.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antibodies, Bacterial; Bacterial Typing Techniques; Cross-Sectional Studies; Disease Outbreaks; Drug Resistance, Bacterial; Female; Genotype; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Prevalence; Rifampin; Sputum; Tuberculosis, Pulmonary; Uganda | 2008 |
Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nitroimidazoles; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 2008 |
Gynaecomastia during antituberculosis chemotherapy with isoniazid.
Topics: Adult; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gynecomastia; Humans; India; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 2008 |
Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean.
Topics: Antitubercular Agents; Caribbean Region; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 2008 |
Hoarseness due to Mycobacterium kansasii.
Topics: Antitubercular Agents; Drug Combinations; Hoarseness; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Vocal Cord Paralysis | 2009 |
Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates.
Topics: Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation, Missense; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA | 2009 |
Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoroquinolones; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Moxifloxacin; Pyrazinamide; Quinolines; Recurrence; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2008 |
Update on the treatment of tuberculosis.
Topics: Antitubercular Agents; Comorbidity; Directly Observed Therapy; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis | 2008 |
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Combined Modality Therapy; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Isoniazid; Korea; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Pneumonectomy; Pulmonary Surgical Procedures; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2009 |
GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples.
Topics: Antitubercular Agents; Bacteriological Techniques; DNA, Bacterial; Drug Resistance; Genotype; Germany; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis | 2008 |
Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Nigeria; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Measurement of the concentration of three antituberculosis drugs in the focus of spinal tuberculosis.
Topics: Adult; Antitubercular Agents; Biopsy; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sclerosis; Spine; Tomography, X-Ray Computed; Tuberculosis, Spinal; Young Adult | 2008 |
[Application of wavelet transform-radial basis function neural network in NIRS for determination of rifampicin and isoniazide tablets].
Topics: Isoniazid; Neural Networks, Computer; Rifampin; Spectroscopy, Near-Infrared; Tablets | 2008 |
Scapholunate dissociation: a rare presentation of TB wrist in a case of multi-focal skeletal tuberculosis.
Topics: Adolescent; Antitubercular Agents; Arthritis, Infectious; Arthrodesis; Carpal Joints; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lunate Bone; Pyrazinamide; Radiography; Range of Motion, Articular; Rifampin; Scaphoid Bone; Tuberculosis, Osteoarticular | 2008 |
An unusual case of a pleural effusion with an abdominal mass.
Topics: Adult; Antitubercular Agents; Drainage; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pleural Effusion; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Tuberculosis, Renal | 2008 |
[Susceptibility testing of Mycobacterium tuberculosis isolates to primary antituberculous drugs on chocolate agar: a preliminary study].
Topics: Agar; Antitubercular Agents; Coloring Agents; Culture Media; Erythrocytes; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Rosaniline Dyes; Streptomycin | 2008 |
[Sternal tuberculosis].
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Debridement; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Sternum; Tuberculosis, Osteoarticular | 2008 |
Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.
Topics: Antitubercular Agents; Bacterial Typing Techniques; Codon; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uzbekistan | 2009 |
Prostatic tuberculosis: case report.
Topics: Adult; Antitubercular Agents; Humans; Immunocompetence; Isoniazid; Male; Mycobacterium tuberculosis; Prostatic Diseases; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Male Genital | 2008 |
Chest wall abscess likely due to BCG vaccination in a child.
Topics: Abscess; Antitubercular Agents; BCG Vaccine; Female; Humans; Infant; Isoniazid; Mycobacterium Infections; Rifampin; Thoracic Wall; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Nodular granulomatous phlebitis: a phlebitic tuberculid.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Female; Granuloma; Humans; Isoniazid; Mycobacterium tuberculosis; Panniculitis; Phlebitis; Rifampin; Treatment Outcome; Tuberculosis, Cutaneous | 2008 |
Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation, Missense; Mycobacterium tuberculosis; Oxidoreductases; Point Mutation; Polymerase Chain Reaction; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2009 |
Postoperative Mycobacterium tuberculosis infection after total knee arthroplasty.
Topics: Aged; Antitubercular Agents; Arthroplasty, Replacement, Knee; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Taiwan; Tuberculosis, Osteoarticular | 2009 |
Tuberculosis in a patient on temozolomide: a case report.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antibiotics, Antitubercular; Anticholesteremic Agents; Anticonvulsants; Antineoplastic Agents, Alkylating; Atorvastatin; Brain Neoplasms; Combined Modality Therapy; Cyclosporine; Dacarbazine; Dexamethasone; Female; Fluoxetine; Glioblastoma; Heptanoic Acids; Humans; Immunosuppressive Agents; Isoniazid; Middle Aged; Omeprazole; Phenobarbital; Prednisone; Pyrazinamide; Pyrroles; Radiotherapy; Red-Cell Aplasia, Pure; Rifampin; Temozolomide; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary | 2009 |
[Application of near infrared spectroscopy in rapid and simultaneous determination of essential components in five varieties of anti-tuberculosis tablets].
Topics: Algorithms; Antitubercular Agents; Isoniazid; Models, Chemical; Principal Component Analysis; Pyrazinamide; Rifampin; Spectroscopy, Near-Infrared; Tablets | 2008 |
Tuberculous peritonitis after treatment with adalimumab.
Topics: Adalimumab; Aged; Antibiotics, Antitubercular; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Opportunistic Infections; Peritonitis, Tuberculous; Pyrazinamide; Rifampin | 2008 |
A 13-month-old with persistent right knee swelling.
Topics: Antitubercular Agents; Arthritis, Infectious; Arthritis, Juvenile; Diagnosis, Differential; Drug Therapy, Combination; Edema; Humans; Infant; Isoniazid; Knee; Knee Joint; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Synovial Fluid; Synovial Membrane; Tuberculosis, Osteoarticular | 2008 |
[Effectiveness and tolerance of antituberculosis treatment regimens without isoniazid and rifampicin: analysis of 85 cases].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2008 |
Mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent HIV infection in Mozambique.
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mozambique; Mycobacterium avium Complex; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA Probes; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Fluorescence Resonance Energy Transfer; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pakistan; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Effects of rifampin on CYP2E1-dependent hepatotoxicity of isoniazid in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Deoxyguanosine; Glutathione Transferase; Isoniazid; Liver; Male; Rats; Rats, Wistar; Rifampin | 2009 |
Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum | 2008 |
Needed: new and better tools to combat latent tuberculosis infection.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Humans; Isoniazid; Patient Compliance; Rifampin; Tuberculosis | 2008 |
Persistent pyrexia post-liver transplantation: a unique case of pericardial tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Fever; Glucocorticoids; Humans; Immunocompromised Host; Isoniazid; Liver Cirrhosis, Biliary; Liver Transplantation; Middle Aged; Mycobacterium tuberculosis; Pericardiocentesis; Pericarditis, Tuberculous; Prednisolone; Pyrazinamide; Rifampin; Treatment Outcome | 2008 |
Tuberculous liver abscess.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Liver Abscess; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Hepatic | 2008 |
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
Prevalence of tuberculosis drug resistance in 10 provinces of China.
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Reproducibility of Results; Rifampin; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2008 |
Gynecomastia: a rare adverse effect of isoniazid.
Topics: Adolescent; Antitubercular Agents; Diagnosis, Differential; Gynecomastia; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
[Pain, swelling, and progressive weakness of the left knee over 6 years].
Topics: Accidents, Traffic; Antitubercular Agents; Arthritis, Infectious; Disease Progression; Ethambutol; Humans; Isoniazid; Knee Injuries; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin | 2008 |
Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Recurrence; Retrospective Studies; Rifampin; Streptomycin | 2009 |
Tuberculosis incidence among contacts of active pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Brazil; Carrier State; Cohort Studies; Disease Transmission, Infectious; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Practice Guidelines as Topic; Predictive Value of Tests; Pyrazinamide; Retrospective Studies; Rifampin; Risk; Tuberculin Test; Tuberculosis, Pulmonary; Young Adult | 2009 |
Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid.
Topics: Antitubercular Agents; Bacterial Proteins; Biological Assay; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Predictive Value of Tests; Reproducibility of Results; Rifampin | 2009 |
[Distribution of mutations in the rpoB, katG, inhA, ahpC gene of rifampicin and isoniazid resistant M. tuberculosis strains isolated in Kyrgyz Republic].
Topics: Antibiotics, Antitubercular; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Kyrgyzstan; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Peroxidases; Rifampin; Tuberculosis, Pulmonary | 2008 |
Multifocal skeletal tuberculosis in children.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child, Preschool; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Protein Synthesis Inhibitors; Psoas Abscess; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Osteoarticular | 2009 |
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Point Mutation; Random Allocation; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis; Young Adult | 2009 |
Co-occurrence of intracerebral tuberculoma with lumbar intramedullary tuberculoma.
Topics: Antitubercular Agents; Brain; Child; Diagnosis, Differential; Edema; Female; Humans; Isoniazid; Lumbar Vertebrae; Magnetic Resonance Imaging; Rifampin; Spinal Cord; Spinal Diseases; Tomography, X-Ray Computed; Tuberculoma; Tuberculoma, Intracranial | 2009 |
[Drug-resistant pulmonary tuberculosis at the penitentiaries].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Prisoners; Rifampin; Russia; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
[A role of the HLA-DRB1* genotype in the complex therapy of pulmonary tuberculosis].
Topics: Alleles; Antibiotics, Antitubercular; Antitubercular Agents; Disease Progression; Drug Resistance, Bacterial; Follow-Up Studies; Genotype; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Isoniazid; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Pyrazinamide; Radiography; Rifabutin; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2008 |
[Cerebellar soap bubble lesions and mediastinal lymph nodes].
Topics: Adult; Antitubercular Agents; Brain Abscess; Cerebellar Diseases; Combined Modality Therapy; Craniotomy; Ethambutol; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Mediastinum; Pyrazinamide; Rifampin; Tuberculosis, Central Nervous System; Tuberculosis, Lymph Node | 2009 |
[Acute respiratory distress syndrome: a manifestation of immune reconstitution in an HIV-negative patient with tuberculosis].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Isoniazid; Leukocyte Count; Leukocytes; Prednisone; Pyrazinamide; Respiratory Distress Syndrome; Rifampin; Tuberculosis, Pulmonary | 2009 |
Latent tuberculosis infection in children: a call for revised treatment guidelines.
Topics: Adoption; Antitubercular Agents; Child, Preschool; Cost-Benefit Analysis; Decision Trees; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Emigrants and Immigrants; Health Care Costs; Humans; Indiana; Isoniazid; Microbial Sensitivity Tests; Practice Guidelines as Topic; Rifampin; Russia; Secondary Prevention; Tuberculin Test; Tuberculosis, Multidrug-Resistant | 2009 |
Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
Topics: Antitubercular Agents; Child; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Evidence-Based Medicine; Health Policy; Humans; Isoniazid; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
[Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis].
Topics: Adolescent; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Cycloserine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Pyrazinamide; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 2009 |
Influence of diabetes on liver injury induced by antitubercular drugs and on silymarin hepatoprotection in rats.
Topics: Animals; Antitubercular Agents; Bilirubin; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Experimental; Female; Isoniazid; Liver; Liver Diseases; Liver Function Tests; Male; Protective Agents; Pyrazinamide; Rats; Rats, Wistar; Rifampin; Silymarin; Streptozocin | 2008 |
Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprostatic Agents; Leprosy; Male; Malta; Program Evaluation; Prothionamide; Rifampin; Treatment Outcome | 2008 |
MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis.
Topics: Alkyl and Aryl Transferases; Bacterial Proteins; Benzophenones; Catalysis; Cell Proliferation; Dimethylallyltranstransferase; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Isoniazid; Microbial Viability; Molecular Structure; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Structure-Activity Relationship; Tuberculosis; Vitamin K 2 | 2009 |
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Topics: Adolescent; Aged; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Iran; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; National Health Programs; Population Surveillance; Referral and Consultation; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2009 |
Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Markov Chains; Rifampin; Tuberculosis | 2009 |
Late Mycobacterium bovis spondylitis after intravesical BCG therapy.
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Drug Therapy, Combination; Epidural Abscess; Ethambutol; Humans; Isoniazid; Lumbar Vertebrae; Male; Mycobacterium bovis; Osteolysis; Osteomyelitis; Rifampin; Spinal Fusion; Treatment Outcome; Tuberculosis, Spinal | 2009 |
Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Cambodia; HIV Infections; HIV Seropositivity; HIV-1; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Coccidioides immitis and Mycobacterium tuberculosis diagnosed by endoscopic ultrasound.
Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Antitubercular Agents; Coccidioides; Coccidioidomycosis; Endosonography; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Itraconazole; Lymph Nodes; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
[Practical value of the TB-biochip MDR test system in the rapid identification of multidrug-resistant M. tuberculosis strains].
Topics: Amino Acid Substitution; Antibiotics, Antitubercular; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mutation, Missense; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Rifampin; Tuberculosis, Pulmonary | 2009 |
[Cervical tuberculous lymphadenitis: the location of surgery].
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Combined Modality Therapy; Diagnosis, Differential; Drug Combinations; Female; Humans; Isoniazid; Male; Neck; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Lymph Node | 2009 |
Presumed ocular tuberculosis in an immunocompetent eight-year-old boy.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Granulomatous Disease, Chronic; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Ocular; Uveitis, Anterior | 2009 |
Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Retroviral Agents; Cohort Studies; Drug Monitoring; Drug Therapy, Combination; Feasibility Studies; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifabutin; Rifampin; Tuberculosis | 2009 |
Isoniazid induced gynaecomastia: a case report.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gynecomastia; Humans; Isoniazid; Male; Mammography; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2009 |
[Fever and thin-walled cavitary lung lesions].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pyrazinamide; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 2009 |
Thai drug-resistant tuberculosis predictive scores.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Algorithms; Antitubercular Agents; Cross-Sectional Studies; Female; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Risk Factors; Thailand; Tuberculosis, Multidrug-Resistant | 2009 |
Bactericidal activity of moxifloxacin on exponential and stationary phase cultures of Mycobacterium tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Cells, Cultured; Drug Therapy, Combination; Fluoroquinolones; Isoniazid; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Serum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
[Primary tuberculosis of the tongue].
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tongue Diseases; Tuberculosis | 2009 |
A tumor-like manifestation of extrapulmonary tuberculosis in a hemodialysis patient.
Topics: Diabetic Nephropathies; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Renal Dialysis; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Hepatic | 2009 |
In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv.
Topics: Amidohydrolases; Animals; Antibiotics, Antitubercular; Dipeptides; Drug Synergism; Drug Therapy, Combination; Hydroxamic Acids; Hydroxylamine; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Phenanthrolines; Protease Inhibitors; Rifampin; Tuberculosis | 2009 |
Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Mutation, Missense; Mycobacterium tuberculosis; Ontario; Oxidoreductases; Point Mutation; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2009 |
Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Cloning, Molecular; Fluoroquinolones; Gene Expression Regulation, Bacterial; Isoniazid; Isopropyl Thiogalactoside; Kinetics; Mycobacterium; Mycobacterium tuberculosis; Oligonucleotides, Antisense; Plasmids; Repressor Proteins; Rifampin | 2009 |
A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in central massachusetts.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Female; Humans; Isoniazid; Liver; Male; Massachusetts; Middle Aged; Patient Compliance; Rifampin; Treatment Outcome; Tuberculosis; Young Adult | 2009 |
Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Agar; Antitubercular Agents; Chi-Square Distribution; Child; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Radiometry; Regression Analysis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Turkey | 2009 |
Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay.
Topics: Adult; Antitubercular Agents; Area Under Curve; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Female; Humans; Interferon-gamma; Isoniazid; Lung; Male; Middle Aged; Predictive Value of Tests; Pyrazinamide; Radiography; Reagent Kits, Diagnostic; Retrospective Studies; Rifampin; ROC Curve; Sensitivity and Specificity; Tuberculin Test; Tuberculosis, Ocular; Uveitis | 2009 |
Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Inhibins; Isoniazid; Mutation; Mycobacterium tuberculosis; Point Mutation; Rifampin; Selection, Genetic; Sequence Deletion | 2009 |
Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.
Topics: Animals; Antitubercular Agents; Diarylquinolines; Disease Models, Animal; Drug Therapy, Combination; Female; Hydrolases; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Splenic | 2009 |
Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Azithromycin; Child, Preschool; Combined Modality Therapy; Contact Tracing; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Ethambutol; Fever of Unknown Origin; Humans; Immunocompromised Host; Isoniazid; Lymphopenia; Male; Mycobacterium tuberculosis; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Vincristine | 2009 |
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2009 |
[Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 2009 |
[Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Topics: Acetamides; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Isoniazid; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Rifampin; Tuberculosis, Multidrug-Resistant | 2009 |
Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates in Guangdong, China.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation, Missense; Mycobacterium tuberculosis; Ribosomal Proteins; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2009 |
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2009 |
Renal and miliary tuberculosis in an internationally adopted infant.
Topics: Adoption; Antitubercular Agents; Developing Countries; Ethiopia; Humans; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Miliary; Tuberculosis, Renal; United States | 2009 |
Serum concentrations of rifampin, isoniazid, and intestinal absorption, permeability in patients with multidrug resistant tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Odds Ratio; Permeability; Rifampin; Therapeutic Equivalency; Tuberculosis, Multidrug-Resistant; Young Adult | 2009 |
British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.
Topics: Adenosine Deaminase; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Cerebrospinal Fluid; Child; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spinal Puncture; Tuberculin Test; Tuberculoma, Intracranial; Tuberculosis, Meningeal; Tuberculosis, Spinal | 2009 |
Penitentiary population of Mycobacterium tuberculosis in Kyrgyzstan: exceptionally high prevalence of the Beijing genotype and its Russia-specific subtype.
Topics: Adult; Antibiotics, Antitubercular; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genetic Variation; Genome, Bacterial; Humans; Isoniazid; Kyrgyzstan; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Prisoners; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Too much of a good thing: management of BCG vaccine overdose.
Topics: Adolescent; Antitubercular Agents; BCG Vaccine; Dermatologic Surgical Procedures; Drug Overdose; Female; Humans; Isoniazid; Rifampin; Skin | 2009 |
Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
Topics: Adolescent; Adult; Antitubercular Agents; Cohort Studies; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Mycobacterium tuberculosis; New York City; Regression Analysis; Retrospective Studies; Rifampin; Young Adult | 2010 |
Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Proportional Hazards Models; Pyrazinamide; Retrospective Studies; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
Urinary Mycobacterium szulgai infection in an immunocompetent patient.
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Immunocompetence; Isoniazid; Levofloxacin; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Rifampin; Urinary Tract Infections | 2009 |
A pyrosequencing method for molecular monitoring of regions in the inhA, ahpC and rpoB genes of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis | 2010 |
Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis.
Topics: Acquired Immunodeficiency Syndrome; Analysis of Variance; beta 2-Microglobulin; Biomarkers; CD4-Positive T-Lymphocytes; Cell Count; Enzyme-Linked Immunosorbent Assay; Ethambutol; Humans; India; Isoniazid; Neopterin; Pyrazinamide; Receptors, Tumor Necrosis Factor, Type I; Rifampin; Tuberculosis | 2009 |
Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity.
Topics: Animals; Antitubercular Agents; Diagnostic Imaging; Disease Models, Animal; Humans; Isoniazid; Luciferases; Luminescent Measurements; Mice; Mycobacterium bovis; Rifampin; Treatment Outcome; Tuberculosis | 2009 |
LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
Topics: Administration, Oral; Animals; Antibiotics, Antitubercular; Calibration; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Stability; Hydrazones; Isoniazid; Mass Spectrometry; Molecular Structure; Quality Control; Rats; Rats, Sprague-Dawley; Reference Standards; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2010 |
[Modulatory effect of isoniazid and rifampicin in vitro on cytokine secretion in pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Cytokines; Female; Follow-Up Studies; Humans; Isoniazid; Leukocytes, Mononuclear; Male; Middle Aged; Prognosis; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2009 |
Carry on doctor.
Topics: Adolescent; Antibiotics, Antitubercular; Female; Humans; Isoniazid; Lung; Radiography; Rifampin; Thrombocytopenia; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; Catalase; Cluster Analysis; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation, Missense; Myanmar; Mycobacterium tuberculosis; Oxidoreductases; Point Mutation; Polymorphism, Restriction Fragment Length; Promoter Regions, Genetic; Rifampin; Sequence Analysis, DNA; Tuberculosis | 2009 |
Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.
Topics: Antitubercular Agents; Burkina Faso; DNA Mutational Analysis; DNA, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2009 |
Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan.
Topics: Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Observer Variation; Predictive Value of Tests; Quality Assurance, Health Care; Quality Control; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant | 2009 |
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Topics: Antitubercular Agents; Bacteriological Techniques; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; India; Isoniazid; Kanamycin; Male; Microscopy, Fluorescence; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Prevalence; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2009 |
Pharmacokinetic interaction of some antitubercular drugs with caraway: implications in the enhancement of drug bioavailability.
Topics: Animals; Antitubercular Agents; Area Under Curve; Biological Availability; Carum; Chromatography, High Pressure Liquid; Drug Interactions; Female; Intestinal Absorption; Intestinal Mucosa; Isoniazid; Jejunum; Male; Plant Extracts; Pyrazinamide; Rats; Rats, Wistar; Reference Standards; Rifampin; Seeds; Solvents | 2009 |
Experimental ocular tuberculosis in guinea pigs.
Topics: Aerosols; Animals; Antitubercular Agents; Disease Models, Animal; DNA, Bacterial; Guinea Pigs; Isoniazid; Lung; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Spleen; Tuberculosis, Ocular; Tuberculosis, Pulmonary | 2009 |
Anti-tubercular activity of eleven aromatic and medicinal plants occurring in Colombia.
Topics: Achyrocline; Antitubercular Agents; Colombia; Drug Discovery; Drug Evaluation, Preclinical; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phytotherapy; Plant Oils; Plants, Medicinal; Rifampin; Rutaceae | 2009 |
An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia.
Topics: Bacterial Typing Techniques; Bacteriological Techniques; Communicable Disease Control; Cost-Benefit Analysis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Rifampin; Risk Factors; Russia; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2009 |
Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Laboratories; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Assurance, Health Care; Rifampin; Russia; World Health Organization | 2009 |
[Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiometry; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin | 2009 |
Evaluation of direct method of drug susceptibility testing of Mycobacterium tuberculosis to rifampicin and isoniazid by nitrate reductase assay in a national reference laboratory.
Topics: Antitubercular Agents; Colorimetry; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis | 2010 |
Polymorphic exact tandem repeat A (PETRA): a newly defined lineage of mycobacterium tuberculosis in israel originating predominantly in Sub-Saharan Africa.
Topics: Africa South of the Sahara; Antitubercular Agents; Bacterial Typing Techniques; Computational Biology; Electrophoresis, Capillary; Humans; Interspersed Repetitive Sequences; Isoniazid; Israel; Microbial Sensitivity Tests; Minisatellite Repeats; Molecular Epidemiology; Mycobacterium tuberculosis; Oligonucleotides; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Rifampin; Species Specificity; Tuberculosis, Pulmonary | 2009 |
Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Fluoroquinolones; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Rifampin; Sequence Analysis, DNA; Time Factors | 2009 |
[Relapse rate of tuberculosis treated with standard regimen of chemotherapy].
Topics: Adolescent; Aged; Aged, 80 and over; Child; Diabetes Complications; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 2009 |
A mathematical approach for the simultaneous in vitro spectrophotometric analysis of rifampicin and isoniazid from modified-release anti-TB drug delivery systems.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Colorimetry; Drug Delivery Systems; Electrophoresis, Capillary; In Vitro Techniques; Isoniazid; Rifampin; Spectrophotometry, Ultraviolet | 2010 |
Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Republic of Korea; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA | 2009 |
Entrapment of multiple anti-Tb drugs in microemulsion system: quantitative analysis, stability, and in vitro release studies.
Topics: Antitubercular Agents; Drug Stability; Emulsions; Excipients; Isoniazid; Magnetic Resonance Spectroscopy; Models, Molecular; Pyrazinamide; Rifampin; Solubility; Viscosity | 2010 |
A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy.
Topics: Animals; Antitubercular Agents; Cell Proliferation; Drug Delivery Systems; Drug Implants; Equipment Design; Isoniazid; Male; Mesenchymal Stem Cells; Microscopy, Phase-Contrast; Powders; Rabbits; Rifampin; Tuberculosis, Osteoarticular | 2009 |
[Macular tuberculoma and optic neuritis: rare association with tuberculosis meningoencephalitis].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antitubercular Agents; Calcinosis; Confusion; Diplopia; Drug Therapy, Combination; Fever; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Meningoencephalitis; Middle Aged; Optic Neuritis; Papilledema; Pyrazinamide; Rifampin; Spinal Puncture; Streptomycin; Tuberculoma; Tuberculosis, Meningeal; Ultrasonography | 2009 |
A short-term model for preliminary screening of potential anti-tubercular compounds.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Drug Discovery; Female; Fluoroquinolones; Gatifloxacin; Isoniazid; Lung; Male; Mice; Mycobacterium Infections; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rifampin; Spleen | 2009 |
Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ethambutol; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Ionophores; Isoniazid; Membrane Transport Proteins; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Rifampin; Streptomycin; Stress, Physiological; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
[Diagnostic image. A man with a swelling under his jaw].
Topics: Aged; BCG Vaccine; Carcinoma; Humans; Isoniazid; Lymph Nodes; Male; Rifampin; Treatment Outcome; Tuberculosis; Urinary Bladder Neoplasms | 2009 |
Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study.
Topics: Antitubercular Agents; Bacterial Proteins; China; Codon; Directly Observed Therapy; DNA-Directed RNA Polymerases; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Rifampin; Rural Population; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2010 |
In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oleanolic Acid; Rifampin; Tuberculosis | 2010 |
Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.
Topics: Adolescent; Adult; Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; Catalase; Child; Child, Preschool; Denmark; DNA Fingerprinting; DNA Mutational Analysis; DNA-Directed RNA Polymerases; DNA, Bacterial; Female; Humans; Incidence; Isoniazid; Male; Mycobacterium tuberculosis; Oxidoreductases; Polymorphism, Restriction Fragment Length; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2010 |
Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Cameroon; Child; Confidence Intervals; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.
Topics: Antitubercular Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Tween-embedded microemulsions--physicochemical and spectroscopic analysis for antitubercular drugs.
Topics: Antitubercular Agents; Chemistry, Pharmaceutical; Isoniazid; Kinetics; Magnetic Resonance Spectroscopy; Oleic Acid; Particle Size; Polysorbates; Pyrazinamide; Rifampin; Solubility; Spectrum Analysis; Surface-Active Agents; Viscosity | 2010 |
Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Female; Humans; Immunocompromised Host; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Practice Guidelines as Topic; Retrospective Studies; Rheumatic Diseases; Rifampin; Risk Factors; Severity of Illness Index; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2010 |
Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Female; Guinea Pigs; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2010 |
Tuberculous uveitis.
Topics: Antitubercular Agents; Area Under Curve; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Humans; Interferon-gamma; Isoniazid; Lung; Predictive Value of Tests; Pyrazinamide; Radiography; Reagent Kits, Diagnostic; Rifampin; ROC Curve; Sensitivity and Specificity; Tuberculin Test; Tuberculosis, Ocular; Uveitis | 2010 |
Simultaneous scrofuloderma and intracranial tuberculomas: a rare presentation of systemic tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; Brain; Diagnosis, Differential; Drug Therapy, Combination; Fluoroquinolones; Humans; Isoniazid; Lichenoid Eruptions; Male; Middle Aged; Moxifloxacin; Pyrazinamide; Quinolines; Rifampin; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Cutaneous | 2010 |
Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.
Topics: Animals; Animals, Outbred Strains; Antitubercular Agents; Biomarkers; CD8-Positive T-Lymphocytes; Disease Models, Animal; Drug Therapy, Combination; Female; Flow Cytometry; Forkhead Transcription Factors; Guinea Pigs; Interleukin-10; Isoniazid; Leukocyte Common Antigens; Lung; Lymph Nodes; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Th1 Cells; Tuberculosis, Pulmonary | 2010 |
Rapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymorphism, Genetic; Promoter Regions, Genetic; Rifampin; Sensitivity and Specificity; Transition Temperature | 2010 |
Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapy.
Topics: Animals; Antimalarials; Drug Therapy, Combination; Ethambutol; Isoniazid; Malaria; Mice; Plasmodium berghei; Rifampin; Survival Analysis; Treatment Outcome | 2010 |
Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Predictive Value of Tests; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Sputum; Time Factors; Tuberculosis, Multidrug-Resistant; Uganda | 2010 |
Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Case-Control Studies; Female; Humans; Intestinal Absorption; Isoniazid; Male; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2009 |
Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Female; Hepatitis E; Humans; India; Isoniazid; Liver Failure, Acute; Male; Middle Aged; Prognosis; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome | 2010 |
Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Animals; Antitubercular Agents; Child; Clinical Laboratory Techniques; Drug Monitoring; Female; Follow-Up Studies; Humans; Immunoassay; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Mycobacterium tuberculosis; Radiography, Thoracic; Rifampin; Risk Factors; Sputum; Surveys and Questionnaires; Young Adult | 2010 |
Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Retreatment; Rifampin; Risk Factors; South Africa; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2010 |
Rapid diagnosis of tuberculous pericarditis by ELISPOT assay.
Topics: Aged, 80 and over; Antitubercular Agents; Drug Combinations; Enzyme-Linked Immunospot Assay; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pericardial Effusion; Pericarditis, Tuberculous; Pyrazinamide; Rifampin; T-Lymphocytes | 2010 |
Incision infection with Mycobacterium tuberculosis after total hip arthroplasty without any primary tuberculosis focus.
Topics: Arthroplasty, Replacement, Hip; Drug Therapy, Combination; Ethambutol; Female; Hip Dislocation, Congenital; Hip Prosthesis; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Prosthesis-Related Infections; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2011 |
Therapeutic potential of peptide deformylase inhibitors against experimental tuberculosis.
Topics: Amidohydrolases; Analysis of Variance; Animals; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Enzyme Inhibitors; Hydroxamic Acids; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2010 |
Isoniazid-resistant tuberculosis in Denmark: mutations, transmission and treatment outcome.
Topics: Adult; Antibiotics, Antitubercular; Denmark; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Mutation; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis | 2010 |
Predicting outcomes and drug resistance with standardised treatment of active tuberculosis.
Topics: Cohort Studies; Communicable Disease Control; Drug Resistance, Bacterial; Global Health; HIV Infections; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2010 |
[Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2010 |
Dysuria: don't take it lightly.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Dysuria; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Female Genital; Tuberculosis, Renal; Urine | 2011 |
Nasolacrimal tuberculosis: case report highlighting the need for imaging in identifying and managing it effectively.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Endoscopy; Ethambutol; Female; Humans; Isoniazid; Lacrimal Apparatus Diseases; Nasolacrimal Duct; Pyrazinamide; Pyridoxine; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Ocular | 2010 |
Advanced shoulder joint tuberculosis treated with débridement and closed continuous irrigation and suction: a report of 2 cases.
Topics: Antitubercular Agents; Debridement; Drug Therapy, Combination; Ethambutol; Exercise Therapy; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Range of Motion, Articular; Rifampin; Shoulder Joint; Suction; Therapeutic Irrigation; Treatment Outcome; Tuberculosis, Osteoarticular | 2010 |
Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered.
Topics: Antitubercular Agents; Communicable Disease Control; Global Health; Humans; Isoniazid; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant | 2010 |
Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats.
Topics: Animals; Antioxidants; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Glutathione; Guanidines; Isoniazid; Lipid Peroxidation; Liver; Liver Function Tests; Male; Nitric Oxide; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Rifampin; Thioctic Acid | 2010 |
Tuberculous uveitis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Humans; Interferon-gamma; Isoniazid; Lung; Predictive Value of Tests; Pyrazinamide; Radiography; Rifampin; ROC Curve; Sensitivity and Specificity; Tuberculin Test; Tuberculosis, Ocular; Uveitis | 2010 |
Pregnancy during TNFalpha antagonist therapy: beware the rifampin-oral contraceptive interaction. Report of two cases.
Topics: Adult; Antirheumatic Agents; Antitubercular Agents; Contraceptives, Oral; Drug Interactions; Female; Humans; Immunocompromised Host; Isoniazid; Pregnancy; Rifampin; Spondylitis, Ankylosing; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2010 |
[Resistance rates to major anti-tuberculosis drugs in Mycobacterium tuberculosis strains isolated from seven different regions of Turkey in 2003-2006 period].
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Turkey | 2010 |
Female extrapulmonary genital tuberculosis: full-term deliveries after 4 years of follow-up.
Topics: Abdominal Pain; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Laparoscopy; Pregnancy; Pregnancy Outcome; Rifampin; Tuberculosis, Female Genital | 2010 |
A survey of prescribing pattern for osteoarticular tuberculosis: orthopaedic surgeons' and infectious disease experts' perspective.
Topics: Antitubercular Agents; Congresses as Topic; Ethambutol; Humans; Infectious Disease Medicine; Isoniazid; Ofloxacin; Orthopedics; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Streptomycin; Surveys and Questionnaires; Tuberculosis, Osteoarticular | 2009 |
Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand.
Topics: Antitubercular Agents; Bacteriological Techniques; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Thailand; Time Factors; Tuberculosis, Multidrug-Resistant | 2010 |
Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA Mutational Analysis; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidoreductases; Polymerase Chain Reaction; Rifampin; Sequence Analysis, DNA; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifampin; Sensitivity and Specificity; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2011 |
Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Vietnam | 2010 |
Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children.
Topics: Adolescent; Antitubercular Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; England; Follow-Up Studies; Humans; Infant; Isoniazid; Latent Tuberculosis; Rifampin; Treatment Outcome; Tuberculosis | 2010 |
Pott's disease with scrofuloderma and psoas abscess misdiagnosed and treated as hidradenitis suppurativa.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Diagnostic Errors; Ethambutol; Hidradenitis Suppurativa; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Psoas Abscess; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Spinal | 2011 |
Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana.
Topics: Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Bacterial; Ghana; Humans; Isoniazid; Mutation; Mycobacterium; Rifampin; Sequence Analysis, DNA; Tuberculosis | 2010 |
[Onset of neurological symptoms during tuberculosis treatment: description of two cases].
Topics: Adult; Aged, 80 and over; Antitubercular Agents; Aphasia; Child, Preschool; Drug Therapy, Combination; Dystonia; Ethambutol; Facial Pain; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Nigeria; Prednisone; Pyrazinamide; Reflex, Abnormal; Rifampin; Tremor; Tuberculoma; Tuberculosis, Meningeal; Tuberculosis, Miliary | 2010 |
Inconsistent dosing of anti-tuberculosis drugs in Taipei, Taiwan.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Isoniazid; Male; Medical Audit; Middle Aged; National Health Programs; Practice Patterns, Physicians'; Rifampin; Taiwan; Tuberculosis; Young Adult | 2010 |
Evaluation of seven tests for the rapid detection of multidrug-resistant tuberculosis in Uganda.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant; Uganda | 2010 |
[Treatment of tuberculous infection: Where we are?].
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Tuberculosis | 2010 |
The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Autopsy; Drug Resistance, Bacterial; Female; HIV; HIV Seropositivity; Hospitals; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant; Young Adult | 2010 |
[A 95 year old woman with bilateral nodular pulmonary pattern].
Topics: Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Dyspnea; Emergencies; Fatal Outcome; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2012 |
Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
Topics: Antitubercular Agents; British Columbia; Ethambutol; Female; Humans; Isoniazid; Longitudinal Studies; Male; Middle Aged; Pyrazinamide; Quality of Life; Retrospective Studies; Rifampin; Sickness Impact Profile; Tuberculosis, Pulmonary | 2010 |
The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2010 |
Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Emigrants and Immigrants; Female; Greece; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; National Health Programs; Population Surveillance; Prevalence; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
High incidence of intolerance to tuberculosis chemoprophylaxis.
Topics: Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chemoprevention; Female; Gastrointestinal Diseases; Humans; Incidence; Isoniazid; Latent Tuberculosis; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Retrospective Studies; Rheumatic Diseases; Rifampin; Risk Factors; Tumor Necrosis Factor-alpha | 2012 |
Simultaneous determination of isoniazid, rifampicin, levofloxacin in mouse tissues and plasma by high performance liquid chromatography-tandem mass spectrometry.
Topics: Animals; Antibiotics, Antitubercular; Brain Chemistry; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Gatifloxacin; Intestine, Small; Isoniazid; Kidney; Least-Squares Analysis; Levofloxacin; Liver; Lung; Male; Methanol; Mice; Ofloxacin; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tissue Distribution | 2010 |
[Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Poland; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; Fluoroquinolones; Isoniazid; Meropenem; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Quinolines; Rifampin; Streptomycin; Thienamycins | 2010 |
Mediastina Tuberculosis mass in a three-month-old boy.
Topics: Adrenal Cortex Hormones; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Infant; Isoniazid; Magnetic Resonance Imaging; Male; Mediastinal Diseases; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2010 |
Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007.
Topics: Adolescent; Adult; Antitubercular Agents; Bacterial Proteins; California; Catalase; Cluster Analysis; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Genotype; Humans; Isoniazid; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Mycobacterium tuberculosis; Point Mutation; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2010 |
[Three-month course of rifampicin and isoniazid for the treatment of latent tuberculous infection].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Prospective Studies; Rifampin; Time Factors; Young Adult | 2010 |
A nodulo-ulcerative lesion on the nose.
Topics: Aged, 80 and over; Antitubercular Agents; Chronic Disease; Ethambutol; Female; Humans; Isoniazid; Lupus Vulgaris; Mycobacterium tuberculosis; Nose Diseases; Pyrazinamide; Rifampin; Skin Ulcer; Treatment Outcome; Tuberculosis, Pulmonary | 2010 |
High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Codon; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Transition Temperature; Tuberculosis | 2010 |
Scrofula.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Sentinel Lymph Node Biopsy; Tuberculosis, Lymph Node | 2010 |
[A case of tuberculous pleurisy with transient new intra-pulmonary lesions during anti-tuberculosis therapy].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Lung; Male; Pyrazinamide; Rifampin; Tuberculosis, Pleural; Young Adult | 2010 |
[Culture and susceptibility testing of mycobacteria with VersaTREK].
Topics: Algorithms; Antitubercular Agents; Automation; Bacteriological Techniques; Culture Media; Ethambutol; Humans; Isoniazid; Manometry; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Staining and Labeling; Streptomycin; Time Factors | 2011 |
[Exposure of a cohort of newborn infants to tuberculosis in a neonatology service].
Topics: Antitubercular Agents; Humans; Infant, Newborn; Infant, Newborn, Diseases; Isoniazid; Nursing Staff, Hospital; Practice Guidelines as Topic; Rifampin; Risk Assessment; Tuberculosis | 2010 |
Application of genotype MTBDRplus in rapid detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin in a high volume laboratory in Southern China.
Topics: Antitubercular Agents; Base Pairing; China; Clinical Laboratory Techniques; DNA Probes; Drug Resistance, Multiple, Bacterial; Electrophoresis, Agar Gel; Genes, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.
Topics: Binding Sites; Heme; Humans; Isoniazid; Models, Molecular; Peroxynitrous Acid; Rifampin; Serum Albumin; Structure-Activity Relationship | 2011 |
Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cohort Studies; Drug Monitoring; Ethambutol; Female; Government Programs; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Virginia; Young Adult | 2010 |
Granulomatous lesion on the face successfully treated with antitubercular therapy.
Topics: Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Facial Dermatoses; Female; Granuloma; Humans; Isoniazid; Mycobacterium Infections; Pyrazinamide; Rifampin; Skin Diseases, Bacterial | 2010 |
Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Disease Progression; Drug Therapy, Combination; Female; France; Graft Rejection; Humans; Isoniazid; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Remission, Spontaneous; Rifampin; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tuberculosis; Young Adult | 2010 |
Rifampin-isoniazid oligonucleotide typing: an alternative format for rapid detection of multidrug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Bacteriological Techniques; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Oligonucleotides; Oxidoreductases; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2010 |
The use of the QuantiFERON-tuberculosis gold test in the diagnosis of ocular tuberculosis.
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Fluorescein Angiography; Humans; Interferon-gamma Release Tests; Isoniazid; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Ocular; Vision Disorders | 2010 |
Anterior segment optical coherence tomography findings of presumed intraocular tuberculosis.
Topics: Aged; Anterior Eye Segment; Antitubercular Agents; Cataract Extraction; Corneal Edema; Drug Therapy, Combination; Eye Diseases; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tomography, Optical Coherence; Treatment Outcome; Tuberculosis | 2011 |
Hepatoprotection by carotenoids in isoniazid-rifampicin induced hepatic injury in rats.
Topics: Alkaline Phosphatase; Animals; Antioxidants; Carotenoids; Catalase; Cells, Cultured; Chemical and Drug Induced Liver Injury; Glutathione; Isoniazid; Lipid Peroxidation; Liver; Oxidative Stress; Rats; Rats, Wistar; Rifampin; Superoxide Dismutase | 2010 |
[Urinary bladder tuberculosis and Bacillus Calmette-Guérin instillation: reduced efficacy of bisoprolol in hypertension].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antihypertensive Agents; Antitubercular Agents; BCG Vaccine; Bisoprolol; Blood Pressure; Carcinoma, Transitional Cell; Cardiac Complexes, Premature; Combined Modality Therapy; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Enzyme Induction; Ethambutol; Humans; Isoniazid; Male; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Rifampin; Tuberculosis, Urogenital; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 2010 |
[Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Hospitals, University; Humans; Immunocompromised Host; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Senegal; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
Interferon-γ release assay for tuberculosis screening of healthcare workers at a Korean tertiary hospital.
Topics: Adult; Antitubercular Agents; Female; Health Personnel; Hospitals; Humans; Immunoassay; Incidence; Interferons; Isoniazid; Male; Mass Screening; Republic of Korea; Rifampin; Treatment Outcome; Tuberculosis | 2010 |
Risk of relapse and failure after retreatment with the Category II regimen in Nepal.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Cohort Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Nepal; Recurrence; Retreatment; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2010 |
Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2010 |
MODS accreditation process for regional reference laboratories in Peru: validation by GenoType® MTBDRplus.
Topics: Accreditation; Antitubercular Agents; Bacteriological Techniques; Humans; Isoniazid; Laboratories; Microbial Sensitivity Tests; Mycobacterium; Peru; Quality Assurance, Health Care; Reference Standards; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
A relook at preventive therapy for tuberculosis in children.
Topics: Antitubercular Agents; Breast Feeding; Child; Child, Preschool; Female; Humans; Infant, Newborn; Isoniazid; Pregnancy; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2011 |
[Performances of the assay MTBDRplus(®) in the surveillance of rifampicin resistance in Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Bacterial Proteins; Codon; Data Collection; Djibouti; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; France; Genotype; Isoniazid; Mutation, Missense; Mycobacterium tuberculosis; Oxidoreductases; Point Mutation; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Thailand; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2011 |
Simultaneous determination of isoniazid, pyrazinamide, rifampicin and acetylisoniazid in human plasma by high-performance liquid chromatography.
Topics: Calibration; Chromatography, High Pressure Liquid; Humans; Isoniazid; Pyrazinamide; Rifampin; Sensitivity and Specificity | 2010 |
Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Comorbidity; Cross-Sectional Studies; Epidemics; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Multivariate Analysis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2010 |
Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2011 |
Utility of Microscopic Observation of Drug Susceptibility (MODS) assay for Mycobacterium tuberculosis in resource constrained settings.
Topics: Antitubercular Agents; Developing Countries; Humans; India; Isoniazid; Microbial Sensitivity Tests; Prospective Studies; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2010 |
Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Hospitals; Humans; Isoniazid; Male; Meningoencephalitis; Middle Aged; Peru; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2011 |
A mesoporous silica nanoparticulate/β-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapy.
Topics: Animals; Antitubercular Agents; Biocompatible Materials; Calcium Phosphates; Cell Line; Drug Delivery Systems; Isoniazid; Kidney; Liver; Mice; Mycobacterium tuberculosis; Nanocomposites; Nanoparticles; Porosity; Rabbits; Rifampin; Silicon Dioxide | 2011 |
Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutation, Missense; Myanmar; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2011 |
A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Desensitization, Immunologic; Ethambutol; Female; Humans; Isoniazid; Lymphocyte Activation; Middle Aged; Pyrazinamide; Radiography; Retreatment; Rifampin; Tuberculosis, Pleural | 2011 |
Simultaneous identification of mycobacterial isolates to the species level and determination of tuberculosis drug resistance by PCR followed by electrospray ionization mass spectrometry.
Topics: Antitubercular Agents; Bacteriological Techniques; DNA Primers; Drug Resistance, Bacterial; Georgia (Republic); Humans; Isoniazid; Mycobacterium; New York City; Polymerase Chain Reaction; Rifampin; South Africa; Spectrometry, Mass, Electrospray Ionization; Tuberculosis, Multidrug-Resistant | 2011 |
Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480.
Topics: Acetamides; Antitubercular Agents; Ethambutol; Isoniazid; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2011 |
Reliability of the MODS assay decentralisation process in three health regions in Peru.
Topics: Accreditation; Antitubercular Agents; Clinical Laboratory Techniques; Humans; Isoniazid; Microbial Sensitivity Tests; Microscopy; Mycobacterium tuberculosis; Observer Variation; Peru; Predictive Value of Tests; Regional Health Planning; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2011 |
Adverse events associated with treatment of latent tuberculosis in the general population.
Topics: Adult; Age Distribution; Aged; Antitubercular Agents; Case-Control Studies; Chemical and Drug Induced Liver Injury; Comorbidity; Female; Humans; Isoniazid; Latent Tuberculosis; Logistic Models; Male; Middle Aged; Patient Admission; Quebec; Retrospective Studies; Rifampin; Risk Assessment | 2011 |
Rapid molecular detection of tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
Topics: Antitubercular Agents; Bacterial Proteins; Bacteriological Techniques; Catalase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Kuwait; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Predictive Value of Tests; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Location of anti-TB drugs and microstructural changes in organized surfactant media using optical properties.
Topics: Antitubercular Agents; Emulsions; Isoniazid; Polysorbates; Pyrazinamide; Pyrenes; Rifampin; Solubility; Surface-Active Agents | 2011 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
Distribution of three antituberculous drugs and their metabolites in different parts of pathological vertebrae with spinal tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Orthopedic Procedures; Pyrazinamide; Radiography; Rifampin; Spine; Tuberculosis, Spinal; Young Adult | 2011 |
Drug resistance among Mycobacterium tuberculosis isolates from private clinics and a dots center in Delhi, India.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2011 |
Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.
Topics: Animals; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cortisone; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Mice, Nude; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Secondary Prevention; Time Factors; Tuberculosis, Pulmonary | 2011 |
Mycobacteria infection in incomplete transverse myelitis is refractory to steroids: a pilot study.
Topics: Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Myelitis, Transverse; Pilot Projects; Prospective Studies; Pyrazinamide; Rifampin; Spinal Cord; Tuberculosis | 2011 |
Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Follow-Up Studies; France; Humans; Infant; Isoniazid; Retrospective Studies; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
[Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Respiratory System; Rifampin; Streptomycin; Tuberculosis; Turkey | 2011 |
Photoclinic. Cutaneous tuberculosis.
Topics: Abscess; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Skin Ulcer; Tuberculosis, Cutaneous | 2011 |
[Susceptibility of M. tuberculosis to antituberculosis drugs as determined by two methods, in Sucre state, Venezuela].
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Sequence Data; Morbidity; Mutation, Missense; Mycobacterium tuberculosis; Nitrate Reductase; Point Mutation; Prevalence; Rifampin; Sequence Alignment; Sequence Homology, Nucleic Acid; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Venezuela | 2010 |
Targeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005-2008.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mass Screening; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Population Surveillance; Practice Guidelines as Topic; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Rapid detection of multidrug-resistant Mycobacterium tuberculosis by multiplex allele-specific polymerase chain reaction.
Topics: Alleles; Antitubercular Agents; Argentina; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin | 2011 |
An apparently healthy young man with a peculiar-looking chest radiograph.
Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Fever; HIV Seropositivity; Humans; Isoniazid; Male; Pleural Effusion; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2011 |
Interferon-gamma release assay in tuberculous scleritis.
Topics: Adult; Aged; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunoassay; Interferon-gamma; Isoniazid; Leukocytes; Male; Rifampin; Scleritis; Tuberculosis, Ocular | 2011 |
The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice.
Topics: Animals; Antioxidants; Antitubercular Agents; Apoptosis; Chemical and Drug Induced Liver Injury; Cytoprotection; Drug Interactions; Female; Isoniazid; Liver; Mice; Oxidative Stress; Rifampin; Ursodeoxycholic Acid | 2011 |
[Pulmonary paragonimiasis].
Topics: Adult; Animals; Anthelmintics; Antitubercular Agents; Caulobacteraceae; Delayed Diagnosis; Ecuador; Ethambutol; Food Parasitology; Gram-Negative Bacterial Infections; Granuloma; Hemoptysis; Humans; Isoniazid; Lung Diseases, Parasitic; Male; Paragonimiasis; Pneumonia, Bacterial; Praziquantel; Pyrazinamide; Radiography; Rifampin; Spain; Tuberculosis, Pulmonary | 2011 |
Highest prevalence of the Mycobacterium tuberculosis Beijing genotype isolates in patients newly diagnosed with tuberculosis in the Novosibirsk oblast, Russian Federation.
Topics: Adult; Aged; Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Middle Aged; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Prevalence; Rifampin; Siberia; Tuberculosis, Multidrug-Resistant; Young Adult | 2011 |
Genetic variation of Mycobacterium tuberculosis circulating in Kharkiv Oblast, Ukraine.
Topics: Adult; Antitubercular Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genetic Variation; Genotype; Humans; Isoniazid; Male; Middle Aged; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifampin; Tuberculosis; Ukraine; Young Adult | 2011 |
Torticollis in mice intravenously infected with Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Autopsy; Aza Compounds; Disease Models, Animal; Drug Therapy, Combination; Ear, Middle; Female; Fluoroquinolones; Injections, Intravenous; Isoniazid; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium tuberculosis; Otitis Media; Pyrazinamide; Quinolines; Rifampin; Torticollis; Tuberculosis | 2011 |
Antimycobacterial activity of ferutinin alone and in combination with antitubercular drugs against a rapidly growing surrogate of Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Benzoates; Bridged Bicyclo Compounds; Cycloheptanes; Ethionamide; Ferula; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parabens; Plant Roots; Rifampin; Sesquiterpenes; Streptomycin | 2011 |
Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda.
Topics: Adult; Antitubercular Agents; Female; Genetic Variation; Genotype; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Molecular Typing; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Uganda | 2011 |
Protective effect of methanolic extract of Annona squamosa Linn in isoniazid-rifampicin induced hepatotoxicity in rats.
Topics: Animals; Annona; Antitubercular Agents; Isoniazid; Liver; Male; Plant Extracts; Rats; Rats, Wistar; Rifampin | 2011 |
Predicting outcomes and drug resistance with new standardised treatment.
Topics: Cohort Studies; Communicable Disease Control; Drug Resistance, Bacterial; Global Health; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
[Cutaneous reaction after pyrazinamide initiation].
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Eruptions; Drug Therapy, Combination; Dysgeusia; Flushing; Histamine H1 Antagonists; Humans; Isoniazid; Loratadine; Male; Pruritus; Pyrazinamide; Recurrence; Rifampin; Tryptases; Tuberculosis, Pulmonary; Vasodilation | 2011 |
BCG-induced lupus vulgaris complicated by squamous cell carcinoma in a 7-year-old child.
Topics: Antitubercular Agents; BCG Vaccine; Carcinoma, Squamous Cell; Child; Ethambutol; Humans; Isoniazid; Lupus Vulgaris; Lymphatic Metastasis; Male; Pyrazinamide; Rifampin; Skin Neoplasms; Treatment Outcome | 2011 |
Verrucous plaque on the thigh.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Thigh; Treatment Outcome; Tuberculosis, Cutaneous | 2011 |
Case report: Lower extremity sparganosis in a bursa.
Topics: Aged; Animals; Antitubercular Agents; Bursa, Synovial; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Rifampin; Soft Tissue Neoplasms; Sparganosis; Sparganum; Tibia; Treatment Outcome | 2011 |
Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of mycobacterium tuberculosis in north India.
Topics: Antitubercular Agents; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Predictive Value of Tests; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin | 2011 |
The variable clinical presentation of tuberculosis otitis media and the importance of early detection.
Topics: Adolescent; Adult; Audiometry, Pure-Tone; Early Diagnosis; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Otitis Media, Suppurative; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2011 |
Transformation of cinnamic acid from trans- to cis-form raises a notable bactericidal and synergistic activity against multiple-drug resistant Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Cinnamates; Drug Evaluation, Preclinical; Drug Synergism; Humans; Isomerism; Isoniazid; Microscopy, Electron, Scanning; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Pulmonary tuberculosis in infants less than one year old: implications for early diagnosis.
Topics: Antitubercular Agents; Early Diagnosis; Family; Female; Hospitals, Pediatric; Hospitals, Teaching; Humans; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Stomach; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis, Pulmonary; Turkey | 2011 |
Drug susceptibility pattern of Mycobacterium tuberculosis isolates against conventional anti-tuberculosis drugs in Dhaka, Bangladesh.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bangladesh; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis; Young Adult | 2011 |
Resistance to first-line tuberculosis drugs in three cities of Nigeria.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Cities; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Nigeria; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Urban Health; Young Adult | 2011 |
Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Topics: Adult; Antitubercular Agents; Cohort Studies; DNA Mutational Analysis; Ethambutol; Humans; Isoniazid; Jordan; Microbial Sensitivity Tests; Molecular Typing; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2011 |
[Apoptosis-inducing action of antituberculosis drugs of the main group in vitro].
Topics: Antitubercular Agents; Apoptosis; Ethambutol; Humans; Isoniazid; Lymphocytes; Rifampin; Tuberculosis, Pulmonary | 2010 |
Streptomycin resistance and lineage-specific polymorphisms in Mycobacterium tuberculosis gidB gene.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Gene Frequency; Humans; Isoniazid; Methyltransferases; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymorphism, Genetic; Rifampin; Streptomycin | 2011 |
[GenoType MTBDRplus assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis in Sichuan].
Topics: DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2011 |
Treatment of latent TB: first do no harm.
Topics: Age Factors; Asymptomatic Infections; Humans; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Patient Compliance; Rifampin; Risk Factors; Self Administration | 2011 |
Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Kazakhstan; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.
Topics: Adult; Antitubercular Agents; Communicable Disease Control; Directly Observed Therapy; Enzyme-Linked Immunosorbent Assay; Ethambutol; HIV Seronegativity; HIV Seropositivity; Humans; India; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2011 |
T cell monitoring of chemotherapy in experimental rat tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Disease Models, Animal; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enzyme-Linked Immunospot Assay; Female; Interferon-gamma; Isoniazid; Mycobacterium tuberculosis; Rats; Rats, Wistar; Rifampin; T-Lymphocytes; Tuberculosis | 2011 |
Tuberculosis-associated chronic kidney disease.
Topics: Antitubercular Agents; Ethambutol; Fever; Humans; Isoniazid; Kidney Failure, Chronic; Male; Pyrazinamide; Renal Dialysis; Rifampin; Tuberculosis; Young Adult | 2011 |
Multifocal tuberculosis revealed by multiple cutaneous gummas in the immunocompetent.
Topics: Antitubercular Agents; Clavicle; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Isoniazid; Male; Morocco; Pyrazinamide; Rifampin; Skin Ulcer; Tuberculosis, Cutaneous; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Young Adult | 2011 |
Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; South Africa; Streptomycin | 2011 |
A rapid detection of multidrug-resistant Mycobacterium tuberculosis by a nitrate reductase assay on blood agar.
Topics: Agar; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2011 |
Antimycobacterial and synergistic effects of 18β-glycyrrhetinic acid or glycyrrhetinic acid-30-piperazine in combination with isoniazid, rifampicin or streptomycin against Mycobacterium bovis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Synergism; Glycyrrhetinic Acid; Isoniazid; Microbial Sensitivity Tests; Mycobacterium bovis; Piperazines; Rifampin; Streptomycin | 2012 |
Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication.
Topics: Antitubercular Agents; Aza Compounds; Biopsy; Brain; Cerebrospinal Fluid; Drug Resistance, Bacterial; Ethambutol; Female; Fluoroquinolones; Histocytochemistry; Humans; Isoniazid; Magnetic Resonance Imaging; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Multidrug-Resistant; Young Adult | 2011 |
Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers.
Topics: Alginates; Calcium Chloride; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Emulsions; Glucuronic Acid; Hexoses; Hexuronic Acids; Humans; Hydrogels; Isoniazid; Lactic Acid; Microscopy, Electron, Scanning; Models, Molecular; Nanoparticles; Organic Chemistry Phenomena; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Spectrum Analysis; Thermodynamics; Tuberculosis | 2011 |
[Contribution of the surgical treatment of drug-resistant tuberculosis during medical follow-up (experience of the pneumology department of the CHU of Cocody, in connection with five observations)].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pneumonectomy; Pulmonary Medicine; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
Mycotic aneurysm of the aorta as a complication of Bacillus Calmette-Guérin instillation.
Topics: Administration, Intravesical; Aged; Aneurysm, Infected; Antibiotics, Antitubercular; Aorta, Abdominal; Aortic Aneurysm, Abdominal; BCG Vaccine; Carcinoma, Transitional Cell; England; Ethambutol; Fatal Outcome; Humans; Isoniazid; Male; Mycobacterium bovis; Mycobacterium Infections; Rifampin; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2011 |
Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum; Tanzania; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2011 |
[A case of tuberculous peritonitis developed during chemotherapy for tuberculous pleurisy as paradoxical response].
Topics: Adenosine Deaminase; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Peritonitis, Tuberculous; Pleural Effusion; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pleural | 2011 |
Acute liver failure in a pediatric patient with disseminated tuberculosis.
Topics: Antifungal Agents; Antitubercular Agents; Child; Coccidioidomycosis; Drug Therapy, Combination; Ethambutol; Fluconazole; Humans; Isoniazid; Liver Failure, Acute; Male; Pyrazinamide; Recovery of Function; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Drug susceptibility of Mycobacterium tuberculosis in patients with AIDS at a tertiary care hospital in northern India.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Antitubercular Agents; CD4 Lymphocyte Count; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; India; Isoniazid; Male; Mycobacterium tuberculosis; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary; Viral Load | 2011 |
Description of primary multidrug-resistant tuberculous meningitis in an Italian child.
Topics: Antitubercular Agents; Child, Preschool; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant | 2012 |
Shorter treatment duration for selected patients with multidrug-resistant tuberculosis.
Topics: Aged; Antitubercular Agents; Cohort Studies; Drug Administration Schedule; Female; Hong Kong; Humans; Isoniazid; Longitudinal Studies; Male; Middle Aged; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2011 |
What is thwarting tuberculosis prevention in high-burden settings?
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Isoniazid; Rifampin; Tuberculosis | 2011 |
[Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Electroporation; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Oxidoreductases; Plasmids; Rifampin; Streptomycin | 2011 |
Multidrug-resistant Mycobacterium tuberculosis, Southwestern Colombia.
Topics: Adolescent; Adult; Antitubercular Agents; Bacterial Typing Techniques; Child; Colombia; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Public Health; Rifampin; Risk Factors; Sex Factors; Tuberculosis, Multidrug-Resistant | 2011 |
Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China.
Topics: Antitubercular Agents; Base Sequence; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genetic Markers; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2011 |
Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Drug Administration Schedule; Humans; Isoniazid; Latent Tuberculosis; Models, Biological; Patient Compliance; Rifampin; Self Administration; United States | 2011 |
Primary nasal tuberculosis-a rare clinical entity.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Epistaxis; Female; Humans; Isoniazid; Nasal Obstruction; Pyrazinamide; Rhinitis; Rifampin; Sinusitis; Tuberculosis | 2011 |
High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
Bone marrow infection with Mycobacterium fortuitum in a diabetic patient.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bone Marrow; Bone Marrow Diseases; Ciprofloxacin; Diabetes Mellitus, Type 2; Humans; Isoniazid; Male; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome | 2011 |
Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
Topics: Adult; Aged; Aged, 80 and over; Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant | 2011 |
Clustering of Mycobacterium tuberculosis strains from foreign-born patients in Korea.
Topics: Antitubercular Agents; Cluster Analysis; DNA Transposable Elements; Emigrants and Immigrants; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Mycobacterium tuberculosis; Ofloxacin; Republic of Korea; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2011 |
[Lupus vulgaris].
Topics: Adult; Africa, Northern; Antitubercular Agents; Emigrants and Immigrants; Facial Dermatoses; Female; Humans; Isoniazid; Lupus Vulgaris; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Skin; Spain | 2012 |
Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2011 |
Tuberculous damaged lung in a child.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Isoniazid; Lung; Lung Neoplasms; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Pulmonary | 2011 |
Pyrazinamide-induced sideroblastic anemia.
Topics: 5-Aminolevulinate Synthetase; alpha-Thalassemia; Anemia, Sideroblastic; Antitubercular Agents; Aza Compounds; Bone Marrow; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Hemolysis; Humans; Isoniazid; Middle Aged; Moxifloxacin; Peritonitis, Tuberculous; Pyrazinamide; Pyridoxine; Quinolines; Rifampin | 2012 |
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Decision Support Techniques; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Models, Biological; Mycobacterium tuberculosis; Quality-Adjusted Life Years; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
DNA extracted from stained sputum smears can be used in the MTBDRplus assay.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Specimen Handling; Sputum | 2011 |
Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Ofloxacin; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Transition Temperature; Tuberculosis, Multidrug-Resistant | 2011 |
[Anti-tuberculosis chemotherapy and management of adverse reactions].
Topics: Aged, 80 and over; Antitubercular Agents; Child; Drug Administration Schedule; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Liver; Pregnancy; Pyrazinamide; Rifampin; Tuberculosis | 2011 |
[Immune reconstitution syndrome related to a Mycobacterium avium complex infection, revealed by a mono-adenitis].
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Axilla; Clarithromycin; Darunavir; Dideoxynucleosides; Enfuvirtide; Ethambutol; HIV Envelope Protein gp41; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Lamivudine; Lymph Node Excision; Lymphadenitis; Male; Mycobacterium avium-intracellulare Infection; Peptide Fragments; Pyrazinamide; Rifampin; Ritonavir; Streptomycin; Sulfonamides | 2011 |
Adverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis: a retrospective analysis.
Topics: Adult; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Retrospective Studies; Rifampin; Young Adult | 2011 |
Clinical presentations and therapeutic effect of presumed choroidal tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Choroid Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Ocular; Young Adult | 2012 |
Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methods.
Topics: Antitubercular Agents; Brazil; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genes, MDR; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Typing; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2011 |
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug-Related Side Effects and Adverse Reactions; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Infectious Disease Medicine; Isoniazid; Kanamycin; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin | 2011 |
Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Dissolution testing of isoniazid, rifampicin, pyrazinamide and ethambutol tablets using near-infrared spectroscopy (NIRS) and multivariate calibration.
Topics: Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Ethambutol; Isoniazid; Pyrazinamide; Rifampin; Solubility; Spectroscopy, Near-Infrared | 2012 |
Anti-tuberculosis drugs and human polymorphonuclear leukocyte functions.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Flow Cytometry; Humans; Isoniazid; Neutrophils; Phagocytosis; Pyrazinamide; Respiratory Burst; Rifampin; Staphylococcus aureus; Tuberculosis | 2011 |
Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: structure-activity relationships.
Topics: Antitubercular Agents; Cell Wall; Coumarins; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Rifampin; Streptomycin; Structure-Activity Relationship | 2011 |
[Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; DNA, Bacterial; Genotype; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Field assessment of the direct nitrate reductase assay for rapid detection of multidrug-resistant tuberculosis in Honduras.
Topics: Antitubercular Agents; Honduras; Humans; Isoniazid; Microbial Sensitivity Tests; Nitrate Reductase; Predictive Value of Tests; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2011 |
Acute tuberculosis cutis miliaris disseminata in a patient with systemic lupus erythematosus.
Topics: Acute Disease; Antitubercular Agents; Drug Combinations; Female; Humans; Isoniazid; Lupus Erythematosus, Systemic; Middle Aged; Pyrazinamide; Rifampin; Steroids; Tuberculosis, Cutaneous; Tuberculosis, Miliary | 2011 |
Plasma drug activity assay for treatment optimization in tuberculosis patients.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Monitoring; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tanzania; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2011 |
Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.
Topics: Animals; Antitubercular Agents; Aza Compounds; Biological Availability; Disease Models, Animal; Drug Administration Schedule; Female; Fluoroquinolones; Granuloma; Humans; Isoniazid; Lung; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rabbits; Rifampin; Tissue Extracts; Tuberculosis, Pulmonary | 2012 |
Tolerability of rifampin monotherapy for latent tuberculosis infection in children.
Topics: Adolescent; Antitubercular Agents; Child; Drug Administration Schedule; Drug Dosage Calculations; Humans; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Patient Compliance; Rifampin; United States | 2011 |
[Scrofuloderma with hypersensitivity to rifampicin and pyrazinamide, treated with a combination therapy including ofloxacin].
Topics: Adult; Antibiotics, Antitubercular; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Isoniazid; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Cutaneous | 2012 |
How useful is the Mantoux test in the diagnosis of doubtful cases of cutaneous tuberculosis?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Biopsy; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Predictive Value of Tests; Pyrazinamide; Rifampin; ROC Curve; Tuberculin Test; Tuberculosis, Cutaneous; Young Adult | 2011 |
Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Catalase; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2011 |
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability.
Topics: Antitubercular Agents; Computer Simulation; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Medication Adherence; Models, Biological; Monte Carlo Method; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Burkina Faso; Chromatography, High Pressure Liquid; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Plasma; Pyrazinamide; Rifampin; Tuberculosis | 2012 |
Cutaneous polyarteritis nodosa induced by Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Phenylpropionates; Polyarteritis Nodosa; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Cutaneous | 2012 |
Isoniazid (INH)-induced eosinophilic exudative pleural effusion and lupus erythematosus. A clinical reminder of drug side effects.
Topics: Aged; Antibodies, Antinuclear; Antitubercular Agents; DNA; Drug Substitution; Eosinophilia; Exudates and Transudates; Female; Glucocorticoids; Humans; Isoniazid; Latent Tuberculosis; Lupus Erythematosus, Systemic; Pleural Effusion; Prednisone; Rifampin; Treatment Outcome | 2011 |
Palatal ulceration as the first sign of pulmonary tuberculosis: a case report.
Topics: Adult; Antitubercular Agents; Chronic Disease; Humans; Isoniazid; Male; Mouth Mucosa; Mycobacterium tuberculosis; Oral Ulcer; Rifampin; Treatment Outcome; Tuberculosis, Oral; Tuberculosis, Pulmonary | 2012 |
When tuberculosis comes back: who develops recurrent tuberculosis in california?
Topics: Adult; Antitubercular Agents; California; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Public Health; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 2011 |
[Sudden decrease in visual acuity and pulmonary infiltrates].
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Laser Coagulation; Male; Neovascularization, Pathologic; Pyrazinamide; Radiography; Recurrence; Retinal Hemorrhage; Retinal Vasculitis; Rifampin; Tuberculosis, Pulmonary; Visual Acuity; Young Adult | 2012 |
[Comparison of proportion method in Löwenstein-Jensen medium with the BACTEC 460 TB system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis isolates].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2011 |
Molecular characterisation of isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Central Tunisia.
Topics: Antitubercular Agents; Bacterial Typing Techniques; Genotype; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Tunisia | 2011 |
Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis.
Topics: Antitubercular Agents; Global Health; Humans; Incidence; Isoniazid; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Practical preventive therapy for tuberculosis?
Topics: Antitubercular Agents; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 2011 |
Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Contraindications; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Isoniazid; Latent Tuberculosis; Randomized Controlled Trials as Topic; Rifampin | 2011 |
Utility of nitrate reductase assay for detection of multidrug-resistant Mycobacterium tuberculosis in a low resource setting.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductases; Prospective Studies; Public Health; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2011 |
Respirable rifampicin-based microspheres containing isoniazid for tuberculosis treatment.
Topics: Animals; Antitubercular Agents; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Isoniazid; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Rifampin; Spectrophotometry, Infrared; Tuberculosis | 2012 |
Molecular characteristics of rifampin- and isoniazid-resistant mycobacterium tuberculosis strains isolated in Vietnam.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Molecular Typing; Mutant Proteins; Mutation, Missense; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Vietnam | 2012 |
Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility.
Topics: Anti-Bacterial Agents; Cell Cycle; Cell Division; Cell Wall; Cycloserine; Escherichia coli; Isoniazid; Meropenem; Microbial Sensitivity Tests; Microfluidic Analytical Techniques; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rifampin; Thienamycins; Time Factors | 2012 |
Therapeutic drug monitoring in the treatment of tuberculosis patients.
Topics: Adult; Aged; Alcoholism; Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, High Pressure Liquid; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Monitoring; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Precision Medicine; Pyrazinamide; Recurrence; Rifampin; Schizophrenia; Sputum; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
A case of isolated pancreatic tuberculosis mimicking pancreatic carcinoma.
Topics: Aged; Antitubercular Agents; Biopsy, Fine-Needle; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pancreatic Diseases; Pancreatic Neoplasms; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2011 |
Pre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitro.
Topics: Anti-Bacterial Agents; Codon; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Mutation Rate; Mycobacterium tuberculosis; Rifampin | 2012 |
Clinical and anatomic features of female genital tuberculosis in 28 patients.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Infertility, Female; Isoniazid; Middle Aged; Pelvic Pain; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Female Genital; Young Adult | 2012 |
Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Topics: Antitubercular Agents; Colorimetry; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2012 |
Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Cross-Sectional Studies; DNA-Directed RNA Polymerases; Female; Genotype; Gold; Humans; Isoniazid; Male; Middle Aged; Mining; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Resistance, Bacterial; Female; HIV Infections; Humans; Isoniazid; Kenya; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Surveys and Questionnaires; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.
Topics: Animals; BCG Vaccine; Combined Modality Therapy; Female; Granuloma; Guinea Pigs; Isoniazid; Lung; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2012 |
Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Genotype; Humans; India; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Mycobacterium tuberculosis; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2012 |
Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Markov Chains; Mice; Models, Theoretical; Moxifloxacin; Outcome Assessment, Health Care; Quality-Adjusted Life Years; Quinolines; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.
Topics: Antitubercular Agents; Bacteriophages; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Promoter Regions, Genetic; Recombinant Proteins; Rifampin; Signal-To-Noise Ratio; Sputum; Tuberculosis, Pulmonary | 2012 |
N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Case-Control Studies; Chemical and Drug Induced Liver Injury; Chi-Square Distribution; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Genetic; Pyrazinamide; Rifampin; Risk Assessment; Risk Factors; Tuberculosis; White People | 2011 |
First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; DNA, Bacterial; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Oxidoreductases; Phenotype; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection.
Topics: Antitubercular Agents; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2012 |
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacterial Proteins; Catalase; Child; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Mutation, Missense; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Tuberculosis; Young Adult | 2012 |
New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Catalase; Cluster Analysis; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genetic Variation; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Odds Ratio; Rifampin; Saudi Arabia; Tuberculosis; Young Adult | 2012 |
[Rapid detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis using real-time PCR and melting curve analysis].
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Real-Time Polymerase Chain Reaction; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Pharmacokinetic mismatch of tuberculosis drugs.
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
Intermittent hypoxia and isoniazid plus rifampicin affect hepatic ultrastructure in mice.
Topics: Animals; Hypoxia; Isoniazid; Liver; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Rifampin; Sleep Apnea Syndromes | 2011 |
Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Basic-Leucine Zipper Transcription Factors; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Fanconi Anemia Complementation Group Proteins; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Isoniazid; MafK Transcription Factor; Male; Middle Aged; Nitric Oxide Synthase Type II; Oxidation-Reduction; Polymorphism, Single Nucleotide; Rifampin; Risk Factors; Tuberculosis, Pulmonary; Young Adult | 2012 |
Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin | 2012 |
Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles.
Topics: Antitubercular Agents; Cell Line; Cell Survival; Colony Count, Microbial; Cyclodextrins; Drug Compounding; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Isoniazid; Macrophages; Microbial Viability; Microscopy, Electron, Transmission; Mycobacterium tuberculosis; Nanoparticles; Phagocytosis; Polyethyleneimine; Porosity; Rifampin; Silicon Dioxide | 2012 |
[An isolated case of appendicular tuberculosis].
Topics: Adolescent; Antitubercular Agents; Appendectomy; Appendicitis; Combined Modality Therapy; Drug Therapy, Combination; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Gastrointestinal | 2011 |
Assessing the utility of three TaqMan probes for the diagnosis of tuberculosis and resistance to rifampin and isoniazid in Veracruz, México.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Genetic Variation; Humans; Isoniazid; Mexico; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
Rapid direct testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin on nutrient and blood agar in resource-starved settings.
Topics: Agar; Antitubercular Agents; Culture Media; Developing Countries; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Time Factors | 2012 |
Minimally invasive posterior stabilization for treating spinal tuberculosis.
Topics: Adult; Antitubercular Agents; Bed Rest; Casts, Surgical; Combined Modality Therapy; Ethambutol; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Minimally Invasive Surgical Procedures; Orthopedic Procedures; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Spinal | 2013 |
A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Ciprofloxacin; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Virus Replication; Young Adult | 2012 |
Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
Topics: Adult; Antitubercular Agents; Culture Media; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Female; Humans; Isoniazid; Male; Mass Screening; Microbial Sensitivity Tests; Microscopy; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Vietnam | 2012 |
[Neonatal exposure to active pulmonary tuberculosis in a maternity ward: screening and clinical course of a cohort of exposed infants].
Topics: Antitubercular Agents; Cohort Studies; Cross Infection; Female; Follow-Up Studies; Humans; Infant; Infectious Disease Transmission, Professional-to-Patient; Isoniazid; Latent Tuberculosis; Male; Mass Chest X-Ray; Mass Screening; Obstetrics and Gynecology Department, Hospital; Paris; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis, Pulmonary | 2012 |
[Sternal tumour in a 46-year-old woman].
Topics: Antitubercular Agents; Biopsy; Carcinoma; Combined Modality Therapy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Lymphatic Diseases; Middle Aged; Mycobacterium tuberculosis; Osteolysis; Osteomyelitis; Pleural Effusion; Pleural Neoplasms; Pyrazinamide; Rifampin; Sputum; Sternum; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2012 |
Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Birth Weight; Drug Resistance, Multiple; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Tuberculosis, Pulmonary; Young Adult | 2012 |
Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Contact Tracing; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Mycobacterium tuberculosis; New York City; Numbers Needed To Treat; Prevalence; Retrospective Studies; Rifampin; Tuberculin Test; Tuberculosis; Young Adult | 2012 |
Crosslinked electrospun PVA nanofibrous membranes: elucidation of their physicochemical, physicomechanical and molecular disposition.
Topics: Computer Simulation; Cross-Linking Reagents; Drug Carriers; Elastic Modulus; Glutaral; Isoniazid; Microscopy, Electron, Scanning; Models, Molecular; Nanofibers; Polyvinyl Alcohol; Rifampin; Spectroscopy, Fourier Transform Infrared; Thermodynamics | 2012 |
Case-crossover design: an alternative strategy for detecting drug-induced liver injury.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chemical and Drug Induced Liver Injury; Comorbidity; Cross-Over Studies; Databases as Topic; Diclofenac; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Hospitalization; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Odds Ratio; Pregnancy; Research Design; Rifampin; Risk Assessment; Taiwan; Time Factors; Young Adult | 2012 |
Hepatoprotective potential of ethanolic extract of Ziziphus oenoplia (L.) Mill roots against antitubercular drugs induced hepatotoxicity in experimental models.
Topics: Animals; Antioxidants; Antitubercular Agents; Bilirubin; Chemical and Drug Induced Liver Injury; Enzymes; Ethanol; Hepatocytes; Isoniazid; Male; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Rifampin; Ziziphus | 2012 |
Cellular toxicity of isoniazid together with rifampicin and the metabolites of isoniazid on QSG-7701 hepatocytes.
Topics: Analysis of Variance; Antitubercular Agents; Case-Control Studies; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Drug Combinations; Hepatocytes; Humans; Isoniazid; L-Lactate Dehydrogenase; Rifampin | 2012 |
Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB.
Topics: Amikacin; Antitubercular Agents; Aza Compounds; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genotype; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Quinolines; Rifampin; Statistics, Nonparametric; Tuberculosis, Multidrug-Resistant | 2012 |
Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
Training laboratory technicians from the Ethiopian periphery in the MODS technique enables rapid and low-cost diagnosis of Mycobacterium tuberculosis infection.
Topics: Antitubercular Agents; Bacteriological Techniques; Ethiopia; Humans; Isoniazid; Israel; Laboratory Personnel; Logistic Models; Microbial Sensitivity Tests; Multivariate Analysis; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2012 |
Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Biological Transport, Active; Carrier Proteins; Catalase; Chlorpromazine; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Gene Expression; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Thioridazine; Tuberculosis, Multidrug-Resistant; Verapamil | 2012 |
Rifapentine and isoniazid for latent tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 2012 |
Rifapentine and isoniazid for latent tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 2012 |
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Georgia (Republic); Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Predictive Value of Tests; Pyrazinamide; Retrospective Studies; Rifampin; Risk Assessment; Risk Factors; Sputum; Time Factors; Treatment Outcome; Tuberculosis | 2012 |
[Molecular test Genotype® MTBDRplus, an alternative to rapid detection of multidrug resistance tuberculosis].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Genotype; Humans; Isoniazid; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant | 2012 |
The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Oxidoreductases; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Sweden; Tuberculosis, Multidrug-Resistant | 2012 |
[Swelling of right knee in an immunologically compromised patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Arthritis, Infectious; Bacteremia; Candidiasis, Oral; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Isoniazid; Knee Joint; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Radiography; Rifampin; Tuberculosis, Osteoarticular | 2012 |
Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Topics: Animals; Antitubercular Agents; Female; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2012 |
Tubercular epitrochlear lymphadenopathy.
Topics: Antitubercular Agents; Child, Preschool; Drug Therapy, Combination; Elbow; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 2012 |
Drug susceptibility profiles of Mycobacterium tuberculosis isolates at Mangalore.
Topics: Antitubercular Agents; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 2010 |
Multidrug-resistant tuberculosis in Port-au-Prince, Haiti.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Cities; Cross-Sectional Studies; DNA-Directed RNA Polymerases; Female; Haiti; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2012 |
Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model.
Topics: Antitubercular Agents; Biomarkers; Cell Line, Tumor; Drug Discovery; Ethambutol; High-Throughput Screening Assays; Humans; Isoniazid; Leukemia, Monocytic, Acute; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Pentachlorophenol; Pyrazinamide; Rifampin; Streptomycin | 2012 |
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prevalence; Rifampin; Risk Assessment; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2012 |
The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Coinfection; Epidemics; Ethambutol; Female; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2012 |
Trends in drug-resistant tuberculosis in a gold-mining workforce in South Africa, 2002-2008.
Topics: Adult; Antitubercular Agents; Gold; HIV Infections; Humans; Isoniazid; Middle Aged; Mining; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; South Africa; Tuberculosis, Multidrug-Resistant | 2012 |
Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Egypt; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Microscopy; Middle Aged; Mycobacterium tuberculosis; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Young Adult | 2012 |
Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort.
Topics: Adult; Antitubercular Agents; Cohort Studies; Disease Outbreaks; Humans; Interferon-gamma Release Tests; Isoniazid; Male; Rifampin; Tuberculosis; Young Adult | 2012 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
Topics: Adult; Antitubercular Agents; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Patient Compliance; Portugal; Pyrazinamide; Retrospective Studies; Rifampin | 2012 |
[Paradoxical radiologic progression despite appropriate anti-tuberculous therapy].
Topics: Aged; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.
Topics: Antitubercular Agents; DNA Mutational Analysis; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases.
Topics: Antibiotics, Antitubercular; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; World Health Organization | 2012 |
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Random Allocation; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Tubercular serpiginous-like choroiditis.
Topics: Antitubercular Agents; Choroiditis; Drug Combinations; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Ocular; Vision Disorders | 2011 |
Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.
Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Fluorodeoxyglucose F18; Granuloma; Isoniazid; Lung; Multimodal Imaging; Mycobacterium tuberculosis; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Random Allocation; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2012 |
In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.
Topics: Animals; Antitubercular Agents; Aza Compounds; Chronic Disease; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Isoniazid; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2012 |
Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria.
Topics: Amino Acid Sequence; Antitubercular Agents; Base Sequence; Drug Resistance, Bacterial; Isoniazid; Molecular Sequence Data; Mycobacterium tuberculosis; Point Mutation; Rifampin; Syria | 2012 |
Treatment duration for patients with drug-resistant tuberculosis, United States.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; United States | 2012 |
Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Isoniazid; Rifampin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uganda | 2012 |
Rapid detection of rifampicin, isoniazid and streptomycin resistance in Mycobacterium tuberculosis clinical isolates by high-resolution melting curve analysis.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern.
Topics: Abattoirs; Adult; Agriculture; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Incidence; Ireland; Isoniazid; Male; Middle Aged; Mycobacterium bovis; Rifampin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary | 2012 |
The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains.
Topics: Antitubercular Agents; Ciprofloxacin; Color; Drug Resistance, Multiple, Bacterial; Estonia; Extensively Drug-Resistant Tuberculosis; Feasibility Studies; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2012 |
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Bacteriophages; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Feasibility of a fixed-dose regimen of pyrazinamide and its impact on systemic drug exposure and liver safety in patients with tuberculosis.
Topics: Antitubercular Agents; Area Under Curve; Body Weight; Drug Dosage Calculations; Ethnicity; Female; Humans; Isoniazid; Liver; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2012 |
Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system.
Topics: Antitubercular Agents; Automation; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 2012 |
Management of and risk factors related to hepatotoxicity during tuberculosis treatment.
Topics: Adult; Age Factors; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Comorbidity; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver Function Tests; Male; Pyrazinamide; Recurrence; Rifampin; Risk Factors; Sex Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Use of multiplex allele-specific polymerase chain reaction (MAS-PCR) to detect multidrug-resistant tuberculosis in Panama.
Topics: Alleles; Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Operon; Oxidoreductases; Panama; Point Mutation; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
[Resistant tuberculosis: chinese anxieties].
Topics: Antitubercular Agents; Anxiety; Asian People; China; Drug Resistance, Multiple, Bacterial; France; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Tuberculosis | 2012 |
Tuberculosis: an unusual cause of genital ulcer.
Topics: Adult; Antitubercular Agents; Extramarital Relations; Humans; Isoniazid; Male; Penis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Cutaneous; Ulcer | 2012 |
Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Typing Techniques; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Mice; Mice, Inbred BALB C; Mutation Rate; Mycobacterium tuberculosis; Patient Compliance; Recurrence; Rifampin; Species Specificity; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2012 |
Study of rifampicin and isoniazid resistance mutation genes of M. tuberculosis isolates in Nepal.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nepal; Oxidoreductases; Rifampin; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2011 |
[Bilateral tuberculous mastitis nulliparous patient, initially treated as idiopathic granulomatous mastitis].
Topics: Adult; Antitubercular Agents; Diagnostic Errors; Drug Therapy, Combination; Ethambutol; Female; Granulomatous Mastitis; Humans; Isoniazid; Mastitis; Methotrexate; Mycobacterium tuberculosis; Polymerase Chain Reaction; Prednisone; Pyrazinamide; Recurrence; Rifampin; Tuberculosis | 2012 |
The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
Topics: Anaerobiosis; Anti-Bacterial Agents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sulfamethoxazole; Trimethoprim; Tuberculosis, Multidrug-Resistant | 2012 |
Molecular detection and drug resistance of Mycobacterium tuberculosis complex from cattle at a dairy farm in the Nkonkobe region of South Africa: a pilot study.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Cattle; Cattle Diseases; Dairying; Drug Resistance, Multiple, Bacterial; Female; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Pilot Projects; Prevalence; Rifampin; South Africa; Tuberculosis | 2012 |
Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence, risk factors and resistance pattern.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacteriological Techniques; Child; Drug Resistance, Bacterial; Egypt; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Neoplasms; Prevalence; Real-Time Polymerase Chain Reaction; Rifampin; Risk Factors; Sensitivity and Specificity; Tuberculosis; Young Adult | 2012 |
Comparative evaluation of the microplate nitrate reductase assay and the rezasurin microtitre assay for the rapid detection of multidrug resistant Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Oxazines; Predictive Value of Tests; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Xanthenes | 2012 |
[Cutaneous tuberculosis. Report of one case].
Topics: Antitubercular Agents; Biopsy; Diagnosis, Differential; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous | 2012 |
Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
Topics: Anorexia Nervosa; Antibodies, Bacterial; Antitubercular Agents; Ethambutol; Female; Humans; Interferon-gamma; Isoniazid; Lung Diseases; Lymphocytes; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Young Adult | 2012 |
Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh.
Topics: Antitubercular Agents; Bacterial Proteins; Bangladesh; Catalase; Codon; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Early Diagnosis; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Phylogeny; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; B-Lymphocytes; Cohort Studies; Complement C1q; Complement C2; Down-Regulation; Drug Therapy, Combination; Gene Expression Profiling; Gene Expression Regulation; Humans; Immunity, Humoral; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Prospective Studies; Rifampin; Tuberculosis, Pulmonary; Up-Regulation; Young Adult | 2013 |
Sulfamethoxazole enhances the antimycobacterial activity of rifampicin.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sulfamethoxazole; Trimethoprim | 2012 |
Capillary electrophoresis-single strand conformation polymorphism for the detection of multiple mutations leading to tuberculosis drug resistance.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Electrophoresis, Capillary; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Rifampin; Temperature; Time Factors; Tuberculosis, Multidrug-Resistant | 2012 |
Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Delivery Systems; Drug Therapy, Combination; Humans; Isoniazid; Ligands; Liposomes; Mycobacterium tuberculosis; Pyrazinamide; Rats; Rats, Inbred Strains; Rifampin; Tuberculosis, Pulmonary | 2013 |
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.
Topics: Adjuvants, Immunologic; Animals; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Chemotherapy, Adjuvant; Disease Models, Animal; Female; Isoniazid; Lung; Macaca fascicularis; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Rifampin; Secondary Prevention; Survival Analysis; Time Factors; Tuberculosis Vaccines; Tuberculosis, Pulmonary; Vaccination | 2013 |
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kanamycin; Male; Prevalence; Rifampin; South Africa; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Lupus vulgaris in an immunocompromised patient.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Kidney Transplantation; Lupus Vulgaris; Pyrazinamide; Rifampin | 2014 |
In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis.
Topics: Adamantane; Antitubercular Agents; Aza Compounds; Diarylquinolines; Drug Combinations; Drug Synergism; Ethambutol; Ethylenediamines; Fluoroquinolones; Isoniazid; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Quinolines; Rifampin; Spiro Compounds; Thiazines; Thienamycins | 2012 |
Extensive chronic Tuberculosis luposa treated incorrectly with long-term course of isoniazid monotherapy.
Topics: Aged; Antitubercular Agents; Bacteriological Techniques; Chronic Disease; Diagnostic Errors; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lupus Vulgaris; Male; Mycobacterium tuberculosis; Polymerase Chain Reaction; Predictive Value of Tests; Rifampin; Skin; Time Factors; Treatment Outcome; Tuberculin Test | 2013 |
The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antitubercular Agents; CD4 Lymphocyte Count; Cohort Studies; Drug Administration Schedule; Female; Follow-Up Studies; HIV Seropositivity; Humans; Incidence; Isoniazid; Malawi; Male; Middle Aged; Population Surveillance; Recurrence; Rifampin; Risk Factors; Streptomycin; Survival Analysis; Treatment Outcome; Tuberculosis; Young Adult | 2012 |
Improved consistency in dosing anti-tuberculosis drugs in Taipei, Taiwan.
Topics: Adult; Aged; Antitubercular Agents; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Taiwan; Tuberculosis; Young Adult | 2012 |
Gene chip array for differentiation of mycobacterial species and detection of drug resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2012 |
[Treatment of intractable tuberculous meningitis using intrathecal isoniazid administration and steroid pulse therapy; a report of two cases].
Topics: Adult; Antitubercular Agents; Dexamethasone; Drug Therapy, Combination; Ethambutol; Female; Humans; Injections, Spinal; Isoniazid; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2012 |
Optimization of a reversed-phase-high-performance thin-layer chromatography method for the separation of isoniazid, ethambutol, rifampicin and pyrazinamide in fixed-dose combination antituberculosis tablets.
Topics: Antitubercular Agents; Chromatography, Reverse-Phase; Chromatography, Thin Layer; Ethambutol; Ethanol; Isoniazid; Pyrazinamide; Reproducibility of Results; Rifampin; Tablets | 2012 |
[A case of Stevens-Johnson syndrome (SJS) progressive toxic epidermal necrolysis (TEN) onset during hyposensitization therapy for pulmonary tuberculosis complicated with dermatomyositis].
Topics: Dermatomyositis; Desensitization, Immunologic; Exanthema; Female; Humans; Immunoglobulins, Intravenous; Isoniazid; Middle Aged; Plasma Exchange; Rifampin; Stevens-Johnson Syndrome; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Pharmacokinetic and safety evaluation of the use of ciprofloxacin on an isoniazid-rifampicin regimen in rabbits.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antibiotics, Antitubercular; Aspartate Aminotransferases; Bilirubin; Ciprofloxacin; Drug Combinations; Isoniazid; Male; Rabbits; Rifampin | 2012 |
Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs.
Topics: Absorption; Antitubercular Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Compounding; Hydrogen-Ion Concentration; Isoniazid; Kinetics; Liposomes; Luminescence; Microscopy, Electron, Transmission; Particle Size; Polyethylene Glycols; Pyrazinamide; Pyrenes; Rifampin; Solubility; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents | 2013 |
Immunotherapy using IL-2 and GM-CSF is a potential treatment for multidrug-resistant Mycobacterium tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Drug Therapy, Combination; Granulocyte-Macrophage Colony-Stimulating Factor; Immunotherapy; Interleukin-2; Isoniazid; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Rifampin; Survival Rate; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2012 |
Intraretinal tuberculosis.
Topics: Administration, Oral; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Granuloma; Humans; Isoniazid; Male; Prednisolone; Pyrazinamide; Retinal Vasculitis; Rifampin; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2012 |
Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Glucocorticoids; Humans; Interferon-gamma Release Tests; Isoniazid; Male; Middle Aged; Prednisone; Prospective Studies; Pyrazinamide; Racial Groups; Radiography, Thoracic; Rifampin; Risk Factors; Sensitivity and Specificity; Spain; Surveys and Questionnaires; Tuberculin Test; Tuberculosis, Ocular; Urban Population; Uveitis; Young Adult | 2013 |
Outcomes of Category III DOTS treatment in immunocompetent patients with tuberculosis pleural effusion.
Topics: Adolescent; Adult; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunocompetence; India; Isoniazid; Male; Pleural Effusion; Prospective Studies; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis; Ultrasonography; Young Adult | 2012 |
Paucibacillary tubercular vulval ulcer in a sexually inactive pubertal girl: role of therapeutic trial.
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Skin Ulcer; Tuberculin Test; Tuberculosis, Female Genital; Vulvar Diseases | 2012 |
[Directly observed treatment for tuberculosis in a Buenos Aires City hospital].
Topics: Adult; Antitubercular Agents; Argentina; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Self Administration; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Twelve doses for tuberculosis prevention--review of a new evidenced based regimen.
Topics: Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis; Virus Latency | 2012 |
Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Topics: Acetyltransferases; Adolescent; Age Factors; Antitubercular Agents; Area Under Curve; Biological Availability; Child; Child, Preschool; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Infant; Isoniazid; Least-Squares Analysis; Male; Malnutrition; Polymorphism, Genetic; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis; Venezuela; World Health Organization | 2012 |
Prevalence of anti-tuberculosis drug resistance in foreign-born tuberculosis cases in the U.S. and in their countries of origin.
Topics: Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Drug Resistance, Bacterial; Emigrants and Immigrants; Epidemiological Monitoring; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Tuberculosis; United States | 2012 |
Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Real-Time Polymerase Chain Reaction; Rifampin | 2012 |
Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: a prospective validation study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Spinal; Young Adult | 2012 |
Does an interferon-gamma release assay change practice in possible latent tuberculosis?
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Mycobacterium tuberculosis; Practice Guidelines as Topic; Predictive Value of Tests; Prospective Studies; Referral and Consultation; Reproducibility of Results; Rifampin; Risk Assessment; Scotland; Sensitivity and Specificity; Tuberculin Test | 2013 |
Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.
Topics: Adult; Antitubercular Agents; Cluster Analysis; Cross Infection; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Genotype; HIV Infections; Hospitals, Rural; Humans; Isoniazid; Male; Mutation; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prevalence; Pyrazinamide; Retrospective Studies; Rifampin; Sequence Analysis, DNA; South Africa | 2013 |
Postoperative spondylodiscitis caused by Mycobacterium bovis BCG: a case study.
Topics: Antitubercular Agents; Discitis; Diskectomy; Epidural Abscess; Humans; Intervertebral Disc Displacement; Isoniazid; Lumbar Vertebrae; Male; Mycobacterium bovis; Postoperative Period; Rifampin; Treatment Outcome; Tuberculosis | 2012 |
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.
Topics: Antitubercular Agents; Epidemiological Monitoring; Ethambutol; Greece; Humans; Isoniazid; Latent Tuberculosis; Prescription Drugs; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
[Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
Topics: Antitubercular Agents; Cervical Vertebrae; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Epidural Abscess; Ethambutol; Humans; Isoniazid; Levofloxacin; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thoracic Vertebrae; Tuberculosis, Central Nervous System | 2012 |
High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public-private initiative.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Colombia; Communicable Disease Control; Female; Humans; Infectious Disease Medicine; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Private Sector; Public Health; Public Sector; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; Biological Transport; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Escherichia coli; Ethambutol; Genotype; Isoniazid; Kanamycin; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Protein Structure, Secondary; Protein Structure, Tertiary; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis | 2013 |
Multidrug-resistant tuberculosis in children: evidence from global surveillance.
Topics: Adolescent; Adult; Age Distribution; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Logistic Models; Male; Odds Ratio; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 2013 |
The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
Topics: Adult; Antitubercular Agents; Bacterial Typing Techniques; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; South Africa; Survival Analysis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Lung; Mycobacterium tuberculosis; Pakistan; Rifampin | 2012 |
Tuberculosis treatment survival of HIV positive TB patients on directly observed treatment short-course in Southern Ethiopia: a retrospective cohort study.
Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Drug Administration Schedule; Female; HIV; HIV Infections; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Proportional Hazards Models; Pyrazinamide; Rifampin; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Cost-effectiveness of rifampin for 4 months and isoniazid for 9 months in the treatment of tuberculosis infection.
Topics: Adult; Antitubercular Agents; Contact Tracing; Cost-Benefit Analysis; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Retrospective Studies; Rifampin; Spain; Tuberculosis | 2013 |
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug Interactions; Ethambutol; Female; Genotype; HIV Infections; Humans; Isoniazid; Lamivudine; Male; Middle Aged; Organophosphonates; Oxidoreductases, N-Demethylating; Pharmacogenetics; Polymorphism, Single Nucleotide; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Tenofovir; Tuberculosis; Young Adult | 2013 |
Evaluation of biochip system in determining isoniazid and rifampicin resistances of mycobacterium tuberculosis in sputum samples.
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; High-Throughput Screening Assays; Humans; Isoniazid; Microarray Analysis; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant; Validation Studies as Topic | 2012 |
Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.
Topics: Adult; Aged; Antigens, Bacterial; Antigens, CD; Bacterial Proteins; Cells, Cultured; Cytokines; Female; Forkhead Transcription Factors; Humans; Immune Tolerance; Immunophenotyping; Isoniazid; Male; Middle Aged; Rifampin; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2013 |
[Anti-mycobacteria drugs therapy for periductal mastitis with fistula].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Fistula; Humans; Isoniazid; Mastitis; Nontuberculous Mycobacteria; Pyrazinamide; Retrospective Studies; Rifampin; Young Adult | 2012 |
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis.
Topics: Africa; Antitubercular Agents; Asia; Chemistry, Pharmaceutical; Chromatography, Thin Layer; Community Pharmacy Services; Counterfeit Drugs; Crime; Developing Countries; Drug Resistance, Bacterial; Drug Stability; Drug Storage; Humans; Isoniazid; Private Sector; Quality Control; Rifampin; Russia; Solubility | 2013 |
Inadequate therapeutic response to a recommended antituberculosis fixed-dose combination regimen in an overweight patient with Mycobacterium bovis infection.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Humans; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Overweight; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node | 2013 |
Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; India; Isoniazid; Male; Molecular Typing; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Phenotype; Point Mutation; Rifampin; Sensitivity and Specificity; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2013 |
In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
Topics: Animals; Antibiotics, Antitubercular; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Isoniazid; Lactic Acid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin | 2013 |
[Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
Topics: Adult; Clarithromycin; Cysts; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Tuberculosis, Pulmonary | 2012 |
Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Incidence; India; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Rifampin; Risk Factors; Sputum; Tuberculosis, Pulmonary | 2013 |
Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin.
Topics: Adult; Area Under Curve; Aza Compounds; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rifampin; Tuberculosis | 2012 |
Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2012 |
A pregnant woman with dyspnoea, fever & decreased vision.
Topics: Adult; Antitubercular Agents; Choroid Diseases; Ethambutol; Female; Humans; Isoniazid; Pregnancy; Pregnancy Outcome; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Miliary | 2012 |
Blood agar validation for susceptibility testing of isoniazid, rifampicin, ethambutol, and streptomycin to Mycobacterium tuberculosis isolates.
Topics: Agar; Antitubercular Agents; Culture Media; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Streptomycin | 2013 |
The need for coordinated action against falsified and substandard medicines.
Topics: Antitubercular Agents; Counterfeit Drugs; Crime; Humans; Isoniazid; Rifampin | 2013 |
Immigrants with latent tuberculosis infection: a moving target?
Topics: Antitubercular Agents; Emigrants and Immigrants; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Rifampin | 2013 |
[Thyroid tuberculosis; a rare cause of compressive goiter].
Topics: Antitubercular Agents; Biopsy; Combined Modality Therapy; Deglutition Disorders; Drainage; Ethambutol; Goiter; Hormone Replacement Therapy; Humans; Hypothyroidism; Isoniazid; Lymphatic Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pyrazinamide; Rifampin; Thyroiditis; Thyroxine; Tuberculosis, Endocrine | 2013 |
Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.
Topics: Antitubercular Agents; Calorimetry, Differential Scanning; Drug Carriers; Drug Interactions; Drug Stability; Hydrogen-Ion Concentration; Isoniazid; Microscopy, Electron, Transmission; Nanoparticles; Rifampin; Solubility | 2013 |
Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Bacterial; Epidemiological Monitoring; Ethambutol; Female; Health Surveys; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Risk Factors; Saudi Arabia; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
[A case of tuberculous peritonitis in a hemodialysis patient revealed by severe diarrhea and stomachache].
Topics: Abdominal Pain; Antitubercular Agents; Biomarkers; CA-125 Antigen; Diagnosis, Differential; Diarrhea; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Peritonitis, Tuberculous; Pyrazinamide; Receptors, Interleukin-2; Renal Dialysis; Rifampin; Treatment Outcome | 2013 |
Performance of the GenoType MTBDRplus assay directly on sputum specimens from Brazilian patients with tuberculosis treatment failure or relapse.
Topics: Antibiotics, Antitubercular; Bacterial Proteins; Base Sequence; Brazil; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Recurrence; Rifampin; Sequence Analysis, DNA; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2013 |
Early specific host response associated with starting effective tuberculosis treatment in an infection controlled placebo controlled mouse study.
Topics: Animals; Antitubercular Agents; Cytokines; Female; Host Specificity; Isoniazid; Metagenome; Mice; Mice, Inbred BALB C; Placebos; Rifampin; Tuberculosis, Pulmonary | 2013 |
Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Topics: Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Infant; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Radiography, Thoracic; Rifampin; Streptomycin; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Miliary; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Heme; Humans; Isoniazid; Liver; Male; Mice; Mice, Transgenic; Pregnane X Receptor; Protoporphyrins; Receptors, Steroid; Rifampin | 2013 |
Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Health Surveys; Humans; Isoniazid; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Predictive Value of Tests; Prevalence; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Cost-effectiveness of rifampin for 4 months and isoniazid for 6 months in the treatment of tuberculosis infection.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Female; Health Care Costs; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Rifampin; Sensitivity and Specificity; Spain; Treatment Outcome; Tuberculin Test; Young Adult | 2013 |
[Primary sinonasal tuberculosis: apropos of a case].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Maxillary Sinusitis; Mycobacterium tuberculosis; Nasal Obstruction; Nasal Polyps; Pyrazinamide; Rifampin; Tuberculosis | 2013 |
Isoniazid could be used for antibiotic-loaded bone cement for musculoskeletal tuberculosis: an in vitro study.
Topics: Antibiotics, Antitubercular; Bone Cements; Chemistry, Pharmaceutical; Drug Carriers; Isoniazid; Microbial Sensitivity Tests; Musculoskeletal Diseases; Mycobacterium tuberculosis; Polymerization; Rifampin; Solubility; Time Factors; Tuberculosis; Tuberculosis, Osteoarticular | 2013 |
Field evaluation of the direct detection of multidrug resistant Mycobacterium tuberculosis by nitrate reductase assay on 7H11 agar.
Topics: Agar; Antitubercular Agents; Colorimetry; Cross-Sectional Studies; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Reproducibility of Results; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2013 |
Progress and challenges in childhood tuberculosis.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Antitubercular Agents; BCG Vaccine; Child; Child, Preschool; Disease Susceptibility; Humans; Immunity, Innate; Isoniazid; Mycobacterium tuberculosis; Rifampin; Risk Factors; Tuberculosis; Tuberculosis Vaccines; Tuberculosis, Multidrug-Resistant | 2013 |
[Comment on the article "DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico" by Enrique Bolado-Martínez and collaborators].
Topics: Antitubercular Agents; DNA, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin | 2013 |
[Response to comment on the article "DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico" by Enrique Bolado-Martínez and collaborators].
Topics: Antitubercular Agents; DNA, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin | 2013 |
High prevalence of tuberculosis and insufficient case detection in two communities in the Western Cape, South Africa.
Topics: Adolescent; Adult; Antitubercular Agents; Comorbidity; Directly Observed Therapy; Female; Health Surveys; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prevalence; Rifampin; Saliva; South Africa; Sputum; Tuberculosis, Pulmonary; Zambia | 2013 |
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2013 |
Evaluation of antihepatotoxic potential of Solanum xanthocarpum fruit extract against antitubercular drugs induced hepatopathy in experimental rodents.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Fruit; Gastrointestinal Agents; Histocytochemistry; Isoniazid; Liver; Liver Function Tests; Male; Mice; Plant Extracts; Plasma; Pyrazinamide; Rats, Wistar; Rifampin; Solanum | 2012 |
Factors associated with the rapid implementation process of the fixed-dose combination RHZE tuberculosis regimen in Brazil: an ecological study.
Topics: Antitubercular Agents; Brazil; Drug Combinations; Ethambutol; Health Plan Implementation; Humans; Incidence; Isoniazid; Population Density; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 2013 |
Primary gingival tuberculosis diagnosis: a difficult endeavor.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Female; Gingival Diseases; Gingival Hemorrhage; Gingivitis; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Oral; Young Adult | 2013 |
Protective effects of kaempferol on isoniazid- and rifampicin-induced hepatotoxicity.
Topics: Animals; Cells, Cultured; Cytochrome P-450 CYP2E1; Female; Humans; Isoniazid; Kaempferols; Liver; Male; Mice; Mice, 129 Strain; Mice, Inbred ICR; Microsomes, Liver; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Rifampin | 2013 |
Identification of Mycobacterium species in FFPE granulomatous lymphadenitis tissue using REBA Myco-ID®.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Typing Techniques; Child; Child, Preschool; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Lymph Node; Young Adult | 2013 |
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tanzania; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
[Clinical evaluation of a line probe assay kit for the identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2013 |
Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children.
Topics: Acetylation; Age Factors; Antitubercular Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; India; Infant; Isoniazid; Male; Multivariate Analysis; Nutritional Status; Phenotype; Pyrazinamide; Regression Analysis; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2013 |
Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2013 |
Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Area Under Curve; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Indonesia; Isoniazid; Lung; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Risk Factors; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Proteins; Catalase; Codon; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Follow-Up Studies; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Promoter Regions, Genetic; Recurrence; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vietnam; Young Adult | 2013 |
[Dysphagia in a young woman from Somalia].
Topics: Antitubercular Agents; Deglutition Disorders; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Netherlands; Rifampin; Somalia; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Hydrophobic and Hydrophilic Interactions; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tandem Mass Spectrometry; Tuberculosis; Young Adult | 2013 |
A sociodemographic study of multidrug resistant tuberculosis cases from DOTS clinics of Kolkata.
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antitubercular; Child; Child, Preschool; Cross-Sectional Studies; Directly Observed Therapy; Female; Humans; India; Infant; Isoniazid; Male; Middle Aged; Nutritional Status; Rifampin; Sex Factors; Socioeconomic Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant; Young Adult | 2012 |
Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage.
Topics: Alanine Transaminase; Animals; Antitubercular Agents; Apoptosis; Chemical and Drug Induced Liver Injury; Hepatocyte Growth Factor; Isoniazid; Liver; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Rifampin | 2013 |
Severe hyponatremia and MRI point to diagnosis of tuberculous meningitis in the Southwest USA.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Hyponatremia; Isoniazid; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Southwestern United States; Tuberculosis, Meningeal; Young Adult | 2013 |
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis.
Topics: Alcohol Oxidoreductases; Amino Acid Sequence; Animals; Antitubercular Agents; Bacterial Proteins; Benzothiazoles; Biofilms; Carbohydrate Epimerases; Drug Resistance, Bacterial; Female; Genes, Bacterial; High-Throughput Screening Assays; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium tuberculosis; Oxidoreductases; Rifampin; Thiophenes; Tuberculosis, Pulmonary | 2013 |
A breathtaking response to tuberculosis therapy.
Topics: Adult; Antitubercular Agents; Disease Progression; Dyspnea; Ethambutol; Female; Humans; Isoniazid; Mediastinum; Pericarditis, Tuberculous; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Lymph Node | 2013 |
Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design.
Topics: Animals; Antitubercular Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Isoniazid; Lactic Acid; Macrophages, Peritoneal; Male; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Rifampin | 2014 |
[Tuberculosis annual report 2010--(9) Treatment of tuberculosis-2].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hospitalization; Humans; Infant; Isoniazid; Japan; Length of Stay; Male; Middle Aged; Registries; Rifampin; Time Factors; Tuberculosis; Young Adult | 2013 |
Completion rates of treatment for latent tuberculosis infection in Quebec, Canada from 2006 to 2010.
Topics: Adult; Aged; Antitubercular Agents; Databases, Factual; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Quebec; Rifampin; Risk Factors; Sex Factors; Young Adult | 2013 |
Genetic diversity of Mycobacterium tuberculosis in Peru and exploration of phylogenetic associations with drug resistance.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Peru; Phylogeny; Rifampin; Tuberculosis | 2013 |
Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
Topics: Adolescent; Adult; Africa South of the Sahara; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
Topics: Antitubercular Agents; Argentina; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifampin; Sequence Analysis, DNA; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2013 |
Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study.
Topics: Adult; Aged; Antitubercular Agents; California; Cohort Studies; Comorbidity; Drug Resistance, Bacterial; Female; HIV Infections; Humans; Incidence; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Survival Analysis; Tuberculosis, Multidrug-Resistant | 2013 |
Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; DNA, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pakistan; Polymerase Chain Reaction; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2012 |
Clinical outcome of the chronic flexor tenosynovitis in the hand caused by non-tuberculous mycobacterium treated by extensive tenosynovectomy and drugs.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hand; Hand Strength; Humans; Immunocompetence; Isoniazid; Levofloxacin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Mycobacterium marinum; Osteomyelitis; Range of Motion, Articular; Retrospective Studies; Rifampin; Scaphoid Bone; Synovectomy; Tenosynovitis | 2013 |
Serum drug concentrations predictive of pulmonary tuberculosis outcomes.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2013 |
PXR-ALAS1: a key regulatory pathway in liver toxicity induced by isoniazid-rifampicin antituberculosis treatment.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Male; Receptors, Steroid; Rifampin | 2013 |
Treatment response and adverse reactions in older tuberculosis patients with immunocompromising comorbidities.
Topics: Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Comorbidity; Female; Humans; Immunocompromised Host; Isoniazid; Male; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis | 2013 |
Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
Topics: Administration, Inhalation; Aerosols; Antitubercular Agents; Cell Line; Desiccation; Drug Carriers; Drug Compounding; Drug Delivery Systems; Gelatin; Humans; Isoniazid; Lung; Microspheres; Particle Size; Respiratory Mucosa; Rifampin; Tuberculosis | 2013 |
Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.
Topics: Antitubercular Agents; Cycloserine; Drug Stability; Drug Storage; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; India; Isoniazid; Levofloxacin; Ofloxacin; Pyrazinamide; Rifampin; Spectrophotometry; Tuberculosis | 2013 |
[Proposal of anti-tuberculosis regimens based on susceptibility to isoniazid and rifampicin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Clinical Protocols; Cross-Sectional Studies; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Young Adult | 2013 |
Therapeutic potential of thymoquinone against anti-tuberculosis drugs induced liver damage.
Topics: Analysis of Variance; Animals; Antitubercular Agents; Benzoquinones; Blood Chemical Analysis; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Isoniazid; Kidney; Lipid Peroxidation; Lipids; Liver; Liver Function Tests; Pyrazinamide; Rats; Rats, Sprague-Dawley; Rifampin; Superoxide Dismutase | 2013 |
Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Mutation, Missense; Mycobacterium tuberculosis; Precision Medicine; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2013 |
Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.
Topics: Alanine Transaminase; Animals; Antioxidants; Antitubercular Agents; Aspartate Aminotransferases; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2E1; Glutathione; Glutathione Peroxidase; Isoniazid; Lipid Peroxidation; Liver; Male; Metallothionein; Mice; Mice, Knockout; Rifampin; Superoxide Dismutase | 2013 |
Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.
Topics: Adult; Antitubercular Agents; Biological Availability; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Dosage Calculations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2013 |
[Treatment of presumed tuberculous uveitis affecting the posterior segment: diagnostic confirmation and long term outcomes].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoniazid; Panuveitis; Pyrazinamide; Recurrence; Remission Induction; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Ocular; Uveitis, Posterior | 2013 |
Salvage therapy for multidrug-resistant tuberculosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Capreomycin; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Male; Moxifloxacin; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Salvage Therapy; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
A case of skin and lung tuberculosis: diagnostic difficulties.
Topics: Antitubercular Agents; Bronchitis; Bronchoalveolar Lavage Fluid; Bronchoscopy; CD4-CD8 Ratio; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Ethambutol; Facial Dermatoses; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sarcoidosis; Sputum; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 2013 |
Genotype diversity of Mycobacterium isolates from children in Jimma, Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Bacterial Typing Techniques; Child; Child, Preschool; Drug Resistance, Bacterial; Ethiopia; Gastric Lavage; Genetic Variation; Genotype; Humans; Infant; Isoniazid; Mycobacterium tuberculosis; Rifampin; RNA, Ribosomal, 16S; Sputum; Tuberculosis, Pulmonary | 2013 |
Paediatric tubercular spinal abscess involving the dorsal, lumbar and sacral regions and causing spinal cord compression.
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Epidural Abscess; Humans; Isoniazid; Laminectomy; Lumbosacral Region; Male; Mycobacterium tuberculosis; Pyrazinamide; Rare Diseases; Rifampin; Spinal Cord Compression; Thoracic Vertebrae; Treatment Outcome; Tuberculin Test; Tuberculosis, Spinal | 2013 |
Lupus Vulgaris Erythematoides: report of a patient initially misdiagnosed as dermatitis.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Biopsy; Calcineurin Inhibitors; Dermis; Diagnostic Errors; Drug Therapy, Combination; Eczema; Erythema; Facial Dermatoses; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Isoniazid; Lupus Vulgaris; Mycobacterium tuberculosis; Necrosis; Nose Diseases; Pyrazinamide; Rifampin | 2013 |
High rate of completion of preventive therapy for latent tuberculosis infection among asylum seekers in a Swiss Canton.
Topics: Adult; Africa; Antitubercular Agents; Asia; Balkan Peninsula; Chemoprevention; Cohort Studies; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Mass Screening; Medication Adherence; Prospective Studies; Refugees; Rifampin; Switzerland | 2013 |
Olfactory disturbance related to pyrazinamide.
Topics: Antitubercular Agents; Drug Combinations; Humans; Isoniazid; Male; Middle Aged; Olfaction Disorders; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2014 |
Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
Topics: Adult; Antibiotics, Antitubercular; Bacterial Proteins; Catalase; Cross-Sectional Studies; Culture Techniques; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Female; Genotyping Techniques; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Oxidoreductases; Rifampin; Sensitivity and Specificity; Sputum; Tertiary Care Centers; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.
Topics: Antipsychotic Agents; Antitubercular Agents; Colony Count, Microbial; Computer Simulation; Drug Administration Schedule; Drug Design; Drug Repositioning; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Isoniazid; Latent Tuberculosis; Microbial Sensitivity Tests; Models, Statistical; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Thioridazine; Time Factors | 2013 |
Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in ethiopia.
Topics: Antibiotics, Antitubercular; Cross-Sectional Studies; Ethiopia; Humans; Isoniazid; Lymph Nodes; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2013 |
[Papilledema secondary to tuberculous meningitis in a patient with type 1 diabetes mellitus].
Topics: Adult; Antitubercular Agents; Atrophy; Cerebrospinal Fluid; Developing Countries; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Ecuador; False Negative Reactions; Female; Humans; Immunocompromised Host; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Ophthalmoscopy; Optic Nerve; Papilledema; Rifampin; Spinal Puncture; Tuberculin Test; Tuberculosis, Meningeal | 2013 |
Transmission of Mycobacterium tuberculosis in a High School and School-Based Supervision of an Isoniazid-Rifapentine Regimen for Preventing Tuberculosis - Colorado, 2011-2012.
Topics: Antitubercular Agents; Capacity Building; Colorado; Communication; Community-Institutional Relations; Contact Tracing; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; School Health Services; Tuberculosis | 2013 |
[Primary penile tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Isoniazid; Male; Middle Aged; Penile Diseases; Pyrazinamide; Rifampin; Skin Ulcer; Tuberculosis, Male Genital; Vitiligo | 2013 |
Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs.
Topics: Antitubercular Agents; Ethambutol; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin | 2014 |
Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
Topics: Adolescent; Adult; Aged; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2014 |
Pharmacokinetics and serum concentrations of antimycobacterial drugs in adult Turkish patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; Directly Observed Therapy; Drug Monitoring; Ethambutol; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Turkey; Young Adult | 2013 |
Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.
Topics: Adult; Antitubercular Agents; Automation, Laboratory; Colony Count, Microbial; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Feasibility Studies; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Predictive Value of Tests; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Uganda; Young Adult | 2013 |
Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Molecular Typing; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2013 |
Evaluation of rezasurin microtiter assay and high resolution melting curve analysis for detection of rifampicin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; Base Sequence; DNA Primers; Drug Resistance, Microbial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin | 2013 |
Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates.
Topics: Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Directly Observed Therapy; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Organ Transplantation; Prospective Studies; Rifampin | 2014 |
Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Germany; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin | 2014 |
Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin.
Topics: Alanine Transaminase; Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; CTLA-4 Antigen; Cytokines; Drug Therapy, Combination; Glutamate Dehydrogenase; Interleukin-2 Receptor alpha Subunit; Isoniazid; Lymph Nodes; Male; Neck; Rats; Rats, Wistar; Rifampin; Succinate Dehydrogenase | 2014 |
Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
Topics: Antitubercular Agents; Drug Eruptions; Drug Therapy, Combination; Eczema; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Patch Tests; Pyrazines; Rifampin | 2013 |
Effect of mycobacterial drug resistance patterns on patients' survival: a cohort study in Thailand.
Topics: Adolescent; Adult; Aged; Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; Diabetes Mellitus; Female; HIV Infections; Humans; Infant; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Thailand; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2013 |
Anti‑tuberculosis drugs decrease viability and stimulate the expression of chondrocyte marker genes in human nucleus pulposus cells.
Topics: Adolescent; Aggrecans; Antitubercular Agents; Cell Survival; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type II; Ethambutol; Glycosaminoglycans; Humans; Intervertebral Disc; Isoniazid; Pyrazinamide; Rifampin; RNA, Messenger; SOX9 Transcription Factor; Transforming Growth Factor beta1; Young Adult | 2014 |
[Evaluation of multidrug-resistant tuberculosis treatment in Ivory Coast from 2008 to 2010].
Topics: Adult; Antitubercular Agents; Cote d'Ivoire; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Hospitals, University; Humans; Isoniazid; Male; Medication Adherence; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Withholding Treatment; Young Adult | 2013 |
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clone Cells; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Operon; Phylogeny; Polymorphism, Restriction Fragment Length; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam | 2013 |
Cost-effectiveness of treating latent tuberculous infection: a step towards elimination?
Topics: Antitubercular Agents; Drug Costs; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2013 |
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.
Topics: Antitubercular Agents; Computer Simulation; Cost-Benefit Analysis; Directly Observed Therapy; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Hospital Costs; Humans; Isoniazid; Latent Tuberculosis; Models, Economic; Quality-Adjusted Life Years; Rifampin; Time Factors; Treatment Outcome; United States | 2013 |
Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Therapy, Combination; Female; Hospitals, University; Humans; Iran; Isoniazid; Male; Middle Aged; Pyrazinamide; Reference Standards; Reference Values; Rifampin; Tertiary Care Centers; Treatment Failure; Tuberculosis, Pulmonary | 2013 |
Detection of mutations associated with resistance to rifampicin and isoniazid in Mycobacterium tuberculosis by polymerase chain reaction-ligase detection reaction.
Topics: Drug Resistance, Multiple; Isoniazid; Ligase Chain Reaction; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin | 2014 |
[Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation].
Topics: Adult; Antibiotics, Antitubercular; Ethambutol; Female; Humans; Immunization; Isoniazid; Purpura, Thrombocytopenic, Idiopathic; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2013 |
[A clinical investigation of seven patients with pulmonary tuberculosis who developed mixed liver injury during oral anti-tuberculosis treatment].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2013 |
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
Topics: Academic Medical Centers; Alleles; Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA-Directed RNA Polymerases; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Typing; Mutation; Mycobacterium tuberculosis; Prevalence; Promoter Regions, Genetic; Rifampin; Tuberculosis, Pulmonary | 2014 |
Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Case-Control Studies; China; Drug Resistance, Multiple, Bacterial; Female; Humans; Income; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Patient Compliance; Rifampin; Risk Factors; Surveys and Questionnaires; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Common errors in multidrug-resistant tuberculosis management.
Topics: Administration, Oral; Antitubercular Agents; Developing Countries; Diagnostic Errors; Disease Management; Drug Delivery Systems; Humans; Injections; Isoniazid; Medication Errors; Rifampin; Tuberculosis, Multidrug-Resistant | 2014 |
In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Synergism; Ethambutol; Furocoumarins; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Vero Cells | 2014 |
Strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response.
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2014 |
Reply to "strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response".
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2014 |
Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidoreductases; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2014 |
[Antimicrobial resistance in tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spain; Streptomycin; Tuberculosis, Pulmonary | 2013 |
Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the malachite green decolourisation assay.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Reproducibility of Results; Rifampin; Rosaniline Dyes; Sensitivity and Specificity | 2013 |
Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?
Topics: Antitubercular Agents; Diagnostic Tests, Routine; Drug Resistance, Multiple, Bacterial; Humans; Incidence; India; Isoniazid; Microbial Sensitivity Tests; Models, Statistical; Mortality; Mycobacterium tuberculosis; Patient Outcome Assessment; Population Surveillance; Rifampin; Tuberculosis, Multidrug-Resistant | 2014 |
Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid.
Topics: Administration, Oral; Animals; Antitubercular Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Drug Carriers; Ethylene Glycols; Hydrochloric Acid; Isoniazid; Male; Micelles; Nanomedicine; Particle Size; Polyesters; Polymers; Rats; Rats, Wistar; Rifampin; Solubility; Tuberculosis | 2014 |
Hepatoprotective effects of Yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice.
Topics: Animals; Antioxidants; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Isoniazid; Lipid Peroxidation; Male; Mice; Millettia; Polysaccharides; Rifampin | 2014 |
Successful rifampin desensitization in a pediatric patient with latent tuberculosis.
Topics: Child; Clinical Protocols; Contraindications; Desensitization, Immunologic; Diphenhydramine; Drug Dosage Calculations; Drug Hypersensitivity; Exanthema; Glucosephosphate Dehydrogenase Deficiency; Humans; Immune Tolerance; Isoniazid; Latent Tuberculosis; Male; Rifabutin; Rifampin | 2014 |
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; Genotype; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2014 |
Probing location of anti-TB drugs loaded in Brij 96 microemulsions using thermoanalytical and photophysical approach.
Topics: 2,2'-Dipyridyl; Antitubercular Agents; Calorimetry, Differential Scanning; Coordination Complexes; Drug Carriers; Drug Compounding; Drug Stability; Emulsions; Fluorescence Polarization; Fluorescent Dyes; Hydrophobic and Hydrophilic Interactions; Isoniazid; Models, Chemical; Oxazines; Plant Oils; Polyethylene Glycols; Pyrazinamide; Rifampin; Solubility; Spectrometry, Fluorescence; Water | 2014 |
Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity.
Topics: Adult; Antitubercular Agents; Area Under Curve; Case-Control Studies; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Metabolic Clearance Rate; Prospective Studies; Pyrazinamide; Rifampin; Risk Factors; Tuberculosis | 2014 |
Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Early Diagnosis; Gold; Humans; Isoniazid; Metal Nanoparticles; Multiplex Polymerase Chain Reaction; Oxidoreductases; Point Mutation; Point-of-Care Systems; Rifampin; Tuberculosis, Multidrug-Resistant | 2014 |
The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injury; China; Cross-Sectional Studies; Cytochrome P-450 CYP2E1; Drug Therapy, Combination; Ethambutol; Female; Gene Frequency; Genetic Association Studies; Glutathione Transferase; Humans; Incidence; Isoniazid; Male; Middle Aged; Polymorphism, Single Nucleotide; Prevalence; Pyrazinamide; Rifampin; Sex Distribution; Tuberculosis, Pulmonary; Young Adult | 2014 |
Fatal suicidal poisoning with antituberculosis agents with ST elevation and acute coronary syndrome symptoms--a case report.
Topics: Acute Coronary Syndrome; Antitubercular Agents; Drug Overdose; Echocardiography; Ethanol; Fatal Outcome; Humans; Isoniazid; Ketoprofen; Male; Pyrazinamide; Rifampin; Shock, Cardiogenic; Suicide; Young Adult | 2013 |
Hepatoprotective potential of Cassia auriculata roots on ethanol and antitubercular drug-induced hepatotoxicity in experimental models.
Topics: Animals; Antioxidants; Antitubercular Agents; Cassia; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Female; India; Isoniazid; Male; Medicine, Traditional; Plant Extracts; Plant Roots; Pyrazinamide; Rats; Rats, Wistar; Rifampin; Silymarin | 2014 |
Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Biofilms; Culture Media; Deoxyribonuclease I; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polysorbates; Rifampin | 2014 |
Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses.
Topics: Antitubercular Agents; Child; Child, Preschool; Electronic Data Processing; Female; Humans; Infant; Isoniazid; Male; Models, Statistical; Pyrazinamide; Rifampin; South Africa; Tuberculosis | 2014 |
Unfinished battle with childhood tuberculosis: is it curable with less drugs and shorter duration?
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Recurrence; Retrospective Studies; Rifampin; Time Factors; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Augmentation of antitubercular therapy with IFNγ in a patient with dominant partial IFNγ receptor 1 deficiency.
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Gene Expression; Humans; Infant; Interferon-gamma; Interleukin-12; Isoniazid; Mycobacterium bovis; Osteomyelitis; Receptors, Interferon; Rifampin; Tuberculosis, Lymph Node; Virus Diseases | 2014 |
Detection of drug resistant Mycobacterium tuberculosis among patients with and without HIV infection in a rural setting.
Topics: Antitubercular Agents; Case-Control Studies; Coinfection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Guyana; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Probe Techniques; Mycobacterium tuberculosis; Nitrates; Rifampin; Rural Population; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Rolling circle amplification for direct detection of rpoB gene mutations in Mycobacterium tuberculosis isolates from clinical specimens.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2014 |
A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens.
Topics: Adult; Female; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2014 |
Esophageal anthracosis with tuberculous lymphadenitis confirmed on transesophageal endoscopic ultrasound-guided fine-needle aspiration.
Topics: Aged; Anthracosis; Antitubercular Agents; Chest Pain; Drug Therapy, Combination; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Esophagus; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node; Weight Loss | 2014 |
Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Genotyping Techniques; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis; United States | 2014 |
A new rapid colourimetric method for testing Mycobacterium tuberculosis susceptibility to isoniazid and rifampicin: a crystal violet decolourisation assay.
Topics: Anti-Infective Agents; Antitubercular Agents; Cell Proliferation; Colorimetry; Developing Countries; Drug Resistance, Multiple, Bacterial; Gentian Violet; Isoniazid; Mycobacterium tuberculosis; Predictive Value of Tests; Research Design; Rifampin; Sensitivity and Specificity | 2014 |
[Alopecia areata in a patient treated with antitubercular drugs].
Topics: Administration, Cutaneous; Alopecia Areata; Antitubercular Agents; Child; Drug Therapy, Combination; Glucocorticoids; Humans; Isoniazid; Male; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
Optimization of the microscopic observation drug susceptibility assay for four first-line drugs using Mycobacterium tuberculosis reference strains and clinical isolates.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2014 |
Tuberculous meningitis--a case report.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Poland; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Miliary | 2013 |
Joint failure after steroid therapy in tuberculous encephalitis.
Topics: Adolescent; Anti-Inflammatory Agents; Antitubercular Agents; Encephalitis; Female; Femur Head Necrosis; Humans; Humeral Head; Isoniazid; Joint Diseases; Prednisolone; Radiography; Rifampin; Tuberculosis, Central Nervous System | 2014 |
Facing multi-drug resistant tuberculosis.
Topics: Antitubercular Agents; Directly Observed Therapy; Drug Design; Humans; Isoniazid; Medication Adherence; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.
Topics: Animals; Antipsychotic Agents; Antitubercular Agents; Disease Models, Animal; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Thioridazine; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
An unusual cause of breast lump: isolated tuberculosis of the breast.
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Breast Diseases; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2014 |
Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6.
Topics: Alkynes; Antitubercular Agents; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Interactions; Enzyme Activation; Ethambutol; Humans; Hydroxylation; Isoniazid; Microsomes, Liver; Pyrazinamide; Rifampin | 2014 |
In house reverse membrane hybridisation assay versus GenoType MTBDRplus and their performance to detect mutations in the genes rpoB, katG and inhA.
Topics: Bacterial Proteins; Catalase; Colorimetry; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotyping Techniques; Isoniazid; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Oxidoreductases; Rifampin | 2014 |
Cervical lymphadenopathy--pitfalls of blind antitubercular treatment.
Topics: Adolescent; Adult; Antitubercular Agents; Biopsy; Diagnostic Errors; Ethambutol; Female; Histiocytic Necrotizing Lymphadenitis; Hodgkin Disease; Humans; India; Isoniazid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Simvastatin increases the in vivo activity of the first-line tuberculosis regimen.
Topics: Animals; Antitubercular Agents; Bacterial Load; Cell Line; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Isoniazid; Lung; Macrophages; Mice, Inbred BALB C; Pyrazinamide; Rifampin; Simvastatin; Treatment Outcome; Tuberculosis | 2014 |
Prevalence of extended treatment in pulmonary tuberculosis patients receiving first-line therapy and its association with recurrent tuberculosis in Beijing, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Cohort Studies; Cost of Illness; Drug Combinations; Ethambutol; Female; Health Care Costs; Humans; Isoniazid; Male; Middle Aged; Prevalence; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs.
Topics: Animals; Antitubercular Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Female; Galactans; Isoniazid; Lung; Male; Mannans; Mycobacterium tuberculosis; Nanoparticles; Plant Gums; Porosity; Rats; Rats, Wistar; Rifampin; Tuberculosis | 2016 |
Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.
Topics: Antitubercular Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Epithelial Cells; Fibroblasts; Fluoroquinolones; Humans; Isoenzymes; Isoniazid; Lung; Matrix Metalloproteinases; Models, Biological; Moxifloxacin; Mycobacterium tuberculosis; Primary Cell Culture; Rifampin; Stromal Cells; Tuberculosis, Pulmonary | 2014 |
Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
Topics: Antitubercular Agents; Base Sequence; Colorimetry; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Rifabutin; Rifampin; Sequence Analysis, DNA; Tuberculosis | 2014 |
Update on cost-effectiveness of a 12-dose regimen for latent tuberculous infection at new rifapentine prices.
Topics: Antitubercular Agents; Drug Costs; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2014 |
Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Thioridazine; Tuberculosis, Pulmonary | 2014 |
Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
Topics: Adult; Antitubercular Agents; Biomarkers; C-Reactive Protein; Copper; Ethambutol; Hemoglobins; Host-Pathogen Interactions; Humans; Inflammation; Iron; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Serum Albumin; Serum Globulins; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Zinc | 2014 |
Novel bronchoscopic balloon dilation for patients with bronchostenosis caused by bronchial tuberculosis: a case report.
Topics: Antitubercular Agents; Bronchial Diseases; Bronchoscopy; Constriction, Pathologic; Dilatation; Ethambutol; Female; Humans; Isoniazid; Lung; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2014 |
[Surveillance of antituberculosis-drug resistance in Cuba, 2010-2011].
Topics: Antitubercular Agents; Clone Cells; Cuba; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Laboratories; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Prospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Pros and cons of the tuberculosis drugome approach--an empirical analysis.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tamoxifen; Tuberculosis | 2014 |
Genotoxic effects of some antituberculosis drugs and mixtures in rats.
Topics: Animals; Antitubercular Agents; DNA Damage; Drug Combinations; Ethambutol; Isoniazid; Kidney; Liver; Male; Pyrazinamide; Rats; Rifampin | 2015 |
Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Hypromellose Derivatives; Isoniazid; Lung; Male; Nanoparticles; Nasal Sprays; Particle Size; Powders; Rats; Rats, Wistar; Rifampin | 2016 |
An unusual lung mass post stem cell transplantation.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Stem Cell Transplantation | 2014 |
Isoniazid, pyrazinamide and rifampicin content variation in split fixed-dose combination tablets.
Topics: Chemistry, Pharmaceutical; Drug Combinations; Humans; Isoniazid; Pyrazinamide; Quality Control; Rifampin; Tablets; Tuberculosis, Pulmonary | 2014 |
Occurrence of diverse mutations in isoniazid- and rifampicin-resistant Mycobacterium tuberculosis isolates from autochthonous and immigrant populations of Saudi Arabia.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Codon; DNA, Bacterial; Drug Resistance, Bacterial; Emigrants and Immigrants; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Saudi Arabia; Tuberculosis, Multidrug-Resistant | 2014 |
[Mycobacterium tuberculosis strains isolated from Van region four different sensitivity detection method antimycobacterial agents].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity | 2014 |
Molecular epidemiology of tuberculosis in Cambodian children.
Topics: Adolescent; Antitubercular Agents; Cambodia; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Assessing the impact of patient self-selection on the costs to treat latent tuberculosis infection (LTBI) with isoniazid and transitional rifampin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Female; Health Expenditures; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Patient Dropouts; Retrospective Studies; Rifampin; Time Factors; Urban Population; Young Adult | 2014 |
Pulmonary tuberculoma in a patient with chronic hepatitis C: a clinical pitfall in the treatment strategy.
Topics: Antitubercular Agents; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Image-Guided Biopsy; Isoniazid; Lung; Middle Aged; Mycobacterium tuberculosis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Pulmonary | 2014 |
Redefining multidrug-resistant tuberculosis based on clinical response to combination therapy.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
A case of tuberculosis cutis colliquativa treated with rifampicin and isoniazid.
Topics: Aged; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Isoniazid; Neck; Rifampin; Tuberculosis, Cutaneous | 2014 |
A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India.
Topics: DNA, Intergenic; Drug Resistance, Bacterial; Ethambutol; Genetic Variation; Genotype; Humans; India; Isoniazid; Molecular Epidemiology; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin; Tuberculosis | 2014 |
Adsorptive stripping voltammetry of antibiotics rifamycin SV and rifampicin at renewable pencil electrodes.
Topics: Adsorption; Anti-Bacterial Agents; Electrochemistry; Electrodes; Equipment Reuse; Humans; Isoniazid; Reproducibility of Results; Rifampin; Rifamycins | 2014 |
Attenuation of anti-tuberculosis therapy induced hepatotoxicity by Spirulina fusiformis, a candidate food supplement.
Topics: Animals; Antibiotics, Antitubercular; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Isoniazid; Ligands; Lipid Peroxidation; Liver; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Organ Size; Oxidoreductases; Pregnane X Receptor; Probiotics; Protective Agents; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Rifampin; Silymarin; Spirulina | 2014 |
Ascorbic acid improves stability and pharmacokinetics of rifampicin in the presence of isoniazid.
Topics: Administration, Oral; Animals; Antioxidants; Antitubercular Agents; Area Under Curve; Ascorbic Acid; Biological Availability; Chemistry, Pharmaceutical; Drug Combinations; Drug Interactions; Drug Stability; Half-Life; Isoniazid; Male; Metabolic Clearance Rate; Rabbits; Rifampin; Solubility; Technology, Pharmaceutical | 2014 |
Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient.
Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Fatty Acid Synthesis Inhibitors; HIV Infections; Humans; Isoniazid; Leishmaniasis, Cutaneous; Male; Nucleic Acid Synthesis Inhibitors; Rifampin; Skin | 2014 |
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Siberia; Tuberculosis; Young Adult | 2014 |
Molecular detection and characterization of resistant genes in Mycobacterium tuberculosis complex from DNA isolated from tuberculosis patients in the Eastern Cape province South Africa.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; DNA, Bacterial; Female; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Prevalence; Rifampin; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Evaluation of the GenoType(®) MTBDRplus line probe assay on sputum-positive samples in routine settings in China.
Topics: Antitubercular Agents; Bacteriological Techniques; Chi-Square Distribution; China; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Predictive Value of Tests; Prognosis; Reproducibility of Results; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Autoimmune Diseases; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Retrospective Studies; Rifampin; Tuberculin Test; Tumor Necrosis Factor-alpha | 2014 |
Isoniazid and rifampicin resistance mutations and their effect on second-line anti-tuberculosis treatment.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Codon; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Ethionamide; Ethiopia; Female; Humans; Isoniazid; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
[A miliary tuberculosis case without lung involvement difficult to distinguish from autoimmune hepatitis exacerbation].
Topics: Antitubercular Agents; Diagnosis, Differential; Female; Hepatitis, Autoimmune; Humans; Isoniazid; Lung; Middle Aged; Rifampin; Tuberculosis, Miliary | 2014 |
[Reply to "Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid"].
Topics: Antitubercular Agents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.
Topics: Algorithms; Antitubercular Agents; CD4 Lymphocyte Count; Cost-Benefit Analysis; Drug Resistance, Bacterial; HIV Infections; Humans; Isoniazid; Models, Economic; Mycobacterium tuberculosis; Radiography; Rifampin; Sensitivity and Specificity; Tuberculosis | 2014 |
Phylogenetic associations with drug-resistant Mycobacterium tuberculosis isolates in a paediatric population.
Topics: Adolescent; Antitubercular Agents; Asia, Central; Child; Child, Preschool; China; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Incidence; India; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Outpatients; Phylogeny; Prevalence; Retrospective Studies; Rifampin; Sentinel Surveillance; Tuberculosis, Multidrug-Resistant | 2014 |
False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene.
Topics: Aged; Amikacin; Amino Acid Sequence; Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Molecular Sequence Data; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary | 2014 |
Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia.
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 2014 |
Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patients.
Topics: Adolescent; Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Comorbidity; Diabetes Mellitus; Dietary Fats; Drug Administration Schedule; Female; Food-Drug Interactions; HIV Infections; Humans; Hypoglycemic Agents; Isoniazid; Male; Middle Aged; Peru; Rifampin; Sex Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
A field evaluation of the Hardy TB MODS Kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Reagent Kits, Diagnostic; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China.
Topics: Antitubercular Agents; China; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin | 2014 |
Classical against molecular-genetic methods for susceptibility testing of antituberculotics.
Topics: Aminoglycosides; Antitubercular Agents; Culture Media; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Slovakia; Tuberculosis, Pulmonary | 2015 |
Selective determination of isoniazid using bentonite clay modified electrodes.
Topics: Aluminum Silicates; Bentonite; Catalysis; Clay; Electrochemical Techniques; Electrodes; Equipment Design; Isoniazid; Kinetics; Oxidation-Reduction; Pyridines; Reproducibility of Results; Rifampin; Sensitivity and Specificity | 2015 |
Anti-tuberculosis treatments and risk of hepatocellular carcinoma in tuberculosis patients with liver cirrhosis: a population-based case-control study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Carcinoma, Hepatocellular; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver Cirrhosis; Male; Middle Aged; Rifampin; Risk; Risk Assessment; Taiwan; Tuberculosis; Young Adult | 2015 |
Multidrug-resistant tuberculosis around the world: what progress has been made?
Topics: Antitubercular Agents; Brazil; China; Communicable Disease Control; Data Collection; Global Health; Humans; India; Isoniazid; Poverty; Rifampin; Russia; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Female; Isoniazid; Latent Tuberculosis; Lung; Mice; Mice, Inbred C3H; Mycobacterium tuberculosis; Nitroimidazoles; Rifampin | 2014 |
A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
Topics: Antitubercular Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Isoniazid; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Silicon Dioxide; Time Factors | 2014 |
Decision-making dilemma in drug-induced acute pancreatitis.
Topics: Antitubercular Agents; Decision Making; Humans; Isoniazid; Male; Middle Aged; Pancreatitis; Recurrence; Rifampin | 2014 |
Evaluation of the modified colorimetric resazurin microtiter plate-based antibacterial assay for rapid and reliable tuberculosis drug susceptibility testing.
Topics: Antitubercular Agents; Colorimetry; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Rifampin; Tuberculosis; Xanthenes | 2014 |
Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Radiography; Recurrence; Rifampin; Sex Factors; Social Class; Sputum; Tertiary Healthcare; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Thioridazine for treatment of tuberculosis: promises and pitfalls.
Topics: Animals; Antitubercular Agents; Female; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Thioridazine; Tuberculosis | 2014 |
Cost-effectiveness of 12-dose LTBI regimen improved following advocacy to lower the price of rifapentine.
Topics: Antitubercular Agents; Drug Costs; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2014 |
Protective effects of resveratrol on hepatotoxicity induced by isoniazid and rifampicin via SIRT1 modulation.
Topics: Alanine Transaminase; Animals; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Glutathione; Interleukin-10; Isoniazid; Liver; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Oxidation-Reduction; Oxidative Stress; Peroxidase; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Resveratrol; Rifampin; Sirtuin 1; Stilbenes; Transcription Factors; Tumor Necrosis Factor-alpha | 2014 |
Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Isoniazid; Latent Tuberculosis; Male; Mice; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Rifampin; Thioridazine | 2014 |
Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria.
Topics: Adult; Antitubercular Agents; Cohort Studies; Coinfection; Ethambutol; Female; Health Status Disparities; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Retrospective Studies; Rifampin; Rural Population; Sex Factors; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Urban Population; Young Adult | 2015 |
Ursolic Acid Activates Intracellular Killing Effect of Macrophages During Mycobacterium tuberculosis Infection.
Topics: Antitubercular Agents; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Host-Pathogen Interactions; Humans; Intracellular Space; Isoniazid; Macrophages; Mycobacterium tuberculosis; Reactive Oxygen Species; Rifampin; Triterpenes; Tuberculosis; Ursolic Acid | 2015 |
Molecular epidemiology of tuberculosis in Sicily, Italy: what has changed after a decade?
Topics: Adult; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Ethambutol; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Molecular Epidemiology; Molecular Typing; Mycobacterium tuberculosis; Rifampin; Sicily; Tuberculosis | 2014 |
Re-emphasizing Thygeson's warning: conjunctival phlyctenulosis as presenting sign of impending clinical tuberculosis.
Topics: Antitubercular Agents; Blood Sedimentation; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Keratoconjunctivitis; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Ocular | 2014 |
Severe meningoencephalitis co-infection due to Cryptococcus neoformans and Mycobacterium tuberculosis in a child with systemic lupus erythematosus.
Topics: Amphotericin B; Antitubercular Agents; Child; Coinfection; Cryptococcosis; Cryptococcus neoformans; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Lupus Erythematosus, Systemic; Meningoencephalitis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin | 2015 |
Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment.
Topics: Adapalene; Animals; Anti-Bacterial Agents; Antitubercular Agents; Bone Marrow; Bone Marrow Cells; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Leukocyte Common Antigens; Lung; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Naphthalenes; Rifampin; Spleen; Tuberculosis | 2014 |
Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Humans; Isoniazid; Rifampin; Solid Phase Extraction; Tandem Mass Spectrometry | 2015 |
Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Genetic Variation; Genotype; Isoniazid; Molecular Epidemiology; Molecular Typing; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Phylogeny; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2015 |
Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North- Eastern States of India using GenoType MTBDRplus assay.
Topics: Adolescent; Adult; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple; Female; Genotype; Humans; India; Isoniazid; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2014 |
A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Calibration; Computer Simulation; Disease Models, Animal; Dose-Response Relationship, Drug; Granuloma; Humans; Immunity; Isoniazid; Mice; Models, Biological; Mycobacterium tuberculosis; Primates; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2015 |
In vitro interaction of eupomatenoid-5 from Piper solmsianum C. DC. var. solmsianum and anti-tuberculosis drugs.
Topics: Antitubercular Agents; Benzofurans; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Genotype; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenols; Phytotherapy; Piper; Plant Extracts; Plant Leaves; Plants, Medicinal; Rifampin | 2014 |
Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Hospital Mortality; Hospitalization; Humans; Infant; Infant, Newborn; Isoniazid; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Patient Discharge; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Serum drug concentrations of INH and RMP predict 2-month sputum culture results in tuberculosis patients.
Topics: Adult; Aged; Alberta; Antitubercular Agents; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Sputum; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary | 2015 |
Twelve-dose drug regimen now also an option for preventing tuberculosis in children and adolescents.
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Rifampin | 2015 |
[On 'Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid'. Author's reply].
Topics: Antitubercular Agents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
[The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retreatment; Retrospective Studies; Rifampin; Sputum; Thorax; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2014 |
[Fixed drug eruption after taking ethambutol].
Topics: Adult; Antitubercular Agents; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Humans; Hypopigmentation; Isoniazid; Lip Diseases; Male; Rifampin; Tuberculosis, Pulmonary | 2015 |
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Isoniazid; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Stem Cells; Thioridazine; Tuberculosis | 2014 |
Breakpoints and drug exposure are inevitably closely linked.
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Reply to "breakpoints and drug exposure are inevitably closely linked".
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Performance of REBA MTB-XDR to detect extensively drug-resistant tuberculosis in an intermediate-burden country.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genes, MDR; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Republic of Korea; Rifampin; Sputum; Streptomycin | 2015 |
Tuberculous spondylitis in Russia and prominent role of multidrug-resistant clone Mycobacterium tuberculosis Beijing B0/W148.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Resistance, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Prevalence; Rifampin; Russia; Spondylitis; Tuberculosis, Spinal; Young Adult | 2015 |
3D-printed hierarchical scaffold for localized isoniazid/rifampin drug delivery and osteoarticular tuberculosis therapy.
Topics: Animals; Drug Delivery Systems; Female; Femur; Glass; Humans; Isoniazid; Kidney; Kidney Function Tests; Liver; Male; Nanoparticles; Osteogenesis; Porosity; Powders; Printing, Three-Dimensional; Rabbits; Radiography; Rifampin; Silicon Dioxide; Temperature; Tissue Scaffolds; Tuberculosis, Osteoarticular | 2015 |
Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2015 |
Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antitubercular Agents; Dexamethasone; Ethambutol; Female; Humans; Infliximab; Isoniazid; Middle Aged; Prednisolone; Pyrazinamide; Rifampin; Tuberculoma, Intracranial; Tuberculosis, Meningeal; Tumor Necrosis Factor-alpha | 2015 |
Resolution of tubercular abscess with antitubercular treatment.
Topics: Antitubercular Agents; Brain Abscess; Child, Preschool; Drug Therapy, Combination; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Central Nervous System | 2014 |
Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis.
Topics: Administration, Inhalation; Animals; Antibiotics, Antitubercular; Chitosan; Disease Models, Animal; Drug Carriers; Female; Humans; Isoniazid; Mice; Mice, Inbred BALB C; Nanoparticles; Rifampin; Tuberculosis, Pulmonary | 2016 |
Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nigeria; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy.
Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Republic of Korea; Retrospective Studies; Rifampin; Tumor Necrosis Factor-alpha | 2015 |
Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis.
Topics: Animals; Antitubercular Agents; Combined Modality Therapy; Disease Models, Animal; Drug Therapy; Gene Expression Profiling; Immunotherapy; Isoniazid; Lung; Mice, Inbred BALB C; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis; Vaccines, DNA | 2015 |
Dual infection with pulmonary tuberculosis and Lophomonas blattarum in India.
Topics: Antiprotozoal Agents; Antitubercular Agents; Bronchoalveolar Lavage; Ceftriaxone; Dose-Response Relationship, Drug; Humans; India; Isoniazid; Lung Diseases, Parasitic; Male; Metronidazole; Middle Aged; Mycobacterium tuberculosis; Parabasalidea; Rifampin; Trophozoites; Tuberculosis, Pulmonary | 2015 |
Cavitary tuberculosis and tracheal stenosis simulating granulomatosis with polyangiitis.
Topics: Adult; Antitubercular Agents; Dose-Response Relationship, Drug; Female; Granulomatosis with Polyangiitis; Humans; Isoniazid; Methotrexate; Mycobacterium tuberculosis; Prednisone; Rifampin; Tomography, X-Ray Computed; Tracheal Stenosis; Tuberculosis | 2015 |
Diabetes and Other Risk Factors for Multi-drug Resistant Tuberculosis in a Mexican Population with Pulmonary Tuberculosis: Case Control Study.
Topics: Adult; Ambulatory Care Facilities; Antibiotics, Antitubercular; Bacterial Typing Techniques; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Drug Resistance, Multiple, Bacterial; Female; Health Care Costs; Health Personnel; Humans; Isoniazid; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
Chest wall abscess as a complication of bacilli Calmette-Guérin vaccination in an immunocompetent child.
Topics: Abscess; BCG Vaccine; Humans; Infant; Isoniazid; Lymphadenitis; Male; Mycobacterium tuberculosis; Polymerase Chain Reaction; Radiography, Thoracic; Rifampin; Sequence Analysis, DNA; Thoracic Wall; Tomography, X-Ray Computed; Tuberculin Test | 2015 |
[A positive test QuantiFERON-TB Gold In-Tube in a patient treated with continuous ambulatory peritoneal dialysis].
Topics: Aged; Antitubercular Agents; Drug Administration Schedule; Female; Humans; Isoniazid; Kidney Failure, Chronic; Kidney Transplantation; Latent Tuberculosis; Peritoneal Dialysis, Continuous Ambulatory; Rifampin; Tuberculin Test | 2014 |
Effective anti-tuberculosis therapy correlates with plasma small RNA.
Topics: Adult; Antitubercular Agents; Biomarkers; Coinfection; Ethambutol; Female; Gene Expression Profiling; HIV Infections; Humans; Isoniazid; Male; MicroRNAs; Prospective Studies; Pyrazinamide; Rifampin; RNA; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
[A case of tuberculous meningitis complicated with multiple drug hypersensitivity to antituberculosis agents].
Topics: Antitubercular Agents; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Immunologic Tests; Isoniazid; Levofloxacin; Lymphocyte Activation; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2015 |
Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Genotype; Genotyping Techniques; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Malawi; Male; Plasma; Pyrazinamide; Rifampin | 2015 |
Adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future.
Topics: Antitubercular Agents; Dietary Fats; Female; Food-Drug Interactions; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 2015 |
Reply to "adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future".
Topics: Antitubercular Agents; Dietary Fats; Female; Food-Drug Interactions; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 2015 |
Isoniazid-induced acute liver failure during preventive therapy for latent tuberculosis infection.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Hospitalization; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Rifampin | 2015 |
Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.
Topics: Antitubercular Agents; Cyclosporine; Isoniazid; Macrophages; Mycobacterium tuberculosis; Nanoparticles; Rifampin; Vitamin E | 2015 |
Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacteriaceae; Nigeria; Retrospective Studies; Rifampin; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2015 |
Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Female; Humans; India; Isoniazid; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Retreatment; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Safe and effective treatment for patients with isoniazid drug resistance.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis | 2015 |
In reply.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis | 2015 |
Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Brazil; Cohort Studies; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
An interlaboratory quality control programme for the measurement of tuberculosis drugs.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Monitoring; Humans; Immunoassay; Isoniazid; Laboratories; Pyrazinamide; Quality Control; Reference Standards; Reproducibility of Results; Rifampin; Tuberculosis | 2015 |
The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
Topics: Animals; Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Female; Isoniazid; Liver; Liver Function Tests; Mice, Inbred ICR; Organic Anion Transporters, Sodium-Dependent; Rifampin; Symporters | 2015 |
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
Topics: Adolescent; Antitubercular Agents; Area Under Curve; Child; Child, Preschool; Ethambutol; Ethnicity; Female; Humans; India; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Regression Analysis; Rifampin; Tandem Mass Spectrometry; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
[Application of melting curve assay in the quality assessment of drug susceptibility test on Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin | 2015 |
Performance Assessment of the BluePoint MycoID Plus Kit for Identification of Mycobacterium tuberculosis, Including Rifampin- and Isoniazid-resistant Isolates, and Nontuberculous Mycobacteria.
Topics: Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Reagent Kits, Diagnostic; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study.
Topics: Adult; Antitubercular Agents; Coinfection; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Recurrence; Retreatment; Retrospective Studies; Rifampin; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis; Uganda | 2015 |
A Rare Cause of Retropharyngeal Abscess: Cervical Pott's Disease.
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Cervical Vertebrae; Child; Diagnosis, Differential; Drug Combinations; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Neck; Pyrazinamide; Radiography; Retropharyngeal Abscess; Rifampin; Treatment Outcome; Tuberculosis, Spinal | 2015 |
Coencapsulation of hydrophobic and hydrophilic antituberculosis drugs in synergistic Brij 96 microemulsions: a biophysical characterization.
Topics: Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Chlorocebus aethiops; Emulsions; Hydrophobic and Hydrophilic Interactions; Isoniazid; Oxazines; Plant Oils; Polyethylene Glycols; Pyrazinamide; Rifampin; Solubility; Vero Cells; Xanthenes | 2015 |
Tuberculosis of the cervical spine.
Topics: Adult; Antibiotics, Antitubercular; Cervical Vertebrae; Drug Therapy, Combination; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Orthopedic Procedures; Radiography; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Spinal | 2015 |
Ameliorating effects of Tamarindus indica fruit extract on anti-tubercular drugs induced liver toxicity in rats.
Topics: Animals; Antioxidants; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female; Fruit; Isoniazid; Liver; Male; Plant Extracts; Rats; Rats, Wistar; Rifampin; Tamarindus | 2016 |
Xpert MTB/RIF and GenoType MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Resistance, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Osteoarticular; Young Adult | 2015 |
Hepatoprotective activity of hepatoplus on isonaizid and rifampicin induced hepatotoxicity in rats.
Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Chemical and Drug Induced Liver Injury; Curcuma; Cycas; Cytochrome P-450 CYP2E1; Eclipta; Gene Expression; Genes, p53; Isoniazid; Liver; Medicine, Ayurvedic; Orchidaceae; Phyllanthus; Picrorhiza; Pinus; Pistacia; Plant Preparations; Protective Agents; Rats; Rifampin; Tephrosia; Withania | 2015 |
Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy.
Topics: Adult; Child, Preschool; Communicable Disease Control; Contact Tracing; Disease Outbreaks; Ethambutol; Europe; Female; Humans; Incidence; Interferon-gamma Release Tests; Isoniazid; Italy; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2015 |
[The experience of application of test system "TB-Biochip" in the Tambov oblast].
Topics: DNA, Bacterial; Humans; Isoniazid; Microarray Analysis; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Russia; Sputum; Tuberculosis, Pulmonary | 2015 |
The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro.
Topics: Antitubercular Agents; Cell Wall; Colistin; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Molecular Structure; Mycobacterium tuberculosis; Pulmonary Surfactants; Rifampin; Structure-Activity Relationship; Time Factors | 2015 |
Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
Topics: Adolescent; Adult; Antitubercular Agents; Bacterial Proteins; Coinfection; Disease Outbreaks; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Genome, Bacterial; Genotype; Haiti; HIV Infections; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cardiovascular Diseases; Child; Drug Therapy, Combination; Ethambutol; Female; Glomerular Filtration Rate; Humans; Isoniazid; Japan; Male; Middle Aged; Pyrazinamide; Renal Insufficiency, Chronic; Retrospective Studies; Rifampin; Risk Factors; Serum Albumin; Sputum; Steroids; Streptomycin; Survival Rate; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis.
Topics: Adult; Area Under Curve; Bayes Theorem; Drug Monitoring; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis; Young Adult | 2015 |
Evaluation of a novel line-probe assay for genotyping-based diagnosis of Mycobacterium tuberculosis in Thailand.
Topics: Antibiotics, Antitubercular; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Sputum; Thailand | 2015 |
Pyridoxine induced rosacea-like dermatitis.
Topics: Antitubercular Agents; Drug Combinations; Drug Eruptions; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Pyridoxine; Rifampin; Rosacea; Tuberculosis, Pulmonary; Vitamin B Complex | 2015 |
Intermittent Short Course Rifapentine-Isoniazid Combination for Preventing Tuberculosis in Children: Evidence based Medicine Viewpoint.
Topics: Antitubercular Agents; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Rifampin | 2015 |
Epidemiological Characterization of Drug Resistance among Mycobacterium tuberculosis Isolated from Patients in Northeast of Iran during 2012-2013.
Topics: Adolescent; Adult; Drug Resistance; Ethambutol; Female; Humans; Iran; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype.
Topics: Antitubercular Agents; Arginase; B7-2 Antigen; Cell Differentiation; Cells, Cultured; Ethambutol; Female; Humans; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-12 Subunit p35; Isoniazid; Lectins, C-Type; Macrophages; Male; Mannose Receptor; Mannose-Binding Lectins; Middle Aged; Mycobacterium tuberculosis; Nitric Oxide; Phagocytosis; Phenotype; Pyrazinamide; Receptors, Cell Surface; Rifampin; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transcriptional Activation; Transforming Growth Factor beta; Tuberculosis, Pulmonary; Up-Regulation | 2015 |
Pulmonary Infection Caused by Mycobacterium shinjukuense.
Topics: Aged; Antitubercular Agents; Bronchoalveolar Lavage Fluid; DNA, Bacterial; Ethambutol; Female; Genotyping Techniques; Humans; Isoniazid; Japan; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; Hospitals, Public; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Retreatment; Rifampin; Risk Assessment; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Topics: Adult; Aged; Amikacin; Antitubercular Agents; Base Sequence; Capreomycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Ethionamide; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2016 |
Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Female; Genes, Bacterial; Humans; Isoniazid; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.
Topics: Adolescent; Adult; Antitubercular Agents; Case-Control Studies; Directly Observed Therapy; Ethiopia; Female; Humans; Income; Isoniazid; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Role of a GenoType MTBDRplus line probe assay in early detection of multidrug-resistant tuberculosis at a Brazilian reference center.
Topics: Adult; Antitubercular Agents; Bacteriological Techniques; Brazil; DNA, Bacterial; Early Diagnosis; Female; Genotyping Techniques; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Risk Factors; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2015 |
Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence Setting.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Genotyping Techniques; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis | 2015 |
In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment.
Topics: Animals; Antitubercular Agents; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rifampin; Tuberculosis | 2015 |
Isolated hepatosplenic tuberculosis: a rare presentation.
Topics: Abdominal Pain; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Splenic; Weight Loss | 2015 |
Projects related to respiratory infectious diseases, gastrointestinal diseases, viral hepatitis, and miscellaneous infection.
Topics: Antimicrobial Cationic Peptides; Cathelicidins; Guanine; Helicobacter Infections; Hepatitis B; Humans; Isoniazid; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ghana; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Phenotype; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
Prevalence and risk factors of drug-resistant tuberculosis in border provinces of Iran.
Topics: Adult; Aged; Bacterial Proteins; Catalase; Cross-Sectional Studies; DNA-Directed RNA Polymerases; Female; Humans; Iran; Isoniazid; Male; Middle Aged; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2015 |
Multicenter Evaluation of the Molecular Line Probe Assay for Multidrug Resistant Mycobacterium Tuberculosis Detection in China.
Topics: China; Genotyping Techniques; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Immigrants and tuberculosis in Hong Kong.
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Asia, Southeastern; Asia, Western; Child; Child, Preschool; China; Emigrants and Immigrants; Female; Hong Kong; Humans; Incidence; Infant; Infant, Newborn; Isoniazid; Longitudinal Studies; Male; Middle Aged; Population Surveillance; Recurrence; Registries; Rifampin; Sex Distribution; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.
Topics: Alleles; Antitubercular Agents; Bacterial Proteins; Brazil; Cluster Analysis; DNA-Directed RNA Polymerases; DNA, Bacterial; Genetic Variation; Genotype; Humans; Isoniazid; Minisatellite Repeats; Mycobacterium tuberculosis; Phylogeny; Polymerase Chain Reaction; Polymorphism, Genetic; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Dielectrophoretic characterization of antibiotic-treated Mycobacterium tuberculosis complex cells.
Topics: Animals; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis; Equipment Design; Hot Temperature; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2015 |
Lab-on-Chip-Based Platform for Fast Molecular Diagnosis of Multidrug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Lab-On-A-Chip Devices; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
A Clinical Study of Miliary Brain Tuberculomas in China.
Topics: Adult; Aged; Antitubercular Agents; Brain; Contrast Media; Drug Therapy, Combination; Ethambutol; Female; Gadolinium; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculoma, Intracranial | 2016 |
Tuberculosis preventive chemotherapy: the times they are a-changin'.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Rifampin | 2015 |
Treatment for tuberculosis in a patient with Dubin-Johnson syndrome.
Topics: Adult; Antitubercular Agents; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Humans; Isoniazid; Jaundice, Chronic Idiopathic; Multidrug Resistance-Associated Protein 2; Rifampin; Tuberculosis, Meningeal; Ursodeoxycholic Acid | 2015 |
Confinement-Induced Drug-Tolerance in Mycobacteria Mediated by an Efflux Mechanism.
Topics: Antitubercular Agents; Bacterial Load; Biological Transport; Cinnamates; Diffusion; Dimethylpolysiloxanes; Drug Tolerance; Epigenesis, Genetic; Humans; Hygromycin B; Isoniazid; Lab-On-A-Chip Devices; Macrophages; Microdialysis; Models, Biological; Mycobacterium smegmatis; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Rifampin | 2015 |
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Female; Genetic Variation; Genotype; Humans; Indonesia; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
MDR-TB Antibody Response (Western Blot) to Fractions of Isoniazid and Rifampicin Resistant Antigens of Mycobacterium tuberculosis.
Topics: Animals; Antibodies, Bacterial; Antigens, Bacterial; Antitubercular Agents; Blotting, Western; Humans; Isoniazid; Molecular Weight; Mycobacterium tuberculosis; Rabbits; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.
Topics: Administration, Inhalation; Alginates; Animals; Antitubercular Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Female; Glucuronic Acid; Hexuronic Acids; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Particle Size; Rifampin; Tuberculosis | 2016 |
Treatment for Tuberculosis Infection With 3 Months of Isoniazid and Rifapentine in New York City Health Department Clinics.
Topics: Adult; Ambulatory Care Facilities; Antitubercular Agents; Directly Observed Therapy; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; New York City; Patient Compliance; Public Health; Rifampin; Young Adult | 2016 |
Isolated tuberculosis of tunica albuginea and tunica vaginalis presenting as acute hydrocoele: a diagnostic dilemma.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Scrotum; Testicular Hydrocele; Testis; Treatment Outcome; Tuberculosis, Male Genital | 2015 |
The food supplement coenzyme Q10 and suppression of antitubercular drug-induced hepatic injury in rats: the role of antioxidant defence system, anti-inflammatory cytokine IL-10.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Dietary Supplements; Female; Interleukin-10; Isoniazid; Liver; Rats; Rats, Wistar; Rifampin; Silymarin; Ubiquinone; Vitamins | 2015 |
Uniform and amorphous rifampicin microspheres obtained by freezing induced LLPS during lyophilization.
Topics: Administration, Inhalation; Cell Line; Chemistry, Pharmaceutical; Drug Carriers; Dynamic Light Scattering; Freeze Drying; Humans; Isoniazid; Macrophages; Microscopy, Electron, Scanning; Microspheres; Paclitaxel; Particle Size; Phagocytosis; Rifampin; Solubility; tert-Butyl Alcohol; Water; X-Ray Diffraction | 2015 |
Protective effects of the bioactive natural product N-trans-Caffeoyldopamine on hepatotoxicity induced by isoniazid and rifampicin.
Topics: Animals; Biological Products; Caffeic Acids; Chemical and Drug Induced Liver Injury; Dopamine; Isoniazid; Liver; Molecular Structure; Rats; Rifampin | 2015 |
The relationship between chitotriosidase activity and tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Biomarkers; Case-Control Studies; China; Ethambutol; Female; Hexosaminidases; Humans; Isoniazid; Lung; Male; Middle Aged; Pyrazinamide; Radiography; Rifampin; Streptomycin; Thioacetazone; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
A Color-Reaction-Based Biochip Detection Assay for RIF and INH Resistance of Clinical Mycobacterial Specimens.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microarray Analysis; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
Topics: Amoxicillin; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Rifampin; Xanthenes | 2016 |
Pleural tuberculosis in a patient with untreated type 1 Gaucher disease.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gaucher Disease; Humans; Isoniazid; Male; Pulmonary Fibrosis; Pyrazinamide; Rifampin; Tuberculosis, Pleural; Turkey | 2016 |
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Male; Mass Spectrometry; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
[The effect of renal replacement therapy on the plasma concentration of antituberculosis drugs].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Kidney Diseases; Male; Middle Aged; Pyrazinamide; Renal Replacement Therapy; Rifampin; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2015 |
The impact of nutritional state on the duration of sputum positivity of Mycobacterium tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Biomarkers; Body Mass Index; C-Reactive Protein; Female; Glucose Intolerance; Humans; Isoniazid; Japan; Leukocytes; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Nutritional Status; Retrospective Studies; Rifampin; Risk Factors; Sputum; Tuberculosis; Young Adult | 2015 |
Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.
Topics: Adult; Aged; Antitubercular Agents; Drug Interactions; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Greece; Humans; Isoniazid; Male; Middle Aged; Moxifloxacin; Outpatients; Rifampin; Tuberculosis, Pulmonary | 2015 |
Effects of repeated administration of rifampicin and isoniazid on vitamin D metabolism in mice.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Administration, Oral; Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Isoniazid; Male; Mice; Mice, Inbred ICR; Rifampin; Structure-Activity Relationship; Vitamin D | 2015 |
Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Survival; Drug Stability; Humans; Isoniazid; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanogels; NIH 3T3 Cells; Polyethylene Glycols; Polyethyleneimine; Polymethacrylic Acids; Rifampin; Tuberculosis, Gastrointestinal; Tuberculosis, Multidrug-Resistant | 2016 |
Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genes, Bacterial; Genetic Loci; Humans; Isoniazid; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Rifampin; Sequence Analysis, DNA | 2016 |
[Molecular diagnosis of Mycobacterium tuberculosis complex resistant to isoniazid and rifampicin in Burkina Faso].
Topics: Adolescent; Adult; Antitubercular Agents; Burkina Faso; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Real-Time Polymerase Chain Reaction; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cross-Sectional Studies; Early Diagnosis; Ethiopia; Female; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
The concordance between phenotypic and genotypic M. tuberculosis drug susceptibility tests results: observational study.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Phenotype; Predictive Value of Tests; Protein Array Analysis; Rifampin; Romania; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
Primary Gingival Tuberculosis Diagnosed Based on Genetic Identification.
Topics: Aged; Antitubercular Agents; Biopsy; Diagnosis, Differential; DNA, Bacterial; Ethambutol; Female; Gingival Diseases; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Oral | 2015 |
Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genotype; HIV Infections; Host-Pathogen Interactions; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Phylogeography; Portugal; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Antioxidant, Hepatoprotective Potential and Chemical Profiling of Propolis Ethanolic Extract from Kashmir Himalaya Region Using UHPLC-DAD-QToF-MS.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Humans; Isoniazid; Lipid Peroxidation; Liver; Male; Oxidative Stress; Propolis; Rats; Rifampin | 2015 |
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Biotransformation; Body Weight; Clinical Trials as Topic; Cohort Studies; Coinfection; Computer Simulation; Ethambutol; Female; Half-Life; HIV Infections; Humans; Isoniazid; Liver; Male; Middle Aged; Models, Statistical; Rifampin; Tuberculosis, Pulmonary | 2016 |
The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
Topics: Antitubercular Agents; Body Weight; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis; World Health Organization | 2015 |
Childhood tuberculosis in the United States: shifting the focus to prevention.
Topics: Antibiotics, Antitubercular; Child; Humans; Incidence; Interferon-gamma Release Tests; Isoniazid; Mass Screening; Rifampin; Tuberculosis; United States | 2015 |
In silico evaluation and exploration of antibiotic tuberculosis treatment regimens.
Topics: Animals; Antitubercular Agents; Computer Simulation; Drug Resistance, Bacterial; Granuloma; Isoniazid; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis | 2015 |
[Vesicular eruption in a patient under antituberculosis treatment].
Topics: Adolescent; Antitubercular Agents; Drug Eruptions; Drug Therapy, Combination; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 2016 |
Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains.
Topics: Acetylcysteine; Antitubercular Agents; Ascorbic Acid; Drug Synergism; Drug Therapy, Combination; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tuberculosis | 2016 |
New Anyplex™ II MTB/MDR/XDR kit for detection of resistance mutations in M. tuberculosis cultures.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Genotype; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity | 2015 |
The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum | 2015 |
Prevalence of drug resistant TB among outpatients at an HIV/TB clinic in Lilongwe, Malawi.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Coinfection; Female; HIV Infections; Humans; Isoniazid; Malawi; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Prospective Studies; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Thanks to Trauma: A Delayed Diagnosis of Pott Disease.
Topics: Accidental Falls; Antitubercular Agents; Child, Preschool; Delayed Diagnosis; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fractures, Comminuted; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Spinal Injuries; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis, Spinal | 2015 |
New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells.
Topics: Animals; Autophagy; Humans; Isoniazid; Leukocytes, Mononuclear; Macrophage Activation; Macrophages; Mice, Transgenic; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; T-Lymphocytes; Verapamil | 2015 |
Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice, Inbred BALB C; Mice, Inbred C3H; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
A rare cause of pulmonary tuberculosis.
Topics: Animals; Antitubercular Agents; Cattle; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompetence; Isoniazid; Lung; Meat-Packing Industry; Middle Aged; Mycobacterium bovis; Radiography; Rifampin; Tuberculosis, Bovine; Tuberculosis, Pulmonary | 2015 |
[THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].
Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage; Drug Combinations; Early Diagnosis; Ethambutol; Genetic Testing; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin | 2015 |
Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis.
Topics: Administration, Cutaneous; Antitubercular Agents; Female; Humans; Isoniazid; Lymphadenitis; Male; Mycobacterium tuberculosis; Permeability; Phonophoresis; Rifampin | 2016 |
Pott's disease in a Connecticut toddler.
Topics: Antitubercular Agents; Connecticut; Humans; Infant; Isoniazid; Kyphosis; Male; Rifampin; Severity of Illness Index; Spinal Fusion; Treatment Outcome; Tuberculosis, Spinal | 2016 |
Cure of tuberculosis despite serum concentrations of antituberculosis drugs below published reference ranges.
Topics: Adult; Aged; Antitubercular Agents; Drug Monitoring; Female; HIV Infections; Humans; Isoniazid; Linear Models; Male; Middle Aged; Pyrazinamide; Reference Values; Retrospective Studies; Rifampin; Switzerland; Tuberculosis; Young Adult | 2015 |
The Ethics of Isolation for Patients With Tuberculosis in Australia.
Topics: Adult; Antitubercular Agents; Australia; Ethics, Institutional; Family; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Patient Isolation; Rifampin; Sputum; Transients and Migrants; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Painful Red Eye in a Woman in Her 70s.
Topics: Aged; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combination; Ethambutol; Eye Infections, Bacterial; Eye Pain; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Radiography, Thoracic; Rifampin; Scleritis; Skin Tests; Tuberculoma; Tuberculosis, Ocular | 2016 |
On-Chip Construction of Liver Lobule-like Microtissue and Its Application for Adverse Drug Reaction Assay.
Topics: Acetaminophen; Biomimetic Materials; Chemical and Drug Induced Liver Injury; Drug Evaluation, Preclinical; Hep G2 Cells; Hepatocytes; Humans; Isoniazid; Microfluidic Analytical Techniques; Rifampin; Tissue Engineering | 2016 |
Repeat exposure to active tuberculosis and risk of re-infection.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Emergency Service, Hospital; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Parents; Pyrazinamide; Recurrence; Rifampin; Risk Assessment; Risk Factors; Siblings; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
[CLINICAL EFFECTS OF TREATMENT FOR MYCOBACTERIUM TUBERCULOSIS INFECTION IN PATIENTS AT A SPECIALIZED HOSPITAL IN 2011].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Hospitals, Special; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Young Adult | 2015 |
Low Serum Concentrations of Rifampicin and Pyrazinamide Associated with Poor Treatment Outcomes in Children with Tuberculosis Related to HIV Status.
Topics: Antitubercular Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; HIV Infections; Hospitals; Humans; India; Infant; Isoniazid; Male; Pyrazinamide; Rifampin; Serum; Treatment Outcome; Tuberculosis | 2016 |
A molecular platform for the diagnosis of multidrug-resistant and pre-extensively drug-resistant tuberculosis based on single nucleotide polymorphism mutations present in Colombian isolates of Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Colombia; DNA, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Gene Amplification; Humans; Isoniazid; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Polymorphism, Single Nucleotide; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2016 |
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; China; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2016 |
Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Bacterial; Genotype; Genotyping Techniques; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Rifampin; RNA Polymerase II; Sensitivity and Specificity | 2016 |
Drug-resistant tuberculosis plagues India.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Isoniazid; Kanamycin; Medication Adherence; Mycobacterium tuberculosis; Nonprescription Drugs; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action.
Topics: Antitubercular Agents; Ciprofloxacin; Flow Cytometry; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2016 |
Monitoring latent tuberculosis infection diagnosis and management in the Netherlands.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Communicable Disease Control; Female; Health Policy; Humans; Immunocompromised Host; Immunosuppressive Agents; Infant; Infant, Newborn; Infectious Disease Medicine; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Multivariate Analysis; Netherlands; Registries; Rifampin; Rural Population; Treatment Outcome; Tuberculosis; Young Adult | 2016 |
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Topics: Animals; Antitubercular Agents; Clofazimine; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Withholding Treatment | 2016 |
Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Coordination Complexes; Copper; Drug Resistance, Bacterial; Drug Synergism; Ethambutol; Humans; Isoniazid; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2016 |
Epidemiology and Clinical Characteristics of Pediatric Drug-Resistant Tuberculosis in Chongqing, China.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; China; Cross-Sectional Studies; Ethambutol; Female; Humans; Infant; Isoniazid; Logistic Models; Male; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Rapid colorimetric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Colorimetry; Drug Resistance, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sensitivity and Specificity; Tetrazolium Salts | 2016 |
Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
Topics: Adult; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum | 2016 |
Evaluation of efficiency of nested multiplex allele-specific PCR assay for detection of multidrug resistant tuberculosis directly from sputum samples.
Topics: Adult; Alleles; Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Rifampin; Sequence Analysis, DNA; Sputum; Tuberculosis, Multidrug-Resistant | 2016 |
Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.
Topics: Administration, Oral; Animals; Antitubercular Agents; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation; Glycyrrhizic Acid; Isoniazid; Male; Organic Anion Transporters; Organic Anion Transporters, Sodium-Dependent; Rats, Wistar; Rifampin; Symporters | 2016 |
Reparation of Isoniazid and Rifampicin Combinatorial Therapy-Induced Hepatotoxic Effects by Bacopa monnieri.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antitubercular Agents; Aspartate Aminotransferases; Bacopa; Catalase; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Glutathione Peroxidase; Glutathione Transferase; Interleukin-10; Isoniazid; Liver; Molecular Docking Simulation; Plant Extracts; Protective Agents; Rats, Wistar; Rifampin; Superoxide Dismutase | 2016 |
Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.
Topics: Antitubercular Agents; Combined Modality Therapy; Drug Combinations; Drug Hypersensitivity Syndrome; Ethambutol; Glucocorticoids; Herpesvirus 6, Human; Humans; Isoniazid; Leukapheresis; Male; Multiple Organ Failure; Plasmapheresis; Pyrazinamide; Rifampin; Roseolovirus Infections; Tuberculosis, Pleural; Young Adult | 2017 |
Hesperidin Alleviates Oxidative Stress and Upregulates the Multidrug Resistance Protein 2 in Isoniazid and Rifampicin-Induced Liver Injury in Rats.
Topics: Alanine Transaminase; Animals; Antitubercular Agents; Aspartate Aminotransferases; ATP Binding Cassette Transporter, Subfamily B; Bilirubin; Chemical and Drug Induced Liver Injury; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hesperidin; Isoniazid; Liver; Male; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Rifampin; Up-Regulation | 2016 |
Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis.
Topics: Adolescent; Antitubercular Agents; Arylamine N-Acetyltransferase; Asian People; Child; Child, Preschool; Female; Genotype; Half-Life; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Meningeal; Vietnam | 2016 |
The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Comorbidity; Drug Therapy, Combination; Female; Hepatitis; Hospitals, Teaching; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Taiwan; Treatment Outcome; Tuberculosis; Young Adult | 2016 |
Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Peru; Prevalence; Rifampin; Risk Factors; Tuberculosis, Pulmonary | 2016 |
Direct tuberculosis drug susceptibility testing: time-saving and cost-effective in detecting MDR-TB.
Topics: Antitubercular Agents; China; Cost-Benefit Analysis; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Specimen Handling; Sputum; Tuberculosis, Multidrug-Resistant | 2016 |
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2016 |
Ameliorative Effects of Kolaviron, a Biflavonoid Fraction from Garcinia Kola Seed, on Hepato-renal Toxicity of Anti-tuberculosis Drugs in Wistar Rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Antitubercular Agents; Aspartate Aminotransferases; Ethambutol; Flavonoids; Garcinia kola; Glutathione; Glutathione Peroxidase; Isoniazid; Kidney; Liver; Male; Malondialdehyde; Oxidative Stress; Pyrazinamide; Rats, Wistar; Rifampin; Seeds | 2016 |
[Multicenter evaluation of the indirect nitrate reductase assay for the rapid detection of multidrug-resistant tuberculosis].
Topics: Antitubercular Agents; Colorimetry; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Nitrates; Nitrites; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Turkey | 2016 |
In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cynanchum; Drug Resistance, Multiple, Bacterial; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Isoniazid; Isoquinolines; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Extracts; Plant Roots; Rifampin | 2016 |
Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Bacterial; Genotyping Techniques; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2016 |
School-based Study to Identify and Treat Adolescent Students at Risk for Tuberculosis Infection.
Topics: Adolescent; Antitubercular Agents; Directly Observed Therapy; Drug Combinations; Female; Humans; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Poverty; Rifampin; Risk Factors; School Health Services; Students; Surveys and Questionnaires; Texas; Tuberculin Test; Tuberculosis | 2016 |
Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; China; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Regression Analysis; Residence Characteristics; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Topics: Adolescent; Age Factors; Antitubercular Agents; Child; Child, Preschool; Chromatography, Liquid; Coinfection; Drug Dosage Calculations; Drug Monitoring; Ethambutol; Female; HIV Infections; Humans; India; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Spectrometry, Mass, Electrospray Ionization; Treatment Outcome; Tuberculosis | 2016 |
Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection.
Topics: Adolescent; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Isoniazid; Male; Medication Adherence; Rifampin; Skin Tests; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2016 |
Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.
Topics: Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moldova; Mutation; Mycobacterium tuberculosis; Rifampin; South Africa; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2016 |
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families.
Topics: Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxygen; Rifampin; Tuberculosis | 2016 |
Hepatoprotective effect of Anacyclus pyrethrum Linn. against antitubercular drug-induced hepatotoxicity in SD rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antitubercular Agents; Aspartate Aminotransferases; Asteraceae; Bilirubin; Blood Proteins; Chemical and Drug Induced Liver Injury; Cholesterol; Isoniazid; L-Lactate Dehydrogenase; Liver; Male; Organ Size; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Rifampin | 2016 |
Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo.
Topics: Animals; Cell Line; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Myeloid Cells; Rifampin; Transcription, Genetic; Tuberculosis, Pulmonary | 2016 |
Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates.
Topics: Antibiotics, Antitubercular; Benzofurans; Capsules; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Isoniazid; Liposomes; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2016 |
Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance.
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Toxins; Catalase; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Models, Molecular; Mutation; Mycobacterium tuberculosis; Phenotype; Polymorphism, Single Nucleotide; Protein Conformation; Rifampin; Structure-Activity Relationship; Time Factors; Treatment Outcome; Tuberculosis | 2016 |
Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western Kenya.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Kenya; Lot Quality Assurance Sampling; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Rifampin; Rural Population; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Urban Population | 2016 |
DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities.
Topics: Animals; Antitubercular Agents; Base Sequence; Benzodiazepines; Deoxyribonuclease I; DNA Footprinting; DNA, Bacterial; Escherichia coli; Isoniazid; Mice; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Nylons; Pseudomonas putida; Pyrroles; RAW 264.7 Cells; Rhodococcus; Rifampin; Sequence Analysis, DNA | 2016 |
Amelioration of anti-tuberculosis drug induced oxidative stress in kidneys by Spirulina fusiformis in a rat model.
Topics: Acute Kidney Injury; Animals; Antioxidants; Antitubercular Agents; Creatinine; Disease Models, Animal; Female; Humans; Isoniazid; Kidney; Lipid Peroxidation; Liver; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rifampin; Silymarin; Spirulina; Urea; Uric Acid | 2016 |
Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Combinations; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 2016 |
Anterior debridement may not be necessary in the treatment of tuberculous spondylitis of the thoracic and lumbar spine in adults: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Decompression, Surgical; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kyphosis; Laminectomy; Lumbar Vertebrae; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Spinal Fusion; Spondylitis; Thoracic Vertebrae; Tuberculosis, Spinal | 2016 |
A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
Topics: Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Humans; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
Topics: Adolescent; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Ethiopia; Female; Humans; Isoniazid; Middle Aged; Mutation; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Deleterious effects of 28-day oral co-administration of first-line anti-TB drugs on spleen, blood and bone marrow chromosomes in normal rat.
Topics: Administration, Oral; Animals; Antitubercular Agents; Biomarkers; Bone Marrow Cells; Chromosome Aberrations; DNA Damage; Drug Administration Schedule; Drug Therapy, Combination; Female; Glutathione; Isoniazid; Lipid Peroxidation; Mutagenicity Tests; Pyrazinamide; Rats, Wistar; Rifampin; Risk Assessment; Spleen; Thiobarbituric Acid Reactive Substances; Time Factors | 2017 |
[A CASE OF MILIARY TUBERCULOSIS ORIGINATED FROM CUTANEOUS INFECTION].
Topics: Aged, 80 and over; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Cutaneous; Tuberculosis, Miliary | 2016 |
High-resolution melting analysis for molecular detection of multidrug resistance tuberculosis in Peruvian isolates.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2016 |
Chemotherapeutic Evaluation of Guar Gum Coated Chitosan Nanoparticle Against Experimental Tuberculosis.
Topics: Animals; Antitubercular Agents; Chitosan; Coated Materials, Biocompatible; Delayed-Action Preparations; Diffusion; Female; Galactans; Isoniazid; Mannans; Mice; Mice, Inbred BALB C; Nanocapsules; Plant Gums; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Therapeutic drug monitoring of isoniazid and rifampicin during anti-tuberculosis treatment in Auckland, New Zealand.
Topics: Adult; Antitubercular Agents; Databases, Factual; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; New Zealand; Predictive Value of Tests; Recurrence; Remission Induction; Retrospective Studies; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2016 |
[Determination of in vitro synergy by a checkerboard method when 3 core antimicrobial agents of the retreatment new scheme combined against MDR-MTB and XDR-MTB].
Topics: Aminosalicylic Acids; Antibiotics, Antitubercular; Drug Synergism; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Retreatment; Rifabutin; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Early detection of multidrug resistant (MDR) Mycobacterium tuberculosis in a single tube with in-house designed fluorescence resonance energy transfer (FRET) probes using real-time PCR.
Topics: Antitubercular Agents; DNA, Bacterial; Fluorescence Resonance Energy Transfer; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2016 |
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
Topics: Animals; Antitubercular Agents; Bacterial Load; Bacterial Proteins; Biological Transport; Ciprofloxacin; Disease Models, Animal; Doxycycline; Female; Gene Expression; Gene Knockdown Techniques; Humans; Isoniazid; Lung; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Mycolic Acids; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs against Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Biological Assay; Drug Resistance, Multiple, Bacterial; Ethambutol; Gentian Violet; Humans; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2016 |
Design, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives.
Topics: Animals; Antitubercular Agents; CHO Cells; Cricetulus; Drug Synergism; Ethambutol; Furans; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2016 |
Drug-specific CD4
Topics: Adult; Antitubercular Agents; CD4-Positive T-Lymphocytes; Drug Hypersensitivity Syndrome; Exanthema; Female; HLA Antigens; Humans; Immunity, Cellular; Isoniazid; Male; Middle Aged; Rifampin | 2017 |
Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Impact of diabetes mellitus on tuberculosis drug resistance in new cases of tuberculosis.
Topics: Adult; Aged; Case-Control Studies; Diabetes Mellitus; Drug Resistance, Bacterial; Female; Humans; Iran; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis | 2016 |
A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
Topics: Adolescent; Adult; Alberta; Ambulatory Care; Antitubercular Agents; Canada; Child; Disease Eradication; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Mass Screening; Middle Aged; Refugees; Rifampin; Tuberculin Test; Young Adult | 2016 |
[Analysis on drug resistance of Mycobacterium tuberculosis and influencing factors in six provinces of China].
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Streptomycin; Surveys and Questionnaires; Tuberculosis, Multidrug-Resistant | 2016 |
Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using 3 months of isoniazid and rifampicin.
Topics: Adolescent; Adult; Antitubercular Agents; Chemoprevention; Drug Therapy, Combination; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Isoniazid; Male; Maternal Exposure; Pregnancy; Retrospective Studies; Rifampin; Tuberculosis; Young Adult | 2017 |
Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection.
Topics: Adult; Allografts; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antitubercular Agents; Bacteremia; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Immunosuppression Therapy; Isoniazid; Latent Tuberculosis; Lung Transplantation; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Pseudomonas aeruginosa; Rifampin; Tissue Donors; Tuberculosis, Pulmonary | 2016 |
Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics.
Topics: Adenosine Triphosphate; Antitubercular Agents; Drug Interactions; Electron Transport Complex I; Electron Transport Complex III; Energy Metabolism; Hep G2 Cells; Humans; Isoniazid; Lactic Acid; Membrane Potential, Mitochondrial; NAD; Pyrazinamide; Rifampin | 2017 |
Population pharmacokinetics, optimised design and sample size determination for rifampicin, isoniazid, ethambutol and pyrazinamide in the mouse.
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Ethambutol; Isoniazid; Mice, Inbred C57BL; Models, Biological; Pyrazinamide; Rifampin; Sample Size | 2016 |
HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Area Under Curve; Biological Availability; Coinfection; Female; HIV Infections; HIV-1; Humans; Isoniazid; Lopinavir; Male; Models, Statistical; Mycobacterium tuberculosis; Outpatients; Prospective Studies; Pyrazinamide; Rifampin; Ritonavir; South Africa; Tuberculosis, Pulmonary | 2016 |
Dosage of isoniazid and rifampicin poorly predicts drug exposure in tuberculosis patients.
Topics: Antitubercular Agents; Area Under Curve; Body Weight; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Isoniazid; Rifampin; Tuberculosis | 2016 |
Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Female; Genotyping Techniques; Humans; India; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Sample Size; Tuberculosis; Young Adult | 2016 |
Surveillance provides insight into epidemiology and spectrum of culture-confirmed mycobacterial disease in children.
Topics: Anti-Retroviral Agents; Antitubercular Agents; Child; Child, Preschool; Coinfection; Epidemiological Monitoring; Female; HIV Infections; Humans; Infant; Isoniazid; Male; Mycobacterium bovis; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2016 |
[Risk factors for multidrug-resistant tuberculosis in the city of Kinshasa in the Democratic Republic of Congo].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Case-Control Studies; Democratic Republic of the Congo; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Tuberculous cellulitis: diseases behind cellulitislike erythema.
Topics: Aged, 80 and over; Antitubercular Agents; Cellulitis; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Skin; Treatment Outcome; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 2016 |
[EVALUATION OF THE EFFICIENCY OF TREATMENT AND THE CHOICE OF CONTROL COMPUTED TOMOGRAPHY TIME IN CHILDREN WITH MINOR FORMS OF INTRATHORACIC TUBERCULOSIS].
Topics: Antitubercular Agents; Child; Child, Preschool; Comparative Effectiveness Research; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Male; Outcome Assessment, Health Care; Pyrazinamide; Rifampin; Thorax; Tomography, X-Ray Computed; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 2010 |
[EXPERIENCE IN USING TB-BIOCHIP (MDR) TEST SYSTEMS IN THE LIPETSK REGION].
Topics: Antitubercular Agents; Comparative Effectiveness Research; Humans; Isoniazid; Microarray Analysis; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Russia; Tuberculosis, Multidrug-Resistant | 2010 |
[THE SENSITIVITY AND SPECIFICITY OF THE MOLECULAR GENOTYPE MTBDRPL US ASSAY (HAIN LIFESCIENCE GMBH, GERMANY) FOR RAPID DIAGNOSIS OF DRUG SUSCEPTIBILITY IN MYCOBACTERIUM TUBERCULOSIS ON SPUTUM SPECIMENS].
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2010 |
Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mozambique; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
Topics: Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Plasma; Pyrazinamide; Rifampin; Tandem Mass Spectrometry | 2016 |
Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
Topics: Adult; Aged; Antitubercular Agents; Biomarkers; Chemical and Drug Induced Liver Injury; Choice Behavior; Drug Therapy, Combination; Female; Humans; Isoniazid; Kidney Diseases; Kidney Transplantation; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Reminder Systems; Retrospective Studies; Rifampin; Time Factors; Transaminases; Treatment Outcome; Treatment Refusal; Up-Regulation; Waiting Lists | 2017 |
Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Pilot Projects; Rifampin; Taiwan; Time Factors; Tuberculosis, Pulmonary; Young Adult | 2016 |
Cutaneous Tuberculosis Occurring After a Skin Cut in a Child.
Topics: Abattoirs; Adolescent; Animals; Antitubercular Agents; Axilla; Ethambutol; Finger Injuries; Humans; Isoniazid; Lupus Vulgaris; Lymphadenopathy; Male; Mycobacterium tuberculosis; Occupational Diseases; Pyrazinamide; Rifampin; Sheep; Treatment Outcome; Turkey; Wound Healing | 2016 |
Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.
Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genes, Bacterial; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Molecular Typing; Mutation; Mycobacterium tuberculosis; Promoter Regions, Genetic; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA | 2016 |
The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008-2013).
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Genotype; Genotyping Techniques; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Spain; Tuberculosis | 2016 |
Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?
Topics: Antitubercular Agents; Drug Combinations; Drug Monitoring; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Capreomycin; Drug Combinations; Drug Interactions; Humans; Isoniazid; Linezolid; Male; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples.
Topics: Antitubercular Agents; Colorimetry; Cost-Benefit Analysis; Enzyme Assays; Humans; Isoniazid; Microbial Sensitivity Tests; Microscopy; Mycobacterium tuberculosis; Nitrate Reductase; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2015 |
Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates.
Topics: Antitubercular Agents; Codon; DNA Mutational Analysis; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Isoniazid; Lebanon; Microbial Sensitivity Tests; Mutation, Missense; Mycobacterium tuberculosis; Public Health; Refugees; Rifampin; Sensitivity and Specificity; Syria; Tuberculosis, Multidrug-Resistant | 2015 |
ISONIAZID AND RIFAMPIN PHARMACOKINETICS IN TWO ASIAN ELEPHANTS (ELEPHAS MAXIMUS) INFECTED WITH MYCOBACTERIUM TUBERCULOSIS.
Topics: Animals; Antitubercular Agents; Area Under Curve; Elephants; Female; Half-Life; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2016 |
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2016 |
The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Mice; Mice, Inbred C3H; Pyrazinamide; Pyridones; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
Topics: Adult; Age Factors; Alleles; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Gene Expression; Gene Frequency; Haplotypes; Humans; Isoniazid; Liver; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Prospective Studies; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Thioredoxin Reductase 1; Tuberculosis, Pulmonary | 2016 |
Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Topics: AIDS-Related Opportunistic Infections; Algorithms; Bacteriological Techniques; Cost-Benefit Analysis; Decision Support Techniques; Disease Susceptibility; DNA, Bacterial; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Microscopy; Models, Theoretical; Mycobacterium tuberculosis; Prevalence; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Pulmonary; Uganda | 2016 |
Evaluation of the Abbott RealTime MTB and RealTime MTB INH/RIF Assays for Direct Detection of Mycobacterium tuberculosis Complex and Resistance Markers in Respiratory and Extrapulmonary Specimens.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Nucleic Acid Amplification Techniques; Rifampin; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2016 |
Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Isoniazid; Male; Retrospective Studies; Rifampin; Risk Factors; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Surveillance for tuberculosis in a rural community in The Philippines.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Isoniazid; Kanamycin; Male; Middle Aged; Philippines; Population Surveillance; Prevalence; Prospective Studies; Public Health; Rifampin; Rural Population; Streptomycin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
Topics: Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pentosyltransferases; Polymorphism, Restriction Fragment Length; Pyrazinamide; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2016 |
Role of Risorine in the Treatment of Drug - Susceptible Pulmonary Tuberculosis: A Pilot Study.
Topics: Adult; Alkaloids; Antitubercular Agents; Benzodioxoles; Cytochrome P-450 Enzyme Inhibitors; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pilot Projects; Piperidines; Polyunsaturated Alkamides; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2016 |
Tuberculosis treatment outcomes of six and eight month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study.
Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Seropositivity; Hospitals; Humans; Isoniazid; Logistic Models; Male; Rifampin; Socioeconomic Factors; Treatment Outcome; Tuberculosis | 2016 |
Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Gene Expression; Genome, Bacterial; Humans; Isoniazid; Male; Middle Aged; Mutation; Myanmar; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Whole Genome Sequencing | 2016 |
Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Cost of Illness; Female; Humans; Islam; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phylogeny; Rifampin; Saudi Arabia; Streptomycin; Travel; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
Topics: Antitubercular Agents; Bacterial Typing Techniques; Extensively Drug-Resistant Tuberculosis; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum | 2016 |
Role of real-time PCR for detection of tuberculosis and drug resistance directly from clinical samples.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance; Drug Resistance, Multiple, Bacterial; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2016 |
Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Topics: Antitubercular Agents; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Specimen Handling; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Time to review treatment of isoniazid-resistant tuberculosis?
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Tuberculosis presenting as a 'swollen calf'.
Topics: Abscess; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Diagnostic Imaging; Edema; Humans; Isoniazid; Leg; Male; Muscle, Skeletal; Mycobacterium tuberculosis; Recurrence; Rifampin; Tuberculosis | 2016 |
[First clinical isolate of Mycobacterium tuberculosis exhibiting resistance to rifampicin and sensibility to isoniazid in the Elche´s Health Department-General Hospital(1998-2015)].
Topics: Adult; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Hospitals, General; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Spain; Tuberculosis | 2017 |
Natural Terpenes Influence the Activity of Antibiotics against Isolated Mycobacterium tuberculosis.
Topics: Acyclic Monoterpenes; Alkenes; Antitubercular Agents; Bicyclic Monoterpenes; Cyclohexenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Limonene; Microbial Sensitivity Tests; Monoterpenes; Mycobacterium tuberculosis; Rifampin; Sesquiterpenes; Terpenes | 2017 |
Evaluation of highly branched cyclic dextrin in inhalable particles of combined antibiotics for the pulmonary delivery of anti-tuberculosis drugs.
Topics: Administration, Inhalation; Antibiotics, Antitubercular; Dextrins; Drug Carriers; Drug Combinations; Drug Design; Excipients; Isoniazid; Lung; Models, Theoretical; Particle Size; Porosity; Rifampin; Structure-Activity Relationship; Surface Properties | 2017 |
Intestinal Pneumatosis Associated with Tuberculosis after Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Female; Hematopoietic Stem Cell Transplantation; Humans; Isoniazid; Middle Aged; Multiple Myeloma; Mycobacterium tuberculosis; Pleural Effusion; Pneumatosis Cystoides Intestinalis; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; New York City; Retrospective Studies; Rifampin; Time Factors; Tuberculosis, Meningeal; Young Adult | 2017 |
Rapid Detection of Mycobacterium tuberculosis Strains Resistant to Isoniazid and/or Rifampicin: Standardization of Multiplex Polymerase Chain Reaction Analysis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Time Factors; Tuberculosis | 2016 |
Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Ethambutol; Female; Follow-Up Studies; Hepatitis; Humans; Incidence; Infant; Infant, Newborn; Isoniazid; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis; Young Adult | 2016 |
Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethiopia; Genotyping Techniques; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2016 |
Multicenter evaluation of crystal violet decolorization assay (CVDA) for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis.
Topics: Calorimetry; Developed Countries; Gentian Violet; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2016 |
Analysis of discrepant results between the Genotype
Topics: Adult; Aged; Antitubercular Agents; Bacterial Proteins; Catalase; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxidoreductases; Republic of Korea; Retrospective Studies; Rifampin; Sequence Analysis, DNA; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Diagnosis of Pulmonary Tuberculosis and Detection of Resistance to Rifampin and Isoniazid through Direct Molecular Methods in Stool Samples.
Topics: Adolescent; Adult; Case-Control Studies; Child; Feces; Female; Humans; Isoniazid; Male; Middle Aged; Polymerase Chain Reaction; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2016 |
Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Latent Tuberculosis; Logistic Models; Male; Mexico; Middle Aged; Multivariate Analysis; Philippines; Pyrazinamide; Rifampin; Risk Factors; Vietnam; Washington; Young Adult | 2017 |
Tuberculous Meningitis in an Immunocompetent Host: A Case Report.
Topics: Antitubercular Agents; Cerebrospinal Fluid; Drug Therapy, Combination; Emigrants and Immigrants; Humans; Immunocompetence; Isoniazid; Levofloxacin; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Senegal; Treatment Outcome; Tuberculosis, Meningeal; United States | 2016 |
Efficacy and safety of short-term treatment with isoniazid and rifampicin for latent tuberculosis infection in lung transplant candidates.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Female; Follow-Up Studies; Humans; Isoniazid; Latent Tuberculosis; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Prognosis; Retrospective Studies; Rifampin; Risk Factors | 2017 |
Tuberculous pericarditis: a case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Pericarditis, Tuberculous; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculin Test | 2016 |
Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Design; Ethambutol; HEK293 Cells; Humans; Hydrazones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Rifampin; Structure-Activity Relationship; Triazoles | 2017 |
Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cell Proliferation; Child; Colorimetry; Cross-Sectional Studies; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates.
Topics: Adult; Aged; Antitubercular Agents; Blood Pressure; Cohort Studies; Drug Therapy, Combination; Humans; Hypertension; Isoniazid; Kidney Transplantation; Latent Tuberculosis; Middle Aged; Rifampin; Time Factors; Transplant Recipients | 2017 |
[Granulomatous lymphadenitis revealing a deficiency in receptor IL12].
Topics: Axilla; BCG Vaccine; Consanguinity; Diagnosis, Differential; Granuloma; Humans; Infant; Isoniazid; Lymphadenitis; Male; Receptors, Interleukin-12; Rifampin | 2017 |
Anti-folates potentiate bactericidal effects of other antimicrobial agents.
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Bacteria; Drug Synergism; Escherichia coli; Folic Acid Antagonists; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rifampin; Salmonella typhimurium; Staphylococcus aureus; Sulfamethoxazole | 2017 |
One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
Topics: Adult; Antitubercular Agents; Europe; Europe, Eastern; Female; HIV Infections; Humans; Isoniazid; Latin America; Male; Prospective Studies; Rifampin; Survival Analysis; Tuberculosis | 2017 |
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymorphism, Genetic; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Intercellular Signaling Peptides and Proteins; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Peptides; Peptides, Cyclic; Rifampin; Solubility; Thiazoles | 2017 |
Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Coinfection; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Peripheral Nervous System Diseases; Prospective Studies; Regression Analysis; Rifampin; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2017 |
Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.
Topics: Adolescent; Adult; Antitubercular Agents; Cohort Studies; Early Diagnosis; Ethambutol; Female; Humans; Isoniazid; Male; Mali; Microbial Sensitivity Tests; Microscopy; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Curcumin; Isoniazid; Liver; Mice; Photosensitizing Agents; Protoporphyrins; Rifampin; Tuberculosis | 2017 |
Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar.
Topics: Adult; Antitubercular Agents; Diabetes Complications; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Hospitals, General; Humans; Isoniazid; Male; Pyrazinamide; Qatar; Retrospective Studies; Rifampin; Sputum; Tablets; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis.
Topics: Administration, Cutaneous; Animals; Antitubercular Agents; Chromatography, High Pressure Liquid; Guinea Pigs; Isoniazid; Male; Permeability; Phonophoresis; Rifampin; Skin; Skin Absorption; Transdermal Patch | 2017 |
Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine.
Topics: Adult; Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Patient Compliance; Retrospective Studies; Rifampin; United States; Washington | 2017 |
Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study.
Topics: Adult; Drug Resistance, Bacterial; Ethionamide; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; Catalase; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Gene Expression; Genetic Fitness; Genetic Variation; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pentosyltransferases; Ribosomal Proteins; Rifampin; Streptomycin; Vietnam | 2017 |
The tuberculosis taboo.
Topics: Antitubercular Agents; Contact Tracing; Drug Therapy, Combination; Global Health; Humans; Isoniazid; Latent Tuberculosis; Rifampin; Taboo; Time Factors; Tuberculosis; World Health Organization | 2017 |
TB Alliance regimen development for multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Clinical Protocols; Diarylquinolines; Dose-Response Relationship, Drug; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Linezolid; Moxifloxacin; Nitroimidazoles; Pyrazinamide; Randomized Controlled Trials as Topic; Research Design; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Factors Influencing Tuberculosis Treatment Outcome in Adult Patients Treated with Thrice-Weekly Regimens in India.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Drug Dosage Calculations; Drug Therapy, Combination; Female; Humans; India; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Isoniazid-resistant tuberculosis treatment with first-line drugs.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Isoniazid-resistant tuberculosis treatment with first-line drugs.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Isoniazid-resistant tuberculosis treatment with first-line drugs-Author reply.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates.
Topics: Adult; Aged; Antibiotics, Antitubercular; Directly Observed Therapy; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; New York; Rifampin | 2017 |
Failure to reach therapeutic levels of rifampicin and isoniazid by recommended dosages.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Humans; Isoniazid; Middle Aged; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2017 |
Multiplex detection of extensively drug resistant tuberculosis using binary deoxyribozyme sensors.
Topics: Biosensing Techniques; DNA, Catalytic; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors.
Topics: Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Monitoring; Female; Humans; Incidence; Isoniazid; Logistic Models; Male; Middle Aged; Morocco; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Tuberculosis | 2016 |
Challenges and Outlooks in Multi-drug Resistant Tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test.
Topics: Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Siderophores; Tuberculosis, Multidrug-Resistant | 2017 |
Concomitant metastatic cutaneous tuberculous abscesses and Pott disease in an immunocompetent patient.
Topics: Abscess; Adult; Antitubercular Agents; Arthrodesis; Debridement; Ethambutol; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Spinal | 2016 |
Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Fatty Acid Synthesis Inhibitors; Genotyping Techniques; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Transition Temperature; Tuberculosis, Pulmonary | 2017 |
Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2017 |
The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment.
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2017 |
Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
Topics: Adult; Alleles; Antitubercular Agents; Asian People; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2B6; Ethambutol; Female; Gene Expression; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2017 |
Assessments of serum copper and zinc concentration, and the Cu/Zn ratio determination in patients with multidrug resistant pulmonary tuberculosis (MDR-TB) in Côte d'Ivoire.
Topics: Adolescent; Adult; Antitubercular Agents; Copper; Cote d'Ivoire; Female; Humans; Isoniazid; Male; Middle Aged; Oxidative Stress; Prevalence; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Victoria; Young Adult; Zinc | 2017 |
Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Genome, Bacterial; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Uganda; Young Adult | 2017 |
Treatment of latent tuberculosis infections in the Darwin region.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Native Hawaiian or Other Pacific Islander; Northern Territory; Odds Ratio; Rifampin; White People; Young Adult | 2017 |
Near Fatal Poisoning by Isoniazid and Rifampicin.
Topics: Adult; Antitubercular Agents; Drug Overdose; Humans; Isoniazid; Male; Rifampin; Severity of Illness Index; Tuberculosis, Spinal | 2016 |
Use of Video Directly Observed Therapy for Treatment of Latent Tuberculosis Infection - Johnson County, Kansas, 2015.
Topics: Antitubercular Agents; Contact Tracing; Directly Observed Therapy; Humans; Isoniazid; Kansas; Latent Tuberculosis; Mycobacterium tuberculosis; Patient Compliance; Rifampin; Schools; Telemedicine; Treatment Outcome; Videoconferencing | 2017 |
Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
Topics: Adult; Antitubercular Agents; Bacterial Typing Techniques; Cross-Sectional Studies; Cytodiagnosis; Early Diagnosis; Ethiopia; Female; Genotype; Humans; Isoniazid; Male; Molecular Diagnostic Techniques; Point Mutation; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2017 |
Mycobacterium tuberculosis Proteome Response to Antituberculosis Compounds Reveals Metabolic "Escape" Pathways That Prolong Bacterial Survival.
Topics: Antitubercular Agents; Diarylquinolines; Fluoroquinolones; Isoniazid; Mefloquine; Moxifloxacin; Mycobacterium tuberculosis; Proteome; Proteomics; Rifampin | 2017 |
Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Breast Feeding; Case-Control Studies; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Isoniazid; Male; Mothers; Nevirapine; Post-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Rifampin; Tuberculosis | 2017 |
BCG vaccination-induced suppurative lymphadenitis: four signs to pay attention to.
Topics: Adjuvants, Immunologic; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Humans; Isoniazid; Lymphadenitis; Rifampin; Treatment Outcome; Tuberculosis | 2017 |
Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Topics: Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; China; Early Diagnosis; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Promoter Regions, Genetic; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Sputum; Tuberculosis, Multidrug-Resistant | 2017 |
Genotyping and rifampicin and isoniazid resistance in Mycobacterium bovis strains isolated from the lymph nodes of slaughtered cattle.
Topics: Animals; Antitubercular Agents; Bacterial Typing Techniques; Cattle; Drug Resistance, Multiple, Bacterial; Genetic Variation; Genotype; Isoniazid; Lymph Nodes; Microbial Sensitivity Tests; Minisatellite Repeats; Mutation; Mycobacterium bovis; Phenotype; Rifampin; Tuberculosis, Bovine; Tuberculosis, Lymph Node | 2017 |
The Role of Tamarix gallica Leaves Extract in Liver Injury Induced by Rifampicin Plus Isoniazid in Sprague Dawley Rats.
Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Isoniazid; Liver; Liver Function Tests; Male; Phytotherapy; Plant Extracts; Plant Leaves; Protective Agents; Rats; Rats, Sprague-Dawley; Rifampin; Tamaricaceae | 2018 |
The Rate of Drug-Resistant Tuberculosis in Korean Children and Adolescents Since 2007.
Topics: Adolescent; Antitubercular Agents; Asian People; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Incidence; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Republic of Korea; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
[Molecular epidemiologic study on
Topics: Antitubercular Agents; Beijing; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiologic Studies; Genotype; Humans; Isoniazid; Mycobacterium tuberculosis; Polymorphism, Genetic; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2017 |
Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; California; Cluster Analysis; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Rifampin; Texas; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
[Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType® MTBDRplus V.2 in Colombia].
Topics: Antitubercular Agents; Colombia; Genotype; Genotyping Techniques; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
[Characterization of clinical isolates of Mycobacterium tuberculosis from HIV positive individuals in Colombia, 2012].
Topics: Antitubercular Agents; Colombia; HIV Infections; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
[Prevalence of Mycobacterium tuberculosis resistance to quinolones and injectables in Colombia, 2012-2013].
Topics: Antitubercular Agents; Colombia; Cross-Sectional Studies; Humans; Isoniazid; Mycobacterium tuberculosis; Prevalence; Quinolones; Rifampin; Tuberculosis | 2017 |
Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice.
Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Isoniazid; Lung; Metformin; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 2017 |
Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Cameroon; Cross-Sectional Studies; Female; Genotype; Genotyping Techniques; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Mutation; Mutation Rate; Mycobacterium tuberculosis; Oxidoreductases; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Line probe assay for detection of
Topics: Female; Humans; India; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2017 |
Genetic diversity & drug sensitivity profiles of
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Genetic Variation; Genotype; Humans; Interspersed Repetitive Sequences; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Mycobacterium tuberculosis; Phylogeny; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ill-Housed Persons; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Students; United States; Young Adult | 2017 |
Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus.
Topics: Antibiotics, Antitubercular; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Poncet's disease in human immunodeficiency virus: a case report.
Topics: Adult; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Arthritis, Reactive; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2017 |
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2017 |
Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Bacterial Load; Colony Count, Microbial; Disease Models, Animal; DNA, Bacterial; Ethambutol; Female; Isoniazid; Lung; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nonlinear Dynamics; Predictive Value of Tests; Pyrazinamide; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2017 |
Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; China; Cohort Studies; Directly Observed Therapy; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Retreatment; Retrospective Studies; Rifampin; Sputum; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Diagnostic Performance of the GenoType MTBDR
Topics: Adult; Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Preparation, characterization, and in vitro evaluation of isoniazid and rifampicin-loaded archaeosomes.
Topics: Archaea; Calorimetry, Differential Scanning; Drug Liberation; Hydrogen-Ion Concentration; Isoniazid; Microscopy, Atomic Force; Particle Size; Rifampin; Unilamellar Liposomes | 2018 |
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
Topics: Animals; Antitubercular Agents; Clostridiales; Drug Combinations; Dysbiosis; Gastrointestinal Microbiome; Intestines; Isoniazid; Mice; Mycobacterium tuberculosis; Porphyromonas; Pyrazinamide; Rifampin; RNA, Ribosomal, 16S; Tuberculosis, Pulmonary | 2017 |
Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
Topics: Adolescent; Adult; Aged; Bacterial Proteins; Child; DNA-Directed RNA Polymerases; DNA, Bacterial; Ethambutol; Genes, Bacterial; Histones; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mutation; Mycobacterium bovis; Mycobacterium tuberculosis; Pakistan; Pathology, Molecular; Pentosyltransferases; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Massive choroidal granuloma as the presenting feature of disseminated tuberculosis in immunocompetent patients.
Topics: Adolescent; Adult; Antitubercular Agents; Choroid Diseases; Drug Combinations; Ethambutol; Female; Granuloma; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Ocular; Tuberculosis, Pulmonary; Ultrasonography | 2018 |
Silicotuberculosis with oesophagobronchial fistulas and broncholithiasis: a case report.
Topics: Aged; Antibiotics, Antitubercular; Bronchial Fistula; Esophageal Fistula; Esophagoscopy; Female; Humans; Isoniazid; Lithiasis; Pyrazinamide; Rifampin; Silicotuberculosis; Stents; Treatment Outcome | 2018 |
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) as a marker of tuberculosis treatment efficacy.
Topics: Adult; Aged; Antitubercular Agents; Biomarkers; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Receptors, Urokinase Plasminogen Activator; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2017 |
Band pattern analysis of mutations in rifampicin resistance strain of Mycobacterium tuberculosis by Line Probe assay in patients from Delhi, India.
Topics: Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 2017 |
Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Skin; Skin Diseases, Bacterial | 2017 |
Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary; Whole Genome Sequencing | 2017 |
Simultaneous Determination of First-Line 4-FDC Antituberculosis Drugs by UHPLC-UV and HPLC-UV: A Comparative Study.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Isoniazid; Pyrazinamide; Rifampin | 2017 |
A 25-Year-Old Woman With a Deceptive Pancreas Cyst: All Is Not as It Appears!
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pancreatic Cyst; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis | 2018 |
Distribution scheme of antituberculosis drug resistance among HIV patients in a referral centre over 10 years.
Topics: Adult; Antitubercular Agents; Coinfection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Genetic diversity of Mycobacterium tuberculosis and transmission associated with first-line drug resistance: a first analysis in Jalisco, Mexico.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Genetic Variation; Genotyping Techniques; Humans; Isoniazid; Mexico; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Phylogeny; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
Topics: Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed RNA Polymerases; High-Throughput Screening Assays; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2017 |
Oral pyridoxine can substitute for intravenous pyridoxine in managing patients with severe poisoning with isoniazid and rifampicin fixed dose combination tablets: a case report.
Topics: Administration, Oral; Antidotes; Antitubercular Agents; Diazepam; Drug Combinations; Female; Humans; Isoniazid; Pyridoxine; Rifampin; Seizures; Sri Lanka; Suicide, Attempted; Tablets; Treatment Outcome; Unconsciousness; Young Adult | 2017 |
GenoType MTBDRplus assay for screening and characterization of isoniazid and rifampicin resistance-associated mutations in multidrug-resistant Mycobacterium tuberculosis from India.
Topics: Antitubercular Agents; Gene Deletion; Genotype; Humans; India; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sequence Deletion; Tuberculosis, Multidrug-Resistant | 2017 |
Detection of First-Line Drug Resistance Mutations and Drug-Protein Interaction Dynamics from Tuberculosis Patients in South India.
Topics: Alleles; Antitubercular Agents; Bacterial Proteins; Catalytic Domain; Drug Resistance, Multiple, Bacterial; Humans; India; Isoniazid; Microbial Sensitivity Tests; Molecular Docking Simulation; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2018 |
An unusual pain in the gut.
Topics: Abdominal Pain; Africa; Anti-Bacterial Agents; Colon, Transverse; Colonoscopy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Mycobacterium bovis; Pyrazinamide; Rifampin; Thailand; Travel; Treatment Outcome; Tuberculosis, Gastrointestinal | 2017 |
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
Topics: Adult; Antitubercular Agents; China; Cohort Studies; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Isoniazid; Lost to Follow-Up; Male; Middle Aged; Ofloxacin; Retrospective Studies; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2017 |
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
Topics: Antitubercular Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genetic Variation; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mitoxantrone; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Rifampin; Sequence Analysis; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Fibrosis; Foam Cells; Humans; Hypoxia; Isoniazid; Mice; Mice, Knockout; Necrosis; Nitric Oxide Synthase Type II; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
An application of competitive reporter monitored amplification (CMA) for rapid detection of single nucleotide polymorphisms (SNPs).
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Genes, Reporter; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Rifampin; Tuberculosis | 2017 |
The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responses.
Topics: Adult; Antitubercular Agents; C-Reactive Protein; Case-Control Studies; Dehydroepiandrosterone; Ethambutol; Female; Gene Expression Regulation; Humans; Hydrocortisone; Interferon-gamma; Interleukin-6; Isoniazid; Leukocytes, Mononuclear; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Receptors, Glucocorticoid; Rifampin; Transforming Growth Factor beta; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Activity of human beta defensin-1 and its motif against active and dormant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; beta-Defensins; Computational Biology; Hemolysis; Humans; Isoniazid; Leukocytes, Mononuclear; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2017 |
Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs.
Topics: Adult; Antitubercular Agents; Fasting; Female; Food; Humans; India; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 2017 |
Use of Rifapentine and Isoniazid Directly Observed Therapy for the Treatment of Latent Tuberculosis Infection in a Military Clinic.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Antitubercular Agents; Directly Observed Therapy; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Military Personnel; Retrospective Studies; Rifampin; United States | 2017 |
Mycobacterium tuberculosis Subculture Results in Loss of Potentially Clinically Relevant Heteroresistance.
Topics: Antitubercular Agents; Bacterial Proteins; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; High-Throughput Nucleotide Sequencing; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
Topics: Adenosine Triphosphatases; Antitubercular Agents; Bacterial Proteins; Cell Wall; Drug Resistance, Multiple, Bacterial; Ethambutol; Galactans; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Ion Pumps; Isoniazid; Ligases; Mannosyltransferases; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Peptidoglycan; Rifampin; Serine Proteases; Thienamycins; Vancomycin | 2017 |
Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.
Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Antitubercular Agents; Bacterial Proteins; Catalase; Child; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Middle Aged; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Young Adult; Zimbabwe | 2017 |
[Genotyping and drug susceptibility of
Topics: Antitubercular Agents; China; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2017 |
Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.
Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Biomedical Research; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Drug Combinations; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Research Design; Rifampin; Tuberculosis, Pulmonary; Uganda | 2017 |
Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Prevalence; Prospective Studies; Retrospective Studies; Rifampin; South Africa; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Oleanolic Acid-Mediated Inhibition of Pregnane X Receptor and Constitutive Androstane Receptor Attenuates Rifampin-Isoniazid Cytotoxicity.
Topics: Cell Line; Constitutive Androstane Receptor; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Gene Expression Regulation, Enzymologic; Hep G2 Cells; Hepatocytes; Humans; Isoniazid; Oleanolic Acid; Pregnane X Receptor; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Rifampin; Species Specificity | 2017 |
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Comorbidity; Cycloserine; Ethambutol; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; China; Ethambutol; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Logistic Models; Male; Middle Aged; Prevalence; Retrospective Studies; Rifampin; Rural Population; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
A rapid and simple resazurin assay to detect minimum inhibitory concentrations of first-line drugs for Mycobacterium tuberculosis isolated from cerebrospinal fluid.
Topics: Antitubercular Agents; Cerebrospinal Fluid; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Rifampin; Streptomycin; Tuberculosis, Meningeal; Xanthenes | 2018 |
Assessment and management of active and latent TB.
Topics: Antitubercular Agents; Contact Tracing; Humans; Isoniazid; Latent Tuberculosis; Mass Screening; Practice Guidelines as Topic; Radiography, Thoracic; Rifampin; Tuberculosis, Pulmonary | 2016 |
Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Seoul; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2017 |
Achieving High
Topics: Antitubercular Agents; Deuterium; Ethambutol; Isoniazid; Magnetic Resonance Spectroscopy; Pyrazinamide; Rifampin | 2017 |
TB-PCR and drug resistance pattern in BALF in smear-negative active pulmonary TB.
Topics: Adult; Aged; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Predictive Value of Tests; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tertiary Care Centers; Thailand; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing.
Topics: Administration, Oral; Animals; Antitubercular Agents; Delayed-Action Preparations; Dosage Forms; Drug Combinations; Drug Delivery Systems; Drug Design; Drug Liberation; Isoniazid; Male; Printing, Three-Dimensional; Rats, Sprague-Dawley; Rifampin | 2017 |
Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Morocco; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2018 |
The Alternative Sigma Factors SigE and SigB Are Involved in Tolerance and Persistence to Antitubercular Drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Tolerance; Ethambutol; Gene Expression Regulation, Bacterial; Gentamicins; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sigma Factor; Streptomycin; Vancomycin | 2017 |
'A most malignant malady': a rare case of laryngeal tuberculosis in epidermal growth factor receptor mutant lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Dysphonia; ErbB Receptors; Ethambutol; Female; Gene Expression Regulation, Neoplastic; Humans; Isoniazid; Lung Neoplasms; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Laryngeal | 2017 |
Management of Latent Tuberculosis Infection Among Healthcare Workers: 10-Year Experience at a Single Center.
Topics: Adult; Antitubercular Agents; Disease Management; Drug Therapy, Combination; Female; Health Personnel; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Retrospective Studies; Rifampin | 2017 |
High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova.
Topics: Antitubercular Agents; Humans; Isoniazid; Moldova; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique.
Topics: Alleles; Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genetic Loci; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Minisatellite Repeats; Multilocus Sequence Typing; Mycobacterium tuberculosis; Polymorphism, Genetic; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Microbial sensor for drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using
Topics: Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Isoniazid; Microbial Sensitivity Tests; Models, Theoretical; Mycobacterium tuberculosis; Rifampin | 2018 |
Pleural effusion as a late complication of intravesical BCG treatment.
Topics: Aged, 80 and over; Antitubercular Agents; BCG Vaccine; Biopsy; Carcinoma, Transitional Cell; Diagnosis, Differential; Humans; Isoniazid; Male; Pleural Effusion; Rifampin; Risk Factors; Treatment Outcome; Urinary Bladder Neoplasms | 2018 |
Improved performance of the artus Mycobacterium tuberculosis RG PCR kit in a low incidence setting: a retrospective monocentric study.
Topics: Antitubercular Agents; Incidence; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Retrospective Studies; Rifampin | 2017 |
Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.
Topics: Adult; Aged; Antitubercular Agents; Asian People; China; Clinical Audit; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Outcome Assessment, Health Care; Prescriptions; Pyrazinamide; Retreatment; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
A 75-year-old woman presenting with nasal vestibulitis.
Topics: Aged; Antitubercular Agents; Biopsy; Dermatitis; Ethambutol; Female; Humans; Isoniazid; Lupus Vulgaris; Mycobacterium tuberculosis; Nose; Rifampin; Treatment Outcome | 2018 |
Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Gene Expression Profiling; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Proteomics; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Child; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ethambutol; Female; HIV; HIV Infections; Humans; Isoniazid; Lopinavir; Male; Models, Statistical; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Ritonavir; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Deregulation of Genes Associated with Alternate Drug Resistance Mechanisms in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Down-Regulation; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2018 |
Modulation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation by ursolic acid (UA) attenuates rifampin-isoniazid cytotoxicity.
Topics: Constitutive Androstane Receptor; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Hep G2 Cells; Hepatocytes; Humans; Isoniazid; Pregnane X Receptor; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Rifampin; Transfection; Triterpenes; Ursolic Acid | 2017 |
Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Genome, Bacterial; Humans; Isoniazid; Molecular Typing; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis | 2018 |
Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
Topics: Aged; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Nucleic Acid Synthesis Inhibitors; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Tuberculosis of the tonsil simulating a cancer.
Topics: Adenoids; Adult; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pharyngeal Neoplasms; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2017 |
Performance of MTBDRplus assay in detecting multidrug resistant tuberculosis at hospital level.
Topics: Antitubercular Agents; Biological Assay; Drug Resistance, Bacterial; Ethiopia; Hospitals; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2017 |
Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.
Topics: Adolescent; Adult; Aged; Clarithromycin; Drug Resistance, Bacterial; Female; Genotype; Ghana; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Prevalence; Retrospective Studies; Rifampin; Surveys and Questionnaires; Tuberculosis | 2017 |
A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital, southern Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; Ethiopia; Female; HIV Infections; Hospitals, General; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Streptomycin; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; Diagnosis, Differential; Diagnostic Tests, Routine; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Microbial Viability; Mutation; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant | 2018 |
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
A Painful Red Eye.
Topics: Alcoholism; Antitubercular Agents; Conjunctival Diseases; Ethambutol; Eye Pain; Glucocorticoids; Humans; Hyperemia; Interferon-gamma; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Scleritis; Tobacco Use Disorder; Tuberculosis, Pulmonary | 2018 |
Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Spleen; Tuberculosis | 2018 |
Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV-Coinfected Children in India: Recommendations for Dose Modifications.
Topics: Adolescent; Age Factors; Antitubercular Agents; Body Weight; Child; Child, Preschool; Coinfection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; Humans; India; Infant; Isoniazid; Male; Models, Biological; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2018 |
Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children.
Topics: Antitubercular Agents; Child, Preschool; Cohort Studies; Female; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Malnutrition; Patient Compliance; Practice Guidelines as Topic; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Uganda; World Health Organization | 2018 |
Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Topics: Antitubercular Agents; DNA, Bacterial; Ethambutol; Female; Genotype; Humans; Isoniazid; Kanamycin; Laboratories; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Referral and Consultation; Rifampin; South Africa | 2017 |
The Effects of Aloe Vera on TNF-a Levels, the Percentage of Nk Cells and Th 17 Cells in Rat That Received Izoniazid and Rifampycin.
Topics: Aloe; Animals; Antibiotics, Antitubercular; Antitubercular Agents; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Isoniazid; Killer Cells, Natural; Plant Extracts; Rats; Rifampin; Th17 Cells; Tumor Necrosis Factor-alpha | 2017 |
Evaluation of Nitrate Reductase Assay for Early Detection of Multi and Extensively Drug Resistance Tuberculosis in our Setup.
Topics: Amikacin; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2018 |
Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.
Topics: Animals; Antitubercular Agents; Ascorbic Acid; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections, Intraperitoneal; Isoniazid; Lung; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2018 |
Isoniazid and rifampicin heteroresistant Mycobacterium tuberculosis isolated from tuberculous meningitis patients in India.
Topics: Antitubercular Agents; Female; Humans; Incidence; India; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant | 2018 |
Fabrication of Isoniazid/Rifampicin/Poly L-lactic Acid Donut-shaped Implants via Three Dimensional Printing Technique.
Topics: Delayed-Action Preparations; Isoniazid; Lactic Acid; Polyesters; Powders; Printing, Three-Dimensional; Prostheses and Implants; Rifampin | 2017 |
Completion Rate and Safety of Tuberculosis Infection Treatment With Shorter Regimens.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Medication Adherence; Retrospective Studies; Rifampin; Texas; Tuberculosis | 2018 |
Development and In Vitro Release of Isoniazid and Rifampicin-Loaded Bovine Serum Albumin Nanoparticles.
Topics: Animals; Cattle; Chromatography, High Pressure Liquid; Isoniazid; Nanoparticles; Reference Standards; Rifampin; Serum Albumin, Bovine | 2018 |
Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014-2015.
Topics: Adult; Age Factors; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Regression Analysis; Retrospective Studies; Rifampin; Saudi Arabia; Sex Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2018 |
Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs.
Topics: Adult; Antitubercular Agents; Desensitization, Immunologic; Ethambutol; Female; Humans; Hypersensitivity; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin | 2018 |
Automated broth-based systems versus the MYCOTB plate for antimicrobial susceptibility testing of the Mycobacterium tuberculosis complex: challenges in interpretation.
Topics: Antitubercular Agents; Automation, Laboratory; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2018 |
Antituberculosis Treatment in a Patient with Celiac Disease.
Topics: Aged; Antitubercular Agents; Celiac Disease; Diarrhea; Diet, Gluten-Free; Drug Compounding; Drug Substitution; Drug Therapy, Combination; Ethambutol; Glutens; Hemoptysis; Humans; Isoniazid; Male; Metronidazole; Moxifloxacin; Pyrazinamide; Rifampin; Smoking; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2018 |
Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.
Topics: Adult; Antitubercular Agents; China; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2018 |
Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.
Topics: Adolescent; Adult; Cross-Sectional Studies; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Rifampin; RNA, Viral; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2018 |
A Woman With Confusion and Blurred Vision.
Topics: Antitubercular Agents; Brain Mapping; Choroiditis; Confusion; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Meningitis; Middle Aged; Optic Nerve Diseases; Pyrazinamide; Rifampin; Tuberculosis, Central Nervous System; Vision Disorders | 2018 |
First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Ethambutol; Female; Humans; Isoniazid; Liver; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Purines; Pyrazinamide; Rifampin; Tuberculosis; Young Adult | 2018 |
Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.
Topics: Antitubercular Agents; Caffeic Acids; Crystallization; Drug Combinations; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Models, Molecular; Pyrazinamide; Rifampin; Tuberculosis; Vanillic Acid | 2018 |
Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
Topics: Adolescent; Adult; Aftercare; Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Lost to Follow-Up; Male; Multivariate Analysis; Patient Discharge; Patient Transfer; Prisoners; Prisons; Pyrazinamide; Retreatment; Retrospective Studies; Rifampin; Risk Factors; Sputum; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2018 |
BCG-Induced Granulomatous Balanoposthitis and Lymphadenitis Unresponsive to Isoniazid Therapy: A Case Report and Review of the Literature.
Topics: Administration, Intravesical; Aged; Balanitis; BCG Vaccine; Drug Therapy, Combination; Granuloma; Humans; Isoniazid; Lymphadenitis; Male; Rifampin | 2018 |
Latent tuberculosis in childhood: tolerability of two different therapeutic approaches.
Topics: Adolescent; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Latent Tuberculosis; Liver Function Tests; Male; Retrospective Studies; Rifampin; Time Factors; Transaminases | 2018 |
Sex differences and factors influencing the duration of the QT interval in patients on anti-tuberculosis therapy.
Topics: Antitubercular Agents; Clinical Trials as Topic; Electrocardiography; Ethambutol; Female; Gatifloxacin; Heart Rate; Humans; Isoniazid; Male; Models, Theoretical; Multivariate Analysis; Pyrazinamide; Rifampin; Sex Factors; Tuberculosis | 2018 |
QuantiFERON®-TB Gold test conversion in a psoriatic patient with pleural tuberculosis one year after adalimumab treatment.
Topics: Adalimumab; Anti-Inflammatory Agents; Antitubercular Agents; Biopsy; Humans; Isoniazid; Male; Middle Aged; Psoriasis; Rifampin; Thoracic Surgery, Video-Assisted; Tuberculosis, Pleural | 2018 |
Antituberculosis drug prescribing for inpatients in a national tuberculosis hospital in China, 2011-2015.
Topics: Antitubercular Agents; China; Drug Prescriptions; Extensively Drug-Resistant Tuberculosis; Hospitals, Chronic Disease; Humans; Inpatients; Isoniazid; Linezolid; Medical Records; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin | 2018 |
Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Isoniazid; Macrophages; Mycobacterium tuberculosis; Rifampin; THP-1 Cells; Tuberculosis; Valproic Acid; Vorinostat | 2018 |
In vitro antimycobacterial activity of 2-(((2-hydroxyphenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione: a new chemical entity against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Culture Media; Cyclohexanones; DNA, Bacterial; Drug Combinations; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin | 2018 |
Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Cohort Studies; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Rifampin; Risk Factors; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam; Young Adult | 2018 |
Individualizing Tuberculosis (TB) Treatment: Are TB Programs in High Burden Settings Ready for Prime Time Therapeutic Drug Monitoring?
Topics: Antitubercular Agents; Coinfection; Drug Monitoring; HIV; HIV Infections; Humans; Isoniazid; Rifampin; Sputum; Tuberculosis | 2018 |
A comparison of Rv0559c and Rv0560c expression in drug-resistant Mycobacterium tuberculosis in response to first-line antituberculosis drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genotype; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Real-Time Polymerase Chain Reaction; Rifampin | 2018 |
Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Predictive Value of Tests; Pyrazinamide; Reproducibility of Results; Rifampin; Spectrometry, Mass, Electrospray Ionization; Streptomycin; Tandem Mass Spectrometry; Tuberculosis | 2018 |
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Kyrgyzstan; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mutation; Mutation Rate; Mycobacterium tuberculosis; Oxidoreductases; Peroxidases; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2018 |
The World Health Organization global aDSM database: generating evidence on the safety of new treatment regimens for drug-resistant tuberculosis.
Topics: Antitubercular Agents; Communicable Disease Control; Databases, Factual; Diarylquinolines; Humans; Infectious Disease Medicine; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Patient Safety; Public Health; Rifampin; Tuberculosis, Multidrug-Resistant; World Health Organization | 2018 |
Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.
Topics: Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2018 |
Defining the best regimen to treat isoniazid-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Ocular; Uveitis; Visual Acuity | 2018 |
Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Case-Control Studies; Ethiopia; Female; Hospitals, Community; Humans; Isoniazid; Male; Middle Aged; Rifampin; Risk Factors; Surveys and Questionnaires; Tuberculosis, Multidrug-Resistant; Young Adult | 2018 |
Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings.
Topics: Anti-HIV Agents; Antitubercular Agents; Cost-Benefit Analysis; Drug Therapy, Combination; HIV Infections; Humans; Isoniazid; Markov Chains; Rifampin; Tuberculosis | 2018 |
[Management and treatment difficulties of multi-drug resistant pulmonary tuberculosis in a pediatric case].
Topics: Adult; Antitubercular Agents; Female; Humans; Infant; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
[Optochiasmatic tuberculomas as a paradoxical reaction to treatment for meningeal tuberculosis].
Topics: Adult; Antitubercular Agents; Brain Infarction; Diagnostic Errors; Disease Progression; Drug Resistance, Microbial; Drug Substitution; Ethambutol; Female; Host-Pathogen Interactions; Humans; Isoniazid; Magnetic Resonance Imaging; Meningitis, Viral; Moxifloxacin; Mycobacterium tuberculosis; Neuroimaging; Optic Chiasm; Paresis; Prednisone; Pyrazinamide; Rifampin; Thalamus; Tuberculoma; Tuberculosis, Meningeal; Vision Disorders | 2018 |
Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report.
Topics: Antitubercular Agents; Humans; Isoniazid; Levofloxacin; Liver Failure; Liver Transplantation; Living Donors; Male; Middle Aged; Rifampin; Tuberculosis | 2018 |
Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
Topics: Aged; Antitubercular Agents; Arthritis, Rheumatoid; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Rifampin | 2018 |
Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Base Sequence; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nucleic Acid Denaturation; Point-of-Care Systems; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs.
Topics: Algorithms; Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2018 |
Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Granuloma, Respiratory Tract; Isoniazid; Lung; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Rifampin; Small Molecule Libraries; Tuberculosis | 2018 |
National position statement for the management of latent tuberculosis infection.
Topics: Antitubercular Agents; Australia; Chemoprevention; Communicable Disease Control; Disease Notification; Drug Combinations; Emigration and Immigration; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Prevalence; Rifampin; Transients and Migrants; Tuberculin Test; Tuberculosis, Pulmonary | 2017 |
A case of tuberculosis pericarditis with an interesting echocardiographic image.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Echocardiography; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pericardial Effusion; Pericarditis, Tuberculous; Rifampin; Streptomycin | 2018 |
Protein Binding of First-Line Antituberculosis Drugs.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis | 2018 |
Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2018 |
Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
Topics: Antitubercular Agents; Computer Simulation; Drug Resistance, Bacterial; Drug Resistance, Multiple; Granuloma; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
A Breast Lump in an Elderly Lady - Carcinoma or else ?.
Topics: Aged; Antitubercular Agents; Biopsy, Fine-Needle; Breast; Breast Neoplasms; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
Genome sequence and analysis of Mycobacterium tuberculosis strain SWLPK.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pakistan; Rifampin; Sequence Analysis, DNA; Virulence; Whole Genome Sequencing | 2018 |
Hot aqueous leaf extract of Lasianthera africana (Icacinaceae) attenuates rifampicin-isoniazid-induced hepatotoxicity.
Topics: Alanine Transaminase; Animals; Antibiotics, Antitubercular; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cholesterol; Female; Glutathione; Humans; Isoniazid; Liver; Magnoliopsida; Male; Malondialdehyde; Plant Extracts; Plant Leaves; Rats, Wistar; Rifampin; Superoxide Dismutase | 2018 |
Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Topics: Antitubercular Agents; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2018 |
Left lung hypoplasia with a right tuberculous pleural effusion after childbirth: A case report.
Topics: Abnormalities, Multiple; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lung; Lung Diseases; Mycobacterium tuberculosis; Parturition; Pleural Effusion; Pregnancy; Pulmonary Heart Disease; Respiratory Insufficiency; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2018 |
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions.
Topics: Anaerobiosis; Antitubercular Agents; Benzodiazepines; Cell Line; Humans; Isoniazid; Mycobacterium tuberculosis; Nylons; Pyrroles; Rifampin; Tuberculosis, Pulmonary | 2018 |
Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
Topics: Animals; Antitubercular Agents; Arginine; Bacterial Proteins; Containment of Biohazards; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Mice; Mice, Inbred C57BL; Mice, SCID; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nutrients; Rifampin; Tuberculosis, Multidrug-Resistant | 2018 |
Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Genotype; Isoniazid; Mycobacterium tuberculosis; Prevalence; Rifampin; Uganda | 2018 |
Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report.
Topics: Acute Kidney Injury; Antitubercular Agents; Female; Glucocorticoids; Humans; Isoniazid; Latent Tuberculosis; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Remission Induction; Renal Dialysis; Rifampin; Treatment Outcome | 2018 |
Perianal ulcerative skin tuberculosis: A case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Fissure in Ano; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 2018 |
A bioactive implant in situ and long-term releases combined drugs for treatment of osteoarticular tuberculosis.
Topics: Animals; Antitubercular Agents; Biocompatible Materials; Bone Regeneration; Cell Adhesion; Cell Line; Cell Survival; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Drug Therapy, Combination; Durapatite; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Polyvinyl Alcohol; Prostheses and Implants; Rabbits; Rifampin; Tissue Scaffolds; Tuberculosis, Osteoarticular | 2018 |
Hepatoprotective effect of lawsone on rifampicin-isoniazid induced hepatotoxicity in in vitro and in vivo models.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Cell Survival; Chemical and Drug Induced Liver Injury; Hep G2 Cells; Humans; Isoniazid; L-Lactate Dehydrogenase; Liver; Male; Naphthoquinones; Protective Agents; Rats, Wistar; Rifampin; Serum Albumin; Serum Globulins | 2018 |
Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Topics: Antitubercular Agents; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in
Topics: Antibiotics, Antitubercular; Bacterial Proteins; Catalase; Cross-Sectional Studies; DNA-Directed RNA Polymerases; Humans; Isoniazid; Malawi; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Polymerase Chain Reaction; Promoter Regions, Genetic; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2018 |
GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection.
Topics: Animals; Antibodies, Neutralizing; Antitubercular Agents; Cattle; Disease Models, Animal; Granulocyte-Macrophage Colony-Stimulating Factor; Immunologic Factors; Immunomodulation; Isoniazid; Macrophages; Mice; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2018 |
Three months of rifapentine and isoniazid for latent tuberculosis infection in hemodialysis patients: High rates of adverse events.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Isoniazid; Kidney Failure, Chronic; Latent Tuberculosis; Male; Middle Aged; Renal Dialysis; Rifampin; Safety | 2019 |
Diagnostic accuracy evaluation of the conventional and molecular tests for Spinal Tuberculosis in a cohort, head-to-head study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Drug Resistance, Bacterial; Female; Follow-Up Studies; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Spinal; Young Adult | 2018 |
Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients.
Topics: Adolescent; Adult; Antitubercular Agents; Humans; India; Isoniazid; Pilot Projects; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2018 |
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection.
Topics: Adolescent; Antibiotics, Antitubercular; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Rifampin; United States | 2018 |
Diagnosing the Treatment.
Topics: Aged; Antitubercular Agents; Humans; Hypercalcemia; Isoniazid; Male; Mycobacterium bovis; Rifampin | 2018 |
Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
Topics: Adolescent; Adult; Antitubercular Agents; Case-Control Studies; Child; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Ethiopia; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Surveys and Questionnaires; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2018 |
Isoniazid-resistant, rifampicin-susceptible tuberculosis in India.
Topics: Antitubercular Agents; Humans; India; Isoniazid; Rifampin; Tuberculosis, Multidrug-Resistant | 2018 |
Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.
Topics: Adolescent; Adult; Antitubercular Agents; Diarylquinolines; Drug Administration Schedule; Drug Liberation; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Nitroimidazoles; Oxazoles; Proof of Concept Study; Rifampin; Treatment Outcome; Young Adult | 2018 |
Genipin-crosslinked carboxymethyl chitosan nanogel for lung-targeted delivery of isoniazid and rifampin.
Topics: Anti-Bacterial Agents; Chitosan; Cross-Linking Reagents; Drug Delivery Systems; Drug Resistance, Multiple, Bacterial; Gels; Iridoids; Isoniazid; Lung; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanoparticles; Rifampin | 2018 |
Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
Topics: Adult; Aged; Algorithms; Antitubercular Agents; Communicable Disease Control; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genotype; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Predictive Value of Tests; Prospective Studies; Rifampin; Sequence Analysis, DNA; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Drug resistance pattern in Mycobacterium tuberculosis to the first line drugs of pulmonary tuberculosis patients at Hazara Region, Pakistan.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pakistan; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2018 |
Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with isoniazid and rifampicin.
Topics: Antitubercular Agents; Drug Discovery; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imidazoles; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Naphthoquinones; Rifampin; Structure-Activity Relationship; Tuberculosis | 2018 |
Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Isoniazid; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2018 |
Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
Topics: Antitubercular Agents; Autophagy; Diarylquinolines; Host-Pathogen Interactions; Humans; Isoniazid; Linezolid; Macrophages; Mycobacterium tuberculosis; Phagosomes; Rifampin; Tuberculosis; U937 Cells | 2018 |
Direct Susceptibility Testing on MGIT 960 TB System: A Rapid Method for Detection of Drug Resistant Tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2018 |
The development and validation of a LC-MS/MS method for the quantitation of metformin, rifampicin and isoniazid in rat plasma using HILIC chromatography.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Hydrophobic and Hydrophilic Interactions; Isoniazid; Limit of Detection; Linear Models; Male; Metformin; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Rifampin; Tandem Mass Spectrometry | 2018 |
Pharmacokinetics of Efavirenz 400 mg Once Daily Coadministered With Isoniazid and Rifampicin in Human Immunodeficiency Virus-Infected Individuals.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Rifampin; Viral Load; Young Adult | 2019 |
Tuberculosis Screening in Patients with Psoriasis Receiving Biologic Therapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Antitubercular Agents; Biological Products; Chemoprevention; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Prevalence; Psoriasis; Retrospective Studies; Rifampin; Tuberculin Test | 2018 |
Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against
Topics: A549 Cells; Animals; Antitubercular Agents; Biocompatible Materials; Cell Death; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Isoniazid; Lactic Acid; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Proton Magnetic Resonance Spectroscopy; RAW 264.7 Cells; Rifampin; Static Electricity; Surface Tension; Tuberculosis | 2018 |
Cost-utility analysis of high-dose treatment for intermediate-susceptible, dose-dependent tuberculosis patients.
Topics: Antitubercular Agents; Cohort Studies; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Costs; Humans; Isoniazid; Markov Chains; Mycobacterium tuberculosis; Netherlands; Quality-Adjusted Life Years; Rifampin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Evaluation of line-probe assay for molecular analysis and drug susceptibility of extra-pulmonary tuberculosis.
Topics: Antitubercular Agents; Bacteriological Techniques; Cross-Sectional Studies; Drug Resistance, Bacterial; Early Diagnosis; Genotype; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Tertiary Care Centers; Tuberculosis, Multidrug-Resistant | 2018 |
Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.
Topics: Adult; Antitubercular Agents; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary; Young Adult | 2018 |
Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
Topics: Adjuvants, Immunologic; Anti-Bacterial Agents; Antitubercular Agents; Cell Line; Drug Therapy, Combination; Ethambutol; Glutathione; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; THP-1 Cells; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Using routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: A retrospective spatiotemporal analysis.
Topics: Adult; Antitubercular Agents; Data Collection; Epidemiological Monitoring; Female; Geographic Information Systems; Humans; Incidence; Isoniazid; Male; Retrospective Studies; Rifampin; South Africa; Spatio-Temporal Analysis; Tuberculosis, Multidrug-Resistant | 2018 |
Hepatoprotective activity of Tamarindus indica Linn stem bark ethanolic extract against hepatic damage induced by co-administration of antitubercular drugs isoniazid and rifampicin in Sprague Dawley rats.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female; Isoniazid; Plant Bark; Plant Extracts; Plant Stems; Rats; Rats, Sprague-Dawley; Rifampin; Tamarindus | 2018 |
Smartly Engineered PEGylated Di-Block Nanopolymeric Micelles: Duo Delivery of Isoniazid and Rifampicin Against Mycobacterium tuberculosis.
Topics: Drug Delivery Systems; Humans; Isoniazid; Micelles; Mycobacterium tuberculosis; Polyethylene Glycols; Rifampin | 2018 |
Sagittaria sagittifolia polysaccharide protects against isoniazid- and rifampicin-induced hepatic injury via activation of nuclear factor E2-related factor 2 signaling in mice.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Isoniazid; Male; Mice, Inbred BALB C; NF-E2-Related Factor 2; Polysaccharides; Protective Agents; Rifampin; Sagittaria; Signal Transduction | 2018 |
Optic Perineuritis Due to Tuberculosis.
Topics: Adult; Antitubercular Agents; Bronchoscopy; Drug Therapy, Combination; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Optic Neuritis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Vision Disorders; Visual Acuity; Visual Fields | 2019 |
Therapeutic Drug Monitoring: The Need for Practical Guidance.
Topics: Coinfection; Drug Monitoring; HIV; HIV Infections; Humans; Isoniazid; Rifampin; Sputum; Tuberculosis | 2019 |
[Tuberculosis and the eye in Belgium: Report of 3 cases].
Topics: Adult; Antitubercular Agents; Belgium; Biopsy; Child, Preschool; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Male; Rifampin; Tuberculin Test; Tuberculosis, Ocular; Tuberculosis, Pulmonary | 2018 |
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Genome, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Tuberculosis; Whole Genome Sequencing | 2018 |
Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Female; Health Care Costs; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Rifampin; Young Adult | 2019 |
Treatment of latent tuberculous infection among health care workers at a tertiary hospital in Korea.
Topics: Adult; Antibiotics, Antitubercular; Drug Administration Schedule; Drug Therapy, Combination; Female; Health Personnel; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Republic of Korea; Retrospective Studies; Rifampin; Tertiary Care Centers; Tuberculin Test; Young Adult | 2018 |
Rapid drug susceptibility testing and treatment outcomes for multidrug-resistant tuberculosis in Peru.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Peru; Registries; Retrospective Studies; Rifampin; Time-to-Treatment; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2018 |
Vitamin C and Mycobacterium tuberculosis Persisters.
Topics: Animals; Ascorbic Acid; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2018 |
Reply to Yew et al., "Vitamin C and Mycobacterium tuberculosis Persisters".
Topics: Animals; Ascorbic Acid; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2018 |
Sub-minute determination of rifampicin and isoniazid in fixed dose combination tablets by capillary zone electrophoresis with ultraviolet absorption detection.
Topics: Drug Combinations; Electrophoresis, Capillary; Isoniazid; Rifampin; Sodium Bicarbonate; Spectrophotometry, Ultraviolet; Tablets | 2018 |
Pulmonary Isolation of Multidrug resistant "Mycobacterium simulans" and Mycobacterium tuberculosis from a patient in the Horn of Africa.
Topics: Adult; Africa; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Phenotype; Phylogeny; Rifampin; RNA, Ribosomal, 16S; Sputum; Tuberculosis, Multidrug-Resistant | 2018 |
A 9-year massive scrofuloderma of the scalp cured in 3 months.
Topics: Antitubercular Agents; Biopsy; Diagnostic Errors; Drug Therapy, Combination; Humans; Isoniazid; Male; Methylprednisolone; Middle Aged; Necrobiotic Xanthogranuloma; Rifampin; Scalp; Skin; Time Factors; Treatment Outcome; Tuberculin Test; Tuberculosis, Cutaneous | 2019 |
Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Infant; Isoniazid; Longitudinal Studies; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Rural Population; Tanzania; Tuberculosis | 2020 |
Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Retrospective Studies; Rifampin; Risk; Treatment Outcome; Young Adult | 2019 |
Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazid.
Topics: Adult; Antitubercular Agents; Biological Variation, Individual; Eating; Fasting; Female; Food-Drug Interactions; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2019 |
Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Incidence; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Middle Aged; Norway; Prospective Studies; Rifampin; Young Adult | 2018 |
Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study.
Topics: Adult; Ambulatory Care Facilities; Antitubercular Agents; Data Collection; Directly Observed Therapy; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Rifampin; Telemedicine; Videoconferencing; Young Adult | 2018 |
Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.
Topics: Adult; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Female; Haiti; Humans; Isoniazid; Male; Microbiological Techniques; Mycobacterium tuberculosis; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Sputum; Tuberculosis, Pulmonary; Young Adult | 2018 |
Metabolomic Study to Determine the Mechanism Underlying the Effects of
Topics: Animals; Chemical and Drug Induced Liver Injury; Isoniazid; Metabolome; Metabolomics; Mice; Mice, Inbred BALB C; Polysaccharides; Rifampin; Sagittaria | 2018 |
Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children.
Topics: Adolescent; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis; HIV; HIV Infections; Humans; Incidence; India; Infant; Isoniazid; Liver; Liver Function Tests; Male; Prospective Studies; Retrospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis.
Topics: 5-Aminolevulinate Synthetase; Animals; Carcinoma, Hepatocellular; Ferrochelatase; Heme; Hep G2 Cells; Hepatocytes; Humans; Hydrazines; Iron; Isoniazid; Liver; Mice, Inbred C57BL; Mice, Transgenic; Protoporphyrins; Pyridoxal; Rifampin; Vitamin B 6 | 2019 |
Utility of whole genome sequencing for multidrug resistant Mycobacterium tuberculosis isolates in a reference TB laboratory in New Zealand.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; New Zealand; Phenotype; Rifampin; Whole Genome Sequencing | 2018 |
Scrofuloderma with disseminated tuberculosis in an Ethiopian child: a case report.
Topics: Anti-Inflammatory Agents; Antitubercular Agents; Child; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Neck; Prednisolone; Pyrazinamide; Rifampin; Skin; Treatment Outcome; Tuberculosis, Cutaneous | 2018 |
Telfairia occidentalis (Cucurbitaceae) pulp extract mitigates rifampicin-isoniazid-induced hepatotoxicity in an in vivo rat model of oxidative stress.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Catalase; Chemical and Drug Induced Liver Injury; Cucurbitaceae; Humans; Isoniazid; Male; Malondialdehyde; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Rifampin; Superoxide Dismutase | 2019 |
New short regimens for latent tuberculosis treatment: safety first!
Topics: Aged; Antitubercular Agents; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2018 |
Molecular detection of mutations in isolates of multidrug resistant tuberculosis and tuberculosis suspects by multiplex allele specific PCR.
Topics: Alleles; Antitubercular Agents; Humans; Isoniazid; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Pakistan; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2018 |
First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon.
Topics: Adult; Bacterial Typing Techniques; Female; Genetic Variation; Genotype; Humans; Isoniazid; Lebanon; Male; Middle Aged; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Phylogeny; Polymorphism, Single Nucleotide; Rifampin; Tuberculosis, Multidrug-Resistant | 2018 |
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Incidence; Isoniazid; Kuwait; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study.
Topics: Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2019 |
Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children.
Topics: Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Spain; Tuberculosis, Multidrug-Resistant | 2019 |
[TREATMENT OF LATENT TUBERCULOSIS INFECTION WITH A COMBINATION OF ISONIAZID AND RIFAMPICIN].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Isoniazid; Latent Tuberculosis; Middle Aged; Rifampin; Treatment Outcome; Young Adult | 2016 |
Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Gene Expression Regulation, Bacterial; Humans; Hydrazones; Isoniazid; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Transcriptome | 2019 |
Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.
Topics: Bacterial Proteins; Diagnostic Tests, Routine; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Tertiary Healthcare; Time Factors; Tuberculosis | 2019 |
The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study.
Topics: Antitubercular Agents; Decision Support Techniques; Drug Resistance, Bacterial; Humans; Isoniazid; Models, Theoretical; Prevalence; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Uncertainty | 2019 |
Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Desensitization, Immunologic; Drug Hypersensitivity; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation.
Topics: Antitubercular Agents; Drug Carriers; Drug Delivery Systems; Drug Liberation; Isoniazid; Liposomes; Rifampin; Scattering, Small Angle | 2019 |
Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.
Topics: Animals; Antitubercular Agents; Cattle; Drug Resistance, Bacterial; Ethambutol; Genes, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Bovine | 2019 |
Acute tubulointerstitial nephritis caused by rifampicin: An increasing and often overlooked side effect in elderly patients
.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Nephritis, Interstitial; Rifampin; Tuberculosis, Pleural | 2019 |
Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance.
Topics: Antitubercular Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Loss of Function Mutation; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; THP-1 Cells; Tuberculosis, Multidrug-Resistant | 2019 |
Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.
Topics: Adult; Arylamine N-Acetyltransferase; ATP Binding Cassette Transporter, Subfamily B; Female; Genotype; Glucuronosyltransferase; Humans; Isoniazid; Liver-Specific Organic Anion Transporter 1; Male; Polymorphism, Single Nucleotide; Recurrence; Rifampin; Tuberculosis | 2019 |
The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Coinfected Patients in Uganda in the SOUTH Study.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Correlation of Data; Female; HIV Infections; Humans; Isoniazid; Liver-Specific Organic Anion Transporter 1; Male; Outcome Assessment, Health Care; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Pregnane X Receptor; Rifampin; Tuberculosis; Uganda | 2019 |
Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Dysbiosis; Gastrointestinal Microbiome; Host-Pathogen Interactions; Humans; Immunity, Innate; Immunomodulation; Isoniazid; Macrophages, Alveolar; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2019 |
Metformin induced autophagy in diabetes mellitus - Tuberculosis co-infection patients: A case study.
Topics: Adult; Antitubercular Agents; Autophagy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ethambutol; Humans; Hypoglycemic Agents; Insulin; Interferon-gamma; Interleukin-10; Isoniazid; Leukocytes, Mononuclear; Metformin; Microtubule-Associated Proteins; Middle Aged; Pyrazinamide; Rifampin; Sputum; Superoxide Dismutase; Tuberculosis | 2019 |
Genetic diversity and drug resistance of
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ecuador; Genetic Variation; Genotype; Humans; Isoniazid; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Phenotype; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Rapid direct drug susceptibility testing of
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Tuberculosis | 2019 |
Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Lung Diseases; Macrolides; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nontuberculous Mycobacteria; Republic of Korea; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fruit and Vegetable Juices; Humans; Isoniazid; Lythraceae; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polyphenols; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Ending Tuberculosis through Prevention.
Topics: HIV; Humans; Isoniazid; Rifampin; Tuberculosis | 2019 |
High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Area Under Curve; Central Nervous System; Cohort Studies; Drug Administration Schedule; Drug Monitoring; Female; Humans; Isoniazid; Liver; Male; Middle Aged; Netherlands; Patient Safety; Rifampin; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2019 |
Cryptic Resistance Mutations Associated With Misdiagnoses of Multidrug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Diagnostic Errors; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genome, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2019 |
Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly.
Topics: Aged; Antitubercular Agents; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2019 |
Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent.
Topics: Antitubercular Agents; Catalytic Domain; Cytochrome P450 Family 51; Drug Design; Free Radical Scavengers; Isoniazid; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Protein Binding; Pyridines; Rifampin; Structure-Activity Relationship; Thiosemicarbazones | 2019 |
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gene Frequency; Genotype; Humans; Isoniazid; Kanamycin; Kenya; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Emergence of Heteroresistance Mycobacterium Tuberculosis in Saudi Arabia.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Saudi Arabia; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2020 |
Genetic polymorphisms of long noncoding RNA RP11-37B2.1 associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China.
Topics: Adult; Anemia; Antitubercular Agents; Asian People; Case-Control Studies; China; Female; Genetic Predisposition to Disease; Humans; Isoniazid; Leukopenia; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Rifampin; RNA, Long Noncoding; Thrombocytopenia; Tuberculosis | 2019 |
Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.
Topics: Adult; Antitubercular Agents; Case-Control Studies; Demography; Ethiopia; Female; HIV Infections; Hospitals; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Regression Analysis; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Clarithromycin; Ethambutol; Female; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium Complex; Nontuberculous Mycobacteria; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Young Adult | 2019 |
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
Topics: Adult; Antitubercular Agents; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Linezolid; Lung; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tissue Distribution; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Anthropometric and Genetic Factors Associated With the Exposure of Rifampicin and Isoniazid in Mexican Patients With Tuberculosis.
Topics: Adolescent; Adult; Aged; Anthropometry; Antibiotics, Antitubercular; Antitubercular Agents; Arylamine N-Acetyltransferase; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, High Pressure Liquid; Female; Genotype; Humans; Isoniazid; Male; Mexico; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Prospective Studies; Rifampin; Tuberculosis; Young Adult | 2019 |
Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Typing Techniques; DNA, Bacterial; Female; Genome, Bacterial; Genomics; Genotype; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Peru; Polymorphism, Single Nucleotide; Prevalence; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing; Young Adult | 2019 |
Outlook for tuberculosis elimination in California: An individual-based stochastic model.
Topics: Algorithms; Antitubercular Agents; Calibration; California; Computer Simulation; Cost-Benefit Analysis; Disease Eradication; Epidemics; Humans; Incidence; Isoniazid; Mass Screening; Quality-Adjusted Life Years; Rifampin; Risk Factors; Stochastic Processes; Tuberculin Test; Tuberculosis; World Health Organization | 2019 |
Hybrid Design of Isonicotinic Acid Hydrazide Derivatives: Machine Learning Studies, Synthesis and Biological Evaluation of their Antituberculosis Activity.
Topics: Animals; Antitubercular Agents; Daphnia; Datasets as Topic; Drug Design; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Models, Chemical; Mycobacterium tuberculosis; Rifampin; Toxicity Tests, Acute; Tuberculosis, Multidrug-Resistant | 2020 |
Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Cohort Studies; Female; Humans; Isoniazid; Male; Middle Aged; Morocco; Prospective Studies; Rifampin; Risk Factors; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2019 |
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Speeding up the diagnosis of multidrug-resistant tuberculosis in a high-burden region with the use of a commercial line probe assay.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; DNA, Bacterial; Early Diagnosis; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Phenotype; Prospective Studies; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Cross-Sectional Studies; Female; HIV Infections; Humans; India; Isoniazid; Male; Middle Aged; Prevalence; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2019 |
Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment Outcomes.
Topics: Antitubercular Agents; Humans; India; Isoniazid; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2020 |
Prevailing practices in the treatment of tuberculous meningitis (TBM): a cross-sectional study.
Topics: Anticonvulsants; Antitubercular Agents; Cross-Sectional Studies; Disease Management; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Humans; India; Isoniazid; Levetiracetam; Neurologists; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Streptomycin; Surveys and Questionnaires; Tuberculosis, Meningeal | 2019 |
Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA-Directed RNA Polymerases; DNA, Bacterial; Female; Genes, Bacterial; Genotype; Genotyping Techniques; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Molecular Typing; Mutation; Mycobacterium tuberculosis; Prevalence; Promoter Regions, Genetic; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Heterogeneity of ROS levels in antibiotic-exposed mycobacterial subpopulations confers differential susceptibility.
Topics: Anti-Bacterial Agents; Cyclic N-Oxides; Hydrogen Peroxide; Hydroxyl Radical; Isoniazid; Microbial Viability; Models, Biological; Mycobacterium smegmatis; Oxidative Stress; Phenotype; Reactive Oxygen Species; Rifampin; Spin Labels; Superoxides; Thiourea | 2019 |
Fabrication of bioactive rifampicin loaded κ-Car-MA-INH/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration.
Topics: Animals; Antitubercular Agents; Carrageenan; Cell Line; Drug Delivery Systems; Drug Liberation; Durapatite; Erythrocytes; Hemolysis; Humans; Isoniazid; Klebsiella pneumoniae; Macrophages; Maleic Anhydrides; Mice; Nanocomposites; Osteoblasts; Osteomyelitis; Regeneration; Rifampin; Staphylococcus aureus; Tuberculosis | 2019 |
Screening and treatment for tuberculosis in a cohort of unaccompanied minor refugees in Berlin, Germany.
Topics: Adolescent; Berlin; Chemoprevention; Female; Germany; Hepatitis B; Humans; Isoniazid; Latent Tuberculosis; Male; Mass Screening; Minors; Refugees; Rifampin; Tuberculosis | 2019 |
[Advantages and disadvantages of longer and shorter chemotherapy regimens for multi-drug or rifampicin-resistant tuberculosis].
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Compatibility Between Four Anti-TB Drugs and Tablet Excipients Determined By Microcalorimetry.
Topics: Antitubercular Agents; Calorimetry; Ethambutol; Excipients; Isoniazid; Pyrazinamide; Rifampin | 2019 |
Tuberculosis Meningitis in a 10-Month-Old Living in an Immigrant Township.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Brain; Diagnosis, Differential; Electroencephalography; Emigrants and Immigrants; Ethambutol; Female; Glucocorticoids; Humans; Infant; Isoniazid; Magnetic Resonance Imaging; Prednisone; Pyrazinamide; Rifampin; Romania; Texas; Tuberculosis, Meningeal | 2019 |
First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Emigrants and Immigrants; Ethambutol; Female; Germany; Humans; Infant; Isoniazid; Logistic Models; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prevalence; Public Health Surveillance; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant | 2019 |
Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethiopia; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Nitrogen deprivation induces triacylglycerol accumulation, drug tolerance and hypervirulence in mycobacteria.
Topics: Animals; Animals, Genetically Modified; Antitubercular Agents; Carbon; Drug Tolerance; Embryo, Nonmammalian; Fatty Acids; Humans; Isoniazid; Ligases; Lipid Droplets; Lipolysis; Longevity; Macrophages; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Nitrogen; Rifampin; Triglycerides; Virulence; Zebrafish | 2019 |
Rifampin-resistant Tuberculosis in the United States, 1998-2014.
Topics: Antitubercular Agents; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; United States | 2020 |
Hepatocyte growth factor enhances the clearance of a multidrug-resistant Mycobacterium tuberculosis strain by high doses of conventional chemotherapy, preserving liver function.
Topics: Animals; Antibiotics, Antitubercular; Antioxidants; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Hepatocyte Growth Factor; Humans; Isoniazid; Liver; Male; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2020 |
Outcome of inadvertent high dose BCG administration in newborns at a tertiary care hospital, Karachi- Case series.
Topics: Antitubercular Agents; BCG Vaccine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Mycobacterium bovis; Pakistan; Rifampin; Tertiary Care Centers; Tuberculosis; Vaccination | 2019 |
Latent tuberculosis treatment completion rates from prescription drug administrative data.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; Databases, Factual; Female; Humans; Infant; Infant, Newborn; Isoniazid; Latent Tuberculosis; Male; Manitoba; Middle Aged; Prescription Drugs; Rifampin; Treatment Adherence and Compliance; Young Adult | 2019 |
A Rare Case of a Tuberculosis Patient with Sarcoidosis.
Topics: Adult; Antitubercular Agents; Deprescriptions; Ethambutol; Female; Glucocorticoids; Humans; Isoniazid; Prednisolone; Pyrazinamide; Radiography, Thoracic; Rifampin; Romania; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Vitamin B 6; Vitamin B Complex | 2019 |
Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India.
Topics: Adult; Allosteric Regulation; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Humans; India; Isoniazid; Machine Learning; Models, Molecular; Mutation; Mycobacterium tuberculosis; Protein Conformation; Protein Stability; Rifampin; Tuberculosis; Whole Genome Sequencing | 2019 |
Alternative dosing guidelines to improve outcomes in childhood tuberculosis: a mathematical modelling study.
Topics: Algorithms; Antitubercular Agents; Body Weight; Child Nutrition Disorders; Child, Preschool; Drug Administration Schedule; Humans; Isoniazid; Models, Statistical; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2019 |
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.
Topics: Adult; Aged; Antitubercular Agents; Ethambutol; Humans; Incidence; Isoniazid; Logistic Models; Middle Aged; Netherlands; Pyrazinamide; Registries; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Optimization of a paediatric fixed dose combination mini-tablet and dosing regimen for the first line treatment of tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Humans; Isoniazid; Pyrazinamide; Rifampin; Tablets; Tuberculosis | 2019 |
Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Health Facilities; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Sensitivity and Specificity; Sputum; Surveys and Questionnaires; Tuberculosis, Multidrug-Resistant; Young Adult; Zimbabwe | 2019 |
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture.
Topics: Antitubercular Agents; Bacterial Load; Biological Assay; Biomarkers, Pharmacological; Computer Simulation; DNA, Bacterial; Drug Dosage Calculations; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Malawi; Male; Models, Statistical; Mozambique; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tanzania; Time Factors; Tuberculosis, Pulmonary | 2019 |
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Logistic Models; London; Male; Middle Aged; Practice Guidelines as Topic; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2019 |
Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Case-Control Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Spain; Treatment Outcome; Tuberculosis, Pleural; Young Adult | 2019 |
A comparison of hepatoprotective activity of Bacoside to Silymarin treatment against a combined Isoniazid and Rifampin-induced hepatotoxicity in female Wistar rats.
Topics: Animals; Antioxidants; Bacopa; Body Weight; Chemical and Drug Induced Liver Injury; Female; Isoniazid; Liver; Protective Agents; Rats; Rats, Wistar; Rifampin; Saponins; Silymarin; Triterpenes | 2019 |
First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Public Health; Rifampin; Sputum; Streptomycin; Tertiary Care Centers; Tuberculosis, Multidrug-Resistant; Turkey; Young Adult | 2019 |
Antituberculosis drug resistance in isolates of Mycobacterium tuberculosis complex in southeast Spain.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Sex Characteristics; Spain; Tuberculosis; Young Adult | 2020 |
Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pakistan; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Individualising therapy for drug-sensitive tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Precision Medicine; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2019 |
Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Case-Control Studies; Eswatini; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Rifampin; Risk Factors; Socioeconomic Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Evaluation of a membrane hybridization array for detection of Mycobacterium tuberculosis complex and resistance to isoniazid and rifampin in sputum specimens, mycobacterial liquid cultures, and clinical isolates.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2019 |
Multiplex PCR for Rapid Diagnosis of Drug Resistant Mycobacterium Tuberculosis.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2019 |
High mortality during tuberculosis retreatment at a Ghanaian tertiary center: a retrospective cohort study.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Ghana; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Proportional Hazards Models; Retreatment; Retrospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?
Topics: Antitubercular Agents; Isoniazid; Logistic Models; Microbial Viability; Models, Theoretical; Mycobacteriaceae; Phenotype; Rifampin; Tuberculosis, Pulmonary | 2019 |
Pancreatic tuberculosis diagnosed by endoscopic ultrasound-guided fine needle aspiration in a 14-year-old adolescent.
Topics: Abdominal Pain; Adolescent; Antitubercular Agents; Cote d'Ivoire; Drug Therapy, Combination; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Humans; Isoniazid; Male; Pancreatitis; Pyrazinamide; Rifampin; Travel-Related Illness; Tuberculosis | 2020 |
A Shorter Regimen for Rifampin-Resistant Tuberculosis.
Topics: Humans; Isoniazid; Rifampin; Tuberculosis | 2019 |
A Shorter Regimen for Rifampin-Resistant Tuberculosis.
Topics: Humans; Isoniazid; Rifampin; Tuberculosis | 2019 |
A Shorter Regimen for Rifampin-Resistant Tuberculosis. Reply.
Topics: Humans; Isoniazid; Rifampin; Tuberculosis | 2019 |
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
Topics: HIV; Humans; Isoniazid; Rifampin; Tuberculosis | 2019 |
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply.
Topics: HIV; Humans; Isoniazid; Rifampin; Tuberculosis | 2019 |
Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Lost to Follow-Up; Male; Republic of Korea; Retrospective Studies; Rifampin | 2019 |
Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis.
Topics: Adult; Aged; Antitubercular Agents; Asian People; Female; Health Personnel; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Mass Screening; Medication Adherence; Middle Aged; Patient Acceptance of Health Care; Republic of Korea; Retrospective Studies; Rifampin; Young Adult | 2019 |
Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid.
Topics: Adult; Drug Resistance, Bacterial; Female; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Peru; Rifampin; Sensitivity and Specificity; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Uganda | 2020 |
Rapid detection of drug-resistant
Topics: Alleles; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2019 |
Determinants of serum concentration of first-line anti-tuberculosis drugs from China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Case-Control Studies; China; Chromatography, Liquid; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Smoking; Tuberculosis; Young Adult | 2019 |
Differential Expression of Resistant and Efflux Pump Genes in MDR-TB Isolates.
Topics: Antitubercular Agents; Gene Expression Regulation; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2020 |
SHORT COMMUNICATION-Pattern of anti-tuberculosis drugs susceptibility in new and previously treated tuberculosis patients and environmental risk factors investigation.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Environment; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pakistan; Prevalence; Rifampin; Risk Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
First insights into the genetic characteristics and drug resistance of Mycobacterium tuberculosis population collected during the first national tuberculosis prevalence survey of Lao PDR (2010-2011).
Topics: Adolescent; Adult; Antitubercular Agents; Cluster Analysis; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Isoniazid; Laos; Male; Middle Aged; Mycobacterium tuberculosis; Phylogeny; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
[Tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Isoniazid and Rifapentine Treatment Eradicates Persistent
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Isoniazid; Latent Tuberculosis; Macaca; Models, Animal; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis | 2020 |
Association of ABCC Gene Polymorphism With Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity in Western Han Patients With Tuberculosis.
Topics: Adult; Alanine Transaminase; Antitubercular Agents; Asian People; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; China; Drug Therapy, Combination; Ethambutol; Female; Genetic Predisposition to Disease; Genotype; Humans; Isoniazid; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Polymorphism, Single Nucleotide; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Tuberculosis; Young Adult | 2020 |
Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Diabetes Complications; Diabetes Mellitus; Female; Humans; Isoniazid; Male; Middle Aged; Plasma; Prospective Studies; Pyrazinamide; Rifampin; Tanzania; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2019 |
Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Ethiopia; Female; Humans; Isoniazid; Male; Retrospective Studies; Rifampin; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacterial Load; Diagnostic Tests, Routine; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pakistan; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2019 |
MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Ciprofloxacin; Culture Media; Ethiopia; Extensively Drug-Resistant Tuberculosis; Female; Health Resources; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Patient Selection; Randomized Controlled Trials as Topic; Refusal to Participate; Rifampin; Risk Factors; Young Adult | 2020 |
Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
Topics: Adolescent; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.
Topics: Adult; Antitubercular Agents; Brazil; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Weight Gain | 2020 |
Adjunctive Immunotherapeutic Efficacy of N-Formylated Internal Peptide of Mycobacterial Glutamine Synthetase in Mouse Model of Tuberculosis.
Topics: Animals; Bacterial Load; Bacterial Proteins; Disease Models, Animal; Drug Therapy, Combination; Female; Glutamate-Ammonia Ligase; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Reactive Oxygen Species; Rifampin; Spleen; Tuberculosis | 2020 |
Protective effect of pyrrolidine dithiocarbamate on isoniazid/rifampicin‑induced liver injury in rats.
Topics: Animals; Antioxidants; ATP Binding Cassette Transporter, Subfamily B, Member 11; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Humans; Isoniazid; Liver; NF-kappa B; Oxidative Stress; Pyrrolidines; Rats; Rifampin; Thiocarbamates; Tumor Necrosis Factor-alpha | 2020 |
Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?
Topics: Animals; Isoniazid; Latent Tuberculosis; Macaca; Mycobacterium tuberculosis; Rifampin | 2020 |
Exposure to first line anti-tuberculosis drugs in prepubertal age reduces the quality and functional competence of spermatozoa and oocytes in Swiss albino mice.
Topics: Animals; Antitubercular Agents; Cell Nucleus; Ethambutol; Female; Isoniazid; Male; Metaphase; Mice; Oocytes; Pharmaceutical Preparations; Pregnancy; Pyrazinamide; Rifampin; Spermatozoa; Streptomycin | 2020 |
No evidence of increased risk of acquired rifampin resistance.
Topics: Humans; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Rifampin | 2019 |
Miliary tuberculosis and choroidal tuberculoma in a three-month old baby girl: Diagnosis and follow-up of a case.
Topics: Adrenal Cortex Hormones; Amikacin; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Ophthalmoscopy; Pyrazinamide; Rifampin; Tuberculoma; Tuberculosis, Miliary; Tuberculosis, Ocular; Uveitis, Posterior | 2020 |
Clinical Characteristics of Active Tuberculosis Diagnosed After Starting Treatment for Latent Tuberculosis Infection.
Topics: Antitubercular Agents; Humans; Isoniazid; Latent Tuberculosis; Rifampin; Tuberculosis | 2020 |
Improving access to contraception through integration of family planning services into a multidrug-resistant tuberculosis treatment programme.
Topics: Adolescent; Adult; Antitubercular Agents; Contraception; Family Planning Services; Female; Health Services Accessibility; Humans; Isoniazid; Middle Aged; Pregnancy; Pregnancy Rate; Rifampin; Rural Population; South Africa; Tuberculosis, Multidrug-Resistant | 2020 |
Acute paraplegia in a healthy child.
Topics: Acute Disease; Antibiotics, Antitubercular; Biopsy, Fine-Needle; Child; Ethambutol; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Recovery of Function; Rifampin; Spinal Cord; Treatment Outcome; Tuberculosis, Spinal; Urinary Retention | 2019 |
Multicenter evaluation of TB-SPRINT 59-Plex Beamedex®: accuracy and cost analysis.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Costs and Cost Analysis; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Flow Cytometry; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Promoter Regions, Genetic; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Tuberculosis | 2019 |
Prosthetic joint infection: an extremely rare complication of intravesicular BCG therapy.
Topics: Aged; Antibiotics, Antitubercular; Arthroplasty, Replacement, Hip; BCG Vaccine; Humans; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Prosthesis Failure; Prosthesis-Related Infections; Rifampin; Treatment Outcome | 2019 |
Insight into the biology of Mycobacterium mucogenicum and Mycobacterium neoaurum clade members.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Genomics; Humans; Isoniazid; Mycobacteriaceae; Mycobacterium Infections, Nontuberculous; Rifampin; Virulence Factors | 2019 |
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials.
Topics: Adult; Africa; Americas; Antitubercular Agents; Asia; Australia; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug-Related Side Effects and Adverse Reactions; Humans; Isoniazid; Latent Tuberculosis; Randomized Controlled Trials as Topic; Rifampin; Risk Factors | 2020 |
What is the best regimen to treat latent tuberculosis infection?
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2020 |
Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Odds Ratio; Polymorphism, Single Nucleotide; Rifampin | 2019 |
Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Pyrazinamide; Reference Standards; Reproducibility of Results; Rifabutin; Rifampin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tuberculosis | 2020 |
The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
Topics: Antitubercular Agents; Hydrazones; Isoniazid; Molecular Structure; Mycobacterium tuberculosis; Rifampin; Triterpenes | 2021 |
Presumed Intraocular Tuberculosis Manifesting as Unilateral Iris Granuloma.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Granuloma; Humans; Iris Diseases; Isoniazid; Male; Microscopy, Acoustic; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Ocular | 2020 |
Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs.
Topics: Antitubercular Agents; Canada; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Humans; Isoniazid; Latent Tuberculosis; Quebec; Retrospective Studies; Rifampin | 2020 |
Migrations do not modify Mycobacterium tuberculosis resistance rates: a 20-year retrospective study.
Topics: Adult; Aged; Antitubercular Agents; Female; Humans; Isoniazid; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Transients and Migrants; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |
The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey.
Topics: Adult; Aminoglycosides; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant; Turkey | 2020 |
Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; France; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pentosyltransferases; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Whole Genome Sequencing | 2020 |
Co-Loading of Isoniazid-Grafted Phthalocyanine-in-Cyclodextrin and Rifampicin in Crude Soybean Lecithin Liposomes: Formulation, Spectroscopic and Biological Characterization.
Topics: Chemistry, Pharmaceutical; Cyclodextrins; Glycine max; HeLa Cells; Humans; Indoles; Isoindoles; Isoniazid; Lecithins; Liposomes; Particle Size; Rifampin; Spectrum Analysis | 2020 |
Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Promoter Regions, Genetic; Prospective Studies; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2020 |
Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among
Topics: Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Promoter Regions, Genetic; Pyrazinamide; Rifampin | 2020 |
Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department.
Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; New Mexico; Pharmacies; Pilot Projects; Prospective Studies; Public Health; Rifampin | 2020 |
Determination of minimum bactericidal concentration, in single or combination drugs, against
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Isoniazid; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2020 |
LC-QToF-MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Humans; Isoniazid; Mass Spectrometry; Plasma; Pyrazinamide; Rifampin | 2020 |
Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017.
Topics: Adult; Aged; Antitubercular Agents; Female; Follow-Up Studies; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Radiography, Thoracic; Retrospective Studies; Rifampin; Tertiary Care Centers; Tuberculin Test | 2020 |
Encapsulating Rifampicin into SLNs: A Viable Option for Managing its Bioavailability Issues Upon Co-Delivery with Isoniazid.
Topics: Administration, Oral; Animals; Biological Availability; Capsules; Isoniazid; Lipids; Male; Nanoparticles; Rats; Rats, Wistar; Rifampin | 2020 |
Evaluation of the BD MAX™ MDR-TB assay in a real-world setting for the diagnosis of pulmonary and extra-pulmonary TB.
Topics: Antibiotics, Antitubercular; Drug Resistance, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 2020 |
Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Load; Clinical Trials, Phase II as Topic; Drug Development; Drug Dosage Calculations; Drug Therapy, Combination; Humans; Isoniazid; Microbial Sensitivity Tests; Models, Biological; Mycobacterium tuberculosis; Rifampin; Translational Research, Biomedical; Tuberculosis | 2020 |
Improved Mycobacterium tuberculosis clearance after the restoration of IFN-γ
Topics: Adolescent; Adult; Animals; Antibodies; Antitubercular Agents; Bacterial Load; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Female; Humans; Interferon-gamma; Isoniazid; Lung; Macrophages; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium tuberculosis; Primary Cell Culture; Programmed Cell Death 1 Receptor; Rifampin; Spleen; Treatment Outcome; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2020 |
Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries.
Topics: Antitubercular Agents; China; Humans; Incidence; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Prevalence; Rifampin; Rural Population; Tuberculin Test; Tumor Necrosis Factor-alpha | 2020 |
Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2020 |
High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
Topics: Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |
Reply to Decroo
Topics: Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |
Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Tuberculosis; Young Adult | 2020 |
Cytochemical Evaluation of the Toxic Effects of Combined Antituberculosis Substances on Metabolic State of Blood Lymphocytes.
Topics: Acid Phosphatase; Administration, Oral; Animals; Animals, Outbred Strains; Antitubercular Agents; Drug Combinations; Esterases; Ethambutol; Fluoroquinolones; Gene Expression; Glycerolphosphate Dehydrogenase; Isoniazid; L-Lactate Dehydrogenase; Lymphocytes; Male; Primary Cell Culture; Prothionamide; Pyrazinamide; Rats; Rifampin; Succinate Dehydrogenase | 2020 |
A pilot study: VereMTB detection kit for rapid detection of multidrug-resistant mycobcterium tuberculosis in clinical sputum samples.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Isoniazid; Limit of Detection; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pilot Projects; Rifampin; Sputum; Time Factors | 2020 |
[Experience of using TB test kit for the rapid drug susceptibility testing of M. tuberculosis.]
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Streptomycin | 2020 |
Using a Heat Diffusion Model to Detect Potential Drug Resistance Genes of
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Humans; Isoniazid; Models, Genetic; Mycobacterium tuberculosis; Rifampin | 2020 |
Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman.
Topics: Cost-Benefit Analysis; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Markov Chains; Mass Screening; Oman; Quality-Adjusted Life Years; Rifampin; Transients and Migrants; Tuberculosis | 2020 |
Second-line Drug Resistance Characterization in
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Analysis of Severe Adverse Events Reported Among Patients Receiving Isoniazid-Rifapentine Treatment for Latent Mycobacterium tuberculosis Infection-United States, 2012-2016.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Mycobacterium tuberculosis; Rifampin; United States | 2020 |
Tuberculous meningitis manifesting with neuroregression in a eleven month child.
Topics: Acetazolamide; Antitubercular Agents; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid; Early Medical Intervention; Ethambutol; Female; Glucocorticoids; Humans; Hydrocephalus; Infant; Isoniazid; Magnetic Resonance Imaging; Neurodevelopmental Disorders; Nucleic Acid Amplification Techniques; Prednisolone; Pyrazinamide; Rifampin; Stomach; Treatment Outcome; Tuberculosis, Meningeal | 2020 |
Treatment outcome of tuberculosis treatment regimens in Kandahar, Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Antitubercular Agents; Cohort Studies; Cough; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Female; Fever; Humans; Isoniazid; Male; Middle Aged; Mortality; Prognosis; Pyrazinamide; Retreatment; Retrospective Studies; Rifampin; Sex Distribution; Sputum; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary; Weight Loss; Young Adult | 2020 |
New guidelines for latent tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Child; Clinical Trials as Topic; Drug Therapy, Combination; Guidelines as Topic; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Mass Screening; Mycobacterium tuberculosis; Rifampin; Time Factors | 2020 |
Primary tuberculosis of the glans penis in an immunocompetent male.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Penile Diseases; Pyrazinamide; Rifampin; Tuberculosis, Male Genital | 2020 |
Prevention of tuberculosis in HIV infection with novel drugs.
Topics: Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Isoniazid; Oxazines; Piperazines; Pyridones; Rifampin; Tuberculosis | 2020 |
Gene expression responses to anti-tuberculous drugs in a whole blood model.
Topics: Antitubercular Agents; Bacterial Proteins; Blood; Drug Combinations; Drug Repositioning; Ethambutol; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Isoniazid; Models, Biological; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Pyrazinamide; Rifampin; Sputum | 2020 |
Esophageal Tuberculosis - A Mass of Confusion.
Topics: Aged; Antitubercular Agents; Deglutition Disorders; Delayed Diagnosis; Diagnosis, Differential; Directly Observed Therapy; Endoscopy, Digestive System; Esophageal Neoplasms; Esophagitis; Ethambutol; Fever; Humans; Isoniazid; Lymph Nodes; Lymphadenopathy; Male; Mexican Americans; Pyrazinamide; Rifampin; Substance-Related Disorders; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal; Ultrasonography | 2020 |
Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China.
Topics: Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Humans; Immunoblotting; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis | 2020 |
A Complete Triad: Horner's Syndrome in Tuberculous Meningitis.
Topics: Antitubercular Agents; Brain; Ethambutol; Horner Syndrome; Humans; Immunocompetence; Isoniazid; Male; Nucleic Acid Amplification Techniques; Pyrazinamide; Pyridoxine; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Meningeal; Uganda; Young Adult | 2020 |
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
Topics: Adult; Amikacin; Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis; Whole Genome Sequencing | 2020 |
Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on Filamenting temperature sensitive mutant Z (FtsZ)-A cell division protein.
Topics: Antitubercular Agents; Bacterial Proteins; Cell Division; Cytoskeletal Proteins; Drug Synergism; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; In Vitro Techniques; Inositol; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium smegmatis; Mycobacterium tuberculosis; Plant Extracts; Plants, Medicinal; Rifampin; Temperature | 2020 |
Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB® Kit for the diagnosis of tuberculosis.
Topics: Antibiotics, Antitubercular; Biopsy; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Reproducibility of Results; Retrospective Studies; Rifampin; ROC Curve; Sensitivity and Specificity; Temperature; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2020 |
Role of
Topics: Antitubercular Agents; Bacterial Proteins; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2020 |
Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid.
Topics: Antitubercular Agents; Drug Monitoring; Humans; Isoniazid; Mycobacterium tuberculosis; Pharmaceutical Preparations; Rifampin; Saliva; Tuberculosis | 2020 |
No significant influence of diabetic mellitus on isoniazid plasma levels in patients under treatment for tuberculosis.
Topics: Antitubercular Agents; Diabetes Mellitus; Humans; Isoniazid; Patients; Plasma; Rifampin; Tuberculosis | 2020 |
The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance.
Topics: Adult; Antitubercular Agents; Bangladesh; Diagnostic Errors; Drug Resistance; Fluoroquinolones; Humans; Isoniazid; Recurrence; Retrospective Studies; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2020 |
Safety and treatment completion of latent tuberculosis infection treatment in the elderly population-A prospective observational study in Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Incidence; Isoniazid; Kidney Failure, Chronic; Latent Tuberculosis; Male; Middle Aged; Prospective Studies; Rifampin; Taiwan | 2020 |
Bile acids, lipid and purine metabolism involved in hepatotoxicity of first-line anti-tuberculosis drugs.
Topics: Animals; Antitubercular Agents; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Isoniazid; Lipid Metabolism; Male; Mass Spectrometry; Metabolomics; Mice; Mice, Inbred C57BL; Mice, Knockout; Purines; Pyrazinamide; Receptors, Cytoplasmic and Nuclear; Rifampin | 2020 |
Identification of Substituted Amino Acid Hydrazides as Novel Anti-Tubercular Agents, Using a Scaffold Hopping Approach.
Topics: Amino Acid Substitution; Antitubercular Agents; Cell Proliferation; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Organic Chemicals; Rifampin; Structure-Activity Relationship; Tuberculosis | 2020 |
Inclusion of Mechanical Ventilation in Severity Staging of Tuberculous Meningitis Improves Outcome Prediction.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antitubercular Agents; Child; Child, Preschool; Consciousness Disorders; Ethambutol; Female; Humans; Hydrocephalus; India; Isoniazid; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Pyrazinamide; Registries; Respiration, Artificial; Rifampin; Seizures; Severity of Illness Index; Tomography, X-Ray Computed; Tuberculosis, Meningeal; Ventriculoperitoneal Shunt; Young Adult | 2020 |
Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species.
Topics: Antitubercular Agents; Bacterial Proteins; Data Curation; Databases, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2020 |
Tuberculosis sepsis after tocilizumab treatment.
Topics: Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Multiple Organ Failure; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sepsis; Treatment Outcome; Tuberculosis | 2020 |
Ocular adverse events in drug sensitive TB patients on daily fixed dose combination anti-TB drugs: A record review study from Kerala, India.
Topics: Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Eye Diseases; Female; Humans; India; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis; Vision Disorders | 2020 |
Rifampicin and isoniazid behave as non-creatinine chromogens and interfere with Jaffe's reaction: A phenomenon with the potential to give a false-positive result in creatinine estimation.
Topics: Antitubercular Agents; Chromogenic Compounds; Creatinine; False Positive Reactions; Humans; Indicators and Reagents; Isoniazid; Kidney Function Tests; Picrates; Rifampin; Spectrum Analysis | 2020 |
Human mesenchymal stem cell based intracellular dormancy model of Mycobacterium tuberculosis.
Topics: Animals; Anti-Infective Agents; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Bone Marrow; Cell Survival; Drug Tolerance; Host-Pathogen Interactions; Humans; Isoniazid; Latent Tuberculosis; Mesenchymal Stem Cells; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis | 2020 |
Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study.
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Republic of Korea; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Dendrobine attenuates isoniazid- and rifampicin-induced liver injury by inhibiting miR-295-5p.
Topics: Alanine Transaminase; Alkaloids; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Cell Line; Chemical and Drug Induced Liver Injury, Chronic; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Isoniazid; Liver; Mice, Inbred C57BL; Mice, Inbred ICR; MicroRNAs; Oxidative Stress; Rifampin | 2020 |
Simplifying Rifapentine Dosing for Tuberculosis Treatment and Prevention.
Topics: Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2020 |
BCGitis of the wrist after intravesical BCG therapy: A case report.
Topics: Antibiotics, Antitubercular; Arthritis, Infectious; BCG Vaccine; Carpal Bones; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium bovis; Rifampin; Surgical Flaps; Synovectomy; Tuberculosis, Osteoarticular; Urinary Bladder Neoplasms; Wrist Joint | 2020 |
Toxicoproteomic Profiling of
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Heme; Homocysteine; Iron-Sulfur Proteins; Isoniazid; Liver; Mice; Mice, Inbred C57BL; Niacinamide; Oxidative Stress; Proteome; Rifampin; Vitamin B 6 | 2020 |
Use of Rifampin Compared with Isoniazid for the Treatment of Latent Tuberculosis Infection in Japan: A Bayesian Inference with Markov Chain Monte Carlo Method.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bayes Theorem; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Isoniazid; Japan; Latent Tuberculosis; Male; Markov Chains; Middle Aged; Monte Carlo Method; Rifampin | 2020 |
Bayesian Modeling Method for an Observational Data Analysis.
Topics: Bayes Theorem; Data Analysis; Humans; Isoniazid; Japan; Latent Tuberculosis; Markov Chains; Monte Carlo Method; Rifampin | 2020 |
An Unexpected Cause of Conjunctivitis in an Adolescent.
Topics: Adolescent; Antitubercular Agents; Conjunctivitis; Diagnosis, Differential; Ethambutol; Glucocorticoids; Humans; Isoniazid; Male; Prednisolone; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2020 |
Clinical Evaluation of BD MAX MDR-TB Assay for Direct Detection of Mycobacterium tuberculosis Complex and Resistance Markers.
Topics: Genetic Markers; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Reference Standards; Rifampin; Tuberculosis, Multidrug-Resistant | 2020 |
Primary breast tuberculosis in an HIV-infected patient.
Topics: Adult; Antitubercular Agents; Biopsy; Breast; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2020 |
Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2021 |
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2020 |
Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Genotype; Humans; Infant; Isoniazid; Machine Learning; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Phylogeny; Rifampin; South Africa; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2020 |
Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Cross-Sectional Studies; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethiopia; Female; Genes, Bacterial; Genetic Loci; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Intestinal tuberculosis in a patient with end-stage renal disease on hemodialysis: A case report.
Topics: Anorexia; Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Muscle Weakness; Pyrazinamide; Renal Dialysis; Republic of Korea; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal | 2020 |
Safety and Efficacy of Rifampin or Isoniazid Among People With Mycobacterium tuberculosis Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized Trials.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; HIV; HIV Infections; Humans; Isoniazid; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis | 2021 |
Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
Topics: Antitubercular Agents; Cross-Sectional Studies; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nigeria; Predictive Value of Tests; Prevalence; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cross-Sectional Studies; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Risk Factors; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2020 |
Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective Cohort.
Topics: Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cohort Studies; Exanthema; Female; Gastrointestinal Diseases; Humans; Isoniazid; Kidney Failure, Chronic; Latent Tuberculosis; Male; Mass Screening; Middle Aged; Pruritus; Renal Dialysis; Retrospective Studies; Rifabutin; Rifampin; Treatment Outcome; Vitamin B 6 | 2021 |
Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bangladesh; Child; Child, Preschool; Clinical Protocols; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
A biphasic nanohydroxyapatite/calcium sulphate carrier containing Rifampicin and Isoniazid for local delivery gives sustained and effective antibiotic release and prevents biofilm formation.
Topics: Antitubercular Agents; Biofilms; Bone Regeneration; Calcium Sulfate; Computational Biology; Delayed-Action Preparations; Drug Carriers; Drug Interactions; Drug Therapy, Combination; Durapatite; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Rifampin; Tuberculosis, Osteoarticular | 2020 |
Rosa brunonii Lindely fruit as a new protective agent evaluated against Rif/INH induced toxicity in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Female; Fruit; Isoniazid; Kidney; Liver; Male; Plant Extracts; Protective Agents; Rats; Rats, Wistar; Rifampin; Rosa; Silymarin | 2020 |
Anti-tuberculosis site-specific oral delivery system that enhances rifampicin bioavailability in a fixed-dose combination with isoniazid.
Topics: Animals; Antitubercular Agents; Biological Availability; Dogs; Isoniazid; Rifampin; Tuberculosis | 2021 |
Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Latent Tuberculosis; Middle Aged; Retrospective Studies; Rifampin; United States | 2021 |
Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Rifampin; United States | 2020 |
Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Genotype; Humans; Infant; Isoniazid; Laboratories; Levofloxacin; Male; Microbial Sensitivity Tests; Pakistan; Phenotype; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Edible marine algae: a new source for anti-mycobacterial agents.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Drug Synergism; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Plant Extracts; Rifampin; Seaweed; Ulva | 2021 |
Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Humans; Incidence; Isoniazid; Retrospective Studies; Rifampin; Risk Factors | 2022 |
Hemophagocytic syndrome associated with Mycobacterium bovis in a patient with X-SCID: a case report.
Topics: Antibiotics, Antitubercular; High-Throughput Nucleotide Sequencing; Humans; Infant; Interleukin Receptor Common gamma Subunit; Isoniazid; Lymphohistiocytosis, Hemophagocytic; Male; Mutation; Mycobacterium bovis; Mycobacterium tuberculosis; Patient Discharge; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; X-Linked Combined Immunodeficiency Diseases | 2020 |
Tuberculosis drug resistance in Canakkale, Turkey.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Turkey | 2020 |
Intravesical BCG instillation as a possible cause of acute and chronic kidney injury.
Topics: Acute Kidney Injury; Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Ethambutol; Humans; Isoniazid; Kidney; Male; Nephritis; Renal Insufficiency, Chronic; Rifampin; Treatment Outcome; Urinary Bladder Neoplasms | 2021 |
Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Genetic Variation; Humans; India; Isoniazid; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Pathology, Molecular; Rifampin; Tertiary Care Centers; Tuberculosis, Meningeal | 2020 |
Tuberculous Spondylodiscitis after Lumbar Microdiscectomy.
Topics: Discitis; Diskectomy; Humans; Interferon-gamma Release Tests; Isoniazid; Male; Rifampin; Tuberculin Test; Tuberculosis | 2020 |
About three cases of Mycobacterium bovis bone and joint infections after BCG therapy.
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Arthritis, Infectious; BCG Vaccine; Ethambutol; Fatal Outcome; Humans; Isoniazid; Male; Mycobacterium bovis; Mycobacterium Infections; Rifampin; Treatment Outcome; Urinary Bladder Neoplasms | 2021 |
Miliary tuberculosis secondary to intravesical instillation of Bacillus Calmette-Guérin. Report of two cases.
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium bovis; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Miliary; Urinary Bladder Neoplasms | 2021 |
Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda.
Topics: Anti-HIV Agents; Antitubercular Agents; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Male; Quality-Adjusted Life Years; Rifampin; Tuberculosis; Uganda | 2020 |
Lipid peroxidation aggravates anti-tuberculosis drug-induced liver injury: Evidence of ferroptosis induction.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug Therapy, Combination; Ferroptosis; Glutathione; Humans; Iron; Isoniazid; Lipid Peroxidation; Liver; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Reactive Oxygen Species; Rifampin | 2020 |
Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population.
Topics: Administration, Oral; Adult; Antitubercular Agents; China; Drug Administration Schedule; Eating; Ethambutol; Fasting; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
Tuberculosis in the intensive care unit: alternative treatment regimens and association with mortality.
Topics: Adult; Amikacin; Antibiotics, Antitubercular; APACHE; Brazil; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Intensive Care Units; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 2021 |
Hypersensitivity Myocarditis Due to Antitubercular Drugs in Children.
Topics: Adolescent; Antitubercular Agents; Child; Drug Hypersensitivity; Female; Humans; Isoniazid; Male; Myocarditis; Retrospective Studies; Rifampin | 2020 |
Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Reinfection; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2021 |
Genetic diversity of the Mycobacterium tuberculosis complex strains from newly diagnosed tuberculosis patients in Northwest Ethiopia reveals a predominance of East-African-Indian and Euro-American lineages.
Topics: Adult; Africa, Eastern; Americas; Animals; Drug Resistance, Bacterial; Ethiopia; Female; Genetic Variation; Genotype; Humans; India; Isoniazid; Jupiter; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary; Young Adult | 2021 |
Quantification of pyrazinamide, isoniazid, acetyl-isoniazid, and rifampicin by a high-performance liquid chromatography method in human plasma from patients with tuberculosis.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; Isoniazid; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrazinamide; Quality Control; Rifampin; Tuberculosis | 2021 |
Treatment outcomes and factors associated with unfavourable outcome among previously treated tuberculosis patients with isoniazid resistance in four regions of Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cameroon; Child; Child, Preschool; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2020 |
Bacillus Calmette-GuÉrin-Associated Cervical Spondylitis in a 3-Year-Old Immunocompetent Girl.
Topics: Abscess; Antitubercular Agents; BCG Vaccine; Cervical Vertebrae; Child, Preschool; Female; Humans; Immunocompetence; Isoniazid; Mycobacterium bovis; Osteomyelitis; Rifampin; Spondylitis; Tuberculosis | 2020 |
Impact of Age on Outcome of Rifapentine-Based Weekly Therapy for Latent Tuberculosis Infection.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Middle Aged; Rifampin | 2021 |
Safety of secukinumab in psoriasis patients with latent tuberculosis infection.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Contraindications, Drug; Dermatologic Agents; Female; Humans; Interleukin-17; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Psoriasis; Rifampin | 2020 |
Dual antitubercular drug loaded liposomes for macrophage targeting: development, characterisation,
Topics: Animals; Antitubercular Agents; Cell Line; Drug Delivery Systems; Humans; Isoniazid; Liposomes; Macrophages, Alveolar; Mice, Inbred BALB C; Mycobacterium tuberculosis; Rifampin; Tissue Distribution; Tuberculosis | 2021 |
Point-of-Care Ultrasound Image of Intra-Abdominal Lymphadenopathy in Tuberculosis.
Topics: Abdomen; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Lymphadenopathy; Mycobacterium tuberculosis; Point-of-Care Systems; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Ultrasonography; Young Adult | 2020 |
Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment.
Topics: Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Drug Resistance, Bacterial; Humans; Isoniazid; Latent Tuberculosis; Macrophages; Mesenchymal Stem Cells; Mycobacterium tuberculosis; Rifampin | 2021 |
Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Rifampin; Tuberculosis | 2021 |
BCG lymphadenitis: a potential complication of immune reconstitution following haematopoietic stem cell transplant.
Topics: BCG Vaccine; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Immune Reconstitution; Infant, Newborn; Isoniazid; Lymphadenitis; Male; Rifampin | 2022 |
A successful introduction to a non-expert setting of the thin-layer agar Colour Test as an indirect phenotypic drug susceptibility test for Mycobacterium tuberculosis.
Topics: Agar; Antitubercular Agents; Color; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Observer Variation; Rifampin; Sensitivity and Specificity | 2021 |
Ameliorative potential of Adhatoda vasica against anti-tubercular drugs induced hepatic impairments in female Wistar rats in relation to oxidative stress and xeno-metabolism.
Topics: Alkaloids; Animals; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injury; Cholesterol 7-alpha-Hydroxylase; Cytochrome P-450 CYP2E1; Disease Models, Animal; Female; Free Radical Scavengers; Gene Expression Regulation; Glucuronosyltransferase; Isoniazid; Justicia; Oxidative Stress; Plant Extracts; Plant Leaves; Pregnane X Receptor; Pyrazinamide; Quinazolines; Rats, Wistar; Rifampin | 2021 |
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan.
Topics: Antibiotics, Antitubercular; Capreomycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Uzbekistan | 2021 |
Detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary samples with the FluoroType MTBDR assay.
Topics: Antitubercular Agents; Bacterial Proteins; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis | 2021 |
The Outcome of Accidental Bacille Calmette-Guérin Overdose During Routine Neonatal Immunization.
Topics: Accidents; Anti-Bacterial Agents; BCG Vaccine; Drug-Related Side Effects and Adverse Reactions; Humans; Infant, Newborn; Isoniazid; Retrospective Studies; Rifampin; Tuberculosis; Vaccination | 2021 |
Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
Topics: Acetyltransferases; Adult; Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Multivariate Analysis; Mutation; Mutation Rate; Mycobacterium tuberculosis; Odds Ratio; Ofloxacin; Prospective Studies; Rifampin; Sequence Analysis, DNA; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2021 |
Three-dimensional low shear culture of Mycobacterium bovis BCG induces biofilm formation and antimicrobial drug tolerance.
Topics: Antitubercular Agents; Bacterial Proteins; Bacteriological Techniques; Biofilms; Culture Media; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Isoniazid; Mycobacterium bovis; Phenotype; Rifampin; Sigma Factor; Streptomycin; Virulence Factors | 2021 |
Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda.
Topics: Adult; Decision Making; Directly Observed Therapy; Female; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Patient Preference; Random Allocation; Rifampin; Self Administration; Self Efficacy; Uganda | 2021 |
A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Ethambutol; Female; Humans; Isoniazid; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Tuberculosis | 2021 |
Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity.
Topics: Antibiotics, Antitubercular; Antimicrobial Peptides; Cells, Cultured; Cholecalciferol; Humans; Immunomodulating Agents; Isoniazid; Macrophages; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2021 |
Quercetin modulates NRF2 and NF-κB/TLR-4 pathways to protect against isoniazid- and rifampicin-induced hepatotoxicity in vivo.
Topics: Animals; Catalase; Chemical and Drug Induced Liver Injury; Interferon-gamma; Isoniazid; Liver; Male; NF-E2-Related Factor 2; NF-kappa B; Quercetin; Rats; Rats, Wistar; Rifampin; Toll-Like Receptor 4 | 2021 |
Evaluation of the effects of isoniazid and rifampin on the structure and activity of pepsin enzyme by multi spectroscopy and molecular modeling methods.
Topics: Animals; Isoniazid; Molecular Docking Simulation; Pepsin A; Protein Binding; Rifampin | 2021 |
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial.
Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Feasibility Studies; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2021 |
Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes.
Topics: Animals; Antitubercular Agents; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunohistochemistry; Inflammasomes; Isoniazid; Liver; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Rifampin | 2021 |
Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis.
Topics: Animals; Biofilms; Cellulase; Cellulose; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Isoniazid; Mice; Mice, Inbred C57BL; Mycobacterium abscessus; Mycobacterium avium; Mycobacterium fortuitum; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 2021 |
Phenotypic and genotypic drug sensitivity profiles of Mycobacterium tuberculosis infection and associated factors in northeastern Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethiopia; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Phenotype; Reagent Kits, Diagnostic; Rifampin; Tuberculosis; Young Adult | 2021 |
Drug-resistant TB prevalence study in 5 health institutions in Haiti.
Topics: Adult; Antitubercular Agents; Coinfection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Haiti; HIV Infections; Humans; Isoniazid; Male; Mass Screening; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2021 |
Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Duration of Therapy; Female; Humans; Isoniazid; Male; Pakistan; Prospective Studies; Rifampin; Treatment Adherence and Compliance; Tuberculosis; Young Adult | 2021 |
[Treatment outcome of latent tuberculosis infection in persons with fibrotic pulmonary lesions].
Topics: Aged; Antitubercular Agents; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Rifampin; Treatment Outcome | 2021 |
Gallic acid attenuates isoniazid and rifampicin-induced liver injury by improving hepatic redox homeostasis through influence on Nrf2 and NF-κB signalling cascades in Wistar Rats.
Topics: Animals; Antibiotics, Antitubercular; Chemical and Drug Induced Liver Injury; Gallic Acid; Isoniazid; Liver Function Tests; NF-E2-Related Factor 2; NF-kappa B; Oxidation-Reduction; Protective Agents; Rats; Rats, Wistar; Rifampin; Signal Transduction; Toll-Like Receptor 4 | 2021 |
Therapeutic drug monitoring of intravenous anti-tuberculous therapy: management of an 8-month-old child with tuberculous meningitis.
Topics: Antitubercular Agents; Drug Monitoring; Female; Humans; Infant; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Meningeal | 2021 |
Sputum microbiota as a potential diagnostic marker for multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; DNA, Bacterial; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Microbiota; Middle Aged; Mycobacterium tuberculosis; Rifampin; RNA, Ribosomal, 16S; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2021 |
Five-year microevolution of a multidrug-resistant Mycobacterium tuberculosis strain within a patient with inadequate compliance to treatment.
Topics: Adult; Antitubercular Agents; Argentina; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Medication Adherence; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phylogeny; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Whole Genome Sequencing | 2021 |
Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis | 2021 |
Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014-2018.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Uganda; Young Adult | 2021 |
Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting.
Topics: Antitubercular Agents; Canada; Cost-Benefit Analysis; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2021 |
Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosis.
Topics: Aminoquinolines; Drug Repositioning; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rifampin | 2021 |
The protective effect of lycopene against oxidative kidney damage associated with combined use of isoniazid and rifampicin in rats.
Topics: Animals; Antioxidants; Carotenoids; Isoniazid; Kidney; Lycopene; Male; Oxidative Stress; Rats; Rifampin | 2021 |
Drug Resistance of Mouse Somatic Cells to Rifampicin in Experimental Tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Resistance; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2021 |
Isoniazid-induced Immune Thrombocytopenia.
Topics: Aged; Humans; Isoniazid; Male; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Rifampin; Thrombocytopenia | 2021 |
Bioenergetic Heterogeneity in Mycobacterium tuberculosis Residing in Different Subcellular Niches.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Antibiotics, Antitubercular; Autophagosomes; Energy Metabolism; Humans; Isoniazid; Macrophages; Mycobacterium tuberculosis; Phagosomes; Rifampin; Stress, Physiological | 2021 |
A high-throughput screening assay based on automated microscopy for monitoring antibiotic susceptibility of Mycobacterium tuberculosis phenotypes.
Topics: Antitubercular Agents; Automation; High-Throughput Screening Assays; Humans; Isoniazid; Linezolid; Microbial Sensitivity Tests; Microscopy; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis | 2021 |
A decade of drug-resistant tuberculous meningitis: A wake-up call for patient-centric therapy.
Topics: Antitubercular Agents; Fluoroquinolones; Humans; Isoniazid; Mycobacterium tuberculosis; Patient-Centered Care; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant | 2021 |
TB or not TB? Definitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Bacterial Typing Techniques; Cross-Sectional Studies; Female; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Species Specificity; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant | 2021 |
Early and Midterm Outcomes of Endovascular Repair of Tuberculous Infected Native (Mycotic) Aortic Aneurysms.
Topics: Aged; Antitubercular Agents; Aortic Aneurysm; Blood Vessel Prosthesis; Drug-Eluting Stents; Endovascular Procedures; Female; Humans; Isoniazid; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Rifampin; Survival Rate; Treatment Outcome; Tuberculosis | 2021 |
High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; China; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Isoniazid; Latent Tuberculosis; Male; Medication Adherence; Rifampin | 2021 |
A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis Treatment.
Topics: Alkynes; Anti-Retroviral Agents; Antitubercular Agents; Benzoxazines; Contraceptive Agents, Hormonal; Contraceptive Effectiveness; Cyclopropanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Isoniazid; Lopinavir; Medroxyprogesterone Acetate; Nelfinavir; Rifampin; Ritonavir; Tuberculosis | 2021 |
Molecular epidemiology and drug-resistance of tuberculosis in Luodian revealed by whole genome sequencing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Drug Resistance, Bacterial; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Molecular Epidemiology; Phylogeny; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Whole Genome Sequencing; Young Adult | 2021 |
Hepatoprotective activity of melittin on isoniazid- and rifampicin-induced liver injuries in male albino rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Blood Proteins; Chemical and Drug Induced Liver Injury; Glutathione; Isoniazid; Liver; Male; Malondialdehyde; Melitten; Protective Agents; Rats; Rifampin | 2021 |
Characterization of genetic diversity and clonal complexes by whole genome sequencing of Mycobacterium tuberculosis isolates from Jalisco, Mexico.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Phenotype; Phylogeny; Rifampin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing; Young Adult | 2021 |
Distribution and antibiotic sensitivity pattern of Mycobacterium tuberculosis isolates from children, enrolled in a tertiary care hospital.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pakistan; Rifampin; Streptomycin; Tertiary Care Centers; Tuberculosis, Pulmonary | 2021 |
Genomic-based surveillance reveals high ongoing transmission of multi-drug-resistant Mycobacterium tuberculosis in Southern Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Proteins; Brazil; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Gene Expression Profiling; Genome, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing; Young Adult | 2021 |
Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting.
Topics: Adult; Child; Contact Tracing; HIV Infections; Humans; Isoniazid; Levonorgestrel; Rifampin; Tuberculosis | 2022 |
A novel agar base medium for drug susceptibility testing of
Topics: Agar; Antitubercular Agents; Culture Media; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 2021 |
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis; World Health Organization | 2022 |
Transmission patterns of rifampicin resistant Mycobacterium tuberculosis complex strains in Cameroon: a genomic epidemiological study.
Topics: Adult; Antitubercular Agents; Cameroon; Epidemiologic Studies; Genomics; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2021 |
Evaluation of Multidrug Resistant Loop-mediated Isothermal Amplification Assay for Detecting the Drug Resistance of
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Isoniazid; Molecular Diagnostic Techniques; Mutation; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Oxidoreductases; Phenotype; Rifampin; Whole Genome Sequencing | 2021 |
Instant hydrogelation encapsulates drugs onto implants intraoperatively against osteoarticular tuberculosis.
Topics: Animals; Antitubercular Agents; Biocompatible Materials; Calcium Phosphates; Cell Line; Cell Survival; Chitosan; Disease Models, Animal; Drug Carriers; Drug Liberation; Femur; Glycerophosphates; Hydrogels; Isoniazid; Mice; Mycobacterium tuberculosis; Porosity; Prostheses and Implants; Rifampin; Tuberculosis, Osteoarticular | 2021 |
Early phase of effective treatment induces distinct transcriptional changes in Mycobacterium tuberculosis expelled by pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Transcriptome; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2021 |
Analysis of the application of a gene chip method for detecting Mycobacterium tuberculosis drug resistance in clinical specimens: a retrospective study.
Topics: Antibiotics, Antitubercular; Bacterial Proteins; Catalase; Codon; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidoreductases; Retrospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2021 |
Images in Clinical Tropical Medicine.
Topics: Adolescent; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Knee; Lupus Vulgaris; Male; Pyrazinamide; Rifampin | 2021 |
Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria.
Topics: Colony Count, Microbial; Flow Cytometry; Humans; Immunologic Tests; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2021 |
Treatment of spinal tuberculosis in rabbits using bovine serum albumin nanoparticles loaded with isoniazid and rifampicin.
Topics: Animals; Antibiotics, Antitubercular; Delayed-Action Preparations; Disease Models, Animal; Isoniazid; Nanoparticles; Rabbits; Rifampin; Serum Albumin, Bovine; Tuberculosis, Spinal | 2022 |
Diagnostic performance of the Abbott RealTime MTB assay for tuberculosis diagnosis in people living with HIV.
Topics: Adult; DNA, Bacterial; Drug Resistance, Bacterial; Female; HIV Infections; Humans; Isoniazid; Male; Mozambique; Mycobacterium tuberculosis; Prospective Studies; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis; Young Adult | 2021 |
Application of loop-mediated isothermal amplification and next-generation sequencing in the diagnosis of maternal tuberculosis with multiple negative tests: A case report.
Topics: Adult; Antibiotics, Antitubercular; Female; High-Throughput Nucleotide Sequencing; Humans; Infant, Newborn; Isoniazid; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Rifampin; Tuberculosis, Pulmonary | 2021 |
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Isoniazid; Latent Tuberculosis; Mice; Rifampin | 2021 |
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.
Topics: Adult; Amikacin; Australia; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
Topics: Adult; Antitubercular Agents; Child; Drug Combinations; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tablets; Tuberculosis | 2022 |
No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients.
Topics: Adult; Antitubercular Agents; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Monitoring; Humans; Infant; Isoniazid; Rifampin; Tuberculosis | 2021 |
LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Plasma; Pyrazinamide; Rifampin; Tandem Mass Spectrometry; Tuberculosis | 2021 |
Safety of latent tuberculosis infection treatment in older patients with immune-mediated inflammatory diseases.
Topics: Aged; Antitubercular Agents; Female; Humans; Isoniazid; Latent Tuberculosis; Middle Aged; Retrospective Studies; Rifampin; Tuberculosis | 2022 |
Evaluation of the performance of the BD MAX MDR-TB test in the diagnosis of
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2021 |
Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.
Topics: Abattoirs; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Isoniazid; Latent Tuberculosis; Leprostatic Agents; Leprosy, Borderline; Leprosy, Multibacillary; Male; Middle Aged; Prednisolone; Rifampin; Thrombophlebitis | 2021 |
Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda.
Topics: Adult; Aged; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Uganda | 2021 |
Bovine tuberculosis in Taiwan, 2008-2019.
Topics: Animals; Cattle; Cattle Diseases; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Taiwan; Tuberculosis, Bovine | 2022 |
Evaluation of Berberine as an Adjunct to TB Treatment.
Topics: Animals; Antitubercular Agents; Berberine; Cytokines; Dendritic Cells; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Isoniazid; Lung; Macrophages; Male; Mice, Inbred C3H; Mice, Inbred C57BL; Mycobacterium tuberculosis; Neutrophils; Rifampin; Spleen; Tuberculosis, Pulmonary | 2021 |
A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, Using Targeted Isothermal Amplification and Nanopore Sequencing.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Genotype; Humans; Isoniazid; Mycobacterium tuberculosis; Nanopore Sequencing; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant; Workflow | 2021 |
Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide.
Topics: Adenine; Alanine; Amides; Anti-HIV Agents; Emtricitabine; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Piperazines; Pyridones; Rifampin; Tenofovir | 2021 |
Tuberculosis Infection in Children and Adolescents: Testing and Treatment.
Topics: Adolescent; Age Factors; Antitubercular Agents; BCG Vaccine; Child; Child, Preschool; Cross Reactions; False Positive Reactions; Humans; Immunocompromised Host; Infant; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Mycobacterium bovis; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Sensitivity and Specificity; Tuberculin Test | 2021 |
Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis.
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2021 |
Drug-Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection.
Topics: Antitubercular Agents; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2022 |
Genomic signatures of pre-resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Genomics; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phylogeny; Rifampin; Tuberculosis | 2021 |
Multidrug-Resistant Tuberculosis in U.S.-Bound Immigrants and Refugees.
Topics: Antitubercular Agents; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Refugees; Rifampin; Tuberculosis, Multidrug-Resistant; United States | 2022 |
Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy.
Topics: Antitubercular Agents; Decision Support Techniques; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2022 |
Estimating tuberculosis drug resistance amplification rates in high-burden settings.
Topics: Antitubercular Agents; Drug Resistance; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series design.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Humans; Interrupted Time Series Analysis; Isoniazid; Latent Tuberculosis; Rifampin | 2022 |
Effects of Solanum lycopersicum L. (tomato) against isoniazid and rifampicin induced hepatotoxicity in wistar albino rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Isoniazid; Plant Extracts; Rats; Rats, Wistar; Rifampin; Solanum lycopersicum | 2022 |
Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022.
Topics: Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoniazid; Moxifloxacin; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis, Pulmonary; United States | 2022 |
Evaluation of a Molecular Test for Detection of Mycobacterium tuberculosis Isolates Resistant to Rifampicin and Isoniazid.
Topics: Antitubercular Agents; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2022 |
Time to start of tuberculosis treatment in penitentiary system of Kyrgyz Republic: A retrospective cohort study.
Topics: Humans; Isoniazid; Kyrgyzstan; Mycobacterium tuberculosis; Prisons; Retrospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Use of Whole-Genome Sequencing to Predict
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Bacillus; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 2022 |
Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro.
Topics: Animals; Antitubercular Agents; Clofazimine; Ethambutol; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Differential expression of the Mycobacterium tuberculosis heat shock protein genes in response to drug-induced stress.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Endopeptidase Clp; Heat-Shock Proteins; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Clinical evaluation of the cobas® MTB-RIF/INH reagent and the cobas® 6800 for the detection of isoniazid and rifampicin resistance.
Topics: Humans; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2022 |
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection.
Topics: Antibodies, Monoclonal, Humanized; Humans; Isoniazid; Latent Tuberculosis; Psoriasis; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis | 2022 |
Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2022 |
Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review.
Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Uganda; Young Adult | 2022 |
Mycobacterium tuberculosis Lineages Associated with Mutations and Drug Resistance in Isolates from India.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phylogeny; Retrospective Studies; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Development, validation and clinical use of a LC-MS/MS method for the simultaneous determination of the nine main antituberculosis drugs in human plasma.
Topics: Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Humans; Isoniazid; Rifampin; Tandem Mass Spectrometry | 2022 |
Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System.
Topics: Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoniazid; Pyrazinamide; Republic of Korea; Rifampin | 2022 |
Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020.
Topics: Antitubercular Agents; Czech Republic; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phylogeny; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2022 |
Trends in rifampicin and isoniazid resistance in patients with presumptive TB.
Topics: Antitubercular Agents; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS.
Topics: Amikacin; Antitubercular Agents; China; Drug Resistance; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nucleotides; Ofloxacin; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node | 2022 |
Primary psoas tuberculosis abscess with an iliac bone lytic lesion: a case report.
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Psoas Abscess; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Latent Tuberculosis Cascade of Care Among Healthcare Workers: A Nationwide Cohort Analysis in Korea Between 2017 and 2018.
Topics: Adult; Antitubercular Agents; Cohort Studies; Health Personnel; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2022 |
High mortality among patients hospitalized for drug-resistant tuberculosis with acquired second-line drug resistance and high HIV prevalence.
Topics: Adult; Antitubercular Agents; Drug Resistance; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Prevalence; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Intelligence Classification Algorithm-Based Drug-Resistant Pulmonary Tuberculosis Computed Tomography Imaging Features and Influencing Factors.
Topics: Adult; Algorithms; Antitubercular Agents; Humans; Intelligence; Isoniazid; Lung; Middle Aged; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Early line-probe assay using DNA specimens in patients with pulmonary TB.
Topics: DNA; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis.
Topics: Aminoglycosides; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifabutin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Enteropathogen spectrum and effect on antimycobacterial pharmacokinetics among children with tuberculosis in rural Tanzania: a prospective cohort study.
Topics: Antitubercular Agents; Child; Cohort Studies; Ethambutol; Female; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tanzania; Tuberculosis; United States | 2022 |
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.
Topics: Antitubercular Agents; Ethambutol; HIV Infections; Humans; Interferon-gamma; Isoniazid; Pyrazinamide; Rifampin; Stevens-Johnson Syndrome | 2022 |
Prevalence and Drug Resistance Pattern of
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Iraq; Isoniazid; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2022 |
High-Throughput Variant Detection Using a Color-Mixing Strategy.
Topics: Antitubercular Agents; Bacterial Proteins; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2022 |
A high content screening assay for discovery of antimycobacterial compounds based on primary human macrophages infected with virulent Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Macrophages; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Tuberculosis, Lymph Node | 2022 |
Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally.
Topics: Europe; Humans; Isoniazid; Rifampin; Tuberculosis | 2022 |
Diagnosing osteo-articular tuberculosis and multidrug resistance using real-time polymerase chain reaction and high-resolution melt-curve analysis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis | 2023 |
Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
The role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury.
Topics: Animals; Antitubercular Agents; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Ethambutol; Isoniazid; Liver; Pyrazinamide; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rifampin | 2022 |
How Flu-like Syndromes Contribute to Termination of Weekly Rifapentine-Based TB Preventive Therapy Is Still Poorly Predictable.
Topics: Humans; Isoniazid; Rifampin; Syndrome | 2022 |
Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Clinical Isolates from Sputum Samples by High-Resolution Melting Analysis.
Topics: Antitubercular Agents; Bacterial Proteins; Codon; Humans; Isoniazid; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2022 |
Isoniazid and rifapentine treatment effectively reduces persistent M. tuberculosis infection in macaque lungs.
Topics: Animals; Antitubercular Agents; Isoniazid; Latent Tuberculosis; Lung; Macaca mulatta; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Rifampin; Tuberculosis | 2022 |
Altered drug exposures of first-line TB drugs in a moxifloxacin-containing treatment regimen.
Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Isoniazid; Moxifloxacin; Pregnanes; Pyrazinamide; Rifampin; South Africa; Tuberculosis | 2022 |
Superior Efficacy of a TBI-166, Bedaquiline, and Pyrazinamide Combination Regimen in a Murine Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Clofazimine; Diarylquinolines; Disease Models, Animal; Isoniazid; Linezolid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing.
Topics: Alkynes; Anti-Retroviral Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Isoniazid; Nevirapine; Rifampin | 2022 |
Dual Rifampicin and Isoniazid Mannose-Decorated Lipopolysaccharide Nanospheres for Macrophage- Targeted Lung Delivery.
Topics: Humans; Isoniazid; Lipopolysaccharides; Macrophages; Mannose; Nanoparticles; Nanospheres; Rifampin; Tuberculosis | 2023 |
Determinants of stock-outs of first line anti-tuberculosis drugs: the case of public health facilities of Addis Ababa city administration health bureau, Addis Ababa, Ethiopia.
Topics: Antitubercular Agents; Ethiopia; Health Facilities; Humans; Isoniazid; Retrospective Studies; Rifampin; Tuberculosis | 2022 |
A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Community Health Services; Ethambutol; Humans; Internet; Isoniazid; Prevalence; Pyrazinamide; Rifampin; South Africa | 2022 |
Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study.
Topics: Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Evaluation of the MolecuTech
Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Use of 3HP for TB preventive treatment in prisons.
Topics: Antitubercular Agents; Humans; Isoniazid; Prisons; Rifampin; Tuberculosis | 2022 |
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Molecular Characterization of Mutations in Isoniazid- and Rifampicin-Resistant Mycobacterium tuberculosis Isolated in Thailand.
Topics: Antitubercular Agents; Bacterial Proteins; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Thailand; Tuberculosis, Multidrug-Resistant | 2023 |
Effects of Enzyme Induction and Polymorphism on the Pharmacokinetics of Isoniazid and Rifampin in Tuberculosis/HIV Patients.
Topics: Antitubercular Agents; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Enzyme Induction; HIV Infections; Humans; Isoniazid; Rifampin; Tandem Mass Spectrometry; Tuberculosis | 2022 |
Hepatoprotective Effects of Phloridzin against Isoniazid-Rifampicin Induced Liver Injury by Regulating CYP450 and Nrf2/HO-1 Pathway in Mice.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Heme Oxygenase-1; Isoniazid; Liver; Mice; NF-E2-Related Factor 2; Oxidative Stress; Phlorhizin; Rifampin | 2022 |
The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tanzania; Tuberculosis, Multidrug-Resistant | 2022 |
Dimethyl fumarate eliminates differentially culturable
Topics: Animals; Antitubercular Agents; Dimethyl Fumarate; Disease Models, Animal; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 2022 |
Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
Topics: Ethiopia; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifabutin; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Exploration of the underlying mechanisms of isoniazid/rifampicin-induced liver injury in mice using an integrated proteomics and metabolomics approach.
Topics: Animals; Chemical and Drug Induced Liver Injury; Fatty Liver; Inflammation; Isoniazid; Liver; Male; Mice; Proteomics; Rifampin | 2022 |
Tuberculosis: Common Questions and Answers.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Latent Tuberculosis; Pyrazinamide; Rifampin; Tuberculin; Tuberculosis; United States | 2022 |
Pyrazinamide resistance in rifampicin discordant tuberculosis.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifabutin; Rifampin; South Africa; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
RNase HI Depletion Strongly Potentiates Cell Killing by Rifampicin in Mycobacteria.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cell Death; Humans; Isoniazid; Moxifloxacin; Mycobacterium Infections; Mycobacterium tuberculosis; Rifampin; RNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Chronic purulent pericarditis: case report.
Topics: Adult; COVID-19; Ethambutol; Humans; Isoniazid; Male; Mediastinitis; Pericarditis; Pericardium; Pyrazinamide; Rifampin; Sclerosis; Suppuration | 2022 |
Sex Differences in TB Clinical Presentation, Drug Exposure, and Treatment Outcomes in India.
Topics: Antitubercular Agents; Female; Humans; India; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Sex Characteristics; Treatment Outcome | 2023 |
Distribution and Pattern of Anti-Tubercular Drug Resistance in Patients with Pulmonary Tuberculosis in Mymensingh Region of Bangladesh.
Topics: Antitubercular Agents; Bangladesh; Cross-Sectional Studies; Drug Resistance; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment.
Topics: Anti-Bacterial Agents; Antitubercular Agents; China; Ethambutol; Humans; Isoniazid; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium kansasii; Retrospective Studies; Rifampin; Tuberculosis | 2023 |
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Cutaneous Fistula; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Male; Meropenem; Micafungin; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rifampin; Streptomycin; Teicoplanin; Tetrazoles; Tuberculosis | 2022 |
A facile one-step jet-milling approach for the preparation of proliposomal dry powder for inhalation as effective delivery system for anti-TB therapeutics.
Topics: Administration, Inhalation; Aerosols; Dry Powder Inhalers; Humans; Isoniazid; Liposomes; Particle Size; Powders; Rifampin; Tuberculosis | 2022 |
Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milk.
Topics: Antitubercular Agents; Chromatography, Liquid; Ethambutol; Female; Humans; Isoniazid; Milk, Human; Pyrazinamide; Rifabutin; Rifampin; Tandem Mass Spectrometry | 2022 |
Anti-Mycobacterial Activity of Flavonoid and Pyrimidine Compounds.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Drug Combinations; Flavonoids; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Pyrimidines; Rifampin; Tuberculosis | 2022 |
Feasibility, Ease-of-Use, and Operational Characteristics of World Health Organization-Recommended Moderate-Complexity Automated Nucleic Acid Amplification Tests for the Detection of Tuberculosis and Resistance to Rifampicin and Isoniazid.
Topics: Feasibility Studies; Humans; Isoniazid; Mycobacterium tuberculosis; Nucleic Acid Amplification Techniques; Rifampin; Sensitivity and Specificity; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 2023 |
First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Kuwait; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phylogeny; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Whole-genome sequencing of presumptive MDR-TB isolates from a tertiary healthcare setting in Mumbai.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tertiary Healthcare; Tuberculosis, Multidrug-Resistant | 2022 |
In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Genotype; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; World Health Organization | 2022 |
Topics: Ethambutol; Genotype; Humans; Isoniazid; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Rifampin; Timor-Leste | 2022 |
Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis.
Topics: Antitubercular Agents; Chromatography, Liquid; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Substandard Drugs; Tablets; Tuberculosis | 2022 |
[An atypical presentation of tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis.
Topics: Adult; Antitubercular Agents; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Integration of metabolomics and proteomics analysis to explore the mechanism of neurotoxicity induced by receipt of isoniazid and rifampicin in mice.
Topics: Animals; Isoniazid; Lipids; Male; Mice; Peroxisome Proliferator-Activated Receptors; Proteomics; Rifampin | 2023 |
Preparation, characterization, and in-vitro cytotoxicity of nanoliposomes loaded with anti-tubercular drugs and TGF-β1 siRNA for improving spinal tuberculosis therapy.
Topics: Antitubercular Agents; Humans; Isoniazid; Pharmaceutical Preparations; Rifampin; RNA, Small Interfering; Transforming Growth Factor beta1; Tuberculosis, Spinal | 2022 |
Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations study.
Topics: Antitubercular Agents; Arylamine N-Acetyltransferase; Humans; Isoniazid; Liver-Specific Organic Anion Transporter 1; Mycobacterium tuberculosis; Pharmacogenetics; Probability; Prospective Studies; Rifampin; Tuberculosis, Meningeal | 2022 |
Naringenin protects hepato-renal tissues against antituberculosis drugs induced toxic manifestations by modulating interleukin-6, insulin like growth factor-1, biochemical and ultra-structural integrity.
Topics: Animals; Antioxidants; Antitubercular Agents; Cytochrome P-450 CYP2E1; Ethambutol; Insulin-Like Growth Factor I; Interleukin-6; Isoniazid; Liver; Oxidative Stress; Pyrazinamide; Rats; Rats, Wistar; Rifampin | 2023 |
[A clinical case of occupational cutaneous tuberculosis in the healthcare field].
Topics: Biopsy; Delivery of Health Care; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Rifampin | 2022 |
Pharmacobezoar after overdose of isoniazid and rifampin.
Topics: Adolescent; Drug Overdose; Gastric Lavage; Humans; Isoniazid; Rifampin; Stomach | 2023 |
Using the Food and Drug Administration´s Sentinel System for surveillance of TB infection.
Topics: Antitubercular Agents; Drug Prescriptions; Humans; Isoniazid; Rifampin; Tuberculosis; United States; United States Food and Drug Administration | 2022 |
Untargeted metabolomics of pulmonary tuberculosis patient serum reveals potential prognostic markers of both latent infection and outcome.
Topics: Chromatography, Liquid; Humans; Isoniazid; Latent Infection; Prognosis; Rifampin; Tandem Mass Spectrometry; Tuberculosis, Pulmonary | 2022 |
Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Genotype; Isoniazid; Mycobacterium tuberculosis; Rifampin | 2022 |
Tuberculosis treatment without rifampin in kidney/kidney-pancreas transplantation: A case series report.
Topics: Adult; Antitubercular Agents; Humans; Immunosuppressive Agents; Isoniazid; Kidney; Middle Aged; Pancreas Transplantation; Retrospective Studies; Rifampin; Tuberculosis | 2022 |
Effect of teriparatide on drug treatment of tuberculous spondylitis: an experimental study.
Topics: Antitubercular Agents; Chemokine CXCL10; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Teriparatide; Tuberculosis, Spinal | 2022 |
Evaluation Study of xMAP TIER Assay on a Microsphere-Based Platform for Detecting First-Line Anti-Tuberculosis Drug Resistance.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2022 |
Evaluation of Five User-Friendly Whole Genome Sequencing Software for
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Software; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2022 |
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Genomics; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Inhibition of mycobacteria proliferation in macrophages by low cisplatin concentration through phosphorylated p53-related apoptosis pathway.
Topics: Antitubercular Agents; Apoptosis; bcl-2-Associated X Protein; Butanones; Cell Proliferation; Cisplatin; Drug Resistance, Bacterial; Isoniazid; Macrophages; Mycobacterium smegmatis; Nitriles; Phosphatidylinositol 3-Kinases; Rifampin; Thiourea; Tumor Suppressor Protein p53 | 2023 |
Study of drug interaction, mutant frequency and mutant prevention concentration of DFMBT against Mycobacterium tuberculosis H37RV.
Topics: Antitubercular Agents; Drug Interactions; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2023 |
An efficient CRISPR interference-based prediction method for synergistic/additive effects of novel combinations of anti-tuberculosis drugs.
Topics: Antitubercular Agents; Clustered Regularly Interspaced Short Palindromic Repeats; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2022 |
A host blood transcriptional signature differentiates multi-drug/rifampin-resistant tuberculosis (MDR/RR-TB) from drug susceptible tuberculosis: a pilot study.
Topics: Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pilot Projects; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2023 |
Genomic Sequencing from Sputum for Tuberculosis Disease Diagnosis, Lineage Determination, and Drug Susceptibility Prediction.
Topics: Antitubercular Agents; Genomics; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Clinical impact of plasma concentrations of first-line antituberculosis drugs.
Topics: Adult; Antitubercular Agents; Humans; Isoniazid; Pyrazinamide; Rifampin; South Africa | 2023 |
The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability.
Topics: Animals; Antitubercular Agents; Biological Availability; Dysbiosis; Humans; Isoniazid; Mice; Moxifloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Children and TB pharmacokinetics: no longer in infancy?
Topics: Adolescent; Antitubercular Agents; Child; Humans; Infant; Isoniazid; Rifampin | 2023 |
Progress on diagnosis and treatment of latent tuberculosis infection.
Topics: Antitubercular Agents; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Rifampin | 2022 |
Rhus chinensis Mill. fruits alleviate liver injury induced by isoniazid and rifampicin through regulating oxidative stress, apoptosis, and bile acid transport.
Topics: Animals; Apoptosis; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Fruit; Isoniazid; Liver; Mice; Oxidative Stress; Rhus; Rifampin | 2023 |
An analytic feasibility study of the BD MAX™ MDR-TB assay for testing of non-sputum specimens for detection of the Mycobacterium tuberculosis complex (MTBC) and isoniazid (INH) and rifampin (RIF) resistance.
Topics: Antitubercular Agents; Feasibility Studies; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2023 |
Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes.
Topics: Antitubercular Agents; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Smoking; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2023 |
Variation in Treatment of Pediatric Tuberculosis Infection in Different Provider Settings.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Infant; Isoniazid; Latent Tuberculosis; Pediatrics; Rifampin; Tuberculosis | 2023 |
[Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination].
Topics: Antitubercular Agents; Bacterial Proteins; DNA, Complementary; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Verapamil | 2023 |
Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
Topics: Antitubercular Agents; Ethiopia; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2023 |
Toxin-antitoxin Genes Expression in Multidrug-resistant
Topics: Antitoxins; Antitubercular Agents; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2023 |
Epidemiology-based wastewater monitoring for ecological risks of anti-tuberculosis drugs mixture effects.
Topics: Antitubercular Agents; Ethambutol; Isoniazid; Rifampin; Wastewater | 2023 |
Asiatic acid ameliorates rifampicin- and isoniazid-induced liver injury in vivo by regulating sphingolipid metabolism and mitogen-activated protein kinase signalling pathways.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Inflammation; Isoniazid; Liver; Mice; Mitogen-Activated Protein Kinases; Rifampin | 2023 |
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Contraception, Postcoital; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Female; Genotype; HIV Infections; Humans; Isoniazid; Levonorgestrel; Pharmacogenetics; Rifampin; Tuberculosis | 2023 |
A physiologically-based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance.
Topics: Antitubercular Agents; Humans; Isoniazid; Prevalence; Rifampin; Tuberculosis | 2023 |
Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis.
Topics: Ethambutol; Fluoroquinolones; Humans; Isoniazid; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 2023 |
Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
Topics: Antitubercular Agents; Bayes Theorem; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ethambutol; Humans; Isoniazid; Reference Standards; Rifampin; Tandem Mass Spectrometry; Tuberculosis | 2023 |
[Analysis of Mycobacterium tuberculosis Complex Strains Isolated from the Samples of Patients Living in Northern Syria].
Topics: Aminoglycosides; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Syria; Tuberculosis, Multidrug-Resistant | 2023 |
The Effect of Bergenin on Isonicotinic Acid Hydrazide and Rifampicin-Induced Liver Injury Revealed by RNA Sequencing.
Topics: Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Isoniazid; Liver; Mice; NF-E2-Related Factor 2; Rifampin; Toll-Like Receptor 4 | 2023 |
[Recommendations for contact tracing for tuberculosis - update 2023].
Topics: Adult; Child; Contact Tracing; Humans; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis | 2023 |
Newer TB diagnostics: An update.
Topics: Antibiotics, Antitubercular; Drug Resistance, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Alternative dolutegravir dosing strategies with concurrent rifapentine utilized for latent tuberculosis treatment.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Middle Aged; Rifampin | 2023 |
Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen.
Topics: Antitubercular Agents; beta-Lactamase Inhibitors; Humans; Isoniazid; Linezolid; Meropenem; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2023 |
Clinical performance of nucleotide MALDI-TOF-MS in the rapid diagnosis of pulmonary tuberculosis and drug resistance.
Topics: Drug Resistance; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Nucleotides; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Pulmonary | 2023 |
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2023 |
Characterization of Mutations in Genes Related to Rifampicin and Isoniazid Resistance in Multidrug-resistant
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2023 |
Protein binding investigation of first-line and second-line antituberculosis drugs.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Moxifloxacin; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.
Topics: Amikacin; Antitubercular Agents; Humans; Isoniazid; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Verapamil | 2023 |
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2023 |
Molecular identification of multiple drug resistance (MDR) strain of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2023 |
[Recommendations for Contact Tracing for Tuberculosis - Update 2023].
Topics: Adult; Child; Contact Tracing; Germany; Humans; Isoniazid; Rifampin; Tuberculosis | 2023 |
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Lopinavir; Male; Pyrazinamide; Rifampin; Ritonavir; Tuberculosis | 2023 |
Direct Detection of Fluoroquinolone Resistance in Sputum Samples from Tuberculosis Patients by High Resolution Melt Curve Analysis.
Topics: Antitubercular Agents; Fluoroquinolones; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2023 |